<SEC-DOCUMENT>0001650664-23-000017.txt : 20231103
<SEC-HEADER>0001650664-23-000017.hdr.sgml : 20231103
<ACCEPTANCE-DATETIME>20231103160351
ACCESSION NUMBER:		0001650664-23-000017
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		67
CONFORMED PERIOD OF REPORT:	20230930
FILED AS OF DATE:		20231103
DATE AS OF CHANGE:		20231103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Editas Medicine, Inc.
		CENTRAL INDEX KEY:			0001650664
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				464097528
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37687
		FILM NUMBER:		231376254

	BUSINESS ADDRESS:	
		STREET 1:		11 HURLEY ST.
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
		BUSINESS PHONE:		617-401-9000

	MAIL ADDRESS:	
		STREET 1:		11 HURLEY ST.
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>edit-20230930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:604c5bfd-156b-497c-b087-a10c0e2b5278,g:6226a648-f95b-483f-af4b-56ce08cc4d95,d:334ff9925a614490b675b110f235ecb7--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:edit="http://www.editasmedicine.com/20230930" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>edit-20230930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-25">0001650664</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-26">December 31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-27">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-28">Q3</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-29">false</ix:nonNumeric><ix:nonNumeric contextRef="c-5" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="f-96">http://fasb.org/us-gaap/2023#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="f-97">http://fasb.org/us-gaap/2023#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="c-7" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="f-98">http://fasb.org/us-gaap/2023#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="f-99">http://fasb.org/us-gaap/2023#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="c-87" name="us-gaap:RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList" id="f-471">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-111" name="us-gaap:RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList" id="f-472">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-88" name="us-gaap:RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList" id="f-473">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-112" name="us-gaap:RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList" id="f-474">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="edit-20230930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">edit:FollowOn2023JuneOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">edit:AtMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">edit:AtMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>edit:security</xbrli:measure></xbrli:unit><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">edit:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">edit:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">edit:LicenseAndServiceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">edit:LicensorExpenseReimbursementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">edit:LicensorExpenseReimbursementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">edit:LicensorExpenseReimbursementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">edit:LicensorExpenseReimbursementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">edit:LindaCBurklyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">edit:LindaCBurklyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i334ff9925a614490b675b110f235ecb7_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:119%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">September&#160;30, 2023</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:119%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from ____________ to ________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-37687</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">EDITAS MEDICINE, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">46-4097528</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Identification No.)</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">11 Hurley Street</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Cambridge</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-11">Massachusetts</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">02141</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Zip Code)</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">617</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">401-9000</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:37.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.748%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock</ix:nonNumeric>, $0.0001 par value per share</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">EDIT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares of Common Stock outstanding as of October&#160;27, 2023 was <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">81,673,688</ix:nonFraction>. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i334ff9925a614490b675b110f235ecb7_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Editas Medicine, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_10">PART I. FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_10">3</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_13">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_16">Condensed Consolidated Balance Sheets</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_16"> </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_16">a</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_16">s of </a>September&#160;30, 2023<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_16"> and </a>December&#160;31, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_19">Condensed Consolidated Statements of Operations for the </a>three and nine<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_19"> months ended </a>September&#160;30, 2023<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_19"> and </a>2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_22">Condensed Consolidated Statements of Comprehensive Loss for the </a>three and nine<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_22"> months ended </a>September&#160;30, 2023<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_22"> and </a>2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_25">Condensed Consolidated Statements of Stockholders&#8217; Equity for the </a>three and nine<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_25"> months ended </a>September&#160;30, 2023<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_25"> and </a>2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_28">Condensed Consolidated Statements of Cash Flows for the </a>nine<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_28"> months ended </a>September&#160;30, 2023<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_28"> and </a>2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_31">Notes to Condensed Consolidated Financial Statements </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_31">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_67">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_67">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_67">14</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_88">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_88">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_88">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_91">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_91">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_91">26</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_94">PART II. OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_94">27</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_97">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_97">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_97">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_100">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_100">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_100">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_103">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_103">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_103">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_106">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_106">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_106">28</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_109">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i334ff9925a614490b675b110f235ecb7_109">29</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i334ff9925a614490b675b110f235ecb7_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div id="i334ff9925a614490b675b110f235ecb7_13"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements.</span></div><div id="i334ff9925a614490b675b110f235ecb7_16"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Editas Medicine, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(amounts in thousands, except share and per share data)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-30">82,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">141,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-32">267,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-33">202,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-34">2,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-35">5,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">6,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-37">7,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-38">358,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-39">356,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-40">96,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-41">93,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-42">11,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-43">15,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-44">31,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-45">43,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted cash and other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-46">5,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-47">5,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-48">504,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-49">514,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">10,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-51">9,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-52">30,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-53">31,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferred revenue, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-54">8,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-55">8,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-56">9,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">11,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">58,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-59">60,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-60">24,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">32,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferred revenue, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-62">60,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-63">60,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-64">144,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-65">153,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stockholders&#8217; equity </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-66"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-67">0.0001</ix:nonFraction></ix:nonFraction> par value per share: <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-68"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-69">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-70"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-71"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-72"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-73">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-76"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-77">0.0001</ix:nonFraction></ix:nonFraction> par value per share: <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-78"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-79">195,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-80"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-81">81,668,796</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-82"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-83">68,847,382</ix:nonFraction></ix:nonFraction> shares issued and outstanding at September&#160;30, 2023 and December&#160;31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-84">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-85">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-86">1,574,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-87">1,442,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-88">1,452</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-89">3,601</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-90">1,212,476</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-91">1,078,131</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total stockholders&#8217; equity </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-92">360,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-93">360,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total liabilities and stockholders&#8217; equity </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-94">504,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-95">514,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i334ff9925a614490b675b110f235ecb7_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Editas Medicine, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(amounts in thousands, except share and per share data)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-96"><span style="-sec-ix-hidden:f-97"><span style="-sec-ix-hidden:f-98"><span style="-sec-ix-hidden:f-99">Collaboration and other research and development revenues</span></span></span></span></span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-100">5,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-101">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-102">18,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-103">13,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-104">40,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-105">41,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-106">108,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-107">122,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-108">14,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-109">16,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-110">55,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-111">52,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-112">55,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-113">57,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-114">163,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-115">175,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-116">50,163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-117">57,520</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-118">145,219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-119">162,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-120">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-121">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-122">1,590</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-123">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="3" id="f-124">5,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="3" id="f-125">1,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="3" id="f-126">12,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="3" id="f-127">2,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-128">5,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-129">1,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-130">10,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-131">2,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-132">45,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-133">55,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-134">134,345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-135">159,694</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-136"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-137">0.55</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-138"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-139">0.81</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-140"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-141">1.81</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-142"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-143">2.33</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average common shares outstanding, basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-144"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-145">81,648,250</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-146"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-147">68,736,125</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-148"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-149">74,029,645</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-150"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-151">68,621,574</ix:nonFraction></ix:nonFraction></span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i334ff9925a614490b675b110f235ecb7_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Editas Medicine, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(amounts in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-152">45,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-153">55,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-154">134,345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-155">159,694</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gain (loss) on marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-156">833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-157">904</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-158">2,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-159">3,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-160">44,186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-161">56,630</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-162">132,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-163">163,492</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i334ff9925a614490b675b110f235ecb7_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Editas Medicine, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(amounts in thousands, except share data)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.573%"></td><td style="width:0.1%"></td></tr><tr style="height:31pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>(Loss) Gain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Other<br/>Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-164">68,847,382</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-165">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-166">1,442,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-167">3,601</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-168">1,078,131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-169">360,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vesting of restricted common stock awards</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-170">146,209</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="f-171">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-172">4,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-173">4,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unrealized gain on marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-174">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-175">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-176">49,036</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-177">49,036</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-178">68,993,591</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-179">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-180">1,446,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-181">2,279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-182">1,127,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-183">317,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock from public offering, net commissions, underwriting discounts and offering costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-184">12,500,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-185">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-186">117,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-187">117,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-188">3,122</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-189">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-190">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-191">5,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-192">5,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vesting of restricted common stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-193">64,492</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="f-194">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock under employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-195">55,704</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-196">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-197">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unrealized loss on marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-198">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-199">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-200">40,290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-201">40,290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-202">81,616,909</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-203">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-204">1,569,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-205">2,285</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-206">1,167,457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-207">399,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-208">4,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-209">4,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vesting of restricted common stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-210">51,887</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="f-211">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unrealized gain on marketable debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-212">833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-213">833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-214">45,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-215">45,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-216">81,668,796</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-217">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-218">1,574,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-219">1,452</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-220">1,212,476</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-221">360,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.573%"></td><td style="width:0.1%"></td></tr><tr style="height:31pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Other<br/>Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-40" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-222">68,435,257</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-223">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-224">1,411,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-225">493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-226">857,699</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-227">553,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-45" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-228">12,573</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-229">218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-230">218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vesting of restricted common stock awards</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-45" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-231">154,834</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="f-232">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-233">11,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-234">11,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unrealized loss on marketable debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-235">2,016</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-236">2,016</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-237">50,515</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-238">50,515</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-50" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-239">68,602,664</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-240">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-241">1,423,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-242">2,509</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-243">908,214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-244">512,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="f-245">20</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="f-246">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vesting of restricted common stock awards</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-247">77,884</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="f-248">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-249">6,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-250">6,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock under employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-251">37,866</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-252">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-253">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unrealized loss on marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-254">878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-255">878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-256">53,453</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-257">53,453</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-60" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-258">68,718,434</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-259">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-260">1,430,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-261">3,387</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-262">961,667</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-263">465,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-65" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-264">4,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-265">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-266">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vesting of restricted common stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-65" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-267">38,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="f-268">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-269">5,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-270">5,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unrealized loss on marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-271">904</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-272">904</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-273">55,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-274">55,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-69" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-275">68,761,729</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-276">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-277">1,436,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-278">4,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-279">1,017,393</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-280">414,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i334ff9925a614490b675b110f235ecb7_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Editas Medicine, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(amounts in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flow from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-281">134,345</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-282">159,694</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-283">14,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-284">23,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-285">4,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-286">4,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on disposal of fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="f-287">1,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="3" id="f-288">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net amortization of premiums and discounts on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="f-289">2,720</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="f-290">226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-291">2,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="f-292">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-293">771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-294">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="edit:IncreaseDecreaseInRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-295">11,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="edit:IncreaseDecreaseInRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-296">3,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="f-297">502</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="f-298">719</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-299">1,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-300">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="f-301">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="f-302">485</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:fixed-zero" scale="3" id="f-303">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-304">3,333</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-305">9,335</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-306">5,078</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-307">109,938</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-308">135,076</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flow from investing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-309">3,412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-310">3,494</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from the sale of equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfMachineryAndEquipment" format="ixt:fixed-zero" scale="3" id="f-311">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromSaleOfMachineryAndEquipment" scale="3" id="f-312">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-313">219,764</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-314">209,782</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from maturities of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-315">156,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-316">354,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-317">66,571</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-318">141,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flow from financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from offering of common stock, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-319">117,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-320">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-321">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-322">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockPlans" scale="3" id="f-323">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromStockPlans" scale="3" id="f-324">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-325">117,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="f-326">665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net (decrease) increase in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-327">58,984</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-328">7,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-329">145,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-330">207,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and restricted cash, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-331">86,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-332">214,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental disclosure of cash and non-cash activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed asset additions included in accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="f-333">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="f-334">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid in connection with operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-335">9,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-336">11,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets obtained in exchange of operating lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-337">1,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-338">4,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the condensed consolidated financial statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i334ff9925a614490b675b110f235ecb7_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Editas Medicine, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div id="i334ff9925a614490b675b110f235ecb7_34"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="c-1" name="us-gaap:NatureOfOperations" id="f-339" continuedAt="f-339-1" escape="true">Nature of Business</ix:nonNumeric></span></div><ix:continuation id="f-339-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Editas Medicine, Inc. (the &#8220;Company&#8221;) is a clinical stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The Company was incorporated in the state of Delaware in September 2013. Its principal offices are in Cambridge, Massachusetts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its inception, the Company has devoted substantially all of its efforts to business planning, research and development, recruiting management and technical staff, and raising capital. The Company has primarily financed its operations through various equity financings, payments received under a research collaboration with Juno Therapeutics, Inc., a wholly-owned subsidiary of the Bristol-Myers Squibb Company (&#8220;BMS&#8221;), and payments received under a strategic alliance and option agreement with Allergan Pharmaceuticals International Limited, which was terminated in August 2020. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks common to companies in the biotechnology industry, including but not limited to, risks of failure of preclinical studies and clinical trials, the need to obtain marketing approval for any drug product candidate that it may identify and develop, the need to successfully commercialize and gain market acceptance of its product candidates, dependence on key personnel, protection of proprietary technology, compliance with government regulations, development by competitors of technological innovations and ability to transition from pilot-scale manufacturing to large-scale production of products.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, the Company completed a public offering in which it sold <ix:nonFraction unitRef="shares" contextRef="c-74" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-340">12,500,000</ix:nonFraction> shares of its common stock and received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-341">117.1</ix:nonFraction> million after deducting underwriting discounts and commissions and other offering costs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company entered into a common stock sales agreement with Cowen and Company, LLC (&#8220;Cowen&#8221;), under which the Company from time to time can issue and sell shares of its common stock through Cowen in at-the-market offerings for aggregate gross sale proceeds of up to $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="edit:SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued" format="ixt:num-dot-decimal" scale="6" id="f-342">300.0</ix:nonFraction> million (the &#8220;ATM Facility&#8221;). As of September&#160;30, 2023, the Company has <ix:nonFraction unitRef="shares" contextRef="c-76" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="0" id="f-343">not</ix:nonFraction> sold any shares of its common stock under the ATM Facility. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred annual net operating losses in every year since its inception. The Company expects that its existing cash, cash equivalents and marketable securities at September&#160;30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> will enable it to fund its operating expenses and capital expenditure requirements into the third quarter of 2025. The Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-8" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="9" id="f-344">1.2</ix:nonFraction> billion at September&#160;30, 2023, and will require substantial additional capital to fund its operations. The Company has never generated any product revenue. There can be no assurance that the Company will be able to obtain additional debt or equity financing or generate product revenue or revenues from collaborative partners, on terms acceptable to the Company, on a timely basis or at all. The failure of the Company to obtain sufficient funds on acceptable terms when needed could have a material adverse effect on the Company&#8217;s business, results of operations, and financial condition.</span></div></ix:continuation><div id="i334ff9925a614490b675b110f235ecb7_37"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-345" continuedAt="f-345-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-345-1" continuedAt="f-345-2"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Interim Financial Information</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) have been condensed or omitted from this report, as is permitted by such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 (the &#8220;Annual Report&#8221;).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Editas Securities Corporation and Editas Medicine, LLC. All intercompany transactions and balances of the subsidiaries have been eliminated in consolidation. In the opinion of management, the information furnished reflects all adjustments, all of which are of a normal and recurring nature, necessary for a fair presentation of the results for the reported interim periods. The Company considers events or transactions that occur after the balance sheet date but before </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><ix:continuation id="f-345-2" continuedAt="f-345-3"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The three months ended September&#160;30, 2023 and 2022 are referred to as the third quarter of 2023 and 2022, respectively. The results of operations for interim periods are not necessarily indicative of results to be expected for the full year or any other interim period.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Significant Accounting Policies</span></div></ix:continuation><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-345-3">The Company&#8217;s significant accounting policies are described in Note 2, &#8220;Summary of Significant Accounting Policies,&#8221; to the consolidated financial statements included in the Annual Report. There have been no material changes to the significant accounting policies previously disclosed in the Annual Report.</ix:continuation> </span></div><div id="i334ff9925a614490b675b110f235ecb7_40"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="c-1" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="f-346" continuedAt="f-346-1" escape="true">Cash Equivalents and Marketable Securities </ix:nonNumeric></span></div><ix:continuation id="f-346-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" id="f-347" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents and marketable securities consisted of the following at September&#160;30, 2023 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents and marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-348">171,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="f-349">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-351">1,197</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-352">170,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasuries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-353">143,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="f-354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-355">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-356">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-357">143,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-358">82,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="f-359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-360">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-361">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-362">82,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-363">38,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="f-364">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-365">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-366">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-367">37,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-368">12,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="f-369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-370">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-371">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-372">12,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-373">447,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="f-374">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-375">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-376">1,474</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-377">446,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents and marketable securities consisted of the following at December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents and marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-378">161,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="f-379">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-380">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-381">2,556</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-382">159,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-383">141,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="f-384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-386">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-387">141,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-388">57,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="f-389">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-390">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-391">694</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-392">56,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasuries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-393">50,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="f-394">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-395">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-396">229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-397">49,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-398">29,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="f-399">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-400">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-401">141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-402">29,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-403">440,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="f-404">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-405">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-406">3,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-407">437,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, the Company did <ix:nonFraction unitRef="security" contextRef="c-3" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" format="ixt:fixed-zero" scale="0" id="f-408">not</ix:nonFraction> hold any marketable securities that had been in an unrealized loss position for more than twelve months. Furthermore, the Company has determined that there were no material changes in the credit risk of the securities. As of September&#160;30, 2023, the Company holds <ix:nonFraction unitRef="security" contextRef="c-3" decimals="INF" name="edit:MarketableSecuritiesNoncurrentNumberOfSecurities" scale="0" id="f-409">29</ix:nonFraction> securities with an aggregate fair value of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-410">96.8</ix:nonFraction> million that had remaining maturities greater than one year.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" format="ixt:fixed-zero" scale="0" id="f-411"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" format="ixt:fixed-zero" scale="0" id="f-412">no</ix:nonFraction></ix:nonFraction> realized gains or losses on available-for-sale securities during the nine months ended September&#160;30, 2023 or 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i334ff9925a614490b675b110f235ecb7_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-413" continuedAt="f-413-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="f-413-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-414" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets measured at fair value on a recurring basis as of September&#160;30, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-415">82,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-416">82,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-417">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-418">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-419">170,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-421">170,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-422">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-423">37,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-424">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-425">37,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-426">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-427">12,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-428">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-429">12,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-430">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasuries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-431">143,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-432">143,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-433">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and other non-current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-435">3,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-436">3,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="f-437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="f-438">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-439">450,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-440">229,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-441">220,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-442">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets measured at fair value on a recurring basis as of December&#160;31, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-443">141,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-444">141,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-445">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-446">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-447">159,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-448">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-449">159,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-450">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-451">56,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-452">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-453">56,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-454">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasuries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-455">49,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-456">49,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-457">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-458">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-459">29,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-460">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-461">29,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-462">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and other non-current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-463">3,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-464">3,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="f-465">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="f-466">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-467">441,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-468">195,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-469">246,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-470">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i334ff9925a614490b675b110f235ecb7_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="f-475" continuedAt="f-475-1" escape="true">Accrued Expenses</ix:nonNumeric></span></div><ix:continuation id="f-475-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-476" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">External research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="edit:AccruedExternalResearchAndDevelopmentExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-477">17,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="edit:AccruedExternalResearchAndDevelopmentExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-478">16,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-479">9,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-480">10,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property and patent related fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="edit:IntellectualPropertyAndPatentRelatedFees" format="ixt:num-dot-decimal" scale="3" id="f-481">1,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="edit:IntellectualPropertyAndPatentRelatedFees" format="ixt:num-dot-decimal" scale="3" id="f-482">1,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional service expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="f-483">943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-484">1,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-485">1,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-486">1,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-487">30,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-488">31,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i334ff9925a614490b675b110f235ecb7_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-489" continuedAt="f-489-1" escape="true">Property and Equipment, net</ix:nonNumeric></span></div><ix:continuation id="f-489-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-490" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-491">24,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-492">24,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-493">9,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-494">9,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computer equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-495">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-496">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-497">623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-498">1,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-499">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-500">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-501">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-502">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-503">36,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-504">37,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-505">25,006</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-506">21,526</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-507">11,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-508">15,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i334ff9925a614490b675b110f235ecb7_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-509" continuedAt="f-509-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-509-1"><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we entered into a license and service agreement pursuant to which we will lease manufacturing space for our continued research and development activities. As of September&#160;30, 2023, the lease has not commenced for accounting purposes and it is not expected to commence until the second quarter of 2024. The license and service agreement provides for total remaining lease payments of up to $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="f-510">87.8</ix:nonFraction> million over a <ix:nonNumeric contextRef="c-147" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-511">10-year</ix:nonNumeric> lease term. The Company may terminate the license and service agreement in its discretion upon twelve months' prior written notice.  </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to a number of license agreements under which the Company licenses patents, patent applications and other intellectual property from third parties. As such, the Company is obligated to pay licensors for various costs including upfront licenses fees, annual license fees, certain licensor expense reimbursements, success payments, research funding payments, and milestones triggerable upon certain development, regulatory, and commercial events as well as royalties on future products. These contracts are generally cancellable, with notice, at the Company&#8217;s option and do not have significant cancellation penalties. The terms and conditions as well as the accounting analysis for the Company&#8217;s significant commitments and contingencies are described in Note 8, &#8220;Commitments and Contingencies&#8221; to the consolidated financial statements included in the Annual Report. There have been no material changes to the terms and conditions, or the accounting conclusions, previously disclosed in the Annual Report.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensor Expense Reimbursement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is obligated to reimburse The Broad Institute, Inc. (&#8220;Broad&#8221;) and the President and Fellows of Harvard College (&#8220;Harvard&#8221;) for expenses incurred by each of them associated with the prosecution and maintenance of the patent rights that the Company licenses from them pursuant to the license agreement by and among the Company, Broad and Harvard, including the interference and opposition proceedings involving patents licensed to the Company under the license agreement, and other license agreements between the Company and Broad. As such, the Company anticipates that it has a substantial commitment in connection with these proceedings until such time as these proceedings have been resolved, but the amount of such commitment is not determinable. The Company incurred an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:ProfessionalAndContractServicesExpense" format="ixt:num-dot-decimal" scale="6" id="f-512">1.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:ProfessionalAndContractServicesExpense" format="ixt:num-dot-decimal" scale="6" id="f-513">6.1</ix:nonFraction> million in expense during the three and nine months ended September&#160;30, 2023, respectively, for such reimbursement. The Company incurred an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-5" name="us-gaap:ProfessionalAndContractServicesExpense" format="ixt:num-dot-decimal" scale="6" id="f-514">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:ProfessionalAndContractServicesExpense" format="ixt:num-dot-decimal" scale="6" id="f-515">6.1</ix:nonFraction> million in expense during the three and nine months ended September&#160;30, 2022, respectively, for such reimbursement.</span></div></ix:continuation><div id="i334ff9925a614490b675b110f235ecb7_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-516" continuedAt="f-516-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaboration and Profit-Sharing Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-516-1" continuedAt="f-516-2">The Company has entered into multiple collaborations, out-licenses and strategic alliances with third parties that typically involve payments to or from the Company, including up-front payments, payments for research and development services, option payments, milestone payments and royalty payments to or from the Company. The terms and conditions as well as the accounting analysis for the Company&#8217;s significant collaborations, out-licenses and strategic alliances are described in Note 9, &#8220;Collaboration and Profit-Sharing Agreements&#8221; to the consolidated financial statements included in the Annual Report. There have been no material changes to the terms and conditions, or the accounting conclusions, previously disclosed in the Annual Report. </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><ix:continuation id="f-516-2"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Revenue</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, the Company&#8217;s contract liabilities were primarily related to the Company&#8217;s collaboration with BMS. <ix:nonNumeric contextRef="c-1" name="edit:ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock" id="f-517" continuedAt="f-517-1" escape="true">The following table presents changes in the Company&#8217;s accounts receivable and contract liabilities for the nine months ended September&#160;30, 2023 (in thousands):</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="f-517-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-518">5,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="edit:AccountsReceivableAdditions" format="ixt:num-dot-decimal" scale="3" id="f-519">2,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="edit:AccountsReceivableDeductions" format="ixt:num-dot-decimal" scale="3" id="f-520">5,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-521">2,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-522">68,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-523">68,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2023, the Company did not recognize any collaboration revenue that had been allocated to deferred revenue from BMS.</span></div></ix:continuation><div id="i334ff9925a614490b675b110f235ecb7_61"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-524" continuedAt="f-524-1" escape="true">Stock-based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-524-1" continuedAt="f-524-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-525" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total compensation cost recognized for all stock-based compensation awards in the condensed consolidated statements of operations was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-526">2,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-527">3,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-528">7,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-529">9,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-530">2,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-531">2,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-532">7,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-533">14,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-534">4,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-535">5,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-536">14,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-537">23,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Unit Awards</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="f-538" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of restricted stock unit awards activity for the nine months ended September&#160;30, 2023:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock unit awards as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-160" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-539">1,499,070</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-160" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-540">18.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issued</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-161" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-541">1,331,578</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-161" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-542">8.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-161" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-543">262,588</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-161" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-544">19.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-161" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-545">462,777</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-161" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-546">18.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock unit awards as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-162" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-547">2,105,283</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-162" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-548">12.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restricted stock units issued in the nine months ended September&#160;30, 2023 include <ix:nonFraction unitRef="shares" contextRef="c-163" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-549">437,842</ix:nonFraction> units granted to certain employees that contain performance-based vesting provisions. The Company recognizes the fair value of the performance-based units through the expected achievement date if the performance-based vesting provisions are deemed probable.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, total unrecognized compensation expense related to unvested restricted stock unit awards was $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-550">13.2</ix:nonFraction> million, which the Company expects to recognize over a remaining weighted-average period of <ix:nonNumeric contextRef="c-161" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-551">2.54</ix:nonNumeric> years.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><ix:continuation id="f-524-2"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-552" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock option activity for the nine months ended September&#160;30, 2023:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Remaining<br/>Contractual Life (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-164" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-553">5,276,148</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-164" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-554">23.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-165" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-555">8.00</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="f-556">402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-166" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-557">2,195,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-166" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-558">8.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-166" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-559">3,122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-166" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-560">3.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-166" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-561">1,467,700</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-166" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-562">30.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-167" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-563">6,000,626</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-167" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-564">16.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-166" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-565">7.83</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="f-566">342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable at September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-167" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-567">2,449,032</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-167" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-568">22.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-166" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-569">6.34</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="f-570">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, total unrecognized compensation expense related to stock options was $<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-571">28.1</ix:nonFraction> million, which the Company expects to recognize over a remaining weighted-average period of <ix:nonNumeric contextRef="c-166" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-572">2.70</ix:nonNumeric> years.</span></div></ix:continuation><div id="i334ff9925a614490b675b110f235ecb7_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-573" continuedAt="f-573-1" escape="true">Net Loss per Share</ix:nonNumeric></span></div><ix:continuation id="f-573-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and potentially dilutive securities outstanding for the period determined using the treasury stock and if converted methods. Contingently issuable shares are included in the calculation of basic loss per share as of the beginning of the period in which all the necessary conditions have been satisfied. Contingently issuable shares are included in diluted loss per share based on the number of shares, if any, that would be issuable under the terms of the arrangement if the end of the reporting period was the end of the contingency period, if the results are dilutive. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of the diluted net loss per share calculation, unvested restricted stock unit awards and outstanding stock options are considered to be common stock equivalents, but they were excluded from the Company&#8217;s calculation of diluted net loss per share allocable to common stockholders because their inclusion would have been anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders were the same for all periods presented.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-574" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents were excluded from the calculation of diluted net loss per share allocable to common stockholders because their inclusion would have been anti-dilutive:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock unit awards</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-168" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-575"><ix:nonFraction unitRef="shares" contextRef="c-169" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-576">2,105,283</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-170" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-577"><ix:nonFraction unitRef="shares" contextRef="c-171" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-578">1,503,682</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-172" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-579"><ix:nonFraction unitRef="shares" contextRef="c-173" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-580">6,000,626</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-174" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-581"><ix:nonFraction unitRef="shares" contextRef="c-175" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-582">5,216,124</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-583"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-584">8,105,909</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-585"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-586">6,719,806</ix:nonFraction></ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i334ff9925a614490b675b110f235ecb7_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis of our financial condition and results of operations should be read together with our condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on February 22, 2023 (the &#8220;Annual Report&#8221;).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains forward-looking statements that involve substantial risks and uncertainties. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;would&#8221; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. All statements addressing our future operating performance and clinical development and regulatory timelines that we expect or anticipate will occur in the future, as well as expectations for cash runway, are forward-looking statements. There are a number of important risks and uncertainties that could cause our actual results to differ materially from those indicated by forward-looking statements, including uncertainties inherent in the initiation and completion of pre-clinical studies and clinical trials and clinical development of our product candidates; availability and timing of results from pre-clinical studies and clinical trials; whether interim results from a clinical trial will be predictive of the final results of the trial or the results of future trials; expectations for regulatory approvals to conduct trials or to market products and availability of funding sufficient for our foreseeable and unforeseeable operating expenses and capital expenditure requirements. These and other risks are described in greater detail in the Annual Report under the captions &#8220;Risk Factor Summary&#8221; and Part I, &#8220;Item 1A. Risk Factors,&#8221; as updated by our subsequent filings with the SEC. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments that we may make.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read this Quarterly Report on Form 10-Q and the documents that we have filed as exhibits to this Quarterly Report on Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect. The forward-looking statements contained in this Quarterly Report on Form 10-Q are made as of the date of this Quarterly Report on Form 10-Q, and we do not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.</span></div><div id="i334ff9925a614490b675b110f235ecb7_70"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. We have developed a proprietary gene editing platform based on CRISPR technology and we continue to expand its capabilities. Our product development strategy is to target diseases where gene editing can be used to enable or enhance therapeutic outcomes for patients, while maximizing probability of technical, regulatory and commercial success. We are focused on advancing gene editing medicines to treat hemoglobinopathies, beginning with the continued development of our current </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex vivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EDIT-301 program and leveraging the insights gained from this program to pursue next generation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">gene editing medicines targeting hematopoietic stem cells (&#8220;HSCs&#8221;). In parallel, we are pursuing the development of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene editing medicines for other organs and tissues that we believe will significantly differentiate our genome editing approach from the current standards of care for serious diseases. As part of these efforts, we are using existing strategic partnerships and collaborations and pursuing further opportunities to extend the reach of our intellectual property portfolio and access complementary technologies to expedite our drug discovery and clinical execution objectives.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lead program, EDIT-301, is an experimental </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene-edited medicine to treat sickle cell disease (&#8220;SCD&#8221;), a severe inherited blood disease that causes premature death, and transfusion-dependent beta thalassemia (&#8220;TDT&#8221;), the most severe form of beta-thalassemia, another inherited blood disorder characterized by severe anemia. In the second quarter of 2022, we dosed the first patient in our Phase 1/2 clinical trial of EDIT-301, which we refer to as our RUBY trial, for the treatment of severe SCD, and in December 2022, announced initial clinical data from the first two patients treated in the RUBY trial. This clinical data supports human proof of concept by showing that EDIT-301 could safely increase expression of fetal hemoglobin to clinically meaningful levels and correct anemia in SCD patients. After completing sequential dosing of the first two patients, we commenced parallel patient dosing in the first quarter of 2023. Through November 3, 2023, we have enrolled 27 patients in the RUBY trial. We expect to dose the 20th patient in the trial in the January 2024 timeframe. We provided an update on the initial clinical data from the RUBY trial in June 2023 and expect to provide additional clinical updates in December 2023 and in the middle of 2024. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2023, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) granted Regenerative Medicine Advanced Therapy designation to EDIT-301 for the treatment of SCD. A product is eligible for this designation if it is a regenerative medicine therapy that is intended to treat, modify, reverse or cure a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the product candidate has the potential to address unmet medical needs for such disease or condition. The benefits of the designation include early interactions with the FDA to expedite development and review, benefits available to breakthrough therapies, potential eligibility for priority review and accelerated approval based on surrogate or intermediate endpoints.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the FDA cleared our Investigational New Drug (&#8220;IND&#8221;) application for a Phase 1/2 clinical trial of EDIT-301 for the treatment of TDT. This trial, referred to as our EdiTHAL trial, is designed to assess the safety, tolerability, and preliminary efficacy of EDIT-301 for the treatment of TDT. We dosed the first patient in this trial in the first quarter of 2023 and commenced parallel patient dosing in the second quarter of 2023. Through November 3, 2023, we have enrolled eight patients in the EdiTHAL trial. We provided an initial clinical data update on the first patient in the EdiTHAL trial in June 2023 and expect to provide an additional clinical update in December 2023. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, we announced initial safety and efficacy data from the first four patients with SCD treated with EDIT-301 in the RUBY trial and from the first TDT patient treated in the EdiTHAL trial. In the RUBY trial, Patients 1 (male) and 2 (female) reached normal hemoglobin levels five months post-treatment with EDIT-301 and maintained a normal hemoglobin level at the 10- and six-month follow-ups, respectively. Each of these patients had fetal hemoglobin levels of greater than 40% persist during the same time frame. Patient 1&#8217;s total hemoglobin returned to a normal physiological level of 16.4g/dL (male normal range: 13.6&#8211;18.0 g/dL) at five months after infusion of EDIT-301 and was maintained at this level at the 10-month follow-up. In addition, Patient 1&#8217;s fetal hemoglobin fraction increased from 5% at baseline to 45.4% five months after treatment with EDIT-301 and 43.4% at the 10-month follow-up. Patient 2&#8217;s total hemoglobin reached a normal physiological level of 12.7 g/dL (female normal range: 12.0&#8211;16.0 g/dL) at five months after infusion of EDIT-301 and fetal hemoglobin increased from 10.8% at baseline to 51.3% at the six-month follow-up. Patients 3 (female) and 4 (male) in the RUBY trial saw increases in total hemoglobin and fetal hemoglobin fractions at three and two months of follow up, respectively, that followed similar trajectories as those seen in the first two patients at the same timepoints. All four treated RUBY patients were free of vaso-occlusive events following infusion with EDIT-301. In the EdiTHAL trial, the first patient (male) had successful neutrophil and platelet engraftment within 30 days of infusion, and, at one and a half months post-infusion, the patient&#8217;s response resembled that of the first four RUBY patients, achieving a fetal hemoglobin fraction of 34.9% representing 4 g/dL of total hemoglobin. EDIT-301 was well-tolerated and demonstrated a safety profile consistent with myeloablative conditioning with busulfan, the regimen that is necessary for current gene editing therapies for SCD and TDT, and autologous hematopoietic stem cell transplant by the four patients in the RUBY trial and the first patient in the EdiTHAL trial. After EDIT-301 infusion, no serious adverse events occurred, and no adverse events reported were related to treatment with EDIT-301.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also pursuing the development of next generation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> administered gene editing medicines, in which the medicine is injected or infused into the patient to edit the cells inside the body. We are initially focused on editing HSCs through targeted delivery of our AsCas12a enzyme to our clinically validated HBG1 and HBG2 promotor site. We are also in the discovery stage in developing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene editing medicines for other organs and tissues.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are pursuing the right combination of gene editing and targeted delivery tools through internal development and the in-licensing of complementary technologies, while also leveraging our intellectual property portfolio to drive potential out-licensing and partnership discussions that can accelerate the achievement of our goal of delivering lifesaving medicines to patients with previously untreatable or under-treated diseases. In cellular therapy medicines, we are leveraging new and existing partnerships to progress engineered cell medicines to treat various cancers. We are advancing alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors in collaboration with Bristol Myers Squibb Company (&#8220;BMS&#8221;) through its wholly owned subsidiary, Juno Therapeutics, Inc. (&#8220;Juno Therapeutics&#8221;). This collaboration, which leverages our Cas9 and AsCas12a platform technologies, has resulted in 11 programs. We have also entered into a non-exclusive collaboration and licensing agreement with Immatics N.V. to combine gamma-delta T cell adoptive cell therapies and gene editing to develop medicines for the treatment of cancer.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2023, we entered into a license agreement with Vor Biopharma Inc. (&#8220;Vor Bio&#8221;), providing Vor Bio a non-exclusive license for the development of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">ex vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Cas9 gene edited HSC therapies for the treatment and/or prevention of hematological malignancies. Under this agreement, we received an upfront payment and will be eligible for future development, regulatory and commercial milestone payments, as well as royalties on medicines utilizing the related intellectual property.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception in September 2013, our operations have focused on organizing and staffing our company, business planning, raising capital, establishing our intellectual property portfolio, assembling our core capabilities in gene editing, seeking to identify potential product candidates, and undertaking preclinical studies. Except for EDIT-301, all of our ongoing research programs are still in the preclinical or research stage of development and the risk of failure of all of our research programs is high. We have not generated any revenue from product sales. We have primarily financed our operations through various equity financings and payments received under our research collaboration with BMS and our former strategic alliance with Allergan Pharmaceuticals International Limited (together with its affiliates, &#8220;Allergan&#8221;), which was terminated in August 2020.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have incurred significant operating losses. Our net losses were $134.3 million and $159.7 million for the nine months ended September 30, 2023 and 2022, respectively. As of September&#160;30, 2023, we had an accumulated deficit of $1.2 billion. We expect to continue to incur significant expenses and operating losses for the foreseeable future. Our net losses may fluctuate significantly from quarter to quarter and from year to year. We anticipate that our expenses will increase substantially as we progress the clinical development of EDIT-301; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">scale our manufacturing capabilities and expand capacity, including capacity at third-party manufacturers, for EDIT-301; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">further advance our current research programs and our preclinical development activities; seek to identify additional product candidates and additional research programs; initiate preclinical testing and clinical trials for other product candidates we identify and develop; maintain, expand, and protect our intellectual property portfolio, including reimbursing our licensors for such expenses related to the intellectual property that we in-license from such licensors; hire additional clinical, quality control, and scientific personnel; and incur additional costs associated with operating as a public company. We do not expect to be profitable for the year ending December&#160;31, 2023 or the foreseeable future.</span></div><div id="i334ff9925a614490b675b110f235ecb7_73"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Operations Overview</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have not generated any revenue from product sales, and we do not expect to generate any revenue from product sales for the foreseeable future. In connection with our collaboration with BMS, we have received an aggregate of $135.5 million in payments, which have primarily consisted of the initial upfront and amendment payments, development milestone payments, research funding support and certain opt-in fees. We no longer receive research funding support from BMS. As of September&#160;30, 2023, we recorded $56.7 million of deferred revenue in relation to our collaboration with BMS, all of which is classified as long-term on our condensed consolidated balance sheet. Under this collaboration, we will recognize revenue upon delivery of option packages to BMS or upon receipt of development milestone payments. We expect that our revenue will fluctuate from quarter-to-quarter and year-to-year as a result of the timing of when we deliver such option packages or receive such milestone payments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information about our revenue recognition policy related to the BMS collaboration, see Part II, &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Critical Accounting Policies and Estimates&#8212;Revenue Recognition&#8221; included in the Annual Report.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the foreseeable future we expect substantially all of our revenue will be generated from our collaboration with BMS, and other collaborations or license agreements we enter into.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expenses</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist primarily of costs incurred for our research, preclinical development, process and scale-up development, manufacture and clinical development of our product candidates, and development activities under our collaboration agreements. These costs are expensed as incurred and include:</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employee related expenses including salaries, benefits, and stock-based compensation expense;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs under clinical trial agreements with investigative sites;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs associated with conducting our preclinical, process and scale-up development, manufacturing, clinical and regulatory activities, including fees paid to third-party professional consultants, service providers and suppliers;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs of purchasing lab supplies and non-capital equipment used in our preclinical activities and in manufacturing preclinical and clinical study materials;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs for research and development activities under our collaboration agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">facility costs, including rent, depreciation, and maintenance expenses; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fees for acquiring and maintaining licenses under our third-party licensing agreements, including any sublicensing or success payments made to our licensors.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this time, we cannot reasonably estimate or know the nature, timing, and estimated costs of the efforts that will be necessary to complete the development of any product candidates we may identify and develop. This is due to the numerous risks and uncertainties associated with developing such product candidates, including the uncertainty of:</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successful completion of preclinical studies, IND-enabling studies and natural history studies;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successful enrollment in, and completion of, clinical trials;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">receipt of marketing approvals from applicable regulatory authorities;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing commercial manufacturing capabilities or making arrangements with third-party manufacturers;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining and maintaining patent and trade secret protection and non-patent exclusivity;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">launching commercial sales of a product, if and when approved, whether alone or in collaboration with others;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acceptance of a product, if and when approved, by patients, the medical community, and third-party payors;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effectively competing with other therapies and treatment options;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a continued acceptable safety profile following approval;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enforcing and defending intellectual property and proprietary rights and claims; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">achieving desirable medicinal properties for the intended indications.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A change in the outcome of any of these variables with respect to the development of any product candidates we develop would significantly change the costs, timing, and viability associated with the development of that product candidate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development activities are central to our business model. We expect research and development costs to increase significantly for the foreseeable future as our development programs progress, including as we continue to progress our clinical trials as well as support preclinical studies for our other research programs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of salaries and other related costs, including stock-based compensation for personnel in executive, finance, investor relations, business development, legal, corporate affairs, information technology, facilities and human resource functions. Other significant costs include corporate facility costs not otherwise included in research and development expenses, legal fees related to intellectual property and corporate matters, and fees for accounting and consulting services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that our general and administrative expenses will increase in the future to support continued research and development activities and potential commercialization of any product candidates we identify and develop. These increases will include increased costs related to the hiring of additional personnel and fees to outside consultants.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also anticipate increased expenses related to reimbursement of third-party patent-related expenses and expenses associated with operating as a public company, including costs for audit, legal, regulatory, and tax-related services, director and officer insurance premiums, and investor relations costs. With respect to reimbursement of third-party intellectual property-related expenses specifically, given the ongoing nature of the opposition and interference proceedings involving the patents licensed to us under our license agreement with The Broad Institute, Inc. and the President and Fellows of Harvard College, we anticipate general and administrative expenses will continue to be significant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, Net</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2023 and 2022, other income, net consisted primarily of interest income, partially offset by accretion of discounts associated with other marketable securities.</span></div><div id="i334ff9925a614490b675b110f235ecb7_76"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management&#8217;s discussion and analysis of our financial condition and results of operations is based on our condensed consolidated financial statements, which have been prepared in accordance with United States generally accepted accounting principles. The preparation of our condensed consolidated financial statements requires us to make judgments and estimates that affect the reported amounts of assets, liabilities, revenues, and expenses, and the disclosure of contingent assets and liabilities in our condensed consolidated financial statements. We base our estimates on historical experience, known trends and events, and various other factors that we believe to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. On an ongoing basis, we evaluate our judgments and estimates in light of changes in circumstances, facts, and experience. The effects of material revisions in estimates, if any, will be reflected in the condensed consolidated financial statements prospectively from the date of change in estimates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our critical accounting policies from those described in Part II, &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Critical Accounting Policies and Estimates&#8221; in the Annual Report.</span></div><div id="i334ff9925a614490b675b110f235ecb7_79"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three Months ended September 30, 2023 and 2022</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the three months ended September 30, 2023 and 2022, together with the changes in those items in dollars (in thousands) and the respective percentages of change:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Dollar&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration and other research and development revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(814)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,063)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(45,019)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(55,726)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,707&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our results of operations, we have included the respective percentage of changes, unless greater than 100% or less than (100)%, in which case we have denoted such changes as not meaningful (n/m).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaboration and other research and development revenues</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration and other research and development revenues were $5.3 million for the three months ended September 30, 2023 compared to $42.0 thousand for the same period in 2022. The increase from the three months ended September 30, 2022 is primarily attributable to an upfront payment for the non-exclusive license to Vor Bio in the third quarter of 2023. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expenses</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses decreased by $0.8 million to $40.5 million for the three months ended September 30, 2023 compared to $41.3 million for the same period in 2022. The following table summarizes our research and development expenses for the three months ended September 30, 2023 and 2022, together with the changes in those items in dollars (in thousands) and the respective percentages of change:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Dollar&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(570)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">External research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(341)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(474)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sublicense and license fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total research and development expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,512&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,326&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(814)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in research and development expenses for the three months ended September 30, 2023 compared to the three months ended September 30, 2022 was primarily attributable to:</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $0.9 million in decreased other expenses related to cost savings with external manufacturing support services; </span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $0.6 million in decreased employee-related expenses related to reduced headcount as a result of our strategic reprioritization; </span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $0.5 million in decreased stock-based compensation expenses; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $0.3 million in decreased facility expenses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These decreases were partially offset by: </span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $1.4 million in increased sublicense and license fees paid in connection with licensing activity; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $0.1 million increase in external research and development expenses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative expenses</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses decreased by $1.2 million to $15.0 million for the three months ended September 30, 2023 compared to $16.2 million for the three months ended September 30, 2022. The following table </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">summarizes our general and administrative expenses for the three months ended September 30, 2023 and 2022, together with the changes in those items in dollars (in thousands) and the respective percentages of change:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Dollar&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(799)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional service expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property and patent related fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(861)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(676)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility and other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total general and administrative expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,236&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,249)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in general and administrative expenses for the three months ended September 30, 2023 compared to the three months ended September 30, 2022 was primarily attributable to:</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $0.9 million in decreased intellectual property and patent related fees due to reduced legal activity;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $0.8&#160;million in decreased employee related expenses related to reduced headcount as a result of our strategic reprioritization;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $0.7 million in decreased stock-based compensation expenses due to a reduction in the market price of our common stock, resulting in a lower valuation of equity awards granted; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $0.1 million in decreased facility and other expenses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These decreases were partially offset by approximately $1.2 million in increased professional service expenses to support strategic initiatives and business development activities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income, net</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2023 and September&#160;30, 2022 other income, net  was  $5.1 million and $1.8 million, respectively, which was primarily attributable to interest income, partially offset by accretion of discounts associated with other marketable securities. The increase for three months ended September 30, 2023 was attributable to increased invested balances as well as favorable market rates. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Nine Months ended September 30, 2023 and 2022</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the nine months ended September 30, 2023 and 2022, together with the changes in those items in dollars (in thousands) and the respective percentages of change:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Dollar&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration and other research and development revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,074&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14,865)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">175,680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,387)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,590)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,594)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(134,345)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(159,694)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaboration and other research and development revenues</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration and other research and development revenues increased by $4.9 million to $18.1 million for the nine months ended September 30, 2023 compared to $13.2 million for nine months ended September 30, 2022. The increase was primarily related to the sale of our wholly owned oncology assets and licenses in January 2023, as well as an upfront payment for a non-exclusive license to Vor Bio in the third quarter of 2023, partially offset by the exercises of a program opt-in under our collaboration with BMS in 2022 for which there was no similar activity in 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expenses</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses decreased by $14.9 million to $108.1 million for the nine months ended September 30, 2023 compared to $123.0 million for the nine months ended September 30, 2022. The following table summarizes our research and development expenses for the nine months ended September 30, 2023 and 2022, together with the changes in those items in dollars (in thousands) and the respective percentages of change:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Dollar&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(532)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">External research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,621)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sublicense and license fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total research and development expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108,095&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122,960&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14,865)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in research and development expenses for the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022 was primarily attributable to:</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $15.0 million in decreased external research and development expenses related to our reprioritization and targeted focus on our EDIT-301 program;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $2.6 million in decreased stock-based compensation expense </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due primarily to a reduction in the market price of our common stock, resulting in a lower valuation of equity awards granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $0.5 million in decreased employee related expenses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These decreases were partially offset by:</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $1.6 million in increased facility expenses primarily related to increased rent expense incurred in connection with a lease extension for office, manufacturing and lab space; </span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $1.5 million in increased other expenses attributable to consulting and external fees to support patient advocacy and medical affairs initiatives; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $0.2 million in increased sublicense and license fees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative expenses</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased by $2.5 million to $55.2 million for the nine months ended September 30, 2023 compared to $52.7 million for the nine months ended September 30, 2022. The following table summarizes our general and administrative expenses for the nine months ended September 30, 2023 and 2022, together with the changes in those items in dollars (in thousands) and the respective percentages of change:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Dollar&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,067&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(404)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional service expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property and patent related fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,856)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility and other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total general and administrative expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,198&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52,720&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,478&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in general and administrative expenses for the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022 was primarily attributable to:</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $10.1 million in increased professional service expenses to support strategic initiatives and business development activities; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $0.2 million in increased intellectual property and patent related fees. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These increases were partially offset by:</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $6.9 million in decreased stock-based compensation expenses </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due primarily to a reduction in the market price of our common stock, resulting in a lower valuation of equity awards granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $0.5 million in decreased facility and other expenses; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $0.4 million in decreased employee related expenses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income, net</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2023 and September&#160;30, 2022, other income, net was $10.9 million and $2.8 million, respectively, which was primarily attributable to interest income, partially offset by accretion of discounts associated with other marketable securities. The increase for the nine months ended September 30, 2023 is attributable to increased invested balances and favorable market rates. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i334ff9925a614490b675b110f235ecb7_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, we completed a public offering in which we sold 12,500,000 shares of our common stock and received net proceeds of approximately $117.1 million after deducting underwriting discounts and commissions and other offering costs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, we have raised an aggregate of $1.0&#160;billion in net proceeds through the sale of shares of our common stock in public offerings and at-the-market offerings. We also have funded our business from payments received under our research collaboration with BMS and our strategic alliance with Allergan, which was terminated in August 2020. As of September&#160;30, 2023, we had cash, cash equivalents and marketable securities of $446.4&#160;million.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, we entered into a common stock sales agreement with Cowen and Company, LLC (&#8220;Cowen&#8221;), under which we from time to time can issue and sell shares of our common stock through Cowen in at-the-market offerings for aggregate gross sale proceeds of up to $300.0 million (the &#8220;ATM Facility&#8221;). As of September&#160;30, 2023, we have </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> sold any shares of our common stock under the ATM Facility.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our existing cash, cash equivalents and marketable securities, we are eligible to earn milestone and other payments under our collaboration agreement with BMS and our other collaboration and license agreements. Our ability to earn applicable milestone and other payments and the timing of earning these amounts are dependent upon the timing and outcome of development, regulatory and commercial activities and, as such, are uncertain at this time. As of September&#160;30, 2023, our right to contingent payments under our collaboration agreement with BMS is our only significant committed potential external source of funds.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our cash flows for the nine months ended September 30, 2023 and 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash (used in) provided by:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(109,938)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(135,076)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(66,571)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net (decrease) increase in cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(58,984)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,185&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash Used in Operating Activities</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of cash in all periods resulted primarily from our net losses adjusted for non-cash charges and changes in components of working capital.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was approximately $109.9 million for the nine months ended September 30, 2023, which primarily consisted of operating expenses that related to increasing our research efforts, the focused progression of clinical and manufacturing activities in support of the EDIT-301 program, and supporting business operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was approximately $135.1 million for the nine months ended September 30, 2022, which primarily consisted of operating expenses that related to our preclinical and clinical activities, sublicense and license fees, and increased staffing costs to support various business operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash Used in Investing Activities</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was approximately $66.6 million for the nine months ended September 30, 2023, primarily related to purchases of marketable securities of $219.8 million, partially offset by the proceeds from the maturities of marketable securities of $156.6 million.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities was approximately $141.6 million for the nine months ended September 30, 2022, primarily related to proceeds from maturities of marketable securities of $354.8 million, partially offset by costs used to acquire marketable securities of $209.8 million and purchases of property and equipment of $3.5 million. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash Provided by Financing Activities</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was approximately $117.5 million for the nine months ended September 30, 2023, primarily related to proceeds from our June 2023 offering of common stock of $117.1 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">after deducting underwriting discounts and commissions and other offering costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and proceeds received from issuance of common stock under the employee stock purchase plan of $0.4 million.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was approximately $0.7 million for the nine months ended September 30, 2022 primarily related to proceeds received from issuance of common stock under our employee stock purchase plan and exercises of options for our common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Funding Requirements</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our expenses to increase in connection with our ongoing activities, particularly as we progress the clinical development of EDIT-301; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">scale our manufacturing capabilities and expand capacity, including capacity at third-party manufacturers, for EDIT-301; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">further advance our research programs and our preclinical development activities; seek to identify additional research programs and additional product candidates; initiate preclinical testing and clinical trials for other product candidates we identify and develop; maintain, expand, and protect our intellectual property portfolio, including reimbursing our licensors for expenses related to the intellectual property that we in-license from such licensors; hire additional clinical, quality control, and scientific personnel; and incur costs associated with operating as a public company. In addition, if we obtain marketing approval for any product candidate that we identify and develop, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing, and distribution to the extent that such sales, marketing, and distribution are not the responsibility of a collaborator. We do not expect to generate significant recurring revenue unless and until we obtain regulatory approval for and commercialize a product candidate. Furthermore, since 2016 we have incurred, and in future years we expect to continue to incur significant costs associated with operating as a public company. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce, or eliminate our research and development programs or future commercialization efforts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our existing cash, cash equivalents and marketable securities at September&#160;30, 2023, will enable us to fund our operating expenses and capital expenditure requirements into </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">third quarter of 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our forecast of the period of time through which our existing cash, cash equivalents and investments will be adequate to support our operations is a forward-looking statement and involves significant risks and uncertainties. We have based this forecast on assumptions that may prove to be wrong, and actual results could vary materially from our expectations, which may adversely affect our capital resources and liquidity. We could utilize our available capital resources sooner than we currently expect. The amount and timing of future funding requirements, both near- and long-term, will depend on many factors, including, but not limited to:</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope, progress, results, and costs of drug discovery, preclinical development, laboratory testing, and clinical or natural history study trials for the product candidates we develop;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of progressing the clinical development of EDIT-301 to treat SCD and TDT; </span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of preparing, filing, and prosecuting patent applications, maintaining and enforcing our intellectual property and proprietary rights, and defending intellectual property-related claims;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs, timing, and outcome of regulatory review of the product candidates we develop;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of future activities, including product sales, medical affairs, marketing, manufacturing, and distribution, for any product candidates for which we receive regulatory approval;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success of our collaboration with BMS;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether BMS exercises any of its options to extend the research program term and/or to additional research programs under our collaboration;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to establish and maintain additional collaborations on favorable terms, if at all;</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we acquire or in-license other medicines and technologies; </span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of reimbursing our licensors for the prosecution and maintenance of the patent rights in-licensed by us; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of operating as a public company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifying potential product candidates and conducting preclinical studies and clinical trials is a time-consuming, expensive, and uncertain process that takes many years to complete, and we may never generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition, any product candidate that we identify and develop, if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of genomic medicines that we do not expect to be commercially available for many years, if at all. Accordingly, we will need to continue to rely on additional financing to achieve our business objectives. Adequate additional financing may not be available to us on acceptable terms, or at all</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until such time, if ever, as we can generate substantial product revenues, we expect to finance our cash needs through a combination of equity offerings, debt financings, collaborations, strategic alliances, and licensing arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, our stockholders&#8217; ownership interests will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our stockholders. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, or declaring dividends.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we raise funds through additional collaborations, strategic alliances, or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs, or product candidates or to grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce, or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span></div><div id="i334ff9925a614490b675b110f235ecb7_85"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, we had non-cancelable operating leases with future minimum lease payments for a total of $41.9 million, of which $3.7 million will be payable in 2023. These minimum lease payments exclude our share of the facility operating expenses, real-estate taxes and other costs that are reimbursable to the landlord under the leases.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2023, we entered into a license and service agreement pursuant to which we will lease manufacturing space for our continued research and development activities. As of September&#160;30, 2023, the lease has not commenced for accounting purposes and it is not expected to commence until the second quarter of 2024. The license and service agreement provides for total remaining lease payments of up to $87.8 million over a 10-year lease term. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may terminate the license and service agreement in our discretion upon twelve months' prior written notice.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our agreements with certain institutions to license intellectual property include potential milestone payments and success fees, sublicense fees, royalty fees, licensing maintenance fees, and reimbursement of patent maintenance costs that we may be required to pay. Our agreements to license intellectual property include potential milestone payments that are dependent upon the development of products using the intellectual property licensed under the agreements and contingent upon the achievement of development or regulatory approval milestones, as well as commercial milestones. These potential obligations are contingent upon future events and the timing and likelihood of such potential obligations are not known with certainty. For further information regarding these agreements, please see Part I, &#8220;Item 1. Business&#8212;Our Collaborations and Licensing Strategy&#8221; in the Annual Report.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also enter into contracts in the normal course of business with contract research organizations, contract manufacturing organizations and other vendors to assist in the performance of our research and development activities and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other services and products for operating purposes. These contracts generally provide for termination at any time upon prior notice.</span></div><div id="i334ff9925a614490b675b110f235ecb7_88"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risk related to changes in interest rates. As of September&#160;30, 2023, we had cash and cash equivalents of $82.5 million, primarily held in money market mutual funds, and marketable securities of $363.9 million, primarily consisting of U.S. government-backed securities, commercial paper and corporate debt securities. Our primary exposure to market risk is interest rate sensitivity, which is affected by changes in the general level of U.S. interest rates, particularly because our investments, including cash equivalents, are in the form, or may be in the form of, money market funds or marketable securities and are or may be invested in U.S. Treasury and U.S. government agency obligations. Due to the short-term maturities and low risk profiles of our investments, an immediate 100 basis point change in interest rates would not have a material effect on the fair market value of our investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we contract with certain vendors and institutions internationally, substantially all of our total liabilities as of September&#160;30, 2023 were denominated in the United States dollar and we believe that we do not have any material exposure to foreign currency exchange rate risk.</span></div><div id="i334ff9925a614490b675b110f235ecb7_91"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i334ff9925a614490b675b110f235ecb7_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div id="i334ff9925a614490b675b110f235ecb7_97"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may become involved in litigation or other legal proceedings relating to claims arising from the ordinary course of business. There can be no assurance that any proceedings that result from these third-party actions will be resolved in our favor. In addition, if they are not resolved in our favor, there can be no assurance that the result will not have a material adverse effect on our business, financial condition, results of operations, or prospects. Certain of our intellectual property rights, including ones licensed to us under our licensing agreements, are subject to, and from time to time may be subject to, priority and validity disputes. For additional information regarding these matters, see Part I, &#8220;Item 1A. Risk Factors&#8212;Risks Related to Our Intellectual Property&#8221; in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 (the &#8220;Annual Report&#8221;). Regardless of outcome, litigation or other legal proceedings can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.</span></div><div id="i334ff9925a614490b675b110f235ecb7_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information set forth in this Quarterly Report on Form 10-Q and in the sections entitled &#8220;Summary of Risk Factors&#8221; and Part I, &#8220;Item 1A. Risk Factors&#8221; in the Annual Report, includes risks which could materially affect our business, financial condition, results of operations, or prospects. These risks, as well as other risks and uncertainties, could materially and adversely affect our business, results of operations and financial condition, which in turn could materially and adversely affect the trading price of shares of our common stock. Additional risks not currently known to us or that we currently deem to be immaterial may also harm our business.</span></div><div id="i334ff9925a614490b675b110f235ecb7_103"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Director and Officer Trading Arrangements</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the compensation of our directors and officers (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;)) is in the form of equity awards and, from time to time, directors and officers may engage in open-market transactions with respect to the securities acquired pursuant to such equity awards or other of our securities, including to satisfy tax withholding obligations when equity awards vest or are exercised, and for diversification or other personal reasons.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactions in our securities by directors and officers are required to be made in accordance with our insider trading policy, which requires that the transactions be in accordance with applicable U.S. federal securities laws that prohibit trading while in possession of material nonpublic information. Rule 10b5-1 under the Exchange Act provides an affirmative defense that enables directors and officers to prearrange transactions in our securities in a manner that avoids concerns about initiating transactions while in possession of material nonpublic information.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-176" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-587" escape="true">During the quarterly period covered by this report, <ix:nonNumeric contextRef="c-177" name="ecd:TrdArrIndName" id="f-588">Linda C. Burkly, Ph.D.</ix:nonNumeric>, our <ix:nonNumeric contextRef="c-177" name="ecd:TrdArrIndTitle" id="f-589">Chief Scientific Officer</ix:nonNumeric>, entered into a <ix:nonNumeric contextRef="c-177" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-590">Rule 10b5-1</ix:nonNumeric> trading arrangement that is intended to qualify as an &#8220;eligible sell-to-cover transaction&#8221; (as described in Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act). This sell-to-cover arrangement, which was adopted on <ix:nonNumeric contextRef="c-177" name="ecd:TrdArrAdoptionDate" id="f-591">July 3, 2023</ix:nonNumeric>, applies to restricted stock units (&#8220;RSUs&#8221;), whether vesting is based on the passage of time and/or the achievement of performance goals, granted on her start date, July 24, 2023, and any RSUs that may be granted from time to time thereafter (other than those which by their terms require us to withhold shares for tax withholding obligations in connection with vesting and settlement). This arrangement provides for the automatic sale of shares of our common stock that would otherwise be issuable on each settlement date of a covered RSU in an amount necessary to satisfy the applicable withholding obligation, with the proceeds of the sale delivered to us in satisfaction of the applicable withholding obligation. The number of shares that will be sold under this arrangement is not currently determinable as the number will vary based on the extent to which vesting conditions are satisfied, the market price of our common stock at the time of settlement and the potential future grant of additional RSUs subject to this arrangement.</ix:nonNumeric></span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of our directors or officers <ix:nonNumeric contextRef="c-7" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-592">terminated</ix:nonNumeric> a Rule 10b5-1 trading arrangement or <ix:nonNumeric contextRef="c-7" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-593">adopted</ix:nonNumeric> or terminated a non-Rule 10b<ix:nonNumeric contextRef="c-7" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-594">5</ix:nonNumeric>-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the quarterly period covered by this report.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i334ff9925a614490b675b110f235ecb7_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit Index</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Description of Exhibit</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1650664/000155837023012936/edit-20230630xex10d3.htm">Employment Offer Letter, dated July 3, 2023, between the Registrant and Linda C. Burkly (incorporated by reference to Exhibit </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1650664/000155837023012936/edit-20230630xex10d3.htm">10.3 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1650664/000155837023012936/edit-20230630xex10d3.htm">to the Company's Quarterly Report on Form 10-Q (File No. 001-37687) filed with the Securities and Exchange Commission on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1650664/000155837023012936/edit-20230630xex10d3.htm">August 2, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="separationagreement.htm">Separation Agreement, dated October 6, 2023 between the Registrant and Bruce Eaton</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="edit-20230930xex311.htm">Rule 13a-14(a) Certification of Principal Executive Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="edit-20230930xex312.htm">Rule 13a-14(a) Certification of Principal Financial Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="edit-20230930xex321.htm">Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. &#167;1350</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following financial statements from the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets (unaudited), (ii) Condensed Consolidated Statements of Operations (unaudited), (iii) Condensed Consolidated Statements of Comprehensive Loss (unaudited), (iv) Condensed Consolidated Statements of Stockholders&#8217; Equity (unaudited), (v) Condensed Consolidated Statements of Cash Flows (unaudited) and (vi) Notes to Condensed Consolidated Financial Statements (unaudited), tagged as blocks of text and including detailed tags.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cover page from the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2023, formatted in Inline XBRL.</span></div></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Filed herewith</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+&#160;&#160;&#160;&#160;</span><span style="background-color:#ffffff;color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certifications furnished in Exhibit 32.1 that accompany this Quarterly Report on Form 10-Q are not deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Such certifications are not to be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates them by reference.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i334ff9925a614490b675b110f235ecb7_109"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i334ff9925a614490b675b110f235ecb7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:46.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EDITAS MEDICINE, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: November&#160;3, 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Erick Lucera</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Erick Lucera</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer<br/>(Principal Financial Officer) </span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>2
<FILENAME>separationagreement.htm
<DESCRIPTION>EX-10
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>separationagreement</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- separationagreement001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="separationagreement001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">11 Hurley Street  Cambridge, MA 02141  P 617-401-9000  F 617-494-0985  VIA HAND DELIVERY &amp; ELECTRONIC MAIL  October 3, 2023 (as revised at your request on October 4, 2023)  Bruce Eaton, Ph.D.  Dear Bruce,  As we discussed, your employment with Editas Medicine, Inc. (the &#8220;Company&#8221;) will end  effective January 2, 2024 (the &#8220;Separation Date&#8221;).  As part of your separation with the  Company, the Company will pay the Benefits (as defined in paragraph 1 below) if (i) you sign  and return this letter agreement to me by October 10, 2023; (ii) you sign and return the  Supplemental Agreement attached hereto as Attachment A (the &#8220;Supplemental Agreement&#8221;)  on the Separation Date; (iii) you do not revoke your agreement to the Supplemental Agreement;  and (iv) you comply with the obligations set forth in the numbered paragraphs herein (including  in the Supplemental Agreement).    Because both this letter agreement and the Supplemental Agreement will become  binding agreements between you and the Company, you are advised to consult with an attorney  before signing this letter agreement and the Supplemental Agreement, and you have been  given a reasonable amount of time to review this letter agreement and at least twenty-one (21)  days to review the Supplemental Agreement.  If you sign and return the Supplemental  Agreement on the Separation Date, you may change your mind and revoke your agreement  during the seven (7) business day period (the &#8220;Revocation Period&#8221;) after you signed it by  notifying me in writing.    Although your receipt of the Benefits is expressly conditioned on your (a) entering into  this letter agreement and the Supplemental Agreement, (b) not revoking the Supplemental  Agreement, and (c) compliance with your obligations set forth in both the letter agreement and  the Supplemental Agreement, the following will apply regardless:    &#8226; As of your last day of employment, all salary payments from the Company will cease and any benefits you had as of the Separation Date under Company- provided benefit plans, programs, or practices will terminate, except as required by federal or state law. &#8226; You will receive payment for your final wages through your last day of employment with the Company. &#8226; You may, if eligible and at your own cost (except as agreed to in paragraph 1), elect to continue receiving group medical and dental insurance pursuant to the &#8220;COBRA&#8221; law.  You will be sent a COBRA qualifying notice under separate cover and subsequent notices as required by applicable law or regulation.  Your costs to continue the coverage will be set forth in these notices.  The &#8220;qualifying event&#8221; under COBRA shall be deemed to have occurred on the Separation Date. Exhibit 10.2 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- separationagreement002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="separationagreement002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Page 2 of 8    &#8226; You are obligated to keep confidential and not to use or disclose any and all non- public information concerning the Company that you acquired during the course  of your employment with the Company, including any non-public information  concerning the Company&#8217;s business affairs, business prospects, and financial  condition, except as otherwise permitted by paragraph 7 below.  Further, you  remain subject to your continuing obligations to the Company as set forth in the  Employee Non-Competition, Non-Solicitation, Confidentiality, and Assignment  Agreement (the &#8220;Restrictive Covenant Agreement&#8221;) you previously executed  for the benefit of the Company, which remain in full force and effect.  &#8226; You must return all Company property to the Company within 5 business days  following the Separation Date.  &#8226; Except as agreed in paragraph 1, you will have three (3) months following the  Separation Date to exercise any stock options under the Company&#8217;s 2015 Stock  Incentive Plan (the &#8220;Plan&#8221;) that were vested as of the Separation Date (the  &#8220;Vested Options&#8221;).  After that three (3) month period, your stock options will  expire and you will no longer have any rights with respect thereto.  Except as  agreed in paragraph 1, any restricted or performance stock unit awards granted  to you under the Plan shall be subject to the terms of the Plan and the applicable  grant agreement.  If you elect to timely sign and return this letter agreement and timely sign the  Supplemental Agreement and do not revoke it within the Revocation Period, the  following terms and conditions will also apply:  1. Separation Benefits &#8211; The Company will provide you with the following  separation benefits (the &#8220;Benefits&#8221;):  a. Separation Pay.  The Company will pay to you an amount equivalent to  twelve (12) months of your current base salary, less all applicable taxes  and withholdings.  This separation pay will be paid in installments in  accordance with the Company&#8217;s regular payroll practices, but in no event  shall payments begin earlier than the Company&#8217;s first payroll date  following expiration of the Revocation Period.  b. COBRA Benefits.  Should you timely elect and be eligible to continue  receiving group health insurance pursuant to the &#8220;COBRA&#8221; law, the  Company will, until the earlier of (x) the date that is twelve (12) months  following the Separation Date, and (y) the date on which you obtain  alternative coverage (as applicable, the &#8220;COBRA Contribution Period&#8221;),  continue to pay the share of the premiums for such coverage to the same  extent it was paying such premiums on your behalf immediately prior to  the Separation Date.  The remaining balance of any premium costs  during the COBRA Contribution Period, and all premium costs thereafter,  shall be paid by you on a monthly basis for as long as, and to the extent  that, you remain eligible for COBRA continuation.  You agree that, should  you obtain alternative medical and/or dental insurance coverage prior to  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- separationagreement003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="separationagreement003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Page 3 of 8    the date that is twelve (12) months following the Separation Date, you will  so inform the Company in writing within five (5) business days of  obtaining such coverage.  c. 2023 Annual Bonus. You will be eligible to receive a bonus for 2023, as  determined by the Board of Directors of the Company (the &#8220;Board&#8221;) in  connection with the determination of bonuses for the executive team, with  any such bonus paid less applicable taxes and withholdings and at the  same time as annual bonuses are paid to other executives of the  Company.  d. Equity Awards. Your Vested Options and performance unit awards shall  be amended as follows:    i. the period of time for you to exercise all or any Vested Options  shall be extended to January 2, 2025. You understand that this  extension results in any Vested Options that are incentive stock  options being converted into non-qualified stock options; and  ii. notwithstanding your termination of service, any performance  stock unit awards outstanding on the Separation Date will remain  outstanding and will become earned and become vested to the  extent that the applicable performance metrics are determined by  the Board or the Organization, Leadership and Compensation  Committee thereof (the &#8220;Committee&#8221;) to have been achieved on  or prior to March 31, 2024, provided that such achievement is  certified by the Board or the Committee no later than April 30,  2024.  You will not be eligible for, nor shall you have a right to receive, any payments or  benefits from the Company following the Separation Date other than as set forth in this  paragraph.  2. Release of Claims &#8211; In consideration of the Benefits, which you acknowledge  you would not otherwise be entitled to receive, you hereby fully, forever, irrevocably and  unconditionally release, remise and discharge the Company, its affiliates, subsidiaries, parent  companies, predecessors, and successors, and all of their respective past and present officers,  directors, stockholders, partners, members, employees, agents, representatives, plan  administrators, attorneys, insurers and fiduciaries (each in their individual and corporate  capacities) (collectively, the &#8220;Released Parties&#8221;) from any and all claims, charges, complaints,  demands, actions, causes of action, suits, rights, debts, sums of money, costs, accounts,  reckonings, covenants, contracts, agreements, promises, doings, omissions, damages,  executions, obligations, liabilities, and expenses (including attorneys&#8217; fees and costs), of every  kind and nature that you ever had or now have against any or all of the Released Parties,  whether known or unknown, including, but not limited to:  (i)  any and all claims arising out of or relating to your employment with and/or  separation from the Company, including, but not limited to, all claims under Title  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- separationagreement004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="separationagreement004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Page 4 of 8    VII of the Civil Rights Act, the Americans With Disabilities Act, the Genetic  Information Nondiscrimination Act, the Family and Medical Leave Act, the Worker  Adjustment and Retraining Notification Act, the Rehabilitation Act, Executive  Order 11246, Executive Order 11141, the Fair Credit Reporting Act, and the  Employee Retirement Income Security Act, all as amended; all claims arising out  of the Massachusetts Fair Employment Practices Act, Mass. Gen. Laws ch.  151B, &sect; 1 et seq., the Massachusetts Wage Act, Mass. Gen. Laws ch. 149, &sect; 148  et seq. (Massachusetts law regarding payment of wages and overtime), the  Massachusetts Civil Rights Act, Mass. Gen. Laws ch. 12, &sect;&sect; 11H and 11I, the  Massachusetts Equal Rights Act, Mass. Gen. Laws. ch. 93, &sect; 102, Mass. Gen.  Laws ch. 214, &sect; 1C (Massachusetts right to be free from sexual harassment law),  the Massachusetts Labor and Industries Act, Mass. Gen. Laws ch. 149, &sect; 1 et  seq., Mass. Gen. Laws ch. 214, &sect; 1B (Massachusetts right of privacy law), the  Massachusetts Maternity Leave Act, Mass. Gen. Laws ch. 149, &sect; 105D, and the  Massachusetts Small Necessities Leave Act, Mass. Gen. Laws ch. 149, &sect; 52D,  all as amended; all claims arising out of the Colo. Rev. Stat. &sect; 24-34-401 et seq.  (Colorado anti-discrimination and anti-retaliation law), the Colorado Family Care  Act, 8-13.3-201 et seq., Colo. Rev. Stat. &sect; 19-5-211 (Colorado adoption leave  law), Colo. Rev. Stat. &sect; 24-34-402.7 (Colorado domestic violence and crime  victim leave law), Colo. Rev. Stat. &sect; 8-5-101 et seq. (Colorado equal pay law),  and Colo. Rev. Stat. &sect; 28-3-609 (Colorado military leave law), all as amended;   (ii)  all common law claims including, but not limited to, actions in defamation,  intentional infliction of emotional distress, misrepresentation, fraud, wrongful  discharge, and breach of contract;   (iii) all claims to any non-vested ownership interest in the Company, contractual or  otherwise;   (iv) all state and federal whistleblower claims to the maximum extent permitted by  law; and   (v)  any claim or damage arising out of your employment with and/or separation from  the Company (including a claim for retaliation) under any common law theory or  any federal, state or local statute or ordinance not expressly referenced above;   provided, however, that this release of claims does not prevent you from filing a  charge with, cooperating with, or participating in any investigation or proceeding  before, the Equal Employment Opportunity Commission or a state fair employment  practices agency (except that you acknowledge that you may not recover any  monetary benefits in connection with any such charge, investigation, or proceeding,  and you further waive any rights or claims to any payment, benefit, attorneys&#8217; fees or  other remedial relief in connection with any such charge, investigation or  proceeding).  3. Continuing Obligations &#8211; You acknowledge and reaffirm your confidentiality  and non-disclosure obligations discussed on the first page of this letter agreement, as well as  the continuing obligations set forth in the Restrictive Covenant Agreement, which obligations  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- separationagreement005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="separationagreement005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Page 5 of 8    survive your separation from employment with the Company.  In addition, as an express  condition of your receipt of the severance benefits, you acknowledge that you will be required to  agree to the non-competition provision set forth in the attached Supplemental Agreement.    4. Non-Disparagement &#8211; You understand and agree that, to the extent permitted  by law and except as otherwise permitted by paragraph 7 below, you will not, in public or  private, make any false, disparaging, derogatory or defamatory statements, online (including,  without limitation, on any social media, networking, or employer review site) or otherwise, to any  person or entity, including, but not limited to, any media outlet, industry group, financial  institution or current or former employee, board member, consultant, client or customer of the  Company, regarding the Company or any of the other Released Parties, or regarding the  Company&#8217;s business affairs, business prospects, or financial condition.  In return, the Company  agrees to instruct its officers not to, in public or private, make any false, disparaging, derogatory  or defamatory statements online (including, without limitation, on any social media, networking,  or employer review site) or otherwise, to any third party regarding you.  5. Company Affiliation &#8211; You agree that, following the Separation Date, you will  not hold yourself out as an officer, employee, or otherwise as a representative of the Company,  and you agree to update any directory information that indicates you are currently affiliated with  the Company.  Without limiting the foregoing, you confirm that, within ten (10) days following the  Separation Date, you will update any and all social media accounts (including, without limitation,  LinkedIn, Facebook, Twitter and Four Square) to reflect that you are no longer employed by or  associated with the Company.  6. Confidentiality &#8211; You understand and agree that, to the extent permitted by law  and except as otherwise permitted by paragraph 7 below, the contents of the negotiations and  discussions resulting in this Agreement, shall be maintained as confidential by you and your  agents and representatives and shall not be disclosed except as otherwise agreed to in writing  by the Company.     7. Scope of Disclosure Restrictions &#8211; Nothing in this letter agreement prohibits  you from communicating with government agencies about possible violations of federal, state,  or local laws or otherwise providing information to government agencies, filing a complaint with  government agencies, or participating in government agency investigations or proceedings.   You are not required to notify the Company of any such communications; provided, however,  that nothing herein authorizes the disclosure of information you obtained through a  communication that was subject to the attorney-client privilege.  Further, notwithstanding your  confidentiality and nondisclosure obligations, you are hereby advised as follows pursuant to the  Defend Trade Secrets Act: &#8220;An individual shall not be held criminally or civilly liable under any  Federal or State trade secret law for the disclosure of a trade secret that (A) is made (i) in  confidence to a Federal, State, or local government official, either directly or indirectly, or to an  attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law;  or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such  filing is made under seal.  An individual who files a lawsuit for retaliation by an employer for  reporting a suspected violation of law may disclose the trade secret to the attorney of the  individual and use the trade secret information in the court proceeding, if the individual (A) files  any document containing the trade secret under seal; and (B) does not disclose the trade  secret, except pursuant to court order.&#8221;  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- separationagreement006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="separationagreement006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Page 6 of 8    8. Recoupment &#8211; You acknowledge that (a) if you fail to comply with the terms of  this letter agreement or the Supplemental Agreement, or (b) as otherwise may be required by  law, you will be required to repay to the Company any and all of the Benefits that you have  already received, with the value determined in the sole discretion of the Plan Administrator for  the Company&#8217;s Severance Benefits Plan.  Payment is due in cash or by check within 10 days  after the Company provides notice to you that it is enforcing this provision.  In such event, any  Benefits not yet received by you will be immediately forfeited.  9. Cooperation &#8211; You agree that, to the extent permitted by law, you shall  cooperate fully with the Company in: (i) any internal investigation; (ii) the investigation, defense  or prosecution of any claims or actions which already have been brought, are currently pending,  or which may be brought in the future against the Company by a third party or by or on behalf of  the Company against any third party, whether before a state or federal court, any state or  federal government agency, or a mediator or arbitrator; or (iii) any other administrative,  regulatory, or judicial inquiry, investigation, proceeding, or arbitration.  Your full cooperation in  connection with such claims or actions shall include, but not be limited to, being available to  meet with the Company&#8217;s counsel, at reasonable times and locations designated by the  Company, to investigate or prepare the Company&#8217;s claims or defenses, to prepare for trial or  discovery or an administrative hearing, mediation, arbitration or other proceeding and to act as a  witness when requested by the Company.  The term &#8220;cooperation&#8221; does not mean that you must  provide information that is favorable to the Company; it means only that you will provide truthful  information within your knowledge and possession upon request of the Company.   You further  agree that, to the extent permitted by law, you will notify the Company promptly in the event that  you are served with a subpoena (other than a subpoena issued by a government agency), or in  the event that you are asked to provide a third party (other than a government agency) with  information concerning any actual or potential complaint or claim against the Company.  10. Amendment and Waiver &#8211; This letter agreement shall be binding upon the  parties and may not be modified in any manner, except by an instrument in writing of concurrent  or subsequent date signed by duly authorized representatives of the parties hereto.  This letter  agreement is binding upon and shall inure to the benefit of the parties and their respective  agents, assigns, heirs, executors, successors and administrators.  No delay or omission by the  Company in exercising any right under this letter agreement shall operate as a waiver of that or  any other right.  A waiver or consent given by the Company on any one occasion shall be  effective only in that instance and shall not be construed as a bar to or waiver of any right on  any other occasion.  11. Validity &#8211; Should any provision of this letter agreement be declared or be  determined by any court of competent jurisdiction to be illegal or invalid, the validity of the  remaining parts, terms or provisions shall not be affected thereby and said illegal or invalid part,  term or provision shall be deemed not to be a part of this letter agreement.  12. Nature of Agreement &#8211; You understand and agree that this letter agreement is  a separation agreement and does not constitute an admission of liability or wrongdoing on the  part of the Company.    13. Acknowledgments &#8211; You acknowledge that the Company is hereby advising  you to consult with an attorney of your choosing, that you have been given a reasonable amount  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- separationagreement007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="separationagreement007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Page 7 of 8    of time to consider this letter agreement and that you have been given at least twenty-one (21)  days to consider the Supplemental Agreement.  You understand that you may revoke the  Supplemental Agreement for a period of seven (7) business days after you sign it by notifying  me in writing, and that the Supplemental Agreement shall not be effective or enforceable until  the expiration of this seven (7) business day revocation period.  You understand and agree that  by entering into the Additional Release set forth in paragraph 1 of the Supplemental Agreement,  you will be waiving any and all rights or claims you might have under the Age Discrimination in  Employment Act, as amended by the Older Workers Benefit Protection Act, and that you will be  receiving consideration beyond that to which you were previously entitled.  14. Voluntary Assent &#8211; You affirm that no other promises or agreements of any kind  have been made to or with you by any person or entity whatsoever to cause you to sign this  letter agreement, and that you fully understand the meaning and intent of this letter agreement.   You further state and represent that you have carefully read this letter agreement, understand  the contents herein, freely and voluntarily assent to all of the terms and conditions hereof, and  sign your name of your own free act.  15. Applicable Law &#8211; This letter agreement (including the Supplemental Agreement)  shall be interpreted and construed by the laws of the Commonwealth of Massachusetts, without  regard to conflict of laws provisions.  You hereby irrevocably submit to and acknowledge and  recognize the jurisdiction of the courts of the Commonwealth of Massachusetts, or if  appropriate, a federal court located in the Commonwealth of Massachusetts (which courts, for  purposes of this letter agreement, are the only courts of competent jurisdiction), over any suit,  action or other proceeding arising out of, under or in connection with this letter agreement  (including the Supplemental Agreement) or the subject matter hereof.  16. Entire Agreement &#8211; This letter agreement (including the Supplemental  Agreement) contains and constitutes the entire understanding and agreement between the  parties hereto with respect to your Benefits and the settlement of claims against the Company  and cancels all previous oral and written negotiations, agreements, and commitments in  connection therewith, including without limitation the Company&#8217;s Severance Benefits Plan, as  amended.    17. Tax Acknowledgement &#8211; In connection with the Benefits provided to you  pursuant to this letter agreement, the Company shall withhold and remit to the tax authorities  the amounts required under applicable law, and you shall be responsible for all applicable taxes  with respect to such Benefits under applicable law.  You acknowledge that you are not relying  upon the advice or representation of the Company with respect to the tax treatment of any of the  Benefits set forth in paragraph 1 of this letter agreement.     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- separationagreement008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="separationagreement008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Page 8 of 8    Very truly yours,  EDITAS MEDICINE, INC.      By: _/s/ Linea Aspesi_____________________              Linea Aspesi              Executive Vice President, Chief People  Officer     I hereby agree to the terms and conditions set forth above.  I further understand that my  eligibility for the Benefits set forth in paragraph 1 is contingent upon my timely execution, return  and non-revocation of the Supplemental Agreement, and that I am being given at least twenty- one (21) days to consider such Supplemental Agreement, and will have seven (7) business  days in which to revoke my acceptance after I sign such Supplemental Agreement.  _/s/ Bruce Eaton_____________________  Bruce Eaton, Ph.D.  _October 6, 2023____________________  Date  To be returned in a timely manner as set forth on the first page of this letter agreement.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- separationagreement009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="separationagreement009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      Attachment A  SUPPLEMENTAL AGREEMENT  1. Additional Release &#8211; In exchange for the Benefits set forth in the letter  agreement to which this Supplemental Agreement is attached, which you acknowledge you  would not otherwise be entitled to receive, you hereby fully, forever, irrevocably and  unconditionally release, remise and discharge the Company, its affiliates, subsidiaries, parent  companies, predecessors, and successors, and all of their respective past and present officers,  directors, stockholders, partners, members, employees, agents, representatives, plan  administrators, attorneys, insurers and fiduciaries (each in their individual and corporate  capacities) (collectively, the &#8220;Released Parties&#8221;) from any and all claims, charges, complaints,  demands, actions, causes of action, suits, rights, debts, sums of money, costs, accounts,  reckonings, covenants, contracts, agreements, promises, doings, omissions, damages,  executions, obligations, liabilities, and expenses (including attorneys&#8217; fees and costs), of every  kind and nature that you ever had or now have against any or all of the Released Parties,  whether known or unknown, including, but not limited to:  (i)  any and all claims arising out of or relating to your employment with and/or  separation from the Company, including, but not limited to, all claims under Title  VII of the Civil Rights Act, the Americans With Disabilities Act, the Age  Discrimination in Employment Act, the Genetic Information Nondiscrimination  Act, the Family and Medical Leave Act, the Worker Adjustment and Retraining  Notification Act, the Rehabilitation Act, Executive Order 11246, Executive Order  11141, the Fair Credit Reporting Act, and the Employee Retirement Income  Security Act, all as amended; all claims arising out of the Massachusetts Fair  Employment Practices Act, Mass. Gen. Laws ch. 151B, &sect; 1 et seq., the  Massachusetts Wage Act, Mass. Gen. Laws ch. 149, &sect; 148 et seq.  (Massachusetts law regarding payment of wages and overtime), the  Massachusetts Civil Rights Act, Mass. Gen. Laws ch. 12, &sect;&sect; 11H and 11I, the  Massachusetts Equal Rights Act, Mass. Gen. Laws. ch. 93, &sect; 102, Mass. Gen.  Laws ch. 214, &sect; 1C (Massachusetts right to be free from sexual harassment law),  the Massachusetts Labor and Industries Act, Mass. Gen. Laws ch. 149, &sect; 1 et  seq., Mass. Gen. Laws ch. 214, &sect; 1B (Massachusetts right of privacy law), the  Massachusetts Maternity Leave Act, Mass. Gen. Laws ch. 149, &sect; 105D, and the  Massachusetts Small Necessities Leave Act, Mass. Gen. Laws ch. 149, &sect; 52D,  all as amended; all claims arising out of the Colo. Rev. Stat. &sect; 24-34-401 et seq.  (Colorado anti-discrimination and anti-retaliation law), the Colorado Family Care  Act, 8-13.3-201 et seq., Colo. Rev. Stat. &sect; 19-5-211 (Colorado adoption leave  law), Colo. Rev. Stat. &sect; 24-34-402.7 (Colorado domestic violence and crime  victim leave law), Colo. Rev. Stat. &sect; 8-5-101 et seq. (Colorado equal pay law),  and Colo. Rev. Stat. &sect; 28-3-609 (Colorado military leave law), all as amended;   (ii)  all common law claims including, but not limited to, actions in defamation,  intentional infliction of emotional distress, misrepresentation, fraud, wrongful  discharge, and breach of contract;   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- separationagreement010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="separationagreement010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      (iii)  all claims to any non-vested ownership interest in the Company, contractual or  otherwise;   (iv)  all state and federal whistleblower claims to the maximum extent permitted by  law; and   (v)  any claim or damage arising out of your employment with and/or separation from  the Company (including a claim for retaliation) under any common law theory or  any federal, state or local statute or ordinance not expressly referenced above;   provided, however, that this release of claims does not prevent you from filing a  charge with, cooperating with, or participating in any investigation or proceeding  before, the Equal Employment Opportunity Commission or a state fair employment  practices agency (except that you acknowledge that you may not recover any  monetary benefits in connection with any such charge, investigation, or proceeding,  and you further waive any rights or claims to any payment, benefit, attorneys&#8217; fees or  other remedial relief in connection with any such charge, investigation or  proceeding).  2. Non-Competition &#8211; As an express condition of your receipt of the Benefits, you  agree that, for a period of one (1) year following the Separation Date, you will not, in the  Applicable Territory (as defined in your existing Restrictive Covenant Agreement), directly or  indirectly, whether as an owner, partner, officer, director, employee, consultant, investor, lender  or otherwise, except as the passive holder of not more than 1% of the outstanding stock of a  publicly-held company, engage or assist others in engaging in a Competitive Activity or provide  services for a Competitive Company. &#8220;Competitive Activity&#8221; shall mean any work related to the  research, development or commercialization of gene editing therapies to treat  hemoglobinopathies.  &#8220;Competitive Company&#8221; shall mean any entity listed on Schedule A to this  Supplemental Agreement. The restriction on providing services for a Competitive Company will  only apply if you would be performing job duties or services that are of a similar type that you  performed for the Company at any time during the last two (2) years of your employment.   Without limiting the foregoing, you acknowledge and agree that undertaking any leadership role  in a Competitive Company would constitute performing job duties or services of a similar type  that you performed for the Company.  If any restriction set forth in this paragraph is found by  any court of competent jurisdiction to be unenforceable because it extends for too long a period  of time or over too great a range of activities or in too broad a geographic area, it shall be  interpreted to extend only over the maximum period of time, range or activities or geographic  area as to which it may be enforceable.  If you violate the non-competition provisions set forth in  this paragraph, you shall continue to be bound by such restrictions until a period of one (1) year  has expired without any violation of such provisions.  You acknowledge that the Company has  given you seven (7) business days to revoke your acceptance of the non-competition  restrictions set forth in this paragraph 2.  Any such revocation must be submitted to Linea  Aspesi in writing.  For the avoidance of doubt, in the event that you revoke such agreement, you  acknowledge that you will not be eligible to receive the Benefits.  3. Business Expenses and Final Compensation &#8211; You acknowledge that you  have been reimbursed by the Company for all business expenses incurred in conjunction with  the performance of your employment and that no other reimbursements are owed to you.  You  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- separationagreement011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="separationagreement011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      further acknowledge that you have received payment in full for all services rendered in  conjunction with your employment by the Company, including payment for all wages, bonuses,  and commissions, that no other compensation is owed to you except as provided in the letter  agreement to which this Supplemental Agreement is attached.  4. Return of Company Property &#8211; You confirm that you have returned to the  Company (or will return to the Company within 5 business days of the Separation Date), all  keys, files, records (and copies thereof), equipment (including, but not limited to, computer  hardware, software, printers, flash drives and other storage devices, wireless handheld devices,  cellular phones, tablets, etc.), Company identification, and any other Company owned property  in your possession or control, and that you have left intact all, and have otherwise not  destroyed, deleted, or made inaccessible to the Company any, electronic Company documents,  including, but not limited to, those that you developed or helped to develop during your  employment, and that you have not (a) retained any copies in any form or media; (b) maintained  access to any copies in any form, media, or location; (c) stored any copies in any physical or  electronic locations that are not readily accessible or not known to the Company or that remain  accessible to you; or (d) sent, given, or made accessible any copies to any persons or entities  that the Company has not authorized to receive such electronic or hard copies. You further  confirm that you have cancelled all accounts for your benefit, if any, in the Company&#8217;s name,  including but not limited to, credit cards, telephone charge cards, cellular phone accounts, and  computer accounts.  5. Acknowledgments &#8211; You acknowledge that you have been given at least  twenty-one (21) days to consider this Supplemental Agreement (including the Additional  Release herein), and that the Company advised you in writing to consult with an attorney of your  own choosing prior to signing this Supplemental Agreement.  You understand that you may  revoke this Supplemental Agreement for a period of seven (7) business days after you sign it by  notifying me in writing, and the Supplemental Agreement shall not be effective or enforceable  until the expiration of this seven (7) business day revocation period.  You understand and agree  that by entering into this Supplemental Agreement (including the Additional Release set forth  herein), you are waiving any and all rights or claims you might have under the Age  Discrimination in Employment Act, as amended by the Older Workers Benefit Protection Act,  and that you have received consideration beyond that to which you were previously entitled.  6. Voluntary Assent &#8211; You affirm that no other promises or agreements of any kind  have been made to or with you by any person or entity whatsoever to cause you to sign this  Supplemental Agreement, and that you fully understand the meaning and intent of this  Supplemental Agreement.  You state and represent that you have had an opportunity to fully  discuss and review the terms of this Supplemental Agreement with an attorney.  You further  state and represent that you have carefully read this Supplemental Agreement, understand the  contents herein, freely and voluntarily assent to all of the terms and conditions hereof, and sign  your name of your own free act.  I hereby provide this Supplemental Agreement as of the current date and acknowledge that the  execution of this Supplemental Agreement is in further consideration of the benefits described in  the letter agreement to which this Supplemental Agreement is attached, to which I acknowledge  I would not be entitled if I did not sign this Supplemental Agreement.  I intend that this  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- separationagreement012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="separationagreement012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      Supplemental Agreement will become a binding agreement between me and the Company if I  do not revoke my acceptance in seven (7) business days.     Bruce Eaton, Ph.D.     Date  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- separationagreement013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="separationagreement013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      SCHEDULE A    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>edit-20230930xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i29441e99b94c4fc0ad97bff46d95b8d2_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I, Gilmore O&#8217;Neill, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">I have reviewed this Quarterly Report on Form 10-Q of Editas Medicine, Inc.&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.97pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.46pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.58pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.46pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.97pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.46pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:46.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; November&#160;3, 2023</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Gilmore O&#8217;Neill</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Gilmore O&#8217;Neill<br>Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>edit-20230930xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iac60b64d2bb1487390ebb853cc953ba8_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I, Erick Lucera, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">I have reviewed this Quarterly Report on Form 10-Q of Editas Medicine, Inc.&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.97pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.46pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.58pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.46pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.97pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.46pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:46.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; November&#160;3, 2023</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Erick Lucera</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Erick Lucera<br>Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>edit-20230930xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i156d1678318c49a487d2e6e1c753256e_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:10pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with this Quarterly Report on Form 10-Q of Editas Medicine, Inc. (the &#8220;Company&#8221;) for the period ended September&#160;30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. (section) 1350, as adopted pursuant to (section) 906 of the Sarbanes-Oxley Act of 2002, that to the best of her or his knowledge&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.77pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.77pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:30pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:46.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; November&#160;3, 2023</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Gilmore O&#8217;Neill</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Gilmore O&#8217;Neill</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; November&#160;3, 2023</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Erick Lucera</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Erick Lucera</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>edit-20230930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:604c5bfd-156b-497c-b087-a10c0e2b5278,g:6226a648-f95b-483f-af4b-56ce08cc4d95-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:edit="http://www.editasmedicine.com/20230930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.editasmedicine.com/20230930">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="edit-20230930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="edit-20230930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="edit-20230930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="edit-20230930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.editasmedicine.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>0000004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofComprehensiveLoss">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquity" roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>0000007 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusiness" roleURI="http://www.editasmedicine.com/role/NatureofBusiness">
        <link:definition>0000008 - Disclosure - Nature of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.editasmedicine.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000009 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashEquivalentsandMarketableSecurities" roleURI="http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecurities">
        <link:definition>0000010 - Disclosure - Cash Equivalents and Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.editasmedicine.com/role/FairValueMeasurements">
        <link:definition>0000011 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpenses" roleURI="http://www.editasmedicine.com/role/AccruedExpenses">
        <link:definition>0000012 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentnet" roleURI="http://www.editasmedicine.com/role/PropertyandEquipmentnet">
        <link:definition>0000013 - Disclosure - Property and Equipment, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.editasmedicine.com/role/CommitmentsandContingencies">
        <link:definition>0000014 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandProfitSharingAgreements" roleURI="http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreements">
        <link:definition>0000015 - Disclosure - Collaboration and Profit-Sharing Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensation" roleURI="http://www.editasmedicine.com/role/StockbasedCompensation">
        <link:definition>0000016 - Disclosure - Stock-based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShare" roleURI="http://www.editasmedicine.com/role/NetLossperShare">
        <link:definition>0000017 - Disclosure - Net Loss per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashEquivalentsandMarketableSecuritiesTables" roleURI="http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesTables">
        <link:definition>9954471 - Disclosure - Cash Equivalents and Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.editasmedicine.com/role/FairValueMeasurementsTables">
        <link:definition>9954472 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesTables" roleURI="http://www.editasmedicine.com/role/AccruedExpensesTables">
        <link:definition>9954473 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentnetTables" roleURI="http://www.editasmedicine.com/role/PropertyandEquipmentnetTables">
        <link:definition>9954474 - Disclosure - Property and Equipment, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandProfitSharingAgreementsTables" roleURI="http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsTables">
        <link:definition>9954475 - Disclosure - Collaboration and Profit-Sharing Agreements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensationTables" roleURI="http://www.editasmedicine.com/role/StockbasedCompensationTables">
        <link:definition>9954476 - Disclosure - Stock-based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShareTables" roleURI="http://www.editasmedicine.com/role/NetLossperShareTables">
        <link:definition>9954477 - Disclosure - Net Loss per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusinessDetails" roleURI="http://www.editasmedicine.com/role/NatureofBusinessDetails">
        <link:definition>9954478 - Disclosure - Nature of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashEquivalentsandMarketableSecuritiesDetails" roleURI="http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails">
        <link:definition>9954479 - Disclosure - Cash Equivalents and Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.editasmedicine.com/role/FairValueMeasurementsDetails">
        <link:definition>9954480 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesDetails" roleURI="http://www.editasmedicine.com/role/AccruedExpensesDetails">
        <link:definition>9954481 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentnetDetails" roleURI="http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails">
        <link:definition>9954482 - Disclosure - Property and Equipment, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesLeaseAgreementDetails" roleURI="http://www.editasmedicine.com/role/CommitmentsandContingenciesLeaseAgreementDetails">
        <link:definition>9954483 - Disclosure - Commitments and Contingencies - Lease Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesLicensorExpenseReimbursementsDetails" roleURI="http://www.editasmedicine.com/role/CommitmentsandContingenciesLicensorExpenseReimbursementsDetails">
        <link:definition>9954484 - Disclosure - Commitments and Contingencies - Licensor Expense Reimbursements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandProfitSharingAgreementsDetails" roleURI="http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsDetails">
        <link:definition>9954485 - Disclosure - Collaboration and Profit-Sharing Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensationExpenseDetails" roleURI="http://www.editasmedicine.com/role/StockbasedCompensationExpenseDetails">
        <link:definition>9954486 - Disclosure - Stock-based Compensation - Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensationRestrictedStockandStockOptionsDetails" roleURI="http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails">
        <link:definition>9954487 - Disclosure - Stock-based Compensation - Restricted Stock and Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShareDetails" roleURI="http://www.editasmedicine.com/role/NetLossperShareDetails">
        <link:definition>9954488 - Disclosure - Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="edit_ContractWithCustomerLiabilityRollForward" abstract="true" name="ContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="edit_MarketableSecuritiesNoncurrentNumberOfSecurities" abstract="false" name="MarketableSecuritiesNoncurrentNumberOfSecurities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="edit_LicensorExpenseReimbursementsMember" abstract="true" name="LicensorExpenseReimbursementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="edit_LaboratoryEquipmentMember" abstract="true" name="LaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="edit_IncreaseDecreaseInRightOfUseAssets" abstract="false" name="IncreaseDecreaseInRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="edit_AccountsReceivableAdditions" abstract="false" name="AccountsReceivableAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="edit_AccruedExternalResearchAndDevelopmentExpensesCurrent" abstract="false" name="AccruedExternalResearchAndDevelopmentExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="edit_CollaborationAndProfitSharingAgreements" abstract="true" name="CollaborationAndProfitSharingAgreements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued" abstract="false" name="SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="edit_LindaCBurklyMember" abstract="true" name="LindaCBurklyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="edit_ReceivablesNetCurrentRollForward" abstract="true" name="ReceivablesNetCurrentRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="edit_IntellectualPropertyAndPatentRelatedFees" abstract="false" name="IntellectualPropertyAndPatentRelatedFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock" abstract="false" name="ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="edit_AccountsReceivableDeductions" abstract="false" name="AccountsReceivableDeductions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="edit_AtMarketOfferingMember" abstract="true" name="AtMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="edit_FollowOn2023JuneOfferingMember" abstract="true" name="FollowOn2023JuneOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="edit_LicenseAndServiceAgreementMember" abstract="true" name="LicenseAndServiceAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>edit-20230930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:604c5bfd-156b-497c-b087-a10c0e2b5278,g:6226a648-f95b-483f-af4b-56ce08cc4d95-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="edit-20230930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2a75ed07-f8a9-446b-9421-b5274ab32993" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c3240417-acfb-460e-bd0b-66825bbceeca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2a75ed07-f8a9-446b-9421-b5274ab32993" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c3240417-acfb-460e-bd0b-66825bbceeca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_3e152e51-aa43-4f59-9ddb-8a2c480b85b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2a75ed07-f8a9-446b-9421-b5274ab32993" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_3e152e51-aa43-4f59-9ddb-8a2c480b85b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_d161dfde-b622-4169-b826-008881239447" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2a75ed07-f8a9-446b-9421-b5274ab32993" xlink:to="loc_us-gaap_ReceivablesNetCurrent_d161dfde-b622-4169-b826-008881239447" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_56c67c7a-00e4-472b-af24-882c0f67104e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2a75ed07-f8a9-446b-9421-b5274ab32993" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_56c67c7a-00e4-472b-af24-882c0f67104e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ce993ae4-dd97-4043-90be-810612d28c61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_94d841e0-7532-46b6-bd58-9c4f9695196a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ce993ae4-dd97-4043-90be-810612d28c61" xlink:to="loc_us-gaap_PreferredStockValue_94d841e0-7532-46b6-bd58-9c4f9695196a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_66303f76-c6ea-41e4-aa9c-fe7af349a705" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ce993ae4-dd97-4043-90be-810612d28c61" xlink:to="loc_us-gaap_CommonStockValue_66303f76-c6ea-41e4-aa9c-fe7af349a705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_57009bc9-3e62-45f3-8c9d-7b734cc6cd15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ce993ae4-dd97-4043-90be-810612d28c61" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_57009bc9-3e62-45f3-8c9d-7b734cc6cd15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_40d4915b-0725-4898-bda3-96d8d41680fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ce993ae4-dd97-4043-90be-810612d28c61" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_40d4915b-0725-4898-bda3-96d8d41680fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bf879f56-421b-4327-9b9d-13090a1a51e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ce993ae4-dd97-4043-90be-810612d28c61" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bf879f56-421b-4327-9b9d-13090a1a51e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bee0e0f0-0d4a-428c-aa77-485db5959711" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_dda9c90e-922c-4964-8c4b-32702815d184" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bee0e0f0-0d4a-428c-aa77-485db5959711" xlink:to="loc_us-gaap_Liabilities_dda9c90e-922c-4964-8c4b-32702815d184" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7c2d6032-bc67-4721-aecc-fa7e9324320d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bee0e0f0-0d4a-428c-aa77-485db5959711" xlink:to="loc_us-gaap_StockholdersEquity_7c2d6032-bc67-4721-aecc-fa7e9324320d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_add4eb78-a621-4240-ba4d-72bb0ab28f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ea857a8c-4e40-428b-9e49-64d6af8c3306" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_add4eb78-a621-4240-ba4d-72bb0ab28f7b" xlink:to="loc_us-gaap_AssetsCurrent_ea857a8c-4e40-428b-9e49-64d6af8c3306" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_e1def237-9fd2-45c2-9415-79654e57cc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_add4eb78-a621-4240-ba4d-72bb0ab28f7b" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_e1def237-9fd2-45c2-9415-79654e57cc7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4c859d85-6749-4792-86ab-6c1eea7017ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_add4eb78-a621-4240-ba4d-72bb0ab28f7b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4c859d85-6749-4792-86ab-6c1eea7017ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_900f383f-c748-4870-9bb2-55a5bb095b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_add4eb78-a621-4240-ba4d-72bb0ab28f7b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_900f383f-c748-4870-9bb2-55a5bb095b6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8ea217a3-ce31-4ac0-b507-ebdd6d494d48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_add4eb78-a621-4240-ba4d-72bb0ab28f7b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8ea217a3-ce31-4ac0-b507-ebdd6d494d48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b1d6e5cc-1146-4c8a-96ba-d3ff1722ef28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_81599e4c-6d7a-464c-9c26-31a2c69f4107" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b1d6e5cc-1146-4c8a-96ba-d3ff1722ef28" xlink:to="loc_us-gaap_AccountsPayableCurrent_81599e4c-6d7a-464c-9c26-31a2c69f4107" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ec4e12f4-3c48-446f-81e1-a0ca02efc787" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b1d6e5cc-1146-4c8a-96ba-d3ff1722ef28" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ec4e12f4-3c48-446f-81e1-a0ca02efc787" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fd9b68fd-927d-41e2-9463-548fc1662da4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b1d6e5cc-1146-4c8a-96ba-d3ff1722ef28" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fd9b68fd-927d-41e2-9463-548fc1662da4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9e65cb24-f44b-487b-9e60-cec18680f6df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b1d6e5cc-1146-4c8a-96ba-d3ff1722ef28" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9e65cb24-f44b-487b-9e60-cec18680f6df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7d41080d-297a-4ffc-95d8-e44ad6407c66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d12e5e35-102e-4d48-a906-340ec285eda8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7d41080d-297a-4ffc-95d8-e44ad6407c66" xlink:to="loc_us-gaap_LiabilitiesCurrent_d12e5e35-102e-4d48-a906-340ec285eda8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_8a165c66-bc82-4a99-9fcd-9a8ca6500a35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7d41080d-297a-4ffc-95d8-e44ad6407c66" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_8a165c66-bc82-4a99-9fcd-9a8ca6500a35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_db3b79e7-8003-4c72-8b81-1aa256c961ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7d41080d-297a-4ffc-95d8-e44ad6407c66" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_db3b79e7-8003-4c72-8b81-1aa256c961ee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="edit-20230930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ef267e7d-5047-477b-8283-bc369bf1d38a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019fe5c3-e358-4317-8b3c-e9ebc6896e29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_ef267e7d-5047-477b-8283-bc369bf1d38a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019fe5c3-e358-4317-8b3c-e9ebc6896e29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b4c9bef4-d5f2-41a8-914c-6e69264da7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_ef267e7d-5047-477b-8283-bc369bf1d38a" xlink:to="loc_us-gaap_OperatingExpenses_b4c9bef4-d5f2-41a8-914c-6e69264da7a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d3db621c-a516-4762-96cc-82a2e48c7b19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_05cfcb94-0d2e-4d66-b1c0-8883410c67fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d3db621c-a516-4762-96cc-82a2e48c7b19" xlink:to="loc_us-gaap_OperatingIncomeLoss_05cfcb94-0d2e-4d66-b1c0-8883410c67fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_0dbd46d1-5e45-4ddd-9b77-986084556bea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d3db621c-a516-4762-96cc-82a2e48c7b19" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_0dbd46d1-5e45-4ddd-9b77-986084556bea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_84736128-fc8a-4656-ba5d-6963eb1e0979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_18e3c369-2810-40d7-8a04-076a5e477511" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_84736128-fc8a-4656-ba5d-6963eb1e0979" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_18e3c369-2810-40d7-8a04-076a5e477511" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_633ba914-e62f-4266-a46e-a98beebc2162" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_84736128-fc8a-4656-ba5d-6963eb1e0979" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_633ba914-e62f-4266-a46e-a98beebc2162" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_dca8fe93-a015-4cb5-b9d7-810d6d845561" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3d1993cc-2722-4eb9-870f-27fa83b7126e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_dca8fe93-a015-4cb5-b9d7-810d6d845561" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3d1993cc-2722-4eb9-870f-27fa83b7126e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_f9d855bc-6095-4eb8-bba1-9b4ed88a4d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_dca8fe93-a015-4cb5-b9d7-810d6d845561" xlink:to="loc_us-gaap_InvestmentIncomeNet_f9d855bc-6095-4eb8-bba1-9b4ed88a4d2b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="edit-20230930.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_cc143614-6a69-43d8-b143-69761425adb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c605e28b-93bf-4d6f-8e5c-d2ea401e8c03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cc143614-6a69-43d8-b143-69761425adb9" xlink:to="loc_us-gaap_NetIncomeLoss_c605e28b-93bf-4d6f-8e5c-d2ea401e8c03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_29565e5f-0488-484c-86ea-72eeea159321" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cc143614-6a69-43d8-b143-69761425adb9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_29565e5f-0488-484c-86ea-72eeea159321" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="edit-20230930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1bfd85d2-f515-4513-bff2-36b8ad782286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc4b1292-d736-4f79-972b-be925b8a7062" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1bfd85d2-f515-4513-bff2-36b8ad782286" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc4b1292-d736-4f79-972b-be925b8a7062" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7727e335-b301-4e8c-bed9-1a6399555e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1bfd85d2-f515-4513-bff2-36b8ad782286" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7727e335-b301-4e8c-bed9-1a6399555e6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0dbca0ef-97ef-41ee-a074-98174cea2079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1bfd85d2-f515-4513-bff2-36b8ad782286" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0dbca0ef-97ef-41ee-a074-98174cea2079" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6076b80e-64ff-4faa-b3d5-a322c79c0334" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ecd8f5ba-8a56-43f8-9bd9-7266dd53780c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6076b80e-64ff-4faa-b3d5-a322c79c0334" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ecd8f5ba-8a56-43f8-9bd9-7266dd53780c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfMachineryAndEquipment_7dc6ccc3-f10b-4e7a-a34f-0f26df257114" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfMachineryAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6076b80e-64ff-4faa-b3d5-a322c79c0334" xlink:to="loc_us-gaap_ProceedsFromSaleOfMachineryAndEquipment_7dc6ccc3-f10b-4e7a-a34f-0f26df257114" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_c8064e35-09d4-4c8c-b00f-a3bcb4ddd07c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6076b80e-64ff-4faa-b3d5-a322c79c0334" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_c8064e35-09d4-4c8c-b00f-a3bcb4ddd07c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_6f86f3d7-28d4-43c4-92d2-d1718f4fb30d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6076b80e-64ff-4faa-b3d5-a322c79c0334" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_6f86f3d7-28d4-43c4-92d2-d1718f4fb30d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b60374ee-13d9-4994-a455-572f729efd6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_88d3d82a-9b21-4b10-817c-4371eedc0dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b60374ee-13d9-4994-a455-572f729efd6f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_88d3d82a-9b21-4b10-817c-4371eedc0dc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_39e13dab-ba92-4780-87c9-2642de1ad712" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b60374ee-13d9-4994-a455-572f729efd6f" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_39e13dab-ba92-4780-87c9-2642de1ad712" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_3de1188d-ef18-4d48-9665-e7a9f593a18b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b60374ee-13d9-4994-a455-572f729efd6f" xlink:to="loc_us-gaap_ProceedsFromStockPlans_3de1188d-ef18-4d48-9665-e7a9f593a18b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5e07684-e98c-4dbd-99a4-dfc7a66f1554" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_79ab5887-ce64-46d6-8c7f-8d26e7b98378" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5e07684-e98c-4dbd-99a4-dfc7a66f1554" xlink:to="loc_us-gaap_NetIncomeLoss_79ab5887-ce64-46d6-8c7f-8d26e7b98378" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_01c5f5b4-829c-40eb-9855-cdc8bd6162f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5e07684-e98c-4dbd-99a4-dfc7a66f1554" xlink:to="loc_us-gaap_ShareBasedCompensation_01c5f5b4-829c-40eb-9855-cdc8bd6162f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_fc9beb46-f5a8-4e0a-a20e-73841870657b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5e07684-e98c-4dbd-99a4-dfc7a66f1554" xlink:to="loc_us-gaap_Depreciation_fc9beb46-f5a8-4e0a-a20e-73841870657b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_dec79451-d6e0-4e96-98fa-f7075f056e04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5e07684-e98c-4dbd-99a4-dfc7a66f1554" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_dec79451-d6e0-4e96-98fa-f7075f056e04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_9a260b62-19bc-4fdf-8a57-7d3180d4810e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5e07684-e98c-4dbd-99a4-dfc7a66f1554" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_9a260b62-19bc-4fdf-8a57-7d3180d4810e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_803e3af7-c5c3-4697-acb4-cfd8aa559694" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5e07684-e98c-4dbd-99a4-dfc7a66f1554" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_803e3af7-c5c3-4697-acb4-cfd8aa559694" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_611bdf42-8b8f-448f-aefb-f4eefc4b2215" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5e07684-e98c-4dbd-99a4-dfc7a66f1554" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_611bdf42-8b8f-448f-aefb-f4eefc4b2215" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a292cf3c-5cc1-4f7e-b51f-6cd6059670d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5e07684-e98c-4dbd-99a4-dfc7a66f1554" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a292cf3c-5cc1-4f7e-b51f-6cd6059670d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_IncreaseDecreaseInRightOfUseAssets_7588cd4d-9cd3-4a31-9ee9-52caf8d2c7c0" xlink:href="edit-20230930.xsd#edit_IncreaseDecreaseInRightOfUseAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5e07684-e98c-4dbd-99a4-dfc7a66f1554" xlink:to="loc_edit_IncreaseDecreaseInRightOfUseAssets_7588cd4d-9cd3-4a31-9ee9-52caf8d2c7c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5e37b2b7-2378-4ffc-bd93-b01d57de3395" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5e07684-e98c-4dbd-99a4-dfc7a66f1554" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5e37b2b7-2378-4ffc-bd93-b01d57de3395" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_900ae0e8-46ca-4812-9e89-81809eaeda52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5e07684-e98c-4dbd-99a4-dfc7a66f1554" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_900ae0e8-46ca-4812-9e89-81809eaeda52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_631a78be-72e0-44d4-8b5b-127e457f1c88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5e07684-e98c-4dbd-99a4-dfc7a66f1554" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_631a78be-72e0-44d4-8b5b-127e457f1c88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_24d4a984-28ce-4633-9615-459393934b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5e07684-e98c-4dbd-99a4-dfc7a66f1554" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_24d4a984-28ce-4633-9615-459393934b1c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#FairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://www.editasmedicine.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d3b03dca-1663-45e0-a563-45e9761e9e35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_59a03fb7-104d-49b8-b599-d47f3d23af3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_d3b03dca-1663-45e0-a563-45e9761e9e35" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_59a03fb7-104d-49b8-b599-d47f3d23af3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_64a736c3-4bae-499d-9b4e-3e57838921c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_d3b03dca-1663-45e0-a563-45e9761e9e35" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_64a736c3-4bae-499d-9b4e-3e57838921c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_208c8393-bf19-40af-b628-07079caab143" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_d3b03dca-1663-45e0-a563-45e9761e9e35" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_208c8393-bf19-40af-b628-07079caab143" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#AccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.editasmedicine.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_1ecfc58c-09cb-4aba-afa4-25c9f0b77462" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f687d9f8-447d-4055-bd46-173c380a2ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ecfc58c-09cb-4aba-afa4-25c9f0b77462" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f687d9f8-447d-4055-bd46-173c380a2ee1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_IntellectualPropertyAndPatentRelatedFees_b3109b20-aac5-41c8-a214-e385bc9858f4" xlink:href="edit-20230930.xsd#edit_IntellectualPropertyAndPatentRelatedFees"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ecfc58c-09cb-4aba-afa4-25c9f0b77462" xlink:to="loc_edit_IntellectualPropertyAndPatentRelatedFees_b3109b20-aac5-41c8-a214-e385bc9858f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent_d130b728-451a-48ca-a40c-d7b2f3e3d028" xlink:href="edit-20230930.xsd#edit_AccruedExternalResearchAndDevelopmentExpensesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ecfc58c-09cb-4aba-afa4-25c9f0b77462" xlink:to="loc_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent_d130b728-451a-48ca-a40c-d7b2f3e3d028" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b4e118f5-f04f-464c-8656-4f4ba5c785e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ecfc58c-09cb-4aba-afa4-25c9f0b77462" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b4e118f5-f04f-464c-8656-4f4ba5c785e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_c4ea1258-0456-410b-94cb-80185e71e15c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1ecfc58c-09cb-4aba-afa4-25c9f0b77462" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_c4ea1258-0456-410b-94cb-80185e71e15c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#PropertyandEquipmentnetDetails"/>
  <link:calculationLink xlink:role="http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b8eb3c8a-5aec-4287-862b-4b351db7c142" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_d659471a-8f58-4e34-80ed-fd2742180462" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_b8eb3c8a-5aec-4287-862b-4b351db7c142" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_d659471a-8f58-4e34-80ed-fd2742180462" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_36fa8fe5-75c7-4931-b381-ec75ba010ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_b8eb3c8a-5aec-4287-862b-4b351db7c142" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_36fa8fe5-75c7-4931-b381-ec75ba010ea6" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>edit-20230930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:604c5bfd-156b-497c-b087-a10c0e2b5278,g:6226a648-f95b-483f-af4b-56ce08cc4d95-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="edit-20230930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8afd5044-df15-42d6-aea7-b50f6c6dd8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8afd5044-df15-42d6-aea7-b50f6c6dd8f5" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_12465460-027c-4e87-8247-fa48b68696ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_SharesOutstanding_12465460-027c-4e87-8247-fa48b68696ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cdcdaf73-d822-4a65-b20d-ac33cd0276eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockholdersEquity_cdcdaf73-d822-4a65-b20d-ac33cd0276eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_884d3f05-0ce7-4ec3-bf8a-41c1bac7ee46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_884d3f05-0ce7-4ec3-bf8a-41c1bac7ee46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_04f7c9a3-85cb-4173-8f54-4a14969b3502" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_04f7c9a3-85cb-4173-8f54-4a14969b3502" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ae8221b8-20a2-4adf-8230-d13bf82104d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ae8221b8-20a2-4adf-8230-d13bf82104d3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_61f92afd-39b7-4d75-b658-f85993f9e10a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_61f92afd-39b7-4d75-b658-f85993f9e10a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4443c295-d4b8-4553-a685-84bb208057e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4443c295-d4b8-4553-a685-84bb208057e7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_ed148bb9-c81f-4b2b-bcec-35a2c7211331" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_ed148bb9-c81f-4b2b-bcec-35a2c7211331" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_b1e3c36c-7a4e-49c4-a998-f615a2a2c279" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_b1e3c36c-7a4e-49c4-a998-f615a2a2c279" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7eb50e3d-5d5a-40e2-8955-bf151b8a8e15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7eb50e3d-5d5a-40e2-8955-bf151b8a8e15" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7205074a-3833-4a14-949c-b57b38471dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7205074a-3833-4a14-949c-b57b38471dd7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_ac3ee966-984c-4b35-8d12-270577901877" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_ac3ee966-984c-4b35-8d12-270577901877" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8501bf3b-9b48-467f-903c-83f9fef32842" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_NetIncomeLoss_8501bf3b-9b48-467f-903c-83f9fef32842" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_43bdaf5e-5a56-43ef-bd8f-6472058586c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_62c3f4ca-6584-4b0a-a492-f0e33623b5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_461a7969-2b27-47f4-a303-dc18724655eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8afd5044-df15-42d6-aea7-b50f6c6dd8f5" xlink:to="loc_us-gaap_StatementTable_461a7969-2b27-47f4-a303-dc18724655eb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d0108c7e-2af3-43b1-8ef2-bb71a8cd393b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_461a7969-2b27-47f4-a303-dc18724655eb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d0108c7e-2af3-43b1-8ef2-bb71a8cd393b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d0108c7e-2af3-43b1-8ef2-bb71a8cd393b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d0108c7e-2af3-43b1-8ef2-bb71a8cd393b" xlink:to="loc_us-gaap_EquityComponentDomain_d0108c7e-2af3-43b1-8ef2-bb71a8cd393b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0f3ad9e5-9a09-4449-a03d-6573d9dbf943" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d0108c7e-2af3-43b1-8ef2-bb71a8cd393b" xlink:to="loc_us-gaap_EquityComponentDomain_0f3ad9e5-9a09-4449-a03d-6573d9dbf943" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6b418bf7-cd42-4465-bca8-c7e7dbaa0fff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0f3ad9e5-9a09-4449-a03d-6573d9dbf943" xlink:to="loc_us-gaap_CommonStockMember_6b418bf7-cd42-4465-bca8-c7e7dbaa0fff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_42fc9518-e1f7-4c9e-ab0b-0d4a2ffb23d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0f3ad9e5-9a09-4449-a03d-6573d9dbf943" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_42fc9518-e1f7-4c9e-ab0b-0d4a2ffb23d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cb406aad-569d-4c37-bb8b-5a5969148994" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0f3ad9e5-9a09-4449-a03d-6573d9dbf943" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cb406aad-569d-4c37-bb8b-5a5969148994" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_ea3f9829-5032-46ff-9efd-86036eda66f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0f3ad9e5-9a09-4449-a03d-6573d9dbf943" xlink:to="loc_us-gaap_RetainedEarningsMember_ea3f9829-5032-46ff-9efd-86036eda66f2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/NatureofBusinessDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#NatureofBusinessDetails"/>
  <link:definitionLink xlink:role="http://www.editasmedicine.com/role/NatureofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_b2b521d6-267e-4a14-a1ad-c643643b1ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_651b3cc9-fbb3-4f87-8bb8-acf681d1b3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b2b521d6-267e-4a14-a1ad-c643643b1ceb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_651b3cc9-fbb3-4f87-8bb8-acf681d1b3fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e1c773e7-76ac-4157-b02d-aaa99933d082" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b2b521d6-267e-4a14-a1ad-c643643b1ceb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e1c773e7-76ac-4157-b02d-aaa99933d082" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued_6f0eb558-9fa0-433d-bcf6-e149836dbef1" xlink:href="edit-20230930.xsd#edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b2b521d6-267e-4a14-a1ad-c643643b1ceb" xlink:to="loc_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued_6f0eb558-9fa0-433d-bcf6-e149836dbef1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e23f0625-a50e-4004-a18c-44d48bc87e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b2b521d6-267e-4a14-a1ad-c643643b1ceb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e23f0625-a50e-4004-a18c-44d48bc87e1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f541f777-d8dd-4b91-aa10-929a1387912e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b2b521d6-267e-4a14-a1ad-c643643b1ceb" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f541f777-d8dd-4b91-aa10-929a1387912e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_d48618e7-2990-45a4-85f6-af35bfb5bcc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f541f777-d8dd-4b91-aa10-929a1387912e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_d48618e7-2990-45a4-85f6-af35bfb5bcc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d48618e7-2990-45a4-85f6-af35bfb5bcc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_d48618e7-2990-45a4-85f6-af35bfb5bcc7" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d48618e7-2990-45a4-85f6-af35bfb5bcc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b63be2b2-2066-42dc-b680-48e3cfa8d614" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_d48618e7-2990-45a4-85f6-af35bfb5bcc7" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b63be2b2-2066-42dc-b680-48e3cfa8d614" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_FollowOn2023JuneOfferingMember_561aad3e-be4d-48db-a316-4843d7301f5c" xlink:href="edit-20230930.xsd#edit_FollowOn2023JuneOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b63be2b2-2066-42dc-b680-48e3cfa8d614" xlink:to="loc_edit_FollowOn2023JuneOfferingMember_561aad3e-be4d-48db-a316-4843d7301f5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_AtMarketOfferingMember_7c704974-bf75-462c-97fc-b93684249cd3" xlink:href="edit-20230930.xsd#edit_AtMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b63be2b2-2066-42dc-b680-48e3cfa8d614" xlink:to="loc_edit_AtMarketOfferingMember_7c704974-bf75-462c-97fc-b93684249cd3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#CashEquivalentsandMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0853166f-5e8c-46db-bbc9-00826cd89b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0853166f-5e8c-46db-bbc9-00826cd89b6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_e5c40f57-e272-4095-bd8b-abac32412b54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_e5c40f57-e272-4095-bd8b-abac32412b54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_bdda805b-db0a-48ad-a560-567e5f1fc33e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_bdda805b-db0a-48ad-a560-567e5f1fc33e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8b36322c-3b1c-42f2-901e-a78efd859ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8b36322c-3b1c-42f2-901e-a78efd859ba7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8084ede9-0ddd-4c0a-83f5-1bb1df0f2628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8084ede9-0ddd-4c0a-83f5-1bb1df0f2628" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_f4d4bd8c-3fe0-4239-92e2-1f13b953b440" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_f4d4bd8c-3fe0-4239-92e2-1f13b953b440" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_MarketableSecuritiesNoncurrentNumberOfSecurities_1375bc5b-ae98-4b87-992b-88a205aa004e" xlink:href="edit-20230930.xsd#edit_MarketableSecuritiesNoncurrentNumberOfSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_edit_MarketableSecuritiesNoncurrentNumberOfSecurities_1375bc5b-ae98-4b87-992b-88a205aa004e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_a2f90f88-5af2-4505-8fe6-1c0e7f7e60f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_a2f90f88-5af2-4505-8fe6-1c0e7f7e60f3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_a5bac661-30cb-4cd2-b007-8eadac2a7738" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_a5bac661-30cb-4cd2-b007-8eadac2a7738" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_6f9fefe4-42d6-4bed-9777-ae11e24833b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_6f9fefe4-42d6-4bed-9777-ae11e24833b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1a2c48e1-d1a6-46e6-bd55-42a311694589" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_6f9fefe4-42d6-4bed-9777-ae11e24833b2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1a2c48e1-d1a6-46e6-bd55-42a311694589" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a2c48e1-d1a6-46e6-bd55-42a311694589_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1a2c48e1-d1a6-46e6-bd55-42a311694589" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a2c48e1-d1a6-46e6-bd55-42a311694589_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0f31521-2c95-4ddf-9959-1a01988d1dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1a2c48e1-d1a6-46e6-bd55-42a311694589" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0f31521-2c95-4ddf-9959-1a01988d1dc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7bf05769-40e4-4ad7-a82d-183776acbb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0f31521-2c95-4ddf-9959-1a01988d1dc7" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7bf05769-40e4-4ad7-a82d-183776acbb4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_0a59c1b2-c288-4529-b800-5ccda7717df7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0f31521-2c95-4ddf-9959-1a01988d1dc7" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_0a59c1b2-c288-4529-b800-5ccda7717df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_17d674b4-0d9e-4b82-abe0-86467f5b94d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0f31521-2c95-4ddf-9959-1a01988d1dc7" xlink:to="loc_us-gaap_MoneyMarketFundsMember_17d674b4-0d9e-4b82-abe0-86467f5b94d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_bd501481-5afa-4db0-9b12-900bae59d577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0f31521-2c95-4ddf-9959-1a01988d1dc7" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_bd501481-5afa-4db0-9b12-900bae59d577" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e12f59c1-11d2-4f83-a765-69f15db2a73a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0f31521-2c95-4ddf-9959-1a01988d1dc7" xlink:to="loc_us-gaap_CommercialPaperMember_e12f59c1-11d2-4f83-a765-69f15db2a73a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.editasmedicine.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_997fe5c7-d68a-46bf-abbc-26c5ba9b4c50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_e29bddfe-c618-4c0b-be19-6dd46598c985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_997fe5c7-d68a-46bf-abbc-26c5ba9b4c50" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_e29bddfe-c618-4c0b-be19-6dd46598c985" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b9630906-96c0-4c0c-b6f9-fd062e15e1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_e29bddfe-c618-4c0b-be19-6dd46598c985" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b9630906-96c0-4c0c-b6f9-fd062e15e1d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7d6e09f4-c664-44e5-b197-3db44858ff6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_e29bddfe-c618-4c0b-be19-6dd46598c985" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7d6e09f4-c664-44e5-b197-3db44858ff6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_d439711c-7e9d-4c4f-b255-5999c50423d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_e29bddfe-c618-4c0b-be19-6dd46598c985" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_d439711c-7e9d-4c4f-b255-5999c50423d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList_3b821752-7462-40d4-9ee5-a3496f0444e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents_d439711c-7e9d-4c4f-b255-5999c50423d6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList_3b821752-7462-40d4-9ee5-a3496f0444e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c6962492-3f65-460e-ade5-ad068a80163e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_e29bddfe-c618-4c0b-be19-6dd46598c985" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_c6962492-3f65-460e-ade5-ad068a80163e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4eebd31c-1679-4aa0-aaee-cd58634a9045" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_997fe5c7-d68a-46bf-abbc-26c5ba9b4c50" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4eebd31c-1679-4aa0-aaee-cd58634a9045" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_714db94b-9a1c-43a8-a0fc-4edc88675e92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4eebd31c-1679-4aa0-aaee-cd58634a9045" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_714db94b-9a1c-43a8-a0fc-4edc88675e92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_714db94b-9a1c-43a8-a0fc-4edc88675e92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_714db94b-9a1c-43a8-a0fc-4edc88675e92" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_714db94b-9a1c-43a8-a0fc-4edc88675e92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8bcd65eb-e65f-4b5e-ab03-d9720b0fe5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_714db94b-9a1c-43a8-a0fc-4edc88675e92" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8bcd65eb-e65f-4b5e-ab03-d9720b0fe5d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7d0fd852-781c-4685-8d1d-931c742eec4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8bcd65eb-e65f-4b5e-ab03-d9720b0fe5d2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7d0fd852-781c-4685-8d1d-931c742eec4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_829ab712-409b-4630-b04c-ff86e16ee7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4eebd31c-1679-4aa0-aaee-cd58634a9045" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_829ab712-409b-4630-b04c-ff86e16ee7e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_829ab712-409b-4630-b04c-ff86e16ee7e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_829ab712-409b-4630-b04c-ff86e16ee7e9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_829ab712-409b-4630-b04c-ff86e16ee7e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_953ecd69-221b-4a06-8eb7-cceec235a577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_829ab712-409b-4630-b04c-ff86e16ee7e9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_953ecd69-221b-4a06-8eb7-cceec235a577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8ef85d49-a9af-480b-befd-20361b778d75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_953ecd69-221b-4a06-8eb7-cceec235a577" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8ef85d49-a9af-480b-befd-20361b778d75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_95f5b757-d31d-419c-8855-e94449fd792c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_953ecd69-221b-4a06-8eb7-cceec235a577" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_95f5b757-d31d-419c-8855-e94449fd792c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4d28ed0e-05c6-4837-a16e-e19857daaf27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_953ecd69-221b-4a06-8eb7-cceec235a577" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4d28ed0e-05c6-4837-a16e-e19857daaf27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_8c3a3290-2db1-4b7a-a7b0-52139cf4bc55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4eebd31c-1679-4aa0-aaee-cd58634a9045" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_8c3a3290-2db1-4b7a-a7b0-52139cf4bc55" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8c3a3290-2db1-4b7a-a7b0-52139cf4bc55_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_8c3a3290-2db1-4b7a-a7b0-52139cf4bc55" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8c3a3290-2db1-4b7a-a7b0-52139cf4bc55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_576a25a0-dcea-46ca-9734-4dfb5f6e691e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_8c3a3290-2db1-4b7a-a7b0-52139cf4bc55" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_576a25a0-dcea-46ca-9734-4dfb5f6e691e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_7658e995-6421-496b-b56d-a39a46d774ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_576a25a0-dcea-46ca-9734-4dfb5f6e691e" xlink:to="loc_us-gaap_MoneyMarketFundsMember_7658e995-6421-496b-b56d-a39a46d774ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4149b6a9-09ef-4b99-920e-1d87bee993b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4eebd31c-1679-4aa0-aaee-cd58634a9045" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4149b6a9-09ef-4b99-920e-1d87bee993b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4149b6a9-09ef-4b99-920e-1d87bee993b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4149b6a9-09ef-4b99-920e-1d87bee993b3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4149b6a9-09ef-4b99-920e-1d87bee993b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_34fd32c9-fbd0-40b1-8d98-8bb6c26a9af9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4149b6a9-09ef-4b99-920e-1d87bee993b3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_34fd32c9-fbd0-40b1-8d98-8bb6c26a9af9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9d89a810-81f4-4263-8afd-c8b23f9583c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_34fd32c9-fbd0-40b1-8d98-8bb6c26a9af9" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9d89a810-81f4-4263-8afd-c8b23f9583c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_79071556-da1d-4a41-be89-8b62bc9b52df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_34fd32c9-fbd0-40b1-8d98-8bb6c26a9af9" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_79071556-da1d-4a41-be89-8b62bc9b52df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_069c497d-5e09-4bdd-9a9a-e3061d5aac93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_34fd32c9-fbd0-40b1-8d98-8bb6c26a9af9" xlink:to="loc_us-gaap_CommercialPaperMember_069c497d-5e09-4bdd-9a9a-e3061d5aac93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_5cceb5af-c5e0-4c37-bda2-24dded239ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_34fd32c9-fbd0-40b1-8d98-8bb6c26a9af9" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_5cceb5af-c5e0-4c37-bda2-24dded239ba0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#PropertyandEquipmentnetDetails"/>
  <link:definitionLink xlink:role="http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9074c149-204c-45d6-a9b6-794d5485b795" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_edd734a1-6c88-4220-a041-d6934d66a4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9074c149-204c-45d6-a9b6-794d5485b795" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_edd734a1-6c88-4220-a041-d6934d66a4b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ad81546f-c14f-4b60-8119-bd9868fda936" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9074c149-204c-45d6-a9b6-794d5485b795" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ad81546f-c14f-4b60-8119-bd9868fda936" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b50b45e5-7d2e-4037-8500-1b4bed356ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9074c149-204c-45d6-a9b6-794d5485b795" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b50b45e5-7d2e-4037-8500-1b4bed356ed0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_328b4d43-3955-4165-85da-fc3db38b072b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9074c149-204c-45d6-a9b6-794d5485b795" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_328b4d43-3955-4165-85da-fc3db38b072b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e8964b1d-8ca9-4426-95c3-6601af3bb05f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_328b4d43-3955-4165-85da-fc3db38b072b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e8964b1d-8ca9-4426-95c3-6601af3bb05f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e8964b1d-8ca9-4426-95c3-6601af3bb05f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e8964b1d-8ca9-4426-95c3-6601af3bb05f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e8964b1d-8ca9-4426-95c3-6601af3bb05f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e8964b1d-8ca9-4426-95c3-6601af3bb05f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_LaboratoryEquipmentMember_62014965-50d0-4488-bfc5-9004e18fb22e" xlink:href="edit-20230930.xsd#edit_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:to="loc_edit_LaboratoryEquipmentMember_62014965-50d0-4488-bfc5-9004e18fb22e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_aab53d16-c6db-4a89-8771-3e5b315dad87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_aab53d16-c6db-4a89-8771-3e5b315dad87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_25f5a356-87c5-4e58-8670-75011a638d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:to="loc_us-gaap_ComputerEquipmentMember_25f5a356-87c5-4e58-8670-75011a638d1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_ef10297b-74cf-4cf1-9c38-0c09f8779f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:to="loc_us-gaap_ConstructionInProgressMember_ef10297b-74cf-4cf1-9c38-0c09f8779f8b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_8725eb75-fcaf-46d4-b67c-c2ed67df33f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_8725eb75-fcaf-46d4-b67c-c2ed67df33f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_be5506d3-4cbc-4c28-be0b-e4b1db09de81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_be5506d3-4cbc-4c28-be0b-e4b1db09de81" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CommitmentsandContingenciesLeaseAgreementDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#CommitmentsandContingenciesLeaseAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.editasmedicine.com/role/CommitmentsandContingenciesLeaseAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_051dd794-5dbb-4b62-9812-f2a1caeeca42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ead65f2-34c6-4d54-ba93-b07e56a23bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_051dd794-5dbb-4b62-9812-f2a1caeeca42" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ead65f2-34c6-4d54-ba93-b07e56a23bbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_66b8aad2-5129-4801-bd44-02a991791059" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_051dd794-5dbb-4b62-9812-f2a1caeeca42" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_66b8aad2-5129-4801-bd44-02a991791059" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d6bfe404-5894-43cb-ab42-49aebcf2a54c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_051dd794-5dbb-4b62-9812-f2a1caeeca42" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d6bfe404-5894-43cb-ab42-49aebcf2a54c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d88b15de-8ba0-4a58-a110-ccf6e7781b98" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d6bfe404-5894-43cb-ab42-49aebcf2a54c" xlink:to="loc_srt_CounterpartyNameAxis_d88b15de-8ba0-4a58-a110-ccf6e7781b98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d88b15de-8ba0-4a58-a110-ccf6e7781b98_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_d88b15de-8ba0-4a58-a110-ccf6e7781b98" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d88b15de-8ba0-4a58-a110-ccf6e7781b98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2ec9b517-13e5-4516-82f8-b172716e0962" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_d88b15de-8ba0-4a58-a110-ccf6e7781b98" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2ec9b517-13e5-4516-82f8-b172716e0962" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_LicenseAndServiceAgreementMember_46bdd4ea-7230-4468-a25e-ae53ab340117" xlink:href="edit-20230930.xsd#edit_LicenseAndServiceAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2ec9b517-13e5-4516-82f8-b172716e0962" xlink:to="loc_edit_LicenseAndServiceAgreementMember_46bdd4ea-7230-4468-a25e-ae53ab340117" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CommitmentsandContingenciesLicensorExpenseReimbursementsDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#CommitmentsandContingenciesLicensorExpenseReimbursementsDetails"/>
  <link:definitionLink xlink:role="http://www.editasmedicine.com/role/CommitmentsandContingenciesLicensorExpenseReimbursementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_f8d34413-8d25-4060-bdc7-0bfa62b80896" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalAndContractServicesExpense_5939de45-d333-4aff-8f81-12c70bdc3bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalAndContractServicesExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8d34413-8d25-4060-bdc7-0bfa62b80896" xlink:to="loc_us-gaap_ProfessionalAndContractServicesExpense_5939de45-d333-4aff-8f81-12c70bdc3bb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_4946c287-b3a8-46d6-8ce5-1234b69fccad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8d34413-8d25-4060-bdc7-0bfa62b80896" xlink:to="loc_us-gaap_OtherCommitmentsTable_4946c287-b3a8-46d6-8ce5-1234b69fccad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_d497fcee-9f25-4777-8905-e6b54cbc82d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_4946c287-b3a8-46d6-8ce5-1234b69fccad" xlink:to="loc_us-gaap_OtherCommitmentsAxis_d497fcee-9f25-4777-8905-e6b54cbc82d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_d497fcee-9f25-4777-8905-e6b54cbc82d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_d497fcee-9f25-4777-8905-e6b54cbc82d7" xlink:to="loc_us-gaap_OtherCommitmentsDomain_d497fcee-9f25-4777-8905-e6b54cbc82d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_f3d2234f-1e32-4034-83dd-6bd1ae68c00c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_d497fcee-9f25-4777-8905-e6b54cbc82d7" xlink:to="loc_us-gaap_OtherCommitmentsDomain_f3d2234f-1e32-4034-83dd-6bd1ae68c00c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_LicensorExpenseReimbursementsMember_64e3a3ba-de83-41bd-a764-1e8f02eb89ca" xlink:href="edit-20230930.xsd#edit_LicensorExpenseReimbursementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_f3d2234f-1e32-4034-83dd-6bd1ae68c00c" xlink:to="loc_edit_LicensorExpenseReimbursementsMember_64e3a3ba-de83-41bd-a764-1e8f02eb89ca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/StockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#StockbasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.editasmedicine.com/role/StockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fa2073d-259d-4989-b6be-c232a1fe67d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4cfce093-e8e1-49dd-86fa-9c03f8d4066c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fa2073d-259d-4989-b6be-c232a1fe67d2" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4cfce093-e8e1-49dd-86fa-9c03f8d4066c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b3e39d0b-1307-4274-beb4-cf5509f9c37f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fa2073d-259d-4989-b6be-c232a1fe67d2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b3e39d0b-1307-4274-beb4-cf5509f9c37f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_cf9e536a-c659-45e4-b3bb-0fd64582040d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b3e39d0b-1307-4274-beb4-cf5509f9c37f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_cf9e536a-c659-45e4-b3bb-0fd64582040d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cf9e536a-c659-45e4-b3bb-0fd64582040d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_cf9e536a-c659-45e4-b3bb-0fd64582040d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cf9e536a-c659-45e4-b3bb-0fd64582040d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_572cacf6-8544-4aef-99ee-3d2ac72fe706" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_cf9e536a-c659-45e4-b3bb-0fd64582040d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_572cacf6-8544-4aef-99ee-3d2ac72fe706" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4dd5f4d3-752f-4b16-935e-7418eced4de3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_572cacf6-8544-4aef-99ee-3d2ac72fe706" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4dd5f4d3-752f-4b16-935e-7418eced4de3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_fedc0817-afc4-47ed-853a-f7fb8acdb7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_572cacf6-8544-4aef-99ee-3d2ac72fe706" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_fedc0817-afc4-47ed-853a-f7fb8acdb7a6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#StockbasedCompensationRestrictedStockandStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3a1996e8-eefc-4c0a-bf59-930a7ea320b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3a1996e8-eefc-4c0a-bf59-930a7ea320b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_06257733-b735-41c7-b6dc-3d5b0f9a2331" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3a1996e8-eefc-4c0a-bf59-930a7ea320b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_06257733-b735-41c7-b6dc-3d5b0f9a2331" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c26fb378-c828-4f46-9335-32e34339e838" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3a1996e8-eefc-4c0a-bf59-930a7ea320b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c26fb378-c828-4f46-9335-32e34339e838" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_120fdd52-993f-479e-81aa-abb48cee94bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3a1996e8-eefc-4c0a-bf59-930a7ea320b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_120fdd52-993f-479e-81aa-abb48cee94bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1e2dfc1e-1cee-4201-9603-19d3e9913fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3a1996e8-eefc-4c0a-bf59-930a7ea320b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1e2dfc1e-1cee-4201-9603-19d3e9913fdc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75a2041a-8588-4ab4-93d8-b9e8b63159ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_41a42169-2bc0-42d6-851d-d72aa0887b48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_41a42169-2bc0-42d6-851d-d72aa0887b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_23ca9066-3b6a-46d9-b10a-cb69ae4e29fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_41a42169-2bc0-42d6-851d-d72aa0887b48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_23ca9066-3b6a-46d9-b10a-cb69ae4e29fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c2eac397-50ee-4725-b48e-98b79d2542df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_41a42169-2bc0-42d6-851d-d72aa0887b48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c2eac397-50ee-4725-b48e-98b79d2542df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0bb535df-ba8e-4b22-bb80-4d9a08ea261d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_41a42169-2bc0-42d6-851d-d72aa0887b48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0bb535df-ba8e-4b22-bb80-4d9a08ea261d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_846c9412-18c1-4195-8d8a-ade5f3e6c7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_41a42169-2bc0-42d6-851d-d72aa0887b48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_846c9412-18c1-4195-8d8a-ade5f3e6c7c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f01cdfc4-da97-4fc5-9e4b-6100a821cc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_17a7ec3e-1861-48e9-8e9b-0df5b29a0b34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_17a7ec3e-1861-48e9-8e9b-0df5b29a0b34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d30413b4-7dc1-4516-ba47-8a8f91a45b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d30413b4-7dc1-4516-ba47-8a8f91a45b2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acbbdc9d-5c11-4e50-9998-199b025ccfdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acbbdc9d-5c11-4e50-9998-199b025ccfdd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9507619f-4a5b-4461-926e-1ec75870c1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acbbdc9d-5c11-4e50-9998-199b025ccfdd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9507619f-4a5b-4461-926e-1ec75870c1dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b47f392f-151d-4e91-b42a-8153213196b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acbbdc9d-5c11-4e50-9998-199b025ccfdd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b47f392f-151d-4e91-b42a-8153213196b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ac7dea0f-8c4c-437f-8888-dcb7de00411d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acbbdc9d-5c11-4e50-9998-199b025ccfdd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ac7dea0f-8c4c-437f-8888-dcb7de00411d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_b12ad914-8bb0-4e13-b03d-68a1d8724163" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acbbdc9d-5c11-4e50-9998-199b025ccfdd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_b12ad914-8bb0-4e13-b03d-68a1d8724163" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_91c7b883-f57b-4392-a335-074f50f5a66d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a7ea1b29-c934-46fd-ae48-27e0b82628f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a7ea1b29-c934-46fd-ae48-27e0b82628f9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e7723ac7-5cac-4454-8e08-0dec643160db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e7723ac7-5cac-4454-8e08-0dec643160db" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_159b97e6-c9e5-46fa-a79c-2e62a0785d86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e7723ac7-5cac-4454-8e08-0dec643160db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_159b97e6-c9e5-46fa-a79c-2e62a0785d86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4c50fb13-51fc-4e60-b4d6-bdb518b4cbac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e7723ac7-5cac-4454-8e08-0dec643160db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4c50fb13-51fc-4e60-b4d6-bdb518b4cbac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5b820f4e-1066-4ad1-8c8b-5e24c9d8573d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e7723ac7-5cac-4454-8e08-0dec643160db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5b820f4e-1066-4ad1-8c8b-5e24c9d8573d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_de89d87f-3060-4536-b635-0dd2f105ebbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e7723ac7-5cac-4454-8e08-0dec643160db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_de89d87f-3060-4536-b635-0dd2f105ebbf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_31187e16-c7bd-4da2-9a1e-1ea68f25c375" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_29c7a3c1-33cd-439f-8658-972b46da010a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_29c7a3c1-33cd-439f-8658-972b46da010a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_6dd3f758-730c-416b-bc40-86e607f99e82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_6dd3f758-730c-416b-bc40-86e607f99e82" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0388e575-ad6e-4c2f-bf97-4c4c148e596e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_6dd3f758-730c-416b-bc40-86e607f99e82" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0388e575-ad6e-4c2f-bf97-4c4c148e596e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_585793e2-7b59-41ac-925a-374fa98bc88c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_6dd3f758-730c-416b-bc40-86e607f99e82" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_585793e2-7b59-41ac-925a-374fa98bc88c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ff5a0b8a-0fc6-4675-853f-d47d511d99c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_6dd3f758-730c-416b-bc40-86e607f99e82" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ff5a0b8a-0fc6-4675-853f-d47d511d99c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_8b2014ea-941d-429c-97de-77ebe741c9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_6dd3f758-730c-416b-bc40-86e607f99e82" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_8b2014ea-941d-429c-97de-77ebe741c9ee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbeb87ad-2714-43bf-a488-d05ba1809917" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbeb87ad-2714-43bf-a488-d05ba1809917" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_03612598-19b7-439b-b9ed-74c9c24cfa44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbeb87ad-2714-43bf-a488-d05ba1809917" xlink:to="loc_us-gaap_AwardTypeAxis_03612598-19b7-439b-b9ed-74c9c24cfa44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03612598-19b7-439b-b9ed-74c9c24cfa44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_03612598-19b7-439b-b9ed-74c9c24cfa44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03612598-19b7-439b-b9ed-74c9c24cfa44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19dcf83-dc81-45c8-91f3-34693d5621ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_03612598-19b7-439b-b9ed-74c9c24cfa44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19dcf83-dc81-45c8-91f3-34693d5621ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a997bede-31c8-443d-900d-ffa28169482a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19dcf83-dc81-45c8-91f3-34693d5621ad" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a997bede-31c8-443d-900d-ffa28169482a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_c0ed0228-c41e-4de6-be65-c8593ac09a30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19dcf83-dc81-45c8-91f3-34693d5621ad" xlink:to="loc_us-gaap_PerformanceSharesMember_c0ed0228-c41e-4de6-be65-c8593ac09a30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5b9912f9-99c1-4553-a819-dd07d7214dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19dcf83-dc81-45c8-91f3-34693d5621ad" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5b9912f9-99c1-4553-a819-dd07d7214dd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_e48d92f1-f212-46e5-ae1a-a871804d2744" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbeb87ad-2714-43bf-a488-d05ba1809917" xlink:to="loc_us-gaap_GranteeStatusAxis_e48d92f1-f212-46e5-ae1a-a871804d2744" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_e48d92f1-f212-46e5-ae1a-a871804d2744_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_e48d92f1-f212-46e5-ae1a-a871804d2744" xlink:to="loc_us-gaap_GranteeStatusDomain_e48d92f1-f212-46e5-ae1a-a871804d2744_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_1d369797-60c3-49d0-977e-0043db2208b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_e48d92f1-f212-46e5-ae1a-a871804d2744" xlink:to="loc_us-gaap_GranteeStatusDomain_1d369797-60c3-49d0-977e-0043db2208b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_c3e58331-797e-4c47-8405-21a42013219a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_1d369797-60c3-49d0-977e-0043db2208b6" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_c3e58331-797e-4c47-8405-21a42013219a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/NetLossperShareDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#NetLossperShareDetails"/>
  <link:definitionLink xlink:role="http://www.editasmedicine.com/role/NetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d7f46fbf-e7de-4a1e-bff1-c314116236ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a63e80b5-f955-49ea-ba74-e54cce7a252a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d7f46fbf-e7de-4a1e-bff1-c314116236ad" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a63e80b5-f955-49ea-ba74-e54cce7a252a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_215a23fe-464d-4678-88aa-0f5ab750116e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d7f46fbf-e7de-4a1e-bff1-c314116236ad" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_215a23fe-464d-4678-88aa-0f5ab750116e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3a418467-515b-47e8-80b1-eeece25c5fac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_215a23fe-464d-4678-88aa-0f5ab750116e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3a418467-515b-47e8-80b1-eeece25c5fac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3a418467-515b-47e8-80b1-eeece25c5fac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3a418467-515b-47e8-80b1-eeece25c5fac" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3a418467-515b-47e8-80b1-eeece25c5fac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35af975b-fde1-471f-9c6a-c6a16aa07a05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3a418467-515b-47e8-80b1-eeece25c5fac" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35af975b-fde1-471f-9c6a-c6a16aa07a05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_bf7ee824-2235-4fd8-80d6-eca049abf81f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35af975b-fde1-471f-9c6a-c6a16aa07a05" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_bf7ee824-2235-4fd8-80d6-eca049abf81f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9a9daa81-08bd-4189-97e4-ae4917a53ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35af975b-fde1-471f-9c6a-c6a16aa07a05" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9a9daa81-08bd-4189-97e4-ae4917a53ecb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_PerformanceSharesMember" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_LindaCBurklyMember_7d820709-c343-4b75-b6b7-3bda475ca836" xlink:href="edit-20230930.xsd#edit_LindaCBurklyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_edit_LindaCBurklyMember_7d820709-c343-4b75-b6b7-3bda475ca836" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>edit-20230930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:604c5bfd-156b-497c-b087-a10c0e2b5278,g:6226a648-f95b-483f-af4b-56ce08cc4d95-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_699bdba6-9d07-45a1-878d-d16c9bb873ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_638a6cf3-1f71-4488-af65-3e5853f75fde_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_e32966d7-d6f8-4583-be75-a950dde8eb06_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_15a3a390-98dd-4b3c-ae3c-13bccdb78744_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_186eb59f-beb7-477e-9dde-4dea52d6418a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd47cae6-a1ca-48d7-8b49-6a382c4b4d6f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_309a09bd-5776-490b-9b49-20fd553c3930_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted stock unit awards, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3a84bc20-07df-436c-b46b-6e7bc48f49ae_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted stock unit awards, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_2141aca4-d3ad-4f99-b12c-c0258467987c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_d6684c9d-235d-425b-8938-bc08c748be91_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Equivalents and Marketable Securities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_ceac1ba2-fdda-4837-9f2e-9d56d6613a3e_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_2fe32a55-85c5-4df4-8e2e-d1f0c3313bde_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_655aed42-bf3c-4778-a532-0da8f863a5a8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_4b3de2dd-addb-454b-a3e9-4ccdefeb296d_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_0e6e4a3c-f848-43ab-ae55-b490311f10b2_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate notes/bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_e71845bd-6278-417a-b34d-e94f9b7c4d5d_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate notes/bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_a55d2a64-b2c1-4b72-a429-e0eb53b9c925_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_8657a473-242a-4cb6-ad3f-f0db18464420_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_686e5747-9d90-4ac9-8c94-fb64f2280a0e_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Unvested Restricted Stock</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_0dbc657c-48d2-4e22-a536-9c8b8e6de98a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from offering of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_ec5d538d-ad54-470c-9600-7d1818ec55ff_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of shares</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8bef2714-1611-4a16-b1f0-9269bf1f5392_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_3132d458-4a13-42c5-bc9e-ca3e6f6199d0_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_919532a1-8710-4cb8-9e69-8762203b9361_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_b276c35f-accd-46fb-ba59-075d5f9174f5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_761cd5ed-e4dd-45b2-9e72-913b1d4fa20d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted common stock awards (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_17a79a13-9163-4703-b0dd-7769cb6462fb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_8ca44d77-44b7-4294-a931-220d65959e90_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_2f760378-610e-4f4c-bb2c-74b6845e5b69_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.0001 par value per share: 5,000,000 shares authorized; no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_37ad8124-ca8c-4549-9632-6d921419b52f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ed76c829-a6a3-431c-95db-6456a67fc173_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_8895859f-97d9-4026-bae2-a10438fe1706_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e76adb08-7c80-489c-83e8-13d0848443a9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1e886f4a-699f-4b40-935d-05fe39ad40fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_6f9bcf22-1185-4dfa-aac2-5ad2f59f56c4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_AccountsReceivableAdditions_3f282522-73d8-491a-9043-b64343fca3ff_terseLabel_en-US" xlink:label="lab_edit_AccountsReceivableAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, Additions</link:label>
    <link:label id="lab_edit_AccountsReceivableAdditions_label_en-US" xlink:label="lab_edit_AccountsReceivableAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Additions</link:label>
    <link:label id="lab_edit_AccountsReceivableAdditions_documentation_en-US" xlink:label="lab_edit_AccountsReceivableAdditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of additions to accounts receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_AccountsReceivableAdditions" xlink:href="edit-20230930.xsd#edit_AccountsReceivableAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_AccountsReceivableAdditions" xlink:to="lab_edit_AccountsReceivableAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3db1f3b0-c2f7-4a61-83da-c3a79aef0c3c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_98501e2f-7af5-4666-a2d8-6c1cf7b11b8c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_571b43b9-49cf-437b-a340-5ef165774e7a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_7868e650-f94e-434a-933e-5e0f785e2301_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_5887d109-dc41-4966-b53e-c846e01f16ad_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9cdd2b9e-2dc5-4a39-bbe2-cde290d1f8f7_verboseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_28731131-38df-4eb6-897f-e342e8df54db_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_7d8f6c42-7d0a-4cbd-a969-5c0c677303d0_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_7dee5166-4655-480a-9afb-eef48977290b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_0a37e8b4-1ddb-4625-9087-e1d1e554fb4e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_c1d346b9-298a-4744-93e2-f8925b5ea5ce_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_d73af2e9-119c-46ea-8e3c-c8b9419c3540_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_63fd0e84-b584-4a07-a021-21a3677cbcad_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_7084219a-7164-4afb-be0e-e4962c80dd08_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_3367019d-7bc7-4223-a68a-8059538ff6a4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ad140402-3587-49e6-b732-fe82cc52fb41_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_7591aa19-7359-4bdf-8d4a-8910d813ef15_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_1f574504-9b15-478a-88de-ff9864ac620e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, balance at end of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0b6d4a7b-8b9f-4905-b3ca-f1b8730ef7b4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f1b0a2fe-8874-4b38-91cc-80eb20cfdb08_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7167bf11-0eb2-42c5-a749-a52bcbffe246_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_7badcd25-9df5-41fe-9df9-795b0ee302b9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_aa6d2b23-4f06-403b-973e-cd537282a895_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0a06d70-cc2f-441f-b296-6a4c1da5a558_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_4405c5de-bfa8-4c1b-97ed-d2d33d233150_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets for Identical Assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_96ae2588-1d99-4738-9591-722ae404876b_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_18b4a66d-eca0-4151-8bc6-1f799459dac3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_17979f78-423f-446d-9b33-22bd4ae89412_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_be78c9ce-a90c-44b5-bb00-af36aaba4a84_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_812bf49c-0ec6-4462-b02a-8ec0e0f596ba_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_713e0e74-3cf9-45a4-841d-1d14a3412793_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1f7a4b56-09eb-4134-ae1f-6b8d81fde9f7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_6c9a6559-6ee3-4ef7-afb4-8bf44b40bedf_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d38f6da0-902d-4d2b-ae5e-ece6bc1cad61_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_c9cd1792-9952-4f64-a78d-c2e7e231c917_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_efe830f0-74f3-402f-9769-237b3e9d3115_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_24fac8d0-e23d-42ba-97ba-e854708b606a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_7249bddc-e0b7-43dd-979c-3c1dfdb4cfad_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Unit Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_ea97d6d0-f8ea-4159-b512-97800f062fe1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted stock unit awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_cfecaf27-00d9-42d4-a9dc-a7f1820a009e_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_afe62845-d19a-46aa-9147-089bc665c9d6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_7d8c3080-3f7b-46c1-b25f-4e2a7277c123_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Anti-Dilutive Common Stock Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_73c5c5d6-9ba6-4876-8a6f-404211f81edc_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_9fd8d998-1f7a-4a12-9531-eb912d580494_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_faa705fa-68a9-4d39-8749-992e3b6b2367_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_78ff1105-c167-497d-9199-6eb0aa4a2482_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities:</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_003bbfdc-3771-4fba-ac18-b5b2ea1e6106_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive common stock equivalent shares (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_d9a75383-69c6-485c-a5c3-05e7ee8bba38_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3e75d69d-7def-4355-886d-c34abf42889c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_8b52d3a2-d5d3-4f6a-ac9d-51d9d7c0a042_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a09eb206-2456-4d89-a248-8a3ace48eccd_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed asset additions included in accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_76378b46-e608-4a32-ac7b-4a94010b7c0c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_6885d5a2-4bba-49ec-b383-219343a7b8bf_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_f7dbb9ac-3db1-4fcd-a996-a053fae36b77_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3ebda76a-3011-44f6-9d0f-3bb4824cb6e2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining contractual life (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f32bf8cd-6326-4bd3-b9b7-d70ed7eef592_verboseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange of operating lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_cbd48d42-0dbc-4116-9cd2-d2989ede4850_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ec0787bc-d2e8-4e03-876e-4a4581a9493a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_231d83ea-a481-4da1-aa0c-2437b09f0cfc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_95f17a7a-9d01-47a5-8ded-16edfb332772_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a5fbd423-b1ef-49ae-acfc-d3b7336a8c15_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_c2e6f887-d4a7-41b2-a40f-0fa3fd960f56_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_c57bd326-154d-4ad4-a0ec-479286579410_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_65877fe4-ddc4-4c48-81ba-03d9a2c3b545_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6d54fda0-091e-43c0-89ed-0aaf8333a548_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_269384e0-74bb-419c-b821-86d84ad408cd_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_eda0ad49-bcdd-4e5e-8458-7137e6818c53_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c697a8df-2acd-4c1e-b7f5-8046ce1ed700_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_490ff231-e245-429c-aafa-7ca088135b66_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_8ebe2716-86e8-4167-aab4-9a27674c757c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_b984f5d6-708e-4371-b47b-c07d4b81ca4c_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total financial assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_349fa97d-cc1f-4937-846c-ebc947332e4c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of securities in an unrealized loss position for more than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a9087a79-b8be-48f1-b607-e91f9dfee752_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_75b90d26-6af2-4d64-9639-bae32bcec28c_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and Profit-Sharing Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_1f045ba4-c85e-4f17-9f61-5c49362aeaba_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_7ecfa044-abaa-48d3-9dc1-c5e5c5a6537e_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_47cb0be6-c4dd-47a8-86b3-78928f759e8f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_4b67db71-57d7-4797-ae5f-f31fbede1744_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0c450303-cb6f-48e0-9344-8d6d876e3a6d_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_a67084de-0260-4fe2-97e0-ddfba3bcbd08_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_76ce11fa-5e2b-4cb5-a7a3-d5809b9d05b9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_8cbf7404-4cab-4fe5-80e9-9da670129ef6_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_b121582b-fc41-48ab-90e8-a2efc81b1faa_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_72449f4f-4406-41a1-8d4e-6a5bdbc31107_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_73cd9e37-d1e5-4e33-8fa3-9b706f9bebb2_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_260531c5-cd8a-45bb-917e-c5f2493028b7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_fda961ba-32cf-4f2f-8b31-6b2597fd0694_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7d642b05-2eb1-488b-9c57-13b0fb03690c_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from public offering, net commissions, underwriting discounts and offering costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_82f24eab-70ea-4fde-b27a-6f97734535d5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_50461ddf-59e0-4a31-8924-f304fdb2c532_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c1bc12ef-7df3-489a-b93f-b4b95f10678f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_910be172-9a7d-48df-96ac-98e5de9900a5_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a9a1e893-40de-4898-bae0-7f98c828748f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, ending of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_11e95f98-a470-4783-94ab-f30159373e9a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_LaboratoryEquipmentMember_74ed6ad3-79ea-4d96-bf81-6aa3a41b86d7_terseLabel_en-US" xlink:label="lab_edit_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_edit_LaboratoryEquipmentMember_label_en-US" xlink:label="lab_edit_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment [Member]</link:label>
    <link:label id="lab_edit_LaboratoryEquipmentMember_documentation_en-US" xlink:label="lab_edit_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment used for research and development.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_LaboratoryEquipmentMember" xlink:href="edit-20230930.xsd#edit_LaboratoryEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_LaboratoryEquipmentMember" xlink:to="lab_edit_LaboratoryEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5444e848-361f-4a4a-a158-6a6e3d739e65_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_96efb431-df95-4542-b11e-f3b535106af3_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_4eacc0b0-9f54-4c2f-ba69-bfbc9a8265bb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_18b6f3a1-b954-4ae8-aa49-5927aa238d6f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfessionalAndContractServicesExpense_396634c7-483e-4efd-ad0c-e91b246287df_terseLabel_en-US" xlink:label="lab_us-gaap_ProfessionalAndContractServicesExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense for prosecution and maintenance of patent rights</link:label>
    <link:label id="lab_us-gaap_ProfessionalAndContractServicesExpense_label_en-US" xlink:label="lab_us-gaap_ProfessionalAndContractServicesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional and Contract Services Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalAndContractServicesExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalAndContractServicesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalAndContractServicesExpense" xlink:to="lab_us-gaap_ProfessionalAndContractServicesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_69a7b9c6-3f14-464f-ac8a-e55ffe857f63_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_6778ced2-c53e-4ee4-884b-44de6240dd12_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_IncreaseDecreaseInRightOfUseAssets_2301c026-11bc-4f4b-a509-f3d7094d5173_negatedLabel_en-US" xlink:label="lab_edit_IncreaseDecreaseInRightOfUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_edit_IncreaseDecreaseInRightOfUseAssets_label_en-US" xlink:label="lab_edit_IncreaseDecreaseInRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Right Of Use Assets</link:label>
    <link:label id="lab_edit_IncreaseDecreaseInRightOfUseAssets_documentation_en-US" xlink:label="lab_edit_IncreaseDecreaseInRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount represents the increase (decrease) in right of use assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_IncreaseDecreaseInRightOfUseAssets" xlink:href="edit-20230930.xsd#edit_IncreaseDecreaseInRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_IncreaseDecreaseInRightOfUseAssets" xlink:to="lab_edit_IncreaseDecreaseInRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a22e952a-2854-48a2-a32d-063fef8bcd87_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_47c96da7-7d16-4caa-9024-a75462ef2001_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock_f0422598-3a63-42e0-8766-04ff85d7acd3_terseLabel_en-US" xlink:label="lab_edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Receivable and Contract Liabilities</link:label>
    <link:label id="lab_edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock_label_en-US" xlink:label="lab_edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Accounts Receivable And Contract Liabilities Table Text Block [Table Text Block]</link:label>
    <link:label id="lab_edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock_documentation_en-US" xlink:label="lab_edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of account receivable and contract liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock" xlink:href="edit-20230930.xsd#edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock" xlink:to="lab_edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8372148e-552b-43f5-a377-feef7e1ab9fa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_ReceivablesNetCurrentRollForward_c8304947-0e2c-4c69-bc5a-ee69607a261b_terseLabel_en-US" xlink:label="lab_edit_ReceivablesNetCurrentRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current [Roll Forward]</link:label>
    <link:label id="lab_edit_ReceivablesNetCurrentRollForward_label_en-US" xlink:label="lab_edit_ReceivablesNetCurrentRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current [Roll Forward]</link:label>
    <link:label id="lab_edit_ReceivablesNetCurrentRollForward_documentation_en-US" xlink:label="lab_edit_ReceivablesNetCurrentRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_ReceivablesNetCurrentRollForward" xlink:href="edit-20230930.xsd#edit_ReceivablesNetCurrentRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_ReceivablesNetCurrentRollForward" xlink:to="lab_edit_ReceivablesNetCurrentRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_850c1eff-cffc-4789-8e65-20bde7f13fa7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f1046917-3cb3-455f-9150-b0393014b23a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_723449f9-8e6c-4bfb-bc69-d8bbad2f57e0_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_97877724-c897-4024-8fab-ab0c32a90d28_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_6dabc567-1bf6-4f67-a20c-a0e3e836195a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_dbc8fc0e-39a3-4fb7-826b-6ea8a09de6bb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_AccountsReceivableDeductions_cc9e3c80-8ef7-46e9-af4d-b6b58838ffce_negatedLabel_en-US" xlink:label="lab_edit_AccountsReceivableDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, Deductions</link:label>
    <link:label id="lab_edit_AccountsReceivableDeductions_label_en-US" xlink:label="lab_edit_AccountsReceivableDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Deductions</link:label>
    <link:label id="lab_edit_AccountsReceivableDeductions_documentation_en-US" xlink:label="lab_edit_AccountsReceivableDeductions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of deductions to accounts receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_AccountsReceivableDeductions" xlink:href="edit-20230930.xsd#edit_AccountsReceivableDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_AccountsReceivableDeductions" xlink:to="lab_edit_AccountsReceivableDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_53dd3d4e-227f-4c0a-ac69-9745c9bcdbe5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_43ae2b12-e98a-4051-895c-2270e93959fa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_9312f3af-0ed0-4765-ba5e-1d0055488f22_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_LicensorExpenseReimbursementsMember_67a3aec5-6cb8-4d4e-acc3-20da6b2a6b4b_terseLabel_en-US" xlink:label="lab_edit_LicensorExpenseReimbursementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensor Expense Reimbursements</link:label>
    <link:label id="lab_edit_LicensorExpenseReimbursementsMember_label_en-US" xlink:label="lab_edit_LicensorExpenseReimbursementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensor Expense Reimbursements [Member]</link:label>
    <link:label id="lab_edit_LicensorExpenseReimbursementsMember_documentation_en-US" xlink:label="lab_edit_LicensorExpenseReimbursementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment to reimburse the licensor for prosecution and maintenance of patent rights pursuant to the license agreement by and among the reporting entity, The Broad Institute Inc. and the Fellows of Harvard College.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_LicensorExpenseReimbursementsMember" xlink:href="edit-20230930.xsd#edit_LicensorExpenseReimbursementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_LicensorExpenseReimbursementsMember" xlink:to="lab_edit_LicensorExpenseReimbursementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1e6e4eb5-77db-453f-aa41-1a700566877f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3500d1d9-6bd0-4602-8b7a-35f6eecb9b61_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive securities</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_636de039-1efc-40c3-bc17-7e739085fd38_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid in connection with operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_81a9cf56-445b-4ebd-9123-d06221bf0144_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable debt securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b93325c4-b9c4-4ffd-8694-240c67e485f8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_6179787d-8556-4367-b983-9b909274b946_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_cbbddb82-b5d3-49fa-8452-98a0d7dfbf40_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_1afc20d8-e0bd-4466-b26f-fb47e841054b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_69b568c3-eb55-4861-abfd-d5011a40257c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a4418ecb-498d-4176-b9f2-66989de5315e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e8b5294b-7ecd-41ff-bb16-48eff8c39cff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList_677df4e5-8c0b-4e50-939c-bb7b6ab1c1f5_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and cash equivalents, statement of financial position [extensible enumeration]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_IntellectualPropertyAndPatentRelatedFees_2a7ca1f4-171f-4b45-b5ac-8f52c99caeca_terseLabel_en-US" xlink:label="lab_edit_IntellectualPropertyAndPatentRelatedFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual property and patent related fees</link:label>
    <link:label id="lab_edit_IntellectualPropertyAndPatentRelatedFees_label_en-US" xlink:label="lab_edit_IntellectualPropertyAndPatentRelatedFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property And Patent Related Fees</link:label>
    <link:label id="lab_edit_IntellectualPropertyAndPatentRelatedFees_documentation_en-US" xlink:label="lab_edit_IntellectualPropertyAndPatentRelatedFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred through that date and payable for fees associated with intellectual property rights.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_IntellectualPropertyAndPatentRelatedFees" xlink:href="edit-20230930.xsd#edit_IntellectualPropertyAndPatentRelatedFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_IntellectualPropertyAndPatentRelatedFees" xlink:to="lab_edit_IntellectualPropertyAndPatentRelatedFees" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b8ecc8ee-3ba2-49bf-a745-5d07b2b7ff2f_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f15fa019-2153-45e7-8c82-79947352ac9b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_389f2519-504f-415a-be95-715d8acfbd58_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Gain</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_b77cacbc-f56d-4fa8-8f60-205ddceecbd5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_6d375889-23ad-4b45-b64d-cd14163e5ee8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_e4581b4d-59d2-4ddb-b0b9-6c2e8b254373_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_97a40f01-a953-4c49-baf8-a93cdbe68450_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_LindaCBurklyMember_label_en-US" xlink:label="lab_edit_LindaCBurklyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Linda C. Burkly [Member]</link:label>
    <link:label id="lab_edit_LindaCBurklyMember_documentation_en-US" xlink:label="lab_edit_LindaCBurklyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Linda C. Burkly</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_LindaCBurklyMember" xlink:href="edit-20230930.xsd#edit_LindaCBurklyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_LindaCBurklyMember" xlink:to="lab_edit_LindaCBurklyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_5685b5f8-21b7-4c0c-bdf5-86406b6f5801_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_13d01b76-94bd-4d8e-9591-5ed9230a8bf6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_e3fd5ab3-24d1-430f-ba13-d84f6ae0d42c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value per share: 195,000,000 shares authorized; 81,668,796 and 68,847,382 shares issued and outstanding at September&#160;30, 2023 and December&#160;31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_4aebd7b9-f000-4fa3-a070-001ef24a726d_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6451a2e6-b230-4c53-a4e7-63c4d567fa8a_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_0b4c24a4-fb52-4833-afa1-58d9c6040f35_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional service expenses</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_0e3409f3-6278-498d-9052-a6fe7ac469d3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_9391c2aa-e096-4bea-9f96-ae8cf5a6bf82_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued_69f5e525-23b0-42ad-a0d7-aba28fd7fedb_terseLabel_en-US" xlink:label="lab_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales agreement amount of aggregate sale proceeds of common stock agreed to be issued</link:label>
    <link:label id="lab_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued_label_en-US" xlink:label="lab_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Agreement, Amount Of Aggregate Sale Proceeds Of Common Stock Agreed To Be Issued</link:label>
    <link:label id="lab_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued_documentation_en-US" xlink:label="lab_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of proceeds from common stock agreed to be issued or sold under the agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued" xlink:href="edit-20230930.xsd#edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued" xlink:to="lab_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_9da07925-b020-4fa0-a3ff-7facf0d1a708_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash and non-cash activities:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3f9ecd09-ffae-47be-ae5c-46558d66bf7c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_ef8db26a-c2a3-44ac-b799-af5e2c44d528_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_ddc4d41f-3479-494d-b138-179f54d37d64_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_9f974366-a431-46e8-be3b-5eace1d93472_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_LicenseAndServiceAgreementMember_563613b5-e398-49d0-a29a-6cd6805ed774_terseLabel_en-US" xlink:label="lab_edit_LicenseAndServiceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Service Agreement</link:label>
    <link:label id="lab_edit_LicenseAndServiceAgreementMember_label_en-US" xlink:label="lab_edit_LicenseAndServiceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Service Agreement [Member]</link:label>
    <link:label id="lab_edit_LicenseAndServiceAgreementMember_documentation_en-US" xlink:label="lab_edit_LicenseAndServiceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and service agreement and related manufacturing lease space.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_LicenseAndServiceAgreementMember" xlink:href="edit-20230930.xsd#edit_LicenseAndServiceAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_LicenseAndServiceAgreementMember" xlink:to="lab_edit_LicenseAndServiceAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_d19bb9a8-79b8-456b-bd44-255f15739ab5_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents and Marketable Securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_3d4f28c0-f216-4ca4-b55e-8299a32375e5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_84188dcc-388f-47f4-8db1-9997b5b31180_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_8f2c596a-3ec0-4dd2-a7c2-f066e3d0fc28_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_16266f45-0090-4bbb-babd-6a54b72cbb2c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_23d8ebfc-ec9c-4981-ad94-038613ec2476_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent_2e731a29-86a4-4df5-bf8b-758a3a5753d7_terseLabel_en-US" xlink:label="lab_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External research and development expenses</link:label>
    <link:label id="lab_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent_label_en-US" xlink:label="lab_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued External Research And Development Expenses, Current</link:label>
    <link:label id="lab_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent_documentation_en-US" xlink:label="lab_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to accrued external research and development expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent" xlink:href="edit-20230930.xsd#edit_AccruedExternalResearchAndDevelopmentExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent" xlink:to="lab_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_CollaborationAndProfitSharingAgreements_9aa3d152-95b9-4f76-86a9-44b3d6fceaf5_terseLabel_en-US" xlink:label="lab_edit_CollaborationAndProfitSharingAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and Profit-Sharing Agreements</link:label>
    <link:label id="lab_edit_CollaborationAndProfitSharingAgreements_label_en-US" xlink:label="lab_edit_CollaborationAndProfitSharingAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration And Profit-Sharing Agreements</link:label>
    <link:label id="lab_edit_CollaborationAndProfitSharingAgreements_documentation_en-US" xlink:label="lab_edit_CollaborationAndProfitSharingAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No definition available.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_CollaborationAndProfitSharingAgreements" xlink:href="edit-20230930.xsd#edit_CollaborationAndProfitSharingAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_CollaborationAndProfitSharingAgreements" xlink:to="lab_edit_CollaborationAndProfitSharingAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_ca8a14b5-f302-4fc9-996b-3d2e625963bb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfMachineryAndEquipment_7b18af9c-15a0-476a-958c-06dfc4932d67_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the sale of equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfMachineryAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Machinery and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfMachineryAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_35780e4c-05c2-4c3e-b6b2-084c72076179_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_bf410d92-55ef-4f46-82c0-1de6e385700e_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents and Marketable Securities</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents Items [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_eec9f416-4bda-46c3-88a8-28080a5717b7_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and office equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_497c962e-a14f-40ee-938a-8dc3442cace0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_e5c31b44-ca31-4d36-adc8-d37fd3d7c2c8_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_9be0aed5-a9d9-46b1-acfd-f0dad33203cf_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_0e51cc41-20c2-4b3f-b5df-da870054c9b8_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_4e9ff778-b483-4325-830b-8ed15f2ea721_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_4d32b2fd-e1b7-4458-b421-e8dd3513125c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3086a7c5-5da5-45f5-9cdd-85ac3c6b1de2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_0a64b197-4427-436a-af63-96040963bd1c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and other non-current assets:</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0adce507-aea4-4498-b0cf-577ef45a7096_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_5605f4d2-97d1-490b-9f3f-b68b47118fd7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_e9e05e5a-174e-48cb-8fa8-6ec9aa7c3422_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a5815806-9556-4cc1-8ed8-f33dbd56d204_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9c825193-76d9-43fd-ac3b-d7be217b56e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_151a161a-fd05-4dea-8df3-a0c844aa857a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Employee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_205d5df0-7d03-41e2-8cdb-bf146b4f57e6_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7aec45fd-bbd8-4c79-90d1-239aad804eae_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5028b929-7a50-40b5-9379-5edf3472e2dc_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_61a52267-5703-4ae7-a4dd-62ffbe9226d8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_2c9926e1-78f3-4146-9dc0-4602ed389233_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_ContractWithCustomerLiabilityRollForward_6c2a0ed5-4906-4ff3-ac7e-c5867fc121aa_terseLabel_en-US" xlink:label="lab_edit_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_edit_ContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_edit_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_edit_ContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_edit_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_ContractWithCustomerLiabilityRollForward" xlink:href="edit-20230930.xsd#edit_ContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_ContractWithCustomerLiabilityRollForward" xlink:to="lab_edit_ContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_7980eda8-9a2f-403f-a32a-2bcbe41f3188_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ae4d7957-0ec8-484b-9bfb-1b98b56feaea_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5008b1ea-7315-4707-ab29-4564e8feadfc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_508b2916-747e-4182-90a2-57c46b4801e3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_b9df3d6f-fad2-45c6-96c4-5250a10b81fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_23aefee5-dad3-4afd-833f-72f4c8447839_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_5fc9b464-9db2-4aeb-8809-b2917c1df8a5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_4be02f63-7e5b-48f8-8408-346bd8222e47_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_ba64df14-07fe-4960-92e3-8485beef1a65_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_272ebdbd-b0f3-47ad-a07b-04f4700aa293_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6a0ffed6-d73c-47dc-8322-467911f39652_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_e7123ea5-82ab-4b15-84eb-380e706f933e_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_af2bdebd-86fe-4344-b3e7-e16800cfb71a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_64664e7f-1d2d-4eb4-87a7-4494abb31f14_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, balance at end of period</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_9159e712-4261-4f24-84c4-2f1fe0b6b89f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_469c4169-7f81-4323-9c42-72e4cf4f7f06_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_49a3e1d1-a09a-4ffd-931b-7f5ec4d17fea_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_d6866179-10da-4bdc-a82d-7265e5eb96b7_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasuries</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_783d6854-ff41-413e-a870-76af3d43cb23_verboseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasuries</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0e9aa20e-c867-4ba7-ae99-7df781ddd09f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_9e1c0aeb-6cfd-4369-a1a5-aa2b172a5878_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b91ca73a-e104-46da-ad89-d624fe80d646_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_4c6efe1d-7ec1-40ef-b1c7-7a16f6045bae_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_15c21325-04d1-4475-a468-399ff602f4a2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_31241869-7cc2-499a-a445-6c1e1ffd73c2_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amortization of premiums and discounts on marketable securities</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_95e64bc3-f9c5-4e6f-888e-1c0f40b228fb_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_369899b6-fd66-4c0c-93ed-9317e995f72f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_b6bef011-f57a-40e3-81dc-82f33f8946b0_verboseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_be0175f1-f553-44a4-a7bf-55d3c7efe689_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_7655b027-4afa-437a-a18a-daa38db285aa_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_b980e2db-9200-4d80-b903-65819ccdf4c3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_81b997f2-6c18-4ddf-ba66-9457b187a014_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_dd5aaaaf-da6f-4c0a-b740-5a49be03731d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_1c2bd5a4-465c-4a27-9b7d-bedc91250a7f_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_FollowOn2023JuneOfferingMember_03775f2d-cc32-4663-a032-c02a7079854f_terseLabel_en-US" xlink:label="lab_edit_FollowOn2023JuneOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2023 Offering</link:label>
    <link:label id="lab_edit_FollowOn2023JuneOfferingMember_label_en-US" xlink:label="lab_edit_FollowOn2023JuneOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2023 Offering</link:label>
    <link:label id="lab_edit_FollowOn2023JuneOfferingMember_documentation_en-US" xlink:label="lab_edit_FollowOn2023JuneOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2023 offering sale of stock after the initial public offering to the public.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_FollowOn2023JuneOfferingMember" xlink:href="edit-20230930.xsd#edit_FollowOn2023JuneOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_FollowOn2023JuneOfferingMember" xlink:to="lab_edit_FollowOn2023JuneOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_073fd023-e2c8-4895-8306-e9a2e1d7f647_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_0891a3a1-25dd-4bc6-abb1-4d8c7ca86e96_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue type</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_9f8e4982-f698-4bb3-9ed6-c2b6370a2af1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_MarketableSecuritiesNoncurrentNumberOfSecurities_130130bd-57a6-44d9-b0a2-b672a7308a58_terseLabel_en-US" xlink:label="lab_edit_MarketableSecuritiesNoncurrentNumberOfSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of noncurrent securities</link:label>
    <link:label id="lab_edit_MarketableSecuritiesNoncurrentNumberOfSecurities_label_en-US" xlink:label="lab_edit_MarketableSecuritiesNoncurrentNumberOfSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent, Number Of Securities</link:label>
    <link:label id="lab_edit_MarketableSecuritiesNoncurrentNumberOfSecurities_documentation_en-US" xlink:label="lab_edit_MarketableSecuritiesNoncurrentNumberOfSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of noncurrent marketable securities held.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_MarketableSecuritiesNoncurrentNumberOfSecurities" xlink:href="edit-20230930.xsd#edit_MarketableSecuritiesNoncurrentNumberOfSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_MarketableSecuritiesNoncurrentNumberOfSecurities" xlink:to="lab_edit_MarketableSecuritiesNoncurrentNumberOfSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_cd6e9a76-33e4-4df1-a229-c30a8bfb8a10_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_fce1ee76-6da4-47d1-8378-1c6f809c3726_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_731d2605-9d66-415b-92d5-d76cbc2de959_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_0ee98ffa-29ab-4652-acda-7115c176edb4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_204c7c56-913e-40a2-86e3-92e365cf555a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_93f790ff-4021-42ba-9984-466122701892_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4e432056-c0b7-4993-a442-fe5b22285a1d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_57b90822-c852-4bb3-b61f-e2a2168fae12_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_9efe9e59-37d7-48e9-9a6f-46468360a074_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_d0f7c9de-7697-41f6-aecd-67c0b65f06d1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_c9b5105a-190d-46ca-aae1-752a56b533f6_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_08bb845e-0e4d-43b3-a56c-5e92983332b8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_d1cbb62c-a8a4-49f9-b50a-0d4fcd3e6615_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3191c3ed-aa6d-47ef-a2df-506617ba137f_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8c6b1c06-fd76-415a-bcef-16d6d01a48c2_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d2e9fa7a-828c-4503-b48d-25ea0fbc74fc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_47bfa095-8555-4ae5-801a-950067ad33ab_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_17517a02-4ae1-4aa3-bde1-dc0930fa9b88_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_fa44ceb6-ad78-430e-a346-e3ee23893348_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_35188db6-ce9b-4d78-828b-ae0d32cb7b42_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted common stock awards</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_1660a41f-3db3-4b7b-800c-4133008c2ba5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d0a27100-cabd-4d57-b3fb-9b978867bc6e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in dollar per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_61e6b6ea-7315-4012-af24-1390b3df951c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_b6326bba-76fd-4ceb-8552-ee88be723d93_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of fixed assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_d620551d-43ff-4e63-9a08-f0edc48ac3c3_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_05ab6085-755a-4e55-8916-64a16af1936a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_e8b904aa-4755-401e-96fe-52967ae2cc71_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_06c3d3bc-b25b-41ed-b450-cc8313f7be66_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrentAbstract_d2209370-7615-42c1-8b6d-5836b72d10e8_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract" xlink:to="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_6a7c4e16-4ee5-458a-a54c-5ffeec9b1756_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from public offering, net commissions, underwriting discounts and offering costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_560b75ad-b9bb-4fa2-8655-1eef2243903a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and other research and development revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_0755380f-d16a-44c8-a739-73c411a36699_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_2da11bb8-4c90-436b-85c4-cf6a7dbb57b7_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_adc078d7-6f14-4201-92b8-fac878f32685_verboseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_55d9886b-2311-425f-9fd4-c53c2a67eb94_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7bbd70c2-b5bb-4427-bde0-f9a0325510d5_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_cdfed813-962c-4137-9a1b-e6a40e3254b0_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_57624491-a9ee-4309-9a21-3ac15c7b2d88_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6242233c-78b0-4f55-a9a1-fd193892683e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_f7d75383-8d7c-48b7-8de2-686f67ff9047_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_006db161-bd4b-4f24-9836-746def3f2006_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized gains (losses) on available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_3b1769ee-c72a-4efd-b086-bcc92688eab2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c615b5fd-66f0-4207-ba08-374b2e3b5319_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_3784d94d-3352-4856-bdbb-f15bd2f45b01_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_fb5661eb-b9f8-40a2-999c-ec6e3b5603f4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_8aa7a884-4344-407d-887c-f2460aa3979a_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_653e7821-f965-4e95-87d5-0e3f856f8b74_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7683eb6f-3016-4cc9-90ed-e69a124cb635_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_d105258a-8fa2-4bf2-978a-8a5019f3e29f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_cda92240-908c-4a0a-8a2d-9f6a77486b1d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_00871551-b5e3-4377-8146-e582452bb964_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_16d5c2d6-4f8d-42de-a0df-a1e0efd0bbab_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_4795708e-cbca-4e75-8f83-6eaa9ccff070_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction-in-progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_2431cb4e-d57e-4ed6-92eb-945b57ea1722_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_1d62e56a-463a-4c7c-bb2a-87ffff38de25_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f42af1e6-f965-467f-858e-841e41311b0d_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f11eecbb-3453-42db-a52f-92eda973e1fd_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_eee2c961-ba80-45d6-a010-b1472be631d5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_edit_AtMarketOfferingMember_1fe12636-c970-4d9c-a293-48073909ea83_terseLabel_en-US" xlink:label="lab_edit_AtMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At The Market Offering</link:label>
    <link:label id="lab_edit_AtMarketOfferingMember_label_en-US" xlink:label="lab_edit_AtMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At The Market Offering</link:label>
    <link:label id="lab_edit_AtMarketOfferingMember_documentation_en-US" xlink:label="lab_edit_AtMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to at market offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_edit_AtMarketOfferingMember" xlink:href="edit-20230930.xsd#edit_AtMarketOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_edit_AtMarketOfferingMember" xlink:to="lab_edit_AtMarketOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2732cedb-1e63-454f-a857-70cdc18645cb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_bd7564cd-290d-4acc-aa5c-e30b6807aea8_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_9b4f464c-b3df-4d9f-94c8-a1098fd51597_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_bcd0c480-9813-4603-8e77-f72a65d07f91_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_39ada663-56b0-4ddc-bb81-9b2c0e0bfb9e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_9bd66169-1bc7-4e3c-8dcd-568561eaf4ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>edit-20230930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:604c5bfd-156b-497c-b087-a10c0e2b5278,g:6226a648-f95b-483f-af4b-56ce08cc4d95-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.editasmedicine.com/role/Cover" xlink:type="simple" xlink:href="edit-20230930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_610d4985-2a6f-4fd4-aa4f-eeda2d649c84" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_DocumentType_610d4985-2a6f-4fd4-aa4f-eeda2d649c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_58ae614d-451d-4363-bbf6-c76a054c378d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_DocumentQuarterlyReport_58ae614d-451d-4363-bbf6-c76a054c378d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_dd9de20e-62fd-40de-965b-d030ed50241b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_DocumentPeriodEndDate_dd9de20e-62fd-40de-965b-d030ed50241b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_db2cb038-2e9a-4116-bead-bb78be940244" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_DocumentTransitionReport_db2cb038-2e9a-4116-bead-bb78be940244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_77d817b8-ebfc-459c-9495-d4123687749a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityFileNumber_77d817b8-ebfc-459c-9495-d4123687749a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_451d764d-9447-4f7d-a5d5-07a2de33d37d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityRegistrantName_451d764d-9447-4f7d-a5d5-07a2de33d37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_13809b7e-cf11-490c-80d5-b6807604fe9a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityIncorporationStateCountryCode_13809b7e-cf11-490c-80d5-b6807604fe9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_50bc2b28-8270-47b4-a09c-554d9fc7791e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityTaxIdentificationNumber_50bc2b28-8270-47b4-a09c-554d9fc7791e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0a38d908-a5d6-47c5-9832-688e1afbf096" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityAddressAddressLine1_0a38d908-a5d6-47c5-9832-688e1afbf096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_7ecbe885-c4c0-4a7d-b487-128c8e56816e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityAddressCityOrTown_7ecbe885-c4c0-4a7d-b487-128c8e56816e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_25858d51-07d4-492c-b516-d8f7af00dca3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityAddressStateOrProvince_25858d51-07d4-492c-b516-d8f7af00dca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ca105418-7b19-4c9b-a2fb-61ff03116a20" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityAddressPostalZipCode_ca105418-7b19-4c9b-a2fb-61ff03116a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_839d6c98-5747-4a9f-9fc0-c6f99632bdda" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_CityAreaCode_839d6c98-5747-4a9f-9fc0-c6f99632bdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2fae8f41-0176-44c3-829e-9a92c5151b3d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_LocalPhoneNumber_2fae8f41-0176-44c3-829e-9a92c5151b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9c895fa9-33ad-42be-b240-3105381119cd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_Security12bTitle_9c895fa9-33ad-42be-b240-3105381119cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8abd3209-a42a-4c0d-9825-67e7356c458b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_TradingSymbol_8abd3209-a42a-4c0d-9825-67e7356c458b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4ba93547-2bb2-4ed4-afd0-e12717514e0a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_SecurityExchangeName_4ba93547-2bb2-4ed4-afd0-e12717514e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_63ced4fa-9ff5-4647-ac5a-4c6230e7dd14" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityCurrentReportingStatus_63ced4fa-9ff5-4647-ac5a-4c6230e7dd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e330f250-f9ea-4a1e-9758-6b81b7f7f8e6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityInteractiveDataCurrent_e330f250-f9ea-4a1e-9758-6b81b7f7f8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_b9af864d-5b02-4606-86e3-1b7945b85da9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityFilerCategory_b9af864d-5b02-4606-86e3-1b7945b85da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a96dce52-7c29-4474-a64a-d4c4e97cfbb8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntitySmallBusiness_a96dce52-7c29-4474-a64a-d4c4e97cfbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_6e15bb6f-d565-4be4-b491-a1bb3e54b934" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityEmergingGrowthCompany_6e15bb6f-d565-4be4-b491-a1bb3e54b934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_2a22b433-e9b2-453f-9311-74c01f87c217" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityShellCompany_2a22b433-e9b2-453f-9311-74c01f87c217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_6506815b-3287-48da-a6f6-64cb798862d6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_6506815b-3287-48da-a6f6-64cb798862d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_68822ec2-630a-44d4-b69e-34013daaee05" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_EntityCentralIndexKey_68822ec2-630a-44d4-b69e-34013daaee05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_ac1b2406-0040-4ff8-aa73-11f81e753849" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_CurrentFiscalYearEndDate_ac1b2406-0040-4ff8-aa73-11f81e753849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_a9f6cbe7-66f9-48a8-8e70-450cbae22dca" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_DocumentFiscalYearFocus_a9f6cbe7-66f9-48a8-8e70-450cbae22dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_cbd9795e-f47e-41dc-8009-a4bc250641d3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_DocumentFiscalPeriodFocus_cbd9795e-f47e-41dc-8009-a4bc250641d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_76901853-b36e-4952-ad8f-193b028e5b6e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b3aad9c-afc1-47f2-8084-53b1c79113ab" xlink:to="loc_dei_AmendmentFlag_76901853-b36e-4952-ad8f-193b028e5b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="edit-20230930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6d60ffb6-a9e0-4cfd-9e34-b4b65c38adf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_978a3bf4-009d-4cec-8460-4c9cef69b2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6d60ffb6-a9e0-4cfd-9e34-b4b65c38adf1" xlink:to="loc_us-gaap_AssetsAbstract_978a3bf4-009d-4cec-8460-4c9cef69b2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_7f7615d8-9746-4b1f-a205-964e9493b888" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_978a3bf4-009d-4cec-8460-4c9cef69b2c6" xlink:to="loc_us-gaap_AssetsCurrentAbstract_7f7615d8-9746-4b1f-a205-964e9493b888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cfc76d1a-5a05-4e7f-b330-1baf6cdd0cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7f7615d8-9746-4b1f-a205-964e9493b888" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cfc76d1a-5a05-4e7f-b330-1baf6cdd0cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_30e84dc0-744f-4db0-bc84-45fdf249418f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7f7615d8-9746-4b1f-a205-964e9493b888" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_30e84dc0-744f-4db0-bc84-45fdf249418f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_742c5f9a-3ac3-481e-bbd9-94b5b4617458" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7f7615d8-9746-4b1f-a205-964e9493b888" xlink:to="loc_us-gaap_ReceivablesNetCurrent_742c5f9a-3ac3-481e-bbd9-94b5b4617458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c91a7d63-a2ab-415f-815b-45fd63bd0a18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7f7615d8-9746-4b1f-a205-964e9493b888" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c91a7d63-a2ab-415f-815b-45fd63bd0a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_63e76500-8836-4dbc-9a91-72b18d981a59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7f7615d8-9746-4b1f-a205-964e9493b888" xlink:to="loc_us-gaap_AssetsCurrent_63e76500-8836-4dbc-9a91-72b18d981a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_0d9770b1-92e0-496f-a1b0-d4b3a7f18663" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_978a3bf4-009d-4cec-8460-4c9cef69b2c6" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_0d9770b1-92e0-496f-a1b0-d4b3a7f18663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ea47e5b4-a8bc-4548-8648-14ea570b4aee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_978a3bf4-009d-4cec-8460-4c9cef69b2c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ea47e5b4-a8bc-4548-8648-14ea570b4aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_de1873f2-3b45-4251-a895-cc58d56632a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_978a3bf4-009d-4cec-8460-4c9cef69b2c6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_de1873f2-3b45-4251-a895-cc58d56632a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6f5d6475-8fca-4e87-95c4-eca421dcaa43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_978a3bf4-009d-4cec-8460-4c9cef69b2c6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6f5d6475-8fca-4e87-95c4-eca421dcaa43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_01f4e1b9-9062-4c6a-85f8-1f480a43fc83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_978a3bf4-009d-4cec-8460-4c9cef69b2c6" xlink:to="loc_us-gaap_Assets_01f4e1b9-9062-4c6a-85f8-1f480a43fc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f20672e0-b78f-4e84-b0ea-fa3ee9447c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6d60ffb6-a9e0-4cfd-9e34-b4b65c38adf1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f20672e0-b78f-4e84-b0ea-fa3ee9447c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_8e4226a8-6b3d-40d9-8069-b928bda01bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f20672e0-b78f-4e84-b0ea-fa3ee9447c5a" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_8e4226a8-6b3d-40d9-8069-b928bda01bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_18b2d61e-4aa5-431d-8849-8ee2919137de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8e4226a8-6b3d-40d9-8069-b928bda01bc0" xlink:to="loc_us-gaap_AccountsPayableCurrent_18b2d61e-4aa5-431d-8849-8ee2919137de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c644e8df-b20b-47ad-8ff7-54f50897797b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8e4226a8-6b3d-40d9-8069-b928bda01bc0" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_c644e8df-b20b-47ad-8ff7-54f50897797b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1e33b992-6651-4544-9ac2-4b84f4e6d3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8e4226a8-6b3d-40d9-8069-b928bda01bc0" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1e33b992-6651-4544-9ac2-4b84f4e6d3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e21d2103-9ea7-4a0d-9281-f3b056d43523" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8e4226a8-6b3d-40d9-8069-b928bda01bc0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e21d2103-9ea7-4a0d-9281-f3b056d43523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_53e1f396-c3cc-4a46-803a-8548c3506125" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8e4226a8-6b3d-40d9-8069-b928bda01bc0" xlink:to="loc_us-gaap_LiabilitiesCurrent_53e1f396-c3cc-4a46-803a-8548c3506125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ce707489-dcbb-4d22-9fc6-cb42c7e56d80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f20672e0-b78f-4e84-b0ea-fa3ee9447c5a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ce707489-dcbb-4d22-9fc6-cb42c7e56d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a3bb5e04-7305-41ad-ab9f-2f854cbf83e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f20672e0-b78f-4e84-b0ea-fa3ee9447c5a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a3bb5e04-7305-41ad-ab9f-2f854cbf83e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6019dca2-a8b5-4e70-bec3-f5f3b9486e29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f20672e0-b78f-4e84-b0ea-fa3ee9447c5a" xlink:to="loc_us-gaap_Liabilities_6019dca2-a8b5-4e70-bec3-f5f3b9486e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_71f5abda-006b-4941-bbbe-e932764b2bce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f20672e0-b78f-4e84-b0ea-fa3ee9447c5a" xlink:to="loc_us-gaap_StockholdersEquityAbstract_71f5abda-006b-4941-bbbe-e932764b2bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a1612298-ef95-4897-98b3-eb139f602341" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_71f5abda-006b-4941-bbbe-e932764b2bce" xlink:to="loc_us-gaap_PreferredStockValue_a1612298-ef95-4897-98b3-eb139f602341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_1329fce6-3915-4559-a8fc-f839a25cf8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_71f5abda-006b-4941-bbbe-e932764b2bce" xlink:to="loc_us-gaap_CommonStockValue_1329fce6-3915-4559-a8fc-f839a25cf8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_328e430b-ecb3-4297-8b57-c913905eb8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_71f5abda-006b-4941-bbbe-e932764b2bce" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_328e430b-ecb3-4297-8b57-c913905eb8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9bb661f6-1fc9-41aa-aae2-5334f8c70a90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_71f5abda-006b-4941-bbbe-e932764b2bce" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9bb661f6-1fc9-41aa-aae2-5334f8c70a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b6bc326e-afeb-422f-ab53-00c3f6510ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_71f5abda-006b-4941-bbbe-e932764b2bce" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b6bc326e-afeb-422f-ab53-00c3f6510ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_be9cc8da-4063-447d-9fc1-aa2f09684a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_71f5abda-006b-4941-bbbe-e932764b2bce" xlink:to="loc_us-gaap_StockholdersEquity_be9cc8da-4063-447d-9fc1-aa2f09684a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0192d2f6-c19d-490b-b18a-fed60aff214b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f20672e0-b78f-4e84-b0ea-fa3ee9447c5a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0192d2f6-c19d-490b-b18a-fed60aff214b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="edit-20230930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_efb4b060-8c38-4eb9-bec5-bc851827a250" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_3c195abb-5637-406e-af97-597de696526e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_efb4b060-8c38-4eb9-bec5-bc851827a250" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_3c195abb-5637-406e-af97-597de696526e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ea2fc6d6-2f24-4030-9e39-9c708004a624" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_efb4b060-8c38-4eb9-bec5-bc851827a250" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ea2fc6d6-2f24-4030-9e39-9c708004a624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_767d969c-32aa-456d-8446-11c8ee28c02c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_efb4b060-8c38-4eb9-bec5-bc851827a250" xlink:to="loc_us-gaap_PreferredStockSharesIssued_767d969c-32aa-456d-8446-11c8ee28c02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_08c16358-d81c-4c77-b681-c00cc6ac523c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_efb4b060-8c38-4eb9-bec5-bc851827a250" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_08c16358-d81c-4c77-b681-c00cc6ac523c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ebb07acb-05f3-470b-a8f3-750d9789936b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_efb4b060-8c38-4eb9-bec5-bc851827a250" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ebb07acb-05f3-470b-a8f3-750d9789936b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_e2f12593-eb7b-468d-a93f-ec7072e01a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_efb4b060-8c38-4eb9-bec5-bc851827a250" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_e2f12593-eb7b-468d-a93f-ec7072e01a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ffcd4ce9-b59b-4b0e-8c9d-cc7ab98d4ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_efb4b060-8c38-4eb9-bec5-bc851827a250" xlink:to="loc_us-gaap_CommonStockSharesIssued_ffcd4ce9-b59b-4b0e-8c9d-cc7ab98d4ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7406247f-7036-4ee5-bf38-ea59c3c1a294" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_efb4b060-8c38-4eb9-bec5-bc851827a250" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7406247f-7036-4ee5-bf38-ea59c3c1a294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="edit-20230930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_a6e54972-fe39-405f-947d-e79cc6b49ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d70c3a1e-3ddc-4d4b-adee-8128982366e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a6e54972-fe39-405f-947d-e79cc6b49ec5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d70c3a1e-3ddc-4d4b-adee-8128982366e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_d896db2b-4dba-4514-9fde-11ae441bd1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d70c3a1e-3ddc-4d4b-adee-8128982366e2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_d896db2b-4dba-4514-9fde-11ae441bd1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_828807c8-6176-45ea-a17a-75ca1fcb05a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a6e54972-fe39-405f-947d-e79cc6b49ec5" xlink:to="loc_us-gaap_OperatingExpensesAbstract_828807c8-6176-45ea-a17a-75ca1fcb05a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_fb3f7126-4ef7-45af-8be7-00833a251da2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_828807c8-6176-45ea-a17a-75ca1fcb05a3" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_fb3f7126-4ef7-45af-8be7-00833a251da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_024d9e96-3485-4451-a481-27a67a6c1208" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_828807c8-6176-45ea-a17a-75ca1fcb05a3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_024d9e96-3485-4451-a481-27a67a6c1208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e0c4d7df-af92-4116-aa7d-67727faffaeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_828807c8-6176-45ea-a17a-75ca1fcb05a3" xlink:to="loc_us-gaap_OperatingExpenses_e0c4d7df-af92-4116-aa7d-67727faffaeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_79f56ffc-a227-453d-bf59-0d59fceacfd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a6e54972-fe39-405f-947d-e79cc6b49ec5" xlink:to="loc_us-gaap_OperatingIncomeLoss_79f56ffc-a227-453d-bf59-0d59fceacfd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e989eae4-fdc5-4f14-a3a4-eb2216d384e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a6e54972-fe39-405f-947d-e79cc6b49ec5" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e989eae4-fdc5-4f14-a3a4-eb2216d384e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3bdb6613-5da7-4648-a7af-57cbcbf90425" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e989eae4-fdc5-4f14-a3a4-eb2216d384e6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3bdb6613-5da7-4648-a7af-57cbcbf90425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_47b40c9a-6de9-438a-bc68-369bdea2600b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e989eae4-fdc5-4f14-a3a4-eb2216d384e6" xlink:to="loc_us-gaap_InvestmentIncomeNet_47b40c9a-6de9-438a-bc68-369bdea2600b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_16021510-ba6d-446d-983c-a9c5a00bd47f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e989eae4-fdc5-4f14-a3a4-eb2216d384e6" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_16021510-ba6d-446d-983c-a9c5a00bd47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_66a0814e-df96-424f-bf46-460df684fcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a6e54972-fe39-405f-947d-e79cc6b49ec5" xlink:to="loc_us-gaap_NetIncomeLoss_66a0814e-df96-424f-bf46-460df684fcfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_64f016a3-59c3-460c-9d0f-24a3a783b79d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a6e54972-fe39-405f-947d-e79cc6b49ec5" xlink:to="loc_us-gaap_EarningsPerShareBasic_64f016a3-59c3-460c-9d0f-24a3a783b79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d4c50c3c-9fce-484e-8094-a230ae056ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a6e54972-fe39-405f-947d-e79cc6b49ec5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d4c50c3c-9fce-484e-8094-a230ae056ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0e55c76b-afcc-44b6-8c23-519b6a06e535" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a6e54972-fe39-405f-947d-e79cc6b49ec5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0e55c76b-afcc-44b6-8c23-519b6a06e535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_28c3f1eb-c3bf-4278-ba6b-a3235a1e4ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a6e54972-fe39-405f-947d-e79cc6b49ec5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_28c3f1eb-c3bf-4278-ba6b-a3235a1e4ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="edit-20230930.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_96cd6e94-c0f4-4e76-aa34-a05fcbbb5218" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d540c35b-62b0-4eca-ae09-fb2c2d46930c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_96cd6e94-c0f4-4e76-aa34-a05fcbbb5218" xlink:to="loc_us-gaap_NetIncomeLoss_d540c35b-62b0-4eca-ae09-fb2c2d46930c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_ffd1ffcf-f521-4438-a8a8-526a1ba543f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_96cd6e94-c0f4-4e76-aa34-a05fcbbb5218" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_ffd1ffcf-f521-4438-a8a8-526a1ba543f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_193b8987-562f-4b57-b177-eaab6c066094" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_ffd1ffcf-f521-4438-a8a8-526a1ba543f7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_193b8987-562f-4b57-b177-eaab6c066094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_38be1d71-a09f-4496-bfd4-bf0f79eea241" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_96cd6e94-c0f4-4e76-aa34-a05fcbbb5218" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_38be1d71-a09f-4496-bfd4-bf0f79eea241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="edit-20230930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_11633f13-e416-42e6-b11d-8dc011c71ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_461a7969-2b27-47f4-a303-dc18724655eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_11633f13-e416-42e6-b11d-8dc011c71ed1" xlink:to="loc_us-gaap_StatementTable_461a7969-2b27-47f4-a303-dc18724655eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d0108c7e-2af3-43b1-8ef2-bb71a8cd393b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_461a7969-2b27-47f4-a303-dc18724655eb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d0108c7e-2af3-43b1-8ef2-bb71a8cd393b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0f3ad9e5-9a09-4449-a03d-6573d9dbf943" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d0108c7e-2af3-43b1-8ef2-bb71a8cd393b" xlink:to="loc_us-gaap_EquityComponentDomain_0f3ad9e5-9a09-4449-a03d-6573d9dbf943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6b418bf7-cd42-4465-bca8-c7e7dbaa0fff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0f3ad9e5-9a09-4449-a03d-6573d9dbf943" xlink:to="loc_us-gaap_CommonStockMember_6b418bf7-cd42-4465-bca8-c7e7dbaa0fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_42fc9518-e1f7-4c9e-ab0b-0d4a2ffb23d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0f3ad9e5-9a09-4449-a03d-6573d9dbf943" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_42fc9518-e1f7-4c9e-ab0b-0d4a2ffb23d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cb406aad-569d-4c37-bb8b-5a5969148994" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0f3ad9e5-9a09-4449-a03d-6573d9dbf943" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cb406aad-569d-4c37-bb8b-5a5969148994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_ea3f9829-5032-46ff-9efd-86036eda66f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0f3ad9e5-9a09-4449-a03d-6573d9dbf943" xlink:to="loc_us-gaap_RetainedEarningsMember_ea3f9829-5032-46ff-9efd-86036eda66f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8afd5044-df15-42d6-aea7-b50f6c6dd8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_461a7969-2b27-47f4-a303-dc18724655eb" xlink:to="loc_us-gaap_StatementLineItems_8afd5044-df15-42d6-aea7-b50f6c6dd8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8afd5044-df15-42d6-aea7-b50f6c6dd8f5" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_12465460-027c-4e87-8247-fa48b68696ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_SharesOutstanding_12465460-027c-4e87-8247-fa48b68696ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cdcdaf73-d822-4a65-b20d-ac33cd0276eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockholdersEquity_cdcdaf73-d822-4a65-b20d-ac33cd0276eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_884d3f05-0ce7-4ec3-bf8a-41c1bac7ee46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_884d3f05-0ce7-4ec3-bf8a-41c1bac7ee46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_04f7c9a3-85cb-4173-8f54-4a14969b3502" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_04f7c9a3-85cb-4173-8f54-4a14969b3502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ae8221b8-20a2-4adf-8230-d13bf82104d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ae8221b8-20a2-4adf-8230-d13bf82104d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_61f92afd-39b7-4d75-b658-f85993f9e10a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_61f92afd-39b7-4d75-b658-f85993f9e10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4443c295-d4b8-4553-a685-84bb208057e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4443c295-d4b8-4553-a685-84bb208057e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_ed148bb9-c81f-4b2b-bcec-35a2c7211331" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_ed148bb9-c81f-4b2b-bcec-35a2c7211331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_b1e3c36c-7a4e-49c4-a998-f615a2a2c279" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_b1e3c36c-7a4e-49c4-a998-f615a2a2c279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7eb50e3d-5d5a-40e2-8955-bf151b8a8e15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7eb50e3d-5d5a-40e2-8955-bf151b8a8e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7205074a-3833-4a14-949c-b57b38471dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7205074a-3833-4a14-949c-b57b38471dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_ac3ee966-984c-4b35-8d12-270577901877" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_ac3ee966-984c-4b35-8d12-270577901877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8501bf3b-9b48-467f-903c-83f9fef32842" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_NetIncomeLoss_8501bf3b-9b48-467f-903c-83f9fef32842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_43bdaf5e-5a56-43ef-bd8f-6472058586c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_SharesOutstanding_43bdaf5e-5a56-43ef-bd8f-6472058586c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_62c3f4ca-6584-4b0a-a492-f0e33623b5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_813802b0-8407-496f-ab49-34dc8aecea3a" xlink:to="loc_us-gaap_StockholdersEquity_62c3f4ca-6584-4b0a-a492-f0e33623b5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="edit-20230930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_4860fad6-5502-4eab-aeb5-060115db2021" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_65a886c8-8629-4f84-8be4-2b9154e9bbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4860fad6-5502-4eab-aeb5-060115db2021" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_65a886c8-8629-4f84-8be4-2b9154e9bbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d5e519e4-8b68-4f28-a2c9-6b5df7f9e757" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_65a886c8-8629-4f84-8be4-2b9154e9bbb8" xlink:to="loc_us-gaap_NetIncomeLoss_d5e519e4-8b68-4f28-a2c9-6b5df7f9e757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbf2dc76-ca53-45ea-aacd-85c71a3ef3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_65a886c8-8629-4f84-8be4-2b9154e9bbb8" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbf2dc76-ca53-45ea-aacd-85c71a3ef3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1fd674d8-a32f-487a-a7f7-c7eca7c36779" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbf2dc76-ca53-45ea-aacd-85c71a3ef3f2" xlink:to="loc_us-gaap_ShareBasedCompensation_1fd674d8-a32f-487a-a7f7-c7eca7c36779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_4df80e38-7652-42db-90fe-7e77599a6794" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbf2dc76-ca53-45ea-aacd-85c71a3ef3f2" xlink:to="loc_us-gaap_Depreciation_4df80e38-7652-42db-90fe-7e77599a6794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_a5061123-7649-4467-8a62-49b01299c668" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbf2dc76-ca53-45ea-aacd-85c71a3ef3f2" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_a5061123-7649-4467-8a62-49b01299c668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_f8474939-766f-4d4a-aad0-d88305414548" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbf2dc76-ca53-45ea-aacd-85c71a3ef3f2" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_f8474939-766f-4d4a-aad0-d88305414548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c87aa8bb-1873-434c-b5eb-9dfd5db68bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbf2dc76-ca53-45ea-aacd-85c71a3ef3f2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c87aa8bb-1873-434c-b5eb-9dfd5db68bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e69c022e-69e2-4a3d-8bb8-032e242cae7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c87aa8bb-1873-434c-b5eb-9dfd5db68bb8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e69c022e-69e2-4a3d-8bb8-032e242cae7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b4a526be-8979-4320-9850-36f2c98a4ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c87aa8bb-1873-434c-b5eb-9dfd5db68bb8" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b4a526be-8979-4320-9850-36f2c98a4ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_IncreaseDecreaseInRightOfUseAssets_02990ac5-6ab3-4321-8c92-f21f070dd7c2" xlink:href="edit-20230930.xsd#edit_IncreaseDecreaseInRightOfUseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c87aa8bb-1873-434c-b5eb-9dfd5db68bb8" xlink:to="loc_edit_IncreaseDecreaseInRightOfUseAssets_02990ac5-6ab3-4321-8c92-f21f070dd7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_ffaa033b-b2be-4f8f-9c87-903e35c7c4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c87aa8bb-1873-434c-b5eb-9dfd5db68bb8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_ffaa033b-b2be-4f8f-9c87-903e35c7c4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_4f3d6e08-0cb3-4dab-b735-c11fa10d2690" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c87aa8bb-1873-434c-b5eb-9dfd5db68bb8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_4f3d6e08-0cb3-4dab-b735-c11fa10d2690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_4b9e4bac-96cc-4d5b-bddc-b27cfb13ffd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c87aa8bb-1873-434c-b5eb-9dfd5db68bb8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_4b9e4bac-96cc-4d5b-bddc-b27cfb13ffd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_72f1026d-93e5-47c0-93e8-a0e00e8941c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c87aa8bb-1873-434c-b5eb-9dfd5db68bb8" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_72f1026d-93e5-47c0-93e8-a0e00e8941c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_28e55187-6dce-4f8e-b61a-823393d151a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c87aa8bb-1873-434c-b5eb-9dfd5db68bb8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_28e55187-6dce-4f8e-b61a-823393d151a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_eef18f3b-9c26-4835-a9dd-b1e4855693b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_65a886c8-8629-4f84-8be4-2b9154e9bbb8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_eef18f3b-9c26-4835-a9dd-b1e4855693b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_442bd600-732d-4725-85de-310b06bc855b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4860fad6-5502-4eab-aeb5-060115db2021" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_442bd600-732d-4725-85de-310b06bc855b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_11ac26f7-5f0f-43c6-a35a-834e9f754423" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_442bd600-732d-4725-85de-310b06bc855b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_11ac26f7-5f0f-43c6-a35a-834e9f754423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfMachineryAndEquipment_b21e58c7-0425-4fb6-a94c-23b4a2339baa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfMachineryAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_442bd600-732d-4725-85de-310b06bc855b" xlink:to="loc_us-gaap_ProceedsFromSaleOfMachineryAndEquipment_b21e58c7-0425-4fb6-a94c-23b4a2339baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_539987ac-8c25-4e17-8bd3-e8276bafa0df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_442bd600-732d-4725-85de-310b06bc855b" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_539987ac-8c25-4e17-8bd3-e8276bafa0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_d6a9e9fb-d288-4d07-a247-ceb5efd23011" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_442bd600-732d-4725-85de-310b06bc855b" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_d6a9e9fb-d288-4d07-a247-ceb5efd23011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1eafded-d2e9-42c1-9d0f-5a83a6f400bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_442bd600-732d-4725-85de-310b06bc855b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1eafded-d2e9-42c1-9d0f-5a83a6f400bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e67911c7-8525-482f-8fcb-962eb7f97054" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4860fad6-5502-4eab-aeb5-060115db2021" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e67911c7-8525-482f-8fcb-962eb7f97054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8026450b-f025-460d-8d85-ec74dc206e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e67911c7-8525-482f-8fcb-962eb7f97054" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8026450b-f025-460d-8d85-ec74dc206e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_b80dabad-e7cc-466a-b4ac-852331ccd7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e67911c7-8525-482f-8fcb-962eb7f97054" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_b80dabad-e7cc-466a-b4ac-852331ccd7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_4d23da38-c52e-432b-b736-6b81a18baf89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e67911c7-8525-482f-8fcb-962eb7f97054" xlink:to="loc_us-gaap_ProceedsFromStockPlans_4d23da38-c52e-432b-b736-6b81a18baf89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_22a76261-49b9-426c-a8aa-f0327eaf9fea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e67911c7-8525-482f-8fcb-962eb7f97054" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_22a76261-49b9-426c-a8aa-f0327eaf9fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7bfc295c-4404-4682-8500-4a7f968f79a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4860fad6-5502-4eab-aeb5-060115db2021" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7bfc295c-4404-4682-8500-4a7f968f79a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f3e3f9ab-030b-4161-a162-28b9e441cc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4860fad6-5502-4eab-aeb5-060115db2021" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f3e3f9ab-030b-4161-a162-28b9e441cc0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_656aaa44-1aca-47b1-b6dd-0a32488d4e87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4860fad6-5502-4eab-aeb5-060115db2021" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_656aaa44-1aca-47b1-b6dd-0a32488d4e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_7a61c4b1-a449-4011-b5fa-4dd3a0df4f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4860fad6-5502-4eab-aeb5-060115db2021" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_7a61c4b1-a449-4011-b5fa-4dd3a0df4f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_407b7de5-97a1-416a-886d-c70e98918c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7a61c4b1-a449-4011-b5fa-4dd3a0df4f3e" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_407b7de5-97a1-416a-886d-c70e98918c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_9aaa6782-e6d1-4baf-9fe6-e7e57a20036e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7a61c4b1-a449-4011-b5fa-4dd3a0df4f3e" xlink:to="loc_us-gaap_OperatingLeasePayments_9aaa6782-e6d1-4baf-9fe6-e7e57a20036e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e720efff-3d4d-49bc-9144-1baaf675173a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7a61c4b1-a449-4011-b5fa-4dd3a0df4f3e" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e720efff-3d4d-49bc-9144-1baaf675173a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/NatureofBusiness" xlink:type="simple" xlink:href="edit-20230930.xsd#NatureofBusiness"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/NatureofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_27e97de1-f8f8-46d9-81ab-b1d5ef6d8700" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_b744b10e-e091-49e6-a36b-622016b654d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_27e97de1-f8f8-46d9-81ab-b1d5ef6d8700" xlink:to="loc_us-gaap_NatureOfOperations_b744b10e-e091-49e6-a36b-622016b654d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="edit-20230930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_743054e6-9d58-49c5-9913-25248fbe19e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_8f833b2a-135f-467b-ac9b-75b251ed1b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_743054e6-9d58-49c5-9913-25248fbe19e3" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_8f833b2a-135f-467b-ac9b-75b251ed1b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecurities" xlink:type="simple" xlink:href="edit-20230930.xsd#CashEquivalentsandMarketableSecurities"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_822108c4-4ad4-4c5b-9b8a-ce43926f9e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_962d8d9e-e35c-464e-9031-d5eef84d41fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_822108c4-4ad4-4c5b-9b8a-ce43926f9e3f" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_962d8d9e-e35c-464e-9031-d5eef84d41fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="edit-20230930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d776c5b8-d1a9-486a-a170-699b21eaebf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_742b8cab-12b6-4245-870a-7d45c1e9e841" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d776c5b8-d1a9-486a-a170-699b21eaebf3" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_742b8cab-12b6-4245-870a-7d45c1e9e841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/AccruedExpenses" xlink:type="simple" xlink:href="edit-20230930.xsd#AccruedExpenses"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/AccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_5653b893-e801-448d-9fb8-41ab6e95a140" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_91e7c432-2b82-4393-806b-2edbaeba0bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_5653b893-e801-448d-9fb8-41ab6e95a140" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_91e7c432-2b82-4393-806b-2edbaeba0bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/PropertyandEquipmentnet" xlink:type="simple" xlink:href="edit-20230930.xsd#PropertyandEquipmentnet"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/PropertyandEquipmentnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f0b6cf16-c581-40b1-9dc2-9ef3e0ddec65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_b7a5343d-2d35-45aa-81fa-0317350aa76d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f0b6cf16-c581-40b1-9dc2-9ef3e0ddec65" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_b7a5343d-2d35-45aa-81fa-0317350aa76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="edit-20230930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9eb954c1-888c-466a-bc58-2f14c75f7fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_85f450cd-e93a-4516-b35c-53dbbcbd8836" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9eb954c1-888c-466a-bc58-2f14c75f7fbb" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_85f450cd-e93a-4516-b35c-53dbbcbd8836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreements" xlink:type="simple" xlink:href="edit-20230930.xsd#CollaborationandProfitSharingAgreements"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_edit_CollaborationAndProfitSharingAgreements_46bb4313-969b-4b72-8ea4-d4dfe32ced56" xlink:href="edit-20230930.xsd#edit_CollaborationAndProfitSharingAgreements"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_95d3f2d7-6baf-488c-94ea-d29b13feae96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_edit_CollaborationAndProfitSharingAgreements_46bb4313-969b-4b72-8ea4-d4dfe32ced56" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_95d3f2d7-6baf-488c-94ea-d29b13feae96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/StockbasedCompensation" xlink:type="simple" xlink:href="edit-20230930.xsd#StockbasedCompensation"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/StockbasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_24e7aef3-29f1-4034-acd9-6902b5229553" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7059f6e0-204f-46b6-825c-9ac52d0277ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_24e7aef3-29f1-4034-acd9-6902b5229553" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7059f6e0-204f-46b6-825c-9ac52d0277ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/NetLossperShare" xlink:type="simple" xlink:href="edit-20230930.xsd#NetLossperShare"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/NetLossperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e1145c07-7b56-4b19-8ed6-762f4b958533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_d83b1289-1a99-4242-ae14-d2d73e7f561f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e1145c07-7b56-4b19-8ed6-762f4b958533" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_d83b1289-1a99-4242-ae14-d2d73e7f561f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesTables" xlink:type="simple" xlink:href="edit-20230930.xsd#CashEquivalentsandMarketableSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_89d7182f-9596-4305-9b8f-98a0e43b1434" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_3710b1e1-af18-4d84-92ae-498387bfead0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_89d7182f-9596-4305-9b8f-98a0e43b1434" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_3710b1e1-af18-4d84-92ae-498387bfead0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="edit-20230930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_11721427-06a4-4085-aaf0-03dfd3e4ea38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d757cf35-3bae-479b-a166-9e4cc2600e68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_11721427-06a4-4085-aaf0-03dfd3e4ea38" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d757cf35-3bae-479b-a166-9e4cc2600e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="edit-20230930.xsd#AccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/AccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_8e00c8fe-948f-43a5-8e95-3f824e333037" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_9d850021-21d0-43ed-8f59-bb7bcae1b731" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_8e00c8fe-948f-43a5-8e95-3f824e333037" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_9d850021-21d0-43ed-8f59-bb7bcae1b731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/PropertyandEquipmentnetTables" xlink:type="simple" xlink:href="edit-20230930.xsd#PropertyandEquipmentnetTables"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/PropertyandEquipmentnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_086455ed-00b9-4724-9471-4224f3533001" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_438a6985-7c48-4a35-8531-8e68b4e45bab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_086455ed-00b9-4724-9471-4224f3533001" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_438a6985-7c48-4a35-8531-8e68b4e45bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsTables" xlink:type="simple" xlink:href="edit-20230930.xsd#CollaborationandProfitSharingAgreementsTables"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_edit_CollaborationAndProfitSharingAgreements_b4183f1f-cab9-4c72-a461-7cd4f2d38d3e" xlink:href="edit-20230930.xsd#edit_CollaborationAndProfitSharingAgreements"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock_ca7e25c8-7f58-49fb-9484-a831866936e1" xlink:href="edit-20230930.xsd#edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_edit_CollaborationAndProfitSharingAgreements_b4183f1f-cab9-4c72-a461-7cd4f2d38d3e" xlink:to="loc_edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock_ca7e25c8-7f58-49fb-9484-a831866936e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/StockbasedCompensationTables" xlink:type="simple" xlink:href="edit-20230930.xsd#StockbasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/StockbasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1c8fa324-b4ca-46d1-9c2b-48db7871de26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_bd152599-e437-4a40-9e76-785e901a67c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1c8fa324-b4ca-46d1-9c2b-48db7871de26" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_bd152599-e437-4a40-9e76-785e901a67c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_9d67a401-4ffe-4c9c-ad3e-49357ba6e86f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1c8fa324-b4ca-46d1-9c2b-48db7871de26" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_9d67a401-4ffe-4c9c-ad3e-49357ba6e86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3c9b0fa6-b03c-40f6-bf10-d3a34e936e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1c8fa324-b4ca-46d1-9c2b-48db7871de26" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3c9b0fa6-b03c-40f6-bf10-d3a34e936e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/NetLossperShareTables" xlink:type="simple" xlink:href="edit-20230930.xsd#NetLossperShareTables"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/NetLossperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_aa5592a0-d253-4119-829b-e1b403d36674" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_49e3ef12-1e16-45aa-9bdf-540ca4a3d1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_aa5592a0-d253-4119-829b-e1b403d36674" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_49e3ef12-1e16-45aa-9bdf-540ca4a3d1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/NatureofBusinessDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#NatureofBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/NatureofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8e5ec212-42be-49cf-b182-076435f512f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f541f777-d8dd-4b91-aa10-929a1387912e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8e5ec212-42be-49cf-b182-076435f512f2" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f541f777-d8dd-4b91-aa10-929a1387912e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_d48618e7-2990-45a4-85f6-af35bfb5bcc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f541f777-d8dd-4b91-aa10-929a1387912e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_d48618e7-2990-45a4-85f6-af35bfb5bcc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b63be2b2-2066-42dc-b680-48e3cfa8d614" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_d48618e7-2990-45a4-85f6-af35bfb5bcc7" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b63be2b2-2066-42dc-b680-48e3cfa8d614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_FollowOn2023JuneOfferingMember_561aad3e-be4d-48db-a316-4843d7301f5c" xlink:href="edit-20230930.xsd#edit_FollowOn2023JuneOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b63be2b2-2066-42dc-b680-48e3cfa8d614" xlink:to="loc_edit_FollowOn2023JuneOfferingMember_561aad3e-be4d-48db-a316-4843d7301f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_AtMarketOfferingMember_7c704974-bf75-462c-97fc-b93684249cd3" xlink:href="edit-20230930.xsd#edit_AtMarketOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b63be2b2-2066-42dc-b680-48e3cfa8d614" xlink:to="loc_edit_AtMarketOfferingMember_7c704974-bf75-462c-97fc-b93684249cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_b2b521d6-267e-4a14-a1ad-c643643b1ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f541f777-d8dd-4b91-aa10-929a1387912e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_b2b521d6-267e-4a14-a1ad-c643643b1ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_651b3cc9-fbb3-4f87-8bb8-acf681d1b3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b2b521d6-267e-4a14-a1ad-c643643b1ceb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_651b3cc9-fbb3-4f87-8bb8-acf681d1b3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e1c773e7-76ac-4157-b02d-aaa99933d082" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b2b521d6-267e-4a14-a1ad-c643643b1ceb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e1c773e7-76ac-4157-b02d-aaa99933d082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued_6f0eb558-9fa0-433d-bcf6-e149836dbef1" xlink:href="edit-20230930.xsd#edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b2b521d6-267e-4a14-a1ad-c643643b1ceb" xlink:to="loc_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued_6f0eb558-9fa0-433d-bcf6-e149836dbef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e23f0625-a50e-4004-a18c-44d48bc87e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b2b521d6-267e-4a14-a1ad-c643643b1ceb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e23f0625-a50e-4004-a18c-44d48bc87e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#CashEquivalentsandMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_03e78eca-76d4-443f-8426-8fc8e48386ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_6f9fefe4-42d6-4bed-9777-ae11e24833b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_03e78eca-76d4-443f-8426-8fc8e48386ad" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_6f9fefe4-42d6-4bed-9777-ae11e24833b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1a2c48e1-d1a6-46e6-bd55-42a311694589" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_6f9fefe4-42d6-4bed-9777-ae11e24833b2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1a2c48e1-d1a6-46e6-bd55-42a311694589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0f31521-2c95-4ddf-9959-1a01988d1dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1a2c48e1-d1a6-46e6-bd55-42a311694589" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0f31521-2c95-4ddf-9959-1a01988d1dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7bf05769-40e4-4ad7-a82d-183776acbb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0f31521-2c95-4ddf-9959-1a01988d1dc7" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7bf05769-40e4-4ad7-a82d-183776acbb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_0a59c1b2-c288-4529-b800-5ccda7717df7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0f31521-2c95-4ddf-9959-1a01988d1dc7" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_0a59c1b2-c288-4529-b800-5ccda7717df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_17d674b4-0d9e-4b82-abe0-86467f5b94d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0f31521-2c95-4ddf-9959-1a01988d1dc7" xlink:to="loc_us-gaap_MoneyMarketFundsMember_17d674b4-0d9e-4b82-abe0-86467f5b94d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_bd501481-5afa-4db0-9b12-900bae59d577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0f31521-2c95-4ddf-9959-1a01988d1dc7" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_bd501481-5afa-4db0-9b12-900bae59d577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e12f59c1-11d2-4f83-a765-69f15db2a73a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0f31521-2c95-4ddf-9959-1a01988d1dc7" xlink:to="loc_us-gaap_CommercialPaperMember_e12f59c1-11d2-4f83-a765-69f15db2a73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_6f9fefe4-42d6-4bed-9777-ae11e24833b2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0853166f-5e8c-46db-bbc9-00826cd89b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0853166f-5e8c-46db-bbc9-00826cd89b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_e5c40f57-e272-4095-bd8b-abac32412b54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_e5c40f57-e272-4095-bd8b-abac32412b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_bdda805b-db0a-48ad-a560-567e5f1fc33e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_bdda805b-db0a-48ad-a560-567e5f1fc33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8b36322c-3b1c-42f2-901e-a78efd859ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8b36322c-3b1c-42f2-901e-a78efd859ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8084ede9-0ddd-4c0a-83f5-1bb1df0f2628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8084ede9-0ddd-4c0a-83f5-1bb1df0f2628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_f4d4bd8c-3fe0-4239-92e2-1f13b953b440" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_f4d4bd8c-3fe0-4239-92e2-1f13b953b440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_MarketableSecuritiesNoncurrentNumberOfSecurities_1375bc5b-ae98-4b87-992b-88a205aa004e" xlink:href="edit-20230930.xsd#edit_MarketableSecuritiesNoncurrentNumberOfSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_edit_MarketableSecuritiesNoncurrentNumberOfSecurities_1375bc5b-ae98-4b87-992b-88a205aa004e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_a2f90f88-5af2-4505-8fe6-1c0e7f7e60f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_a2f90f88-5af2-4505-8fe6-1c0e7f7e60f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_a5bac661-30cb-4cd2-b007-8eadac2a7738" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4b5d5b7c-dbb3-40d6-bfa9-26d2003c566b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_a5bac661-30cb-4cd2-b007-8eadac2a7738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9a8e9ad4-9bdc-4cfa-8c4b-bd4bf104e44e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4eebd31c-1679-4aa0-aaee-cd58634a9045" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9a8e9ad4-9bdc-4cfa-8c4b-bd4bf104e44e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4eebd31c-1679-4aa0-aaee-cd58634a9045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_714db94b-9a1c-43a8-a0fc-4edc88675e92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4eebd31c-1679-4aa0-aaee-cd58634a9045" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_714db94b-9a1c-43a8-a0fc-4edc88675e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8bcd65eb-e65f-4b5e-ab03-d9720b0fe5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_714db94b-9a1c-43a8-a0fc-4edc88675e92" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8bcd65eb-e65f-4b5e-ab03-d9720b0fe5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7d0fd852-781c-4685-8d1d-931c742eec4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8bcd65eb-e65f-4b5e-ab03-d9720b0fe5d2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7d0fd852-781c-4685-8d1d-931c742eec4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_829ab712-409b-4630-b04c-ff86e16ee7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4eebd31c-1679-4aa0-aaee-cd58634a9045" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_829ab712-409b-4630-b04c-ff86e16ee7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_953ecd69-221b-4a06-8eb7-cceec235a577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_829ab712-409b-4630-b04c-ff86e16ee7e9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_953ecd69-221b-4a06-8eb7-cceec235a577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8ef85d49-a9af-480b-befd-20361b778d75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_953ecd69-221b-4a06-8eb7-cceec235a577" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8ef85d49-a9af-480b-befd-20361b778d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_95f5b757-d31d-419c-8855-e94449fd792c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_953ecd69-221b-4a06-8eb7-cceec235a577" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_95f5b757-d31d-419c-8855-e94449fd792c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4d28ed0e-05c6-4837-a16e-e19857daaf27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_953ecd69-221b-4a06-8eb7-cceec235a577" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4d28ed0e-05c6-4837-a16e-e19857daaf27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_8c3a3290-2db1-4b7a-a7b0-52139cf4bc55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4eebd31c-1679-4aa0-aaee-cd58634a9045" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_8c3a3290-2db1-4b7a-a7b0-52139cf4bc55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_576a25a0-dcea-46ca-9734-4dfb5f6e691e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_8c3a3290-2db1-4b7a-a7b0-52139cf4bc55" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_576a25a0-dcea-46ca-9734-4dfb5f6e691e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_7658e995-6421-496b-b56d-a39a46d774ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_576a25a0-dcea-46ca-9734-4dfb5f6e691e" xlink:to="loc_us-gaap_MoneyMarketFundsMember_7658e995-6421-496b-b56d-a39a46d774ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4149b6a9-09ef-4b99-920e-1d87bee993b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4eebd31c-1679-4aa0-aaee-cd58634a9045" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4149b6a9-09ef-4b99-920e-1d87bee993b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_34fd32c9-fbd0-40b1-8d98-8bb6c26a9af9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4149b6a9-09ef-4b99-920e-1d87bee993b3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_34fd32c9-fbd0-40b1-8d98-8bb6c26a9af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9d89a810-81f4-4263-8afd-c8b23f9583c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_34fd32c9-fbd0-40b1-8d98-8bb6c26a9af9" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9d89a810-81f4-4263-8afd-c8b23f9583c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_79071556-da1d-4a41-be89-8b62bc9b52df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_34fd32c9-fbd0-40b1-8d98-8bb6c26a9af9" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_79071556-da1d-4a41-be89-8b62bc9b52df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_069c497d-5e09-4bdd-9a9a-e3061d5aac93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_34fd32c9-fbd0-40b1-8d98-8bb6c26a9af9" xlink:to="loc_us-gaap_CommercialPaperMember_069c497d-5e09-4bdd-9a9a-e3061d5aac93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_5cceb5af-c5e0-4c37-bda2-24dded239ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_34fd32c9-fbd0-40b1-8d98-8bb6c26a9af9" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_5cceb5af-c5e0-4c37-bda2-24dded239ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_997fe5c7-d68a-46bf-abbc-26c5ba9b4c50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4eebd31c-1679-4aa0-aaee-cd58634a9045" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_997fe5c7-d68a-46bf-abbc-26c5ba9b4c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_e29bddfe-c618-4c0b-be19-6dd46598c985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_997fe5c7-d68a-46bf-abbc-26c5ba9b4c50" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_e29bddfe-c618-4c0b-be19-6dd46598c985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b9630906-96c0-4c0c-b6f9-fd062e15e1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_e29bddfe-c618-4c0b-be19-6dd46598c985" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b9630906-96c0-4c0c-b6f9-fd062e15e1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7d6e09f4-c664-44e5-b197-3db44858ff6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_e29bddfe-c618-4c0b-be19-6dd46598c985" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7d6e09f4-c664-44e5-b197-3db44858ff6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_d439711c-7e9d-4c4f-b255-5999c50423d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_e29bddfe-c618-4c0b-be19-6dd46598c985" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_d439711c-7e9d-4c4f-b255-5999c50423d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList_3b821752-7462-40d4-9ee5-a3496f0444e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents_d439711c-7e9d-4c4f-b255-5999c50423d6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList_3b821752-7462-40d4-9ee5-a3496f0444e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c6962492-3f65-460e-ade5-ad068a80163e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_e29bddfe-c618-4c0b-be19-6dd46598c985" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_c6962492-3f65-460e-ade5-ad068a80163e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#AccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_59f9c0bd-8dcf-418a-8409-854b9e38399c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent_2b9bda54-7c6b-4e44-b5b7-0ac18b215f3a" xlink:href="edit-20230930.xsd#edit_AccruedExternalResearchAndDevelopmentExpensesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_59f9c0bd-8dcf-418a-8409-854b9e38399c" xlink:to="loc_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent_2b9bda54-7c6b-4e44-b5b7-0ac18b215f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_971ccf52-06ad-4651-96ec-eab329122e77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_59f9c0bd-8dcf-418a-8409-854b9e38399c" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_971ccf52-06ad-4651-96ec-eab329122e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_IntellectualPropertyAndPatentRelatedFees_b256138d-4359-4684-8abb-19bbee18e876" xlink:href="edit-20230930.xsd#edit_IntellectualPropertyAndPatentRelatedFees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_59f9c0bd-8dcf-418a-8409-854b9e38399c" xlink:to="loc_edit_IntellectualPropertyAndPatentRelatedFees_b256138d-4359-4684-8abb-19bbee18e876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_5d783c19-6b29-4437-802d-8aea38d16951" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_59f9c0bd-8dcf-418a-8409-854b9e38399c" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_5d783c19-6b29-4437-802d-8aea38d16951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_077836a2-e733-4ea1-a03f-f70b47acdb38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_59f9c0bd-8dcf-418a-8409-854b9e38399c" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_077836a2-e733-4ea1-a03f-f70b47acdb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_dcfd239a-bc6b-4b4c-a8f9-ebf98de68ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_59f9c0bd-8dcf-418a-8409-854b9e38399c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_dcfd239a-bc6b-4b4c-a8f9-ebf98de68ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#PropertyandEquipmentnetDetails"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6e499c4c-32a2-41b2-b565-8b11a9ddcf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_328b4d43-3955-4165-85da-fc3db38b072b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6e499c4c-32a2-41b2-b565-8b11a9ddcf5d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_328b4d43-3955-4165-85da-fc3db38b072b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e8964b1d-8ca9-4426-95c3-6601af3bb05f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_328b4d43-3955-4165-85da-fc3db38b072b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e8964b1d-8ca9-4426-95c3-6601af3bb05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e8964b1d-8ca9-4426-95c3-6601af3bb05f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_LaboratoryEquipmentMember_62014965-50d0-4488-bfc5-9004e18fb22e" xlink:href="edit-20230930.xsd#edit_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:to="loc_edit_LaboratoryEquipmentMember_62014965-50d0-4488-bfc5-9004e18fb22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_aab53d16-c6db-4a89-8771-3e5b315dad87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_aab53d16-c6db-4a89-8771-3e5b315dad87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_25f5a356-87c5-4e58-8670-75011a638d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:to="loc_us-gaap_ComputerEquipmentMember_25f5a356-87c5-4e58-8670-75011a638d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_ef10297b-74cf-4cf1-9c38-0c09f8779f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:to="loc_us-gaap_ConstructionInProgressMember_ef10297b-74cf-4cf1-9c38-0c09f8779f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_8725eb75-fcaf-46d4-b67c-c2ed67df33f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_8725eb75-fcaf-46d4-b67c-c2ed67df33f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_be5506d3-4cbc-4c28-be0b-e4b1db09de81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a424b80f-b55c-4fca-9aee-c125c574ae39" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_be5506d3-4cbc-4c28-be0b-e4b1db09de81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9074c149-204c-45d6-a9b6-794d5485b795" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_328b4d43-3955-4165-85da-fc3db38b072b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9074c149-204c-45d6-a9b6-794d5485b795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_edd734a1-6c88-4220-a041-d6934d66a4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9074c149-204c-45d6-a9b6-794d5485b795" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_edd734a1-6c88-4220-a041-d6934d66a4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ad81546f-c14f-4b60-8119-bd9868fda936" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9074c149-204c-45d6-a9b6-794d5485b795" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ad81546f-c14f-4b60-8119-bd9868fda936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b50b45e5-7d2e-4037-8500-1b4bed356ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9074c149-204c-45d6-a9b6-794d5485b795" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b50b45e5-7d2e-4037-8500-1b4bed356ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CommitmentsandContingenciesLeaseAgreementDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#CommitmentsandContingenciesLeaseAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CommitmentsandContingenciesLeaseAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_803d6100-fba0-47a2-a4a7-414628a9d11d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d6bfe404-5894-43cb-ab42-49aebcf2a54c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_803d6100-fba0-47a2-a4a7-414628a9d11d" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d6bfe404-5894-43cb-ab42-49aebcf2a54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d88b15de-8ba0-4a58-a110-ccf6e7781b98" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d6bfe404-5894-43cb-ab42-49aebcf2a54c" xlink:to="loc_srt_CounterpartyNameAxis_d88b15de-8ba0-4a58-a110-ccf6e7781b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2ec9b517-13e5-4516-82f8-b172716e0962" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_d88b15de-8ba0-4a58-a110-ccf6e7781b98" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2ec9b517-13e5-4516-82f8-b172716e0962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_LicenseAndServiceAgreementMember_46bdd4ea-7230-4468-a25e-ae53ab340117" xlink:href="edit-20230930.xsd#edit_LicenseAndServiceAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2ec9b517-13e5-4516-82f8-b172716e0962" xlink:to="loc_edit_LicenseAndServiceAgreementMember_46bdd4ea-7230-4468-a25e-ae53ab340117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_051dd794-5dbb-4b62-9812-f2a1caeeca42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d6bfe404-5894-43cb-ab42-49aebcf2a54c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_051dd794-5dbb-4b62-9812-f2a1caeeca42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ead65f2-34c6-4d54-ba93-b07e56a23bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_051dd794-5dbb-4b62-9812-f2a1caeeca42" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ead65f2-34c6-4d54-ba93-b07e56a23bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_66b8aad2-5129-4801-bd44-02a991791059" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_051dd794-5dbb-4b62-9812-f2a1caeeca42" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_66b8aad2-5129-4801-bd44-02a991791059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CommitmentsandContingenciesLicensorExpenseReimbursementsDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#CommitmentsandContingenciesLicensorExpenseReimbursementsDetails"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CommitmentsandContingenciesLicensorExpenseReimbursementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8f247486-d1c4-412b-aca5-d6802fdd2a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_4946c287-b3a8-46d6-8ce5-1234b69fccad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8f247486-d1c4-412b-aca5-d6802fdd2a6f" xlink:to="loc_us-gaap_OtherCommitmentsTable_4946c287-b3a8-46d6-8ce5-1234b69fccad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_d497fcee-9f25-4777-8905-e6b54cbc82d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_4946c287-b3a8-46d6-8ce5-1234b69fccad" xlink:to="loc_us-gaap_OtherCommitmentsAxis_d497fcee-9f25-4777-8905-e6b54cbc82d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_f3d2234f-1e32-4034-83dd-6bd1ae68c00c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_d497fcee-9f25-4777-8905-e6b54cbc82d7" xlink:to="loc_us-gaap_OtherCommitmentsDomain_f3d2234f-1e32-4034-83dd-6bd1ae68c00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_LicensorExpenseReimbursementsMember_64e3a3ba-de83-41bd-a764-1e8f02eb89ca" xlink:href="edit-20230930.xsd#edit_LicensorExpenseReimbursementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_f3d2234f-1e32-4034-83dd-6bd1ae68c00c" xlink:to="loc_edit_LicensorExpenseReimbursementsMember_64e3a3ba-de83-41bd-a764-1e8f02eb89ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_f8d34413-8d25-4060-bdc7-0bfa62b80896" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_4946c287-b3a8-46d6-8ce5-1234b69fccad" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_f8d34413-8d25-4060-bdc7-0bfa62b80896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalAndContractServicesExpense_5939de45-d333-4aff-8f81-12c70bdc3bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalAndContractServicesExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8d34413-8d25-4060-bdc7-0bfa62b80896" xlink:to="loc_us-gaap_ProfessionalAndContractServicesExpense_5939de45-d333-4aff-8f81-12c70bdc3bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#CollaborationandProfitSharingAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_edit_CollaborationAndProfitSharingAgreements_3c91feb3-9f85-4b16-9c6b-b2b409fb514b" xlink:href="edit-20230930.xsd#edit_CollaborationAndProfitSharingAgreements"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrentAbstract_d140e292-f6f3-4664-a8d3-0284da7ad07b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_edit_CollaborationAndProfitSharingAgreements_3c91feb3-9f85-4b16-9c6b-b2b409fb514b" xlink:to="loc_us-gaap_ReceivablesNetCurrentAbstract_d140e292-f6f3-4664-a8d3-0284da7ad07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_ReceivablesNetCurrentRollForward_1f9132e1-3eab-4374-b5b5-c6aeb08edb2f" xlink:href="edit-20230930.xsd#edit_ReceivablesNetCurrentRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_d140e292-f6f3-4664-a8d3-0284da7ad07b" xlink:to="loc_edit_ReceivablesNetCurrentRollForward_1f9132e1-3eab-4374-b5b5-c6aeb08edb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_80728154-b044-4bd8-8575-5946222be078" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_edit_ReceivablesNetCurrentRollForward_1f9132e1-3eab-4374-b5b5-c6aeb08edb2f" xlink:to="loc_us-gaap_ReceivablesNetCurrent_80728154-b044-4bd8-8575-5946222be078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_AccountsReceivableAdditions_27d81dd4-93ea-4b8b-9d5d-9d43957d7569" xlink:href="edit-20230930.xsd#edit_AccountsReceivableAdditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_edit_ReceivablesNetCurrentRollForward_1f9132e1-3eab-4374-b5b5-c6aeb08edb2f" xlink:to="loc_edit_AccountsReceivableAdditions_27d81dd4-93ea-4b8b-9d5d-9d43957d7569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_AccountsReceivableDeductions_7503311c-5dfd-4bdd-a217-b251de9e9b41" xlink:href="edit-20230930.xsd#edit_AccountsReceivableDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_edit_ReceivablesNetCurrentRollForward_1f9132e1-3eab-4374-b5b5-c6aeb08edb2f" xlink:to="loc_edit_AccountsReceivableDeductions_7503311c-5dfd-4bdd-a217-b251de9e9b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_0ca1d493-be65-4806-86bb-00648d67aede" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_edit_ReceivablesNetCurrentRollForward_1f9132e1-3eab-4374-b5b5-c6aeb08edb2f" xlink:to="loc_us-gaap_ReceivablesNetCurrent_0ca1d493-be65-4806-86bb-00648d67aede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract_d1b64fab-128f-4281-9477-233c27ae6376" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_edit_CollaborationAndProfitSharingAgreements_3c91feb3-9f85-4b16-9c6b-b2b409fb514b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityAbstract_d1b64fab-128f-4281-9477-233c27ae6376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_ContractWithCustomerLiabilityRollForward_2ba12302-6a74-49c6-a7fe-16acc461d8a9" xlink:href="edit-20230930.xsd#edit_ContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_d1b64fab-128f-4281-9477-233c27ae6376" xlink:to="loc_edit_ContractWithCustomerLiabilityRollForward_2ba12302-6a74-49c6-a7fe-16acc461d8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_3ccb406e-d4c9-4a89-b0a3-303b20cde99d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_edit_ContractWithCustomerLiabilityRollForward_2ba12302-6a74-49c6-a7fe-16acc461d8a9" xlink:to="loc_us-gaap_ContractWithCustomerLiability_3ccb406e-d4c9-4a89-b0a3-303b20cde99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_08bf429f-71fe-4287-a54b-b830b634396b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_edit_ContractWithCustomerLiabilityRollForward_2ba12302-6a74-49c6-a7fe-16acc461d8a9" xlink:to="loc_us-gaap_ContractWithCustomerLiability_08bf429f-71fe-4287-a54b-b830b634396b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/StockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#StockbasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/StockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d7cad1e5-16bf-44ba-a568-5f2be88c26e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b3e39d0b-1307-4274-beb4-cf5509f9c37f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d7cad1e5-16bf-44ba-a568-5f2be88c26e2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b3e39d0b-1307-4274-beb4-cf5509f9c37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_cf9e536a-c659-45e4-b3bb-0fd64582040d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b3e39d0b-1307-4274-beb4-cf5509f9c37f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_cf9e536a-c659-45e4-b3bb-0fd64582040d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_572cacf6-8544-4aef-99ee-3d2ac72fe706" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_cf9e536a-c659-45e4-b3bb-0fd64582040d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_572cacf6-8544-4aef-99ee-3d2ac72fe706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4dd5f4d3-752f-4b16-935e-7418eced4de3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_572cacf6-8544-4aef-99ee-3d2ac72fe706" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4dd5f4d3-752f-4b16-935e-7418eced4de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_fedc0817-afc4-47ed-853a-f7fb8acdb7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_572cacf6-8544-4aef-99ee-3d2ac72fe706" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_fedc0817-afc4-47ed-853a-f7fb8acdb7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fa2073d-259d-4989-b6be-c232a1fe67d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b3e39d0b-1307-4274-beb4-cf5509f9c37f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fa2073d-259d-4989-b6be-c232a1fe67d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4cfce093-e8e1-49dd-86fa-9c03f8d4066c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fa2073d-259d-4989-b6be-c232a1fe67d2" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4cfce093-e8e1-49dd-86fa-9c03f8d4066c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#StockbasedCompensationRestrictedStockandStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2f3bdbfb-9ad3-47ca-a679-2fbff835098d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbeb87ad-2714-43bf-a488-d05ba1809917" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2f3bdbfb-9ad3-47ca-a679-2fbff835098d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbeb87ad-2714-43bf-a488-d05ba1809917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_03612598-19b7-439b-b9ed-74c9c24cfa44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbeb87ad-2714-43bf-a488-d05ba1809917" xlink:to="loc_us-gaap_AwardTypeAxis_03612598-19b7-439b-b9ed-74c9c24cfa44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19dcf83-dc81-45c8-91f3-34693d5621ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_03612598-19b7-439b-b9ed-74c9c24cfa44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19dcf83-dc81-45c8-91f3-34693d5621ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a997bede-31c8-443d-900d-ffa28169482a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19dcf83-dc81-45c8-91f3-34693d5621ad" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a997bede-31c8-443d-900d-ffa28169482a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_c0ed0228-c41e-4de6-be65-c8593ac09a30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19dcf83-dc81-45c8-91f3-34693d5621ad" xlink:to="loc_us-gaap_PerformanceSharesMember_c0ed0228-c41e-4de6-be65-c8593ac09a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5b9912f9-99c1-4553-a819-dd07d7214dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d19dcf83-dc81-45c8-91f3-34693d5621ad" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5b9912f9-99c1-4553-a819-dd07d7214dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_e48d92f1-f212-46e5-ae1a-a871804d2744" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbeb87ad-2714-43bf-a488-d05ba1809917" xlink:to="loc_us-gaap_GranteeStatusAxis_e48d92f1-f212-46e5-ae1a-a871804d2744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_1d369797-60c3-49d0-977e-0043db2208b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_e48d92f1-f212-46e5-ae1a-a871804d2744" xlink:to="loc_us-gaap_GranteeStatusDomain_1d369797-60c3-49d0-977e-0043db2208b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_c3e58331-797e-4c47-8405-21a42013219a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_1d369797-60c3-49d0-977e-0043db2208b6" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_c3e58331-797e-4c47-8405-21a42013219a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbeb87ad-2714-43bf-a488-d05ba1809917" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3a1996e8-eefc-4c0a-bf59-930a7ea320b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3a1996e8-eefc-4c0a-bf59-930a7ea320b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_06257733-b735-41c7-b6dc-3d5b0f9a2331" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3a1996e8-eefc-4c0a-bf59-930a7ea320b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_06257733-b735-41c7-b6dc-3d5b0f9a2331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c26fb378-c828-4f46-9335-32e34339e838" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3a1996e8-eefc-4c0a-bf59-930a7ea320b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c26fb378-c828-4f46-9335-32e34339e838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_120fdd52-993f-479e-81aa-abb48cee94bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3a1996e8-eefc-4c0a-bf59-930a7ea320b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_120fdd52-993f-479e-81aa-abb48cee94bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1e2dfc1e-1cee-4201-9603-19d3e9913fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3a1996e8-eefc-4c0a-bf59-930a7ea320b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1e2dfc1e-1cee-4201-9603-19d3e9913fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75a2041a-8588-4ab4-93d8-b9e8b63159ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3a1996e8-eefc-4c0a-bf59-930a7ea320b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75a2041a-8588-4ab4-93d8-b9e8b63159ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_41a42169-2bc0-42d6-851d-d72aa0887b48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_41a42169-2bc0-42d6-851d-d72aa0887b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_23ca9066-3b6a-46d9-b10a-cb69ae4e29fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_41a42169-2bc0-42d6-851d-d72aa0887b48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_23ca9066-3b6a-46d9-b10a-cb69ae4e29fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c2eac397-50ee-4725-b48e-98b79d2542df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_41a42169-2bc0-42d6-851d-d72aa0887b48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c2eac397-50ee-4725-b48e-98b79d2542df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0bb535df-ba8e-4b22-bb80-4d9a08ea261d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_41a42169-2bc0-42d6-851d-d72aa0887b48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0bb535df-ba8e-4b22-bb80-4d9a08ea261d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_846c9412-18c1-4195-8d8a-ade5f3e6c7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_41a42169-2bc0-42d6-851d-d72aa0887b48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_846c9412-18c1-4195-8d8a-ade5f3e6c7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f01cdfc4-da97-4fc5-9e4b-6100a821cc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_41a42169-2bc0-42d6-851d-d72aa0887b48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f01cdfc4-da97-4fc5-9e4b-6100a821cc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_17a7ec3e-1861-48e9-8e9b-0df5b29a0b34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_17a7ec3e-1861-48e9-8e9b-0df5b29a0b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d30413b4-7dc1-4516-ba47-8a8f91a45b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d30413b4-7dc1-4516-ba47-8a8f91a45b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acbbdc9d-5c11-4e50-9998-199b025ccfdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acbbdc9d-5c11-4e50-9998-199b025ccfdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9507619f-4a5b-4461-926e-1ec75870c1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acbbdc9d-5c11-4e50-9998-199b025ccfdd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9507619f-4a5b-4461-926e-1ec75870c1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b47f392f-151d-4e91-b42a-8153213196b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acbbdc9d-5c11-4e50-9998-199b025ccfdd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b47f392f-151d-4e91-b42a-8153213196b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ac7dea0f-8c4c-437f-8888-dcb7de00411d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acbbdc9d-5c11-4e50-9998-199b025ccfdd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ac7dea0f-8c4c-437f-8888-dcb7de00411d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_b12ad914-8bb0-4e13-b03d-68a1d8724163" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acbbdc9d-5c11-4e50-9998-199b025ccfdd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_b12ad914-8bb0-4e13-b03d-68a1d8724163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_91c7b883-f57b-4392-a335-074f50f5a66d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acbbdc9d-5c11-4e50-9998-199b025ccfdd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_91c7b883-f57b-4392-a335-074f50f5a66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a7ea1b29-c934-46fd-ae48-27e0b82628f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a7ea1b29-c934-46fd-ae48-27e0b82628f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e7723ac7-5cac-4454-8e08-0dec643160db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e7723ac7-5cac-4454-8e08-0dec643160db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_159b97e6-c9e5-46fa-a79c-2e62a0785d86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e7723ac7-5cac-4454-8e08-0dec643160db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_159b97e6-c9e5-46fa-a79c-2e62a0785d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4c50fb13-51fc-4e60-b4d6-bdb518b4cbac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e7723ac7-5cac-4454-8e08-0dec643160db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4c50fb13-51fc-4e60-b4d6-bdb518b4cbac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5b820f4e-1066-4ad1-8c8b-5e24c9d8573d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e7723ac7-5cac-4454-8e08-0dec643160db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5b820f4e-1066-4ad1-8c8b-5e24c9d8573d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_de89d87f-3060-4536-b635-0dd2f105ebbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e7723ac7-5cac-4454-8e08-0dec643160db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_de89d87f-3060-4536-b635-0dd2f105ebbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_31187e16-c7bd-4da2-9a1e-1ea68f25c375" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e7723ac7-5cac-4454-8e08-0dec643160db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_31187e16-c7bd-4da2-9a1e-1ea68f25c375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_29c7a3c1-33cd-439f-8658-972b46da010a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_29c7a3c1-33cd-439f-8658-972b46da010a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_6dd3f758-730c-416b-bc40-86e607f99e82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d4344a9-5273-4591-a3a0-1482f7d8a7ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_6dd3f758-730c-416b-bc40-86e607f99e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0388e575-ad6e-4c2f-bf97-4c4c148e596e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_6dd3f758-730c-416b-bc40-86e607f99e82" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0388e575-ad6e-4c2f-bf97-4c4c148e596e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_585793e2-7b59-41ac-925a-374fa98bc88c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_6dd3f758-730c-416b-bc40-86e607f99e82" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_585793e2-7b59-41ac-925a-374fa98bc88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ff5a0b8a-0fc6-4675-853f-d47d511d99c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_6dd3f758-730c-416b-bc40-86e607f99e82" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ff5a0b8a-0fc6-4675-853f-d47d511d99c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_8b2014ea-941d-429c-97de-77ebe741c9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_6dd3f758-730c-416b-bc40-86e607f99e82" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_8b2014ea-941d-429c-97de-77ebe741c9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/NetLossperShareDetails" xlink:type="simple" xlink:href="edit-20230930.xsd#NetLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/NetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d9f03cc5-68c5-41c7-b3ec-0fa9a20ddf0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_215a23fe-464d-4678-88aa-0f5ab750116e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d9f03cc5-68c5-41c7-b3ec-0fa9a20ddf0c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_215a23fe-464d-4678-88aa-0f5ab750116e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3a418467-515b-47e8-80b1-eeece25c5fac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_215a23fe-464d-4678-88aa-0f5ab750116e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3a418467-515b-47e8-80b1-eeece25c5fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35af975b-fde1-471f-9c6a-c6a16aa07a05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3a418467-515b-47e8-80b1-eeece25c5fac" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35af975b-fde1-471f-9c6a-c6a16aa07a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_bf7ee824-2235-4fd8-80d6-eca049abf81f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35af975b-fde1-471f-9c6a-c6a16aa07a05" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_bf7ee824-2235-4fd8-80d6-eca049abf81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9a9daa81-08bd-4189-97e4-ae4917a53ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35af975b-fde1-471f-9c6a-c6a16aa07a05" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9a9daa81-08bd-4189-97e4-ae4917a53ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d7f46fbf-e7de-4a1e-bff1-c314116236ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_215a23fe-464d-4678-88aa-0f5ab750116e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d7f46fbf-e7de-4a1e-bff1-c314116236ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a63e80b5-f955-49ea-ba74-e54cce7a252a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d7f46fbf-e7de-4a1e-bff1-c314116236ad" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a63e80b5-f955-49ea-ba74-e54cce7a252a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_PerformanceSharesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_edit_LindaCBurklyMember" xlink:href="edit-20230930.xsd#edit_LindaCBurklyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_edit_LindaCBurklyMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>separationagreement001.jpg
<TEXT>
begin 644 separationagreement001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM?6:2^4UU LG389 #^58'Q#_ .1 UC_KB/\ T(5P-M\$+E[8-=ZU''.1DI'
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC $!B50,Y )QN)_.G:;X6MM-N;69+NZE%H\Y@20IA%F(++PH) (R,\\GD\4
M8]I\0H+O4;=%CM#:W%W]EC5+K-P#N*AVCVX"DC^]D @^P;IWQ"CU*ZM!#%9-
M#>R-%;JMV6F4X.QI$V_*K8[$D9'7MM6OA=+.YC\G4[]+&*=KA+%741JY))&0
MN\KDD[2V/PXHL/"Z:=-;K#J=_P#8;9V>"RWJ(T)SQD*&91DX4DC\A0 G@R^O
M]2\*V=WJ11KB0,2R-G<,GD\#!]A6_6=HFD)H>G"QBN)IH4=C'YVW**3G:" ,
M@<]<GWK1I %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5Y;\;;V2+1=,LE8A)YV=\=]@&!_X]^E>I5Y
MQ\9-(EOO#-O?PJ6-C*3)CLC#!/YA:3 DT76-$\ ?#W39+EU^T7, N/)C_P!9
M,[ '\AD#)XXKC"?%/Q8U/ S::1&_OY4?_P 6_P#GBJ_P\\)6WC&\DN=5U!I(
M[/8GV7>=[J!QSV3C''Z5[Q:VEO8VT=M:PQPP1C"1QK@ 4#.+U#P]#X=T+3[>
MVDDDC@!B+R').26S^9-2^&M)MKO6XM<PIN;>V:U8'KRP*M^6Y:I^(/%]I>^*
MQX8AE1U,+AI >EP""J9^@(^K8[4_PAJ M]5:WD;"SKM&?[PZ?UKS9)4<6I=)
M'HPC[;"-=8G?5R7Q,LH[WP%J6]06@59D)[$,/Z$C\:ZVN&^*^LP:=X,GLS(/
MM-\1%&G<@$%C],<?B*],\TPOA%_R).M_]=G_ /18K)^"/_(<U3_KV7_T*M;X
M1?\ (DZW_P!=G_\ 18K)^"/_ "'-4_Z]E_\ 0J0RO\2/^2JV?TM__0J]IU.P
ML=2L)+;4H8YK4X9UD^[QSDUXM\2?^2J6?TM__0JZ[XQZK<V/ABWM('*+>3;)
M2#@E0,X_$X_*@"9O'W@CPI;M8Z8?,17+&*RCW+N[G<< ].QK)G^,<EX&AT7P
M_<SSMPA=LX/KM4'/YU=^&?@[1?\ A%[75;FT@O+NYRY:9 XC ) 4 \#IUZ\U
MZ _V/3+26<I#;P1(7=E4*%4#)- 'AOPE,DGC^<S@^8UM+O!&.=RYJ+4O#OB3
MX=^(WU+2H99+52?*G1-ZF,_PN.WX^F13OAE>!/'%_>I&S@6EQ*$'5N0<?6O3
M_"'Q L?&%W<VL-K);20QA]LK [QG!QCTX_.D@.2T[XW1$*NI:.ZGN]O+G/\
MP%L?SKK=&U[P;XMOEGMX[234N&"W$"B88Z8)'./8G%;&H>%M!U4$7NDVDI/5
M_* ;_OH<_K7AGCS08?!/BNW_ +(N)4#1K<Q9;YHCN(QGTXI@?15%0VLK36<$
MKC:SQJQ'H2*FIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR%DQE<]LY[>E'M8::[C]E/738TNE%%%:F04444 %%%% !1110 4444 %%%%
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MW#O_ !; H QT %0#2@-&BT[SCB,(-^WKM8'I^%:-%'LHM6?:WWA[62=UWO\
M<4++28;"^NKB%B%N-N8^RD9)Q]<]*KV.B&QOFN%GC8,[L1]G4-\V>-_7O6O1
M4^PIZ66VJ*]O4UN]]PHHHK8Q"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH A%K$+TW>#YIC$9.>-H)/\S4>H:?;:
MI8R6=W&7ADQD!BI!!R"".000"".A%4-6U*YM-0M[:%E19(V<L;=YCD$#HISW
MZU4\:7EU9^$V: R&:::W@8PGRV(DE1&VDGY202 <\9K.$XN3BNA<HR45)]34
MTS1K;2FGDB>>:>X*F6>XD,COM&%&3V'. /4^IJ-O#^GMH4NC&-_L4I<NN\Y.
MYR[<_4FL+0K>:WO=7TB*,Z3>F&&9%BG-U JL67>@=5(;Y2"",9 //-1Z':V4
MG@2?^V99[FVL[N]DDEDE8.1'/+\Q92,G -:D':U4N].MKZ6TEG0EK2?SXB#C
M#[67GUX<UR_APVGA?P^E_J NHI-2D\\PI'-<>2",K&  Q&%QD]SGVK'UOQ=8
MWWB?32NL0V]I8ZFL)@,H1I6VMO=U/(53A1GON/I0!V7_  B^F_VG]MQ/_K_M
M/V?SF\GSO^>FSIN[^F>>O-7WT^W?5(M193]IBA>!#GC:Q4GCZHM>>ZK)<Z;+
M?7DMIJ)UE=51H+L;_)^SM,JJ@;.W:4.TIUW'..].'BNRU7QYH]RNL0I:BXFM
MH;02@$_(R[W'JSX"@]@.[&@#O-3TJWU:&))S*CPR"6*6%RCQN 1D$>Q(]"":
MIGPMIOV"*V3[1&T4QN$N4F83"4Y#.7ZDD$@YXP<8Q6/J^M6>O3:3IUM)<BVN
M-06*[#P2P;E$4KA<L%R"T8SCMP>M9,\,T=]=:;Y5Y=:#8:L!-;VY=W$;VRN%
MP#N9%D;.T9X(XP* .M;PKIOV*VMXOM$+V\CRQW$<S"8.^=[%^I+9.<YS^ H?
MPKIIM+."'[1;-:;_ "9H)V60;^7RW4[CR<YR>>M</'=7%\T6EQVMU<0QZQ.L
M6FSS&,R6ZPJWSN3D!&D!"G/88XXL6MCJ>L:3I=BD23?9+N[^U6MS>O'Y)!(2
M,NN6<*'&".N!TH ]#L+&WTVQALK2/RX(5VHN2>/<GDGW/6K%8OA2Y@N=!18;
M5K3[/++;R0&4R;)$<JP#GEAD'!]#VK:I %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %9.M>)='\.M9KJUZMK]LE\F LC$,_'&0"!U[XK6KAOB[X=/B
M/X<ZC%$NZZLQ]L@QUW)DG'N5W#\: .GUS7]+\-:8VHZQ=K:VBL$,C*6Y/08
M)-0V/BC1M2UJ?1[2]$FH00I/+ 8W4JC!2I.0!T=>.O->.7VO#XI7'P]T -YB
M2K_:&JKV_=90@^F2L@_X$M=%X=*I^T?XP9B HTV$DGH!L@H [[4/%V@Z7K]G
MH5[J4<.IW@4P6Y5B7W$@<@8&2".36W7R?XBUK2/%-WXJ\52ZQ';ZO#>0_P!B
MPDD,8HCC(XQR,$>X-?2WA+7XO%'A33=:BP/M4(9U'\+CAU_!@10!,/$>DMXC
M;P\+Q?[56'SS;[&SL]<XQW]:#XCTD>(QX>-XO]JF'SQ;[&SY?KG&/UKR/Q#=
MZ[9?M"S2^'M,AU&^_LE1Y$TPB79D9.2?I^='AV[UV]_:$BE\0Z9#IU]_9+#R
M(9A*NS/!R#]: /5=:\7:#X=O;*SU;4H[6XO6VVZ,K'><@=@0!DCDXJ[K&L6&
M@:5/J>J7 M[*#'F2E2P7)"C@ GJ0*^;O&^J:%XS\6>,+O4=6BMCIUJ+31T8G
M]Y(C;F(QQR5<<_\ /0>E=MXA\3#Q9^S/=ZD[[KD10PW/KYJ31AB?KPW_  *@
M#U.3Q-HT7AK_ (2)K^/^R?*$OVE58C:3@' &>IQC&:S]7^(/A70K:PN-3U9+
M>+4(1/:L8I&\Q" <\*<=1UQUKP:YU"[\&>!=:\%:K(SV6I6$=_I$[=#N*L\?
M\_Q!_O"NHU"*.?Q3\'XIHTDC;3D#(ZY!_=)U!H ]7\/^.?#/BF9X=%UBWNYD
M7<T0RKX]=K $CWK7U'4+72=.N-0OIA#:VZ&260@G:HZG YKR3XCZ?9Z%\2_
M&H:1:PVE[<ZAY$WV= GFQEHU.0.O#L,^]=W\2?\ DFGB/_KPE_\ 0: *5O\
M%WP%=3I#'XDM@[G ,D<B+^+,H _$UM>(?&&@>%;>WGUK44M8KDD0L49PY R<
M;0?45P&E^']&U#]GR.2]T^U9UT>243&)=Z.JL0P;&<@@5Y_J-WJ%W\-_A=+Y
M*W=XNHO'!%,<++LE"QJ2>V !]* /;-+^*/@O6=3M].T_7(Y[NX;9%&(91N/I
MDJ!6YIGB'2M9O-0M-/O$GGT^7R;I%4@Q/DC!R/53T]*Y#PVWC"37[9=7\$:+
MIUC\QDNK>:-GC(4[< '/)P/QK)^$O_([_$G_ +#!_P#1DU 'HFK>(])T.ZT^
MUU*\6";4)O(M5*,?,?(&. <<L.N.M-T;Q+H_B"6]BTN]6XDL9?)N4V,IC?G@
MA@/0_E7GOQ>_Y&WX=?\ 897_ -#BJG/=P_#SXY7]Q<MY.D>(+![EFZ*LL8+-
M^/RM_P!_!0!Z'=>.?#=E>:G:W&IHLVEQB6]41.1"IVX)(7!^\.!D_D:QO^%R
M_#__ *&*+_P'F_\ B*\UT^PFG^"'C3Q9>KB\U^5I\GM&LH"C_OHO^&*UO"DG
MC@>$M&%GX!T*ZM?L<7E7$MQ&'E3:,,P)SDCF@#T;6OB+X3\.W$%OJVL);2W$
M"W$2F*1MT;$@-PI]#4FA^/O"WB266+1]8ANYHD,C1*K!]HZD*0"?P!KS+Q]-
M>6GQZT1]-T*/69TT;"6+2+&&&Z;)RP(X'/X5'X%\SQQ\6!XC_LZQT$Z'$]O/
MIT3?OY'(=<L-J\#<1G'\('T /7]!\3:-XGL9+W1KY+NWCD,;LJLNU@ <$, 1
MU%)H/B?1_$\5Q+HUZ+N*WD\J21$8*&] 2 #^&>H]:\8^(6D:OX.\8R6_A>>.
M"U\:_P"B21$X$4Y=0S#TR'//;<WM7LWA;PY9>$_#EGHUB/W5NF&<C!D<\LY]
MR?\ "@!/$7BO0_"EM%<:W?I:I,VR(;6=G/\ LJH)/;MWJ;0O$&E>)M-&H:/>
MQW=J6*;U!!5AU!! (/(X([UY1\5[V]U;QOI-AX3LY[GQ)H*/?NZ[?+CC(!VD
M'[S'"\?[6.<\6_@QXDT)X7TV*\NKKQ!J;2ZEJ)>#:L<A;#+QPHR!CUW#IG
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,2RP^(KK7@ETZ-=W-L86!VJ=FT]@"#GWKLJ** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1YX;S,F)\>JN",^CFNOK@O%]DS1>"_#D<C37!U*WE9SU,5NN]W/Y*/JPKO:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@!D<,4(811I&&8NP50,L3DD^Y-/HHH **** "BBB@ JG
M>Z9::A+:2W$6Z6SF$\#JQ5D?!'4=B"01T(-7** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#(M?#.DV?B"YUV*V/]HW*['F>5GPO&0H)(4' S@#-:]%
M% !1110 4444 %%%% %+^R;'^VQK/D?\3 6WV7SMQ_U6[=MQG'7G.,U=HHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDL,4\3131I)&W5'4
M$'\#3Z* "BBB@ HHHH **** *?\ 9EI_:YU4Q9O/(^SB0L3M3=N( Z#)QD]\
M#T%7*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!N4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5A^,-?/AKPM>ZG'&LMRBA+:)
MN?,F8A47 Y.6(SCMFMRO./&G]I^(O'6C>']&>T#Z6O\ :]R;M&>(.#LA5@I!
MSDLV,]@: .D\%^(+K7]&F.I10PZK97,MG?10Y"+*C=5R2<%2I'UJ:U\9^&;W
M5?[+M==L);[<4$*3 EF'4#U/L*XBR.L>%_B1-_PD#V<EOXGMF&=.B=%%Q"G
MPS$[F0D<'D@5@V.H)HNBZ MEJFC^(]"6]@6ST^XA$5_;N7P-H4\NA))R >#0
M![3?7]IIEHUU?7,=O;J55I96VJ"2 ,GW) _&DDU.QAU*'3I+N%+V=&DB@+@.
MZKU('<"J?BC1D\0^%M3TA\?Z7;O&I/\ "^/E/X-@_A7C,6MS:B+?XDW22C^P
MI[*QFX.0GEE;KCO\\X_[XH ]JN/$.C6MK>75QJ=I%!9R>3<2/* L4F =I/\
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MW\&L:=<Z6^IP7T$EBBNS7"N"BA,AB3VQ@Y^E9][XT\,Z=%YEYKEC"NR-QOF
M)5P2A ZD$ D>PKSC6(+BSU_5/A[ KK;^(K^*\@9?X+:3+70![8,3#'_32NFT
M6PM#\7_$KFWB+0:;91194?(K;\@>@.T?E0!T+>-?#"WEK:'7M/\ /NU5H$$Z
MG>&^[CGOV]:GUGQ1H7AXQ+J^JVMDTO*+-( S#N0.N/>O(TL;6#]F^]DBMXD<
MW3R;E4 [EO-H.?4  ?05KW#ZA:?%KQ,[:[I6DRS6]L;5M3M?,\VW"881L9$
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M $\>O+HVL16MRMG/=0"2VD&[#QMN( ; &,'/6@#V;3-5T_6K%;W3+R"[MF)
MEA<,N1U''?VKBO$?CS4-"^)^DZ!]FMFT>Y@B:YF96\V-Y)'C0@YP%W!!R.YJ
MQ\.=3>_;7X);33%GM[[$][I9/V>[D9 2PS_$. W)YK&\6:*?$7Q&UC2U.)IO
M"BF%O[LJW+,A_!@IH U_BCXXOO!6B6\VE6]O<7\\C'9<*2BQ(,NQ (/4H.O\
M5=+J_B?1/#Z0G6-4M;(S#Y%ED +>I ZX]Z\<U[5'\9^ ?$OBF:-D6VTVWTZ)
M67&)B\<EP0#_ +11?^ 5O7;ZA:_%S7)#KFEZ3)-96WV*34K7S1)"%.\1L9$
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MW/BHNJ+$L'^E?:/-Y.<9QMS[8P.O%==HNE?;?CC90:_;175W!X:A>83J''G
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA+INDFPD%_%JJSO#E<A!>&3=UQ]WFNOMOB#X1O-373K?Q#I\ETS;%191AF]
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M> J'**K!@NX@;@6QC/:O1*R;>/2?#:Q6:2I;)>W3F"%GX:5\NRH.V3N; ]Z
M,?PWI]]%XX\4ZI<6<EO;:@EDT!DQEML1##@GD$X-<1)X&U1O#FB7-SI$MW)I
MFJ7LT^G)/Y4DL$TC?,C!A\P&U@,C/2O4U\0Z0RQL-0@(DNS8H=W6<9S'_O<'
MCVK2H \^\':%%'XIFU2U\*SZ19QVODQS:A<.]S*[,"P"^8P5, =>2:]!HHH
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M^M>CTV21(8GEE=4C12S,QP% ZDGTH X3X/:'J7AWX?6^GZM:/:W:SRL8G()
M+9'0FN=URT\5:'\9;SQ/I/A:;6+273TM1LN4A&?E).3GIM].]>AZ5XR\.ZW+
M%%INKVUS),[I&J$_.4 9@,]<!@?QK8AGAN8_,@E26/)7<C!AD$@C(]""/J*
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ME;WA+0H1XL_M.T\)W.DV<%LT:W&HW#M</(Q&55/,8!,#DGDG&*]$HH ****
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M.U=H#;O=0AWB/\#=&'/;(-<Q\,X(KYO$.OW2+)JESJUQ#)*XR\<<;;4B![
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MSFZ^(%U)XT\.0V'EMH=W# ;QMH+"2Y5S ,]N4Y_WA4,?BK5+^[T>\)@:QO\
MQ)+:6@:%21;(CJ&!/()9&.?0U+:?"K['X/UC18]6/VF\NHY[6[\OFV6(KY*@
M9YV[>O'4UM?\(0D6G>$[*VN5CCT"=)3E,F;;&R'OP26SWH X.V_X]-+_ .R@
M3?\ H4M>E>.-5N]#\$:QJEBRK=6MLTD3,H8!A['K6-%X ECAM$_M!#Y'B)]:
M)\H\JQ<^7UZ_/U]NE7/BA_R3'Q%_UYO0!F7.I^*?#<NAZCJ^IVU[:ZE>16=U
M9I:B,6S2\*8W!R0K8!W9R.>*RO$OBW4K&\U?=XSTW3[JU9_LFEVUJ+MG11E?
M-."RLW<#&WWK;LO"FN:F^BG7]:M[O3M,DCNH(H;4QR3R*/D:5BQ'RYSA0,GF
MH(/ FN6-IJ^D6.MV<.DZE/--)*;,M=J)<[EW[]IZX#$$T 3:9XNU*?5O"<]Y
MY::;XATS<$5?]5=A1)C=UPRE@ >ZUK>#M9O?$$.IZI*ZG3Y+Z2+3E50,PQ_)
MOSU.Y@Q^F*X[QG8PZ5\/=$\(IJ ?Q+!]F72O)0AWE1@F\#G"A=V23P,UZ1HN
ME0:'HECI5J,0VD"0KQUVC&3[GK^- '#16FH?\+OU*3^T_P!R-&B=HOLZ_-&9
M) $SGLV6SUYQ7+>';[Q5X=^#FG>);?5K86=E&K#3#: B6+S=IW29W!CDGC '
M QWKTFZ\-WY\>)XBLK^&."6R%E=VTL)8LJLS HP(P<MW!Z5GGP%*?A0/!?\
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M".]>>>$HHKKP=XR@N.89-5U-'S_=+$']*WOAW<377PY\/37!)E:PB!)ZD!0
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M0^19VZ[(H]Q;:/3)))_&LJY\#^';N]U.\FL"9=4A\F\VSR*LR\=5#8!^4<@
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M1LVL<GH"1DBHO"_Q$M=2T?7-3U<O96^G7LJ>9):R1((@^U!\PY?CE1R"<8'
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MEL[:X"JJ.,;2Q'+8P/RKT2@#YABBG\/6GB;PWKFI:U:W-W>R$6%IIR3#4%?
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M_@19B>Y/L* -2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#*O) .",C(K%'Q"\27'AZ^\0VOARS.F:=+,MP)+TK+*L3D,T8"$8 &?F(YR
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MNX=<'C/>@#R[P=XOU?3?AIHDMW:+J.I:E<M;:>GVIB\[%W+-*S+\H&&R1NX
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M5**(CD+.Z@;]Q+9P" &[U;T7PQ<MXBTZZ'@;0= M[0F2>9%BFEE;&%$151L
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MR!)[:92DD3C*LIZ@UPMUXJN/">N^+(-5N'GMX[,:KIPD.25QL>('_KH%P/\
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MMT^W.89 -JX.3P>1QBNQ\<'7%\+3GP^LS7F^/>("OG>5N'F>7NXW[<XS_/%
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MT-HZI&'5BV7&"7R<#!.,#WJ:^\8:GK%UX:T^1]9B@N="BU6\.B0;IY7? "Y
MRB Y)(]0* /6+6TM[&UBM;2"."WB4+'%$H55'H .E35Q/@#4-8GGU>QU"'5F
ML;:2-K"ZU6W,4TB,#N1N!N*L.O7!&:@UT:GJOQ/M]"AUJ]T_3FT=KJ9;1@KN
MPFVC#$';U&2.<#'>@#O:*\BGUS6],\,Z_9?VO=3RZ7K]M:07<I'FM"[Q':Q
M^8X=AGOFNQU[4;RV^(?A&QAN'2UNUO3/$#Q)LC4KGZ$T =917B)O/$B_"V;Q
MI_PD^HG4+6Y?R(-R^046Y,>V1<?/D9Y)XX Z5UT<.J>&_B%X?LGU_4-1@U>"
MZ^U1W;*5$D2JP:, #9]XC XQ0!V.BZS9>(-*BU/3Y&DM92ZHS*5)*L5/!]U-
M7Z\4\-:3J]I\))?$5GXDO[>YLDN[JUMD9?LX5)9&*.F/GW$-DDY&1CI5Z]\7
M7OB+Q&MHW_"0V^G0:;;731:'"6D>69=_SN 2J@< =SGTH ]=HKQVXUSQ8_AR
MPLGN=3L+A_$<-A;WUW;>5--:R*V&92,%ATZ8)4>]6M=O-0TCQ'IWA!=4\375
MG'9/?W-S9IYUY,6D*HA<+\J#!Y ]!0!ZQ5"]UFRT_4M.T^XD9;C47=+=0I(8
MHA=LGMP#UKS ^*/$NF>']9M4758U-Y:VVE:AJ]KLE43MM?=D .4.<'W&:OZA
MX?NM%^(G@AFUS4=1MWN+D,E_()&63[._S*0 0",Y'3IC% 'I]%<G\2K^_P!,
M\ ZA=Z7<FVO5>!8I1_"6GC4_A@D?C67>1:GX/\0^'7_M[4-2@U2[^PWD-XZL
M"[(S+)& !LP5Y XP: /0**\4UW7;DZ5K6J67B3Q)?:C:M-)%-IEL5TZ#820A
M++L90!ACDD\UN.^L^*O&]MIPU^_TRR?0+>_D6Q948RL[#@D' ]?7 H ]/HKR
M77=3:YU+6UC\0^);NZM9'2"'0K=A!:;5X65RNUGSDMEO;BIM+UO6/&+^%-(E
MU2XL!<Z*=3OKBS(CEG8,J!5;'RC)+''TXH ]4JM+I]G/?V]_+;QO=VRNL,I'
MS(&QN /O@?E7DVJZGK_A^P^(=K_;]Y='2[6S>QFE(\R(/N)R0!D]L]P!6YK%
MO=>&]!MA?>--3674+M#._E^=._RDM%;(BG9D^QP!0!WNH:?9ZK8RV5_;QW%K
M* )(I!E6P<C/X@59KQZQU_4K+5?$FGVUYK_V-/#TVH6_]M)B>.525W(2-VWI
MU[BK,[:[X?\  ND^,I/$>H7EYBTDN[:5E-O-'*R*45,<$!QAAR2,GK0!Z38:
MS9:E?:A9VTC--I\JPW *D;6*AA@]^"*OUY9I7A^ZUOQMXWV:]J6FPI?1!$L'
M6,F3R$^9B020!C Z=<U477/$^L>!?">J/_:UQ9R+,-6?10HNF93MC8#KM)#%
MMO- 'KU4/[9LO^$@_L/S&^W_ &7[7LVG'E;]F<].O:N>^'VJ0ZCIM\D.NW6J
M+!<E0E] 8KFU! (CES@L>I#8_/%8^MZ7<:O\9X;:'4[O3X_^$?+3/:,%D=?M
M'"AB#MYP21SQCO0!Z117CUUXKUS0O#6LZ:E_=7EW!X@32;6\>(2SK%(JMG&,
M.X!8#U)%:6@:AJ]IXNTRWLX_%EUI=T)([XZW:G$+!<I(KX&,D8(Z<T >GT5X
MSIFKZ[IOPPO/'EUKM_>WBQ3106<C+]G7]^8D8KC+,#SG/3CM5JRU'7=/U/1Y
MK'_A,K^66YCBU)-3L2(&B;AW7C]V5)R,<8&#0!Z?I^J6VIF[%MYG^B7#6TN^
M,K\ZXSC/4<CD<5=KR*_U_7GTO4DM=6F@N3XT73H9L!O+A8H N#P5&<XK?L(]
M0\.?$BQTC^V]1U&PU&PFF=+^02-')&R?,I & 0QXZ4 =Q=W<%A9S7=U*L5O
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M,>_C!1S@,K9&#^% '->*],A\7^/]#TY;"]"Z1,;B]NGA9(6CPKK$&/#[G"'
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ML_"R:3JD4-^\LANKQI$RLUPS[V?!_P!KIZ "@#HZ*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"YU&U$5RF]6SN4JN1E<@E>]=EXEUB_L8_!YMKDQF^U6""YPH/F1M$[$<CC)
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M_@1]J /7J*\DOO$5_+XIU#0KG6_$$%KH\4$'GZ7IQFENIFC#-)(RQL%'(^4
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M=?VMKO\ N^?,J;OID\T 8&I>$;M_$%QK>A:W)I-Y=Q)%=@VZSQSA.$8JQ&&
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M#*\B1RH[1G:ZJP)4^A]* /.KC0]6N?BO?3Z9JD^F-%H]O&)S;"6*7YWRI5L
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M+2_M;A(O]8T4RN$^I!XJ4W5N+7[49XA;[=WF[QLQZYZ8H FHH!! (.0>A%%
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M+Z9H \F\2P'1#\3+;18OL<'V33Y6BM5VA%<L)F51P"4!SCTK9\3:+X8TW6O
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MB&ZA$UO-'-$V</&P93@X/(KS7Q9JS> /%^H:Q&A:'7-.940#.Z^A&(Q_P)6
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M2U>-]/\ #/B72[!8;?2QXNB@FB=C'!';NL996*\K&6(!QV)KV_\ L^T_M/\
MM+[/']M\GR//Q\WE[MVW/IGFHAHNF>3>PFPMVBOG,ETC1@K,Q !+ ]> !^%
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M^4L  <=,@=J\D:2XTN)QX6_X2+2M>^U8_P"$=E@>XLB3)\Q#,FQ4(RVX,,4
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MTF,\+Z67B6,[DVM'NR,9&.<^E5=2T\M/X[:_T*]U"RFU*T?9;[DEV"*/,L1
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MFV;S7?$F_&T*-V221C!]J /2-8\8:?I-_#IZ6][J-_-%YXMM/A\UQ%G&]N0
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MS'&,\G)R".F#6=X-\6SBP\&Q/IUA9Z7K-K,B+:HR+#<(2P09) 5E#8'7(ZT
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MOLBWC1A(2PVEL(J[FQD9.>M<E%\3KZUMK#5=0U+PO/9W4D:S:=97.ZZMDD(
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MT%W8R%XKJ NOS( Q*-N(!!)& ?45Z=:C4!IB"Z>V:_V'<T2,(MW; ))QT[T
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M>HEVS+'(%5E*DJ"1][T[5U%4KC5;*VU6STR6;;>7BR-!'@G<$ +'/08R/SH
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M$I(H920<C@^A /X4 <W\.]+N=)\%627J&.\N6DO)T/5'E<OM/N P'X5U-%%
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MPL+1!#F-6S\Q<[01CC!KH]>\*6VMWUIJ"7M[IVHVJM'%=V3JK[&QE&# JRY
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M^;A7#CG;CJ/2@##2TG\7^.?$=M>:KJ5I::08(+6"QNF@PSQAVE;;]XY.!GC
MZ58^$\4EOX/GAEG\^2/4[Q'F( \PB9@6X]>M:FJ^#+;4=8?5;74]2TJ\FB6&
MYDL)53[0B_=W!E(R,D!A@C/6KOAKPW8^%-(&EZ<TQMA*\H\Y][ NQ8C..1SW
MY^M '(6FGW>O?$_Q,MSK>JQ66E2V<EO:6UTT:%FB#-N ZJ=OW>GS&N1T_5-<
M\1>&YO$"6WC!M9N#++:7%G.BV4.UF"((S( R# #;E)/->Q6.A6NGZWJNK0O*
M;C4S$9U9@5'EIL7:,<<=<DUSUQ\-=.E%W;0:KJ]II5Y(TEQIEO<*L#ECE@,J
M656YR%8#DT 86EV,M_\ %ZPU"_>]M[V3PW%=SVZW3A$E\P*R8!QLSGY>F>>M
M00:QJ1_9VNM4;4;K^T%M[@BZ,S>:")W ^;.>!@5V\W@^P;7]-UBUN+NRGL+<
M6JQVSA8Y( <B-U(.5!';%8MQ\*M)N;&[TPZKK*:1<L\G]G)<J(8V8[B5^7.
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M20&5@6R[LYY '=C0!IT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"RJ"< \\Y.>N37?^+KN'3?%WA_3M/L]&L[PQ3S07^H@B&  *K*B*5#.1CN,
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M_A'Q,_B6?72'MI+6ROS;VTMN<B2/RT8,3D@GYCR.*O:MXJT#0I3%JNKV=G(
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M8Z/JMK>M",NL4@)7T)'7'O7EUW8O;^"] US6HL6^I^((M5U@.,K'')N\L/\
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MF\2F.%DLQ>-(&E.W<N HZ9/4]N] 'T=;:+I5G&D=KIEG B/YBK% JA7_ +P
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MT,Q2,1]U_8]#]:\RT'0+RW\2:1-X?\.ZSX<1)=^K13W(-FZ;3E43>VXEL8(
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MSPAX8N+GQIIVHR^"KO2H+&-F:ZU#5)9I%E((Q$I<@J?<=/P%;WPD\/:IX?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% "*BJ254 L<G ZFEHHH *:T:.RLR*67[I
M(Y'TIU% !1110 4444 %%%% !1110 4444 %%%% !33&C.KLBEUZ,1R*=10
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-K%]'+);PO&CB(9;YW"9Q[;LUCOX\:"RMC<^'=4AU*]N&ALM-81^=. H8O\
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M,?0 D5CV;ZQX5T[7_#X\.ZC?RW-U<SV%Q;QAH95F)8>8^?D*DD'/IQFO3J*
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MFHZ=<64LDL<=Q&T;M$VU@",'![''>I+6U@LK2&TMHEB@A18XXU& J@8 'X4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBL:N\48#.1SM R3]*N:'X:\1>(?!_AW3]7U*P;0D@M;EQ%"PN)U4*Z1/D[0
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M21]:KV?P[U*#3H[:XU6"XF7Q(FMO/Y93> 0S+M[$D''..: /1:*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ***Y?XA:W/H7@R]EL@6U&ZVV=DBGYFGE.U<
M>XR3^% !X7\<Z=XKU'4K*SBFC:R?Y'DQBXCWLGF)ZKN1A745XHLU]X/U+PCJ
M,GAF^TK3]/B&DW]S/-"RO%(0 S;')&)/FZ=S71Z?HMEXS\6^*I=>,\LFG7:V
MEG"MP\8MH_+5A(H4C#,23N]J /2**\*TNW?5_#'@73Y]1NIH+K6;Z*:99V5Y
MXP9L@L#G# 8_'BM/5--9_'1\,6V@SZIHNE:=');Z=_:/DIND=LR,6;,F,;1D
MG'XT >Q45X??7OB/2?"<VCA)8H;C7X+*&!-322>"WD!9H3,"=G*[06Y >M[0
M=.U+1/'.DK9Z%_8-A=1S1W=M)JR3"XPNY72/<264XR1V;F@#U*BO 8=$CC^"
MECXJ2[O1KR3Q^5>_:7W1*;H1;5&<;=I/&.3R:[&?3+?P;\0]/&B).JWFE7DE
MS$\[R"X>+8R,VXG+9)YZ\T >FT5X#86>LZCX(B\11Z/<?VU-']J7Q#)K4<85
M\YY4L L8^[L(QCWKKX=%@\5?$G5H=;\V6VCTJRE:S2X80F1M^6^4C=CG';G/
MI0!WVKZU9Z(EFUV7_P!,NXK.$(N<R2'"Y]!U)/M5JXL;2\*&YM8)RARIEC#;
M?IGI7B,VG07_ (;T6ROC-<QV'C-M-@,LSEA;^:1L)SD\ #/48XKW**)((4AC
M&$C4*HSG ' H ?17&?$.XM#::7IUQ_:4\EY=@1Z?I[A'O-JDE&8D;4'4G(Z5
MQFE)<:1XM\0:;#I4FAVLOAN6Z^P?;O/'F!RHDX)"'!(P#VS0![-17B;:';Z5
M\-?#'BNWGN_[<W:>[7C7+LSK(R*8R"<;-K8QCM]:Z/3=$L_&7BCQ5<:X]P\V
MGWPL[.-+AX_LL8C5@Z!2,,Q8G=[4 =GX9UZ'Q/H%OJ]O#)#%.TBA),;AL=D/
M3W4TZ;6HD\26^B11-+</ US,P.!!&#M4GW9N /9CVKG/A$H3X8:2HD\T![@"
M3^]_I$G/XU'X:FD;Q=X]OF7?<Q7$,")_L) "H'U+,?QH [NLNUUJ*XU^^T:2
M)H;JV1)DW'(FB;@.OT8,I'8@>HKSKP_X>TG4_ %CXNU36+BTU>8+>3:R;E@T
M3;^5P3M"#[FW&,5T?B%S!\4?!<T)P]S'>V\N/XHQ&KC/L&4?G0!VU%<5\19I
MGC\/Z4MQ+;VNJ:K%:W<D3E&:/:S; PY&XJ!Q[U@^+K*R\ :)K=UX;U*2QNY=
M.!73A*75?WBH;A58D@J&QD<=,\T >IT5Y?X@\/:?X)M]"U?09;B._;4K:VE=
MKEY#?I(VUU<$D,2"6SV(XK$DT"UU/PM\0-:O)KN2^T_4M0:Q<7+J+8Q_.I0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?)ND$[B*9=NWYDS@G;QFJ2?#[0%T&#1_+NFMK:;SK5VNY#+;,!@>7)G<H '
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M.[U"U>*XB?P];M#.A# JTSG(/H<"N&U6WN/["U:XAE:"SL?',EQ=2I")1#&
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M@N'-MX7?RS=QA)5_>1@;E!.U@IP1FL?Q-&?^$?\ BPD2' N[=RJC_IG$6/\
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ME)R0BA03Z\4 >!MI=]J5EJ6B!7,W@>TF:U<_Q2^>)(2/^V4('_ JU;V0ZO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW3'<3_#D#&/6FZ-XQUJ?2_ VO7UPOV'52UC?QK&H7SFR(I!QD99"",X^8<4
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MVQM((B6+ <N'&"?:NG;4_$/B3QK;Z9::K/HUA-H4&HRQI C3)([L"H+J=IZ
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M.*VK#Q#::CK^K:/"'$^F>4)6;&&,B[AMY[#&?>M)9X7E:)94:1/O(&!(^HH
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M\8R>F<5LT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$ \1>W+.RGL2<L?4BLZ/0KVQT#0=4L=)\.Z5.LUO)#K(U-S-<%B,ASY0,GF
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MO"P]]H"$>FVNBT*ZU:Y_MSQAI.E1ZI<:E??9K2&2Z$ %G#N16#$'JX9L8YW
MUK>)-"O;?PBWAGPOI%J;6]26WD>:XVI:K(26?:02_+,<9ZXKI=(TRWT71[/3
M+5<06D*0I]%&,GWH 9HUSJ5WIJ3:MIR:?=DD-;I<"8*,\'< ,Y'M5^BB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M",I9HWPRD'Y>,@TVSTM8].\)2PP:HT-SXI:]SJ**)"&23]X550$4D;@"!C-
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M%NB[+CU*J1[YH [G3/'VA:K?VUG$]Y ]V";1[NSDA2Y &?W;.H#<<XZTV_\
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M<B#YB%96!#<'(&>*],HH \ST_P !:NG@;Q/H]W]ABOK[4)+^R:U)$4<F(VC
M&,J%=,?2J>H_#36+WP]X>MEN($OA),NLN'(\R*XD$DX4XY.1@5ZQ10!GR-J4
M>KVL-O;6W]E^4WG2%R)$<8VA5Z$=<UH444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;V&WM7:6TIFM8I2 "Z!B![C->0>,?^/GXG?]@6R_E)7KEA_R#K;_ *Y)_(4
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M[=H2XWB0W#X7;US@@_3FNBTC2-/U+XJZA)?6<%R8-$LO+$T8<+DOD@'OP.:
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MYN_[4,^WSA<;WQG/.[[NW\,5;\'W<UKXWT=M:G$-W-X/M@QN&VEW65BP.>K
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MXZU5US7+3P_917EZ)?(>XBMRZ+D(78*&;GA<D9/O5;_A*M,_X3'_ (1;>_\
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M% QC\:[JB@"F-(TT:6=+&GV@T\J5-KY*^5@G)&S&,9YZ5;(PF$ ! P/04M%
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M:%LXP'Y!P>.1D _45MT4 <K?>']4UCQG8WVHR6']C:6YGLHH@QFDF*;<R9X
M7+$8Z\9KJJ** ,J\\,:!J.H)J%[HNGW-XF-L\ULC.,=.2,\5>:SM7O([M[:%
MKF)2D<Q0%T4XR W4 X&1[5/10 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7C9T[_A'O$/B--7G\6VXO-0DO;-]'\UHKA9 "%^13B0$;3NQP!7LE% 'EFB
MZ#<Z?JGP[5-(O+2&W749)HI9#.;8R)D!Y H ))/&!R2.<5OZ%97,7CGQW/);
M2I%</:>3(T9"RXM@#M/?!XX[UVE% 'B.F7,WAN'X6O?:;>,\%I?+-"ENS31
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG#@9)P?[J@=* /4J*\*N[N:PTW1]:TN/Q8;@WEL)=7U"Z,<-VKNH/[AI#\K
M\ (,#'-=;::*?$WC_P 80ZCJNI_8[.6V2VM;>]DA6)F@0E_D(YST'3.3@YH
M[6_UVUT[6M)TJ993<:HTJP%5!4&-"[;CGC@<8S6G7B,#WWB:^\$6-]J5UYL&
MI:G9-?0OLEFCB1AG<.A91M)'/4]:[/PI#)HOC_7M @O+R;34M+:ZABNKAIC"
MS%U8*S$G!V@X)H [6[N[>QM);J[GC@MXE+R2R,%50.Y)K*T;Q/9^(/"_]OZ5
M#<7%LPE,4>T+)+Y;,OR@G')4XR1U&<5<U71=-UR&"'5+..ZAAF$Z1RC*[P"
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MFVS)NY?+$'=N/)W Y-+%\/\ 1!I&I6%S]JO6U-E>[N[F8M/*R_<.\8QMP,
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MKEXFBBE#E4#,J.?3<%)%-E\<:=#\0D\)O/;+*UIYQ=IAN\XLH6+;ZE26^F*
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M>N;WG,#*65$3S  $'#$MUZUSVA2I-X6TAHYTGC_X3U=LD<?EJP+$@A/X0<Y
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M2.5F8-OSUPWW<9S@?0 [B\\8NLMC:Z7HE]J=[=VBWGE1,D:Q1'&"[N0H.3C
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M;P_;65W:VI0W%M)'T;8S#*G+ XZ$5H?#BZNK[6_&=W=V;6<LFIIF!F#%,0H
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M5KJ<<$D<^C7$JF.5(PCHZ(ZG!P""<XSB@#I[KXD:7;Z#I^JQV5_/]LOO[/\
MLB1CSX[@!LQLI/WLKCKW!Z<U<TWQBL^I7.F:MI=UI%_#;&[$4[)(LD(."RLA
M()!ZCKR.M>?W]G<^'/#_ (8N8?#TEM<3>)Q=#3S=--,X:.0?,[L1YA4 XSC/
MXUT-PFO>)/$DNO:;I5UIO]FZ3<P6)U",1O/=28Q\F3A%VCD]2: +P^(KQQ65
M_=^&=4M-%O98XHK^5HN-YPC-&&W*I)')'?I5N3QR6\6W7AZQT+4+V>SEA2ZF
MBV".%)%5@Y)(_O'CK\IKS?4=$U+5/#MB5T3Q7>:W#/;RWL^I7#^7&5=2_EH7
MVMDYQM7@9.17I'A[3KRU\<^,KR6W>."[EM3;RL/ED"P!3CZ'B@"G>?$9[:RN
M=6C\,ZI-H5L[++J ,2\*VUG6,L'*@@\X'2F)XHU67XM+I45G<2:0VDK.K!X@
MGS2?Z_D[L<;,=<@G&#FN&U#1M=UGPAJ5KJVC^)]0\4R)*&\RY9+%#DX:,!PC
M#;C"@$D_G77)8ZA;^.-,N9=+OFL[[P['IKSPQ@_9I=Y8^9R"H /7UH OGXDQ
M&TDU>/0M2D\.1N4;5E\O9@-M,@CW;S&#_%CISBNU$T9@\X2+Y6W?OSQMQG.?
M2O#K+PHVG^&AX?N_".O7NLQ@VX9-0G6PG4G <L) JH5Y*X![8KV-M+5O#C:2
MN(E-I]F&TDA!LV\$\G'O0!S,/Q'CFAAU(:!J8T">988]4.S:<MM#F/=O"$_Q
M8[]*L7?CI_MVH0Z1X>U+5X--D,5Y<6QC54<#+(@9@9&'<"L70M5\3:1X7TSP
MQ;>&;H:S9K%:&YFC!L@B$ R^8&&04&<#YLG&*?I-UJO@B76]-D\.ZGJ0N-0G
MO;&>RC#I*)3N"NQ(V$'()/&.: .BT[QKIFJ:GI5K:B1H=5LGN[2Y( 1]A >/
M'4. <D?6H+OQ]IMFFKR/;W4B:?>1V">4H9KJY8 ^5&,\L"0#G'?TKF3X2UG0
M?AMH$EK;"X\0:'<_;E@B/W_,=C+"#Z;9"/\ @(J/5/ NH-\-M$@%O)>:E9W\
M>JW\$<QBDN)&+&95<$8;]X<'(^Z* .OTKQ<]UK4>CZMHUWH]_/$TULD[QR).
MJXW;61B-PR,J><&H/"'C@^,1'<6FA:A;Z;)"72]GV!&<$ H #DX)/.,<'TKG
M_#FBVEQXQL;^Q\,ZU:0644K->:S=S[T=UVA(XWD;.03DD8].U=#\,].N])^'
M.BV-_;O;W4,+"2)QAE.]CS^= '64444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !117FWB7Q+?VFMW]O+XQTO1/*P+.RBM
MA=SRC:#ND7[PR>@ Z=Z /2:*\N@\9^(]<L/ HTZ6TL[G7HKC[5(\/F+&8U!+
M*N<]FP,]2,U+-XSUKPK#XMMM7N(=5FT>VM[BTG$(A,OG$JJNJG'# <CM0!Z'
M=ZA:6#6XN[B.$W,P@A#G'F2$$A1ZDX/Y59KRKQ)8>*+74?!KZSK%MJ$,FN6[
M2)':B(P2[7P$(/S)@L.>>!ZUWOBO4-1TKPKJ5]I-I]KOX(2\,.TMN;Z#DXZX
M'7&* -BBO._!GB>YU?6XX8?%VG:U;M"YN+:6U^R74#C&-J=67J#GIQR:9'XQ
MUAO@?-XI,L7]J+;RR!_+&W*RLH^7IT% '?)J%I)J,NGI<1M>11K*\(/S*C$@
M$CT)!_*K->8R6NN:A\6M272M2BTY3H]JT]P;<3/]^3:JJ3CGG).>GO4=WXW\
M0V_AF[27RUO].UC^SM0U"WM&E6*#;N^T"('/0J".0"30!ZE17F=GX[FT_P *
MZ_K;:]IOB.RL85DMI(%\F<.W&R6,<*,[<'@]>*SK/XAW=G?:1)+XGLM:^VW,
M<%W80V#1?9PYQNC?J0I(SNSD>E 'KM%>>6^K>*O$,>MZOI.HVMI::?=36UI9
M26HD%SY7#-(^<KN((&WIQG-+X>\6ZMJ-YX)CN)(RNKZ7-=7>(P-TBB,@CT'S
M'B@#T*BO.M<\>WN@3^.)9$BFBT=;);.(KCYYE_B(Y(W$'Z UF:;X^N;77=&@
M?Q/::_'J%RMK<6\-@8&MV?[KHW=0V 0W/.: /6*8TT2S)"TJ"5P2B%AN8#J0
M.^,C\Z\QCUCQIJND^)M6M=:L[.+1[V\B@@-D)/M"PDD!V)X& %X&>ISVJ."X
MU/7/B5X1U>._2V2\T(W9@$ ;:A,3/'DG^(GKVQ0!ZK17,?$'6[[PYX)O]5TW
M9]KA:$1AQE3NE12#^#&LI;_Q/H/C'0;'5M6M=1M-8,T;QQV@A^S2)&7&P@DL
MO!'S<T =Y3#-$)U@,J"9E+B/<-Q4$ G'IDCGW%>;6>L^,=?\+7'C#3M4L[6V
MQ+-9Z6]H'62*,L )),[@S!3TP!D56TB[O=?^+&DZU;WX@MKSPVEV+<P!BL1D
M3=%NSUW<[OPH ],L-0M-4LTN[&XCN+=RP62-LJ2I*GGV((_"K->5Z-XLUG4/
M#_AC3-.:SL]2UFYO@]R+<;((H)7W%8Q@%C\HYXR236CKOB'Q-X'\/ZG<:K<6
M>HCS88M.O&C\K+R'#>:B]EZY7J..* /0Z*\MT7QU/'XITK3F\2V_B"WU%FBE
M\NQ-N]M)M)5AC@H2,8/(XYJKIOC?6KS5$BNO$>GZ=J_VO9)H&HV9@3R_,VX2
M8\LQ7D$9!/&* /7**@O99H;"XEMUC>9(F:-9'VJ6 X#'L,]37DI\>ZC8WND2
M#QAIFL3W-[!;WFG6EF#%$)&"MLF4G[I/&X\_I0![#17E.N>,]6MO$VJV-QXC
MM/#LMO)MTZWOK',%XFT$.TYX ))'!&W'>O4+.22:R@DF\KS7C5G\EMR9(YVG
MN/0T 345Y;I?BKQ*-!U?Q;J6H6S:7IDEY$NGQVH#7'ELRH3)GY3G P!T&>]9
MUM\2+VS_ +,OYO$UCJC7,T27>EPV#1^2KD F)^I*9_BSD ]* /8Z*X*VU/Q1
MXFU#7;K1]2M;&TTN\DLK>UDMA)]IDC WF1B<JI8X&W!'7FJOAWQCK&I'P%]I
MDB_XG,%X]X!&!DQJ"N/3F@#T"\O+;3[.:\O)D@MH5+R2N<*BCJ2:ECD26-9(
MV#(X#*PZ$'O7GGB7Q1J-O+X[ME\AX-*TN"XMDDB##<ZN6W _>'RC@TDNJ>*M
M6\8)H6D:G::;;)I%O?/,]H)2&9F!4+D#!P/IMXZT >C45Y!<?$6YU#4-7>'Q
M58Z,MC<R6UK9RV)F^T>6<%Y'[!F!P%P0*UK/QEK'C"70-/T:2/29[W36U&]G
MDA\UHE5Q'L16XR7SR>PH ] @U"TN;RZLX;B.2YM2HGB4Y:/<,KD=LCFAM0M$
MU%-/:XC%Y)$9DA)^9D! + >@)'YUP_@*+4H/'/C:/59XKB[66S!FBCV+(ODG
M:VW)P2,9'3.<5%XEMM6NOBYI$.D7D5G*='G\VXDB\TQQ^:F2JD@%B=HYXY)H
M ]&HKS*[\5^)M+T[Q):RS07FH^');>YDFC@"B[M'&Y@5SA7"A^1Z"ND'B&?4
MO'&G:9I<L;:>FGF_O9-N=RR?+"H/8GYF^@H ZFBN;\9ZI>Z7I<$EKJ>G:7&\
MX2XOKYAB%,$_(I(#.2  ,^M<AHWCF_DO_$%A%KD&MPVNCOJ%M?"S\DJX+ H1
M]UQP#D?2@#U.BO+SK_B_2?!NF>,]2U.TN+61;>2[TY+4*%AE*KN5\YWC<"<\
M=1BM&*[\6Z_XL\2Z?8ZS;Z;8Z9/'' _V-97=FB5MK9.-H)SZG/48H Z?5+;1
MYM?T2:^E5=1ADF.GH9,%V,9#X'\7RYJ_8ZA::G;?:+*XCN(=[)OC.1N4D,/P
M((KS*UU^X\1Z_P##Z]O(HXKV.\U&VN4CSL\R.)T8KGL<9_&GZ9XLUB[T;1-,
MTXV=KJ>KZE>PBX^SCRX(H7<LP08#-@#KU)R: /4Z*XR67QCH>EZR;J^TN]6*
M))+*_N\6RJ2<.)0.,*.01C/2N?TCQM=#QKHNF1>*[7Q%:ZBTL4_E60B$#+&7
M!1UX()&,$DT >E66H6FI0M-97$<\:2-$S1G(#J<,/J",5C:EH^AZMXML6O;J
M634+.(74-B;AA'A6($IBS@D,<!C[5P/A>'Q;#X6UO4]*U6TMH+74;Z6"SDM1
M(+C;*Q;>^<KD@@;<8QGFK:>*H'\81^*VA80_\(6U\80>?]:'*Y_2@#U6HYYX
MK:WDGGD6.*)"[NQP%4#))_"O&H_B=?6NGV>M3>);&^ED>-KG1(;!E\N-R 1'
M)U+*#GG@X->I>*O^10UO_KPG_P#1;4 5-1\-Z1XHDL]9BNKN&X\C$%]I]TT+
MO"WS!<J?F4\'FM#0]!T_P[8&STZ)D1I&ED>1R[RR-]YW9B2S'U-<!'K=WI?@
MWPA%_P )#IN@V$FD0M)=7 62>1Q&@"1QMQC!))Y["JUCX_UC^P=0O3?P7T&C
MZQ;Q7%XMJ8OM%G)MW'8?NL-^<CC _&@#UJBO/8_'=U%\2-2T^[,::!#!-'#*
M%Y-Q!''++D^@60_]\FNE\&WVI:IX1T[4=5VB[O(_M!55VA$<ED7'LI7\: -V
MBO.['4O%_BJQU#7-(U6TL+6*XFBL;)[02"<1,5S*Y.1N*G[N,#UJFGC#Q#XK
MO?#=OH-W;Z6FK:5)=SR2VXF,#HZ@[02,\Y7GL<]J /4**R-:NKS2?!VH78F6
M2]M-/DE\W9@-(D9.[;Z9&<5P-QXM\3:!X'L_$.K:I8RS:T;6*SA-KMBLFE!8
MN[ [G 49(XY''% 'JM%>6Z-X_>V\36FG3>(H?$%E=PS.\T=D8)+9XT+\XX*L
M P'<$#FH;W7_ !Q_PKN?QQ;ZI91K);FYCTPV@98H3]T^9G)<##<\'D8H ]8J
MM>:A:6'D?:[B.'[1,L$6\XWR-]U1[G%<]I.NWUWX[U+2970VD&G6UPBA0"'<
MONY_X"*X_4]:O-;M=,>]9&:U\=K:1;5QB.-V"@^IQWH ]:ICS11R1QO*BO*2
ML:LP!<@$D =^ 3^%>9^)?%.HV6IZI')XRTO29;=B+/3H;87<LJA<@R_Q*6/8
M 8'K5&:^U;Q/XB^&>L)?QV4E[:W$AC6W#K&_DYD(R>0PX /3&>: /5+34+2_
M-P+2XCF-M,8)@ASY<@P2I]",C\ZLUY@?&&J00ZK:6$5FNHW7BA])M)&A 2,;
M%8R.!C>0 WN>*UX=3\0>'?%VEZ-K&I0ZM:ZO'-Y%P+8020RQ)O((4X*E<X[Y
M% '<45X_!XI\:CX;6_CJ;5K(I&JR/IHLQMFC\S829,Y#'D\# X'O7L .0#0!
MGZGHUEJ\MA)=HS-8W*W<&UB,2 $ GU&&/%26NJV%[>W=G;7<4MU9E5N(5;YH
MB1D;AVR.E7*\_P#'MO+X9U"#Q_IL>Z2R00ZI;J0/M5J3U_WT."/R]J .U;5+
M%=532S=1?;WB,RV^[YS&#C=CTSQFK=>>:?YWA/PCK?CK6HEGUN\@-U-&&XB0
M#]U;J>RC(!/<DGGBF7VJ>+_"^DV/B+5M5M+ZU>6%;ZP2T$8@65@N8G!))4L/
MO9SSTH ]&HKE_#>MWNIZEXI@N70IIVH&WM\*!A/*1N?7EC7'V7BSQ9KECX)M
MK&_M;6[URTNI+JY>V#B,QE2&5,@9P2,=.?:@#UBBLRYO)="\+S7VHS?:I;&S
M::XD1-GFE$RQ"]LX/':N6T=_'5YI^DZ\=2L)TO3%-/I?V81I% ^#\DN2Q=00
M>>"<T =Y17G=AJ/B_P 5V6H:WH^JVEA:Q7$T5C9/:"03B)BN97)R-S*?NXP/
M6LS4/B+>WECX>OS?'P]I&HV)GEU#[$;D+<!@OD^B#J=Q'/M0!ZI+-% @>:5(
MU+!078 $DX Y[DD"GUY%XHN-8UGP?X;N6U[3;A_[?MXUN[",21S?O0(Y""?E
M8=2@)&>,U=\1^*]5TOQ-+I6H>)(M MXK>+[)>3:=YD5](5^<LY^5 &XV\'WH
M ]0HK/T*YN;S0K*YO)+.6YDA5I)+*0O"QQU0GJIK0H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA8/!VO:9JFMG2
M=7L(;/5[I[J66:T9[F%G #*C;@I Q\NX<>AKNJSK+6[/4-7U/3("YN--:-+C
M*X4%TW@ ]^"/SH Y?0O ,^CKX05]0CE'A];I6(C(\X2@@=^,9YZYJUJ?@2#6
M-3\1S7MSFUUFRAM?+1<-$8]Q#@]SE@1QVKKZ* ."E\(^*=3O-$?6?$%E-!I%
MY'<HL%FR-<E01ND)<@-@]N.3[5UNMZ=-JNBW5C;7\]A/*F([J X>)@<@CUY'
M([C(K0HH XJT\):S>^*=+USQ#?:9++I:R"#[!:-$TK.NTF1F8\ $_*.,FL:?
MX;^('\)WGA&#Q#9Q:$YD,!^QDW #.7",V[;M#'D@9(XXKTZL[6];M- L%O+T
MOY;S1P*$7)+NP51^9H YR]\*Z]#XMF\0Z)JUG%)+916C6UW;L\;A"QW$JP(/
M(QCWSUX;;^"=4T_13_9_B!XM;DU ZC<W;1?NKF1A@QO&"/W>, #.1@&NICO9
MGUF:Q-C,L,<*R+=G'EN22"@[Y&,_C5V@#@5^'<FK3ZW=^([FT>YU6R%BR:=
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>,7<,?AW4/B
MEK.DP&/4+-(O(D#,3'YD"L[8)QU);GICTKV>L0^$M(.OW>M&"3[5>P^3=)YK
M>5.NW;\\>=I.WC..E '!^(/#VG>$/#.E^(M#FG&K)<VH-R;AW:_$CJKK)DD-
MN#$^V.,5VOCS4KO1_ >MZA8$K=06CM&P'*'&-WX=?PJO8?#SP]IUY:W$<5W*
MMF^^TM[B\EEAMF]8XV8@$=O3M73S0Q7,$D$\:R12*4='&0RD8(([B@#@[3PE
MX?T%-"U:VU&>TOFDC4W)N68ZDSJ?W;[B0VX\CN,<8KF]*T*QUSX67'C'4+JX
M_P"$@DM[B\_M$7+J]O(A8JJX.%5=H&W'K7>:9X T'2K^VNH([N3[)DVD-Q=R
M2Q6V1C]VC,0O''MVJ*X^''ANZNII'M[E;>XE\Z>RCNY%MI9,YW-$&VGGD\8/
M>@#C]/LU\:^-]*.O>=)#-X3M;N>T65HXY)6E?E@I&<9/'T]*Q=1TRVD\'ZII
MLWFS6VE^+TM+-9)68Q0L\.4!SDCYR.:]F31;"/7#K*0[;TVBV>\,<"(,6"[>
MG4GFL^Z\%Z%>:;J>GS6KF#4KO[;< 2L&,WR_.I!RI^1>GI0!PGB9?L&I^-K2
MU=XH+;PF@A0.?DQYH&.>N .>M%WH%IX?M/!&N6,ERNJW6I6<%W=/<.S7"2J=
MX<$X(/88X[5W9\&:*\5TDL4TIN[!=.G>2=V:2!00 23G/S'YNM7;OP_IU[::
M=:SPLT6G3Q7%L Y&QX_N'KSCWH Y3PI<-Y'CUI93B+6+G!9ON*(8S^ KA[6Y
MU'5=,\!:(UE-J=E+I+W<UH+S[.+IU( #L?O!0<[>^>>E>GW_ ( T#4=6N-0F
MAN5>ZP;J&*ZDCAN2!@>9&I"MQZCGOFI+CP-H-QHVG:6;:6.+31_H4L,[I-!Q
MCY9 =PXZ\\T 87@&VU+3/$.LZ?)9II^F>7%-!IQU!;E[9SD-@ Y5&X(!XR#B
MH_%6BZ?>_%OP?+<6^]Y(+LL=[#)C",G0]B3]>]=;H7AG3/#JW!L8Y6GNG#W%
MS<3-++,0, L[$DX'0=!2:UX9TS7KJPNKU)A<V$ADMYH9FB9,XW#*D9!P,@T
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M,3@#[^/?TKJO$/A*&PT+2M+TGPXNHZ1:W#RO;1W)BN8"Q+*\$A=<88MD9Z'
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M*ZG=DY.>>>] &-\.I[&&YUG2X+#5-*NK>2.6;2[R82QVX=3@PL,Y5MI)YZ]
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MAFA)X.UU((![CI0!Y-JR:OI/@;QO9&/^S;.'[))9V:ZBMS)9LSKN&0<JIP&
M/J<5TU_X=L/"OCCPE+I1N(I+^>:VOF>X=S=+Y+-F3<3D[AG-=/'X#\/QZ%?:
M0;662WOW$EW)+.[RSL"""TA.X]!WK5OM'LM1OM/O+F(O/I\K2V[!B-K%2I.!
MUX)ZT <1\+]!TNU3Q))%9IN37;F%=Q+86-P4QDGD>O6O0XH8H(Q'#&D:#.%1
M0 ,G)X%96F>&=,T?5M0U*Q2:*:_<R7"><QC+DY+!"< GN16Q0 4444 %%%%
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M5YO)<_:F^(T@U2YU42Z ACO)H%B$X D!,855!0'@$9Z'DUVOAT$?$R(X./\
MA%;0?^17H U/&?BIO#&L^&_.NDM].N[F5+LLFXE1$S*!@$YW8X')Z5KZ-XKT
M;74NFLKL[K3'VF*>)X9(01D%E< @8[XQ7+_$.^M-,\4>"KZ_1FM(+Z=I&"%M
MG[EL.0.RG#$]@,]JY_7P_C?6/$U]X68W5L/#C6!N(1\EQ.9-XC4]&(4$9'3?
MB@#N]/\ '_AK5+^&SM=08O<,4MY)+>2.*=AU$<C*%<_0G/:NCEEC@A>::18X
MHU+.[G 4#DDGL*\22[L=;T[0=*7Q?J>H3_:+?9I-OI\"36KQD'+_ "*8U3')
M)''K7IGQ T^]U7X?ZY8Z>K-=S6CB-%ZOW*CW(!'XT <_K'Q,T^XFT.#0+]C+
M>:M;P,9;5T6:!FPYC+J PZ<KG&:Z#5/'GAS1]0FLKN^?SK<!KCR;>25;<'H9
M&12$_$BN'\0>+/#VO6_@RRTIQ+<Q:S8NT"QD-9A6VD/Q\AYVX/7MTK,L[O\
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M3P*YWPI\0['6].UN^OY4M(-.NYD,DD,D2+ K81B7'WCCD=03C K<\'C'@G0
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M.3S0![G;:SI]WJMWID%P'O+5(Y)H]I&%<$JP)&&!P>1FLZX\:^'K6PFO9=0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0J"02!D=#Z4M% !1110
M@4 G  SR?>@JI() )'3(Z4M% !1110 A56(+*"1R,CI2T44 (%4,6"@,>IQR
M:6BB@ HHHH **** "DVKNW8&[IG'-+10 4A4,,, 1Z$4M% !1110 4@ 484
M =A2T4 (%4,6 &3U..M+110 @4 D@ $]?>@JI() )'3(Z4M% "$ @@C(/8T
M     #M2T4 %%%% "!5!)  )ZX'6C:"<X&1WI:* "BBB@! H7. !DY.!2T44
M %)M4,6 &3U.*6B@ HQD8-%% " !0 H  ["E(!&#R*** $ "@   #H!0% )(
M !/4XZTM% ";1NW8&[IG%!4$@D D=#Z4M% !1110 A5202 2.AQTH(### $'
ML:6B@ I&4,,, 1Z&EHH **** "BBB@ I%55&% '?@4M% !2!%4DJH!/7 ZTM
M% "%5;&0#@Y&16/JGA]-3\0:'JS7#1MI4DSK&%R)/,C*8)[8SFMFB@!  H
M  ["@*J] !WX%+10 4@5020 ">O'6EHH *0@,"" 0>QI:*    8 XHHHH **
M** $90PPP!'N*6BB@!"H(P0"#VH  & , =J6B@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
-HHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>separationagreement002.jpg
<TEXT>
begin 644 separationagreement002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHJAK6K0Z'H]SJ=PDCPVZ[F6, L1G'&2/6@"_1
M7/>&_&-AXGTJZU"S@N8XK9BKK,JAB0N[C!/K3_#/B_2O%EO++ISR!XB/,BE7
M:Z9Z'TQP>AH WJ*J3ZG86UP+>>]MXICC$;RJ&.>G!-6Z "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>A(J:F(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/F5\!F R%"GJ*OZCXL\27WB>ST7PW:Z8#<Z1'J9FU#?B,%RI4[#S_"!^)]J
M.^HKS2Y^(-_=ZMJEMIVJ>&-/BTR8VK+JLY62ZE4#?M <;$R< G=G!KL?"?B&
M'Q7X7L=:AC,2W*'='NW;'5BK#/<!@>>] &U4;SPI-'"\L:RR9*(6 9L=<#OB
MN)C\0>*_$%[JS^&X=)BL--NGLU-^)&>ZEC^_@J0$7/ )W=,USM]XBU#Q/X@^
M'^KZ':0QWMS#J"F.[8E+=E"+)NV\L 5.,8SQTH ]9FFBMH6FGE2*)!EG=@JJ
M/<FD6X@>9H5FC:55#E P+!3T./2O*_%^OZI/X.\9^'M>BM!J-GIZW$<]H&$4
M\+G 8*Q)4@J01DUIWOBNV\.:YKUW/IT#?V?HEM<&9 1-,69E6,MTQG&..,F@
M#T6BO/;SQ%XWT.;0GU:TT62WU34(+21;82![7S#T.6(?C(SQ@CH<T_Q%XH\1
MZ=<:C(+GPWI%K:DBWBU68F6\ &=PVN @)X ()XY H [_ #17D]YK>L^(O$GP
MXU6P-G;1WT$\PAF#MMD\D^9G!&1M.%[YSG@XJW<_$2^O=1U4:7J7ABQM].N'
MMDAU6YVS73I]XC# (N> 2&SC- 'IM1I/#)-)"DL;2Q8\Q%8%DR,C([9K@H/'
MM_XE70;;PQ;VL=YJ=D]]-)?;GCM8D8(1A2"YWDJ.1TS2> VU)O'GC;^UXK>.
M]#V2O]G),;@1, RYY (P<'ITR: /0LT5Y[XE.L_\+<\*I:36:VYMKIE25')P
M-GF9P0,X(V^G.<TZ#Q/XNUVRO]:T"TTD:5;32QV\%T)#->",E68,I"IDJ0,@
M^] 'H%1PSPW"%X)8Y5#%2R,& (X(X[BJ/A_6H/$7AZPUBV5DAO(5E5&ZKD<@
M_0Y'X5YCX)\5S*LOA?0EMI]9DU2]GN#<$^7:P"=LNP!!9CD *#WR<#J >P45
MYYJ_CR[/BC4-&TW4_#VFKIH19I]7E(,TC+NVQH'4@ 8RQ)Y/2JS_ !5$WAO3
M)K==.@U2^O9;%FN;D?9(7BYDD,G&Y,8(P1G<.: /3**\UM_B+=P-K5C<7>B:
ME>6FDS:E:W6F2%H9/+!RCKN)5@<'[W(/:IE\7>*M/T?2O$>LVFEKI%Z\"SV\
M D$]LLI 5RQ.UN6&5P,9ZF@#T2BL[7]8@\/Z!?ZO<JS16<#3,J]6P. /<GC\
M:YW3=2\<>;IEWJ.GZ5-87K#SX+0NLUDK#(9F=MK@=&P ?3- '9T5YS#XN\7:
MIX>N/%>E66E?V-'YDL%G/YGVBXA0D%MX.U&.TD#:>W-3R>,M;UGQ%8Z9X:@T
M\07NC1:JMS?!SY2LY&"JD;C]WC([\]J .\EEC@A>6:1(XD!9G=@ H'4DGI5>
MSU33]1 -E?VMR&7>/(F5\KG&>#TR",^M>3>,==US7_A=KT%W%I\-UI^J)I]^
M(PY28"6+:T?.0#O7(.>,UMG68/"'B"^2]TK2HFT_PY]LEET^ Q%OWS_NE!/"
MD\X]23F@#T6:>&W"F:6.,.P12[ 98] ,]SZ5)7D?BBZ\77.G^&+K6;?2A9W6
MM6$GE6OF"2V)D!4,6)#^A( P?45J7WQ O+K7=6L]+U3PUIT&F3&V/]KSD27,
MH +!0&78H)QNYR0>* /2**\W7XB:GJ]KX3;0;&S,^NFYCD6Z=BL#PCYCN7[R
M@AC_ +0QTS4.K>(/$DV@>-M#U#^S4U/3=-^T)=6RR+')#(CYPI;*N K8.2,X
M].0#TIKB%)8HFFC627/EH6 +X&3@=\5)7FVB7UU;S_#JTU"UTZ>>ZLY_+N$C
M8/ BVZ$;23P2,!O7MBJVO^/?$F@Z?<ZK>R>&[,0.2-%GG+7;QAL??5]N\CG
M4B@#TX3PFX:W$L9F50YC##<%/0XZXJ2N&TR43_&#4Y5!"OH5JPS[R2&MKQ1J
M6KZ?#:KI4-BHED(GO;^4+!:H!G+#(9B3P /Q(H WZ*\TL_B)J L_%L<LVC:C
M=:)8?;(;K3F8P2_*QVL-Q((*\X;OVJPGBSQ79-X>U'5;321I>LW,-M]GM_,\
M^W,HRA+$[6]P ,=L]: /0B0H))  Y)--AFBN(4F@D26)QE71@RL/4$=:X*;Q
M#XHUX:[-H5MIG]EZ=-+9B.YW^==O&,2;6!VH,Y R&R1SBM3X8_\ ),O#O_7D
ME '645YPOBKQGJ<?B.YTJVT6*VT6]N+<?:1*SW(CYP-K *<8YYR3T&*MCQKJ
MFN2:%8>';6TBOM2TQ=4GDO=S1VT)P -JD%V+' Y'3- '>45Y+XP\1Z[<^"?&
M&B7Z65OJNFVZ/+-!O\JXMY <-&"<JW!!!)'US7I6B"^&A6@OVMVN_*&XVZLL
M?M@$D],9YZYH T,T5Y!X<\1ZUX<T;Q1?7B6=]/+XAEM+:"+>ADNG=4 W,3B/
MI@=0!UKJDU_Q+H>O:39>)8]+FM=5D-O%<:>LB&";:6"L')W @$ C'(Y% ':T
M5S_C'7KCP[H\%Y:Q12/)>V]N1*"1MDD"D\$<X/%)JNOW-AXRT#1HXHW@U&*Z
M>5B#O4Q*I7;SCG<<YH Z&BO,O#GCW7O$,UK<6TF@2K)<>7<:.)6CO;6/<06)
M=L,RCDC:,]C4VH>/[RYU_5;'2]4\-Z;#IDOV=CK$Y#W,H +!5#+M49QNYYSQ
M0!Z/16'X0\1Q>+/#%IK$<0B,VY9(PX8(ZL58 CJ,@X/<8K#7Q!XHU_4]73PU
M%I,-EI=RUF7OUD9KF90"X&PC8H) R<_2@#N**\VD^(6LZI;>&$T+3K-+[66N
MH98[UF*VTL(^;)7J 0WUXZ5W,=U<:?H'VS66@\^WMS+=-; ^7E5RVT-SCCO0
M!<GGAMH6FGECBB7&7D8*!DX')]Z%GA>:2%)8VEC +H&!9<],CMFO'O&6K>+=
M;^%\FKW5II<>DW_V>5;>/?\ :((FE1D9F)VL3\N0 ,9Z\5T.J^*FT'6/'%W;
MZ1;RSZ;:6<GF(K"2;>&'[PC.53KP.F: /1**XCPUXHU6_N6FN;[0-4TG[.TT
MEYI4A4VS+@[71G8D$9Y&.G(JMIOB/QKJVDVGB.STO3)=+NG5X].!871@9L!_
M,+!-V/FVXQCOF@#O(IX9FD6*6.0QML<*P.UO0^AYJ2O*K'Q#+X=?Q=):VRW5
M_>^)Q96<+MM5I9(HP-Q[* "3]*Z&#Q!XBT;Q)INE>)(]-GBU02+;7.GHZ;)4
M7<4978Y! .&!ZCI0!VE%>9>&_'NO>(IK6XMI- E66XV7&CK*T=[:Q[B"Q+MA
MF7J1M&>QJ6_\?WESKVJV6EZIX:TZ#3)OL['6)R)+F4 %@JAEVJ"<;N<G/% '
MI%%8?A#Q'%XL\,6>L11>49@RR1A@P1U8JP!'49!P>XQ6#X@\2>(;&_OMEUX<
MT:SM\"W.KS9>[XR6&UQL7/ SD\=* .ZHKSA?B!K.J6/@U]'T^R%SXACG+K<L
MVR%HU!)R.2!\QQU/ R.M/;Q=XIL[;Q38W-IIMQK&BV\5Y$UNL@BN(F!)&TMN
M# (PZGG% 'HE%<K-XM-UJ?ABTT=(IEUA&NY7D!/E6JH"6X/#%F11GCDUJ>([
M[4]/TAIM)LX;FZ,BH#<2B.*)2>9'.<[5') Y- &M17 :!XTU";QJGAZ_O]"U
M,36CW"3Z2S Q,A&4D4NW4'(.1TZ5C0>/_&+> [?QO/8Z,NE@*T]HOF><Z;]C
M,K9VKSR 0>._:@#UBHX9X;A6:&6.158H2C!@&'!''<5R-WK_ (AU/Q5J.C>'
M(]-BCTJ.(W5Q?J[[Y)%W+&@0C'RX)8YZ]*K?"AYY/#&H/=0B&X;5[PRQ!MP1
M_-.5SWP>,T =W4<L\,+1K++'&9&V('8#<WH/4\=*Y+Q'KNO66JS0VUQH6D:?
M%$K+>ZO+G[0YSD(JNI4+P"3Z\"N7D\2R>+-+\"ZG-' D_P#PD?DR?9WW1LR+
M,NY"?X3C(^M 'JL4\,X<PRQR!'*-L8':PZ@XZ$>E25Q7PV_X]?$O_8Q7W_HR
MDOO$'B>[\;:CX=T2'2XTM+6&X-U>+(VW?N&W:I&2<#'(Q@]>* .VHKSJ#X@Z
MI/X?LXTTZU/B.YU2721%O;[.LL9;?(3][8%7..O:K\7B77M(UX:+XACT^66Z
MLYKFQNK)71':( O&Z,200"#D'I0!VU%>6P^.?%Z>$=-\87=EHZZ3.8//M(_,
M\\([A-ZL3M')R%P>.^:]#.N:0M_]@.JV(O-VS[.;A/,W>FW.<^U %^BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N%\7?"7PSXSUN+
M5M2%W'=*H23[/*%$RCH&R#],C!Q7=44 16MM#96D-K;1K'!"BQQHO15 P /H
M!4M%% !7-^-O#]WXDT>UM+.2%)(K^WN6,K$#;&X8@8!YP.*Z2B@#"\7^'F\3
M>'I+&&X%M=))'<6TY7<(Y8V#*2.XR,'V-8IT/Q/XAUK1Y_$2:9:66E3_ &H1
M64SRM<3A2JMEE78HW$XY-=O5#6]7M= T6[U:]W_9K6,R2>6N6P/04 <!+X/\
M7P:!KOABPDTC^S-0DN7BO)9)!*B3$DQE N,Y8C=G@'.#TKT'2+22PT6PLY2I
MDM[>.)RIR"54 X]N*M12+-"DJYVNH89]#6'!XNL+E)&@M[V41:J=*D\N'=ME
M!P6.#P@[M0!P47PZ\0P^&=2T".T\/^=="<-KDI9KF<2%C\R[,AB#M)WD = :
MZW1O#&H6/BJQU:XDMO*AT"+39%C=BWFJ^XD9 ^7'?K[5U]% 'G4G@_6M'U?6
M)='TW0-2M=3N6NU.I962VE?[_1&WID9 R#R:[+P]IMQI.@VEC=W*7-S$G[V:
M.%8E=B23A5  '/I]>:FTK4H]7TZ.]B@N8$=F41W,9C<;6*\J?7&1[8JS//';
M6\MQ,X2*)"[L>R@9)H XB'0_%?AR\U>+P\NE7-CJ-U)>1F]E>-[663E^%4AU
MSR!D'G%45\!:WH:^$WT&[LIY=%CNOM'VPL@NGG*EL;0=H)W'/;Y>#S77>&?$
MT'BFP-]:V&H6UL<&*2\A$8G4C(=.3E?<XK;H \XU'P1KNO:9XGN]2EL(M8U>
MS2RMX8I&:&VB0D@%RN6))))V_2G>)O"43_\ "2ZCK-TD&D7.BPVSR1*SR1-$
MS,7V@<@$@\>AKT6D(#*58 @C!![T >.ZOJ.O:M>^"[2\U30KM3J]M,BZ9(TD
MERJ L96!QL4 9(&>2.1BM>+P1KMIJ.N"&RT*Y;4[J6>/6+LLUS;H_1-FP[MO
M\.' KNK#P]HNE7#W&G:186<\G#R6]LD;-]2!FM$D $G@"@#SFV\%^(=-TKP2
MUHVFRZAX?66*:.65Q%(KIL)5@N<@8/(I#X-US1KW5DT?3O#^H6FH7,EU#+J(
M*R6KR<L" C;T!Y R#SBNOB\3:?<Z?IE_9"XN[349Q#!+!"6 SN^=NA5?E/)]
M1ZULT <))X2UO2[G1=8TFYLKS5;&S:RNTN$%O'=1LP<[?+4A"'&1\IZ\^]WP
MEH6N6&O^(-8UR6R:75#;LD=HS%8A&A7;E@,]1SWY.!TKKJ* .5\1Z'J]SXL\
M/ZYI/V-_L GAN(KIV3='+LRRE0>1MZ&LBV\.^+_#]C?Z'H3:3)IEQ-+):W5S
M*ZRV@D8LRE I#X+'!R/>O0:* ,SPYHL/ASPYI^C0.9([.!8@[#!<CJ?Q.37$
M1?#G4+31EGL9K*W\1VNJSZA:7*[MCK(Y)CD.W)#)A3P<8&.E>E44 >?7?A/6
M+'Q)J.L:;INB:BFJ+&]Q;:@Q4V\RJ%+(^QMRD 9! .13+OP'JT^C:/.UQI=Q
MKNFW4ESLDM1':2"08>+:JY VX 8@GY<GV]$HH \UU+1M:A\/>*=3U.VTC3K?
M^Q;F&&PTZ,/SY;$R/*45L]@HXQUYJ+3-#\4>)_"7A_2M5;3(]&2.UN)KB&1S
M-<H@5T385 0Y"[CN/3BO3)8HYX7AFC22*12KHZ@JRG@@@]12QQQPQ)%$BQQH
MH5448"@= !V% &?X@T:'Q#X>U#1YW*1WD#0EU&2N1P?P.#7.6.G>-YWTNRU*
MYTVULK%T:XN;.5VDO548";&4! W\7)]JZS4;U--TZYO9(II4@C:0QP)O=@!G
M"KW/M4L$HGMXY@K*)%#!7&&&1G!'8T >=V_A;QAI/ANX\):9+I3:4XDBM]0F
MD<300N22IC"X9@&(!W =,UM:-X/DT7Q9:7MO)&=-M="BTJ-68^8623=DC&,8
M[YZ]JZZB@#SS4/ FJ7?AWQ7I\<]H)M7U=+Z L[;5C5X6(;Y>&Q&W3(Y'-:&N
M>"9->\3:K=7,L:Z??Z%_9AVD^8K^8S[L8Q@;AWZCI73ZIJMEHUG]KOYA#"9$
MB#$$Y9V"J,#U) J&+7+27Q'<:&OF?;(+9+E\K\NQF*C!]<J: .*N_#OCC5[7
M1-.OY-&CMM+OK:XEN(I9"]VL3@_=*80X&<9.3CD"I)O"&LZ3K>L7&CZ;H.IV
MNJ7!N@-2RDEM,P ;D(V]"1G'!'/UKT.B@#B;7P?J<&I>#[J>\M;AM(%T;R18
MA#YC2Q[1L1%VX!/?' SR:DO_  A>7VM>*[GSX$@UG24L83DED8+("6&,8^<=
M#ZUU&HZC9Z1IT^H:A<);VD"[Y97. H_SVKE!\3=)3RIKS2];L=.E8*FHW=BT
M=N=W"DMG*@\8) % %;3O"OB![CPA/J3:?"^B0W%O+]FE=MZM"L:,N5'.1D@]
M/>N=7X;>(E\&7GAJ*R\.Q32I(KZR6=I[G)+#<-F5)X!8LV!G ->P @@$'(/>
MB@#EM)\.WUGXRFUJ=[?R9-*M[/8C$L)$9BQY ^7YN#U]JJ^-O"]_K>K:)J5I
M;:?J,6G-*9--U!RL4N]0 ^0K#<N.,J>O:NSHH \S_P"$$U^XD\4RSG2+?^V=
M'^Q06]J66.V<!P%)V_,OS9+8!R3\M;^L>&+W4-%\,6<4D DTJ_L[F<LQPRQ#
MY@O')],X_"NMHH X-?#OBG1)]9L] ?3)-.U2YDNDFNI'62SDD^_A0I$@SR!E
M>N#70>#M'N/#_@[2M(NWB>XM+=8I&B)*DCT) ./PK<HH Y31?#-[IVE>)[6:
M2 OJNH7=U 48D*LJ@*&XX/'.,UC6?@W7M!B\.ZCI4EA/JFGZ4NEWEO/(RQ3Q
MC#91PI*D,#C*\@]J]$JG/JME;ZK:Z9+,!>72.\,6"2RIC<<]!C(_.@#B+CP-
MJ^LZ5XJN-5N;./5]=MEMHXX"S0VR(#L7<0"V222<?05V>AKJ2Z-;)J\=M'?*
MNV1;5V>/@X&"P!Z8[=:;HNN6FNP7,UGYFVVNI;1_,7'SQMM;'MFM*@#S:7P%
MK<\&OV)N;&*&?5CK.FW:EFDCGWJP61,8V\$9![UIKHGB77]>TB\\1)IEG9Z3
M*;A(+*9Y3<3[2H8EE7:HR2!R:ZK5=5LM$TV;4-0G$-K%C>Y!.,D*!@<\D@?C
M5R@#GO&N@7/B3PW)964\4-XDT5Q;O,"4WQN' ;'.#C''K6-#H7BK5/&6CZ]K
M!TRTAL(;B(6]I*\C R*!OW,H!Y XQP!U.>.ZHH \MU'P-XDUU;6TU:WT%KB"
MXCD/B&+*7;(CAN$" *Y P?FV^U7Y_"&L:3KNKW6CZ;H6IVNJ3FZVZD2CVTQ
M#$$(VY#@''!'->AT4 97AO3+K2- M;*^N8KF[0$RRQ0+"C,22=JJ  !G'J<<
M\US<>A^*?#FIZP?#J:5=V.J737@6]F>-K:9P Y^56WJ2,XX/\Z[FB@#@M)\
MW6CWGA%TNXIUTEKR6]E?*M-).IR5 !&-Q/4CC'6NVO;2+4+"YLIP3#<1-%(!
MW5@0?T-3T4 >77_A#QO=^"T\'K/HWV*W$4:7S22"2:*-E**4VX5L*,G)Z=.<
MC>NO#&N#7/%.IZ9J-O9SZG!:)9RE?,*-$&W!U(QM;..,G!)X-=G5+4M2CTN*
M"22"YF$TZ0 01ERI<X#'T4=SVH X:P\$:A>^+;36M2TK1=(6W@FBG72Y&9KT
MR+M^<[% 4<D9R<XI]AX=\;:=H=MX7MKW3X=.MV6--6CD?[2(%;(41;=H?'RY
MW8QVKT.B@#SVZ\ ZC<0ZS)'>6T-])KJ:QITAW,JLB*H608'7# XSP<^U7(M"
M\1Z[XDTS5/$ T^QATH2-;P6,K3-),Z[-[,RJ  "<#!Y/-=M6;HNMVFO6]Q/9
M^9LM[J6U?S%P=\;;6Q[9% ' :AX&\2:Z+2UU:WT%KBWN(Y#X@ARMVRHX;A @
M"N0,'YMO7BKT_A#6-)US5[G1]-T+4[75)S=;=2RCVTS !N0C;T)&<<$<UZ'6
M;HNMVFO6DUS9^9Y<-S+;-YBX.^-BK?AD4 ,\.:;=:1H%K97MS%<W2*3++% L
M2,Q))PJ@  9QZ\<\UQB>#=<LO$&N7-O8Z%>MJ5TUQ#JE\6:>T4@ )LV'<%Q\
MH#*/6O2*I:IJ4>DV7VJ2"YG7S$CV6\9D;+,%!P.PSDGL* .)\/>!=5TE/!"W
M$]HW]@K>)<%'8[Q*I"%,KSVSG&/>MV#1WT[QGKOB"]GM4T^\M+>$;WP5,>_<
M6R, ?,.]=-45S:V][;26UU!'/;RJ5DBE0,KCT(/!% 'FWPHT18;G6-42X%S8
MPS2:;I,@Y M4E=_E/<;GQGOY8KI/'OAN\\3:/9P67V:1K6]BNGM+LD0W2IG,
M;D \'(/0C('%=+;6T%G;1V]M#'!!&NU(XE"JH] !P!4%WJME8WEC9W,X2XOI
M&BMTP2795+'ITP 3S0!QFF>$];7QIIFNSVFBZ=96UK/;FPL2QV;]I#;MBAB2
M,$8& !US3#X%U3_A2H\&^?:?VC]F$7F;V\K/F;NNW.,>U=AI>N6FKW6I6]MY
MF_3KG[-/O7 W[0W'J,,*TJ .,N]#\0:1XKU'6?#JZ?<Q:JD0NK>]E>+RY8UV
MK(K*K9!7&5P.G!J[X&T#4?#NB7-KJMQ!<7<]]/=/+!D*WF.6S@C@\].<>IKI
MJ* //;[PCK$7C?5-:M]-T/5DOUB$,FI.P>RV+M(4;&RI/S8!4YZ^M0:5X UF
MQTS0[6XNK*633]?DU*65"RB2)M_1<<-E_N]!ZUZ310!SWA'0KK08=82Z>%S>
M:M<WL?E$G"2-E0<@<^O\Z+#0KJU\>:QKCO";6]M+>"-03O#1E\Y&,8^88YKH
M:* /.1X!U:&Q:XM;JS35K77KC5K(N6:)TD)S')QD95L$C.#ZU>C\.Z_K?B!-
M:U\6%JUI9S6UC:6DK2@/* 'D=RJ]@  !7<44 <'<>"M2E^$=GX46:U^WPQ6R
M-(7;RR8Y$=L';GHIQQ74GPYH;:E_:3:-IYO]_F?:C;)YN[UW8SGWK3HH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF@R\D>]I&*\L>0 #QP>*Y?0I[_2O#^@VZ:A,9'\:36US*C;/M"[IMVX#@@D
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M5 =V[Y?ER0#T#$@?7FNIM-"M;+Q!J6M1O,;G4(X8Y59AL C#!=HQD?>.<DT
M>57MSJ>D75U=>);KQ/I]TMZSQZS:2M<:>L7F?*K0JV%7;A2&7.><U?U75[O7
M?'>MV4L'B6YT[3!#%;Q:',(AN>,.9)&WJ6/(VCD8%=))\--/>&>Q35M7BT6>
M5I9-*CF00'<VYE!V[PI.25##K5_4_!5M=ZLVJZ?J>HZ/>R1+#/)8.@$R+PH9
M75AD#@$ $4 -\ 7.M3^'737(KI+BWNI(87NPHFEA!^1GVDC=@X/N*ZFLO0-
ML?#>E+I]@)/+#M(\DK[Y)9&.6=V[L3WK4H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K%U3Q=X=T2]2SU36[&TN7
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MJ[KQQX5LIT@NO$&G12L[1A'N%!#*Q4@\\8((Y[@UO @@$$$'H17E&B:=9O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^EZ=+++8Z;9VLDO^L>"!4+_4@<UR!\>Q:=%HNE6&D:MJUY=Z5%>P*&1I&CP
M3(Y(&[')/<GWJQ<>/Y1-J!L/#6IW]KIC^5?30O$#&X4,RJA;<Y4$9Q^&: .H
METG3;BP%A-I]I)9KTMWA4QC_ ("1BI+:PL[//V6T@@RJI^ZC"_*N<#CL,G ]
MZDMYTN;:*>/=LE0.NY2IP1D9!Y!]JY#XI:E/I'@IKVWGN(&CO+7<UNQ#E?.7
M<!CDY&1COF@#I(-"TBUD,EOI5C"YD$I:.W127&<-D#KR>?<U-_9]E@C[';X,
MWGG]TO\ K/[_ $^][]:Y_3?&3W&N6VDZKH=]I%Q>H\ED;EHV6<*,LN48[7 Y
MVGM2Q>.+*7P!-XO%K<"TB25S"<>81&[(>^.2I[T =#-:0S/YIC43A&1)@HWH
M#UP>W;\JX"X\!Z_JMN-+U?4=(EL7=/M5]#9%+V[C1@P1VSM&2HR1GITK:O/&
MLHU2;3M(T&]U6XMH([BZ$,D48A60$J/G8;F(!.!^=1MX@LM1UWPA,O\ :UN^
MHI<O# 3Y2?+&"PGC/4CMZ'F@#L*SH_#^BPM.T>D6"&X&)BML@\P=?FXY_&N.
M7XJ1R:.VMQ>&]5?1H'9+J]!C B(;:2%+;G [D# _ UN:KXO%KJT>DZ3I=SK&
MHM +EXK=T18HB<*S.Y !/.!U.* .ACMH(II)HX8TED #NJ ,P'3)[X[5B>(]
M(U2ZT5].\/3V&G?:2Z7$DD!;:C@[F0*0-^3GGBJ#?$+3_P"PDOTL;UKQ[X:;
M_9Q55F6Z/_+,DG:..=V<8J2/QNEM9:M/KFCW^DOI< N)DE"R+(AS@QNA*L>,
M8R,&@#?TK3;?1M)M-,M%VV]K"L,8/7:HP,^]6&MX7N$N&AC:9 520J"R@]0#
MU&<"N;TGQ;=WNJ6MEJ'AO4=-%[&TEM/(T<L; #)#%&.PX/ /7US5_P 4^)+7
MPGH,FKWD4TL$<D:,L(RWSN%R!WQF@#46V@2665(8UDFQYKA0"^!@9/? ]:KV
M6CZ7ILLDMAIMG:R2_P"L>"!4+_4@<UB:?XQ>;6[72M5T2^TF:^1GLFN&C99M
MHRRG8QVN!SM/O6=IGQ,M=1L[G4VT>_M=%M8Y6FU&;8(U:,D%0 =S9[$#KQ0!
MV:V=JD,L*6T*Q2EC(@0!7+?>)'?/?UJ2.-(8DBB14C10JHHP% Z #L*Y"U\>
MO]JT\:KX>U+2K/4I%BL[NX,;*SM]U756)C+=LCK4<GQ".Z\N;3P[J=YI-G<M
M:SWT!C.'5MK%8MV]E![@?A0!=M/!EF/$.NZEJ4%G?1ZC<0SPQS0!_)*1!/XL
M\G&<BNANK&TOK5K6[M8+BW;@Q2QAT/X'BN:U'QLUOXEF\/Z=H=]J6H16Z7)$
M3(D>QL\EG( Q@<=3GCOA/^%A:7_PCBZK]FO//:[_ +/&G>6/M'VK./)QG&>^
M<XQS0!T,6DZ=!"88M/M8XFB\DHD*A3'S\F,?=Y/'3DTEOH^F6MX]Y;Z=:0W3
MC:TT<"J[#T+ 9(K&TSQ@)]4DTO6-+N=&OA;FZ1+F1'26)>&970D97(R.HS6?
M;?$5;B.UOSX?U./0KN988=3;9M.X[5<QAMZH3T8CN* .M;3[)A(&L[<B202N
M#$OS.,88\<G@<]>*CO='TS4I(Y+_ $ZTNGB_U;3P*Y3Z$CBN"T7QY>VK^,K[
M7[*\BT_3+M@C;HF\H!8PL("MDL2V<].>373:5XHO+O5XM-U+PYJ&ER3Q-+!)
M(T<L;A<9!:-CM;D<&@#I.@P*K+I]DH0+9VX"2&5 (E^5SG+#CAN3SUYJS7.:
MOXIN+/6&TG2]"O=6O(X1/-Y3I%'$I) R[D L<'@9H WC;0&X-P8(S,4\OS"@
MW;,YVYZXSVIAL+,V/V(VD!M-NWR/+'E[?3;TQ7(R?$O3HO#]GJK:=J!>XU(Z
M6UFL:F:.X&[*$9P>5QP>XZ<XN:7XU6XU6[TO6-*NM&O+>T-]MN7C=7@!P7#(
MQ'!ZCM0!O6NDZ;96;V=II]K;VK@AX8H51&SP<J!@YJ9K.V>**)K:%HX65HD*
M A"OW2H[$=L=*\M\6^/;^_\ "4-U9:/J^G6=[=VPL]2\Q5\Q3,A.55MZ*RYQ
MD8(..]>DZU>7&GZ+=W=I:O=3Q1EDAC906/U8@<=>3VH M_9X/M/VGR8_/V>7
MYNT;MN<[<]<9YQ4$NEZ?/;36TMC;26\SEY8GA4K(QY)88P3[FO*? UT8])\+
M7VIR>(5OM6O!^]DU'S([EO*=MS+N.(^3\N <@<<5TDGQ-S:ZC>V?AG5;NPTR
M>6&^N4,2B/RV(8J&8%^!NXZ CWH [&VTK3K,0BUT^U@$(81"*%5\L'KMP.,X
MYQ0FD:9$[/'IUHC-*)V*P*"9!T<\?>Y//6L;4/%XCEL+?2-*O-7NKVV^UQI
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MU?P]?:3-J"N;.266*5)"B[F4E&.UL<X- '645R'PVO+J^\*RS7=S-<2C4+M
M\KEVVB9P!D]@  *Z^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU3',RO$ A7ZGBO1** /)8;Z\\.^._#P;2+R\:/PHD5S#;(&EBQ(H)VY&[#
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MF:Z4S?9)3_9C_/\ ,[98J4*Y.  <]J]7\26\MWX6U>W@C,DTME-'&B]68H0
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MZXCM[6$;I)9#A5'J34&L:/9:_IWV*^1GMS)'+A6*G<C!UY'N!0!R,CZCXO\
M%OA^<:)J&FV6D2R75S+?(L9:0H46- "=W+$ENF!UK/L?".J7_P #[GPZ\)M=
M1E-PR1S<?-]I:1 ?9@!^!KT6_P!0L]*LI+W4+J&UM8\;YIG"(N2 ,D^Y _&L
MBU\<^%+VZBM;7Q'I<UQ,X2.*.Z1F=CP  #R: .7UBZU?QO!I.CKX;U+3G2]@
MN;^>\14BA6)@Q","=Y)&!CL<G%86MZ/>?;-5FT[PWKNE^*))W-O=Z/,5M+DD
M_))(2VP ]6! /6O7+_4+32[)[R^N([>VC(#RR'"C) '/N2!^-6: /+XM9O\
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MC!VM,S*?Q!!KK*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "N @U#Q5XJO==GT75K;3+73+R2QMX7M!*;B
M6,#<9&)^52QP-O..:[^N)E\)Z_IU]JQ\-ZS9VEEJT[7,T=U:M(]O*P =XB&
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M/V=I3A6C8') ; (;)(KK/$>A6WB7P]>Z/=LZPW4>TNGWD((*L/<$ _A7.?\
M")^(=6NM,3Q+K=G=6&FW"7*):6K1/<RI]QI26( !YPHP30!Y_=VNHP_#GXF/
M=:D+F,:I,C(+<)ND!A)DR#QD8&WIQ7<'4/%7A_Q#X=75=5M;ZTU>=K::VCM!
M$+=_++J4;)+ ;<'=_P#J;??#[4KJP\6:7'JULNG:[,UT@:W)DAF8INR=V&7"
M=, \UT>N>'GU?4-!NEN%B&EWGVEE*Y\P>6R8'/'WL_A0!YS)\2;S45U+4;;Q
M18Z9]GFE2STR2P:7SEC) ,K]07(/W<8!'6M8>*/$OBG7=(L-"O(-(BOM#74I
M7GMA,T+>9M*@$C/) Y[9/6M-/!_B32(K_3O#NO6EKI5Y-),@GM6>:S,A)<1,
M' (R21N'&>]:UCX5>R\66NLF_DN%@T@::1/EI)&\P/YC-W)QSQWH Y34/&7B
M&Q\.:U8(\4WB6VU==/M"8@!(KXDC<KT_U>[_ +YJS+XUO=7@LFTXP^0?#DVJ
MWH>,.-S)MC3GI\P<D=]M;5SX)6?XCVWBH7>V*.$"2TV<23*KHDF<]0DC#IZ5
M2\/?#I= TSQ):+?>:=5\R.!BF/L\!#[(^O.TR,>W6@# O/&>IVFF^%OM6IKH
M&F7NC0W,FI1Z=YR&X95_=8QMC4 YZ>W&*MZKX\U#2O">C&35M'FO=3O&MUU6
MV5I;=(ER3*4'\>T ;,XW'KBMJ/PMXATJRT>/1M;MS]BTV+3Y[6^A=[:;8H'F
M!58%6X/KD<=JI0?#22UT2);;5$@UN'4WU6.ZBM@(4F<89!%G_5E>,9SWS0!'
MX2\9S7?B[^PGUJ+7;::U:>*\2T,#Q.I ,;@?*00<@C'0BMCQUJ^M:8-"M]#D
MMX[G4=36T9IX]ZJAC<DXR.FT'KSC'>K6C:3XA767U/7M9AFQ#Y,5C8QM%;KS
MDNP9B6?M["L3XGPW5Q)X2BLKK[+=-KL7E3;-X1O*EP2O&1ZCN* &S^)M6\':
MS=6.O7J:K:G2Y]1MYU@6&0-#@O&0O!!!!!_#FN63XFW]KIEIKDOB2RO99&C>
MYT2*P9=D;D96.3J74'.3D'!KM[?P;>:GJ5YJ/BJ]MKR:>Q?3XX+.%HHHH7^^
M1N9B6;CG/&*KVGA/Q9#8V6BR>*(5TBT9 )[>W:.\DB0C;&7W[1P "P&2/J:
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M\/A_P_8:3;\QVD"Q!O[Q Y;ZDY/XUPK6VNR_%SQ%+H5_:6\B6%F)(KR!I(Y
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M:!AY*;@"TF<[\+N],X&*LC6O%NN^)K31],U6UT^)M#MM1FN'M!,WF,S J%)
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MK*&!'S $$'\Z?J'@K6M;\,:Y8:OKXFO=5\L#RXF6WM50@A8T+$\XY).3QZ4
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M>,J<>@(':@#I:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG( ))8DYX%<%H_AW2/&5QXMU#Q)']HNX-4N+.*220@V<,8&SR^?D.#NR.N:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\A+WPTEI;LX.))O-0[ ?7%<UX9FCT6W\%Z_J:LND6SZG;R7!4E;662=MKMZ
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MIH ET?XFZL=8T6V\1^'XM.M-<XL9X;L2E6(!59%QP3D?GTZXZ#XF>(+GPO\
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MDM?#VH2/?W=R'U*Z0),5*H5F<%AA0<MU/;/0"@#T&J.L:Q8:!I,^IZE.(+2
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MU*\V7/V)T3[$(F.?*VA=WW>-V<YK'G\47^N:YKQ?4?$UC%87LEE91Z/IC3Q
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MQ4^6"B_(N /E';.3SUH Z6PT^TTJPAL;"VCMK6%=L<4:X51["K-%% !1110
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M*TJ65ND"R,,%@HQDC\*I:5X5L].TG5=-E=KJVU*ZN+B99!CB8DLG';G%;U%
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M<CC/3VI^C>$M0T;0=.TF/Q)=/%874<D;^1&K-;H,?9VP.5/][K7544 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !6-K'BSP_H%U!:ZMJ]I9SS\QQS2!21G&?89[GBMFO%?B
M?\&M7\9>,%UG3-0M$BFC2.9+EF!CVC&5P#D8[<<_6@#VD$, 000>012U2T?3
MQI&B6&FB5I1:6\< D;J^Q0N3]<5=H *X*/Q#<^$/%]]IGB._9](O4>]TV]G/
M^JVC,D#'V W+[>IKO:X?XJZ6VK>%[.%+%KQEU.U<HL7F$+Y@#'&.FTG/L30
MF@:[=1Z/J?C7Q)=R66EW&'L[-QQ;VXX1B!R9'R#CGJ *TM,\<V-_JMMIUSI^
MJ:7<7:EK0:A;>4+C R0I!/('.#@^U1?$72KS4_"+)IUN;F>UN8+L6R]9ECD5
MB@]R <#U K$U/5/^$XUSPS;Z3I^HHEAJ*7]Y<75G) L"HC#R\N!EF+8PN>E
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M<PRHB-C!Y&X'.3TQ0!J:Y\1L'PM<Z+;7MS9:G=LLWEVN7955P8@&(PX9>1Z
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M_97#F,7$C$Q@C]Y\K _+FMR?4)?$GC^+4+#3=1&G1Z'=P+<SVCQ"20E#M 8
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MED@E4 E!_$RD X[U!<^-[[7;BST_PGIM_P#:))T-U=WUC)%#:Q Y?.\#<Q'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 56?4;**^CLI+RW2[D&4@:51(P]0N<GH:L
MUX[9WMQH7C/QYXGUFVTNX&F&(L\<+><"8!Y:Q,Q.T$, WN3VH ]BJ WMJ Q-
MS" L@B;,@X<_PGWY'%<3-XE\6:#'IVI>(K/2O[,NYXH)H[,R":S,A 4L6.'
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MM-6NDS/!&S$_/&8R'9<D [L' S7J=% $%G;_ &2QM[8N'\J-8]P0)NP,9PH
M'T'%</8Z9X\\,QR:;IATK6-.$CM:SW]S)'/$K,3MDPK;P,\$'.*[^B@#S23X
M:WJ^'[5EN;"XUV'5)-6<31'[++))D/%MY(3& #@G(S5RWT364;4]2U"PT;2K
M5-/EBBLM/19&=R#EVE,:D<<!1Z\UW]-=%D1D=0R,,,K#((]#0!Y'X>T7Q3XH
M^&.B:!=?V;%HMQ:P&6]25S.UN,-Y8CVX#8 7=NQCG&:V9_!^L6WC#5]4@TG0
MM56_:-K>ZU%V\RR"J%V!=C97(R I7/>O0;>WAM+>.WMH8X88U"I'&H55 Z
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M\6['W3GG<<<8YXX /H.BJ6C1WL6AV$>I2"2_2VC6Y<=&D"C<?SS5V@ K@?\
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MAT6]DGCM=7L)WMXQ+,(KA&\M",AFP>!CG->9:C)HDOQ'\3-HS6S-_P (G/\
M:FMB"IDWC&<<;MNW/X54UG2K?3_@?X<EL+6TMXI_[/?4IGARKQ-AF,NW#,F\
M@GGIF@#UG2_$&C:V9!I6K6-\8O\ 6"VN%D*_7!XIC>)="75AI3:SIXU$G;]E
M-RGFY]-N<Y]J\Y>WO_\ A-M"E&K>'%U%;>X^SPZ19R*T\7EGASO90@.TC=@9
M'%<KI]O+/\(V6\U7PQ:VI#?:9)K25KZ*XWG))#Y,H;I\OIQB@#W34]>TC1?*
M_M75+*Q\TXC^TSK'O^F2,UG^$O$$OB.SU*>6.)!:ZE<6<9B)(9(WVAOJ17*:
M(+-?B1KP\1R6\EV=-LOLCW:A=\'EGS2H;H/,SN'TS5SX1BQ'AO5!IFW[!_;-
MW]FV?=\O?\N/;&* .G_M<V^LZC%>7>FPV%K;QS;C< 2QYW;C(#PJ\#![\U+;
M>(]$O-3?3;76+">^3.ZVCN$:08Z_*#GBO,_&?_(4^)'_ &+UO_[5K1U_2=/T
MS3_AY)8V<%O)'J]I$LD:!6VM$^X$CDYP,^M 'I-S<V]E;27-U/%!!&NZ265P
MJH/4D\ 52M/$.BW^H2Z?9ZO8W%[%G?;Q7",ZXZY4'/%8WQ-_Y)EXB_Z\9/Y5
MRNM'03I7@1/#9M#>?VC:FR^S;=_DX_?9QSMV9W9[]>: ._U#Q3X?TJ\6SU'7
M-.M+DXQ#/=(C\]."<U-?Z]H^EKNU#5;*U'E^;^_G5/DR!NY/3) SZD5Y/=WR
MWVB^+[VQMO#VF:8;JZCNWU'?<74TBC:3M+ *21\JY..,"I/"^GV>KZ_X"74+
M>*Z2/PJ9%690Z[@8US@^Q- 'IM_XI\/:7Y/V_7--M?/0/%YUTB;U/1AD\CWZ
M5:NM8TRQTX:C=ZA:P6) (N9)E6,@],,3@YKS=[I+CQ+XH;2[3P[IL-I(EO?W
M>KEY7<+&,%8L@+&%X R <=*YSP=+:#3OAS+K#Q'2%74%B><8B6Y\UO+W9X!V
MAMN?PH ]F@\1:)=6TEQ;ZQI\L$<7GR2)<H52/D;R<\+P>3QP?2DB\1Z',EX\
M6L:>Z61 NF6Y0B#/3><_+T/7TKR36'T:35?B:VBFW:(Z"GGFWQL,N)-V,<9Q
MC..^>^:WM=MM&T/P7X7LX-"L)IKVXM(X?/<PP^<$+*\S+RX'S'!SDF@#OM,\
M1:+K2RMI>KV-Z(N9/L]PK[/K@\5%#XI\/7%]#90:[ILMU,H:*%+I&=P1D$ '
MG(YKS>QDN5^+QCO+K1I+O^P9UE32HBBH-ZE5<EB6;OVP,<<UDVQ\.?\ #.UN
MMF;4ZBT:>2(\>?\ ;MXQC^+?N_\ '?:@#TC_ (3>RL_%6NZ9K%W8Z?9Z>MJ8
M9YYA&9&E5B0=QQQM[5U%O<07=O'<6TT<T$B[DDC8,K#U!'!%<!X?TNUO/BKX
MKN-0M()[J*SL$#2(&V[HVW@9]2H_*KOPJ18?"$]O& L,&IWD<2#HBB9L >U
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M0JK^3.(GC#1[VV@*_P V , 9[ 53\&N4\4>.FF5FN5U)"5'WC'Y">6!^&<4
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MM86L-B5*FVCA58R#U&T#'/>N:;XD:1#X:N];NK6_MTLKQ;*[MI(AYT,I91R
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MD?2M(L;%Y?OM;6ZQEOJ0*8_AG09-5&J/HNGMJ ;<+HVR&3/KNQG/O7.-XKU
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MEV4EK/(9IH7@4I)(3DNPQ@L3WZTEEH&CZ;Y)L=*L;8P!A$8;=$,8;&[&!QG
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M@\4 ='=6=M?6YM[RWAN(20QCF0.I(((.#QP0#]10]G;27<5V]O"US$K+',R
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M/F8-@<DT ;>I>'-$UF>.?4](L+V6+A'N+=)&4>@)%6KK3[*^LC97=G;W%HP
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M.M<;J-KKNM>%-6MM7M/%MYXFE2=3:1^9#8IRVTH5PCJ%P0"6+'C!S7NE% '
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MWH>EQ:%<6TYN;86S7<AY7$?4A0/O'Z5>L-8U#3? 7@^*'5])T2PDTF%IM0U
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MC&/+(R.C!2""I)'U% &'HUOXGN?%?C=="U"QL8H]15MUQ;&9I9/)3Y?O *N
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M "BBB@ HHHH **** "BBB@ HHHH *Y>7QSIRRSPPPS7$T37:B*-DW.;8#S
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MW\;IKNK:U>W_ -L34KFUMC#>21"Q2)MJA%4@!N-Q)!SF@#TQ8T5W=44,^-S
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_B;H^G6&C7FGW<%U!?Z@EJ[[7/E1@_O"0!D,./E.#ST-=9?ZK;:?HLVJ2/\
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MBN"GF&)4>1E3^\P0':/<X% %33? .E:=?6=TUUJ=[]AYLXKV\:6.W.,953W
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7BUI=2:'XA\7PZGXQM]
MFEU*6Z\FZLXW-Q P'ELC.<N-OR[1G&#ZU[344MM!.R--#'(4.5+J#M/MGI0!
MX[/9Q2_#CPOX6THWDFMW4WVG3)KF,0362+(7,[!2=JJIP!GD$#V%:_O-,M_A
M);Z7<V7D7&D:M:PZM9G+NSB8%W]7$@RP/?..U>W[%W[]HW8QNQSBL3Q/X<7Q
M'I\-L+@6S1W<%T9!'O+>4X;;U'7&,]J .6N]7TSQ/\1_"DGAZ[@OC8)<S7D]
MLP=8H7CVJK,. 6;&%Z\9Q7+>$88YH/A4LJ!PL^IN 1GD"0@_@0#7M44$4&[R
MHDCW'<VQ0,GU-.$<:[<(HV_=P.GTH \GU>2?2?BQK%Q=^)8?#\=[96_V*YN;
M:-XY40$.@=R I#<[<\Y!KHOAC# -'U2[M;ZYO;>\U*6=;B6V6!)6(4,\:@GY
M"02#QDYXKM)K>&Y39/%'*F<[74,,_C3P H    X % 'F.M:^8/B%J]F-8TCP
MQY%K 6OKNW5Y[Y2"<(68#:IR,8)S7*:5Y=YX4TM)6>X1_'B[C-$$9P6)RR8
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M>(-;@OAIS/);06ME]G4R,I7S'^=MQP3@# YKJWMH)94EDAC>1/N.R@E?H>U
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M2L[R8\KRV& P?/!X[Y'%8M]KFNW7Q"\%VNJZ+)I.^:Y<".\$\<H\AOE8@##
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MB1I48+C.>@/;%<I?^'/$\6CZ\EG;7(6Z\3&\E@MKE8IKJR*H&"."-I)'0D'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ>A 'IQG-'B'Q3?0+K=Q%XTG_M.S:9K>PTG3_M%O$J E4E<Q'G ^8E@%Y]*
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MUJ^U_P )65_J5LUO>MN29&B:/+*Q7<%;D!@ V#ZUQ.BZ[J.D^.?&L=EX;O\
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M_+"FU@SDXZ@X&3BN0TKQ=J4=YXFL+?6;_4+6VT1]0L[K4+$02I(-PX!1=ZY
M.2N."* /6:*\I&H^*]-\/>&/%%UXC>Z.H3V:75@;:-8?+GVCY2!N##<#G/)[
M <5K6DWB+Q;J^OW%AKSZ7;:7>O86MO';QNLDD:J6:4L"2"6QA2N /6@#M-+U
M2RUK38=1TZ<3VDX)CD (# $@\$ ]0:9<ZUIMG;W\\UY$(]/3?=E3N,(V[OF
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M,[GJS,Q)8^Y)K@X]=\1^(]0\'VUGJO\ 9L6JZ,U[?-#"C,"/+YCW X.6QSD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMG?P'4);Y[R]DO7FF0*Q9PH.<<'E<\8Z]*N^'-=MO$V@6FL6:.D%TI=%DQN
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MKHVOOI\Q@\B6":#[1!(H.0P3<NUAD\@\BLVR^'D-G!I8_M&22>TU9]6N)6B
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M]H.%)'#$Y'I6G!?>,->D\4RV?B"'3X-)OY[>V1;))#)L56PY;^'D#CGD\]*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.3Q.;F^=1K,UO/$T28>UDA10K YY.5![>E=D'5D#!@5/((/%()$+,H=2R_>
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M-\UM]E:4D\Q;BVW&<=23TK%M/AYX5L;^*\M]*57AD\V&,S2-%$_]Y(BVQ3]
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M,'Z&N9T#Q%I?A/PCJ?AO74D768Y[L-:&!F>_\QW9&CP/G#!@/PYQ5;1=*O\
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M%8)X<O9-5&IVD4?BN]DCU*QX:Q;<P$C<'Y#G:>".: /2],\8:)JEK?7$=TT
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MVQ4D$R,JD*,@\GTJYJGC70=(ELX;B\9Y;V'SK2.WA>9KA<C[@0'<?F' [<]
M:X/P[XPT'0H_&5EJ(=;J36[UD@$#,;S)P%3 ^8_PX[<9X-4=*FC\%:SX$3Q&
M&B:#0IXY9&0L+9BZ$;L9P /DST&: .O\3^.(W^'NJZSX=NV2[LY8XG66 K)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S6J>&M3GUB7
M4M(\276F//&L<\)A2>)MN<,JM]QL'DC@\9%=+10!D^'- MO#6CII]M++-\[R
MRSS'+S2.Q9G;'<DUK444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/H&@1: NI"*=Y
M?MVH37S;@!L:0@E1[#%%QH$5QXLLM?,[B6UM9;81 #:P<J22?;;6Q10 5SUS
MX9EO_%EMK%]JDT]I9GS+/3_*58X92FTN6'+'!;&>FXUT-% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !116-XF\3Z7X2T6;4]5N%CCC4[(\C
M?*W95'<G_P#7Q0!LT5D>&-?A\4>&[+6K>&2&*[0NL<A!9<$CG'TK7H ****
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M^7(D:PPAPA<ECSR>@YH Z.BBN9U7QI::5>:W;26LSMI.FC49"I&'0[OE'O\
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MWBU72=6(DT^,<A?+!(4JN,AE&/7O7NOA?4[?5?"&FZA8RW5U#);*8WNB/.?
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MDEC@#0+=-#C"<8)7<68XX.*HZ[ OA?4/%FA:/+-%IDWA6XO_ +-YK,+>9=R
MIDDJ&';U7->AZEX2T74]*M=-ELQ%!9E6M#;.87MRHP#&RD%3]*KV?@C1+33]
M3M?+N)VU2(PWMQ<W#RS3(5*X+L<@ $X QB@#SV]\+VME:^!;NWNK^.]U6XAM
M]0N5O)-]S')"S.K'/ .W QC Z8J74K*+PY+\0])TII;>P70%NXX/-9A'*5E!
M9<DD9VC/TKTN?P[IMQ%I,<D+%=*D26T&\C8RJ4&?7@GK65XK\,1WVC^)+G3[
M=I-7U+2WLQ^\P'PK;%Y.!RQYH X_4-%M/#/AKPUXBTJXN&UB2ZLTDN#<.YOE
ME*AT<$X8$$D#'&!C%0:O;67B#4?$5S;Z'J>O-!/)"U_<7ZVT%FR+@I%\V<*>
M20O)SR:[#P[\/M)TR+2KF:*Z>YLXD:*WGNWEAMI=N&,:%BJG.>G3MBK$WP^T
M&:^N[@K>)%>RF:ZLX[R1+>=SU9XP<'/<=#W% ' V"3>)Q\,;?4[RZDBN]-NS
M=A9V0W 5(\!V!!/(&?7GU-78O#C/<^/O">CS3V]O!#:7.G1"9CY$[(S_ "DG
M(!9%R/K7>V'@_1M,.CFV@D4Z1'+%9[I6.Q9,;@<GGH.O2GW-A#H\^K:]I^G3
M7FI7<<0EACE ,WEY"A=Q"@@,?3- '(:'KS>/?$WAZ>)F2UTW3_M]ZBD@?:I,
MQK&P_P!G;*?RK8\>M)IK:#XAC=E33=1C6YP>/(F_=/D=\%E/X4_X?^')="TR
M_NKNSCM+_5KV6^GMT8,(=S?+'D<' ].,DXKHM5TNTUK2KK3+^+S;6ZC,<J9(
MRI]QT/O0!XO'XHU'2;CQ!K1GE=/$UI.^E1LWW98Y_(B51[K)&W%:.KV+Z/)X
METCSY)([3P-L)9B=S#S06^IQUKT27P7H,\&APR60,>ALCV WG]V5  SZ]!U[
MBI[[POI6I7=_=7,#M+?V)T^X(D(W0$L=HQT/S'D<T <;X8_Y*)I/_8G6_P#Z
M-J[\1;9;_5O"%A)=36\%SJ;1RF&4QEU\ER4R"#\WW?QKJ+3P[IMCJ<.HP0LM
MS#8KIZ,7) A5MP7'KGOUK"\=>&)?$U_X;B-LTUE;7YENBLOEF-/+8!@00<AB
MN-O(H YK5[2+PMK^NZ/HS2PZ==>&;F\DM1*S+#*AVK(N2=NX$@XZD9JBVCQ:
M/X$\,S6MU>17?B2XT^VU2^^TN9#'(I9@I)PF>%&,<$"O1+#P5HUA;:C$%N;B
M348C#=W-U<O--(A!&W>Q)  )P!BKEQX;TF\\.)X?N;19M-2%(5B=CD*@ 7#=
M01@<YSQ0!Q5]H5AX5\;>'+'15E@M-9^TVM]9"9V25%B+"3#$X8'^(<\UD6][
M>7NBZ;\.Y;B4ZC%JK65W)N(=K*#$N_/4;HS$N>^XUZ#H_@S2=&U'^T8VO+N^
M$?E)<7UT]P\:?W5+D[1]*M1>&]*A\3S^(X[4#5)X!;R3;CR@(/3IG@<^PH \
MPU>_O([CQ1917D]O#>^)K*PFFC<JT,$D<>_:?X<],^]:MWX9TOPS\4/"!TE)
M(4DBOLVOG,ZDB(?. Q."<X)[X'I7:S>$M$N8-7@N+,31:O();Q'8D.P4 $<_
M*1M&,8P1FJ>F^ M%TS5[;5E-]<ZA;*R17%Y>23,J,NW:-Q/RX)X]Z /*-,MM
M8U_P7)XC?1+B36+A9;A-=.M)"+=PS8PI8!$7&"IXP#7M^F--?:!9M?B-IY[5
M#.(V#(691NP1P1DGD5@W'PV\.7-Q.S17B6MQ+YT]A%>2);2OG)9H@VTY/4=#
M76*JHBHBA548"@8 'I0!X[%>7DFAQ?#A[F8ZDNKFPDEWGS#8K^_\S/O%A/QK
M8T;0;#QKKGBBXU\37#V.I/86D G=%MHD12K(%(PS;B=WM6GX<T6\O_'6H^+]
M4T;^RY3:I8VT,DBO(R@DO(VTD#/RJ.^%K4U7P-HVK:E-J#F]M;FX01W+65Y)
M!]H4< 2!" W'&>N* .!\.:M?7NH> 1=7LMR([_4[47#ODW$<:.J,Q_B. .?;
M-==I<[/\7O$,/FLR1Z9:?)NX4EI.W8XQ6I?^"M"O]&L=*^R-;6]@P>S:TE:%
M[=AQE&4Y!Y.?7O3]#\(:1X>O;B]L8IOM=S&L<\\T[RO+M)(+%B23\QY],#H!
M0!B>,+X>&O%NA>(YI62P>.>PO.?EP4,L9Q_O1D9_VJ\]TZ^U>VT34/#5Y=S#
M4O$\EG=VS%CNC6ZSY^/0((W^F:]F\0^'M-\4:/+I6K0&:TD9690Q4Y4Y!!'(
MZ4R?PQI%SK^GZY): W^GQ-%;2!B BL"",=#P3CTS0!Y/XRM(I])^)\,H=X[*
M2Q:W4NV(R($''/H36[J'A;2[OXFZ'H[QS+IT.AS.8$G<"0><GRL<Y*Y;.,]0
M*[>Y\):->+K2W%J9%UH(+T&1OGVH$7'/RX '2C3?"FF:7=VEW#]IDN;2U>TB
MEGN'D;RV<.02QYY Y/0#% &!\/X1INL>+-$MWE_L^POXQ:Q22%_*5XE8J"23
MMR3@55U'1=/N/CEIEQ+ 6E_LF2XW>8P_>)+&%. >P[=#WKM;'1K+3M0U"^MH
MV6?4)%EN&+$[F50HP.W '2JVI^&=-U76-/U:X6=+ZP/[F6&=HR5R"58 X920
M.#0!Y+I_A;3Y_A7X@U^1KK^T[:74)[2=;EU-LT<CE=@!P.1D\<Y-7]1NM2\3
M>+[.PN](EUFT@T2WN_L2WPMD>23[TK D;\8V@=!^->E0^%]*@\.W>A1P.-/N
MQ,)H_,.3YI)?GJ,EC]*KZEX*T?4EL69;JVN+&(06]U:7+PS)'C&W>I!(XZ'-
M &3\.4U.TBUC3[Z,0VUO=C[);/?+=26R,H)B9@20 >0&YP:RM0T6P'QK>\%H
M9+B/06O5'F/\TRS *< ^@ QT]J[G0] T[PY8M::;"T:/(997=V=Y9#U=V8DL
M3ZFI/['LCKXUORV^WBU-IOW''E;]^,=.HZT >4VNAV=[\))/&D]]='Q$UE)J
M U,7+ATE7+! ,[0H(V;<8J/5KN;4%\77MPNR>X\%P2R*!C#,LI(_,UWDGPV\
M-RSN6@NA9R3>>^GK=R"T>3.=QASMZ\XQCVK3O?"ND:A/J4UQ;LSZC9BQN<2$
M!H1NP!CI]X\B@#AM,T^W\6>*UTK6C)+IVFZ+9RVUEYK(DCR [I6"D;B-H49X
M&:RII;G1EU<VUW<3:?X3UVWEA9Y6=A;2(HFAW$Y(0.3SG&*]'U+P7I&IFSD8
M75K=6</D075G<O#,L?\ <+J02/8YJ>T\)Z+8^'KG0H+/%C=+(+A6=F:8N,.S
M.3N+'U)S0!Y8?%=YH?B#7?%,EP\EEK,%Y%IT><KYEJRQQ8'^W\Y]ZT$L;G0=
M8_LI[B5I+;P1,9"9"=TWF?,WUR3S7=R>!O#TVDZ/IDECNM-(F2>S3>WR.O3)
MS\W7D'K5V[\.Z;?:G-J,\+-<S6+:>[!R 86;<5QZY[]: /*FT.WTGX>>%/%-
MM/=_VXTFGL]XUR[,ZR,@:,@G&S:V,8Z#ZUT&EZ)9>,_$7BJZUY[B2>PU V5I
M&MP\?V2)8U*N@4C#,6+;O:NRF\+Z5<:!9Z') YL+/R?)3S#E?*(*<]3C:/K7
M%^)-$N;CQ+J%S<>#;G4A,JI!<Z9J'V9;A O^KN5,BYP<C.",?E0!K_"61YOA
MKICR7+W+%[C]\[9+_OY,'-=K7.> ] G\+^"M-TBY,9N($9I?*^Z&=V<@>P+8
M_"NCH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J.K:QI^A6#7V
MIW26UNI"[WSRQZ  <DGT'-7JXWXDC3?[$L)-2N[VP6+4(I(-0ME5A9R@,%DD
MW<;.2#D=Q0!M:/XIT77H[E].OTD^RX\]75HWBR,@LK@$# /)':JNF^._#.KZ
MBEA8ZM%+<29\H;&59<==C$!7_P" DUYK=WFL:YIWB_1[.]TWQ%/_ &.&76=-
MMU21_F/^CN4)5F*[B #WZ<T"ZL]:MO#5E'XV_M%A>6[VNG6.FPB>W9.<N P,
M:J 0Q/;/6@#T>^^('A;3KF>VN=6C6:WD,<Z+&[F(C&2^U3M'(^8\>_%7M3\4
M:)H]C;7M[J,*076/L[)F0S9&?D"@EN.> :X+PYXH\,Z#K?CJ+6+RVM)VU:21
MO/P#/'Y: *N?OD'=\HR?F]ZQ=*O+W0=(\%:9>/I^AW#VES*FJZI#O-LC/E84
MRRA6*%<Y/08H ]0M?&GAV]T>\U6#5(VL[(XN79&5H3_M*0&'Y5%%X^\+36-Y
M>IK,!MK240RRX8#>>BKQ\Y.#C;G->17-V+O2?BI+_:IU3?96;+>>2L2S@!P6
M0*,%01@$9SCJ:[_QOJ$>B:9X7MX8=.M8WN4CCU"^AWPZ>5C.UL9&&/09('6@
M#=MO'?AV^L[^XL]0$AL8_-GB:*1)$7L2C*&Q[@5CZ#XX/B+P_P"'=22^M+.:
M\O%@N8&A<AV*,WE(3_%C!W=.#7.>'[PWWQ9O#_;R:XQ\/21BZAMTCB+"9240
MKD-C.2<G&<9JEH6H6E[X,^&<-M<1RRVFKQ07"*>8I!%+E6'8\B@#TG4?'OA?
M2M1DL+W5X8KB(@2@*S+$3T#L 53_ ($15G5?%N@Z))''J.IPP/+%YT2X+&1,
M@94 '=R1P.:X#PWX@T#PYX2UW1_$=Q!!JB7=V;RUGXEN_,=BK(IYD#*5 (S4
M?@W3;JS\4>"+;5(B+RV\-S';(/FC/F( /8A6Q0!Z7HFOZ7XCL3>:3>)=0*YC
M8J""C#JK*0"#R."*Y[7?&D7A[QW9Z=J-U%!IDVFR3G,99VF$BJH4#)/!/ !Z
M>U,\'J$\=^.U4 +]MMFP/4VZDFL_Q#JFE:/\8]'NM7EB@A_L>9([B;A(G,JX
M)8\+D;AD^N.] '86/B;1=1T:75[74H'L(=WFS,VP1%>H?=@J1Z'%5]&\9^'_
M !!=FTTW4DEN GF"-HWC9T_O*' W#W&17E/B&&77-/\ &VLZ+ODT2?4+!_,A
MBWK.L/\ KY$7HX!VY['8:VK2YMM;\:>&BGC3^WKBWD>XB6PL8@(4V$-YKJV4
M4@XP>2<<4 =A-\2?!\$BI)KD )<HS;'*HP8KAV PG(/WB*T]:\4:+X>$']IW
MR0M<9\F-5:1Y,=2JJ"Q ]<5YSI5O"/@1XJ(C3,G]INYQ]Y@\@!/N-H_(53E>
MYTWQKIM]=>(H]"@NO#]M%:WMQ;I)&Q7EX]SD!6Y#>] '6^,OB'9:;X'_ +7T
M/4+>::ZD6&UE,;2(K%U5RP'0J"3@XY'X4R+Q9+H^FWUW?>(;755M=*%V$6R:
M"1V9W",0,X4_*F.N02:XVYC@?P+XAO[;4KC48;O7;-C<M:K!%+()HE9X@I.Y
M3@9; R0>M=-KJ-)X[\71HI9V\* *H&226FXH W=,^(.BR^$=+UK4;V.![R-
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M*Q7L+1?V4H[@6\0F>X\QI-HW%OM13.?7;Q]* /<O$7C+P]X46$ZWJL-H9O\
M5JP+,P]0J@G'OC%<YX[^)5AH?P_;7=$OK2ZGNL)8'EDD;< W3NH).#CI7GOB
M"2YT?XIV&JW^KQ:1:7.BQ):7]S8_:HP0J[DQD;3G<<^_^U5*[T^UB^ ?B>]M
M+J>[M;K4DFA>:Q%L%8RQAC&NYOE/ XQTQVH [C0/&&MW4?A5Y?%>B7:ZG=2K
M,/LSQO*H$?[N/"D;E);). <BM3PO\5=-\1^-]6T(26\4-OA;%\L6N2 YD;D
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M"Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYGV= I.X1KN8D]!@$?G5^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML<GZDUE>)? 6D>*-3L]3N9;ZTU"T4I'=6-P89-AS\I([<G\S0!Y%H,/B#5_
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MW&: .8O]*C\$^*/##Z-=7HBU*\-E>6L]W).LRF-F\S#DX92HY&.M4;#4;L_
MC7;Q[R<W*)J&V8RG>I$L@7#9R,< 5U^E^"-/TW58=3FO-2U*[MT9+:34+HS>
M0K##;!P 2.">3[U0NOAAH5W]NA>?4TL+UWEFT^.\9;?S&Y+A/7/.,XSCB@#"
M73V\1>/]/TV_O[_^S_\ A&8+B6VANGB$TGFD98J0>_KS@9Z5SFK60G\':MIM
MU=7EQ#I7BJ*TM#)<R%TA9XOE+9RV-YP3DCM7KUKX<L+/68]5B$GVF.Q73UR^
M5\I6W#CUSWJC=^!M&O=-U:PE%P(M3O/MLS)*5=9AMPR$?=QL6@#9")IFD^7
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MX?L=1BTN.X$FW3+F.YM]K8^=%*KGU&&-16'ABRTSQ%?ZU:S7:2W_ #/;^<3
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M3/$.EZ5INF3-%)J=M:7E]/&5B42$?)&3]]B#R1POUZ2V0,?QHU43?>FT6W:
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M]LN9Y)&MWWK&#;OM#$=">>#SP: .NM/&GAR_UI-'M=6@FU!]X$"9)RA(8'C
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MKA7N[9$>:(=4#9VY^N#^5<K\0[7[#I6G^)+2(";0+I;HJ@P3;GY)E'ML.?\
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M9S70DA022 !R2>U>$#5K?1- C31-:LM5TY+P*GA75[5#>1OYW*+M.[<&)(W
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW^\[8X)!Y_A'KBND\.^*;C5M6U#1]2TE]+U.R2.5HC.LR/&^=K*X SR"",4
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MA&",'@YS6YJ?ACP%#'?ZM>A1917.;V)+N4VWGEE^_"K;"VYER-O?FNZ
M '0"@#B?"L?B30/"D$=[8W=_/+J!6*":[5YK6U9OE\R0\.5')P3UP.E=O4-U
M=V]C:R7-W/'!!&,O)*P55'N347]J67]L#2?/7[>;?[3Y.#GRMVW=GIUXH MU
MR?PYTF^T7PG]CU&W,%Q]LN9-A8'Y6E9E/!/4$&NLHH \VL_#>KQ?!+4M">R8
M:G+%>*EON7+%Y9&7G..0P[]ZG?0=<3Q'>WEMI]O+N\,PV<0N\-#).KN3&X!S
MC!&>W->@.ZQHSNP5%&69C@ >IKE8_B9X-EO%M4UZW+,_EK(5<1,WH)2-A_.@
M#DM \.WEOXITFYT'PWJGAJ*.1FU9)KM3:RKM(V)&';<=V,, H&*[OQC;7EWX
M;GAL]*M-6+,GFV-U]V>/<-RJ20 ^.03P"*WJ* /(+#P5>7\NJ6.D:;JOA[0+
MO2YK:2UU&Y$BM<-]QHXP[[0.<G(ST J"S\(--::=I;?#YHM1C>-+R\N[PM9A
M5(W2)MEW,3C(7 P3STKV:B@#R_2];U32O'7C9+3P_=ZK"]Y"5:TDC#))Y"</
MO884C'S#.,'BJ<GA3Q!I>B^'[>[MKZ]L#/=7.LV6DW/E2&25MZ '<I9%)((#
M#UYKT^STBQT^]OKRU@\NXOY%EN7WL=[*H4'!.!P .,5=H \<@\'ZHG_":&Q\
M-2:=:ZIHGD64#7"O(\@#C$AW'#G(/4C&.<YKI_%.FZZW@O0K33XKMU@DMQJ5
MM93B*>2!4PZ(^1SG&0",@=:[RB@#RWPYX:N+3XCV.L67ABYTK2OL,T#O=7 D
MG9R5(+C>Q .,#DG@YQQ572O#_B!?"'AO1)]%GAGT;7X)I9&DC*20B61S(I#=
M &''7VKU+4M1M-(TVXU"^F$-K;H9)9""=JCJ<#FIX9H[B".:)MT<BAU;U!&0
M: //M,/B#P6^LZ;!X;NM6BN;Z:\L+BVEC"'S3NV2[F!3:2><'(J#P[X,U70M
M2\$1RQK,FG6E\+V:-AM268JX SR1DL!QVKTNB@#EM#TJ]M?B!XLU&> I:7J6
M0MY,C$A2-PW&<C!(ZUB^,;^]T[XF^%;BRTZ34&%G>B2")E60I^ZR4W$ D<'!
M(SS7H=4I](L;G5[3598-U[:))'!+O8;%?&X8S@YVCJ.U 'G6H:/XMU6W\4^(
M;"TFTS4;Z"WM;&U,R+/Y,;9<E@2J.P9@.>*I0^%YI/%/AK4]*\):C8P6=YNO
M+G4KL23L"C#@&1SM!/)R.2, \UZ_3)94@A>61ML:*69O0#DT >6ZQH5Q/\6H
M]'@*G2=2:'6KZ,'[KV^4P1Z.WDD^NTUZHZ+(C(ZAE88(/0BL'PUI&@0+-KFB
M(9/[5 F:Z:1W,BG) &\Y5>3A1@>U;] 'C-GX!\0+H/B"&>WS=:?'';:"V]<R
M1P3-/&>O!;*+SC[M;*^%-87PCX922T+ZF=?@U;4P&7Y"TK/(2<X.T$#C/2O3
M:* /++GPMK<EMJJ+8,6F\7PZA&-Z_-;@Q9?KT^4\=>.E=YXKLY]0\':W96L9
MDN;C3YXHD! W.T; #GCDD5KT4 >7S6GB3Q%X9T?PG=^';BP,+6OV^^DEC,(C
MA*M^[VL69F*@8P,9YJC<^#UTGQ!KLE[X/O->CU"\>\L[FSN@F"^"8Y 9%VX;
M/S8/!]J]>HH PO!VE2Z+X4L;&>RM+*959Y+>T9FCC9F+$ L23UY.>N<5Q6@Z
MYJVE^(_&D5EX=NM4B?5F,3VTD:[9?*C^63>PVK@+\PSWXKU*N;M-1\+Z1)JE
MS;7"0M/J8@O6R[9NV"J%YS@D%!QQ0!PS>$M=T;2/#6GWEMJ&I:5"EQ)J=II-
MSY3FXD<NN?G0L@+,, CIFJT7@W5TT_QY'9^&WT^#5M/@2PMO/1W9E#@AVW'Y
MSD$\D<]37LU% 'GT5KK'A3Q3>:M!HMUJEGJMG;)*EH\?FV\T*E0"'905(/4'
M@BM+X>Z?JUCINKOK-D+.ZO-6N+L0B0. KD$8(Z]Q^%=?10!YSXG\.:O?ZMXR
MFMK-I([_ $!+2V8,H\R4>9E>3Q]X=>.:T-?T34;S1/!T%O:EY;#4[*>Y4,!Y
M:(I#GKSCVKMJAEN[>">""6>-)K@E88V8!I" 20H[X )H Q_&]A=:KX&UNPLH
MC-=7%E+'%&"!N8J0!D\5DZ)HNHVOCP:A/;%+7^P+:T\PL/\ 6J[%EQG/ (]J
MZFQU2RU-KM;.=93:3M;3@ C9(H!*G/L1^=6Z /,6\/ZO#HOB.*;P[;:K!>>(
MI;I[*X9=TUJP7YXCN #Y&1DCH?:H=!\,:FK:_#I>GZGI.@W6E/;6^GZE="0F
MY;(WH-[[% XY/.?:O5** /))+'Q'<>'/"5K>Z'K"Z9I\)M=3T^SNECFF9(T6
M-P5<;H\AN P/<BJT/@_5$'C3[#X:DTZUU311#90-<*\CR .,2'<<.<@]2,8Y
MSFO9*J:CJEEI%LMQ?SK!$TB1!F!.7<A5''J2!0!Y_=^&=8DO]2D2R8I+X/&G
M(=Z\W&7^3KUY'/3WJ[?:!JDOASP#:I:,9M,O;*2[3<O[I4A96)YYP2!QFN^H
MH \]\2>$+_7_ !-XC4)Y5IJ&@)90W+$;?.$CM@CK@97/'0US]EX4-PNF6'_"
MOGMKZ.6/[;=WEX7M452-SQ[9=SDX^48&,\]*]<^UVYO#9B>/[2(_-,.X;PF<
M;L=<9XS46H:I9:6MNU[.L(N)TMHB03ND<X5>/4T 8'A72KW3];\63W4!CBO=
M1$UNQ(/F)Y2+G@\<@CFN.TKP_P"(-"T/X>W+:+/<S:.;E+RUBDC\Q!*K*",M
M@@9&<&O6Z* /(?$GAV]O-0U65?!]Y'XA>1_[/UG1KH6\;J?N/*3("&'\65.<
M<5ZIIL=U#I=I%?3+-=I"BSRJ,!W"C<1]3DU:HH \L\-^%M:LH/ *W-@T9TVZ
MU"2[!=3Y2R>;L)P><[EZ9ZUU5GI5[%\3M5U5X"+&;3+>&.7(PSJ[DC&<\ C\
MZZFB@ HHHH **** "BH;B[M[4Q"XGCB,T@BC#L!O<]%'J?:IJ "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** ([AWCMI7C\O>J$KYC;5SCN>P]Z\9NO&^HV%K::C!XS;5KT
M74*7=G;:<#8[6D"LJS",8 SPQ?)Q[UZ_JFGQ:MI-YIL[.L-W \#E#A@K*5./
M?!KA;CX=:U?^&K70+SQ5']ALO*^S"#3@A;RR"OF_.=P '1=O.#[4 61<Z_XJ
M\3Z[::?KLFCV.D2);1^1;QR/-,4#LSEP?E&X  8SZU%)?^*[_7=*\*3:E;Z=
M?KIS7VI7ME&)"X$GEHL8D&%SU.0<=![ZE[X3U2'7;_5?#NNIIKZB$^V136@N
M$9U&T2)\R[6Q@'J#CI58> )-/72KG0]:EMM5L('MVNKJ+[0+J-VWL)%R#]_Y
MA@C% %+4]0\7:+#8:#)J=K/?ZIJ1MK34S"-Z6X0NS/'@*9!@@8X/!J1]1UWP
MOXGM]'OM8?5;74K*YFMIYX(TE@EA4,0=@"LI![C.14\GP]DN;%Y;G7;A]>-\
MM^FI+$ (I578JK%DCR]O!7/.>35FT\'7T^KOJ^OZRNH7RVLEK:B&U\F*W5_O
M,%W,2QP.2>G% ')V/B#Q=:_#ZS\37>N)=WNKI;VMK:-:(D4$LKJJRDKR3C+$
M=,G&,"KE_I6M:;\1_!']H:[)JUNT]UAIK>.-XY/LSYQL !4CL1D8ZG-=*/ ]
MM)\/K7PG<7<C+;0QI'=QKL=70@K(HR<$$ XS56#P;K5QXET;6M;\2K>OI32>
M5!#8B%'#QE"6^<_-R#GIQ@ 9S0!R'B'Q?J5G;:Q=Q^-<ZI9M*\6FZ9I_VFV1
M4R0DDGEDYP/F8L I)]*WIM7\1:_XQTW2;#5O[+L[K08]1G:.W21U<R8PA8'&
M<@<Y&!TR<TL?PWU2'PU=^%X?$XBT*82A$2Q'V@*Y+;6D+889//R@D<9%;^E>
M$CINOV6JM?>:]MHR:48Q%M#[7#>9G<<9Q]WGZT <BOC#Q#8Z#J6FR7D-UK$6
MOIHMK?2PA01)M*R.BX!(#'IP<"MN\?Q+X,L]0U:\UD:WI=O82SR)<Q)%,DRC
M*[/+4 HW((/(XP34US\/H+NTUN*34)5EU'4EU*">.,!K290@0C)(;!3VR"1[
MTJ>"[W4[J2;Q3K0U1/LDMI';V]M]FB59!AV8;F+.0 ,YP.PH XJ#QSJMK::?
MJJZ_?ZI>2R1&[TK^Q)(X=CD!A$_E@@H#D$L0=OO7I'C2XU2S\':I>:++Y>H6
MT)GB.P-NV?,RX((Y4$?C6-:^"]>CAL=-NO%TTFCV3H4CAMO)N)43[J/,&Y'
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M;' .".X(/8@@$>XKDI_!/B>^T\Z/?^-Y9M)=?+EV6*I<RQ="AEW$<C@MMR:
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M*LV,[E#OOPP!QG 4G'44 6;J[\1:W\0;W1+'7&TS3H=.@NBT5O')*'9G&%+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7*RGS2CI(VPH5((8'Y3R#Q6M!X,\/6^A76BIID36%V2UQ'(S.TS<?,SDEBW
MY)R,#%/7Q3I,EKHT\=PSKK./L6U"2^4+Y([ *#G/2L+3O'>DZ=X:T.;4=7N=
M2FU*.0VUPMB5DNBAP0(T!PWS  #K0!I6G@'PU9W-M=1Z>SW-M(LL,\US++(A
M ( #,Q.WD_+T]JHV&B:CJGQ"?Q+K&F0626%L]G8*LPE>7<Q)E) &T;> O7YF
MK2TSQKHNIV6HW(FFM/[,YO8KV%H9+<8W LK#." 2#WJE:_$C0+F[L;9EU"VD
MOY5CL_M-C)$+C=T9"PP1TY]Q0!T4&E65MJMWJ<, 6\NTC2>7<?G"9VC&<#&X
M]/6J7_"*Z)_PCA\/_85_LHMN-OO;&=_F=<Y^]SUK3N[NWL+.:[NYDAMX4,DD
MCG"JH&22:Y[2_'NBZK?VUHBWULUX";.2\LY(8[H 9_=LP /'..N* +6M>#M"
M\07:7>H63-=(GEB>&:2&0I_=+(P)'L>*FB\+:)!9Z;9PZ=%';Z;,)[2-"5$4
M@!&[@\GYFZYSFJC^.-!BTW4[Z:Z>)--G^S74;QL)%DR %"8R=V1C'7M4=_X[
MTC3]3.EM%?SZEY*3_8[:T>678V>< =L<^G'J* -EM)L6UC^UFMP;[[.;7S23
M_JBVXKC..O/3-8B_#KPK'I?]G1Z4$M1/]H15GD!BDQC<C;LIQV4@5'=^*M/U
M'3-$U#3M:>VM[K5(K;*VV]I6)(,#JPS&21@GJ,>]2Q>/=#N-??18&NI;N*=H
M)RELYCA9?[[XPH.#@GT- &GHGAW2O#T,T>F6OD^<V^:1G:221L8RSL2Q_$U!
MK/A'0_$%W%=ZG8^=<Q1F.*9971XP2#\I4@@Y'4<]NA-92?$OP\[PO_Q,%L9Y
M1#%J+6,@M78G:,2$8P3QGI[U7A\:33^/]:\/O#<PVUI:(T4PLW(5\.6=F(QM
MPHV] 3P,T =#9>%M$T_19M'M].A%A/N,T+Y?S2W4N6R6)]22:JZ/X'\.Z%?I
M?6%@5N8T,<4DT\DQB4]53>QV#Z8JC:^,]-T[PQHEQ=ZC<ZI<ZA"#;F"S/GW9
M R6$2#CCD]A5J/QWH,FA7^KM/-%#I[!+R*:!DFMV)  9",CJ/:@#AM:\$:MJ
MPU.UF\(:4VHWK2)_;,=WL@VMD"5H.3YH4^A^89S7HD/A7241#+;"68:<-,:4
MLP+V_=< XY/.>OO5+3O'NB:GJ]OIL7VV*6Z#-:27%I)%'=!1DF-F #<<_2M[
M4=0M-)T^>_O[A+>U@0O+*YX4"@"K-X>TJ?2+32I;0-8V9B,$6]L)Y6-G.<G&
M!U/;FM)E5U*L RD8((R"*YG3?'FC:E?Q60CU"UGN$:2U6\LY(?M*@9)C+#YN
M.<=?:L'P)X@U#Q/XIURZN+W5([:UNI;>WL9+'RH%C7:!N8KGS<DDJ3D>E &]
M9_#WPM87\-Y;:4JR02>;#&TTC10O_>2,L44_0<5)=^!/#=]J<^H7&G;IK@AK
MA5GD6.<CH7C#!'_$&J&J^,9K#XD:5X=%M<M;7%N[R.EH[Y?<@4A@,;!D[CVX
MR16+H'Q.M;?3]1;7)+^X>UU&YBFN(+%WBMHEE(3S&1<#Y<>IQR: .SLO"FAZ
M<=.-I8+%_9OF_8\.Q$7F\OC)[^_3MBEO/"VBW_\ :GVJQ63^U4CCO<NP\Y4!
M"C@\8R>F*AU;QAI.D26L#&XO+J[C\V"VL8&GD>/^_M4'"^YXJ[HFNZ?XAT_[
M9ITQDC5VBD5T*/&Z_>1U(!5AZ&@"IK/@_0M>GAN+^R+7$*>6D\,SPR!/[NY&
M!(]B<4^+PIH4&GZ?80Z=%':Z?<+<VT:$@)*N</P<D\GKG.>:YKQ!=:Y>_$RV
MT"P\03:39G2&O&,4$4A9Q+L_C4]C^E16^I:[H'Q T70[KQ$-=MM4CG,D<EO%
M'+:^6NX/F,#Y3TY'TH ]#KGI_ WANYGU.:7306U0 7@$L@67!!R5#8!RHY !
MXJK>?$70+.[N8G:]D@M)/*NKV&SDDM[=^ZO(!@8[^G>MFVUW3[O6I])AF+7<
M,$=R5VG#1/D*RGHPR".* );S2;'4+FRN+J 22V,IFMV+$>6Y4KG@\\$CFL1_
MAWX5DN)Y7TH,L[M)) 9I/)9SU;RMVP'WQ[U+<>.=!MK&YO'N9#'!>MIX5(69
MYKA>J1J!ESGCCT/I4NC^+])UF2[A1I[2ZM$$EQ;7T#02QH>CE6 ^7W'% %JS
M\.Z5I]U:7-K:".:TL_L,#[V)2#(.SD\\J.3SQUJQ9Z596%W>W5K (YKV02W#
MAB?,8*%!Y/'  XK L/B)H&H7MK!$;V.*\D\JTNYK.2.WN'[*DA&"3@X]>U-O
MOB/H-C+= KJ,]M9R&*ZO+>QDD@@8?>#.!CCOC.* -C4?#>D:MJMCJ=Y:>9>V
M#;K>99&1DY!P=I&X9 X.11'X;TB'09]#CLU&FW D$L&]L,)"2_.<\ECW[US]
M[XW:'XA:1H<$,\MC>6C3&6*U=PS$H$8,.-@#$L>@XR14UCXNT[3O#LVHZCK,
MMZG]H36L;?9-LC2!R!"D:C+D8P".N,T :6J>#]"UF.T6\L<M9IY=O+%,\4D:
MXQM#H0V/;-7M'T73= T];'2[1+:W#%MJY)9CU8D\L3ZDDUF:=XUTC45OE_TJ
MUN;&$SW%K>6SPS+'@G>%8<CCJ,U1M?B7X<O)[)8WO1;7KK%;WKV<BV[R-T3S
M",;L\?7(H W=<\.Z3XDLUM-7L8[J)6WINR&1O56&"I]P:J:'X,T#PY<RW6F6
M 2ZE7:]Q+*\TA7TW.20/8&M+59I+;1[Z>)MLL=O(Z-C."%)!KSSP[9>,M9\&
M6.O-X^F@FN+07!273[<Q(<9P3M!Q[T =3=_#WPM?:A+>W&E*TDTGFS1B618I
M7_O/&&V,?<@YK932+"/6&U9+=5OFMUM3*"?]4&+!<9QU)/2N4T+XAVTW@;0]
M9UA)%O\ 4U98[2TA:62=U)#%$&3CC=Z $<UIIX\T%M$O]5DFF@BT]E2\AG@:
M.: L0 &0C(SD<]* +_\ PC.C_P!CWND_8E^PWSR27$.]L2-(<N<YR,GT-<U?
M^ K?5_'TNHZA:;M-32X;:WDCN&CD217<D H0P&UAWYJPOC.QUF[TAK#4+VRB
MEOS $ET]@+W]VS  L.%Q\VX>F.]3WOQ%T"QN[J)C>S0V<GE7=Y;V<DEO;N.H
M>11@$=^N.] %Z7P9X=F\/Q:$VEQ#3HG$D<2%E*.#G>&!W!LD_-G//6DT_P %
M>']+U"'4+6P(O8@ZK<R3222L& !#,S$L, 8!SCMBEU?QAI.D-9Q,UQ>7%ZAE
MM[>P@:XDDC')<!0?EY'/2LOP+XFE\37WB27[2TUG;WXBM5>+RS&GEH2I& <A
MBV=W(/% &U_PBNB_\(Q_PC?V%?[(V>7]FWMC;NW8SG=UYZUB>)=$U'Q1XFTF
MSN=,@30]-NTOVO'F#/,ZJ=L83&0-QY)X(%=G10 5S%O\//"UK?1W<.E!6CE\
M^.(S2&%),YW+$6V YYX'%=/10!#=6L-[9SVEPGF03QM'(F2-RL,$<>QJE'X>
MTJ&;2Y8[0*^E0M!9'>W[I"H4CKSPH'.>E:=% &7!X<TBV\/_ -@QV$7]E%&0
MVSY=2K$DCDD]235/1_!7A_0KU;VQLF%RB&..2:XDF,:'JJ;V.T?3%=!10!E:
M/X;TCP_->2:7:?9C>2>;.%D8J6R3D*20O4] *YS4O T.N?$.YU74[7S+'^S8
MH()8YVCD257<M@H0P&UAWP:[BB@#"E\&>'IM BT-M+B&G0N)(XD+*4<'.\,#
MN#9)^;.>345GX,T+1[M-2L--W:C CB.>2XD:1]P *L[$EAP/O9QVQ7144 <?
MX1T*^37]:\4:QI\%AJ.IF.);:.42F**-0!N<#!9CR<=@M='8:38Z7]K^Q0"+
M[7</=3X8G?*V-S<GC.!P.*NT4 <Q!\//"MMJ"7D6DH'CE\Z.(RN84DZ[EB+;
M ?<"K]YX5T34!J@NK%9/[5$8O<NP\T1C"=#QCVQ6Q10 5R<WPT\(7$LKRZ.A
M65S(8A-((E<G)94#;5/N /UKK** .?U+P1X?U?5)-1N[%C=2H$F>*XDB$RCH
M) C .!T^8'CBB3P/X;DT.713I42Z=)<&Y,".RA9"<[EP<ISV7 %=!10!SVI>
M!_#VJM;O=6+^;;PBWCFBN)(I/+'1&=6#,/J36MIFF6.C:=#I^G6L=M:0C$<4
M8P!W_//.>]6Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!
MK_<;Z5XUI%M=:;X&^'6M7%G<26>DS2->Q)$S/$KJZB0H!DA203@9YKV>B@#R
MW4KR/Q=XL?5-$CFET_3]$O(9KSR61)I) -L2[@"Q&">.!GUK-TW2;Z]3PO9Q
M1212R>#)[8.RD".1EC !/8Y_E7LE% 'C=YK=MJ'PFB\%V^GW9\1-91:>=-:U
M<-'*NU2Y;&T(,;MV<5:\2Z-?0^-[71XH9)K'Q(+,WLH4E0UJVZ3)[;D"#WKU
MJB@#R?P)I5\/%]Q87=M(ECX62XMK)W4@2&>4LK+ZXB55_&J?@ZRN$'PL\VVE
M7R+?4=^Z,CRR5XSZ9KV2B@#R3Q7H>H:QJWQ"M;&V=Y9['3FB7&!,8V9F0'N2
M%Q^-2^)?%NG>(=3\&06-G?!TURW>5KBSDA%N=K_NR6 &X\\#/W3[5Z3J^F0Z
MSI-UIUP\J17$91GA<HZ^A4]B#S6!9^"[@ZI87VM>(;[5_P"SF+VD,T<<:(^"
MN]MB@NP!."?4T +\2])O=<^'>L:?IR-)=21*R1IU?:ZL5'N0I'XUQ$#:=K^K
M:!;V^N^*M7GBOHKIK6:*.);(Q\[I3Y*XQ]W .3GBO8J* /&=:M[K4O&,OCZS
MT<S:3H]Q'%);E&\R_$>X/<*O0F/?\A(Y //2M<>*M(TCXKZM>WID6UNM)M&C
MNU@=U7ER%.T$KN!R,_W?6O3ZR;?0(+;Q1?:\LTAGO+>*W:,XVJ$+$$=\_,:
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MI;'.4W[1],8KU.B@#R[QOI0TKQ=X?U,7-_I>B6]E+9&XTR)6^R,2I7*E&PA
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M.UQ:/<FW2X:- 41G /&23MQ\VW%8#Z??:.GBZU73]/T6PG\.7$KZ5;:@)R)
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M;3/;2)#,_P#<61E"EO;/7CK6W9:O8ZC=7UM:S^9+8RB&X7:1L?:&QR.>".E
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)MEMKR"X9(3'% SA?+)7^ .%R >F:KW.OB>;XDZWIFFKJ5NT&G^2ES;%HYD
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M]3N!=6[KI<-C DEHT9!W28C4HJ8P3GZ9KVVC SG'-% !11D9QGGTHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@"GJM[_9FCWU_LW_ &:WDFV^NU2<?I7
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MBTLM(\+:*T5K#;:=IMJC2,%PB(O5F)_4DT-KVG+J&G6/VC-QJ,3S6JA"1(B
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MG:00&P@/IN]>E7[O7=5\#ZIXFLGU.ZU>WM-$75+4WVUI(Y"[IM+*!E20#[4
M>AZIK%EHT5O+?2F-+BXCMHR$+9D<X4<#C)[]*FM[&UM9[F>"%4ENG$DSCJ[
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M;2M2OHK&&W6,(!$25\S*DN.@QD<#U->@^%]1FUCPGH^IW 43W=E#/)M&!N9
MQQ^)H UJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1AN4CU&*X]/A[
M:1^$M(T2+4+F&XTAQ+97\8421N,\X((((8@J>"*[&L]->T>34#I\>K6+WH.#
M;+<(9,^FW.: ,*U\$LUW>:AK&L7&IZE<6;V23M$D201-U"(O&2>23DG%/L/
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M\M[FVY_?0RJZ<=?F!Q0!%K&DV>O:1=:7J$7FVES&8Y%SCCU![$'!!]17(O\
M#[5;FR.DWWC?5KG167RWM6AB662/^XTP7<01P?45UUEK6E:B)38ZG9W0A_UA
M@G5]GUP>/QJ?[;:?8OMOVJ'[+MW^?Y@V;?7=TQ[T <[J7@P/J=MJFAZG+HU]
M#;"S+11++')".55D;@[>Q&"*YGQ?X/EM/!D=C'>:CJ%Y>ZU;3W5WUER9%!90
MHP@4#@ 8&*]!O=:TK3?*^W:G9VOG?ZOSYU3?],GG\*FN+^SM$5[F[@A1@65I
M) H( R2,GL!GZ4 <Y9>#)&U9-2UW6;G6+B&"2WMA)$D20HXPYP@&7(X+>G85
MCR_"^:X\+OX8G\4W[:(J;(+=((E90#E0[@9< X..,X&:[.;7M&MK**]GU:PB
MM)O]5.]RBH_^ZQ.#^%6([ZTELOML=U ]IMW^>L@*;?7=TQ0!FV/AV.R\27>M
M_:7DFN;2&V="H"@1[CN'UW5@+\.YH;74-+MO$E[;Z'?2RR26<<,>\>82742D
M;@I)/OCO75V>LZ7J&S[%J5G<^86">3.K[MN-V,'G&1GTS1_;.EC4?[..I6?V
M[_GV\]?-_P"^<Y_2@#G(_ AMF\,RV>LW%O<:%;_9!((D87$/R@HP/3(0<CD<
MTC?#RT.E?98M0N8;N/4I=3M;V(*'@E=B2 ""&7D@@]1795B:%KK:W)J=RB1I
MIEM<-;6\Q/,ICXD?TV[LJ/\ =)[B@#.M/!+F\O-1UC6+C4]2N+-[))FB2)((
MFZA$7C)/))R3BI;CP7;W'@BP\,&[E$-F+8+,%&YO)96&1TYV_K6Q8ZYI.IS/
M#8:I97<L8RZ6]PDC+]0#Q2C6]);43IRZG9&^!P;87">9_P!\YS0!-?VBW^G7
M5FS%%N(7B+#J P(S^M<19_#K5;72H=('CG5UTV*(0K#!##&PC Q@.%W#COUK
MOZSX->T>YOC8P:M8RW@R#;QW"-(,=?E!S0!A7W@&R.G:);Z-<R:3-HCEK&6-
M!(%W*5<,K?>W G)ZYYS2Z;X):U\23:]?:S=ZA>W%BUE-YJ(B%"P8;%4#:!@\
M<]22:W;K7=(L6VW>JV-NV_R\37"(=V =O)ZX(./>I[B_L[15:YNX(592RF20
M*" ,DC)Z <F@#CK;X<"#P[8Z4==O&FTN?SM+O5CC66T & G PZXSG<.<_2M3
M2?"]U8ZE<ZMJ6MW6IZC+;_9XW,:Q1PIG.$C7C)/))R?I4^L^)[6S\'ZGK^F3
M6VH1V=O),IBF#(Y49QN7-2Z=JUW>ZE#$T5JMM)I\=UD39E#L>1LZ[<?Q>O%
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MZ$4 >=C5$L?A6VE:_87EQ=11/H\MO;V[R--(J%5*X!X=0K!NGS>M;'@_2O\
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MC3/!5AR>1@\8Q[FHYOAW:MX9CTNWU*[BO$OUU/\ M%@KRO=!MWF,"-I^F,8
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MYI9B-CHEA T4@E1TA4,K@$ YZYP2/QI/^$,\,C5_[6_L+3_M^_S//\A=V_\
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M  .O?-8EMI%OJ?Q+\;-/XFU/1RD]J MG>) ),P+R=RG./ZUZ/HWA?0O#V_\
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MF<\X]!Z5K_"B1Y?A=X?:1BS"VVY)SP&( _("NJM["TM);B6WMHHI+E_,G9%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO[)M["RN9;:WBO(G=[QHSAB65@$4D$#@GUH [VBO-T\>ZSKTWA>+P_;64/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[#M!$8(MT@0 MC]YV!%;=EXOBN=2TO3[C2]1L;O48YY(XKI$!01$ [L,<9W
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M-E=6WV:X: &X3:)@ #O3GE#G /L:NT >?OX#U!OA5J'A07-K]LN9)G67+>6
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MQ!,Q*AN,Y&>< UI:1X:NM/\ %USJ\DT+02Z;;V812=P>,L2>F,?,,5T]% '
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M ACMY=0NFF,"G@[ > 2.">OO4\/A+2X/"MUX<19?[/N1,L@+_-B5F9L'ZL:
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MV?/=L]O#<!1N8)TR&R<9(!Z"NML-%L]-U'4KZW#B?495EN"S9!95"# [< 4
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M/=Z=J=M<06^?.97QY7&?F!Y7CUJMIGC;PUK-T]MI^M6EQ.J%]BM@LHZE<_>
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M4 >F6OC/PW>QW\EOK5F\>G@&ZD$@"P@],D\=C^/%2:+XIT+Q$TJ:1J=O=O$
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3S@D=*R;6W\1^%[37=!L_#\^HI>7-Q<6%Y%-&L0$Q+8FW,&4J2>@.>U>DT4
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M$8EBD (#*1D'FH[;5+*\O[VQMYU>YLF1;B, YC++N7/U!SQ0!<HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@"IJD,MQI5U%!<O;2M$P69%5F0XZ@,"#^(KQ.QM-2'PT^'*V
MVIDW$^L0FW>:%2ML#'*,  #<!R?F)Y[XKW9U#HR-T88-<+I?P\N;'2M#TV?7
M?M-OHNHK>6O^B!&\M5=1&Q#<GYR=WMTH ;IU]KNB^-[S0+S6O[4@?2&U&":]
MC2(Q.L@0JQC4#8<@YQD8KDY_&NH6,.GZA;>,IM7O&NX8[RU@TW_0=KN%94E\
ML8 SPQ8DXZ<UZ'J_@V#6=>NM1N+N18KG1Y=)>%%P0LCABX;/7C&,5A7'P[UG
M4- L]%OO%2FSL&A:V6#3UCW>41M\SYSNX'0;><'G&* $\-65XGQ?\82MJL[Q
M(EHS0F.,*X9'VJ2%R G08.3WS7HE<P?#-Y:^,-0\066K&&*_MTCN;0VP<L\:
ML$96SQC=G&#G%:7AH:H/#=A_;4ADU+R@9W9%4EO<+\H.,9 XH YB3Q?<^'M3
M\7VVM3^<EA -2L"552\#+CRQ@#.)%VY//S#FJ5G>^*]4U32O#$^LO8W<>DKJ
M.IWD5O&96=W*K$@*[5"X.3@G@>]1^++'3_%_Q(T/3+4S/-IKL^K;8V"" %)$
MC<D8;=(J$ $\;C74:YX7N;W7;?7M'U3^S=5B@-J[O )HIH2V[:Z9!X;D$$=3
M0!QVJ>+/$6B:1XGTR;45GU'1[BQ\C4/(16EAGD489,;=P&X$@#.0>*Z[7]7O
MK+QMX3TZWGV6M_)=+<Q[0=X2$LO)&1@\\8J@_P .HKS0=<M-2U6>YU+67CDN
M;]8PA5HR#$$3H%7 XR<\\U);>#-7F\2:/KFM^)/M\^EF411162PQD/&4)(#$
M[N0<]., "@"?XBZOJFB>%/M>CS)#>M>6\*,Z!E(>55((/8@X]?2N9\0ZWK/A
M>ZTGP[=^)[J26^,US<:HFFB26*)0H$<<<:,.6)^8@X'X5W'BCP^/$NDI8-<F
MW"7,-QO";L^6X?&,CKC%5_$GAB36;W3]3T_46T[5M/+^1<"(2J4< .CH2-RG
M [@@CB@#@9O'.LV?A_Q5':ZC>7JV%DMU8:I=:<;=P2VUHW5D56(X((7D'VK2
MOI/&6G>(/#ME_P )0)&UX2I.'LX]EJR1^86A &>@91O+=B<UL77@6_U71=<M
M=8\1S75WJL*P&1(=D%NB\@)#N//J2<FMK4/#@O\ 7?#^IFZ*'1VE81[,^;OB
M,?7/&,Y[T <K9:UKVG#QGI5QK=K<3Z.L$EKJ.I*L2HLL>[]YL&#M(...:RM.
M\774'BSP_!9^*K[7;34)VM[H7.FB&$'8S!HY!&HSD?=RW%=1K7P]@UH^)S+J
M$D8UP6I&R(?N&@^Z>3A@2 2#CT]Z;+X,UG4=6T;4M8\2K<2Z5<B:*&WL1%$P
MVE6W#>3N((P<X'/'- '.7'BGQ&^DJ+'4(H;N;QC)I2RO;HRK!EP 5P,XP#GJ
M<=:Z#1[G6](^(?\ PCVH:U)JUI<Z8U[')/!'')$ZR*A *  J0V>1QBI%^'Z+
M%"G]I-^[\0MKF?)ZDECY7WO]K[WMTK:D\/B3QI;^(OM)!AL'LO(V==SJ^[=G
M_9QC'>@#%^(OBBY\/6FEVUG.;6?4KOR#="W:<P1A2SLL:@EFP  ,$<Y/2N>T
M[Q/>2W^H:0NIZCK.FSZ9/*MU>Z:]M);RJOW2?+165@21QD$5W'B?PVOB.UM?
M+O)+&^LKA;FSNXU#&*0 CE3PRD$@CO5&T\+:M)=7=WK?B)[V:6T>TBB@@\B"
M)6ZL8]QW-[D\4 <AX=\176C:7X,BWYL!X9FNYH@BY<Q)&1AL9'!/0TW5=0\:
MVGPU'C2/Q-BYN((KIK+[)$88HY"N%0E=VY0PY).>>*ZJR\"Q:?\ V'(]R;M-
M(TJ73C"8@/M(8*"?O?+]WISUZUYCJ0_M7P?'X6TCQ!JLS/)%%;:#/8;+BW D
M'RS28^X@!.>.@Y(H Z?QWJMY<V7Q'TV64-:6FF6CP)L4%2X<MR!DYVCJ>.U:
MMQ-XE\(S>'[V_P!=.HV]_>0V-Y9M;QHD1E&%:(J-P"G PQ.1[UIZSX#35W\4
M,=1:+^WK6"V/[G=Y/E!N>OS9W=..E)!X+U&;4-,;6O$+:C8:5*)K2V^RK$S2
M*,(\K@G>5!XP%YY- '%)XHN?#>B:O%9S?9[C4?%]Y:BY^SM.8$W%F<1J"78
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MQ'"&/"KV]@35FSL)-%^*/A(1^&],\.B[6[C>"RNO,>=%A+?O J*N <8.2<T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** (YVD2WE>&,2RJA*1EMNYL<#/;/K7*>#]!O;?5];
M\2:O8P66IZM)&#;12"3R8HU"J"X !8G)./;TKKZ* .;U'P#X8U;4);Z\TM7G
MG(,^V61$F(Z&1%8*_P#P(&K6L^$]#U^&TBU"P5Q:?\>S1.T30\8PK(00, <
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M\>;,\CRR/CH"[DL0/3-6+#0],TR_O[ZRLXX;G4'$EU(N<RL!@$_F>GJ:T**
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5RE_X"L;^:^!U/5H+*_D,EW80W 6&8G[V<J64-W"L
M:ZNB@!D420Q)%$@2-%"JJC  '0"GT44 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
G%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>separationagreement003.jpg
<TEXT>
begin 644 separationagreement003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHJAK6K0Z'H]SJ=PDCPVZ[F6, L1G'&2/6@"_1
M7/>&_&-AXGTJZU"S@N8XK9BKK,JAB0N[C!/K3_#/B_2O%EO++ISR!XB/,BE7
M:Z9Z'TQP>AH WJ*J3ZG86UP+>>]MXICC$;RJ&.>G!-6Z "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>A(J:F(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M (W(PR#@\]#4]>6V6K^)-=U#PEIL&N/91ZAX=6^O9HX(R[/^[RR97"DEL=,
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M9H_OQI(&9?J <B@#'O?"MMJ'BB36+F7S(I=*DTR2U*<,CN&)W9]L8QWK&M_
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M*ZE75T#HP96&00<@BN9U_P 5W%CK4&@Z+IAU/69H3<-$THBB@BSC?(^#C)X
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MUCY&S@@R!]V<_P"SC&*UFEC618V=0[YVJ3RV.N!0LT3,ZK(A:/[X##*_7TH
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M:9Y1CP"$<MOSGOGI^M=%10 4444 %%%% !1110 4444 %%%% !1110 4444
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M^'6@W.HL[W3VBEGD^\PZ*3ZDK@Y]ZL:CX'\,:OJ+:A?Z+:SW38WNRG]YCIO
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MDT,JE)(Y%#*RGJ"#U%86F^!O#&CW<5U8:-;0W$+;HY0"60X*X!)X&&(QTYH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
MV21(HVDD=41 69F.  .I-<?!\2]%F,$S6FJ0Z9<2B*'5)K0K:NQ.%^;.0">
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7*W_@E+G5+R^L==U?2C?8-W%9RH$D(&W<-R,4;  RI'2N
MJHH I:1I-GH6DVNEZ?%Y5I;($C3.>/4GN2<DGWJ[110 4444 %%%% !1110
M4444 %%%% !0>1@T44 <3_PK2Q-L--?6=7?0Q)O&DM,GDXW;MA;;O*9_AW5V
MP&!@=*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+:,_F-%'->"4!87D^ZI7'/53G(Z^U 'H5%(2%ZD#ZTBR1N[(KJS+]X Y(^M
M#J*8TT2#+R(HSC)8#GTIQ8 @$@9Z4 +12;ANVY&?2F>?$9?*\U/,Z[-PS^5
M$E%<O8^,DO?B)J?A$63(]C:I<FY\S(?=LXVXX^_USVJ/X@^-E\":';:D=/:^
M,]TMLL2R^6<LK'.<'^[C\: .LHKS)_BQ?Z7>62>)O!>HZ/974RP+=O,LBJYZ
M9  ^OK@'@UZ7))'$A>1U11W8X% #J*3<NW=D;?7/%-$L9D\L.N_&=N><>N*
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M-IX>8S-$<E-I5C^('->9:Y:VL/A/3O%.BZ*]@DNI;H-6N]4,M[<-N;.44;0
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MW/\ 9MG"N9;@O,Y54'8$<YZ 5N:-8S:$NJ^,_%MQ''?SP#SDA!>.RMTR1&N
M2V,DL<<GI6IK'@?PWKT5E%J.EQRQV*&.U17>-8E( PH4CL!^5+HW@?PYH$D\
MFFZ8L1N(C#*&E>0.AZ@AF(Q0!RGC2.2TUKP[XK35&U*T?48([;390/*'FC8)
M(MN"7 )8;MW4]*]*!!) ()'6N<TSP#X8TC4(KZRTL)/!GR-\TDBPYZ^6C,53
M_@(%7-*T&/2]:UK4D*[M3FCD95!&-B!<G).2>>F!C'% '+^.19:EXITC26T:
M;7;Y();I-/EN$BM F0OF2[@=Q!X48.,GBN.L+%_L'Q$T(W.G>'XQ+9A(H;EF
MM8'D4%DW84@/@*V .I KUC6O"NC>(9K>?4K1GGM\B*:*:2&1 >H#(P.#Z9Q4
M-MX)\-6EK?6T&D6ZP7\:QW4?)68+G&X$\GDG=UR<YH XSPO!#H'CJQLK_P *
M0Z#J%[;2Q02Z7<*UI=A,,VY  0P'0D9YZUZE6#HW@S0-!O/MFGV++<[/+66:
M>29D3^ZID9MH]ABMZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_%5[/<-91YFBB9G E12K9"YS]T\$XKI?"L-AJ?CR+4;#5/$6LK9V;H;^]")
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M02N=P89X.*YC4;6[U'1/$NMPV-S%9ZIKMA+:1/$RNZ1O$K2[",@,03R,X&:
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M<J/FY YP,=:F3Q3XOO==U#0K'1])^W:?;V\UQ--<N(0TB9V+A<DY!P>!@<T
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MMM!RG!)]PO![96F7/B=?B'XVBT2PTV27S;-YY;R=UC#?9EPBA5))//)P!^-
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M79 J,#QV8'ZUH7'B;3+-=4DO))+:'3&1;B66)@F7 *[3_%]X#COQ5C^VK/\
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M6T.WGS),A6<GGYC@#C%4H/$.MM\)-#\9OJDGV[3G=KF&1]J7T8E:(QL!QO(
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M@^H)8M]0#6W?>'Y+OXM6>FIK.IV\,7ATF6>*?$\RBXX!DQD<D$D8/&*Z?4?
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M'L+CH8]PY)X]ZM2WVKQ:GK>GO;:/=Z_-X?N'MM3T5F5MJ_=61,G#%B"I!ZC
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MP^^K'25UO3VU$-M^RBY3S-WIMSG/MUHNQJ7_  B$XCS_ &I]@;;CKYWE\?\
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M @."N>XXYKG[>:+0/#.F3VUQHGB/PW%>QFVADC-OJ,<AEP-N#\SJ3SD G!H
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M>YLH)I9=5E@=I(PQ,8B0[>>V6/YUQ>FO?/;?#5VNM/A@&F3+;2:I$TD N 0
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M@#;A'<PK(H/KA@>:2VT?3+(J;73K2 K%Y ,4"KB/.=G ^[DDXZ5=HH S-/\
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ML23<I;()"3U.X#-%_P"'-#U6Z2ZU#1]/N[A,!);BV21E^A(S6G10 @
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MJ+73K*WL[<'(BMXEC7/K@#%6J** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *YWQ-XNL-!TG5)8KRREU*SM9+A;)KA1(VU2W*YW8_"NA;.TXZXX
MKPZ.RT"?X!:M>:K%:G5]MRUW-*%\\7N]L G[P;.T8]#Z&@#VJPN3>:=:W3*%
M,T22%1VR <?K5BLO1KNW32M+M6N(EN'LXW2$N [*%&2!U(K4H ANYC;64\X
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M-O//%:6HTZ.Z4,! 5;S"@;_;SDBN/CDM[:PA-JZKH5KX[B^QN#^ZCBQ\VT]
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MROM1C\837L?AB1O[1N5OWU99#/'&#A.1T0)C;C\* /9K[4;'3+?[1J%Y;VD
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M1$FKO:XM22=H.<[@I/&XKCWH W;#PKH&E(%L-&L;8"-X_P!U H)5\;@3CD'
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M*NM-M)=/4 +;/"IC4#IA<8&*T** *5OI&FVAF-O8V\1GC2*4K&!YB(-JJWJ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% %+5[NYL=(NKJSMH[FYB0M'#),(E<^A<\+]:MQLS1HS
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;PSXTMM"GU2YU>TU.RFFM3>[/-CGBVEEW*H!5@PZC@BL;7O^$K\,>$AXGO\
MQ+<-K2R1EM+"1FUD+N!Y"*%W9P<;@V>,T =MH_@WP[H%VUUI>DV]M<%=GF@%
MF5?[JDD[1[# K1U32;#6]/DL-3M(KJUDQNBE7()'(/L1ZUYQXP\4>5X\DTN;
MQ9<:!96NG1RN+>%97DF=V[%&. H&3[BN\\,,C^'[:6/6WUJ.0%TOGV9D!/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'TRV%[J\US;30W<C8MI80=WS+U ()Z<C'3-74T;Q1X;U;6'\/0:9>V.JW)O
MMY.\+6T[ !R=JMO0[0<<'K]:ATKP#>:3=>$I!=PW!TR>\N;^5LJ99)T;)08Z
M;F[D<"@#3\,Z_K-QXBU7P_KT-E]LLHHIXY[+<(Y8Y-P^ZQ)!!4]S4?B[Q'KF
MF^(-"T30K2RFN=66YQ)>%@D1B"-N.WDC#-QW..E7K/0KJW\?:IKKO$;6ZLH+
M>-0QWAD9R<C&,?,.]&K:%=7WC;PYK,3Q"VTV.[6968AR950+M&,'[ISDB@#F
M[SQQJPUN70H[WPW87NGV\37]QJ$S+$\SKNV0KN5BH')8GN.*@F^*,K>%K2]B
MCT^WNI-3;2[JYGE+V=NZ@DOO7EE8 ;>GWN3Q5_5?"6HVOB[4==TS2]'U>+4T
MC\^VU$[&BD1=H='V-P5QD8ZBI$\.^*++PW;QP3Z/->&Z>>\L#:I%:3Q,,>2"
M$W#;QAB"3CGB@"*Y\8:]IO@O7M9NH=(O/L$:R6=Y8S;K>Z!ZC;N+*5[\\YXK
M=U[Q#<:3>>'(8H8G&J7RVTI?/R*8V;*\]<J.M<C;_#:\N]/\4K+;Z=H@UJT2
MWBL+!R\,;+D^8YVJ"22!\JCCU-7I-"\9:WJ?ARXU:/2+6#2+M9I$MYWD:?",
MI<90;>O"\]3R,<@''7KZFGAZ]_LZ2W0-XZD5_-W<M]H78/E/W<]1^5=?JOC7
M68/%$OA^*[\/Z?=VUK#(6U-I%6\D<$D0_,,*",9))]J9=>!M9_X1S4;>VELC
M?-XC;6;97=A&R^:'5&.W(.!V!JWK6C>)M1N'-YI&@:W97$$>+*]?9]BFVX?8
M_EDNA/.3AOI0!U^DW-Y=Z3:W&H68L[R2,--;B02"-NX##@CWKSUO&%SH^G:Q
M<:7HUD;@^*CIOE*603LVP;V.3ASD#/3CI78^"] F\,>$-/T>XN1<2VR,&=<[
M1EBVU<\[5SM&>P%<S)X%U5H;E!+:9E\6)K2_.W^H!0D?=^_\IXZ>] &EIFO^
M(K7QE!X?\0PZ8XO+22YMI[#S %*,H9&#DY^\"",?2MOQ'?ZGI^E>;I-E%=73
MRK'F>41Q0J3S(YZ[5'4#DU4OM"NKGQ[I&N(\0M;.SN()%+'>6D*$8&,8^4YY
MJKX^\-WOB32["*R6VG^R7L=U+97;%8;M%!S&Q /J#R",CD4 9FA^-=1E\72>
M']0N]#U!FLGNH[C2I&_=E" 4D4LV,YR#GMTK*@\?^+O^$)L_&EQIVD+I+>69
M[56D\\H7"%U;.T<G(4@\=\\5I:9X1UI?&-IK<MCHNF64=C/:?8+%B?++%2&W
M;%#$D8/ P .M+)X'U1_@Q%X0$MK_ &BL$<9?>WE964.>=N>@]* -NV\4/%XI
MU[2-46&".QMX[VWE7(\RW(.]CD]592#CVJWX2U:]U[PQ9:K?VZ6\EXIF2),_
M+$23'G/<KM)^M<7\3M.CUG7] L-/ODCU.\D?3[N&-@9#9.N^4D#D !!C/]ZO
M3(HD@A2*) D:*%50. !P!0!PG@F2/PQJ'B7PQ<.(K73ICJ%H6X"VDV7P/97#
M@UC:9X@?PWX.N/%]Q!&VJ>*=24VR7,GEHB/\L =^R+&NXGW-;WCSP7J'B2\M
M+G2;N&U>2%]/U!G)!DM'92P7 .6&TX!P/F/-:'C'PE_;_A^SL[#[-#<:=<17
M-FDZ;H2T>0$<?W"I(- &1I'CJ[7Q+:Z+J=WHFI->PRR6TVC2EMKQKN:-T+,>
M5R0V><'BJOACQWKWB.2QNK8Z!<P3S!;G38)RMY9H206;>V&*]QM&>U:6CZ!K
MLFN17UUI^AZ';00NBQ:?&DTDLC# <NT:[0O. .N><BL6[\$>(M:GT^/5;#0H
M[RTNHYI/$-LQ6YE5&!X0(-K,!@Y8J,G Z4 -TK7=2T#Q'\0M7U:2UEL+!XWD
M2(/O)$*F-4R< $'!_P!H^E36_P 1]1M)-,NM5N_#<]G?3QPR6NGW1>XM#(<*
M6RQ#@$@-@#';-7KWP3J6H:OXNM)VM?[%\0Q(WGJ[>=!*L:H/DQ@C*YZU#8^%
M_$CRZ;:W.E^&K&.UE1KG4+6)99+E5[+&T8"%NYR<=J +$WB/Q-KCZ[)H-GIK
M:9ILTMF5NF?SKN1!^\V$?*@R< D')':M#X7_ /),/#O_ %YK_6J*:!XJT*ZU
MFTT$:;-I^JW,EW'-=2NDEG))]_Y0I$@SR!E>N#6_X,T:Y\/>#=*TB\:)KBTM
MQ%(T1)4D>A(!_2@#E/"NDV'C'7O$6O:]:1:A+;:G-IUG#<H)([>&+ ^5#P&8
MDDG&:>EA;>#OBII-GHT2VVG:_;W'VBRB&(DEA4,)%7HI(.TXXJ]+H'B+P[KV
MHZEX7^P75EJ<OVBZTZ\D:+9/@!I(W4'[V!D$=1P:GT3PYK%QXG/B?Q--:&]B
M@-O96=F6:*V1CECN8 LYP 3@#% '/V'CCQC=>"1XQ?3-)&FQ(TLUHID\^2)&
M(=U;.U> 2%(.0.O-6+*\U6\^,\DT,UF^G2:'#,BD/N\EI&((YP'+=3TQCO6!
MX-T[Q;KWPGL]"A_LV/2[Z*2)K]I7\Z*$R,'3RMN&;&0#N P1FNV'AO4].\>V
M>JZ8EH^E_P!EQZ;.DLC+)$J.S*RX!#=0,$B@# \/>+[V?PSX6TSP]I6G6^H:
MG#-,(VW"VM(8W(9L [CDD #/4GD5>O/'&LZ):>(K/5[2Q.L:7I_]H6[V^_R+
MF(DC.TG<I##!&3[&JVE>!=>\/Z1X8NM/DL)=8T>":VG@DD80W,4C[B ^W*D$
M @[?7-2W_@O7O$%MXDU'4VL8-5U/3?[-L[:&5GBMX@2WS.5!8ECDX7C'>@"P
MOBKQ387N@7.L66EKIFM7"6RQ6[2&>V>12R;F/RMTP< 8]ZI?\)[KM_K.J6VE
M_P!@B:PO'METB[F:.\N54XW*Q8*-W4<$=.:Z+7?#E[J=IX8B@> -I>HV]U/O
M8@%(T92%XY.6&,XKF_$O@_Q'KT6HZ;>:=H&II<._V/5[D^7<6D;=!M6/EE[$
M,,X&>] 'H\YN6LI#;"-+HQGRQ-DJ'QQNQVSUQ7AEI/K0^%'A:XE6VNI?^$CA
M>T0,RM(WVB7(D8YZMW Z5[C86S66G6UJTSS-#$D9E?[SD #<?<XS7G6G>!_$
M,'AS2=#N#IWE:3K<5[#.DSYFA$KR-D;>&^8 #I[T ;>F^(/$-IXO30/$$&G2
MFZLGN[:;3]ZX*, R,'/)^88/'TK U?X@>(M!LDU35/\ A'8(_-42:-]H)O51
MG"\,&VLX!R0%QP>:ZC6O#=]J7B^SU6WN4@ABTVZM"X)\Q'DV[648QQM)ZCM7
M"R_#?Q#-X(;PY!I/ANQG5$$NII(SRW95@V3^[!4L0,DENX ] #H=$?6F^,GB
M1)9;-K-+6VW+A]PC/F[-O. <_>[>E=3XEU#5=/T^-M(L[>>>298VENI0D-NA
MSF1^<D#'0<G-9EOHNL67Q'N]9A6SDTS4;6&*XW2,)86B#XVC;A@2P[CO^+/'
MGAJ^\0Q:3):16EXEC=^?-IUZY6&Z7:1AB >03D9!'K0!CV'C[45U36M+NY]$
MU&>RTF34H;C3)&,?R'!CD4LQ!R0>O2HU\>^(;#P?#XDUBRTF.'4EMTTRVCE=
M6\R7H9G;Y57'S<=!Q[T1>"==FUR_U*2UT73X+K0Y],BLK-FVPLS!E);8 V3G
M) &., UJ:GX)N=2^'.C:&9K9-2TJ.UDB>13)"9H5 PPQDH?F'3H>G:@"OH_C
MF['BC3]%U2^T"_&HK)Y$^CS$^5(B[BCJ6)P1G#<<CI6MX^OH]/T&VEELK>\5
MM1M8Q'."5!:50&&#U&<CW%4=%T'7&\0VE]>Z5H.CV=JC[HK!%FDN7(P#O,:F
M-1R<#D]#Q6KXST*Z\0Z-;V=F\2R1WUO<$RL0-L<BLW0'G XH PAXD\8:MJOB
M"TT2TT>.+2+HPB6\,A,_R*P4!3P>3ELXY''6B'Q[J&M:;X9CT.QMEU36[=[@
M_:F8Q6J1XWL=N"WS'  QGOBMOP]H%WI6H>)9[AX634[\W, 1B2%\M5^;C@Y4
M],US6F^!]=T'2/"UU8/8S:QHMO+;3P22,L-Q%(<D!]N5((!!V^N: +FI^,]=
M\,:+=OKVFV7VT7<-I8SQ3>7;732]&)8EHPN#NSZ<&DT7QQ=GQ38:)JE]H-__
M &BDAMY](F)\N1%W%)%+,<$9PV>V,5'JOA#Q'XHTNZFU>\LH;Y;R"\TZQ&9K
M:W,6?E<E07W[F#<>F!5O1-"UMO$5K?WNE:#H]G:QN##8(LTEQ(1@$N8U**.2
M O)[\4 8,/C[QA+X'_X3+^SM'73(=QEMBTGG2HLA1F4YVKT. <],]\5HQS:S
M+\<&"2VALCH<<@1@^X1&5NG.-^X=>FT#O4D7@C4T^#4WA$RVO]HO!+&'#MY6
M6E9QSMST([5HR:#K%M\0;+7;06<MDVF)I]VLDC*\>V0OO3 (;KC!Q0!B^#_%
MDD>F^$(_[,LK+2M76XA46X8""X5V*J,D\,%;WS5C5/B-+I\&O7BVMO):6FH1
M:78%Y/+\ZY('F;V/"HI/7_9:BW\"ZE%\*['P^)[9-:T^07-K.&8QI.LID0YQ
MG&#@\=S3[CX>23?#C3]!6X@_M.SECOA/,F^*2Z#%W+CJ59F8?0_A0 FC^.;Q
M?$^GZ-JM]H%^-25Q#-H\Q/E2(NXJZEB<$9PPQR.E;GC?Q)+X5\/?VA#%$SM<
M10>9.2(H [8\R3;SM'?'M65HV@ZX_B&SO;W2M T>SM4??%8(LTERY& =YC4Q
MJ.O')Z'BN@\2VFL7FDA=$N;:*[257,=T@:*X0'YHGX)4,.X&1B@#DYM<\2ZA
MX4\0%9]#NXDT]Y;;5-.F)B)P=Z%-Q8.%R00<=/I5;0_$6NV/A+P;HEI!83ZO
MJ=DC0.Y<0P6\<2$O)W9N0,# )/:I-,\!WTFKZOJ4NG:5H*7NER6'V/3I"ZR.
MY_ULGRJ,CH !GD\TMIX4\46NF>&KU%TQ=:T")K-8?.<PW=N45#EMN4;Y01P0
M* +;^.K[P]+K-EXIMK4W6GZ?_:4,MB6$=S%NVXVMDJP; ZGKFKNFZEXW%UIL
M^IZ9IDMC>L!-%9LXFL@5R&8L<.!T. .3QFLV?P/J7BF?6K_Q*]M:3W^F_P!F
MVUO9N95MX]V_<S$+N;?@\ # Q5^QM/'%S<:7;:E+IUE:64BO<W-G,TCWH48"
M[&0!%)Y;DGTH Y/X>^*IFTFQ\+Z"EO/J@N;J>\><GR[2#[2_) (+,<C"CU!.
M!7K]>967PZU+2M TVXTY[&'Q+I]]/<+,"1%<1RRDM%(P7)!0J,X."HQ7IBDE
M06 #8Y .<&@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%'O$B%R2">A&<<B@#T*BO"X;?48/@M:^-F\0:S)KD$23I(]ZYCVB4+L,>=K
MKU)!)/?M7::GXAD\&>+M=DU&YEETZ[TTZC9I+(2$EA&V2),]-V4; [DT >@4
M5XQ/<:]#<^&_#>I'7;YI=.DU/48]/N D\LK/_JR[.I6--V,*1VI-2U#Q%I/@
MGQDBIK-C96\4$VFR:A<JUS"2X#IO5V8KT(R<X)% 'K>H:M9:7)9QW<WEO>W
MMK==I.^0@G''3@$Y/I5VO(_%/@NWL+[PFDNKZW=2W6LHLTLNHRYR8G)9 " A
MR.HQC) XIEQ?7OB#Q9X@CNK'Q1=VNG7(L[2/2+M8$AVH"7;]ZA9R3G)!&,4
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MR"0N%!'%=;96$WC/Q3XEDOM4U.UCTRZ6SLH+.[> 0XC5C*0I^9B6_BR,#&*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?3;PRM!*02J2 @9!P1N'?MS5&W\?>);K0M7U]=&T]-*TU;M27N&\V5XBV"H
MQM. #DYSFI=*\,ZC+KFFS2>#O#6APVC^;<3V\<4TD[ ?*(L(#&,\Y)S4]KX1
MU2'X7:WX?80_;KPWOE /\O[UW*9/;AAF@"O+XW\5VLNBR3^']/:#7#Y=E$EV
MWF0R%-R^<2N,8R3MSC!Z]VZCXJOGT+QEI?B32;&6YTJQ$[QV\SF"YBD5B!D@
M,I^4@UM:EX<O[J7P:T8BQI-PLESE^PA9/E]>2*SM?\(:IJ-[XTEMQ#MU?2H;
M2UW/C]XHD!W>@^84 /?Q3KDFOV_AS0=*L"W]DP7PFNIW6.)6++M(4$GH,?CD
M\5/IWC'6-0\-7<\.A++K5IJ+:;-;1S_N5D4@&0N1D1@$'IGM[U8TCP[?V7C4
MZK,(_LW]BV]CPV6\Q'8MQZ8(YKG-3\#:Y/H^J01QV\ZS^)7U1[)IRBWEL0/W
M3,!P21G!XXH U=/\7ZV?$[^'+Z+1)KV:RDN;66QN7:-73 V2@C<N<@Y'8=*Y
M;PWJEX/AUX<GUNSM;]9]?CCMW:>0NKM<R R,3CYE;H,D$=:W=$\):E;>.=,U
MI- TG1=-@M9[=K2S=2X+;2'8JH#9(Q@9QCJ<\5=/\'>(XO#&E:%<6MHJZ3KL
M-Y'<)<;A/")WD8[<#:0& QWH VO^$H\2:S?:K_PC.EZ=+8Z9</:N][<.CW,J
M??6,*I"@'C+=355_B)>:BGA<:!I44TVO1W.$NI3&+=X=H8.0#D [LX&3@8ZU
M):Z9XK\*W>L6^BZ;8ZE9:A>27MO+-=^2;:23EE==IW*&Y&WG'%1Z+X$OM$OO
M!NV:.XCTF*]^V39VEI)\-E1Z;MWX8H V?"WB+4M1U;6-%UJSMH-1TLQ%WM)&
M>*5)5)4KN (/RD$&E\1>([^TUNPT#1+."YU6\C><M<R%(8(4(!=L DY)  'Z
M4_2=$O+/QWXBUB41_9;^&T2'#9;,:N&R.WWA5;Q%HVK1^*-.\3Z'#!=7-O;R
M6=S9S2^5YT+,&&U\$!@R@\C!'I0!R_BWQ1KL_A#Q9HEW9V=IK%C9>;,\4SF*
M:V=6'F1'&=V1C:WYUVG@C2ETCPI9V_V#3[)V42/'8@[&) PQ) )8@#)KE[[P
MAK^O67BK4M0BM;;4]5TX6%G9QS;UAC7<?G? !8LQ/ P/>O0;&%K?3[:%\;XX
ME1L>H % '!0>/-=U.^U Z1I^DW,=C=O;-IKWA2^D"-M+A2-JYY(![=ZOZQXR
MOO\ A)KG0=%32TFLH8Y;NXU2Y,2*7&5C4*"6.!DGH.*Y_P 2>#=>UY;VSN_#
MVC7=[)*WV3Q LP@E@0G*%E5=Q9!QP<' JYJ7@B[LO$]SK$>@Z7XGBOK:&.>/
M4"B2QRQ+LWJS*PPP R.N10 ^;XF7DFAV$]AI,,VJ3:N='FM?M&8TF",<K(!R
MAPISCH3Z5MZ1XBUE/$T.@>(K.RM[JXLFNH9;.1FC=E?:Z#< <A2C?B?2L:W\
M%ZLMEH!>UTFVFMM<&HW%O81+%%#%L=0HPHWL,J-Q&3^%:OQ!\.:IKFFVESH$
ML4&M6,K-;RR-M&R1#'(,_1L_510!D2^*H];?0KV?28);6;Q&UIITID;(5$D4
M3C'<E7 '3%6QXN\3:K'J.I>'M%L;G2K&>2!5GN&6>\,9PYC 4JO((&>N.U6;
M_P 'R0V7@ZPTL1_9M$O8I)"YVDQK$ZDCU)+ _B:S[32/&/AFRU'0]#L[&XM;
MBXFFL=0EN=AM1*Q8AX]IW%221@\\9Q0!8O\ QO?W&O2Z/HT&FV\UI;Q37<FL
M7!B$;2+N6(*H)+8Y)Z"MSPAXF7Q1I$MR8%@N;:XDM+J))!(J2H>=K#[RD$$'
MT-<E?>"+ZQ\2W.L'0]*\5"_MX$N1?B.*5)XT">8I*%=K  D#&#TK3LTU7P;X
M2C?^S](%]=:BF^TLHA#%&LKA J[5&]E&.2,G'H* .VE<Q0O($9RJEMJ#);'8
M>]>=7_COQ'HMO9ZGJ^FZ/;65Q/'&]@+QC>Q*[!02"-K$9!*C\Z[W5;:XO-'O
M;6TN#;7,UO)'%..L;E2 WX$@UY%+\/-:F\*0:7;>%=$L;^!H7N-1-P));MD=
M6)5MFX;B,DL?;'.0 =C<>)_$M]XLUO0=!TS3F.F"%FN;V=U4B2/<%PJDDYS[
M #WJ/3OB#->67AB_GTY;>UU6[EL+HF3<;>X4LJ 'H0S(PS[BM?1=$O+'QKXG
MU68)]FU(VOD8;+?NXBK9';FN5O?#IT?X.:GI^KW,%K<P/<WT$P?(203--$0?
M7.T<>N* .QTW7Y=3\5ZQID,"?8],2)'N,G+3N"Q0=L*NW/NU9FM>)=<C\:Q>
M&=%TZTFDDL/MK7-U*RI$/,*G(4$GH, =SZ"K'P_TRYT_PG!/?KC4M1=]0O.,
M?O93N(_X"-J_\!K UJYUFU^,T4FCV4%ZPT#]];2S>477[0>5;! ()'7C&?:@
M"Q+\1Y-.T74O[3TZ--<L+V/3S:13_NYI9 #&RNP&$8'.2,@ U8TOQEJ$?B2P
MT;6UTAVU%7^S3Z7=&55=%W%'# $9&2&Z'&,5D7WP\U36](U6^U#[ NNWVHP:
MBEL^9;9!"H6.%R1\P*[@QQU;I5_0O#E\?$EG?2>$O#^@6EHCE_LT<4TT\A&!
MM=4&Q1R<]3TH QIO%OC#Q+\/M7UBVTO3+/338W2B5[F3SB4W*S* N!T.,GJO
M8&I/#%]>^'= \/:!HNB:2NL:I;"[)C=DA2%43,TQV[F<D@8'?O6YH_A74K+X
M17/AJ81?VA):7D*@/E-TK2%>?^!BHI_#6MZ;)X:UG2HK:YU#3-.&GW=G+-Y8
MFC*KG8^" 0RYY&"/2@"&_P#B#J6AZ9X@BU?3+9-8TBWCNE2"5FAN87;:'4D!
MA@Y!![]Z??\ B_Q7I-KICWNA:>;G5;];:UMXKILHK1LP\QBN 00,X!&,XK/U
MKP9XB\36'B74;Z&TM=3U*QBL+.S2?>L,22;SODP 6))/ P/>NJ\3:'>:K?\
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MNFZQ87;N&*K!<*[$+C=P#GC(S]1ZU=O;ZTTVTDN[ZZAMK:,9>6:0(B_4G@4
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MK6'N+-74(DPV8E0[<AAL7J2/:@^ ?M=]IE]JOB+5M0N=-N%GMC(8D5<=051
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M>V@N1<V$AD42V+@DCRV"_P"T?O9ZUT&I^)M!T66*+5-9L+.289C2XN%0L/4
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M5U:V][;26UW!%/!(,/%*@96'H0>#5&Z\.:'>V<%G=:-I\]K;C$,,ELC)$/\
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M61:Z%?-JGBR:ST;6X[2]\-R06TNHO)+-<2_-P=Q)4G=PAP<#.!F@#I/#GQ!
MT70#JFE:K#:WD4%NFJW"J8Y9BH&6^8N S=&8 '/O3M,\5)I%SXUO=8N[B2UL
MM42&"(9D8;HH]L<:^I9N .YK'N'U;Q)X,T;P@/#NIV5X#:+>3W$&R"W2%D9F
M63HQ.S 4<\\XQ4&N>$M7U.U\5-#8W#.OB"#4((E<Q-=1QQH&$;\8/WL$'J*
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MGAC6H]8,8G@L2D1::(DC?N#[% (P=Q') Y-6HOB%I3^&&UJ2WO8F6[-B;$Q
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M8+3)>X!C?";<_-EL<'BI_P#A8$$,.J)J&BZG9:AIUH;U[&01M)+ #R\95BK
M=^>*C^($>H+=>&+ZPTNXU'[#J@GFB@7+"/RI 3SQGGCU.!WJ#3H[GQ1X_77'
MTJ\LM*L]-DLU^WPF)[AY'!8!#SL 7J>I/% '0WGBFPM;?19D66Y&L31Q6BP@
M$L'4MO.2/E"@DFMNO*/A_I-Z?%\]C>?/8^$5EL;%R<[VF;<&^JP[%]MU>KT
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M2W<,T5KY#1NC*"A7<05(;KUK/TO5=6F^&FD^(4US3-"LTLO-N5_LT/&#D_=
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M=Q(5@NHYF 4XR=K?>4X)P1Q0!ZW5>[OK2PB66\N8K>-G6-6E<*"S'"KSW)X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH P?&?A^7Q/X6NM*M[E+>>1HY(I77<H9)%<9'H2N/
MQJOIOA_44\7#Q#J-S:M.^E)8RQVZ,%\Q9&<LN23M^;&#S6WJFIV>BZ9<:EJ$
MZP6ENA>61N@']3VQWKD9/B/+;6@U.]\)ZY:Z)P3?2)&2B'^-H@Q<+WSCIVH
M;<?#V:XL=60:BL-Y/KG]LV-PL>[R) JA0RG[P^4@^QK3TO2_%,NMPW^NZK9+
M;V\;(EEIL;K'*S?QR%R2<=@.F>M=+#-%<P1SP2+)%(H='4Y#*1D$'TQ3Z .;
M\<>';KQ/X?6PLKF&WN$N8;A))D++F-PV"!SVK$U'PEXL\46Z:=XDUO2QI)E2
M2X@T^S='G",&"%G<[1D#H,\5W]% '&S^&]?TO7]3U+PS?Z>D6J,LMS;7\3LL
M<H4+YB%".H RI[CK67)\-KJTM-$FL+^VNM2TZ[GO)SJ$),-W+,/G9E4_*1_#
MC.*]&JEJE_)IUJDT=E<WC-*D?EVZ@L S %CGL,Y/L* .._X0C6[S5-:U+4M4
MLY)M3T9]-$4$#(EN23MVY))7YB3GG)[#BM+4/!TE]X,TC2$O1!J&E"VEM;M4
MW*L\*@!BIZJ>01Z&M;_A)--%WK-L97#Z/&DMX=AP@9"XQZ_*,\>M7--OX=5T
MNTU&VW>1=0I/'N&#M90PR/7!H Y6S\-^([KQCIGB#7-1T]A8P30+:V<+JHWA
M?FW,223CGV ]ZU?%GAR3Q#96AM;O['J%A=)=V=P4WJLBY&&7C*D$@C/>M^B@
M#CK3PSK6H>(K?6_$E[8O-902PV5M8QNL:-( 'D8L222!C'0"M;PAH<GAKPEI
MNC33+-)9PB-I$& W)Y _&M+4=0M]*TRZU&[<I;6L332L 20J@DG Z\"LQO%%
MF-5T*P6*8MK,$L\#X "*B*QW<]2''3- %36/#VI7'C/2/$&FW=K']FA>UN8;
MB-FWPNRL2A!&&^7C/%5K+P;/:^ M9\.M=QM+?_;-LP4[4\\N1D>V[]*["B@#
MB'\'ZMIM]IVJZ#?6:7\.G1Z?=PWD3-#<(GW6!4Y5@<^O!K=\.:9JNGV]S)K.
MJ"^O;F8RL(T*0P#& D:DDA1ZDY-;5% '+^(_"UW?:Q::_HFH)I^M6L1@WRQ^
M9%<0DY\N1<@XSR"#D52C\*Z]KFKV%]XMU*QDM]/F%Q;Z?IT+)$TP^[([.26Q
MV' KM:PO$_B5/#=K9L+&XOKJ]N5M;:V@*AI)"">K$ #"GDT ,T?PZVFZOXCO
M)Y4FBU:X241A?NJ(E0@^N<?K7C^JWS'X;W7A[2/%5G-9OFVM-+>V(U/)? MV
M7?P >"VW.!7O5I++/9P336[6\LD:L\+L"8R1DJ2."1TXXKG$\4:(+&;7WM0E
MO]L%E!="(,]P2XCW*1SMWY )/09Z8H SI/".MV/BNXUS2+C2G>[M88)%U"!W
M: Q@C,94C@YR5XR1UJM9_#O4+?3(K6XU:*XE3Q&NMO.8BID&0S+@="3GVYKK
M8=>MYO%-UH"Q2BXMK6.Z:0XV%79E '.<_*:UJ .>O_#LMYXQLM<6X18[>PGM
M#$5.29"I!SZ#;7(/\.O$4>F>&M.@U32YK/1H@3;7<$C133@G$C!6!(4$8![Y
M/->H5E:SX@LM#DM$NV(-RSA3D# 1&=CR>>%Z#)Y^M ',:UX5\4>(K&U.IWVB
M-=V%]'>6L<=K)Y$FT,"LJLY)^\,$=,59T_POKA\:6?B35-0L6,-G):?8[2%D
M2-6*D%2223D<YQVP/5^N_$?1= T#3-3N5GFEU-%:SLK4+++*2 <#!P<9'.>_
M&:I^'?BC8:SX@30=0TG4]$U25=\$&H0[/-')^4^N >H[4 5M-^'^KVNA:/HU
MQJ5E);:1J\5];2)$RN\2N[%7R2-V7X(XXJZOA;Q-HMQJD/AO5=.BT_4;A[G%
MY [R6DDGWS'M(##/(!Z'UKN** .,TKP%'HNH>&'L[K-MHMI<0,)!\\S2[26S
MT'()/UJ>;1;_ $C4/%^OV=RAGU&VA-L@A:0QO#$R\J.6R2.!7644 5-,:[?2
M;-[]0MXT"&=1T$FT;A^>:XNU\+^,=%U76I]%U715M=2OWO=EW:R.ZE@!C*N!
MT45W]4=9U+^Q]'NM0%I<7?V=-_D6R;I)/91W- ',WGAGQ#->Z9K\&HZ<GB*U
M@DM;C,#_ &6YA9MP7&[<N" 0<GG-5]2\$ZYX@\-:O9ZQKD3WM_)%)%'#$?LM
MN(V#! A.6#$?,2>?3CG:_P"$STR(Z!#=K<6M[K:@VUI+$1(ORAB'[+MR >>M
M6XO$NF3^*I_#<4S/J5O;_:9D"'"(2H&3ZG<#@4 <V?"?B+4-;T'4M1OM*@CT
MFX,BV5C;NL;!D*L=S'.>1@8 '/6JTW@?Q':Z-J?AS1]8L(-"O3,8S-;LT]LL
MI):-2#M*Y8X)Y )Z\5Z)10!P[^#=5TZYTC5-#O[1-2L]-CTVYCNXF:&YC3!!
M^4Y4ALD'GKBDN_!NMZKHDL.JZU'/?3ZC!>$)&5@@2)U;RXUR3T7J>I-='KFM
M_P!B_8/]"GN?M=TML/*Q\A()!.>W&/QJC9>,(+JWT*XGLY[6'6-R1-(1^[E
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M8)[B)BDN6D.UP""/]8<X]*]&HH X:^^'\FJR>)9+N_6*75GM)H9($.;::!
MV#U&Y<X].*E3PUXBUC6-*NO$VH:<]MI<WVB&"PA=?.F"E5=RQ.,9)"CN>M=I
M10!R-CX.GM/!&N: UW&TNHM>,DH4X3SRQ&1[;JZ'1[%M,T2PL'<.UK;1PEP,
M!BJ@9_2J^E:];ZMJ6KV,,4J/IEPMO*SXPY*!\K@],-WK5H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>&>Y.;D6UPT:S_[ZC@_ABM6[\#Z!=QZ)$;/RHM$F6:QCA<JL; @C([\@=>M
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M?MI_VB:\N;9MZ0PO'M"LPXRS8^7KQF@#IM'\<>&]?U+^S]*U-+JZ\HS;$C?
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M)*!O616YVA@6&W.0<5Z%10!QVDQ3>"-,\)>&8K=+M)BUM-.)=I1A&TA8+C+
MD-Z8XS78TA52P8J"PZ''(I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR2[&A4G!<>IZ# YYSVJ2[\7ZC!=V.CVN@&YUZXMS=2V@NU6.WB#;=SRX[GH
M#WH ZZBL'PUXF&O/?VES8R:?JFG2B*[M)'#[-PW*RL.&5AR#QT/%9VO^,[[3
M?%">'M*\/RZM?R60O %N5A4)O*G)88&,#ZD@>] '7T5QTOC/4[J_O[?0?#;Z
MG'IS^3=S&[6$>< "T<>0=[#(SG:,T2_$&VN=/T230[";4KW65=K6U+B+8J?Z
MPR,<A0IX/7G@9H [&BN,?QZ]AIE[)J^A7EIJ-M<16L=FC"074DO^K$4F &SW
MZ8P<BK.G>++[^WK71M>T,Z5<WL;O9NETMQ'*4&70D ;6 .<8P1GF@#JJ*X#P
M=XLLUT[PS8PV%S#::LMU]GEGN?-99(W8E&)&3D;B#[8K0OO']G8/KI:SFEAT
MN>&T1HB&:ZN9 #Y2+ZC<H)SW]J .OHKE+#Q;?KKMGI.OZ$=*FOU<V<B72W"2
M,HW,C$ ;6QSW!P<&NKH **YW6-?U6UU==,T?P_+J,_D^?)-+-]G@0$X"[RIW
M-QT X%8S_$J.'PRVJS:-<K<PZH-*N;))%9TFW ':W1^HQTSGM0!W=%<?9^,=
M4.N'1M4\.-8WTUI)=62K>+*L^S&4+ ?*W(]1[T[_ (3VVD\$:?XBM[-Y9+^2
M*W@LM^&,[OL,><=5(;)Q_": .NHK/U[55T/P_J.K-$9ELK:2X,8;!?:I;&>W
M2N8M_'UZ%TN]U/PY-8Z/J<D<5O=M<J[HTG^K\R,#Y WKDXR,XH [>BN1U'Q7
MKD=UJ*Z5X4FO+6P8I+/<70MO-8+N/E*RG>!GKP">E/TKQS:ZMJ6B6\=I)%;Z
MSI[7EI.[#EE(WQ%?[P!SG/K0!U=%</J?Q'BL([V:+29[J"VU:/24:*0;II2/
MFV@C^%OEZ\GN*8OCO7/[;DT&3PA(NLF 74,*WZ-$T.2I=I,?+@@#&#R1VYH
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M$<XKD-(\+>(="T;PIJD>F&XOM'FOUN=/$J!WAGE8[D;.W<!M;!/.<<&O6**
M//1I&L^)O$&J:Y=:9)I<)T:73+*WN9$,LC.=S.^PD*,@ #)[FM[P$NH6_@O3
M+'4],FT^ZL8([1HY'1]^Q%&\%21@\^_%.UCQWX8T"]-GJ6L00W(&YH@&=D'J
MP4';^.*V;#4+/5;&*]L+J*YM91F.6)@RL/J* .%MW\1^'/%GBBZC\,W.I66H
MW,<EH]M/$&W+"BG<&884D8SU&#QR*P;GX<W]MI7AV]N],CUBXLYKJ;4=/BFV
M;OM#;CY;$@$H0."1GFO8:* .#\$Z"+37K[4X?"L6A6;0+!!Y\F^ZE^;<Q;#L
MJIP,#KD9S3?B#X5EU?5M$UE-*_M>&P\V.YL!*(WDCD ^9"2!N4KG!(SFN^HH
M \F7PC<W.B>*GTWPC'I N],>SLHI9MUU.Q!)W'S"B+G&!U[YJSK/A&[OKC4C
M?%+'3Y?"D=BUY+(H2*979CNYZ#@D],=Z]0J.>"*ZMY+>>-)895*21N,JRD8(
M([@B@#R7Q-J_B.\TCPO9:AH*6:?VO8++=?:XY4G8."/)"DD@XW9., =ZM:WX
M6\0S6/BS[#8"2XN];M+RS5Y5"R)'Y1+$YX VGKSQTKK],\ ^&])OH+RUL'\V
MVS]G$US+*D&1C]VKL0OX"NEH X0PZUXJ\6:'=WFAW&D6.CO)<2&YEC9IIF0H
M%38Q^49)W'&>.*Y4> -3'A?PK/>Z)]OFTB>]^U:69U1Y(II&(9&#;=PPK8R,
MYQ7L,\\5K;RW%Q(L4,2%Y)'.%50,DD]@!5#0_$.E>);)KW2+L75LLAC,@1E&
MX 'C<!G@CGWH Y7P5H M?$-YJD/A2/0K/[,((?/DWW4I+;F)P[*J<#CKD9SV
MK4\6Z5?:EJWA::T@,L=EJHN+@[@-D?ENN>3SR1T]:W]2U*STC3YK_4+A;>TA
M&Z25^BC./ZTD.IV5QJ5QI\5PC7=LB231#JBOG:3]<'\J .+LTUWP;J^O1VWA
MZYUBRU.]>_M9;6:-2DCJH:.0.PV@%>&&>#5'0/!FLZ5JW@^XN8DD>WDU*YU!
MXG&R&2X *J,G)&>./2O3:* ,G^V91XN&AFR(B:Q-VMUY@()#A"FWJ.H.3UY]
M#69XTTF^U5_#9LH#*+36[>ZGPP&R)0^YN3SC(X'-;]Y/9:;;W.IW1CACAB+3
M3E>1&N3R>N!DG\34\,T=Q!'/"X>*10Z,.A!&0: .+\0^&+S6_&DDGEE-/N/#
MUUI[W (^221UP,9STR?3BL.[M/%>K>!(O \OAV2VN3!'93ZDT\9M1$N 9%PV
M\DJO"[1@GVKU.B@#E/#NBWFG>-_%-[+ 4L[M;);60L#Y@CB*MP#D8/KBKGC*
MUO;SP])#9Z39ZL#(AGL;K&)HL_,%)( ?N">,BMJXN8+.$S7,T<,0(!>1@H!)
MP!D^I.*A74K-]5DTM;A3>QPK.T/<1DD!OID$?A0!YCI'A;4HIM:_L71M2T;1
M9](FMQIU[=J_FW+#Y2B;V" #(SD9STK9U+P[JL_PP\-Z3%:%KZS.G&>+>OR>
M44W\YP<8/0]N*] HH \KU#0=2NO$VLMK?AN_U_SI\Z6XO52SCAVC".A<;2#G
M)VL3V]SPKX2UW3K7X?17=AY;:1+??;<2(1&'60(1@\@Y'3UYQ7IE]?VFF64M
M[?7,5M:PKNDEE8*JCW)K$T?Q[X6U^^%CIFLP373 E(B&1G _NA@-WX9H A^'
MNDWVB^$H[+4(#!<"ZN9"A8-\K3.RG()'((-<M\2='N[CQ5I,.FR!&\0Q'2;Y
M0<-Y"L)2X'<A!*O_  ,5ZE63#X9TB#Q%/KZ6N=3F3RVF>1FVK@#"J3A<X&<
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M3 =B"S$LP '7 ':J%OX&\06FEQZ!:^+7@T*)@(_+MBMXD0.1&)@^ .V[;G%
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MXVC!)#@8(/3(/:M#2M"UY=;CU/7/$ NO(B:*&TLH&MX"6QEW7>V]N.,\#M0
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M5.UI,94#<.0,\G.>*Y;4O'FIZ9IPU./QI;ZCJ$4Z?:--LK 26>TR!603!,C
M/WBW)'O7H^F>$TL;3Q';2W;2QZU>37+;$V&(2(J%0<G)&W.>.O2N9N/AOKM[
MX/C\+7'B>WCTRV1$@-OIVUW"$%/-)D((&!G:%)(SGU (+6#4;7XF>.+M=5=D
MAL()3"8(\."DI12<9PF/Q[YI=(\0:_XC7PUHECJ":=-/H<>J7U[';HS$,0BI
M&A&Q<G)/!X'%='<^$;Q_%>HZM;:JD5MJ=DMK>6SVVXDJKJC*^X8QOR1@YQ[\
M4H_ 5WIMMH4^C:PEMJVE6 T]IY;;?%=0C!VNFX$?,,C#<<]: ,/6?%_B/P]H
MOBW3YKV*ZU/1TM9[6^\A5\Z*9P,.GW0PPPR!SD' K7:Z\3^'O%WAZWU+74U.
MUUB26":#[(D0@=8RX,97G'&,,3Q2W/PYFU'0M>AU#6?.U;6VA-Q>BWPD:Q,"
MB)'NX4 $?>R<Y-=%K/A_^UM;T+4?M/E?V5<//Y?E[O-W1LF,Y&/O9[T 8OQ<
M_P"25>(/^N"_^AK6QXBTG3]8\'WEIJ,$<ENUHQ)=0=A"Y# ]B.N?:G>+_#__
M  E7A34-$%S]E^UQA/.\O?LPP.=N1GIZUSUSX+\4ZM9-IVK^-O,TV5?+GAL]
M-2!Y4[KOW,0".#@4 85CXFU)? 7A":\\2VNBPW-G_I%S(@ENIF4 *(T92#D<
MLV">GK67J?B#4]?^'_CS3Y-8ENXM,2-HKR2Q$$EQ$\>XHZ%1CD?> &1R.M=[
MJ/@RXCUO2]7\.WMM83V%D=/2&YMC/%Y.01@!E*D8ZYY'%5(_AW/):^*XM0UU
M[N7Q%#&DLOV8(8G5"N5 ;!7!&%Z@+U/6@#&UGQ3?:+<Z%X9E\026C/8&\NM4
M6P\Z4KNVI&D:J5!ZY8CHOJ:W? /B>[UF\U?3;FZ?4([)HVM]1:T:W,Z.#D,A
M &Y2""0 #D<4LG@W6<Z5J<.O01^(+"![5[K['^YN82V0CQ[\C& <ANN?6MKP
M]HVHZ;)>W6K:S+J5Y>.K, IC@A"C 6./)V^YSD]Z ,K7M3UB_P#&EIX6TB_&
MFC["VH75X(5EDV;]BH@;*@DY))!X%</XYU'6W\(>,O#>IZF)YM,BM[E+M(%0
MW4$AQL=1PI##JN,X'3FO1-?\,W=]K=IKVC:DFGZM;0M;EI8?.BGA8AMCKD'A
MAD$$8K*F^';ZAHGB&'5-7:XU7741)[Q( B1*G^K5(\G"CZY.>M &1J.G:V_Q
M1T>RM=<\N[_L*83W[6R%RGG*?E3[@;.T<@C&>,U'=>.M:\.^'_$5O?745]J6
MG:E%86UX\&T,)55E9T3J5#'A1S@<5UVG>&;^+Q)8Z[J6J175Y!ITEC*(K;RU
MD+2!PX^8XP% QWZ\=*J7OP^@U!?$0GOY%.K7<-W#)$FU[62)5"L#D[N5SVZX
M]Z ,#1/&-W#XJTJP3Q!<^(+2_9HKCSM*:V:V?:2KJ0B@J2,$')&0<UI?#^[\
M3Z_'_;>IZXC62SW-NEC':(-X21E#L_4$8Q@<8 [DUJZ?X?\ $;:Q:7NN>)1<
MPV:L([:RMS;),Q&-TOSMNQV7@9YJ_P"%/#__  C&A+IAN?M.)YIO,\O9_K)&
M?&,GINQ^% '+>,K.^G^*/@EK;5)+56%V%584;85CRQY'.X$+STQD<UCZ'9>(
MYV\<76DZ^NF0VVMW;QQK:I*99 B$[R^<+C:,#!Z\]*[CQ+X:N]8U71=5T[4D
ML;S2Y)&0R6_FHZ2+M8$;A@XZ'-/TCPP=*M=?A^V>;_:U]/=Y\O;Y7F*J[>OS
M8V]>,YH Y:\\7WMWX8\,:E/X@L/#\&HVHFN90@EN'DVC"PQL",9))."1Q60O
MCW68?"7C62#5&OI=&\A[._FLA [K( <-&5 XY .T9!S716_P^U#23H%UI&LV
MZ7^E:?\ V<SW5F9(IHR0=P4."C9'9CZ4R?X:7=YI_BJ"[\0F>X\0I )9FM /
M*:/^ZH;E<8 '48ZF@!TMWXH\/>)O#HU+7(]0MM7G:VN+7[(D:P/Y;.#&P^;
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M81)#(5D0$8RK=01V-<>O@C6KZ?1X]>\0P7]EI-S'<P%++R[B5X_N>9(7/XX
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%4=4UG3-$MA<:KJ%K
M90D[0]Q*L8)]!D\F@"]15>QU"SU.T2[L+N"ZMG^[+!('5OH1Q5B@ HHHH **
M** "BBL*]\:^%]-O);.]\0Z9;7,1Q)%+=(K*?0@GB@#=HJEINKZ;K-N;C2]0
MM;V$':9+:99%!]"03S5V@ HJG!JVGW6HW.GP7MO+>VP!G@20%XL]-PZC-7*
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M :-%5KG4+.SM[BXN;J&&&W&Z9W< 1C&<L>W'K5A'61%=&#*PR".A% "T444
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MU!I%GX&T^QT34UU*RM5:+[4.-[[BS<=N6/'84 2_\+!\&_\ 0TZ/_P"!L?\
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MHGGM[^%V\F;:%+H5(SD 94]QUJ+3OA^=,D\,M%?^<VE75Q=74LB8:YDF1@S
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MX0[1YSL;HPSWP0:YU/"WB?1)=3M_#>JZ=%IVH7$ERHO(':2T>3E_+VD!AG)
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MJ-MK$4Y4P6A@-O)$H8@?,=RD''/-8FB^+=6O?#OAG3=*BT^SU+6;F]!F%O\
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M1110!%<6MO=H$N8(IE!R%D0, ?QJ0 *H50 !P .U+10 4444 %%%% !1110
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MLZ+%+!//?R3+MCCC)S&JYW%R %SC&&-=%X@T,ZT-*57$?V+4(;S=N8$",DX
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M\/\ BJZTDZ1X?EM;NWA9XMJP2O*&65P!\GF*#R?7FO62H888 _6E(!&",@T
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M.0( 2F_DY.!W[UW3*K## $>XJM?:?;ZBD,=R&9(9TG"AB 70[ESZ@, <>H%
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MQN!P>< X/-9^M>$O$/B'1?%VHSV"6^I:O%;V]I8>>K&.*)P<N^=NXDL< X&
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MDM7B4KA1*2P<E3W&X$=A5^WT3Q-X8UFRUF&V_MZ6;2H;'446=8Y3+'DB52Y
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MI<7;01EUM[9"\DA[*H'<URV@3:UX6TOPGH&J*+^ZNVEAN;DW.6AVJTBC!&7
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M,B@#2US6-9MM2M].T71/MLTD3327-S*8;>)00 "X5LL?[H'3FN'\1>*9]?\
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M&*3<,ET9RPQU'WA0!FR>-]8O7U*ZT+P_#?:7ITSPR32WOE27#)]_RDVD$ Y
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M,3!0NW=@,$ P>YQ[U);>"[N[\*>+](OD$+ZGJEU=6CAP<;BK1/QTPR@XZ\4
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MPV[B6 /S9R">.E:NI>+[K7/%=W8_:?$%CIME:V\@71;)II)))D\S+N$;: "
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M>X@D8;6>-@ 2,X. ,X]ZW$@U?1_'-KH#^)-3O+/5M.N)#)<>69;>5"OSQD(
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0G2;>TGU6\N;A-4BU2:ZFP6FE1@V,=%7@# Z5KW6@177BK3M=:=UELH)H%B
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M**N!ZCY:T;J_L[*(2W=W!!&W >60(#^)K)\1>)5T2QTRZ@B2[COM0M[,%9,
M"5MN\$ YQZ=Z ,>/X>"UTSPU;V&LW%K=:!O6"Y$*/YBN,.&4\<COVI$^']Q
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M]I5F;%;AH$E6:(D$AD/0Y&<@TU_AI'-9^)(;G6[RXEU^*)+J>5$W*T><,H
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MK2[72K:.RNP1<1A?]=G^\3RWXF@#S_Q-X4T2R\->$+.VL(HH[[6K%;QD&'N
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M-MI\,7]GK(MIM'^I#_?"^F: /*/%?G:+)\1(]%3[+Y&E:;%&(!M\J++JV,=
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MA/,8$,RCLQ!&X>QS6S;V\-K;QV]O$D,,2A(XXU"JJCH !T% $E%%% !1110
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M7*N!A?D4XD!&WYL< 4 >LZ9J5GK&FV^HV$ZSVEP@DBD7HP/\OIVKG-.'BO\
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M!@ ?A4M%<9<ZYXBU?Q5JFD^'3IMO!I*Q"XGOHGD\Z5UWA%"LNT!<9;DY/ H
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MU,6)PRQ A@O'4]LXK6T>YTCS;W2])CAB&G2".>&"+RTC=E#8   Z$'CUK4H
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M8((Q5:X^'VJ7N@ZO+<ZA:_\ "1:C?0WYD1&^SQM"5\N,#[Q4!<9Z\YQ7HM%
M'$6N@>*+_P ::1X@UN72HH["&>$6MFTCX\P ;MS*,DD=,#  ZYJ&+P/J$?P?
MF\'FXM?MTD,L8E!;RLO(SCG&>A]*[VB@#CI?#6M0^-TUBQN;-;2?3$L+K>6$
ML10LP>/@J>6'#>E8EQX'\1ZS/I<>M+H)DL;F*9M9MU87DPC.0-NT!"V!GYB/
M05Z910!C:1?:G=:SK4%[%"+2VG1+22-&4LI0,P8MP2"1R..W4&MFBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$<D;VNIW#7=M?.%SE)2S ,,$\8STKK;GP%I%YJ6L74\EX\.KQ".\LO._<.0
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M":V(<;BT*[4W''(QUQBGWWA;3]0U6]U&9IQ/>:<=-D"L HB)8Y Q][+'G]*
M/.[I=:O--\+WUS;ZQK&CG0X&GM],OVBN%N"H)E<!E:3(Z<]<^M323ZCK'@G3
M%T._U;5H+;4)(]0M99_L=^Z*&_<ER0=R97/.6 ZUUT_@'3S_ &=)8ZAJ>FW5
MC9)8I<V<RJ\D*@;5<,I5L=>G4TUOAYHW]E6]G#-?07%O=/>1ZA'/_I/GOP[E
MR""6'!!&".U '"7>M+:^ /&<.FZAX@LKNUABE2PU-G6XL@2!E)"Q9E;!_B./
MQKI([23QCXZU^PU'4+^*PT>.VB@M;2Z> ,\D>]I'*$%CV'..#Q6L?AYI4VF:
MM:7MYJ-[-JL:175Y<3 S%%.552%"J!SP%[U:U7P99ZCJG]J6VH:CI=^T0@EG
ML)@AF0= X92#CG!QD>M 'G<NHZU<VUCH1UR_4VOBUM*-]'+B:6W\EFPS#JP#
M8R1U /45O0V=]H'CC5=!T?5;OR;GP^]Y +^Y>=8;D2;%<,Y) Y!(]JZ6W\"Z
M-:V>EVL"SHNG7OV]',FYY9R&!:1CDL3N.?PJY>^%],U'69M3NT>62?3WTV2)
MF_=M"S;B",9SGOGI0!YQX=N'T?7-#CUD>)](U*6003375TUY9:C(RD;=VXJI
M)Y7 &.E>P5R-C\/;"TN;!Y]5U>_M].<26=I>7 >*%E&%( 4$E0>-Q.*U=$TR
M\L+[69KFZEEBN[PS6\<DQD\I-BC S]T;@QVCH,4 <]KZS:_\1K+PU/>7=MID
M6F/J$J6L[0M</Y@C"EE(;:O)P".2*YFU1?#4OQ&BD\0W=LL<MFB:@ZFXG0-$
M J@=6?!" ]>A->B:]X6M->N+2[-S=V-_:;A!>64@255;[R\@@J<#@@UE1_#3
M0UTW5K*6;4)QJCQRW$TUQNE\V/E9%;'#9Y]/;'% '(6-Q/I?CKPP-/L_$]A:
M7TTL%S_;%X9%NOW3,#Y;2,0P(!SA?2LZ2#4'^&6M>*WU_6#JEA>7+69%XX2)
M4G(VE,X8'G[V>,#H*]%B\ V?]JZ=JE[JVKZA?Z?+YEO-=7"G:"I!7:JA<'/)
MQDX'-6#X(TH^$KWPUON?L-X\KR-O&\&1R[8.,=3Z4 <V+"?PYX]\)B'5M2N/
M[66Y2_6ZNFD24I#Y@8(3M0AA_" ,<5RFMWQN?#NL:WIMSXKU*]A,T\.M0SFU
MLXPK' 1#( R+C:<*V[!]:]?O- L[[5M)U*4R^?I9D, 5AM/F)L;<,<\?2N;/
MPNTDZ7/I!U/6/[&DW[=-%T!#'N)/RX7=@$Y +$9[&@#.@\_QIXO;3]2OKV"Q
ML=)M;D6]I</;^?+,"2[,A!(7: !G&:YN?6M;T7P_K>G0:KJ=]-+XJ32H[D2A
M[A(6C0[4+$*'P"N>/F)/!KI?$VD+8ZQIQ&E:^T-M8+;0ZKHDN;@@'F*5!C*\
M!@<=2>E+X/\  <$OA'6+'6;"XMX-4U)[V&"6<FX@7"A&9P21)E-Q.3R>>] %
M70AK&G>+].CT[2_$-EI=S'*EZNLWB3H&"Y21,RNP;<,-C@@UC:=->:'<Z=/X
MG?Q)I^H_:T\[6([IKJPNPS8"LH;;&C9 'RC%>AZ;X'LK/54U.]U#4M7NXHFA
M@?49ED$*-PP4!0,D<$D$D=ZIP?#32X4@M6U+5I=)MY5EBTN6Y#6ZE6W*,;=Q
M4'!"EB.* .SHK&TS3+RT\1:W?374KVMXT/D0O,76/8F&*KT0$D<#NN>_&S0
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M'GA739S!>:]8PRK(T3(TO*LIP0?3!XR>*O:KXCT;0[**\U+4K:VMYB!$[O\
MZS(S\N.6X]*X?PQ96SZ'\17>"-FFU>_20LH)90@P#[#)X]S6-X:O;72=3\#Z
MGKL\<&G/X86WM+FX8"..YRI8;CPK&/ !.,X(H ]4TG7](UU9&TK4;>\$04N8
M'#;=PR,X]<'\J36?$&D>'X(YM6U""S21ML?FM@N?11U/X5QGP^O-,U#QUXZN
MM(,;6<D]H1)$/DD;RVW,/4%LG/?KWI_B[5VM_B!IEC;'2-/O?[/EF35=4#,J
MH7"M'$NY07XR<GI0!IZ[\0]&T_P1>^)--O;6_CAS'$JRX#R]D/<'OC&:KR_$
MO1AXCT'3(;RTDAU.*21IQ)]P@A44#ON8D?\  37G;3_;/"OQ6==0BU$GR7-S
M!"(DE_=C+*H)&,@\Y.<9R<UV>HZQI;>/_ VH+J%J;*>SO8HK@2KY;N1$ H;.
M"<@C'KQ0!U5_XU\,Z7J?]G7VN65O=@@-&\H&PGIN/1<^^*FU?Q7H&@$+JNK6
MMHQ02!97P2I. 0._->?>&M6\/:3X%\0Z?XCN+2+45NKS^T[>X8"6=F=BI"GE
M]RE=I&<]J@\$:9+_ ,)?X7BUFWWW=OX2SMG7+1GS@!D'H0IQ^= '?WWCOPKI
MI*WFO643!MA4R<@[0W0<XPRG/3D5?O?$&D:=I*:K>:E:PV$@4I<-(-C[N1M/
M\6>V*Y3P?96TGB_Q[(\$;/)?QPN64'*>0GR_3D\5YYIGVJ'0OAI>-J5OIUE%
M'=QK>7=OYT,,Y8A-P+* 2H8*2>.: /9H/%WAZZT>;5H=7M'L(6"2SA_EC8D
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MO^#])U:[6-;B[MDED$0(4$CG )/'XUP>CZEH6E:1XWL/$<]M%?2:C=O<PW!
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M6RMH!'G8(HE7;GKC XS@?E5;7]:30=,-VUI<W<C2)%%;VR;GD=CA0,\#W)(
MK)TOQ==3^(H]"UC0KC2KR>![BV+3QS)*JD!AN0\,,C@T ;ZZ;8K(\BV5N'D<
M2.PB7+..C$XY(]:+K3+"]ECEN[&VN)(O]6\L2N4^A(XKA(?BJ9M A\1#PQJ*
MZ 2%GOC)'^[^;:2$SN90>"1[]<5NZGXOF@UV71M'T2YU>\MHEFN_*E2)(%;.
MT%G(RQ )"^G>@#I6AB>6.5HD:2/.QRH)7/7![9I!!")))!$@DD #MM&6 Z G
MO7&_"_4I]6\/ZE>3O<MOU>[V+<D[XT\SY4()XP.,=JLZCXUN(/$MYX?TO0+O
M4[^VACG;9+'''L;/)9B #P!CDG/L: .BL]+T_3V=K*QMK9I/OF&%4+?7 YIF
ME:3;Z/;2PVY8B6>2X=FQDL[$GH ,=AQT%<_!X^M[KPQ!JUMI5_-=371L1IZJ
M/-6X#%2K'.U0,$EB<8_*DM?&=]+J-[I%YX=N;/5XK(WL%N;B-UN(PVWY7!P#
MN(&#B@#IKS3[+48UCO;.WN44Y"SQ*X!]<$5(UK;M''&T$1CC(**4&%(Z8';%
M>>>"/&]])X2\+OK5I<276K7!MDN6D0^:=K/YF!T'RD8X/'I73ZCXLM].UR^T
MM[:5Y+326U1G!&&0,R[1[_+0!L6NGV5A&\=G9V]O&YRRPQ*@8^I '-.%E;*(
MPD$2>4I6,H@!C!ZA?3\*XVT^)"RZ#)KMWH.H6FFND1LI&9&>\=SA41 <Y)Z9
MQD<]*T=-\77$FMVVD:UH=SI%U>([V9DFCE2;:,LNY#PP'.#VSS0!AW7@/Q!J
MEDVCZIK=A<:9(0L]V+(B^GB#!A&S[MO8 L!VZ5W-SI>GWDL4MU8VT\D7^K>6
M)6*?0D<5RWQ-UK5=#\,13Z3%*99+R")Y(W12BF11CYO[V=N1TSGBLB;Q'K-K
M\3YK>#1[Z\GFT."7^SEN45(&\Q]Q9BVP'H,C.>* /1'L;22&6%[6!HIFW2H8
MP5<^K#N>!UI8;6WMSF&WBC.T)E$ ^4=!QV'85R]OX^M[CPU)JBZ5?F[CO3I[
MZ<BAI5N0VW9G.W'.=Q.,?E26WC._;5I='O\ PW<V>IM:/=VD/VF*1;E5(!4.
M#A6R1U_.@#I;;3+"SGDGM;&V@FE_UDD42JS_ %('-3);PQK(J0QJ)&+. H&X
MGJ3ZFN0^%VM:KKW@6RO=6BE\]]Q^T2.K>>-S?, OW0.F#CIZ5M6'B*&\\1:M
MHKPO!<:<L4A9R-LL;@D.OL""#Z$4 7Y],L+JU2UN+&VFMTQMADB5D7'3 (Q5
M?4=#LM2TD:9)&(K3<A\N)5485@VW&. <8XP>>"*YN/XBPW>GZ9)IVD7=Y>ZJ
M\ILK1&52\4;8,S,3A$/!&>3D4Y_B'!:Z1KD^HZ5=6>HZ-$LMS8.ZLS(WW61P
M=K*>>>Q'- ':$ C!&0:A2TMH_*V6\2^2"L6U -@/4#T_"LS5O$4.DRZ+')!)
M(=5NUM8RI'R$HS9/M\M3Z]KEGX<T6XU2^+^1"!\L:[G=B0%51W)) 'UH E72
M-,26:5-.M%DG!$SB!09 >NXXY_&G7&E:==H4N;"UF4A05DA5@0O3J.V3BN>L
MO&-U_:UGIVM>'[K29;\-]B>6:.1)64;BC%"=CXYP>N#S0OCVQ_X027Q0UK.J
MQ%HFLR1YHF$GE^7_ +V[ _&@#IS;0,D:&",I$0T:E!A".A'IBFFSM2"#;0X:
M3S2-@Y?^]]>!S7-7GC&Z_M>XTK1] N=5N[.-'O?+GCB2 N,A-S$;GQS@>W-5
M;OXDV,6CZ1?V>G7MX^IW#VD=J@"RQSJ&S&X)P#N7:><#KTH ZZ2PLYIVGEM(
M'F9#&9&C!8H>JYQT]J2YT^RO+9;:ZL[>>!<8BEB5E&.G!&*9I5W=7VF07-[8
M26%RX/F6TCJ[1G)&-R\'UX]:\O\ "OCS4M*\&37MSH>IZC8V5W<_;-0,Z91?
M.<_*K-N<*I&>@&,=C0!ZL+2V6U^RK;Q"WV[?)"#9M],=,5';:;96-O)!96EO
M:QOG*P1*@)]< 8-8FI^*KB&_@L-&T2ZU:XEMA=%D=88DC)P,N_&3_=&3WXJE
M'\1++_A&[C4Y]/O(KN"^_LUM.PK2M=9 $:D':<Y!SG&* .ETG3+?1M)MM.M=
MQAMT"*6QD^I.,#).3Q3Y=,L)[Q+N:QMI+F/[DSQ*77Z,1D5P4?B#5K[XI^'[
M&_TR\TDBRNWDMVN%DBF!V;6!0X)&&X/(S[UU_B3Q%;>&M/CN9H9KB:>9;:VM
MH #)/*WW57.!V)R>@!H T5L[5"A2VA4HQ=,1@;6/4CT)J00Q"<S"-!*5VE]H
MW$>F?2N8T[QC+)JYTC6=&N-)U!X&N+=))4E2=%^\%=3C<,C(/UIO@_QG/XPC
MCNX= O+32Y8/,BO)Y$Q(X(#(%!W<'/.,':: .@CTG38IGFCT^U25W$CNL*AF
M8'(8G')![U<KE]=\8/I/B*VT&TT>ZU'4+JV:XA2%T1<*V#N9B H[Y_#J:JP?
M$2Q70-3U'4;"[LKK3;D6EQ8G;)*9FQL5-IPV[<,'^G- '3PZ7I]M=O=P6%K%
M<R??F2%5=OJP&34T=M;Q1/%'!$D;DED5  Q/7([YKE;;QK=IJ=OIVL^';O2[
MF]1VL=\\<J3NJ[C&64_(^.QXZ\U7N_B;I5GX8T'7)+><PZO.D*QC&Z'.0[-[
M(1@T :3^#[67Q>^KS1VLEDVF)8"R> %05E+[N>,<XQBNA6")(! D2+"%VB,*
M H'ICTK-M]=BNO%-[H<4+L]G;1SS39&U3(6VIZYPI/TQ7*>)=;U#2_BCI$-E
M:7FH>?I<X6R@E"*S^8GS,6(4  'YC]!UH [>STVPTX.+&RMK4.<N((E3<??
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MD95BI1U.#G:1[4VV^($CWFDF]\.W]EIFK2K#97LLD9WNP)0,@.Y P!QG\0*
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MY LT:K)R@+G)S\@)X[YXS6#X>\;:KIFF>(9SH>I:K:6&K7IN;H3H!%&LA.U
M[9?:O.!P* /53#$9A,8T,H4J'VC< >V?2J\FEZ?->I>2V%K)=)]V=H5+K]&Q
MD5@W_C6)9M.M-&TZ?5K_ %"U%[%!$ZQA(#C$CLQPH.0!U)-7O#OB2+7TO(GM
M)K'4+&7R;NSG(+1,1D'*DAE(.01UH T[RQL]0A\F]M8+F+.=DT8=<^N#3A:6
MPM?LHMXA;[=GD[!LV^F.F*\S\;W.F_\ "SM-L]=URXTS2FTF23Y-0>U5I1*
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MZN7*G8#P,\=<@ =.:KQ^-/$%KX?O+&6:VN=;3Q -"M[QH=J,6"L)70'&0I/
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M=-8^&&L[[Q+<F[#_ -M2!POEX\G$0CQU^;IGM5#0_ [:->^';@Z@)?[(TQ[
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 (%4$D  GJ0.M+110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'L[)-BNT2-@RLS$*B'@@D\Y% ':45QC_ !%L[;1-:O+[3;RTO=&"&\T^389
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M/&(PON5D"-CV->IUC7OAC3]1\06>LW9N99K, P0-.WD*XSB3R\[=XW'GZ>E
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MY@DA@OKF$P2D8\Q1 JDCZ'(KI[V^M=-LY+N^N8K:VC +RRN%5<G')/3DBK%
M'A=CX3?3/#1\/W?A/7[[6(PUNK1:A,EA<*2<.6$H5%*GE< ]L5T]]HGB'3M7
MUR;0+3RIU\.6]K8R Y3S49\JI;J0",9]LUZ;5634;*&[:TDNX$N5A-P8F<!A
M$#@OC^[GC- 'CT^B7-_<^&[JST/Q3-<VFJ6MQ?7>L7#L416&X+&SD'GDE5P
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME6&2.X(-93?#V]N+.6>\U*&;5[S5K;4KN98BL>V$C;$BY)P%& 2<^M $)O\
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MN9K<S.C&1DPJ[@#G Z],'KFLJ+QUKL>@26DD=G/KXUXZ%%-L986;&[SF7.0
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M.[&[KT]*O3>"_$NHQ:'#>7NBVEOI%]!=I;V%LZK,8S_$2?EXS@ =3UXJQ=>
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MB^'-,U:P@NI=:U,7MY=3>85B0I# N,!(P23@>IY)-;5 !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !371)  Z
MJP!R 1GFG44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4T(BNSA5#-C<0.3CUIU% !1110 5&D$,<LDJ11K))C>ZJ 6QT
MR>]244 %%%% !1110 4444 %%%% !00",'D444 0V]G;6@86UM#"&.6\M N3
M[XJ:BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.Z!$J6N\^4'SSG;CKSC% '5T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<I?^ K&_FO@
M=3U:"ROY#)=V$-P%AF)^]G*EE#=PK &NKHH 9%$D,211($C10JJHP !T I]%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
0% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>separationagreement004.jpg
<TEXT>
begin 644 separationagreement004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHJAK6K0Z'H]SJ=PDCPVZ[F6, L1G'&2/6@"_1
M7/>&_&-AXGTJZU"S@N8XK9BKK,JAB0N[C!/K3_#/B_2O%EO++ISR!XB/,BE7
M:Z9Z'TQP>AH WJ*J3ZG86UP+>>]MXICC$;RJ&.>G!-6Z "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>A(J:F(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUN6X5;O2M5L%BMI%)P4@<)UZ;3O.>_6O7+BXBM+:6YG<)#"ADD<]%4#)/Y4
M4%\1:2_B)_#ZWL9U5(?/:VP<A..<XQW'&<UIU\[+XLTJ*S@\:?:93X@_MEK^
M6#[/)G[&_P"Z,.[;MXB"MU[5ZEJ^J:CKGC.R\.:1JKZ=9G3?[3GN[=$>25&?
M8BH7!"C@DG![4 =A=7EM9)&]U<1PK)(L2&1@-SL<*H]22< 5/7DWC32?$<>E
M:';ZGK[2E/$=K';7,,48D>-G&QI 4V^8ASC'RG/(->JP1O%;QQO*TKHH5I&
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MP:\ZTR*\E^*^MZBNI7<:_P!CV]Q]F>.,##>9MC;Y<@*>>N<]21Q4.B>(M?\
M$MGX2T>+56L[B^TM]0O[Z*&,RLJL$"H"-JDEN3CH.* /5:*Q?#UEKFGK>6VK
MZE'J,*R@V=R5"S&,CD2!5"Y!S@CJ.N*VJ "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEY;M<CK")5+C_@.<UC1^++>[U77]+LHEEO=)B1MKS*BS.R%PH/8# !)Z$^U
M%GP[H<VB6MQ]KU2YU*\NIC-/<3?*-QXPB#A% ' %5/$?A,ZQJ-IJ^G:E-I6L
MVB-''=Q1K(&C;DQR(>'7/..,'FM>'4432;:]U%H+)I(D:0-,I1&(!*A^AP>,
M]ZL"Y@,"SB:,Q-C;)N&TYZ8- '+:9X-O/^$@M]<\1:X^L7MHC+9HMNL$-ON&
M&8("<L1QDG^E+!X$MD\!7?A66[>2.X:9Q<!,,C/(TBL!GJK$$<]JZ:"]M+F6
M2*"YAEDB.)%CD#%#[@=*QO&WB1_"/A&]UR.S^V/;&,"#?LW[Y%3K@_WL].U
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MLY.2?E].<U9\+^([3Q5H4.JV:E(Y6<"-V!9=KLHW8Z9VY_&M:65((7ED8*B
MLS$X % '*7W@&SU)_$ANKN7;K4L$P,:[6MGB155E;G)RH/3VJ%O U]JDQ?Q+
MXAEU)$M9K:&."V6V51*FQW;!.Y]IP.@'I2Q_$*VN]$\-ZK9VF^+6M02SV/*
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M#=@_WAGIFKJ^!9KJ#7)M7UAKW5-5L6T\W2VXC2WA(/RI&">[%CD\GTINA?$
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M/ )XIHEY4,I(.Y<G# Y[5"W@1Y]'AM+S6[J[NQJD6IS74RYWNC!MBIG")P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUS<SV4D*PLUNX"$L!SGKVZ<\T ;6C>*K"WTNT::^O;W[=J\MA#+-$ PDWO\
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M7MSJ9OH%6U=DFA9H "K 88\'@<\'T- ':_\ "S=(6[CM9=.UJ&:X0R62R6+
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M;GP=+XFGMKV2R/F-&$MK>, !(MYY<G>Q"\\CGD4 >STV21(HVDD=41 69F.
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MV<J1\J8Y R#DBNHUGQ]*=<M](TFYTBR=K)+V>ZU>7:B*_P!Q%4,"S'J>< 4
M=_6=J<FD[[=-3N+9&BD6>))I@GS#.&P3S@]/< ]0*R?!?BL^)[2^CG%J+W3[
MDV\[6DOF0R< J\;?W2#T/(((KC?&K:6OQ>L3JV@3ZW;_ -AMMMH++[4RMY_#
M[.P R,^_O0!ZA;:A97K,MK>6\[*,L(I5;'UP:LUQ.AR:7::-JFI^&O!%Q87L
M:;5MI;%;)[DXR "<?+GOVK/A\;ZS8>)=&TW5;KPY=KJ4WV=H--F;S[9]I()!
M8[ER,$X'6@#T..:*;?Y4B/L8HVU@=K#J#Z'VI]>6GQA>Z58W1T;1K#[5=>+9
MM*\LEE61B&/FL<GYB5&3Z9XKT/1_[6_LN+^VS9?VAEO,^Q;O*ZG&-W/3&?>@
M":\U&QTZ-9+Z\M[5&. T\JH"?J34T4T<\2RPR))&XRKHP((]B*\X\$Z-IWBZ
M76/$VO64&HW<VH3VT"7<8D6V@C;:J*K9 Z$DCKFK]_IT7PT\-^)=:T4_Z,5%
MS#IKC]Q XX;8!R W4CIQQ0!W=%>=:AXU\1Z+960U:#0X+[6)PNGJT[I%;Q[=
MSM.[=2HP/EQDGBEL?B/]CN]4L]:N=*O&L].?48[K2)=T<D:<,A4DE7!QCD@@
M]J /099HH%#2R)&I8*"[  D]!]:$FBD>1$E1GC.'4,"5.,\^G%>2>*K_ ,6W
MV@:#>:M9Z7'87FJ6,@BMF?S;;,JLH<MP_H< 8)[U%X[U&YD\/?$.+3[:SM6M
MKJV2YG4,))T:-#DD'[W('IMS0!['5&36M*BD:.34[-'4E65IU!!'4$9J:P^V
MBQB_M VYN\?O3;@B//\ LYY_.O$]&U'PAITWBR?Q%X6DU!X]>OF:]_L?[0B)
MOZ&0J0,<\9XS[T >XQRQS1K)$ZNC#(93D'\:?7DOAO4T\&^&/%/BJ/3);/P]
M<3QS:3ISN%/S )N !(17<@X[ =*U++Q]?VNLZ3;:O>^'+R#4YQ; :3<EY+:5
M@2H8%CO4D;=PQ@D4 >C45YW:^*?&>K6^M7VFZ?I"VNEWMQ;+'.9/,NQ$Q'RD
M'"'  R<Y.> *L+XXU#Q#=:58^%;>T$]YIRZE-/?[C';Q,=H7:I!9RV1U &*
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M  E.FW;2K;K>6-RUK<?99?,A=@ 0\;=U8$$=QR.U=+0 4444 %%%% !1110
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MQV\A=%.>S$ GC':L3PAX=N=#M]<BOC!(+_5[J]0(2P\J5@0&R!SCJ.17344
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!E4?)N,BJS@\LQSUQBNOA^'^DQV\:R3WMQ<#4(M2ENYI0TT\T?W-YQC:!QM
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MY(+*RMKRRGDN&:>V\Q]K)YF=Q'&1DY ->E:_X6L]?GM+MKF[LM0L]WV>\LY
MDJ!OO+R""IP."#52V\!Z-%I.JV%R;J_;5AB^NKN7=--@87+  #;V   H K>+
M[VYM_$W@V&"YEBCN-1=)41RHD40N<,!U&<'FLOX6Z3#8S^*I([B\D*:Y<VX$
MUR\@*KL(8AB<MSRW4^M:MG\/+&WU'3;^ZU?6=1N=-DWVK7ER'$8VE2N H!!!
M&3U.!S6GI'A>UT76M3U&TN[W;J,IFFM'E!@64XW.JXR&.!WH W**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'U/Q7X
M?T6\2TU/6K"SN' *Q3W"HV#T)!/ ]S6Q7F7A6ZT*SF\:Q^(Y;**^.JW#78O"
MH9[8@>5][JFSI^- &GXZ\=#P_>:1IFGZCH]O>:@Y9IM1D_=P0A6.\@,#AB-H
M.<9KH/$&OIX7\)W6L:@T#O:VY<J'\M99 O"*3G&X\#J>>]>8>&8)?LGPM%W$
MW-Q?>4)A\WD^7*8@<]MFW'MBO1?B"@?X=>)!MW?\2VX(&,_\LVH RG^(EFM]
MX9D^UZ<NE:G:W$US=-,-L+1JAVALX^\Q!SZ5U6EZYI6M637FF:C;7ELI(:6&
M4,JD=0<=/QKSI8]-U;Q3\-&46UW;QV%TZ[=KH'6*+GTR#^1K)\7V]Q&_Q2AT
MN,QEK;3I)%A7JIW>:<#U0-GU% 'J>F>*O#^M7DEIIFM6%Y<1@EHH)U=L#J<
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M6XM(99)=1\EVD0-E/)0[>>W)KE/#4]M!9?":XO98HXA'>QF69@%'[I@H)/X
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MX>LM572[K6]/AOV( MY+A0^3T!&>">PJ35_$FB:!Y7]KZK9V)E_U8GF"%O7
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M<!Y0L2EBHZG QF@#JZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_#FAW5E#97&C:=+:P9\F"2U1DCS_ '5(P/PJ_!!#;0)!;Q)%$@VI'&H55'H
M.E<U?>-X%.EP:/I]QJU]J=L+R"WB98]L& ?,=F("CD#W/%7O#OB2/7OMD#VD
M]CJ-A((KNSG(+1$C*D%20RD<@CK0!K+:VZ7,ERD$2W$BA7E" ,P'0$]2!1<V
MMO>VSVUU!%/!(,/%*@96'H0>#7D_Q UC4]'^*.FW]M?7*:?ING1W=Y;)(WER
M1&X\IR5S@D+)G/\ LU;^-.LZA#H$>GZ/>S6L_E27]Q-;R%66&/"@9!R-SN@_
M T >AVFAZ18+$MGI5C;K"Q>(0VZ)L8C!(P."1QFI8M,L(3 8K*VC-N6,.R)1
MY9;[VWCC.3G'6L&]\3WEK>0Z7I>A7FK7BVJ3S,LB11QJ>!EW."QP>!FJB_$6
MT?P_#?IIEY]NEU Z6NG,46070)RA8G:!P3NST_*@#LZR&\*>'&8LV@:46)R2
M;./G]*RE\;_8].U>ZUW1;[2WTN$3RJVV594.<>6ZG:QR,8XQD5+I/BF_O-4M
MK'4O#5]IPNXVDMYS(DT9"@$ARA.PX/&>#ZT ;<&D:;;1PQP:=:1) YDB6.%5
M$;'@LH X//45.MM ES)<I!&L\@"O*$ 9@.@)ZD#)_.N*O/B+<6MA<:POA?4G
MT&W=EDOC)&C;5;:76(G<5S]#CG%:>J>,&M]7CTC1])N-8U!K<74B12)$D41.
M%+.Y !/.!UXH -7\(6^HZSX?N(HK2.PTR6X>6U,(VRB6-D("XQU;)SUYK:M]
M(TRSL'L+;3K2&R<$-;QP*L; ]<J!@YKSS6_&L]QJW@Z_L[+5%9[V[MKC3!\D
MCRK$5V,,A2 V#DG '-;T/CX):Z]_:FC76GW^BVGVR:T>1'\R+:Q!1U.#]TCV
M- '2WNCZ7J5K':W^FV=U;QXV13P*ZKCI@$8%5M5M-3@T46OAD:=:7"X6,7$1
M\I%[X5,<^G:J^H>*;?3]-T2]>WE==6NK>VC4$90S#()]AWK)N?'LXN-3?3O#
M>H:CI^EW#6UW<P21[@ZXWA(R=SXS[9[9H V_#OARUT#PM:Z$-MQ#%$4E:1!B
M9FR7)'^T23CWK2:QM&CMXVM8"ENP:!3&,1$# *CL0.!BN?U3Q>;;5(-)TG2;
MG5=2DMQ=/"C+"L,1. SLY&"3D!>O!Z5S?BOQY>R^!YKW1K.[MK^#4(K*]B=H
MUDM7\Q 5.3@A@P 9<_>!X[ 'HPMH%NFNA!&+AD"-*$&\J#D GKC)/%5+?0='
ML[][^VTFQAO'SNN([=%D;/7+ 9KCK;Q1KS_%+^SKK2KFWT\:.D\D+3Q,(27.
MZ4[3\W39@9/!(&#FKFF>/I]2%A>IX:U$:-J$HBM[Y7CD/S$A6>-2613CJ>G?
M% '816MO \KQ011M,V^4H@!=L8RWJ< =:K2Z+I4]G%9RZ9926L)W10/ I1#Z
MJN, _2LGQ];7MUX$UA=.N)K>]CMS/#)"Y5]T?S@ CUVX_&N1\;:IJ7BG1?#]
MCX?O;BTNM0LI=6,EM(58)'#E%)'9I)$'X4 >GS0Q7$+PSQI+%(I5T=0RL#U!
M!ZBECC2&)(XT5(T 5548"@= !Z5Y[>:_-XF/@&*QN)8?[3E&HW)A<K^ZBCW,
MC8[%V52*O7_CZ[MH-0O[7PMJ-UI&GO(MQ>>9'&2(_OLD;$,RC!YXSCB@#L?L
MT!NA=>1']H">6)M@W[,YVYZXSSBJDVA:1<ZBFHSZ58RWR8VW+VZ-(N.F&(S6
M+J'C5$N["QT73+C5[Z\M!>K%$ZQ+' >CNSD 9/ '4X-5+7XDZ?)I.L7]WI]]
M9G2[A+22VD0-+),P&$4 X)+-@<X/7I0!U$FCZ9-IYT^33K1[(DDV[0*8R2<D
M[<8ZG-+'I.FPZ<=.BT^T2Q((-LL*B(@]1MQBL+3O%\\FM6NE:UH5UH]Q>JS6
M;2RQRI,5&67*$[7 YP?0\UT-]>0:=I]S?73A+>WB:61CV51DG\A0 VVTVPLV
M1K6RMH&2(0J8HE4K&#D*,#A<\XZ5%;:'I%E?27UKI=E!=RYWSQ6Z+(V>N6 R
M:\X\#ZKK5EXCL)M<NIW@\66TEY;Q2N66VF5V=8E!^Z#"Z\>JUUNI>,)XM<NM
M(T70[K6+JR1'O#%+'$D.X95=SD98CG [=Z -FXT'1[N_2_N=)L9KQ,;;B2W1
MI%QTPQ&:?J.C:7K"(NIZ;9WJH<H+F!9 I]MP.*X.Z\;ZG?\ BWP=_9.G7ITW
M4(KF26%VCB9V4!2&#'(,?)/8Y&,XKTF@!D,,5O"D,$211(-J(BA54>@ Z4RV
MM+:SB,5K;Q01EBQ6) H)/).!W->5?%'4]6TOQIHMYIUY=)#I]G)?W%M%(P2>
M..6/>&4'!^0L>?2M+XN:U=CPE'9Z+>R07%W#+>?:('*LMO#&9"0PY&6\M?\
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MQAECW ;':N;U_7H(+KQ4=7\1:K9^);6[==)M;6X=8A'@>1A%^1MQ^]N]\XH
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MXS7JM% &1X6TRYT;PII.F7DWG7-K:QPRN#D%E4 X/IVK7HHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O)+SQ_<:AK>M1
M1^*8-"BTZ[>SM[<Z>;@SM'PSR-@X4MD +@X%>MUX]+X@T_1]4U9O#?C&TM+;
M4KAKB>"[TN>8P3-P[QD8ZXSALC- !+JFJ>+M:^&^L1W?]FS71NU:+[.'$<J1
M.)&&[DA@, 'H,'K7I?B:]U'3?#&I7FDVGVO4(8&>"#!.]@..!R?7 Z]*\TU#
M6M :#PW+8>-';4M$=V%UJ%E/.;CS$*/NX!S@G'/'2O1/%US9Q>%KLW>JW&EQ
M3($2]MPWF1,?ND;1GK0!R7@_Q7<:EK,4:^,+/58?)=KRRNK/[)=0,!D&- !N
M'4$'H.<FN=3XFZC>Z+-X@A\1VT%Q\\MOH1TYG5XU)PC2XSO8#J#@$]*LV^OZ
M1?\ B+2M5\1^*M/N3I>\P"STF>)YF92N9&.[C!)VK@9JM;ZQ9:9I;^'](\>Q
M6FAEF\I_[,G-W;1L22B2# [D!B,C/L* .NBU[6O%WB*33]%U :/9VEA;W<\K
M6RRRO).I9$PW 4*.>^?2M+P%J^L:M8ZNNN2027=CJDUGN@38A5 N"![Y)YYY
MKD+_ ,2:%;:Z-:\.^*X;:[EMDM;N.^L)YTG5,[') 5MXR><\YK+\'^+[*PT/
M7+7_ (2E8-0EUV:<7DM@\@FC)3+; ,+N /':@#VN>5;>WDF?.V-2YQZ 9KQZ
M_#S_ +.>K:K/\UYJJ-?W#_WFDE!'X!0JCV45ZY:W5KJNG1W-N_FVMQ'N5BI&
MY3['FO/-*\.RZO\ #35OA_-<BVO+!VL_-=-V8M_F128R,@I@=>H/I0!%I6KR
M>#_"?BG18QFYT>X*Z='_ 'DN3NMP/7YW*_\  :H>"K6Y\(Z#XUM--GLH[FQO
M(XQ<7\FR$-Y,8>1S^+-[GBNRU;P-'JGC72?$!O#'':*HN+4)Q<-&6:(DYXVL
MQ/0]JHZG\.FU&Q\10?VDJ/JNH17\3&'<L31A,*ZD_."4YZ=: ,?1O&EU_P )
MOHNF0>*XO$-GJ/G1S$6 A$+)&7!1U&&!QC!).*K:5XUUJ[U2&*]\2V>FZP;O
M9+H.I67D1^7OQM2;&6;;R""03VKISX2U_4/$6B:UJ^M69;2I)"EI9VC1Q%7C
M*,<LY;=R,'H,=.<U2OO 6O:MI8T#4_$-O>:*)@_G36C->E ^X)YA?;GMOVYQ
M0!G>(O&&JV?BG4["[\11>&UA*C35NK#?;W8V [GF(( W$@@$8QW-;'B3Q!?V
M<6D?:/$VCZ';7%MYD]U'B=YI<#Y8%8<IR3NP3TX%6M5\,^))[G4XK#7;1]-U
M(Y>WU*U:X-L2H4^4=X&WC.TC /UJE#\/KW0]0TF^\.ZE:K-8Z8NF,NHV[2JR
M!MV]=K*5;)/'3% &-8?$354\,:X5N(=4OK748;"PNY+9K=9C-MV,Z<8QN/3&
M<#US713V/BW3H;I;_6+?5]-EL9_/9[98)() GRE OWE/(P>1ZFJT?PVFFL?$
M$&HZV]Q/JUQ#>)=1P!&MYXP,,!D@@%1@>G!)ZU>3PQXBU"\6XU[7H)5@MI8(
M(;&W:&-VD7:9)07.X@=%X /- '%Z-?>*O#?PS\.>(/[7MI+&-+2)M,%H-I@=
MEC!\S.[?A@?3VKO]"UF]OO&?BK39W4VVG26JVZA0"H>+<V3WYJK<^")+CX<6
M/A07ZJ]JELIN?*X;R71ONYXSLQUXS27GA;7+?Q3J6KZ!K5K:)JJ1+=QW-H9B
MC1KM#QD,.=O8Y% ',/XWU]_!&B:G-<M:PW5[=1:AJ<%EYYM8TDD5/W8&.=H!
M8@X_&K+>/;O2O FJZPFMZ7KXCGC@L+J%2C9D('[^-1\I4DGCJ!VK5T[P/J^A
M>&])L-'\0M'=Z;-/)NFB+0W2R.S;94##)&X8(/!!/>HE^&QOK/7GU>_B_M'6
M&A=I;"#R8[=H>8V12220>22>>G% &3IOC:\B\0:78IXGCUV+47-O+MTTP-:.
M5)61> "F1@ALGD<URUS8ZJOP<\4N^L[XEUF0-']E4;B+K#'/;<Q5O;;CO7J=
MAH?BF75K*YUOQ%#);662L&GV[0?:6(P&F)<Y Z[1@9^E94GP\OI?#OB30'UB
M'[!J=R]U:L+8^9;NTOF$,=V'&0!V[T 5/%7B+6- UBQT[4?$$FEZ<;/>VL+I
M@E6>XWD%&X*Q@+@].<]:['PI?76H^'+6YO;[3[^9MP-UI[9BE 8@,/0XQD=C
MFLJXT/Q<+B"^MO$%DUTUMY%W:W%J[6LA#$B1$#@HV#@\G-:'A#PROA71I+/[
M0)YI[B2ZGD2,1H9'.2$09VJ. !F@#D([Z\T[6_B-=6%Q86UPEW9XN+]]L,0,
M" LWK@9P.YQ4&D>,+Z;QCIVC6?BR+7;?4H+A3-_9XB^S2(FY65E 5P>>.<?C
M6SK7PZDU6779TU)(I;^^M;Z /!O2-X$50KKGYU..G%6(_">NWGBO1?$&KZS9
MO)IGG*EI:6C1Q;9$*DY9RV[H<GCC&.] '+:C\2=:MO"/AV\A6,ZB)))-838#
MMBMW$<_'\)+,"*[C1]9N]6\8Z[!'(ATG3DAMTVJ#OG9=[G=[*R#'N:S;;X<V
MT7B#Q-?S7?FVVLP/"EML_P!0)1^^.<\[F /;I6IX(\+GPCX;CTV6[-Y<F5YI
M[DKM,KL>N,GH HZ]J ,CQ)J/B2Y\>67AS0]3@TZ*?39+J6XDMA,R%9 ,J"0"
M3D#GC!)ZU@7OCJZN-?U33W\5PZ+'I;BU4C3O/>ZE"@N[<$*N3@*.>O-=[)X?
M:3QS;^(OM "Q:?)9>1LY):17W9S_ +.,8[UDS^%M<TW6]2O_  SJ]G:Q:HXE
MN;:]M6E5)=H4R1E67!( R#D9% &%8^.-;\36/AO3M/>'3M3U,W)N[HPEUB2
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M@1@&XXYYQ4=K\0_#5Y?06L5[+BXE\BWN&M95@FDSC:DI78QR.,'GM4NK>.=
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MBSG&8Y%!&<'!X/((((P:NT %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR7%DN<,=X :/RQGD\<=?7W  #H*,#.<<T 4;/6+&_P!0O["VE9[FP9$N%*,
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MCU ]*L2QK-$\3C*.I5AG&0: /%=7AO;.?1-,O-%72_%<,T%KI>M63A+6Y12
M5<\$ H#^[())Z=:]LKA;;X>7*?V=9WGB2[O-&TVY2YM;.2! ^Y#E \O5@I]A
MFNZH XME;_A=L;;3M_X1QAG'&?M*UD:5XBTWP)K'BJPUZ9K9[G4I-2L\H3]J
M215XCP/F8,I&.O2O2Z, ]1TH \;C\37?P^^'?AW19=EGK.I>;*TMS&S1V2/(
MTA9U4$EAO "^O7I73>"-6\(6.E:B=+U>34+B)&O=3O989/-F('+ME1GH<*.@
MZ5WU,FB$\$D19U#J5+(V&&1C(/8T 0Z??6VJ:=;:A9R>9;742S1/M(W(PR#@
M\C@]Z\A$$MEIWB+Q'#$YGT3QA/>85?F> K&DRCZHQ/\ P&O8+.T@T^QM[*UC
M$=O;QK%$@_A51@#\A4] 'D-E9W U/P)J=S$RW>K:K=ZC< CE/,A8HI]-J!%_
M"LR]U^:_T?Q':S:V=)NVENHU\.Z;IR":4\@%B59FW\%G&!@GD5[C1@9SCF@#
MQ<RZ9;:9X/NY]:U#PY?C0(8HM615:VD "Y@D# @L#\V#CKU-/_M"/4O!UK>>
M(&NK6.#6I/LFOZ7;>0 -IVW3H0<*Y+*3@@_K7LI (P1D44 >9^#?$LL5[X@N
M+W58-9T>RMHYCKD-EY3.1NS&=@Q(549RO3/O7H]K<Q7MG#=0,6AFC62-B",J
M1D'!Y'!J4  8 P** /+M*U>S^']SKF@^)6GL;*[OIKNQU$(WE21R\E=Z@[74
MYZX[5F:' VK>)KU?"FJZ_?Z.=(N(7N[^YF> W+8";#)C)'/('%>R$ C!&110
M!\_6\EK-X!M?#5[XFUDWGEQVDOAR"P@$XD! *C,8. 1NWENG.<UZ1X9MS'\4
M?%S.K,ZVFGH)&')^1\\_@,UW.!G..:* /// FJV6A>$97U!VACFURZMXL1LV
M7>=@HP <#WZ5Z'110 44$@#).!10 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7#^!V)\6^.022!JB8R>G[E:[BO.;
M.'Q;X<\4^);FR\+IJ5IJ5XL\4O\ :,<. (U7&T@GJ* .KU_5M5L9[.TT?1S?
MW-T6S)+(8H(%49S(X5B,YP !SSZ5S#?$>]LK+7#J.CP+>:)-;"\6VN_,C,,I
MQYB-M!RHR2I Z=:@\2:5XA\0W.BW^I>&VNK"))EN]#CU%!B0D;)"V5608'0G
MC--\,^![J*^\617VB66E:5K5G###;6CJPB 616#8 ^;Y@Q(&,GJ<9H Z"7QO
M#'\1X/"0M2PEM?-^UA^!+AF$>,=T4MG/X5CO\2KBX33X['3;03:I=745E)>7
MGE0M% VWS"VTG+'HH!^M8"^!?%R^!FNBL)\7QZA'<QL)5P42(6X&[./]7N;Z
MFNDU?PO=67A_0M'MM L-?TBS@\BYLIMB2E@H"RQL_ .=V>AYZT =/X?U+4M1
MM9_[6TDZ==P3&(J)?,CE  (>-L#*G/< \&L[6?$VH1>(D\/:#IL-[J/V;[5.
M]S<&&&",MM7)"L2Q(. !VS5/X>>'K_0(-4^T6S:?8W-PKV6EM<_:/LB!0#\V
M2/F/. 2!2ZKIVM:1XW?Q)I&FC5(+RR2TNK59UBD1D8LKJ7PI&&((R/6@#G?$
MWB#5KJX\(W<F@7$&IPZU+;M8O)A9'$3@,LA !C.0=V.@/'%=9H'B;4KOQ'>>
M']<TR"RU""V2[C:VN#-%+$S%<@E5(((Q@BLE]&\5:KJ'AW4=6C@$EMJTMT]O
M&ZD6EN8F5$W<;V!/)'KZ"M9M(U"/XE7.NI KVAT5;5#O +2B9GVXZC@CGI0!
MU-<'X@\*:#&^L^(O&5Y]KMN#;[W>-;.(* %C ;[Y;)R.22*[#2I[ZYTNWFU*
MS6RO'7,MNLHD$9]-PZUYUJ]AXNOO&\VHWWA1=6TRRD_XE5L=2BBB0C_ELR$'
M<Y[9^Z.V>: -;PW;^+KOX8Z/ MZMGJTJXEN;Y#)+% 2VT[>\NW9][CKGFF?#
M"ZCT[X8I=:A>$Q6\]X\US.V20L\F68^O&:['2;F^O--BGU+3QI]VV=]L)Q-L
MP2!\PX.1@_C7):#X(-Q\.F\->((Y(A+=32R+!-@X-PTB?,O_  $T 8>E76J:
MG\6-%UF_:6"WO]/NFL[%N/)@4Q[68?WWR6/IE1VKU:O-W^&\L/CS1M1@U/6Y
MK&V@E\V6?5)'=7W(549.=IP<@<' S78:9K%Q?:]K6G2VBQ1:>\2QS++O\W>F
MXY&/E(]/0@]Z .2^)I:]U'0=.AL)=8$<DEY=Z/&=HGMU7;N)R =K,N%/WCQ6
MG\.SH']FWW_"/7=P;1KDLVG7 VM8.0 T>P\H,@G'3.<4_P 8:98WNK:0T.LO
MH_B)O-33;A%W"0 !GC=3\KKP#@XZ<5F> /M=UXM\4W>LK FN0-;VERMFN(&1
M4+(X)))9MQSGD  4 =5XBL]:O[*.TT:_AT\ROMN+IHR\D<>.?+'3=[G@=:\_
MT3Q!=>'?V<X=:@8O>0VC^6[_ #?.\Q4,<]<%@?PKUBN$T'P5-+\'X?".M*()
MWM7AEV,'\MB[,K C@X.#^% "0_"CP]+I2B_CGN=8>,&757N'-QYN/OJV>,'H
M!Q76Z):7MAHEG::C?_;[R&,)+=>7L\TCN1D\XQGGGK7(0:G\1+/2UTQO#-I=
M7\:>4NIC4$6W<@8$C(1O]RH%=5X<TV[TCP]96-_J$NH7<4>)KJ5B6D<G)//;
MG ]@* .6M)CKNN>+M6D.8=+232K-?[A$8>9OJ6*C/H@K ^"=T^EZ1+HUY,3'
M)9PZM;/(?^6<B[9!]%=#_P!]5O\ AVUDL]4\<Z 1^_GNGU&WR<>9'<1@9'T=
M&4UA7G@/Q$?!_A:VL!'!J=O9MI>H_O!\MM*H#D'/)4J",4 5O 5Y<3?$?7-?
MN!/(-3T@:C' H+,(O.98E4=R8T3\3727'CCQ!I::;J&L^'+:STR_N(H @OB;
MJ#S" K/&4 [C*@Y'X4^]\*ZLGB?5KG1REG#)X<73K&<.!Y4RL^WCJ  5YQ7'
MR^ ]4N-&T^*U\%6UGJ=M/;S7=_<WL<TUP4=2_EMDGGECN*\#&.: .SN_&VKS
MZ[J^GZ%H]E>'26"S13W_ )5Q.=@8^5&$/&#@$D FI-2\:Z@->L]#TO3+4:A/
M8I?.FIW?V?:&) C "L6?(.<<"L;Q9X:U#5]3U$7O@RRUDN<Z=J5M<I;2P#:
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MN_B("\GU-9<]MXFT;Q_K6LV&B+J6GWUM;1!$NDBDWQA^1N.,#<0<X/(QG!H
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MKNE<*6P,@=!R>35X'(R*\K\>Z/JVC_#WQ3%/K<VI:8]I&T"WA#7$4GF#<-P
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MT<T+C*21L&5AZ@C@U(3@9/2@#CKCX>VD^D7UDNH7,4T^KMK$-S&%WV\Y;<,
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M7)&< L10!/#I]K!ID>G)"OV1(1 (B.-@&W;],<5Q]K\.%T[3=*BT[7+RVO\
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MTDN[34;2XMHL^9-%.KHF.3E@<#%3O>6T<44KW$*QS,JQL7 #EON@'N3VQUH
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MY/JU[:PO#:[H(X4B#XW'"#EC@#)/X5>\2>'(?$5O;?Z3-9WEG.+BTNX,;X9
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
MB^KZ:L*^+M0M(=!\0Z.;N:34K>^#V]Y X W1I+CH,?*>/8U[17FVH^#=?U35
M3J-YH?@>XN<@^=-!,S-CIN]2/>@#$:2]U[XBVLMK:Z44?0;>?3K;6][;8WR7
M* 9RX. Q/.!6=+;?9=!EM;F^TZ;0V\5VZZA!8"06ULAYDC)< ;/,V$@$@;C7
M9ZOX=\6:_#'#JVF>#+Q(CF,313ML^AZC\*EAT7QC;Z3_ &3#IW@M-.*E#:K#
M,(R#U!7H<T 5;NRT6S^-'AW^S8K:&Z?3KHW$< "_)A/+) _X$,^@]J[PZGIX
MM'NS?6PMD;8TWG+L5LXP3G .>,>M>9V?@/Q5I?B'3]4TJR\(6/V2.9#';I.J
MR>9M&6XR2-O'/%=%;^%-2U#0-0T36K;0K6RN760+ID+_ 'M^YV(?C<<##=CS
MVH [6O"/"^HQ>#O#7A;Q=,"+.2"^T^]([XFEEA_'<K+_ ,#KW>LT^'M&;2DT
MIM+M#IZ-O6V,*^6&W;LA>F=QS]: /,] LWT#QIH\VH!OM;^'KN_OBH^8RR3+
M(_X@G ^@KF/$*$?"/^U+72?#^EZ7,4FLW>9I[]V,@(._ P_4GEB!D&O?6L+1
M]02_:VB-XD9A6<H-X0G)4'T) .*QH_ GA.*2=T\.Z8&G!63_ $9>0>HQCC/M
M0!Q6LZ3+<^,/$=YI#:!J[/'"FI:;J\;1R0 1\".7& K+STQG/-4H5MO$47A&
M^\/-IUK?1Z7(+71M;22>%H0P5BLG7<"N >25(.,5Z3JGA#PYK=Q'/J>BV-W-
M&H19)80S;1T&>X]C4NI^&=#UFS@L]1TFSN;>#B&.2($1<8^7^[P.U '-?#[5
M=.@T;5HGT^UT4V6I21721W6^V,S;23&QP%!W#Y1C![5V.HV[W>F7=M&^QYH7
MC5O0D$ U57PYHJ:0ND+I5FNG*P86HA7R\@Y!VXQG(SGUK3H \X\!:DEQ\-[?
M0;;5(=(US38_LMPDJ*SV\B-R3&Q&00,YZ<^U<QJWB+Q!=^%OB#8)X@CUF/3H
M+58KVU@2( .3YX^3.<+G//&*]3U?P?X<U^X6XU71+&[G P)9807QZ9ZD>U:-
MEIEAIUB+*RLK>VM "!##&%3GKP.* /*)-*N+:^\(3I-X3TY%OHA92:8DQEN(
MR/FC! .59<Y)XZ$D58T/P]I&H:)\0KJ\TZVN+A]5U"/S98PS*JC("D],$D\=
MSFN^TWP?X<T:_:^TW1+"UNCD>;% JL >H'I^%:,.F6-O#<PPVD,<=U(\DZJ@
M E=_O,WJ3WH PO U]%_P@GA=+FZ07-QIT/EK(XWRD1J3@'DX')JE\6_^25^(
M/^O<?^AK73)HNEQM8,FGVRG3U*69$8_T=2NTA/[HP,<=JFOK&TU*REL[ZWBN
M;:48DBE4,K#KR#UH KV>J:?)!;QI?VK.RJ JS*23CIC->-:F8M3^'_B36+'1
MM!M-(G:Z9KK4I&GO)I,L,C@;&+#Y06...*]4M? GA.RNHKJU\.:7#<0N'CDC
MMD#(P.00<<&I#X+\,-J,NH-H&G&ZF+&24VZDL3U/3J<G)Z\T >9ZSJ-QX:L]
M,U> LTOB#PTE@I!Y:\55\ECZDB1_^^:;H>GFTU^Q^&N6>#3-6.IL3R#:K&LJ
M ^QF<#\*]<DT32Y;6RMI-/MG@L722UC:,%86084H.Q Z8Z5*NFV*:F^I+:0B
M^>,0O<!!YC(#D*6ZXSVH \7OK.+3=!UG5([?0O$?AL7TUQ<-*7M=0BD\W++Y
MF,EE;@="1C'!%>QWEQ/+X?N+BQ1Q</:L\"L/FWE,J"/7.*I3^#/#-UJW]J3Z
M%I\E\6#F=H%+%O[QXY/OUK<H \GT&S\%Q_"C0]1U*.+?N@D>YA&;HWA<9PP^
M<OOR".N,]J70/#NCZAI?Q"N[S3K:XN)-6OXS)+&&8*J@@ GI@DGCO7>Q^$?#
MD6LG5X]$L%U$MO\ M @7?N_O9]??K6A#IMC;Q7,<-I#&EU(TLZJ@ E=OO,WJ
M3WH P/ 5]%_P@/A=+FZ07%QI\(C61P'D(C&< \G ZUNZMJMEH>DW.IZA,(;2
MV0R2.>P_J3T [DTQ-$TN,V!33[93IZE;/$8_T<$;2$_N\<<5+J.FV.KV3V6H
MVD-W:R8+PS(&5L'(R#[@&@#A=$9_&&O6/B+6[BWM;:V8OI.D><I=688$TV#S
M(0>%_ASZU=^(B*O_  BI50"WB6S)P.I^;FM>U\"^$[&[BNK7PYID-Q"X>.6.
MV0,C#H0<<&MBZL;2^\C[7;13^1*L\7F*&V2+T8>A&>M '$^*H_$D_C*PEA\-
M2:KHVGH)X4CO(8@]R<@.X<Y.P?=&.ISV%5?A)JDZ>!YGU*S&GV<%U<,MU-<(
M4<M/(6'!^7:>,GKVKTBL;4O#.GWWAB\T&"""UM+I'5E2$%5W'+,%Z;LDG/KS
MS0!L A@"""#R".]>&W,,.A/=MJUW?Z'XVC::6WU5=TD.K#<2B8Y5QC:OED C
MC'I7N,<:Q1)&@PJ */H*\\\1^%_%VM6.JZ%+-I-]I=].9(+R[+":S4D' 15P
MQ7G:=P]Z .WT6XO+O0["YU&W^SWLMO&]Q#_SSD*@LOX'-<MXP14\9>!@JA0=
M2G)P,<F!\FNSMXC!;10F1I#&@7>YR6P,9/O4<]C:75Q;3W%M%+-;.7@=U!,;
M$8)4]C@D4 >:>)-/AU+XTQQ3:Y>Z0J^'0PGL[E868_:&&TE@<CG./84[PG''
MHOQ4O=*L=7EUV*\TX7-S=W,BS3V[(^U4,B\;2"2%QQUKNM5\*^']=N4N=6T:
MQO9T3RUDN(%=@N2< D=,D_G5C2M#TG0XGBTG3+2Q1SEUMH5CW'WP.: .8\>D
MG6?!:R?\>QUQ"_IO$<A3]:Q/&6B?\)%\1KG2@<27'A681-_=D%RC(WX,%/X5
MV_BK0CX@T*2TBE$-W&Z7%I.1GRIXV#(WTR,'V)J[;V43W$&I7-G FI_9Q"\J
M#<RJ2&9 V,E=PS^% 'C&MZPWCCPAK6NR*0FE:"+8J1]V\EPT^/=0J+_P(UTM
M\PU+QG;66FZ+IMYJEIH\327.K3MY,43'@1QA3ELCEACC S7?#0=(6PNK%=-M
M1:7;M)<0B(;)6;[Q8=R<#-0:IX4\/ZW)!)J>CV5V\"[(VEB#%5_N_3VZ4 >0
M:1;6>H>#-;LY]6TVR"^+?]%:.!GL7E C*QE,G]TS9ZG'0UISFWM[GQ)HWB2P
MT_1KVYT0R3ZIHKR/"8 ^T%H<9# MUP21D9P*]0_X1O1/L5U9?V19?9;H@SP^
M0NR0@  E<8. !^0INE^%]"T2">#3-(L[6.X&)ECB \P>C>HY/!H \\TE9=!\
M5^&8]7T?0K@SK)!IVIZ*[1-M\O)\R+HRE1UR0"<BN9U<QW_PJU76++1]!L=&
MN?.DCGO96GOI9"YYS@8<MT^8X_"O9=*\(>'=#NVN]+T6QM+A@09880K 'J >
MP]A40\$>%A=SW7_"/Z;Y\X82N;=3NW##=NX)SZYH Y'2H;35/B6%UR.&Y9-!
MMGT]+D!E(8GSF4'C=G:">N*R[W3?"VH:UX4TW2H1/I"Z]>"2%P3#YBQ,S*@/
M!CW=A\O4>M>EZEX7T+6+.WM-1TFTNH+8!8$EB!\L8QA?08 Z5/%HFE0)9)#I
MUK&EB2;14B $!((.S'3()''K0!YGX@L+?3_$?CJTTZVCMXKCPF9GA@0*K2?O
ME#8'&<<5/KVHV<G@SX=Q)=1/)-J>EF-5<$L%QDX]N]>E_P!GV?VZ2^^RQ?:I
M(A"\VP;FC!)"D^F2>/>LJT\$^%["=I[30-.AE,BR[TMU!#*=RD<<8(!X[T >
M;ZOIHC?Q??V46@>(=*:ZE?4[:_#P7=NZJ-R)+CH /E/&.QI(9+WQ!\08IK2T
MTHHVA6LVFVVN;WV1."7* 9RV<!B>>!7I>H>#O#6JZB-0U#0["YN^,RRP*S-C
MIGUQ[U8U?PWHNOPQ1:MI=I>)%_JQ-$&*?0]1^% 'CUW80P^ =626XTNZMH?$
M<!2.SC?R+0F6/S(T+@?+DD_+D?,178&TTJ#XT!EM[6-!X<5XC'&N<B<@%,#J
M%  QSCBNT_X1_1SHIT;^R[3^S"NW[)Y*^5C.?NXQUY^O-1_\(SH?F:?)_9-G
MYFG*%LW\H9@ Z!3V% 'D%I;Q>'?#VCW\EIH?B'PY%>Q-::A:[[:_5S)A6(_C
M8$\C()P<BO4/B#_R3GQ)_P!@RX_]%FK$/@SPS;ZM_:L6A:>E]O\ ,$ZP*&#?
MWAQP??K6O=6L%[:RVMU"DUO,A22.1<JZD8(([B@#R[5M$TS1_"'@HZ?8V]O)
M-J^EF:2.,!YCG.7;JQR2<GU-&BV_AVYL_&\OBA+)K]=2N1=O=;?,C@ _<[2>
M0NS&TCOTYKTN;3+&X@MH)K2&2*V=)($9 1&R?=*CL1VKA];\*^(+W5[R==,\
M,ZDTCDV6HWT6V>S4CA<+&=^TYVG<#ZT <GX<TVSU4?"BWO[>.X@6PO9/*E4,
MI(5",@\'!Y^HJYK>G6=J_P 5K.WM(8[5=,M[A84C 19##)EPO0'@'(]*]'T#
MPO8:'I&CV?EQW$^EV_D0W+H-XR '(]-V.16B=+T]IKN9K* R7B".Y8Q@F90"
M K>H )&#ZT 5/"\=K'X7TQ;-(5A^S1D"$ +DJ"3Q[UP'A:P\.ZAX7\3W/B6&
MSEOOM]V-4EN54R1 ,0HR>5 0+MQ^%>DZ9I5AHMBMEIEG#:6JDE8H5VJ"3D\?
M6J.H>#_#FJZBNH:AH=A<W8Q^^E@5F..F>.<>] 'F7A6U-[J_PYGU:UCENY='
MNFD>:,%G"^7Y;,3R2%Q@GUKL?B[L_P"%7:UYC%4VQ;BO4#SDSBNN>PLY+V"\
M>VB:YMT9(92@W1JV-P![ X'Y5C>.=!N?$W@W4-'LWB2XN0@1IB0HVR*QS@$]
M >U '+:]9:+I^N>!&\-PVD5V]\$C^R  R67E-YA./O+C:<GO6'HFB:9'\'/$
M^K"QMSJ$D>J9NFC!D W2+@-U P.G3K7J&F>%]!T6\FN],T>RM+F;(>6&%58C
M.<9'09["K,>D:=%ILNFQV-NME,'$EN(P$?>27R.ASDY]<T >:7VI1^!W\/\
MBR13]AO-%6RNP.AE2+S8#]3AT_$5%+IRZ3HO@_1KW2H-2\0:G=37Y6]G,5N+
MDJ7D:7 .XKOPHP>E>H7.D:=>V$=C=6-O-:1E2D,D89%V_=P#QQCBF:OH>EZ]
M:K;:M86]Y"K;U69 VUO4>A^E 'CLCZE8^(O'4=K_ &9#J2^'-[Q:.K*B2 MC
M.>3(%/7 ZCBNNLK#P/9^'_"%RD,$;F:W&GS6BXEDF9<<E>6!YW9X]:['3_#N
MC:3(DFG:79VCI$80T,*H=A.XKD=L\_6H+'PCX=TS4VU*QT2PMKULYFB@56&>
MN/3/?% 'F5Q'+;3WOPNCW*EYJJR08XVZ=)F:0#Z%'3_@0KU;646/PYJ"(H55
MM)  !@ ;#6)H^@:I+XQNO$NO+8K<);?8;**T+,%BWEF9BP'S,<<#@ >]=5)&
MDT3Q2*'1U*LK#((/4&@#QO2)([VS\"Z7::/97^KQZ"MS&^ISLMO#&0JDA &W
MN2/3('>J%EI\]]I_Q$BM3I_VS3[NUO[==-4K EQ$F\[ 3U)0J?4YZ5ZW?>$?
M#NI6=I:7FBV4T%FNVW1H1B)>F%]!P./:K=AHFEZ6938:=:VOFHJ2>1$J!E4$
M*#@= "<?6@#QF;Q,MKKC?%%2YTZ>:;3$7DAHEMPT?YS1L/QKI-=T<Z'^S[>6
M=V3]J%B)YV/4W#N)"?KYC5WW_".:+_9$>D_V59_V=$V]+7R5\M6W;LA<8SDY
MJIXET2?Q VFV3&,:8ETMS>@GYI1&=R1@>A?:3[+CO0!IV=VDBQVTD\1O5A5Y
M80XWKD=2.H&<UQOQ,MK.6?PA)=PP.O\ ;\$;-*H(V%),J<]B0./85U,.B01>
M);G6P5\^>V2VPJ ?*K$Y)ZL>1],>]3ZII&G:W9&SU2R@O+8D,8IT#+D=#@]Z
M .%T/0M)U+XI>-Y[W3[6Z,8LHH_.B5PBFW&0 >!G _*N'@6ZD\,> [!/L3:=
M_:M_&8]1+?9BZ22>0CXZ_P 6T>H%>ZVNF6-C---:VD,,LP02O&@!<(NU<GO@
M<#VJN_A_1Y=)?2I-+M&T]V+-;-"IC))+$[>F<DG/K0!Q/A:QNK'XFWOGW.AP
M32::#=:?I22A20XV2OD;0V"PZY((XQ7I%9NC^']'\/PO#I&FVUDDAW.((PN\
M^YZG\:TJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "O*M&\3ZQ#\8]4L+Z]DET:XN7L;>)ONP3+$DJX_WAY@
M^HKU6O);_0M2FC\;WMM93B]M-8AU/3LQD><T4:'"<?-D!UX]<4 6_%_B75D^
M)OA_3=-O'ATZ"\@M[Y4Z2R3!V"'Z)'G_ (&*Z/4/']C9W=]!:Z5J^IKI[;+N
M:QM@\<+ 9*DEAD@$$A<XKDO[)U*XLO"^K3Z?<B]U'Q,NIW<9B):WC*.J!^/E
M"H(P<]#45[<ZG?:CK]KK$WB>.]%U+'I^FZ7 T4$\.,1L9E7!S_$S.,4 =O=>
M.M+CM]+DL8+W5)=3A-Q:V]E#ND:( 9<[B H&X#DCDXIH\?Z.=".J&*^#"[^P
M?8C;G[1]I_YY;/[W?KC'>N MM/@B\&^#EUK2==LS;V+Q_P!JZ;YJW-E)D H\
M:J6VMCJ01D=.<U<4:G?^#+I-?TS6-;TJ+5$^QW#HT%_' !_Q\!%4,2K9QP&(
M)/3B@#N-/\;:;=C45O+>]TJ;3H/M-S#J$01EBP?G&TD,ORGH3TJG:_$33Y[O
M3XY]*UFRMM1D6*TO+JU"0RNW*#(8D;NV0,UR>FWGB>WAU]?#EQK.L:9%IA>S
M?6K8K+]JW?<0NJM(-N3R.N!WK+O(IM2?PS/:S>+M6N(-6LY[YKVWDB@M@'&[
M]WL5203V#8 //J >BZGX^T_3]0O;2#3M5U$V 'VV6QMO,CM^,X8DC)QR0N2*
MP[GQV(?B';K:&_U/3;W08[JUM;&+S#([3-\^#@+\HY+$>G6FZ7JK^"+[Q+8Z
MCI6IW$EYJ<U_9/:6;S+=+( 0@900K C:0V.W:K>AV^J2_$JWU'4-+^QL_AJ.
M.18U)BBE\]F,8?&,@8XH U8/'^CSZ(FJ;+R-/MZZ=+!)#MEAG9@NUUSQ@D9Y
M/!K6O->L['7;#2)O,%S?12RQ$ ; L84MDYX^\*\SU'2=4&B^*9XM-NY6A\5Q
MZ@D*1'?-"GDDM&/XNAZ=<&M9M4E\2?$CP_J&GZ3J)T^UL[Q#<75J\*-(RI\O
MS#(Z 9(P<G&<&@#8M/B/I=W+9L-/U:+3[V806VI2VV+>5F.%P<[@">A*@59U
M+QS8V.IW5A;:;JNJ2V8!NVT^V\Q;?(R Q)&6QSA<FO.K);O3FLD\)P^)M*U8
MW2+/H-S%)-8Q(7_>?.Z[53&2&5N>,"K3:=_PCWB/Q&NKS^++<7E_)>V;Z/YK
M17"N!\N$4XD!&WYL<8H Z/5_'[#Q#X131XKJ]TO51++));P!O.41MM5<D$%6
M&YAP0!]13=(^(3#4?%LFM6]Y;:?I4P\N1[< 1J%3Y#@DEV9L@=P1TK%AT^;P
MW!X OFT34X+2SGO&N;==UW+;F=&V[RJ@\EN>.,XJ>>.2&_\ '^EW?AN]U07L
MJ7<5N$9([F$1QJVR4 C>,$@#G*\4 =CI7C*VU+5X]+N-,U33+R:)IH$OX GG
M*N-VTJQ&1D9!P>>E9?Q4O-6M/"]HFB7TEE>W6I6]JDR'D;V*_ETK$\*27T/B
M[3[?0+_Q'=Z$T<IU"'6K=PMKA?W:I)(H;=NXV@D8S71?$6TN;S3=$6UMY9VC
MURRD<1(6*H),ECCH!W- $47C*5_A.OB,+G4#:>6(L<F[SY6S'_77BLSP5XMF
MTKX?+>>);VXO[T:E-8H8T\R6XD$A5411U)P?RJ"#0M23XC2:$;.8>'UU Z^M
MQL/EERN/*STR)B7Q[5FP?V_H_@J)((-0LX9?$-R;Z>WM#)<0V[2.0Z(5)YX^
M8 X!R* .YL?'-K>7EW82:1J]GJ-O:F[6SN;=1)-&#C,>&*MR0,9[UC^%/B$)
M?AW9Z[K\=TMS+)Y*A+?FZD9CM6%5^]Z?@<^M9/AJUD;XIVU_;+XANM.?29H1
MJ&K+)\\GF(V%# ;!CIPN3G&<5A6NEZC<_#OPQ$=/UJ*?PY?G^T(((GBN K;P
M7A)'SD;@?ESP30!Z=8^-["ZDO+>YLM1TZ\M;9KMK6]A"2/".KI@E6&>.#P>M
M9T7Q2T231YM9>QU>'2HUB87LMIMBDWL$^0Y^;!/./0XS7-6NGV^J:I>WFG0>
M)K]+;2KF-;[59)%4.ZX\J.-T#.3C)(P!@=:NZII=Z_P-T*P2QN&NDBTT26XA
M8NI62(OE<9&,'/I@T =1I?CBQU+6XM(ET[5-.N;B-I;7[?;>4MPJ_>V<GD @
MX.#CM7)S>.;G3])\+MIK:KJ<-]JDL4T\ENC2R(KR@QCG ;*@#_97K71^(K2Y
MF^(O@NYBMY7@@-]YTJH2L>Z$ ;CT&3P,]:XFUM+_ $KP/X/N[C3+]AI_B">X
MN8H[9WE2,R7 #; ,X^9>W<4 >GZ;XCL-3?5(T\R!]+F,-TLZA2N%#!NOW2#D
M'ZU/HFKV^OZ+::K:I,EO=)YD0F7:Q4]"1[CD>QKS;Q_9W\/B>*'25=8_&-LF
MFW+ 8,;(P)D(Z_ZEI1_P$5ZI;6T5G:PVMN@2&%%CC0=%4# 'Y"@#E?AWJ=[J
MNC:E+?7+SR1ZM=PHS]519"%7Z 5HZWXLL]%OX-.6TO=0U&>,RK9V,0DD$8."
M[9("KGC)(R>E</X.\3+X7M-5T_4-#\0&9M6NYE:#2Y9$9&D)4A@,'(IFO6Q/
MC>+Q-=?\)'::1J.F1QK/IR2++!(K$[)HU4L 0V>G6@#LU\>:(?#MQK+O<11V
M\WV::VDA(N$GR (C'UWDD8 ]<YQ3+'QS:W>J?V9<:1J^GWKP/<00WENJFX5/
MO!"&()&1P2#S7#K%JNF^&-3U31+#7+<7VJ0">ZO!]HO&ME&UKA8F7*G&  03
M@9XJ72K9I_B;X<OK(^);^PCANDDU#54D";V08"JRKL''7: 20,G% '=-XUTA
M?!T/BA6F>PF5#&B)F5F9@@0+G[VXXQGL:AU'QS96.IW.GVVFZKJ<]HJM=_V?
M;B1;?(R Q)&6QSM7)KDK+P[J:^/D\.O9RCPY8ZA)KD,Y0B-BP&R$'I\LK2-C
MT JE)IW_  C_ (G\1C5Y_%=NE[?->V<NC^:T5PKJ/DPBG#@C'S8XQ0!ZMI6J
M6>M:7;ZEI\ZSVEPF^.0<9'T/0]B.QKCOB%J.MW%YI_ASPS=O:ZI/%->R2Q@$
MI'$AVJ<]GD*+^!K8\ Z:=*\&V5N;"XL"Q>4VUS/YTD9=RWS-@<G.2,<9Q7,Z
M;X9U#Q1XJUWQ)<ZEK6BGSOL%DEOMB9[>/'S'S$8X9RS#I0!U&E^,=.N_ EOX
MJNYEM[,VPFG)S^[8<.N.I(8%<=2:I1?$*SDF6WET?6K.YFA>:SBNK4*;H*,D
M1_,?FQSM;!Q7#77A;6M-TOQ5X/LX;V_M_-@UC3YIEXGQ(K30EP N[<A(7CKG
M%=S:^+7U_5K*TTO1+XQ[7:]N+ZTDMQ:?+PHW@;G)P,+D8R<T 2?#CQ%>^)_!
M5EJ.H0S+=.I\R1X@BRG)Y3'\/;\*WM9EDM]#U":)BDD=M(Z,.H(4D&N%\!Z\
MGA[X:Z7;ZEINJ0SV<J6$\;6C*4D=R W. 4Y'S#CFNYUM'ET#48XU9W:UE554
M9))4X % '#?"#Q%JFJZ%<6>NW;W5_ L-TLTG5X)HPZ_7!#K^%4_!7BW4=2\;
M>(KW4K]ET0V?VVSC<X2& 2.@?\5CW?\  JR9M)U_2_"_A2ZTG3[G[=?Z,NAW
MBB)MUN7 ,<CCJNP[\D],UNOI>I:%XHUXZ%ISO]F\,P6]AOC/EO(A?:F>A/3B
M@#;M_B/ILTM@TNEZS:V.H2I%:W]Q:A8)&?[G.[< W8E14VI?$#3]/N[^)--U
M:]@TYMM[=6EL'BMR%#$$E@20""=H.*\VU%+K5-+T26*7Q=JM_#?VDU\ES;20
MP6V)%W_NPBJ2#P -V!DYXS6OXCBAM=?UNYMX?$^A:VTA:W?2HY+BWU([1L=E
M"%-W8J<8QU- '<ZAXVL+2ZM;6SL]0U6YN+47BQ6$(<K 3A78L5 !/3G/'2M3
M0];L_$.DQ:C8F3R7+*5E0HZ,I*LK*>A!!%><:U"\T^C7GBBRUO3-4_LN,/K6
MAF1F67.7@=(U; SR,@@Y(%=#X4UO6;+PK!/X@MM3NY)M0-M:O]DQ.8&;$<DR
M#&SC.3V&,T =9J>H0Z3I-YJ-QGR;2!YY,==JJ6/Z"N'T/0]?\6Z-;Z]K'BC5
M=/EOHQ<06>F.D45O&PRBG*DN<$$D^N*[76=-CUG0[_2Y6*QWEO);LPZ@.I7/
MZUYQ!J\%IX2@\)>-_#>K226D:0;K2UEFANA'@(R/'SD@ D''- '6:;J.H^&O
M#-]<^,KV%TL)6"7RJ 9X>-C,B]').W ZG'K3]+\;6>H:I;Z;<Z;JFEW-TC/:
MC4+<1BX"C)"D$\@<[3@X[5YJO@O4[CP7XCDT[1;[3[:?4;:]L=.EEQ<-%%MW
M#DDJQP2 3G.*V=+M;+5_%.B&SC\77_V24W$LNJRRQ16;!2!D.GSL<[=JGN><
M4 ;TGQ3T9;:>\CTW69[&UE>*[NXK/=';E6*G<<\],_+G (SBNVBECGA2:)P\
M<BAE8="#R#7FFF:9>Q_!GQ/9M8W"W4PU/9 8F#ON:3;A<9.<C'KQ77:)J!L[
M30=(ELKT32Z>C&40'RHBB*"KM_"WH* *'Q'U.]TGPU!<6%R]O,VH6L1=.I5I
M5##\0:Z\D 9)P!7$?%6&XF\'1FVM+BZ>*_M96CMXFD<JLH)(4<G@5;M/'4&J
M7'V.RT;7([J1'\IKO3988MP4D!G(P <8_&@"J_Q/TA+<7_\ 9VKG1C)Y?]K"
MU'V;[VW=G=NVYXW;<5L/XNTN*/7WF,T?]A#-X&49V^7O!7GD$=/>O'=<75==
M^'UW#<-XMOO$;QYN--6U>"UMR&R1M5 K* .!EB3CCTZ[QGHNHW/C"RCL;.>3
M3O$<5O;ZDZ1G$0@E63<_INC9TYH [&'QGI-QIFAW\)F>+6I5BM5"#<"59B6&
M> H4Y],5GVWQ(TJZDM9!8:K'IUW.(+?4I+;%O(Q.U<'.X G@$J!7.^$]"U.'
MQ[>VES92+I>@-=/IKR*525KI@XVMC!VKN4XSC=6):K=Z;]E3PI!XFTG63=*L
MN@SQ236$:E_WAWLNU4QDAE;TP* /:;BXAM+66YN)%B@A0R22,<!5 R2?8"N6
ML/B)IE[=6*-8:K:6NH2".RO;JUV07#$94*<Y&X#C<!FM/QAI5QKG@W6-+M"!
M<75I)%%DX!8J< GT/3\:Y[2_%L]W;:)I-EX=O_[05HH[V.[M'BCLT48=_,(V
ML1CY=I.?:@#)\.?$D66AW\VK6NLWZ6E_<I<WL-KOBMT$K;0S9&<+@_*#@=:]
M/AFCN((YH7#Q2*'1AT8$9!KS;2M-O8_A!XIM'LKA;J8ZF8X3$P>3<TFW"XR<
MY&/7BNJT+4#96'A[2)K&]$TNG(S2B ^7$41<J[?PMZ#VH V-1N9[33I[BULW
MO)T0F.W1@ID;L,G@?4UR'@/5=?U#7O%-OX@>(3VMQ $MX&W1P*T0;:#CD\C)
M[G/:NYKBM"T^^_X2SQX0)K3[7- +:Y:(XS]G5=RYX;!_48H R?%OB[4W\5:-
M9:++Y>F6^LVUGJ%PO_+:5SDPK[*HRWNRCL:T+Z74_$GQ!OM!BUF[TG3],LX9
MF^Q[%FN))"V#N93A5"XP!U/-<MK7@3Q/H^E^'-/LO$37D$.LV[J(]*7="Q+$
MSN0Q+8)).[@YY-;GBRWL(O$-E+KMAJZM'9!(]<T?SE>5\_/"ZPC*@\,,Y')P
M10!N^!=;N]3M]6T_4+E;J[TC4)+%KD*%,RJ 58@<!L'!QW%=63@9/2O-_"21
M>!_">KZY>:5=VEM>Z@;B.R2/?-#"=L:;P3][ W,2<C)SSFO0[FWCNK6:WER8
MY49&P<'!&#0!Y)X9UB^\0:FS1^+YX/$,=^[FQF9397-J)",0@#YUV#[P).0<
MU[!7B?B?3]1TCPG;:!J5K::AIT31VVC^(HFV-8-N"H9MH)7;P-R\' !QFO:8
M4=(8T=S(ZJ SD8W''6@#S]]>\3R?%#0[.[MET[1[D7BQ6_F!Y)_+0?O'QPHY
M!5<YZYJS</J?BKQOK.D6^M7NE6&C10*39;!)-/*I?+,RGY57'RCJ35O7K2YE
M^)?@^YCMY7MX(KX2RJA*Q[D0+N/09P<9ZUG27A\&^/M?O[ZROI=.UF.WFAGM
M+5YPLL:&-HV" D$@*1GCKS0!C:EXVU.+X>;;O5%L]5BUP:+<:BB*N-DOSRA2
M"!F-2<8ZDXK9\*7]K=#4YK+QO?ZU)!;,&MKJ)(FA/4/MV*W;&>G-4-+BU30/
M#4>LWGAMKPWVMS:G=6IB\RXLHY&.UT3G+J N0.1D^AJ="_BCQV=>TVPO(=/L
M])FM9+FXMGA:Z=R"J*K ,P7!.<=3B@"IX.T'7_$/@K3-:/CG78+ZZ@\S!\J2
M)6R?X2F2..F:ZSP)X@O-?T&;^TUC74]/NY;"\,0PC2QG!9?8@@_C7(>"/&)T
M'P)I.DS>&?$LNH6UOY;11Z7( 6R>-Q &/>MGPR)_!7A9[_7K6;[=K&K-<W,-
MLOF"WDG<!03G&T?*"?7UH [MW2*-I'8*B@LS$X  [UQB_$W2C';W;:;K$>DW
M$JQ1ZH]KBW.YMJMG=N"DXP2N.:ZO4GNH]*O'L8EEO%@<P1OT>3:=H/L3BO#-
M974-9\$(KR>+M2US,$EY9O:R0VULRR*SC8$56 P0H!8]#VX /4=0\?6%GK-_
MI%OIFKZC?V.PSQ6-KYFU60,&R2!C!QC.2<X!Q4DGC[1!X>T[6;<W-W'J3^79
MVUO"6GF?G*A.,$;3G) &.M5_#5I<0_$+QK<R6\L<-Q)9^3*R$+(%@P=I[X/'
M'2N*T73M2T32?!^NW&F7KP:5>:DEW;QP,9HTGD<+*(\9(&!G SALB@#J?#WB
MFXUSXEZC9A+ZUMK?2XF>QNX]C13&1LG'(.5V\@D8JQXZ\5WWAW4?#T%G:7<R
M7E\(Y_(A#ETVL=BY/WB0#] >:J>'KV36OBEJ.K0Z9?6^GMI$4$-Q<VSQ"<B5
MR2 P!'7&#@\9Z$58^(OG6[^&=22TNKF"PU=)K@6L+2NB>7(N[:O)&2/SH SK
M;QQ<6'C3Q98366KZHMM- T-M96_F?9XS"I8G) &6)XSD\X%=%+X\T1/#^G:O
M UQ=QZD=EE;V\1::=^<J$]1@YS@#'6J?A.VG3QKXSNY+::*&ZN;5H9)(RHD4
M0*#@D<X.1[&O/K?P]J5OX8\%:G<VVLPP:;-?QWB6"LEU"LLC;9 H&XCCG SA
MJ /5]"\4V>NW-U9BVO+&_M0K36=[%Y<JJWW6&"0RG!Y!/2MRO._!5E;7'B^]
MU>TAU^>".R%JFHZO,X,N7W%$C=0VT8SN/<D8[UZ)0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:'4;*XO)K2&\MY
M+F#_ %L*2J7C_P!Y0<C\:LUXKIY;1OC#JFO@D03ZP-)N_3;+"C1'\)% S_M4
M >Q7%_9VL\$%Q=P0S7#%88Y) K2'T4'J>1T]:L5XWXK9M7^*.BZD&)MM,UNV
MTN#!X,AC>68_K$O_  $UT/B3Q3KVFW>HLVK^&]$@MB?LEOJ+^9-> +G<=L@V
M G@#!- 'H=%>8W_Q(O'TKPM<)-I^BQ:S:M/+?W\;RPQ. O[L8*\DDG+$# JY
MJ7C/7-)\$)JET-*DF>_6U&H6S-+:+ QXN&526 [%=W7'- 'H5%<9X>U_6[VT
MU*47&C:_## )+.YTR41":3!_=.K.VPY YSC!K _X3W5]-U?1(;[6O#5^^HWD
M5I<:;8$^=:F0XR&\QMP4X!R!GM0!ZE47VJW^UFT\^+[2$\SR=XW[,XW;>N,\
M9KB1KOBOQ!?ZTWAPZ7;V>E7+V:+>1/(]W,@!<95E"+DX!Y/>L>:;Q)>_%:V-
MC;V>G:A-X:B:Z%YF9;;]^V5 0C><\#D#&3[4 >IT5YNGCO6H= F:[@L3J5EK
M\6CW#1JWE2*SH"Z@G(.UQP2>172ZKK]W8^-=#T:**-[>^M[J64D'?F((5"G.
M.=QSD4 ='17EWAGQYKGB"YLYHK_0'DEN/+NM$(:&[M4R03N=_G9>I&P ]J??
M_$.YN=>U>SL->\-Z/#IDYM@NK/F2ZE4#=P'78@)VYP22#]* /320" 2!DX'O
M1D$D C(ZBO()?$.J>+M>^'FL:;+9VJW+7@\J6-I0DR1NLG(8;EP"%Z>O.<4_
M3M7\0>'KCXB:N1:7_P!DN@WD1PN&:3RX]K9W'"*AR1C)P2".E 'KM([K&C.[
M!549+$X 'K7$>$/$FJ:SJ2#^V- UK3I(6=YM.S%+;/QA6C9V)4Y//!&.:T?B
M!H=_XA\'76GZ=L:=GCD\F1RBSJKAFC+=@P&* -2P\1:'JMRUMIVLZ?=SKRT5
MO<I(P_ '-:=>17%[X;FO-)MM<\*7_A"^M[N)K6^BMHQ$) >(Q.@(VMT(( (K
M<N/$/B_4?$'B?3]'_LFWM]%:/9+=12.TVZ(/LP& '.<MZ$<=30!Z#17F%OXW
M\4OHN@>)[B#2X])U*Y@MWLD5S,BR-L\P29QG/.W;TXSFM/Q'XCURQU2\0ZQX
M<T&S@"_9CJ;B22[XR6P)%V+GCH3QF@#MY+JWAGA@DGB2:<D11LX#28&3M'4X
M')Q1;75O>0B:UGBGB)(#Q.&7(.",CT((KS&S\0/XIUGX8:U+"D,ET;\NB'*A
MA RG'MD5O?"C_D0;?_K\O/\ THDH ZY+RUENY;2.YA>YA ,L*N"Z ]"5ZC/O
M3OM5O]K^R>?%]I\OS?)WC?LSC=MZXSQFO'-5M]3L?BGXL\5:1YDMQHZV1N+-
M3_Q\VSPGS5'^T-BL/=:W5\0:=-\35\0P3>;IW_"(O="1.Z"<,>/7@\>M '71
M^%[8>*F\03WM[=7"HR6T$T@,-J& #&-0!@G'))-;M>/CXKWD&D0^(;C6/#,E
MLY1Y-%AFS=QQ,1T??\T@!R5V#H1752ZYXBUWQ)JNF^&Y=-M;;2O+26YO(7F,
M\KKOVJ%9=J@$9/)R>!0!VU%>;ZOX^U2QET?1[TZ3H&KW5L]S>3:C,&A@56V#
M9AAO9CR!N&!UJO'\3;M/#_B1D.FZIJ&C>2RW-@S/;31RG D(!9AL^8LH)^[P
M>: /4**X7PUXGU:_DN9!J.B>(+!+5IEETO,<J2CI&T9=CR.AXYZBLWPGXWUK
MQ#<Z=-'J?AZ[%PX%YI40:&ZLE(.3\[DN5/!^49[4 >C17=M.)3#<12"%S'+L
M<'8XZJV.A&1P?6E%U;M=-:B>(W"H':(.-X4G )'7&0>:\=\47]_?^&==%C%I
MUDMOXL2WDV6[ S$/#M=L,,MN(W'N !QUKI;_ ,4GPYXBUJ?4[.REET_0(;J:
MYMX2DDS[W&P$DX3<. <XSU- 'H5%>46WQ+N[272[J_USPQ?P7T\<,]AI\O[^
MT\PX#!MY\P*2-WRCVJ>[\=ZU-XAU>PL]1T&PN;"Y:&WTK4E9);Q0!AQ(74#=
MD[< ]LT >H5#;75O>1&6UN(IXPQ7?$X89!P1D=P:?$SO"C2)L<J"R9SM/<9[
MUQ/PF_Y$R7_L)7G_ *.:@#LKJSM[Y$2YB$J)(LJJW3<IRIQWP0#]0*GKS_Q/
MXYDM/%C>'K/5M%T@P6ZSW%YJK9!+$[8XTWKDX&2<\ BFZ5X[U/6?"^H3:?'I
M5QJEA>BTFN%N0+/8<'[1N)SLVG.T'.1B@#T*BO-]'\::I<>+#X>&M:!K,EQ8
MRS07-@A @E3&%D42,"ISV(/!JROCN^NO!.BWEI;P+KVI7B:>;>124BG#D3$J
M#G:H1SU]* ._HKS"]^(EU=ZUJ]O8:]X:TF'3+AK58M5DS+=2)]X\.NQ,\ X)
M."?:NT\(>(H_%?A6PUN*+RA<H=T>[<%=6*L >XW*<'TH U+J]M+%8VN[J&W6
M1Q&AED"!G/11GJ3Z5/7DOCYM,\6>,9_#][JMI96^DZ<\RM/<+'_IDPQ$>2,[
M%&[C^]6Q9_$.2;X7Z=KT$,=SJMR\5@L!;"F[9Q&02.BYRWT^M 'H5("&&001
MZBN*F;QW;1W-M>-I-U#-9RNM[;PM&+64#[K(9"74C."I!!'-.^%"WH^&NBF\
ME@D#6ZF#RHRI6/ P&R3ELYY&!TXH [*21(8GEE=4C12S.QP% ZDGL*BM+RUO
M[9;FSN8;F!\[987#J<'!P1QUK/\ %?\ R)VM_P#8/G_]%M7G?PJOHO"_A^ZT
MZ]D*6B:5;:Y"S?\ /*2$>=CZ2(Q_X%0!ZG#?V=Q=36L-W!)<08\Z)) 7CSTW
M <C\:L5XY\.8M0L/$_B>_DMFN-5O=,M]1>W+A=TLIE<1Y/"X!5?08K0/CW6-
M-U;1(K[6O#-\^H7D5K<:;8D^=;>8<9#>8V[:<9R!GM0!ZG17F%[X[UF3Q'J^
MGVFHZ#I]S83F*VTS4E9);U0 0PD+JH#9.W /O5OQ%XUU*R\4QZ+_ &AI&@ V
M<=PLVJ1M(MQ(Q(,:L&50%P 3G)SP* /1**SM!NKZ]T.TN=3AMX;R1,RI;R^9
M'G/56[@C!_&J_BW5)M%\'ZSJ=L,SVMG++'D9PP4D'\Z );[Q)H6F70MK_6M.
MM+@](I[I$8_@3FM)'21%=&#(PRK*<@CU%>?:-HWA7PUX!L]1UBPBO'NX8Y;R
MZDLS=2SRR $EL*S$9)]@*SK#Q=X>\)> ]0G\.74MW!'J/D6]O?*\"6LDI!$>
M74%8U!+<]L\T >J45YOHWCZ=?%&F:1>ZYX>UF/4MZ))I+8:WE5=V&7>V5(!
M;@YZU1C\9^-;GP5=>+8X]%2SLGF+6K12%[A(Y&5B&W80X! &#R,]\  ]6J&Y
MNK>SB$MU<101E@@:5PH+$X R>Y-+:SK=6D-PH(66-7 /4 C-<7\6/^11MO\
ML*6?_HY: .YHH/ )QGVKR;7?B%K_ (?T^35+_4O#,,\4GSZ )-]SLW8QYBR$
M;\<_=Q0!ZS17"ZEXVO=);Q?#<0P&?2X8I]/ 4CSUE7$8;GD^:"IQCM4>F>.-
M1U.Q\)QQV]NNIZG/,E]'M.V)8 PFVC/!W!0,D_>[T =O>6=O?VYM[J(2PEE8
MHW0E2&&?7D#BIZ\N\-^/-=U^YM98K[0&EDN?+N="<-#=VT>X@G<S_,ZCDC8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM=XU)7#VTS@;\%5.]21G'RXS77Z#I]QI6AVEE=7?VRXB3$MQY:Q^8Q.20JC
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ML!#@#@'@\5$?AM=W'AS4H;W5XY-;O=034_M*V^(8ITQM 3/*X7!R<G->B44
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3%0FS.U@0.=P).>M=>MN_C+Q[K5EJ-]?P66DVUKY%O:73P!I)4+M*Q0@DC
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MM]3NM2U35;JU5DM6U&X$@MPPP2H  R1QN.3[T =/7F6O#73\:X?[ ;3A=?\
M".G?]O#E-GVCG&PYSG'ZUW^F:6FE_;-EU=S_ &JZ>Y/VF4R>66Q\B?W4&.%[
M5"=!LSXI'B',OVT67V'&[Y/+W[^F.N>^: ."\//JNO?$L#Q=<6MMJ^@12/9V
M%G"RQRI*-IG#LQ+C'&,#!KFM.O-<\2>&I_$/V#Q2^L7#32VMY:WT<=K;[68(
M@C,H!0;0&W+D_-7KNI^&;#5-;TS69#-#?Z<S&&6%@I96X9&X.Y3Z?EBL:Y^&
MNDSM=Q1:AJUKIUY(TESIMM=;+>0L<MQC<H;N%(!H S(]=OM \1Z;J>NS20V6
ML:-ON(3)NCM[N!/,?;R0 R%^G4I6[X 74)/"D.HZI+,]YJ<CWS)(Y80K(<I&
MN>@";1CUS5GQ#X.T;Q-H4&C7T#+90.C1)"=FS:, #T&TE<>AJ_J.DQ:BEFAN
M+JV6TN$N%%K+Y>_9G"-CJASRO>@";4I+6'2[N6^8+9I"[3L<X$84[CQSTS7G
MNG:-XNT/0(%\+ZMI>O: 8 UK::C"8Y# 1D(LB\-P>"PKTIT26-HY%5T8%65A
MD$'J#7$#X7:9#&]K9ZWX@L],<G.G6^H%8 #U4 @L%/H#0!R[KI/BK6_AIJ5G
M;W.GVETETBVMO</"L(CB8[5"$ ?,",@#<.#QQ3]:DAU;4-?D@;Q3K-Q!-)'%
M/I]P;2UL&1?N F159E/+-@Y]*[K4?!&DWMII%O;O=:;_ &0<V4EC+Y;1 KM*
MY(.01P<\FJK_  \TTW-\8]1U:&QOYFGNM.AN=L$KM]_H-P#=P& - '#Z?"WB
M'7/ACJ6HW5X]W=:;</,Z74B;F1$(.%( ))^;'WNAR!7LU<G_ ,*^TM++0K>"
M\U&W;1-PM)X9PLFUL;D8XP5( '3M6]8Z6EA=WUPMU=S&\E$K)/*76,@8P@_A
M'M0!P?Q "W/C+0K>]U230H(X9);#58U'%V2%\IF/ 4ISM.-W3/%;W@_6]3NM
M0U?0];AMO[3TPQ&2ZM.(KE) 2CXZJV%.1^7%2^,+B[BCM8G\/C6]$GWQZA!'
M&))DX&QE0D!AG.>XX(K-^&6C7&C:?JJ_V?/I^G3WS2V%O=8\]8MJCYR"3U!P
M&)(% &OXDUG1_#,D>IW%H)]7N$^R6D4$0:YN>=WEKWVYY/8=:Y"ZGU;P5X;U
M/7K] /$/B&]16$$3316(V;4R%!+"-%)) ^8\>]=/KW@.QU_7X=:DU35[.]A@
M\B-K*Z\H*N23CC.3GGUP*TM!T :#'.@U75=0\T@YU"Z,Q3&?NY QUH \R\$Z
MOX=L/B7+9Z7)>2QRZ1%"LDMG,LD\XDD=V?<HP6SG<< DX![5W=EXLMM8CNX=
M6\/:II5@D#233ZS;QQVY7(!4G>1WZ'C -;$>AVD7B2?75,GVR:U2U8%ODV*Q
M88&.N6/>K=[96VHV,]E>0K-;3QM'+&W1E(P10!Y[XTCO[#7_  [K%[/;77AR
MWU*%8+*W3RWBD<;$E+9/F!2Q.T;>HZXKB?'OB;3=?TSQ)=ZC]KCN8$-GI5H]
ME-MC7>N^9GV[ SXP.>% '4FO4;'X>:;:75C)/J.K:A!I[A[*TO;G?# PX4@
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MU%8\9W%21U[T =R?$NB+I,&JG5;3^SYW"17/FCRV8\ ;NG8_E5/_ (3GPO\
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M!B+<?$+6;Y?$4&KSBRBANFL;$16^[<2F7$C!I -PQZ$<\5Z/0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6*-#:#Q
M>VN6LJHMS;"WO82/]84.8W'^T,L/<$>E;5><?$%-2\2Z[:>%='O)K6:"TFU.
M>6%RA# %(%)'8R$DCT6@#O+O2M.U!T>]L+6Y=/NM-"KE?ID<59,:&/RRB[,;
M=N.,>F*Y*Q\>63?#BW\67B28\E1+!$N7\_=L,:CUW\"DB\6:Z+H6=_X3N+2X
MN());0I=+*CL@R4D8#$;8Z9R#ZT =/9Z?9:>C)96=O;*YRPAB5 3ZG I6L;1
M[,VC6L#6Q&#"8P4QU^[TKE/A;JNJ:SX!TZ\U9',[J2+AY0[3C)^8X^[SQCVK
ML)O,\B3R=OF[3LW=,XXS[4 116%G!:?9(K2".V((\E(P$P>HV]*=/:V]S;&V
MGMXI8",&*1 RD>F#Q7A&EZS;/;:')9ZOJ3^-YM22&[::ZD,$GSGS4))\DIMS
MM"<],<U[[0!7@L+.V$0@M((A$"(Q'&%V ]<8'&:8=*TYIY9VL+4S2@"20PKN
M?!R,G&3R!^5<#XDD\2+\0/#$EW>00:2^J/#!9VQ8M(!$Y\R5CCGCA1P,^M;/
MB[2+6XNO[5U_5;J/0+2WVFRMFECS,S8\QC$=S<$ +VY- '3W>G6.H!!>V=O<
MA#E1-$K[3ZC(XJP %4*H  & !VKC/A??W&H^$GGDNY+JT^VSK8232;Y?LP;Y
M!(<YW#G@\XQFE\7:1927DFL>(]6NUT.W@5(K*U::/$I)S(QB.YST '0<T =3
M/IMA<W,=S<65M+<1_P"KEDB5F3Z$C(IXL[52"+:$%7,@P@X<]6^OO7+?#*^N
M]1\$6]S<W;W4;32BUEED#RF .?+\PC^/;C/?UYS5WQ!X;N/$.JV*W.H31:+"
MCM/:6\SQ/<2'&W<RD'8!DX!'.* .@\F+S_/\M/-V[/,VC=MSG&?3-0PZ=8V^
MWR;.WBVN9%V1*N&(P6&!U([UY(VNWNB>'_&PT"_N)]*M[FVL]*N9Y3-Y4TA"
M2A'8DLJ%@1DGFMZ]TI? NO\ AFXTV]U"2'4+T:=?1W-W),)RZ,5D(<G#!EZC
M'4B@#T:JB:5IT<SS)86JRR.'=UA4,S Y!)QR1ZUP/C.3Q(GBSPW-->06VCG6
MX+>*UMRQDGRK$O*W& -N HR.<GM7I- $1M;<K*I@BVS<RC8,/QCYO7CUIEGI
M]EI\9CLK2WMD8Y*PQA 3ZX KC7^(5W+:7>KZ?X;N;SP_:.ZR7RW"*[JA(=XX
MCRRC![C.#BH&\2ZK=?%72K:P@:XT:YT@W"%;@*CHSQ_OMN,DJ#@#KR<4 =Q%
MIMC!=R7<-E;QW,GWYDB4.WU8#)J1;:!(GB6&-8WR70( &SUR.^:R?%/B.+PQ
MI*7DEN]Q)-/';00JX3?(YPH+-PH]2>E4[+Q5=Q?VA_PD.ASZ0EE;?:VN!)Y\
M#QC.<2 #YAC[N,]Z .B2V@C=72"-71/+5E0 JO\ ='M[4"VMQ'+&((@DI)D7
M8,.3U)'?-<9#X^O(X;'4=3\-7%AHE](D<-Z]RCNGF'$;2QCE 21W.,C-6;GQ
MI>2:KJ-MHWA^?4[;2W\N]N$N%CQ)@,4C4_?8 C(R.>* .I^R6V<_9XLB/RL[
M!]S^[]/:E-K;M D!@B,*8VQE!M7'3 ]JS/"VOQ^*?#5EK44#01W2LRQLV2H#
M%>OX5L4 59=-L)[M+N:RMI+F/[DSQ*77Z,1D4LFG6,MN;>2SMW@+;S&T2E2W
M7.,8S7(>,+F]U3Q9H?A&UO9[*WO(Y;J^GMWV2F*/ "*W5=S'DCG IZ> $T;5
M+"_\+WUQ8-',/MD$]S+-%=0_Q J['#^C#I0!V*V\*&39#&OF'+X4#<<8Y]>*
MBM-.L=/#BRL[>V#G+B&)4W'U.!S7+3^-=0N+_48M \-SZK;:;*8+FX%RD.95
M&62-2"7(S@].>*SG\1V^N>,O VIV%S(NGWEG?RLK$J/E5.''3*G(]CF@#O1:
M6PMC;"WB$!R#%L&TYY/'2I0 H    X %<%_PL>Z;2F\01^&;M_#2DDWXG02F
M('!E$/79WZYQSBN[AFCN((YHG#QR*'1AT8$9!H K+I.FI/-,NGV@EG!$KB%=
MT@/4,<<_C4Z6\$<GF1PQJ^P)N50#M'09]/:N)^+UQ]F\!M(;B2"/[;;++)'(
M4(0RJ&Y'(XS7%:_/X(ATB9_!FOZC)XB&/L,5CJ-Q<.\F1A2C,P*^N1TH ]K%
MM J2(((PDI+2*$&')ZD^N:BMM-L;(*+6RMH F=OE1*N,]<8'? _*N>OO%=_:
MZA9Z)8Z.=3UQK1;JZB6=88H%Z99R#U;(  )XJLOQ#A6PCN+G3)[:6+4X]-U&
M&21<V;OC:Y(X9"2N"/[U '7W%O!=P-!<PQS0N,-'(H96^H-1PZ?96ZQ+!9V\
M2Q B,)$JA >N,#C-9[>($_X3"/P]%;M))]C-Y/,&PL2[MJ@CN6.[\%K9H A^
MR6QM1:FWB^S@8\K8-F.O3I2265K-<)<2VT+S(I59&C!90>H!Z@<UY5XIFTJ+
MQUJ7_"?-JD>C%(1I4D3S+: ;?GW&(\/NS][MCVJ:[N[S0OAAXCOO#FO_ -L:
M> S:?.MUOELD*_,"YR6VGH.H!H ]4CCCAC6.)%2-1A548 'H!2+#$DLDJ1HL
MDF-[!0"V.!D]ZY0>)M8@T[2+>+PW<76JW<#2/%]H BB5<#<\V,9;(( !/)]*
MP/$GCG59O OBG[/ILVFZWI($5R@N5;R0Z[EE1P/FX/3 - 'H<NF6$UXEY+8V
MTETGW9FB4NOT;&14DUI;7$L4LUO%))"=T;N@)0^H)Z56T6>[NM&M)KZV^S7+
M1@O%YHDQZ?,.N1@_C63\0+R>R\#:HUI>-:7LL7DVLB EVE<A55<9.YB<#'0G
M/:@#972=-2::9=/M!+.")7$*[I >H8XY_&I?L=J0P-M#\T?E-\@Y3^Z?;VKS
MOP$FC#7@NGSZCI&HPVQCU#0KZ5W:1LC$HWL<XY^=>H/.*]"OWO$T^=K"**6\
M"'R4F<JC-VW$ D"@!MSI>GW@B%U8VTXA_P!6)85;9],CC\*E-G;%9E-O"5F_
MUH*##\8^;UX]:X3P"=93QAXQMM;U$7MW%):$F-2L2;HBVU%)X49QZG&3R:Y:
MSV7OPSU+QQ>Z[?0^(XO/F\P7CJMM*C,$M_*SMVG"C:0<[O<4 >QPV=K;%3!;
M0Q%4\M=B!<+UVC';VID.FV%O=R7<-E;1W,GWYDB4.WU(&34.A:@=7\/:9J3*
M%:\M(K@J.@WH&Q^M>2ZA?V.H>+/%%[J\?BN6TM+P6Z-I33+#;QQQJ'9MC <M
MN)QDC&: /9TABC9VCC16D.YRJ@%CTR?6B*&*WB6*&-(XU^ZB* !] *IZ(]E)
MH5@VFW+7-D8$\B9I"Y=,<$L>2<>O-<YK/A:&_P!5U/5O$NJSC28HE^R00W<E
MNELJKEW<HPRQ/.3T'% '5O96DD<T<EM"T<YS*K1@B0_[0[].]-@TZQM5B6WL
MK>%823&(XE4)GKC XS7$>$KOQ3?_  VM9+&6.6]EFD2UN]3W;OLN]MDK@<LV
MW&!QG@DU9^%LEX_@^?[;=R7MTFHW://*>9"LK#/MTZ=J .R%O K2LL,8:7_6
M$*,OQCGUXJAK6ES7WAZYTO3IDLC/'Y(D5/\ 5(W#%0.^TG'OBN+T!_$:_%UT
M\07L+--H;3)9VN[R;<>>J@ G[S<<L0.N.@KOM3OXM*TJ\U&?/DVL#SR8_NJI
M8_H* *9\.:?Y&D6Z(8[?2F5K:)<8^5"B@G&> <\$<@9S6L0",$9!KRZYU35]
M*^&VFW<,_EZ]XHO8%-PWS"![@Y& >R1@*!["M6[^&-I%8--HVJ:G:Z\@W1:E
M+?2R,\@_YZ*2593W&* .SAT^RMO+\BSMXO++%/+B5=I/7&!QGO4RPQ+*\JQH
M)' #.%&6 Z9/>N7U'Q5?6FJP:#IVE?VMK*VJW%T$F$$,*GC)9L\D@X7!.*YW
MQ'XK;6O#4!CAN=-U"SUZSM;VU=_GC;S5R-R\,K Y!'!% 'H=OIEA:7$EQ;6-
MM#-)]^2.)59OJ0,FK5<A=>,M0GU74++P_P"'9=6337\J[G-TD"B3 )C3<#O8
M C/0#UJI=?$J!K#09](TFZU&;6C-';VX=8G22,?,CYX&#D$]MI/- '72:3IL
MMX+R33[1[I3D3M"I<?\  L9JQ<6\%U T%Q#'-$_#1R*&4_4&N6F\4Z\9X;*S
M\)3RW_V99[I);M8X8"Q(""7!#MP?NC'O5=/B+ _AI-0_LNZ_M&2_;2UTP.I<
MW0)!3?\ =P,$[NF* .MBL+.&T^R16D$=M@CR5C 3!_V>E)=:?97T*PW=G;W$
M2G*I+$KJ/H"*\^M_$&I2_%6V36;"725M]$N)I8S<B6%U\Q#O## . &!R 1^-
M7/\ A8]TFEQZ_/X9NHO#4A!%^9T,BQDX$K0]0G(/4G'.* .Y-K;F*.(P1&.,
M@HA084CH0.V*9>6%GJ$:QWMI!<HIW!9HPX!]<$5)+.D5L]P<M&B%_D!8D 9X
M Z_A7$2>/]3M+:SU/4?"ES9Z-=31Q"XDND,T8D8*C/#C(!)&1DD9Z4 =M';0
M0N7B@C1BH4E4 )4=!]!4,&E:=:L6M["UB8OYF8X54[NF[@=>3S[USM[XQO6U
MR^TW1/#\VJC3MHO9EN$B",PW!$#???'.. ,@9KFO!GC%]/\ ASH&+6ZU/5M4
MNKJ.TM2X#OMFD)+,WW550,GG'% 'I$VFV%Q=1W4]E;2W$?W)GB5G7Z$C(JU7
M'1>.I(/[7M=8T:33]4TZP?4!;>>LJ7$*@Y9) !W&""!C(JM;?$.Z-IIFJ7_A
MRXLM#U!XXXKUKA&9#)@(SQ@95"2,')ZC(&: .WBAB@#"*)(][%VV*!N8]2?>
MH[NRM+^'R;RUAN8LYV31AUSZX->;IXAU:36?B)#JEE.=,L;;(6.\ ,*"W+83
M X+@EMW\)(]*V8O&#Q0Z/I&A://J5_-IL5XT4ER$6"$@!3)*0<L3QP"3@GB@
M#K?[/LMA7[);[3'Y1'EC&S^[TZ>U2M!"[QNT2%HN8R5&4XQQZ<5Q5Q\2K>S\
M.WVHW6E745[IUY%9WNG[@TD;.R@%2.'!#9!'7VJYIWC"_?Q+:Z)K7A^72Y;Z
M*26SD^TI,)-F"RMM^ZP!![CWH Z=[2VD\W?;Q-YP EW(#O Z!O7\:AO;:?[+
M<OIOV:'4'CVQS2Q;ER.FX @D>V:YKXE3S6_ARS>&5XF.JV:DHQ4D&901QV-2
M7?C"_EUB_P!/\/\ A^35O[.(2[F-TD"+(1N\M-P.]@",] ,]: -#PKX??P_I
MUP+JY6[U"]N7N[RX5-@>1O0<X4   >@K=KDO^$X^W:1I5YH6CWFHSZD7$<)Q
M$L!3[XE<Y"$$$8YR>F:IM\0KBUT_7WU#P_-;ZAH:137-JEPL@:%^=Z.!S@!B
M00.E '6II.FQWIO4T^T6Z)R9Q"H<_P# L9I]WIUCJ 07MG;W(0Y3SHE?:?49
M'%9=_P")[>TU30["WB^TR:L7=&5P%CA1-S2'VY4>^ZL _$:Y?39=>@\-W,OA
MJ)FSJ N$$C1J<-*L/4H,$]0<#.* .U:RM&W[K6$^85+YC'S;?NY]<=O2GSP0
MW,+0W$22Q.,,DBAE(]P:6&6.>&.:)P\<BAD8="",@T^@"&UL[6Q@$%I;0V\(
M.1'"@11^ J:BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "O.=)\!1Z[JNM:]XHM;R&]O+QEMXHKZ2+R[9 %C!\IP
M"3@M^->C55L]2L[^2ZCM+A)7M9C!.%_Y9R  E3[X(_.@#RZ?P%K%C;>(= TB
MW)TS[3;ZMI+SS[E\Y&4R0L22W)7@GCGDUU]CK'B36=8M8_[!GTC38XW-ZU\T
M;/(Y&%2+8QX!Y+'L.E=910!YSX3O]6\'?#O3[+4M N$N+&XBL7!GCVR"23:)
M$()R,L..IKN=8L7U/1+^PCF,+W5M)"LH_@+*0&_#.:74[JPL;/[7J31I;PNK
M>9(N1&Q( ;IQR>O:KE 'DMSIOB'5/ %GX%_X1::SNHD@@DU RQ?98A&RDS(0
MVXL=N0-H.3S7;_\ "#Z%_P )!_;GDW7V_P WSM_VR;9N_P!S=M_#&*Z.N9U#
MXA^$=+U![&\UZSCN8VVR+N+",^C$ A3]2* &>*M*O=0U_P *7%K 9(K+46FN
M&# >6GE.N>3SR0.*=K.I^(='U])X-*FU71);?:8K/8)X)@>N'9=RD8Z'@BND
MAFBN(4FAD22*10R.C JP/0@CJ*;<W,-G:S75Q(L<$*-)([=%4#))_ 4 </X=
ML]<T+3]?UMM#+7FJZ@+F/28IT!B0[4)9ON[B 6;'\ZU-5U7Q%HWB%Y4TB?5M
M$F@41I9>6)K>8$YW!V7<K#'.>,=*Z2VN8;RUANK>19()D62-UZ,I&01^!J6@
M#SS0/ *:AI&H-XELWMVO]4EU%+*WNW3[-N 4*6C89.!DXXR:K^+],URSM=,\
M,^'='U*;PZ$9KZ2UNU$\BDD^2'E?< 3DL>N" .]>EURMU\2O!EE=S6MSXBLH
MIX7:.1&8Y5@<$'CL10!BW.E7WB3P#J'AVV\,R>'?L\<36"3RQLC.C[P/D8XY
M09)_O9YJ61=<\8:]H'VWP_<Z19Z5<?;;I[F2-O,F5"J)'L8[ERQ.XXX%=EI6
MKZ=KEBM[I=[!>6S$@2P.&&1U''0^U7: .6\9Z5>ZG<^&6LX#*MGK4-S.0P&R
M-4<%N3SR1TYYKJ:*CG@CN;>6WF7=%*A1USC((P10!XK:>!9-#TB?1)/ TVK:
M@CR+::@+S;;3(S$JTH\Q2N <%0.<<'G-=>-&U+1/&OAN\MM)^T6,6D_V7,;-
MP$MF+H=V';=L 4^IXJ?4? /@#2+&6^U&Q@M;6(9>6:[E51^)>L_PU8?"[5=6
MB_L%K6:_MV$T:"XF#@J<A@K-\P'T(H Z?QI:W=YX>:&UT>TUA#*AN+&YQ^]B
MS\P0D@!QP03QQ7!Z=X*OK_\ MRPTRPU/0?#U[I4ELMGJ-R)!]I8_*Z('?8H'
M!YYSTKT35]$T+Q3_ *-J,4=X;1^469@8V('7:00<8ZUE?\*P\'?] 8?^!$O_
M ,50!Q%GX0:>WTW33\/C!J$<D:WEY=WA>T55(W.FV7<Q.,A<#!//2NEM$UWP
M?JVOP6F@7&JVVJ7KW]I/!+&JI(ZJ&27<P*@%<[@#P?7BKL?PX\#S22QQ:9$[
MPMMD5;N4E#C.#\_!P0?QJ7_A5_@W_H##_P ")?\ XJ@#+^&E]>P?#GPJD&G-
M=)<&1;B5)%46Z[W.X@_>&>,"NLT_69+W7]7TM[)H18>25F,@83"12<@#[N""
M,'Z]ZX2ZT#X2Z'?C2+I;6WN$V@QM=38CW=-S;L+G/<BO38;>&#<88D0N06*C
M!8@  D]S@ ?@* .3\7Z-JAUG1_$VA6\=UJ&F>9')9O((_M,$@ 90QX# @$9X
MZU5DU/Q;XEU"PM;+1KWP_8Q3K+>W=W)$7=%Y,4:J6SN[L>@K<O\ QMX8TO4O
M[.OM<L;>[! :)Y0"A/3<>B_CBMPNH0N6 0#);/&/6@#S[3?[?\%W.MV,'ARZ
MU:"\OYKZQN+66-5S*=Q27>P*X;^+!R*HZ3X$U33Y?!]I<H)([6TU%;^>)AMC
MDN,-@9Y/)8# [5Z/INI66KV$5_I]S'<VDN?+EC.5;!(./Q!J/5M9TW0K(WFJ
MWL%I;A@OF3/M!)Z >I]A0!YS';^*[?X?/X%7PW*]Y]E;3TU$31BT,)!7S2=V
M\':?N[<YKN],%UID]CH:6$CV%MIZ#^T#(NTNN$$>SKD@;L]*MZ3K6FZ[9?;-
M*OH+NWW%2\+YPPZ@^A]C3WU2QCU6+2VNHA?RQ&9+?/SE <%L>F: .=^(ND7V
MM^%X[33[<SS"^MI2@8#Y%E5F/)'0 U'XW\,7-]:PZQX>5(/$6FMYMJZX7SU_
MBA?IE6'KWQTYKL:J76J6-C=VEI<W445Q>.4MXV/S2L!D@#V% 'FNN^&IKSQ3
M!XGU'PK=:E:WNGQQ7-E!<!;BSF4D\?.H=2#C@]LUI:+X+6]\'^(-/NM#@T5-
M6++% LK2RHH7$;RL68;P><+P,#K76:UXIT+PZ\2:OJMM9O*"465\,P'4XZX]
M^E6+K6]+L=)_M6ZU"VBT\J'%RTH\L@]"&Z'/;'6@#EO .EZY9Z?J6M^(K7&O
M7[*)(0ZG"1($1<C(Y(9O^!UUNEW5U>Z9;W-[8O8W,BYDMG<.8SZ%AP?PJMHO
MB31O$4<KZ1J5O>"(@2")LLA/3(ZBC6?$FB^'5A;6-3MK$3$B,SN%WXQG'TR/
MSH YRZU'Q7X?UW41-HUQX@T:Z<2VKVKQB6V!4 Q,C%=RY&0<]^?; 3P?K%]X
M?\<W,>CQ:5+KMNJ6FE+(GRLB$;F*_*&<GMTQR:[S1_%_AW7[MK72-9L[VX1#
M(T<$@8A00"?IDC\ZTKZ]MM-L9KV\F6&V@0O)(YX51WH \UU6VUS5;G0[G4]
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M @#!MV&7Y.5P,YZT^X\&>(-6N=%FU;7[/;I%Y%<Q6]G8&..39P=V7)R02!C
M&3P>P!5^'5I?P^)O&3W&IM<1KJC(T9A1=S^7&=^1R..,=.]>B5R5IX6U;3=8
M\176GZU#%;ZMNFC1[3>]O<E%4/G=AE&W.T@=>OKT]I'/%901W,PGN$C5990F
MT2,!RV.V3SB@#R&SGU!X?$VL6^D6^K^&]0OYUU'2-^;N$IB-G'0$D)N\OJ!M
MP>:]6T:^LM2T2RO=-;=930(\!P1\A''6O)O&][H2W>OSV=W>>'/%<&Z)8H]P
M_M9=OR?(O#ALX##YE/)Z5ZMH%LEIX=TVWCLELECMHU^RJ<B'Y1E<]\=,T <=
MXD72/#>B7_AO2K+^T-9UYIG2R)WO*\F=TLA/1%SU/I@53OKBVAM=(^'ESK-O
M#':V,/\ ;-U).(RT04 0J20<R8.?1,^HJQ8> _%>EZMJ6IVOBRQ-WJ$IDFFF
MTGS'V_PH&,G"@= .*ZH>%M+O(HI=;TS2]2U'RU6>[DL8\RL!C.#D@>V3B@#C
M?AUXIT#P_P#"32)]1U2VMX8WDA8[MVQFDD*J0N2,@$\UU:/H?BRVL?$FFJFJ
M/8><U@PD9$,A&TCGC/&,D'':E\%>$K7P=X<@TN(023*6,US' (S,2S$%NN<
MXY)Z4OB/P_>:G=:?J6E:E]@U+3V<QEXS)#*KC#)(@(R.!@@Y% '%:-XDB\-:
MUXVU;Q);'3=186]P=/C8.C1A3'&R..'9V."<#!Q5'09K6+XJZ1J>H:O8SZIJ
M5A<-=&*Z5TB8M&(X$P<84<#N3D]Z[?2_!0>_O]4\336NL7]]&D+(;4+;Q1(2
MRHB,6_B.<DDY]*1OAYHB^+M/UNWT_3K>*T@DC^S1V2 -(64K)D="NWCC//44
M 2#XD>#VN[FT77;<W%LLC31X;*B,$OV[ &O.IM5LM3\8^%/%6HZG:)<7.H.(
MK8W*$6-H(7V!QGAF)W,3W(':O:KBV@N[>2WN8(YH9%*O'(@96!Z@@\$5R>J_
M#?0-0U+2+F#2]+M8[*X:6:%+"/%PI0KL;&.,D'G/2@"OX81+WXC^-KF=5DDB
M:UM(]PSMA\D-M'L68D^M9G@K2=,N]!G&I$"Q\/:]>M9AWVQ1JCMM+9XPNYL9
MZ5OZCX7U:'Q#=:UX;U:VL)KZ%(KR*YM3-&Y0$)(N&4A@#CN",>E9.J_#2YNO
M">F^'[#7!#!!<-=7K7-MYOVZ0MO)<!E^7<2=O(Z>E $OAICXF\?W?B^R@:#1
MUL/[/MYF7:;YO,W&4#KL&-H)ZY-=CJLUE9Z;<7^H)&;>UB>9V=0VU5&2>?85
MCZ-I/BFRE<:EXALKJV\@I%%!IHA\M^-K9WG('/&*36?#>HZ[X"N/#][K"M>W
M,(BFOEMPH;Y@6/E@\9 (Z]Z ,_X=:4[:=-XHOX$CU36\3E0N/(M_^642^@"X
M)]23FG>-9#>>(_".@-_Q[WU\]Q..SK;H9 I]07V'\*[**-(8DBC4*B*%51T
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MN1P#P<'MW!-8C^$=<U9KF77M?BF<V,]G;Q6=LT,2&5=K2.I<EVQC R .<=:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCEMU5R@; :9$;@@CHQ%3:OXTT;1M0>PF:[N+R-!)+#96DEPT2'HS[%.W/O0
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M*H*(/F//!8G K>\(>(-.T%?&<6HRR0RVFM7=Y+'Y+EA"[C8X '(.>V:])HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4+GWH W;S7XK/Q/IFAM"[2W\,TJ2 C:@CVY!^N[]*UZ\LN_#^F^%?B?H3:)
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M5\W 0%P".02"0>XY[UN^)[K3M-\::M/#XFO/"VIR1Q-(;F!9K74%"8#*A')
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MEQ<>&KV&.3IAV9 O/U-<EXA\3Z0WP7M_#OV:=-6M8;6WGLFMG#6TD;H&9CC
M&0<'/.X>M>WS1+-#)$Q8*ZE3M.#@C'!'2N*_X0+4;JVMM,U7Q5=ZAHMO*D@M
M9+=!+*$8,BR2]6 (&> 3CK0!5%M-<^//'D,2%GFTBUCC']YBDP _6N0NO%&F
M7OPI\/:#;222ZI;2:?#=6PB;?;&.2,,9./E&1CGJ2*]QI, $D 9/6@#C/"JD
M?$3QV2" ;BSP<=?]&6NTHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)<RYN5D:!D95V$+P0=P^;..U=%0 4444 %%%% !1110 4444 %%%% !1110
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MR#S[4 24444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSQS]:Q-!\*W*>*;*?2/#FH^&=-\N9=4AFO%:&?<A"K'&KL,ACG=A1Q0!M?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK"^UVR@N48*Z-)_JR>S'HOXXJUJGBG0M%(&I:K:VI,7G*)) "R9QD>O) XH
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M%Y"K;&:)L[6]".H/L:P_$/CJP\/>+-#T.YE@3^T/,::21\&)0IV<?[3<?@:
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M+M1*6B\SYE\O._/IC:WY'TID7CSPG->FSC\0:>9UC,A7S@!M W'GIP.2,Y%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS! O_?=>]V=A9:?&8[*T@MD8Y*PQA 3ZX IXMH%\W$$8\[_680?/QCGUX]:
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MQQ].*]M2SM8O*\NVA3RL^7M0#9GKCTSWH^QVOV;[-]FA\C_GEL&WKGITZ\T
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M^\42JS?4@<T >::'9VZ>!?B)<B&/SWU#52TFT;C@,!S],_F:AU'3;(^!?A?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** (Y[>&ZA,-Q#'+$2"4D4,#@Y'!]P
M#4E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMJ-K+8!2QN4F4Q@#KELX&.] %ZBLC3O%?A[5Y$BT[6]/NI)&*HD-PK,Q R0
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M[6\330 K%(4!:,'&0IZC.!G'I2?8K7S;B7[-#YEPH6=_+&90 0 Q[@ GKZT
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M?7-.M-:&G(DMGJ]N6@GAWL04?((YR#MSVS7HL$$5M!'!!$D4,:A4CC4*J@=
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MD6)F)8J&8DGDGO\ I7,0#5? GB+6C'HE]JNB:K=&_C?3U5Y;>9@!(K(2"5)
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M?PO\-_$UQJ<#0%;G4)T1^KJSL4Q_O9&/K73>"]-FT?P1HFG7 (GM[*))5/\
M"VT9'X'(H AM?&%K=>%M5UY;:80:<URLD9(W/Y!8-CMSMXJC=>/E2_TW3[#1
M;Z_OM1T];^"&)D4!">C,Q 7'K]!WKE?*U_3/"GBCPI'X:U&YN[R:]:VNHPGV
M=XYBQ#%RW! 8_+C.<#OQNZ!HVHVWC/0[N>TD2W@\+I:22$<+,)$)0^^ ?RH
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MHD8-N5F [  9J>VFU/5OBSH.IQWT5O#=>'A=&$V^[;&7B+Q[MW4DYW8XZ8-
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MR<8K6M=2\5^*[O6+G1=2LM,LM/O)+*WBFM/.-R\?#,[;AM4MP-HSB@#J=?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZL=*E\/ZU'?RP^?9P- F^Z3.,CYODQU._;@=?2IH?B%ITGAZ;5)+&^BFAO\
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M)UN&,:1[G@C#-)$-S##<#)Z8S@Y-=OX@UJ#P[H-YK%U%-+!:1^9(D(!<KGG
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M=&\#:'I[1M')#91"1'7#!RH+9'8[B:WZ "BBB@ HHHH **** "BBB@ HHHH
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MM?D9MP?>P91MP<@9K,M-5UC3(/B'XONKBQNHXY6L(X?LS 220@1QXRY^3<[
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MSA3'+MW!'5@ZDCN,J,^U9EOHGB75KXR^)+^TALUM9+<66F/)LF:0;6>0L!G
MSM7!P3G)J6Q\7:C>7\%M)X-UVU21PK3S"'9&/5L2$X^@KJ: /.D\&^*;CPS;
M^$+S4M-30XHUMY+JW5_M,]NN $VD;4)4 %LGOQ6@_AO7M$\0ZEJ/AA]+:WU)
M(1+;WQD7R7C38K(4!R-H&5..G6NUHH \AU+PO?66M^&= LM12;5I+RYU^]NY
MH_DDG0 *2H/"$L%X/ 'K74Q^#]0UN_OM1\53VIGFL)-.M[>Q+&.WBD'[QMS
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MD#6\9C)C"\X/R$ 9/!Y-;_B30=4U'Q/X;U;3Y;/9I<LQFAN=PW"10FY=H/S
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M1W8C&/2NFH)P,T >::O967A7X=^)++7;^V-]K<E[.L<;9::27A%C4X+$9C'
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MWMO;7J6YGN9%^_(S.I91M/ /7DUZ _@_1W\)P>&3#(-+A$:B,2')",&&3WY
MSZTW6O!VG:UJ2:D9[^ROA%Y#7%A<M \D><[&(ZC//J* ,KX=+J$5OK$%Q%)#
M817I6R@FO4NI(%VC?&75FQM?. 3D UE>*H-4USXL:-8Z/>P6<^D:;-?&:> S
M(#*PB V[AS@''-=YI&CV&A:9%IVFVZP6L6=J DDDG)))Y))Y)/)K$U3P#I>J
MZY/K#WFJVUY-&L<CV=]) "J]!A2/\F@"M/)XK\.:5JFL:OK5AJ-O9V,TZV\%
M@82SJNX9;>W'!XQWKB]=T"2V^'EAJPUB_/BC6'MH3=BZ?$K7# -&$SM"A6;
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MMYW/4L@/?N!@'O69XMT*?Q=J&G^%SHKP:%97$=S<7K%5C=$3B*)0<Y.[:>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_21;,C[0)$:(Q9&06#@$ @$YZ<56TOQSX:UK45L-/U2.:Y=6:-=CJ)0O4HQ
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M2_X1O5/#'B7R))_LMQ<6OE1C+2&:%MBCZNBBL34M&/AZ#PI<>(G5H+G5VO\
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M9[66 /O+R1OM"J<#)8[<<?Q"NCLKF:;3(+F\MQ:3/$))82^[RCC)4M@9QZT
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M,TK0Q/(DCQHSI]UBH)7Z'M7.:#XHO-2\0:AHFIZ0-/O;6&.X 2Y$ZO&Y('(
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M50,L3DGZDDFH!J5B7NT%W#NLP#<_./W.1GYO3CGGMS0!YQKNB>)O$B:YK?\
M9;VEQ)I;:7IEA),AEVRL/-E<AMJG'0 G@>M>DV-G%I^GVUE ,16\2Q(/15
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M0:O/JFN/=:MJ%DU@MTMN(X[:%OO+''N.,]R6)/%=A:6T=E9P6L(Q%#&L:#T
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MOB5>36'P[UNYM[J6VF2W(1X@I)9B%"_,#U) ]>>,'FJ]MX*U*:^TB77/$/\
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MHC5 J!06&&7#?-T.[D<"@#EI/'^L6.@_V7)>>=JIUNXTI-16T,I\F+#/-Y2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1<W5U/MWOE\$E",Y!XP>W%<J+"PA^'7BS6M/L;:*]UW4Y["RDCB ;R9)EA"
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP<[D0G) [=S^=5KGPKHEY9:E9W&GQR6^IR^=>(Q;]Z_&&)SD$;5QC&,5L44
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M8KK9B,;1"'&&P!QR.Y]_6K,.EV5OJ=UJ44"K>72HDTN22ZIG:/;&3T]:MT4
M9VLZ%IGB"T2VU2T6XC1Q(GS%61QT964@J?<$55M_"&@6NG0V$.F1+;17*W:K
MEB3,IR'8DY9L]V)Z5MT4 5)-+LI=5@U22W5KV")H8I23E$8@L .G.!^58+_#
MCPC)]H#Z+"R3EF>)G<Q@MU*INVH3ZJ :ZFB@"G;Z58VNH7%_#;JMU<1QQRRY
M)+*F=HY],G\Z\TU_P9K>N7.I17/AK1)+V[9XH]<$Y4)">%9H<9:15. ?4#!&
M*]7HH P;CP=HE[H6GZ1>V:SV^GQHENQ9D>/:H4%64@J<#L:AO/!>EMX2N_#F
MG6L-G9W>1+@$DY(W,3G+/QP23SC.1Q7244 -CC2&)(XU"HBA54=@.E94/A?1
M;>.SCBL$5;*X>ZMQN8[)7W;GZ\D[FZ^M:]% %1=+LEU=]5%NOVYX!;M-DY\L
M,6"^F,DFH;#0=+TN_OKZRLHX;J_<274JYS*PS@G\S^=:-% '.ZCX$\,ZKJ;Z
MC>Z3%+<R%3*=S!92O0N@.U\?[0-6]8\+Z-KPM_[1L5D:VSY$B.T3Q9ZA70A@
M/8&M>B@#GY/!'AN71%T=]*B^PK/]H"!F#>;_ ,]-X.XM[YS1JF@O;Z9JTWAZ
MVLDU:]CC5FNPSQS! %"./39E?QSS7044 >8Z#X#<^*M-U23PU8:!:::7E$4-
MS]HDGE92J\X 1%RQ ]3TKJ[GP'X8N]0N+VXTF*2:Y;?,I=_+D;&-QCSL+?[6
M,]\UT=% &))X0T&5M)9M/3=I "V+!W!A48P,@\CY1P<CBI&\+Z(^D7.DOIT+
MV-S*TTT+Y8.[-N+9/.<\Y[=JUZ* ,33/"&@Z0ET+*P"-=)Y<\KR/)(Z8QM+L
M2V/;-6'\.Z3)HUMI#V2'3[;R_)@R=J^604[\X('7TK3HH *YRU\!>%[+44OK
M?2(4FCD,L2EF,<;G^)(R=BGW %='10!4M-,L[&YO+FV@6.:\D$MPX))D8*%!
M.?8 5;HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *\O?Q+8:?\7==U#4XK@6MG90Z=
M#=16[RJLA_>NGR D$[QVYVXKU"LK1-!M]#DU.2&66634;U[R5I,9#, -HP/N
M@* * /,SHU_JD=JM]I\T*^)/$JW\UK(AS%:1)N42#^$MY:Y!_O8ZUT>O7,>A
M_%"QUS58IAI/]DO:PW"0M*L$YE#-NV@E=R  'O@BN^HH \:\0Z=J?B73O%?B
M*#3KM;&[%G;P6QB*S7-M#)OE?8>?FR< \D#IS763Z^/%GVFP\/::\\45C,R:
MG/$T*P7!0K&D8=02W)R1C:/KBNYHH \*TJP@OO"FF^%H+SQ;->2Q);7VE;$@
MBM1_RU+NT! 4')')+<=S6I>V\>A>._$4^JZKXBT[[4+?["^FP>8MU$D84(#Y
M3_.&SQD?>S[U[#10!X^VER>'[?PIK.I6>IBQ_M6?4=3CN2+B6&62,K'(XC0=
M#@G"_*6J?4-5FU+Q'XH\36>GWBQ:;X?^R6+R6[HUQ)(6<,JD9QD*.G3GN*]9
MHH \S\.:"]OXQ\-V,ML_V?P_X>&'*':+F4A6P>F=J-_WU61K&E:AJMAXNU=;
M"XN%DU^V$MJD9WW%I:E 0J_Q9^8@=\5['63XAT&/Q!90P->75G-;SK<07%JX
M5XY%S@\@@CDY!!!H XB[UZU\8_$?PK8V5I=?9++S]1DFN;9X=Q5-BA5<!L!G
M&3C&<8S@U>T*]C_X2+QIXND61]/C:.S@,2%VD%NK>85 ^]EV(&.NVM:S\&-;
M/?WDVN7]UK%Y;BU.HRA \,6<[8U50J\DGIUYK?TW3K32--M]/L85AM;= D:#
ML!_,]R>] $MK.MU:0W"*ZK*BN%==K $9P1V/M4M%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %<[KOB>73=6M='TW2I=4U2XB:<0
MK*L21Q*0"[NW Y( &#FNBK)U"_M[F\D\/P:HUEJTMM]HC,<89UCW;2R[@5//
M&.>O2@"/PUXCB\1V=R_V66SN[.X:UN[68@M%*N"1D<,,$$$=0:VJX#X<+)IN
MI>*= FD6[EL;Y99-1YWW33(&._DC>N IQ@=.!7?T %%%% !1110 5PGB7XDC
M2O$1\.Z'H=WKVL1QB2>"W8(L*G!&YR#@\CMW'/-=W7C_ ("N[?1_C'X\L=5F
MC@O;R=)K;SF"^9%ESA2>O#IQ[>U '7^"_B#;>+;N^TV?3KG2M9L,&XL;GE@#
M_$#@9'3L.H]:Z_>N_9N&X#.W/.*\_P!5\?:9<VWC"W\-HTNKZ58O+)=11*8V
M8)QAQ]XKZ'^Z?2O+;K0-"L/@U:^.;34YU\5%TF%\+MC(\QD :,C..!GMGC)X
MH ^E"<#)JAJVL6>BZ+=:M>2$6EM&99&0;C@>@'6O&[S2T\6_&?1+;7(Y0ESX
M;BEO+9)&C#MEB4;:0<;L''L*PHM'M$\'?%+1,2-I^CWWG6,+2,1"P,@!'//
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MDQY97."&3G!'?/:@#Z>9U12SL%4=23@5G:[KMCX=T*ZUF_=A9VR!W,:[B<D
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MD;DR7ID=0RN<_O REB0:Z#P?*D6M>/&D<*L>J%V+'&U?(3D^W!H [HD $D@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@O["XCN+6==\<L9R&%8NK^.=!T74)+&ZN)Y+F%!)/':VLD_D(>C2;%.T=^:
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M=FT V(_LN9F:2#S'^8L^\\YSRQSUJY<:38W>I6.H3P![NP\S[-)N(\O>NUN
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MD@XSEU< J, G/3@U2TWQ_P"'=5OX+2VNY@UR2+62:UEBCN".HC=E"M^!Y[4
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M)US3=(^"VI>$-01UU^WMKBWDL/)8R-(69A*..4Y#[NE>X @]"#CCBEP,Y[T
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M<BH/%\3F^^)^V-OGT:TQ@?>.V3\Z]>I"0!DD >IH \DUN?3M.\0BX_X2&_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC?9C>C!@"K $'T(K3\5^(F\.V-J;>T^V7]]=):6=OOV!Y&R?F;!PH ))QVK
M\->'+J/Q-%J3>$=#\/6EO"RA+>.*2XED;C(=%&Q0,CU.>:U_&>A7VKVVFWFE
M&$ZCI5ZEY!',Q5)L JR$@'&58\XZXH H3^+]8\.VNIS^*M(BC@L[3[5'=Z?(
MTD,IW;?*^8 J^2,=B#VQ3#XL\1Z1-IMQXDT6RMM.U"=+<-:W3226COP@E!4
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MP"X&<KD9^ZQZD8K:O_#OB'Q1>ZEJNI6,&GNNCW.GV%D+@2LTDH^9W<# '
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MY<4*HHW/(X!)/(''4YYIS?$>73M,U_\ M6P@;4M&@2X*65QYD-Q&YPK*Q&5
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M!L,#+MQ@?0&LC2[+QWI^A:?X8@MK.V6S\N#^VEG5P8$(Y6%E)WE1MP>,Y.:
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M896&01Z&L+3/!7AG1M0^WZ=H=E;70SMECB *9Z[?[OX8K>HH **** "BBB@
MHHHH **** "CI110 4444 %%%% !1110 4444 %%%% %/5-)T_6[%K+4[*"[
MMF()BF0,,CH?8^]0:-X>T?P]#)#I&G6]FDAW2>4F"Y_VCU/XUIT4 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
00 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>separationagreement005.jpg
<TEXT>
begin 644 separationagreement005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHJAK6K0Z'H]SJ=PDCPVZ[F6, L1G'&2/6@"_1
M7/>&_&-AXGTJZU"S@N8XK9BKK,JAB0N[C!/K3_#/B_2O%EO++ISR!XB/,BE7
M:Z9Z'TQP>AH WJ*J3ZG86UP+>>]MXICC$;RJ&.>G!-6Z "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>A(J:F(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD9 Q X!( Z4 =317E.J^,+G4/%VLV#:WJVDV>F2+;PKINEM<M+)M#,\C>6X
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MT%<O:?$OPC>WL-K#JZAYWV0R2021Q2-Z+(RA2?H>:S_BD/M%CX<TZ;_CPO\
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M>/XBBGEU%OGD5V24EPO*JH./EZ8X[UZ3;7MK>1&6UN89XP<%XI P!^HIWVF
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M^3C).20.BG([8H YVQ\/Z5K7Q>\57&IV4-VUI#8F 3+N6-BC$L >,_*.:O\
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M2SN,^?$4W"7/!WYR6_'- ' 6FBWVD^._#<PM/#&B._FQ&#39I-]Y#LR5*^6
MVTX;)/&*V?B[';3>#K:.]D\NT?5+19GW;=J&4;CGMQGFNAT;P;X=\/W376EZ
M5!;W#+L\T99@O]T$DX'L.*T-2TJPUBU%KJ-I%=0!UD\N5<KN4Y!Q]: . U?3
M;'P[\0?#(\,65M:75Q;7:7$%J@1985BRA<#KAPN"?7%</IND7NH?"YM6FM?#
M,3RAKB77+FZE6\BGWGYV81DAPW&T'V[U[5HWA/0?#TTLVDZ9!:RR@*\B@EBH
MZ*"<D+[#BJTO@/PM/JIU.30[1KII/-9BORL_]XK]TM[D9H Y*PT2RUSXI7C:
MY:VVH21:'9L5ECWQ&1B^6"L,>N"1D GIFN3NUG@\*KHEHL TL>,Y[)H+B5HX
M/)#,4B=@"0A;':O<4TZSCU*;44MT6\FC6*28#YF122 ?89/YU6?P[H\FGWEA
M)IMN]I>RO-<PNFY9)&.68@]R0#0!Y_IF@3VOQ"M(+RQ\,Z?#=V$T=WIE@[N+
MN(8VLT9C"_*W&3U!(K T.QM+7X<> I[>U@BFG\20&:2.,*TFV68#<1UP.!FO
M6=%\*:%X=DEDTG38;:64!7D&6=@.@W$DX]NE2Q^'-'BL;*QCT^%;6RG%Q;1
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M'WW4.S*2MZE3P.O:I-%\*Z'X=:5])TV&VDE $D@RSL!T!8DG'MG% &Q1110
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MC*UUGP\L8DN=<U2&VUA8KR:-4NM6E)ENEC7 ?854H.<#/) '2@"6\\6WMO\
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MA\IM\864%BPQD8[YH ZJ[^(.G0:KJ&F6^G:M?W>GL!=)9VN_RP5#!B<@8(/
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M RQ)P<>@!Z[J_C.RTK56TN*QU'4[](A--!I]OYIA0]"Y) &<' SD^E<UJOQ
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MCCGU%F>:\6.1?F$10,J@$C)SD#MBN[\56MQ-XU\%3102R107EP971"5C!@8
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MM[M8Y8EGB641S)M=0PSAAV(SR* )Z*** "BBB@ HHHH **** "BBB@ HHHH
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M!:*B>YA2"68RJ8X@2Y!SC'7I63X5\46/B_1%U;3EE%J\CHGF@!CM8C..P.*
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M+!_:<,<2*<_(%P>!GC\*NZ!H6L>%[]K[1_A'9V]T05$I\0+(5!ZA=X.W\,4
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MD,LC11/_ 'DB+;%/N ,5-JO@CPYK>I_VEJ&FK+=% CNLKH)5'0.JL X]F!H
MR/A$XD^&.DNIRK-<$'U'GR4>$Y$C\<^/=[A0EY;,V3C ^SKS].#75Z7I5CHN
MG1Z?IUNMO:1%BD2DD+N8L>ON2:RM4\#^'-:U0ZE?Z:LMVRA)'$KH)5'0.JL
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M5V"@D @%<X^M<SKD<_BD>.-<TBTN7T^70ULH',+(;R52S%D4@%@ 0N<<]LT
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M&0>0<=JY6U^*'AJ\A@NHI+W[!,ZQB_:SD%NCMP%:0C .2!Z GDUUTJA;5U4
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MBF!QSN+/TX_E6/\ #6[\0ZKI]YJNKZN]_I]Q+C3?,M8X7:)21YA"@??/0'L
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTIY7M9[AMT:EX_,R%!4R*>!@X/J* .J\-^&UT!;R6:^GU'4+Z42W5Y<!0TA
M"J,*  H X ]ZW*\]USQGXGTFPOM8;2=*M=.M&<K;7UXT=U<1H2"R@+M!;&0.
M:B?5=:OOBUHKV8MO[-N-&:X6.69P?+9X]S%0"/,&0!V(ZD4 >CT5YH?B1J=U
MIUWKVG66DOHMLTFV&:^V7=Q&A(9T7&T=#A3R<>XK0F\:ZMJ?B*'2?#6GV=PM
MQI4.IQW=Y,T:*CLPPP4$D\+@#U/I0!W=%>8#XB^)G\+W7B)?#]@EGI<CPW\<
MEVWF2-&VV0PX7&!_M'GGCC)VM7\:79\0G1-#CTWSXK9+FYN=2N#%%&'SL0
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M ;NF[VZUIT >.?\ "OM;;1]7TV;P[H]YJUX;@?\ "0W=P'=U<M@A2I96"D*
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MC:0,]<4_Q5X5UG6KC4[:[\,:/K'GLW]GZFTPMY;12/E5\+N.P\Y!Y]J]-HH
M\I$?B#0_B1I=K8QQ:Q=6WA>.*Z$\_E-/MFP75B#\V[GGJ"><U+J7@?Q#J6BZ
MK>SBV.J:IJ4%W=Z<EPRQ26T0"BV,F.I4<MC&:])^P6G]H_VC]GB^V>5Y'G[1
MO\O.[;GTSSBK% 'FFD^$-1B\;:%K$'AO2=#TVRCN(Y+:UD5I273 =BJ@'D
M<D<G/.*LVG@_7(?@W+X8AN8[35VCF59$D.T;IF?&X<C*G!/;-=KI.IP:SI<&
MH6R3)#,"56:,HXP2.5/(Z4:OJMKH>D7>J7K,MK:QF64JNXA1UP.] 'FB>"=2
MDO\ P]/8^$=&T*#3M0BN+@13K)/, "#\X49 !)Y))..F.1)M6T'0O%%IH<VD
M76CQW-V_VV>Z:-[!FR9(WCVG>0Q.WD9R*]5AE2>".9,[)%#+GT(S6+>^"_#&
MI:G_ &E>Z#I\]X2"9I(%)8CH3ZGZT <AX1\.ZA):^!M3$:K;VF@O#*&;#!I%
MC*\?@:F?P9J[?!"/PH%A_M1;=(R/,^3(E#'YOH*]&  &!P** //6_M+2/'GB
M&7P[_9NH&[2"6^M+JZ:W>TD";5DSL;<C* 3[BLWP3J^I:7\/QJ$<=O>SWNOR
MJ6#%5E62X*L\?<\Y('H#Z5W>L>$O#WB"XCGU;1[.\FC&U9)8@6 ],]2/:J]E
MXET6.R2.QAE6WAU'^R5C@MR%CE4[<8'1!Z]* -?4K&+5-+N]/F)$5U \#D==
MK*5/\Z\UU#0/'-YX'A\(?V?IWEVH@B.HB[XN(HG4KMCVY5B%&<G'!QG->J44
M >;:MX,N+7Q?JFL0^%]'\1VVIB-S%>F-);:55VG:SHP*, #Z@U-9>#-5@/A:
M62VTJ![+49KR[BL(5ABC5XV554 #<1E1D\G%>AT4 <9J6E:YI'C.X\1:'90:
MC%?VL=O=VDEQY+JT9.QU8@@C#$$''K7-ZIX8O;73I]>U>_L+'7[O6[>^MD=F
M:W21%\N*!GQDY7<"V!R:]7K,U.31[V=-!U);>X>]B=Q:3)O$B(1DD$8P"1U[
MT <!+<>(-4^*V@1:C#96$L.GWCI!:W!N&AW*B^8[;5&"< #'\)YYK$F^'&NS
M^#+O1!X9T9=7D1A-KD]R)9+@[LY7*[P6Z<D 9->L:-X9T/PZ)!H^E6MD9<>8
MT,8#-CID]36K0!Q%YH&K/XZCU);.&?3;[1UTR\_TC8]OAV8L!@[A\V."/\<@
M:#XT7P6? XL]/-MY!L1K'VGC[-]W/D[<[]G&,XSSFO3JAN[J*RLI[N8D101M
M(Y R=JC)_E0!S7ASPU<:+XMUN[POV"XM;*WMCNRQ\E&4Y';J*YB[T07_ ,:%
MM[6XCDTPI#K%_"ISMN(@\<6>PW95L=_+S7I&F:A;ZMI5IJ-H6-O=PI/$6&"5
M8 C([<&LSPU;:'$NH3:-IJV9>[D2Y/D>6TLBL06Y^\,YP>G/% %_6M,CUO0K
M_2IF*1WEO) S#JH92N1],UP-WH7C+6_"<'@W4+&PM[0+%;W6JQW6[S84(Y2+
M;D.P4#DX'->F44 <UH.AW>G>+_%&I3*@MM1DMFM]K9.$A"-D=N13_&F@7/B#
M18DL)8HM0LKN*^M&FSL,L;9 ;'.",C\:Z*B@#@AIWBG7?&F@ZMJFE6FG:?IZ
M7"20I=^=(S21[=V0H&.@ Z]2:YVT^'^IZ/I#Z#;>$/#-_(K,EMKETD9*QEB0
MTL90LSJ#C@X.!7K]% '(0^&;ZW\:#4(7ABM$T!=-CDC4+ME$A8$(. H&.!QV
MK@9OAQKL_@RZT1?#.C)J[H1-KD]R)9;D[LY4E=P+=.2 ,FO;:* .7TK1+ZW\
M=ZGK,Z(MM=:?;0( ^6#H7+ CT^8<US\G@K6&^#^J>&@L/]HW,L[1CS/EP]P9
M!D_[IKTBB@#S?6O">HS>.;[5KCP[I_B.TN(8DLEO;D*MB5&&&QE8$,?FR 35
M"W\#^(['PC#;I;V$NHV7B,:M'!'+Y<4R!MVU3@[.IP".,5ZG/,EM;RSR$A(D
M+M@=@,FJ^DZG;:UI%IJ=FS-;742RQ%EP2I&1D=J .0CT_P 3^'_$&IZKIFDV
MNH6^LB*>:U:\$3VMPJ!6PQ4AT.!SP>.E4K3P+J]O'HD\\EO+>_V_)K&HF-B$
M0NC@JF>2!E17I%% 'GGQ9BF&E:9>Z7<)%KT%XL-B"?FD\\&)E ^C;O\ @%=I
MHFDP:%H5CI5L/W-I D*GUP,9/N>OXTDVAZ5<ZS!K$^GV\FHVZ>7%<N@+HO/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*Y3QO>WFCC1-8@N)([6VU&*.^0-\CP2_NR6'?:S*175UGZYI%MK^AWNDW>X0
M7<31.R'#+GH1[@X(]Q0!Y?%X[U+3=:\3ZI>7+R:7=6MS)I$3'*A[:3R<*/\
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M3/(8P6+I-(%.>N0%&/I6OXCU0^"M1TCQBRM);WNE&QNQUW3+&98"?<D.F?\
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M?#%CJUU'%JEQ9+Y<$T@$L@50>%/)(7;GT[U#\5T1_A?KY95;;;%ER,X.1R*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ6WG)'RA0236/<?$:UC^V7-MHNJWFD64C1W.I01H8D*G#E06#NJ\Y*@C@]:
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M@T34YM7TU;N?3+S39"Q4V]V%#C!Z_*2,&GZQJ]EH.D76J:A+Y5I;)OD;&3[
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M+(0.0/FX8\>]8MAHVMS:?IDMSH]U!,WC=]0EA9-QBB82'>2.-H+ ;NE>PT4
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MN:\M3$(B874+SU&3RPXZ<\UM_$VPNM3^'^HVEE;2W-Q(]N5BB4LS 3QD\#T
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MUVVB27TV@Z?+J:"/4'MHVN4 P%D*@L,=N<UDZ-X5%C9>(K.]E2>#6+^XN65
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MG7NEZ1';ZCJ4FHWFYGEN'7;N9CG"KV4= /05IT %%%% !1110 4444 %%%%
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M%:8[2P.<$#'L.F*OZE<3^ ]0\9VNA23K;0Z)%?002RM*L,Q9T++O)(Z D>U
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MXT5Y3I%IK6D>(Y(++3IO#VF7.G3^9%>ZK%<+'*HRDR+YC,,=&QQTS6;H4?\
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M/.-OK$4BPF(.RQOM!D(5!G;@DD@<=#UQ6W<:I96NI6>G3SJEW>B0V\1!S($
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MB:> !I(FC>-PIZ-M< D>XXJUK.O:5X>MHKG5KV*T@ED\I)),X+;2V,_13^5
M'!>"OAC:Q>$=-@UV._2529;K36O&-L\@<E6:,$J> IQT..17?6NBV5GK5_JT
M*,+N_2))R6R"(P0N!V^\:IZ7XOT'6$NVLK\.;1/,GCDB>-T3&=Q1P&Q[XQ5B
M3Q%I,6AP:T]Z@TZX$9BGVMAO,("<8SR6';O0!C7GPYT*]N;N0OJ$%M>R&6[L
MK>\>.WN&/4L@..>^,9[U;U3P5I6I7-K=1/=Z==6T'V:.?3KAH&$(Z1G;P5'8
M$<=JQ?\ A85EI?C+Q'I>N7R0P6;6_P!D1('=]K1!G)" G )')&!FM#5?%##5
M/"7]DW,$]AJ]TZ/(N&#H(F8;3VY H R/$O@"VET_PYI.FV4SV4.L"[O7^T'S
M<%)-TK2$[BVXCD'/3TKI='\(:9H\]U<AKJ]N[J,137-_.T\C1CHF6Z+[#KWS
M5>Q\3V5GH-YJ>KZW:26\-Y-#YZ1F-5PY CP>68=..IZ5?T3Q/H_B+SQI=Z)G
M@($L;1M')'GIE' 8 ]CCF@#'M_AKH%O+  VH26-M*)H-.EO'>UB<'((C)QP>
M0#D>U6]6\$:7JVIRZCY^H65U<(([E["[>#[0HX <*><#C/7'>M#6_$6D^'8(
MI=5O4MQ,VR)=K.\C>BHH+-^ JM#XR\/7&ASZS'JD1L('$<TI# Q,6"A64C<I
MR1P1WH AG\#Z)(=&,$4]D='!6S-I.T15#C<AP?F4[1D'KSZFJ3?#70&=X]VH
M#3I)O.?3!>.+1GW;C^[SC&[G;T]JV]"\2:1XEMYKC1[Q;J&&0Q.ZHR@-@' R
M!G@@Y''-4=2\=^&M)OKBRO-3"W5N0)H4ADD=/E#9(53A<,#GISUH M0:-+%X
MOO-8,Q$$UI';K%YC$%@S$MMZ+Q@<9SSFI==\/:?XCLDMM0C<^5()H98I#')#
M(.CHPY4U5U#QIX<TJPM+^\U:WCM;Q&DMY1EEE  )V[0<]1QU.<50B\::6+R[
MU"37+?\ L=+*"X6/[.ZO&'<J)&)'W6X&,<8.: +5AX(TBQBU#<UW=W.H0&WN
M;N\N&EF:(@C8&/W1R>!BMK3[&#2],M=/M@1;VL*01!CDA5 49/?@4R]U6QTZ
M6SBNKA8Y+R806ZX),CD$X&/8$YZ5AW/Q%\)V=Y):SZQ&KQR^3)((I#$CYQM:
M0+L!SZF@#8.BV9\0C7=K_;A:&S#;OE\LN'QCUR.M9]CX+T;3ET=;>*4#2))I
M+3,A.TR[M^?7[YJC+XYMHOB5'X58J$:R\TOY;EC,67:F0,8VDG/3G&1BK4WC
M_P +6^IOI\NL1+.DODNVQS&DG]UI,; WL30!9OO">CZG=ZC<7EL9FU&T6SN5
M9SM:-22 !V.6/(YK+3X<:,9+*2ZN=4O9;&:.:T>[OGD\AD((V@\=AGC) QFN
MOJAJVM:;H5JEUJEW':V[R+$))#A=S= 3V^IXH 98:%8Z:VI-;(X.HW#7-QEL
MY=E"G'IPHK+E\!Z(^BZ9IB+<P+I8_P!"N()V2>#/!VN.>1P0>#44?Q*\(213
M.NLIF$J&C,,@D;=G&U"NYP<'E0>E:,?B[0)?#O\ ;ZZI!_9?3[020 <XVX(S
MNSQC&?:@"G#X"T.*Q^S,ES,S7D=]+<33L\TTT9!1G<\D# XZ4R?P!HT^H7MR
M)=0ABOI#+=V<%X\<$[D8)9 >^.<8SWJ:R\:Z)K*7L.E7_F7MM;M,8)87B<*!
MPVUU!(SCD<56\,^+X+KPIX;N]8NHTU'5XE\N*-"3*Y&3M49.!W/0=S0!;T[P
M7HVEC1A:Q2J-&$PLPTA.P2_>!]?;/2M/5](L==TN?3=2MQ/:S !T)(Z'(((Y
M!! ((Z5EZGX[\,Z/J$EC?:JD=Q%@RJL;N(<]/,900G_ B*Z".1)HDEB=7C<!
ME93D,#T(/I0!SVF>"=*TZ[ENY7O=1N9(#;>;J5RUP5B/5%W< 'OZ]ZJV?PYT
M*SN+5]^H3VUG();2QN+QY+>!AT*H3CCMG..U6-3\?^%](O9K2]U54F@($VR&
M2182>SLJE5_$BK.I^,/#^CBW-]JD,7VF'SX, OYJ9 RFT'=]X<#DYH N6&BV
M>FZAJ-[;*XGU&59;@EL@LJA1@=N *R6\!:&= L-'2.XBBT]S)9SQ3LDT#DDD
MJXY_B/M4]MXV\.7>E?VG#JD;68N%M6D*,I25B %92,J<D=0.M:=SJEE9W]E8
MSSJEU>EQ;Q8),FU=S=/0=S0!@VOP^T.UAU9/],F?5K;[->S3W+223+\PR6/?
M#$?0#TJY/X0TR;5-*U%6NH;K38A!"\-PR;X@0=C@?>7('!K'^)'B^3POIEC#
M:726M[?W<<"S26[2B&,L \FT<$@'IWS5L^--%T.QLK?5]<^U7KVZSL\5F^]T
M/(=HT4E ??% $S^ ]"?0;;2!%.D-K.]S;31SLDT,C,S%D<<@Y8TMGX'T>TL]
M3A8W=U-JD)M[N[NKAI9I(RI7;N/0 $X Q535O%H=_"EQHEW!<6&K:B('E4;@
MT>QR<>AROZ$5;G\?^%[;4GL)M6C69)?(=O+?RDDSC:9-NP'/&": +MUX:TV[
MTO3=.E20V^G2P2VX#D$-%C9D]^GXU9M=)M[35;_4HWF,]]Y?FJ\A9!L&!M7H
MO!YQUJEK7B[0O#UQ%;ZG?B*XE4NL,<3RR;1_%M0$A?<C%:6GZC9ZM80WVGW,
M=S:S+NCEC;*L* +-84_A'2;EM>:2.0G78UCO<2'Y@J>6-O\ =^6MTG R:\\\
M4?$_2(-)D_L'58)M0%S#$F8F,<@,RJX1B KD G[I..M '77GA[3[^UTRVG1S
M'IMQ%<6X#D8>,87/KUJ?6=(M->T>ZTJ^5FM;I#'*%;:2/8]JS%U^WLM4\0MJ
M.L6BV6GB!FC*%&M0R9^=CPVX\C'TI^E^-/#^LR7$5EJ&Z6WB,TD4L,D3B,?Q
MA74$K[@$4 6=9\.Z;KVE)IU_"SPQLKQ,CE'B=?NNC#E6'J*IZ1X-TO2;RXO3
M)>7U[/%Y#W5_<--)Y778">BYYP.M0VGQ#\*7UU;6]MK$3M<E5A?RW$;LPR%#
ME=N[G[N<]L58UCQIX?T&\-IJ&H;+D)YC110R3,B_WF"*=H]SB@"BGPYT)/#\
M>BA]0^RP7 N;5S>.9+1P,#RGSE0!GCIR:EL_ .B6<E],#>3W%_:-9W5Q<7+2
M22H>N6/?L,= !5JZ\:>'++2;35;C5[=+"\#&WG&2LF%+$# ZX4\=<C'7BH)O
M'WAB"PL[Q]3S%>JSVZI!(\DB@X)\L*7 !&,D4 7+GPQIEUH-CHTL<AL[(P&%
M0Y!'DD%,GO\ ='UJS=:+9WFM:?JTRN;NP658&#8 $@ ;([_=%58/%N@7/A^7
M7HM4MSID61)<,2H0@X((/(.2.",\CUJ#2_''AS6;^*QL=262\E#%('B>.0A1
MDG:R@@8Z$\'MF@"QX8T>;0](:TGF,KM<33#,C2;5=RRKN;DX! I+KPOI]WXE
MM_$!:ZBOX8?()AG9$ECR2%=1PP!8GG^@K,T_QGI5EX;TZ\UK7[.5KOS?+NHX
MFC2;8QR%7&<@8&.YZ9S6IH_BS0M>MKJXT[48Y([3_CY\Q6B:'C.65P"HP#R1
MC@T 0GP;HY\&CPH8I?[*$8BV>8=VT-N^]UZTW6/!NFZQJ:ZGYU]8ZAY?DM<V
M%RT#R1]0K8X8>F>14%I\1?"=]<P6]OK$;2W$JQ0*T4B^<S':-A*@,,\9&1[U
MU% &?HFB:?X>TR/3]-@\JW0EN6+,[$Y+,QY))[FJ?B#PEI7B1[>:\6>*\M2?
ML]Y:S-#-%GJ ZG.#Z'BK.M>(-*\.VJ7&JWBV\<CB.,;2S2-Z*J@LQ^@KG_#?
MC6'7_%/B"*"]@DTBPMK:6.3;L*%A)YF_.",;!P<8H T]!\&Z5H%[/?PFZN]1
MG01R7M]<-/,4_N[FZ#V&*SS\-/#Q<QXOO[.,OG'2_M;_ &3?G=GRLXQGG;T]
MJO:7XZ\-:UJ"6-AJB27$H)B5HW03 ==C, '_ . DTL/CCPW<:Z-$AU6.343)
M)%Y"HY(9,[@3C QM;J><'% &C:Z+96>M7^K0HPN[Y(DG);@B,$+@=OO&L_\
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MV0Q)&N<[44 ?I3F574JP#*1@@C(- 'E6I7UGX@\8ZYJFAS1W5A;>&KBVN[R
M[HGE8[D0,.&( )XSC-*G_(!^$G_72W_])&KU*.&**,1QQHD8Z*J@#\J=L7"C
M:/EZ<=* /%M<@DD;QC-Y+SVEKXDL;F]B12Q>W1(B_P HZ@#DCT%;OBW7-'\7
M6=WIWAE(M7U9M*NC'>695Q:JR@;"PZ-)]T+UXYKTP* 20 ">O'6F1010 B*)
M(PQR0B@9/K0!X>MS9ZOX?T#2QXTEO)#/;+!I-GIL(N;>1"#\PR&0)@Y8XX!Z
MUW'A"&+_ (2?Q]*8/,=M01&"CYG40*0OZG\Z[A8(4F:58D$K<,X4 GZFGA0"
M2  3UP.M 'A=CJ\.E:?I%OH6O6^LV8O(HX?#.JVB->6QWX."OS*R<G+# QUK
MU7QW_P D]\2_]@JZ_P#135N"WA68S"*,2D8+A1N(^M/(!!! (/4&@#S+788H
M? GP^6.-56/5-)V #&.@X_,T>'?$&B>%+[Q=9^);R"QO9=5GN\7/!N;=\>64
MS]\;?EVC.,8Q7II52 "HP.@QTIDD$,K(TD2.R'*EE!*GV]* /%M#;_A'(?AK
M<ZSFPMEEU''VCY?)64,8D;T)!&!7H_Q$C>7X<>(T12S'3YL #)/RFND>-)%V
MR(K#.<,,\TZ@#RB#7=)@\7>%_$EU>P'0Y-%>R@O6;]S!=!U+!FZ(2H*Y..A%
M:&@:OITGC7Q=XIMIU'A^.T@2:]0$Q32QAB[*1][:I )%>AF"'R3"8H_*/5-H
MP?PJ.ZLHKK3IK++112QM$3%A2H(QQZ4 /MKF&\M8;JW</#,BR1N!]Y2,@_D:
M\76*.:QL(Y$#H?B')E6&0?FD->T6UO%:6L-M @2&%!'&H_A4# 'Y4_RT_N+U
MW=._K0!Q<Z@?&ZS8  MX>F!/KBX3'\S57XJ75G8P^%;K4%W6D.OP/+\N[:!'
M(=Q'<#K^%=_M&[=@;L8SCFL;Q!X?&O3:/(;GR?[-U".^QLW>9M5AMZC&=W7G
MITH XN_O+7Q9X]^T>')X[Z*UT2Z@N[FV8/&S2;?*BWC@MD%L=JYJ\\4Z/<_!
MS0-%@O$EU.)K&&>U7)D@,<L8;S%ZH,C&3C)(]:]PBBCA39%&D:YSA5 %(+>%
M7=Q#&&?!8A1EOKZT >;:?XBT'P_\4O&S:Q>6]C)+]D,<]P=JNJP#*ACU(R#M
MZG-8>A6\L+^"I6A>"VNO$%_<V<+KM*0.DI08[9'./>O99((91B2*-^0?F4'D
M=#3RH)!(!(Z<=* /$;-EL[31]7O03I%AXKOWO&VY6(LTBQR-Z!6(Y[9KT;1M
M>T'7?%MX^CP17DD-HB3ZM;[6C.6)$.\?>(Y;C(&:Z?8NTKM&T]1C@TD44<$8
MCBC2-!T5% % '!>(;NUT/XJZ3K.LR)!I;Z9+:074W$4-P9 QW,>$+(, G&<$
M5Q7B^:VUNR\?ZQIA$NCSQ:?;&X0?N[F9)EW%3_%@$*2*]SDC25"DB*Z'JK#(
M- BC6,1A%" 8"@<#\* !$6-%1%"JH "@8 %>9:7XE\/^'_B7XY&KWMO8S226
MS++<':)$6W7*J3U()SMZ\]*]/K"T[PS%8Z_KFJ22K<?VI-#,(GB'[DQQA.#D
MYSC.<#% 'F/ARP9=5^'YN+9HK>;4=5N[2"5,&.)E9X^#T[,/J*ZF73+?6?B9
MXITRZ7-O=Z%;PN/9FE''O7H)4$@D D=#CI1M&XM@9/&<4 >4^!)=0\0^(;4Z
MI$Y?PE9O8/D?ZR\+%&<'O^Z13_VTKD]4\0-J7PPU)1KNG:;YD<X'AK3[)?-B
M(8DB3<2P[LS;5 Y.:^@@H&< #/)QWI@MX5D>00QAW&&8*,L/<]Z /-HM0M[3
MXFZ*TUU' ;[PPMO:2.>))3*I"@]SCG%<1IDT=I\.)]!U;Q>UI.@EMKK0ETZ)
M[II&8Y" X9RQ((;W'(Q7T"8HVV913LY7(^[]*0P0M,)C$AE P'*C<!]: ,G2
MM0L[,Z;X?ENW;4Q8)-Y4RXD9% 4LV,@'/49ZU@_$^))])T**5 \;Z_8JRL,@
M@R<@UUCZ;;R:O%J;[S<10-!'D_*JL5+<>IVK^7US;*AL9 .#D9% '#R0QM\<
MX)&C4NOAURK$<C_2 /Y$_G7'/JG]DZ'JS""Q"R>-9XQ>7T7F0V)W9$Q&1R#P
M#D#)Y->T[1NW8&[&,XYIK11LC(R*5;[RD<'ZT >-VVH?;/B; S>)$UW_ (DM
MY']I@MTCA#?*2B,N0Q Y/S'&1TJK\/8Y?"*^&=<U6?[9I^M6,=DEU*@!TZ3)
M,<8/:-QP3W89->W)#%&JJD:*JC"@* !]*4QH4V%%V^F.* /#["Z;0SXHLM7\
M91:+.=0N9IK*>QBD:Z1SE70OS(&7  &<8Q7J/@6R&G^!M'M5-V4CME"?;(PD
MH4\J&4$@$ @8SVK=>"&5T>2)'=.59E!*_3TJ2@#Q*[\1-=:;XHB_MS3]"8W-
MU%_8=K9(]W<OR-S;B2S/ZJN,'K6CX36*?7OAPY"N8_#,A4GG:P6)3CWY(KUC
MR(?.\[RD\W&-^T;L>F:<$1<851@8&!TH \U30H?$/B#XG:*^$6Z-HJG^Y(;9
M2K?4, ?PI/AY>WGB_79/$.I0O&^DV2:4JN/^7GAKEOKD(OYUW^JVU]<:;/'I
M=Y'8WSXV7+P"4+@C.5R,\9'7O5?PUH,7AS1(M/29[B0,\L]PX ::5V+.Y^I)
M^@P* ,#XD?\ 'OX8_P"QCL?_ $,U@ZEXB,/COQ!;'7-*\+"!8-TTMJKW6H#9
MD,I8X(7.T !C_*O4BH;&0#@Y&:8\$,DB2/$C.GW6*@E?H>U 'B'AA]WA_P $
M F0LOBFY#"5-C@_OC\RX&T\\C Q2:CJEKHVGZN-&U^ H+R4R^$M;M$E>64R9
M*H =^&/*XW#D>]>Y>6G]Q>N>G?UIIMX6F$QBC,H& Y4;@/K0!Y#=7%UI?Q+U
MRZU'Q)'X8_M"VM9+9[FWCD21%CP\8=^ 5?.5'7.:W_ >H:5H?AB2\FU*Y>UU
M36)!;3W5J(1-)(0!Y:+G",P)!..IX%=_+!%.H6:))%!SAU!&?QJOJ&F6^IPP
MPW&XQ13QSA%. S(P9<^P8 X]O3B@"OXEM;J]\+:O:V)(NY[*:.$@X^<H0OZD
M5Y-K?B3PY<_"71='MY8O[3@DL8C9!?WMK)')&)"Z]4_B7)QDM[U[;4?D0^8T
MGE1[WQN;:,G'3)H \GUR/3Y=7^)*ZJE\;+=IC2/8J#+#A 1( >RD!CUX!XIE
MAK=S+K[6"Z[I?BR!]+N6.HP6R+<62A<A7="5PQXQP<C->O;5!) &3U..M59[
M"&2PN;6%$@$\;(2B <D8S@=: /&%US1-4^!FF^&M+EBDUR>"W@@L(_\ 7"?<
MK&3;U SE]_3'>MR\\1-#XS\0VSZ]I?A<V[0J[-:*]WJ'[L8D&XX8#[J@*QKT
M#PYH47A_0=.TT.L\EG;);_:/+"LX48]\?3-:300O*LKQ(TB?=<J"5^AH \/\
M+HEQX>^'44R,Q37[O<DJ ,K S,-R]B#@X[5U/B;73:?$1[/^U-)\-[-.5_[4
MO;=7EN5+G,:,S!<*><<G)Z5Z3Y:#^!>#GIWILD$,Q4RQ(^TY7<H.#ZB@#P?3
MF>?P[J6H-)<7]G8^,X[^^=K?:\MN$3,IC '&2KXQT&:ZV;Q%H?B'XN^%)-'G
MCNS%:W@EN8E)0@HI";NA(Y)';</6NZU[29]6TXPV6I3Z9=K(DL=S ,D,ISAE
MXWJ>A4]:RM*\*WZ>(8=<UW5X]0NK:!X+6.WM?L\4(<C>V-S$L=H&<X]J ///
M",4<T'PJ61 P%QJ; $9Y E(/X$ U?\8Z=>:EKWCZSTR-FNI]#M"$C^])AWRO
MN2H(_'%>N"-!C"*-O3 Z55U.P_M'3;JT6XGM7GB,8N+=]DD9[,K=B.M 'E_B
M;Q;X9UX^"K72)$GGCURR81I&0;10<%7X^0]!M/7'M7I]IJ]A?ZA?6%M<+)=6
M#*ES& 08RPW*#D8.1SQ7,P^#M8N]1TV;Q!XACU"VTV<7,,,%D(#),H(5Y&W-
MDC).!@9KI[;38+6_O;U-YGO"AD9CG 5<*H] .3]2: ..\6W,&C_$3PUK6JNL
M6DQV]S;"YD_U=O.^W:6/1=R@C)KC-8DC\42_$YO#/^D&>PL0)+<9%QM+[]A_
MBRJE<CKCO7MSQI*A21%=&&"K#(-"1I& $15  ' QQ0!XT+NRURZ\,6L7C9]6
M=;Z">WL;'3H5DM]G.9 "#&@&0<]CT-:V@Z?/=^"OB)!IR8OKK5M42,KPS.<A
M1G]*]-2"&.1Y$BC5W^\RJ 6^I[T\*%S@ 9.3B@#QO6M>T+6?A)8^&]'EBDUN
M2.VMK;38Q^_@G1ER63JFW:Q+' X//-;6E:YI?A+Q3XMM_$LZVUU?7BW-O)*A
M/VJ QJJJG'S%2&&T<\]*]'$$*S-,L2"5A@N%&XCZUS.H^'?$3:K=W6D>*/LM
MO=[2T%U:?:1 P7!,)+C;GK@@C/- 'F>@ZRNG>!_!4<*:?ID=Q>ZAY>J:C!O3
M3\2R84 D .P)7D@<&K^D73:AXR\6[-9.M/)X=VI=) L:2D,XQ&%&&4$XSD\Y
M&>*]0T'P[9:!X<M-$A!GMK=2,S ,9&)+,Q[9+$G\:U5C1<;448&!@=!Z4 >,
MZ7K&FI8?#76YKF.31]-M'LKN<<I:71@C"^9_=Z$9/3/O1XLO;37M3\7:MHDJ
M7.G0>%Y;6YNX#F*2<MN50PX8JN>1G&<5[*(8@C((D"-G<NT8.>N:$ABCB$21
MHL8XV*H _*@#B/$.B/>_"VT73(PE]IMM;WM@%'W985#*!]0"O_ J3X>3_P#"
M1W&K>-'C9$U.1;>R5^J6T0VC\W,A_*NE\1:=JFIZ4;32=6&ES.V'G^SB4^60
M00H)&#R"#VQ5G2-+M=$T>STNR4K;6D*PQ@]< 8R?<]30!=HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME3&Y'S#!YZYZUR_QCADF^%VL&.YDA$:H[A I\P;@-IR#QD@\8/ YZT =W17
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M5"YD(RPP !@$X_"@#2HKR/2_$7B2U\#ZEXXU'6WNH[3[5'!IP@18WVRLB%V
MW9#>F. /?,=IXKU>RN=)N8=8US6)Y[B./4+.XT22&$(YPS1-Y2[-N<\L<@4
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M!2/"[E*AN&+'..1S73^'-6OK[Q?XMLKF<R6UC<P);)M \M6A5B,@9.22><T
M=317+?#K5K[7/ FG:CJ,YGNY3,'D*A<[974<  = !74T %%%% !1110 4444
M %%%% !1110 4A52X<J-P! ..0#U_D*6B@ HHHH **** "BBB@ HHHH ****
M &R1I+&T<B*Z."K*PR"#U!%<]IW@/POI.H1WUEI$,5Q$28B69A$3UV*Q(3\
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M^QK%(TB A#)("2V,]@,]Z1_ NIVGV^UT/Q/-INEWTKS26WV59'A9^7\J0D;
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MGC>]NKV\+V\87DF+;*2[$CY<@ =Z]%\6Z=<:OX.UK3K10US=6,T,2DX!9D(
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MZ+MGO[>VDTN^=&"CR)U_>,"<9"L 1WH Z/3?B7:ZGX,@U^'3IA-/?)81V3.
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M,[21E)(0\C&12&Y ##CK[4 =?IGC*X?79](U[1FT>Y2S:^C<W*S1O"I 8[E
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MS .6Z#! XP>IR:[KPQJLFN^%=)U65%CEO+2*=U7H&902![9- '(_\*2\#?\
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MP^<KM@JR$ ;E.1D#!!' H VO^%)>!O\ H'W7_@=+_P#%4?\ "DO W_0/NO\
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M'&97"1AV WL>@'J?:N(AO/$GBS7-<32M;31[#2KHV,82T29YY556=GW]%&X
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M8 =K YY.<$<#I5?_ (0_Q'J&L:)?:WXCMKA-(N/-CBM[$Q>=\C*6<ES\W/;
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M&SB\O!^>1L GGH.IH YNU\(>)XK2RTB?Q9_Q)[-DVM;VQBNY8T(VQM*'P!P
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M;B*RL[0PI)*OW7D)9B<==HP,U;U+Q=?Z+HEUJ.IZ"T!AGMH51;M7$IE**Q!
MX"LY'(YV]LUOVMW=S:E?V\U@T%O 4$%P9587 *Y8A1RNT\<]: .7?PCKNFWV
MIMX;UZWLK/4YVN9HKFS,S02M]]XB'7KUPP(!J;3O 5MI%YX8>RNF$&APW,>R
M1=S3M,%W,6SP<@GIW[5UB2QR%@DBL5.&"G./K6=HFO6NO+?M:K(JV5[+9/O
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M&( 4JQ;"@]<_(<\>E %;4[*_TK0=)L/#C&'[/<6T&P1!P;<$*X)/"_)D[O;
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MS^'$\/-9*=*141;?>V %8,HSG/! /6M>@ HHHH **** "BBB@ HHHH ****
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M02S'/3C@5SMK\2GC\/ZW<ZA8V\NH:5=I9B*PN/,BNI)-OE[&(XR6P<],'Z4
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M0EMVQE8JPSWY4\T ;5%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %87BS2]5U32(QHFHFRU&VN$
MN869F$<I4_ZN3;R48'!'TK=K-UK7++0+.*ZOV=8I9X[=2B[CO=MJ_J: .*UK
M3O&/C:PCT/5="T[2K-IHI+F\6^\]\(P;]TH4;6.,9)X!-1ZCX+N;#Q3J^I0>
M%='\16NINLZB\9$EMI0H5AEU;*' /'(YXKTLG S5+2=3@UG2[?4+99EAG7<J
MS1E' SCE3R.E 'F&KZ9K/A__ (06"WM]*_M8:E/*8+:(6]L28G)0;5X^7Y=Q
M'7DUL77AKQ-XBN]8UFZ\G1K^72GTW3H8KCS3%N;<TCN ,$D #;G ]ZZ_7YM*
MT[3VUO58%>/2U:X63R]S1<8)7WP2*TH95GACF3.QU#+GT(S0!Y#_ ,('JLMG
MHL=EX1T;2)=/OK:YN;@7"R3W7EN"P5@N<'EOF.3P,=Z[C0=!U#3]1\5SR.D0
MU.\\ZUD0[BH\I5R1Z@@\5U-% 'B4_P .-<N/!=UHB^&-&35W0B;7)[D2R7!#
M9RI*[@6Z<D 9-=Y)I.M6_P 1H-;@LX)K&ZTM+&Y)GVO;LKL^X#'S#Y@.#5^;
MQMHT&E7FI/)-]FM+\Z?*1&<B8.$( [C<1S714 >7Z/X,\0^'=*\+:A9P6MQJ
MFE6TUI=V;S[%FBD?=\CX(# @'D8/-2ZGX2\0^([?Q-JE_;VUIJ&H:7_9MC9)
M/O$48)8EWP 26/88 ]:]+HH Y/7_  _?:C;>%8[<1EM-U*WN;C<V,(B,K8]3
MDBM+Q?IEQK/@[6=,M IN;NSEAB#G W,I R>U8-O\4]$NXO.M-.UZYA+%1+!I
M<KHQ!(.& P>0177Z?>IJ.GP7D<4\23*&"3QF-U]F4\@^U '#6Y^(O]A0:/;Z
M-I&GNENMN+Z34&EV *%WA @R>X&<9JGJWP]N+&P\+6%C81:WI&DQR)<Z;<3^
M4)Y& (E.<J2&W'!_O<5Z=10!YCIG@C5ENO%;/IVEZ7;:SI(M+:WLV^2W8*ZX
M;"C)^8$D#';G%13^#=:O=-\,W]YH.EW5_HL#64VF74RR174.U5#JY4A7RN0"
M.Y&:]3K/L=:L]0U/4M.MV<W&G.D=P"N "Z!Q@]^"* .2T72[_0HM<UQM!T+1
M@MJ?LME;K&I&T%B9IE4<$@<#@ 5V&CW<VH:)87MS!Y$]Q;1RR0\_NV902O/H
M3BKM% 'ENNZ(-2^,%E:6EQ&UE=Q1:AJT"G/S6S$1%O\ >9D&/^F=;MUI>OZ#
MXQU/7-$T^WU2VU:.$7%L]R()(I8E*JRD@@J5P".N172Z?H6E:5=7ES8:?;VT
M][(9;F2- &E8DG+'OR3^9HTW6K/5;G4+>U9S)I]Q]FGW+C#[0W'J,,* ."F\
M#:]_8+7VZSEU]M>37'MQ(1"2ORB$/C/W?XL=:U=+TSQ)??$*W\2:M86MA:QZ
M;+:+;1W/G.K&1&RS8 .<'ITP.>>.XK+UW78- M([BXM;^Y61]@6RM7G8'!.2
M%!(''6@"EXUT6ZUWPS-;Z>47489([JS9S@+-&X=<GMG&/QKB+SX9ZG+8>%;:
M*6$>7#]GUTEO]=&TJ3N%]<R*P^C5T-G\4M%OYWAM=.UV1HY?)DVZ7*1&_&5;
MCY2,C.:[>@#@O$?A+5-3U;Q3<VRQ&/4M!%A;[GP3+F3KZ#YAS5W1O#FH6/C*
MWU298_LR:!!I[$/D^:LA8\>F#UKI]0O8M-TZYOIUD:*WC:5Q&A9B ,G ')/M
M4,.LV$]];V*SXNY[7[6D#*0WE9 W$=N6 Y_H: ,/QGH^JWMSH>K:-##<W>DW
M9G^RS2^6)D9&1@&P<'GC/%<SJND^('/B_P 1ZQ:6MI%<^')+:*WAG\UH]HD.
M&.!D\YR..<<XS7HVG:G9ZM:?:K"=9X/,>/>N<%D8JP_ @BI[BWAN[:6VN(EE
M@E0QR1N,AE(P01Z$4 >86&F^*?%G@W0-$U"QLK;2_+M)KF_2YWM/$FUU58]H
M*L<+DDX'.,UKP:7XH\-:EK<&B6%E?66JW;WL,\USY1M)9  ^]=IWKD;AMY[5
MW$$$5K;Q6\$:QPQ($C11@*H&  /3%24 >2#P'K<'A_PC;7>FVNLV^EQ3)>:7
M)<[$D=CE) 2-K;>>#Z\5=TWP/JZR^+M^G:7I=OK6E"UM;>S;Y+=@LBX;"C)^
M<$D#')':O3J* /+;GP=K-]8>&M1O- TNZOM'MVLI],NIEDBN8MJ@.KE2%<%<
M@$=R,UT7@[0;NPU&_P!0N="T?18IE6.WL[&)#(JCEFDD51G)QA1P,5T^HWT&
MEZ9=ZA<DBWM87GE*C)"JI8X'?@4ZRNXM0L+>]@),-Q$LL9(P2K $<?0T <5X
MU\-7^K>)=+U'^RK?7=+MX)(Y-,N+@1JLI((EP05;@$8/3M6 _@#7I=&\;6ZZ
M?I=DVMPVPL[:S<"*'R\@H?E'.,'.,$DUU$GQ,T9;V\M8;#6[IK.X>VF>UTV6
M5!(APPW*,5TND:I%K.FQWT,%U CD@1W4#0R#!QRK<CI0!C^)-#O-4U3PQ<6P
M0QZ=J'VB?<V"$\IUX]3EA7)ZEH@U#XS06UK<1OI\L<.JZE ISB:#<D6>PW%D
M.._EUZE6?INA:5H\UW+IVGV]K+=R&6X>) #*QR<L>_4_F: +%]#-<:?<PV\Q
M@GDB9(Y0,[&((#?@>:\:G^'.N7'@Q]&A\*Z+;ZJ%3[1J\MR)9;IE8,2IV[@6
M(YW$8!(Q7MM9^M:WI_A[3)-1U.X$-NA"YVEF9B<!54<DD]A0!E:1HMY:>.O$
M6L3*@M;^"T2'#9;,:N&R.WWA7,0>"=<L-.LKZT6V;5M-UF[OH8))<)/#,S!D
M+ ?*Q5A@X."*Z+3?'^DZAJD&FSVNJ:9=7.1;+J5D\ G(&2$)&"<=NM=50!Q.
MC:=XDN_B$_B+5[&VL;3^RS9Q6\=QYKJWFJ^6( '.#TX&!3O'_AW4-<ET:6WL
MXM3L;.=WO-*FG\I;D%<*<]#M/.#P<UVE% 'EEMX(UC^TM?NH]&TK2K74-!DL
M+:TLW&(Y"3C>0H!)W$D@8' YQFMW0/"^I:=XFT6_N%B$%IX;3392KY/G!T)P
M.XPIYKMJ* .<\7V6JWEI:C3[*PU*W24_;-.O0H6YC((P&((5@<$9&#7%6OPV
MO[K2_$4<5M;>'X[\V\ECI\4YFCAFB;?YC8&!N( (7M7K%48-6M9]9N]*!=+N
MVC25D<8WQMG#+ZC((/H1],@'(W&F^*?%>HZ*FLZ99Z79:9>1WTSQ7?G-<2QY
MV! %&U<G)SSTJO9Z3XQ\,Z??Z!HEE93VTT\TECJ,ESL^RK*Q;YXRI+%2Q(QP
M>.E=SJ6IV>D6+WE_.L%NK*I=L]6(51QW)('XU;H \VU;P5XBN_\ A*_LVH(+
MG4M/LK>&[+>6TKQ;O,W!1\FX''']ZJ47@K49-4\/7-CX1T?0K?3K^.>X6*=9
M)YA@@G<%&0,]"23GMCGU:B@#F_!>B7FAV.IPWH0/<:K=74>QL_NY)"RY]\4:
M7HEY:>/?$&L2A/LE];VD<)#98F,/NR.WWA725A>(/%=AX=GLK:>"]NKN]+^1
M;65N9I&"@%FP.PR/SH Y/_A"M8_X4P_A?;#_ &D968#S/DP;HR_>_P!W]:76
M/!MQ;>,=3UJ'PQI/B*VU-8V:&\*)+;2HNW*LZL"C #(ZYKM]'UJSUVUFN+)G
M,<-Q);/O7:0Z-M;]16C0!YPO@O6K32M&U*TMM(BUO3;Z6\%E:QB"W9)%*-$&
M5?O;, .1U'-2QZ+XHU?Q3J.LZE86MC#/H<NGV]NESYK*Y<,"[8 YYZ<  5Z%
M52RU.SU%[M+.=9C:3FVGVY^20 $K]0&% 'F<O@?5XE\,&]T:TUZST_1TLI=-
MFN0B17 QF4;@5?@;>?2NA\!^&M3T'5/$-Q?V=A:0ZA-#+;PV)_=QA4VE,8'3
M YP,\FNKFU.SM]2M=.EG5;NZ5VABYRX0 L?H,C\ZBTC6K/6XKJ2R9V6UNI+2
M3<N,21G# >V>] '(>,/#%_J7B^RU1M&M=?TN*S, TZYN!&L,V_/FX8%6ROR\
M\C%9%M\.]9ETWQ)#)%IFG7%W>VU_IRVIS!$\0!"$  X&T*3CG)(':O5JJ:GJ
M=GH^G37^H3K!:P@%Y&S@9( Z>I('XT <J]IXL\3R-9ZM:V^C:2UI-!=117"W
M#W32(4&#M&Q5R6ZY)P.E5=,M/'=OI6E^'A!96<=D8HI=7CN!)YL$>!A(BO#L
MH .>!DX[5W]% 'GMEI?B_P +6NHZ-HVFV-]9SW$TUC>2W?E?9A*Q8K(FTEMK
M$GY>H]*@A\&ZQX3?PQ=:'!!JK:58RV-S!)-Y!D\PJQ=&(('S \'L:])HH \K
MO?!?B;5-$\:"[BLDOM<GM98(XIB401[,J6('("XSCDBNP\0Z+>:EXE\+WUN$
M,&G74LMQN;!"M$R# [\D5TE% 'G-CH'BS3=)UW3;:TTUEDU.2]MWN) \=Y%)
M(6>%U*_(=O&>>?SIWA/PE>6/C-];CT*T\.61M&AELK6Y\P7,A8$.54!%"@'&
M.>:]$HH XOX@1FUD\/>(/^6.DZFCW)_N0R Q.WX;@?H#3-?\+ZEJ7B36[ZW6
M(P7GAM]-B+/@^<6<C([###FNSN+>&[MI;:XB26"5"DD;C*LI&""/3%+##';P
M1PQ+MCC4(HSG  P* .,U/PQJ5WX)\,Z5$L7VK3KBPDG!?  A*[\'OT.*ABTW
MQ1X7U77!HFFV>I6>JW37L3RW7DM;3.H#AQM.Y<J",<]17>44 <#%X/UN?7&N
M-5OH[HS>&VTRXNPH4M.TA8D( /E /'TK(D\/>-;[PMHGAR?3-/MXM)GM#)=+
M>;_M*0LN-B[1MX&3D]L8YX]1N)TMK:6XD)$<2%VP,\ 9-5])U.VUK2;34[-F
M:VNHEEB++@E2,C([4 <C'IGB;PUK>M-H>GV>H6.KW/VQ&FNO)-K.RA7WC:=R
M':#QSU'O5#0/!>M:?:>!H[OR&DT>XNY+QE?M() I7UY<5Z310!P=CX3U2W^%
MVM^'W6+[=>"^$0#_ "_O6<ID]N&&:HQV>I:!XM@?1O[/O=2DT:WAO],N+DPM
MB/*I,C[6!&=RD8]*]*K)UGPQH?B'RCJ^E6MXT6?+::,%ESU /7'M0!YYX7UG
M5]+\+^-]=$5G>7XUF1E2.0B&5@L2E4;&6[J/4@>M>LU7LK"TTVSBL[&VAMK:
M(82*% JJ/8"K% 'F4/PXNY=<\4+=O"=(N[:XBTU0<F-KDAY3CMAU&*9'X%UZ
M3X5:CI=XT$OB'4KI+JY;S/D)66/ W>T<8_&O4** .)NM#UJ+QUK%[;6D$^G:
MOIR6[S&?:\#QK)CY<?,"6 Z\55N_".JS?!_3_#2+#_:,$=HK@R?+F.1&;GZ*
M:] HH X?^S?$?AGQ'K-YHNFVVJV.K2K<F-[H0/;S!0K9)4AE. >.1SQ65_P@
M^NZ;H^E7UL;2]URUUB75KJ#S#'%,TH8.B,0<8##!([5WNN:U9^'M&N=6U!G6
MUME#2%%W$ D#I]2*T* //8?#OB/5_$FM:MJMM:6*7^B'3X(8Y_-,1W,1O.!G
M[Q/ QSCFNA\$6VJV'A'3].U>SBM;FQA2U BG\U9%1%4/G QG!X[5T-% 'FVL
M^"M8OK/Q=%"L.[5-3M+JVS)C*1F+=GT/R-71:/H=[9>+?%>I3!/L^IM;&W(;
M).R'8V1VYKIZAO+J*QLI[N<D101M*Y R=JC)_04 >?IX,U=?A-H_APK#_:%I
M-;O*/,^7"3AVP>_ IVM^"M5U.+Q_'$8%_MQ;?[&6?J8XE4[N./F7%=UINH0:
MMI5IJ-J6-O=PI/$6&"490PR.W!J'2=:L];2[>R9V%I=26DNY<8DC.& ]1GO0
M!P6L>'=>UG6M*UC5?#5EJ=O'8M!)H\U\"EO/YA/F@E=KY7 Z9%4_^%?Z])X9
M\96'V73+2;59K>XLX;5\0ILVGR_NC&-F,X&2<\5ZS10!P%[X5U3Q-KEQ>ZK;
M1V$-]X=ETV9(YQ*896EW#!P-P YS^%5+S0_&/B#PS;>$=3L+"VM!Y45YJ<=U
MO\Z*,J?W<>T$,VT=3@<UZ510!S>@:+>:=XK\4:C<!!;ZE<026Y5LDA(50Y';
MD&L;0(M7\$^#_#FDRVUO-<S:BUO.OF_=CDED?<F/O$*02/0'TKO:* "BBB@
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M<DAT[1H7:ZN"" &+IDH@Y],D]>*Z3PWH-OX8\/VFC6LLLL%L&"O*1N.6+<X
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M-@:2[NPJYV1E02H!P6..G<5;T3P;%I&OS:[-JM_J&HW%L+::6Y*88!MPPJJ
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M*P8,TA(Y)W$\8_*@#;TG3O[)TR&Q^V7=YY0(\^\D\R5\DGYFP,]<?05=HHH
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M%#:01QW+M).JQ@"5V^\S#N3W)ZUS/BKPS?ZUIMKX<T^/3;7P\X1+P882K&C
M[(E V@$#&3C':NOHH JW6FV-]:+:7=G!/;J5812QAE!4Y4X/'&!BK5%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMB/D:-GW$YZ^U8MO\/[M+>TTRX\4ZC<:':.C161C1'94.41Y0-S*,#CCIUH
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MODS/! NX,B./D9PR\XXYQ5_P]IMYI7Q?U&WNM3GU%?[$B,$MR%\U4\Y_E8J
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MC0*US"#<?ZD&0#S.,_+Z\>E>5S6FIZG\6/$Z"VT&YE@@MEMH]85V*VY3+&(
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M@DKH"H/)SM]*ZBO#]&TWPLWP,UJ]GALS>+]L:6X8#S4N [^4 W4'[F /7WH
M]FOM2L-+A$VH7MM:1$[0]Q*L8)],DBLGQ)XE_L:QTNZM4BNH[[4+>T#!_EVR
MMC<".N*\XMX==U3X@0QWL&CSZA'H5HT,.L!R/F4^<T:@$;MXPQZXQ5>.W:TT
M*&!;W3Y[=/&5ILAT\2>3:MO4O&A8#@-S@9 R: /8KS6-,TZ:.&^U*SM99?\
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ME=QVEUJ5G!<R?<AEG57?Z*3DUS7BSQC<Z5K^E:#I/]EO?WHD=WO[DQQPJ@7
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M9[5=0M_+%P%&2%()Y YVG!QVK \5_$BUC\-Z\VE6^J$6T,T$>JPVV;=+@*0
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MBU>"TM-3N!8(\=Q?VUMO@MI0N<,V<Y7(S@''>@#?T?PQH?A\2C2-*M+/S?\
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MT3) ZFH;>UM-9N=%LXHO&EY=)=PRW%KJ$LD4-EL.[>[-'M;:1P%//J*]DHH
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MRYU G;/.Z!BL2%U(0=R23R!BHIOBC<S>$[&_A.GVLTFI/IMY?ONGL[=D!/F
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MZ_>C+*5##W&<UYH_P]\2S>$K;0(X/#>GI:F!FGMA(7NS&RD;SL&S.,D_,2:
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MM$77JI/1A]#@_A7*67ASQ<\FFVMZ^@VUK:2(T]Y9Q%I[I5_AV.FU-W<@GVH
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MC<2VJ2D!7WEB&(+#(VCKP>].\!+J_P#PFGC,WES:20"_576.%E;?Y4>T@EB
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MQ^5#=)+RZD(/DP0-I /3G.:M^&= UZT\5:SKVN7%BSZA!!&D%H7*PB/?\N6
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M]VD27%W )9%B!"@GT!)/ZUNUR_PXM9K+X<>'X+B-HY5LHRR,,$9&>1^-=10
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MB>*5%>-U*LK#(8'J"*XD_"[3%MWLK?6M?MM)<G.F0WV(-IZH,@L%/H&KN**
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAD0 L@897/3([4^@ HIDDL<(4R2(@9@J[F R3T ]Z?0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%,BECGB62&1)(VZ,C @_B*
M:]S;QF0//$IC7<X9P-H]3Z"@"6BD!# $$$'D$4V.:.7?Y<B/L8JVU@=I'8^A
MH ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7)>.-
M*\*KI5WXA\1:/:7IL;8X:5 6(!)5 ?=C@>YKK:YOQIH-WXCL=-L;=HOLZZE;
MSWJR,1O@1MS*.#DDA>* ,_X:^$8_#'A]KB2UBMM2U-A<W<<2[4BSDK$H[! <
M?7)[UVE4]5;45TNX;24MY+\+^Y6Y8B,M_M$<X^E68O,,*>:%$FT;PO3/?'M0
M ^BBB@ HHHH *\ \8Z4VD?$?6-8\6^$;[Q'HUVJ?9+BW=B+5 .5V@X'XD=,C
MJ:]_KQN^FU_P[XLU74O"_BOPY?V.I/YCV>JZAS;OSG9AN!DGH1QQC@&@!/!G
MBCPSX-^&.LZSHVHWNHV%O<;DL+H!)+=W("Q]^#D'/(X8]<UTF@>)?'TNJZ8-
M<\-67]F:BF\36$C%[3@$>;N..XZ>_IBN,L?!>EW7A#Q/;:WXNT+^V=?G6Y=[
M:Z3R871BZ@#(SRQSQT/MFM;0=3\42ZKI":WXP\,V6EZ:NV46%ZK/?8  W;N
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M%\P!H@VX.I&-IW8R,GDGM6=HW@_46\;6&OSZ)I&@"TCE6==.F+M>LZX&X!%
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M.QL'CF,MYYGELD9*+L&3N;HOMGK7)7WB"3PGXUU?^U+J5]*NM,.H6@D;(C>
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M7998M)UBQOI(N72WG5RH]< ]/>HAXN\-M*T:Z_IA=(FG8"Z3B,'!8\]!@Y-
M!<>&K.Z\1R:U*\IFDTYM.:+(V&,OO)Z9SGCK2>%_#R^%]%CTJ/4+N]MX3B W
M14M$@  0%0.!COSS3H_%OAR6ZN+6/7=-:>V0O-&+I,QJ.I// '?TJQIFNZ3K
M-H]WIFI6EY;QDAY()E=5(YY(/% &'+X& U;4;S3]>U33H-2D$MY:VQCVR/@
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M@%75@",G!'(JJ/AOI4?A>?08;R_CB>^^WQW'FAI8IMP8$,0<X([Y-;%YXO\
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M_*+E@5;"QHV QP<8-:Y\57__  D$NE#^S0$\/KJ8N2Y\KS2[+RV?]5QG/7%
M&Q?^&[+4M>MM6N6D:2"UFM/)R-CI+C=GC/\ #ZUA6WPY@B2RL[C7=5N]'L94
MEMM.F:/8I0Y0,P0.RJ<8!/8=:VD\3:99Z3:7&L:OI5O,]HEQ(5N5$9! !="3
MDH6. >^15VTUG2[[3#J5IJ-K-8@%C<QS*8P!URV<#'?TH DU+3K35]-N=.OH
M1-:W,9CEC/\ $I'/T^M<S:> (DN;!M1UW5=4M--D66SM+MX]D;K]UF*J&<KV
M+$XK9T[Q7X>U>5(M.UO3KJ1V*(D-RC,S $D  Y/ )^@K3GGAM8'GN)4BAC4L
M\DC!54#J23T% &=I>@VVE:GJU_#)*TFISK/*KD85E0( N!TPHZYHU#0;;4=<
MTC5I9)5GTMI6A52-K&1"AW<9Z'C&*32O%&@:[/)!I6LV%[+&,M';SJ[ >N >
MGO6G--%;PO-/(D44:EG=V"JH'4DGH* .3O/ 2/?7\^F:]JNDPZDYDO;>T:/9
M(Y&&==RDHQ[E2,U+=> ].-II,>EW-UI-SI,9BL[FU92ZH1\RL'!#@X!.1UYK
M7TGQ'HFNF5=)U:ROFB_U@MYU<K]<'I[U':^*O#]]J;:9:ZWI\]\I(-O'<HSY
M'48!ZB@#'L_AUI4-KKEO>W-[J0UL)]M>[D!9F0$!@5 VGG(QP,#&,4ZR\"B/
M4;"[U/7M5U9-.;?9P7;1[(VQ@.VQ078 \%B>M:NH>*_#VE2-'J&N:=:NDGEL
MDURBE6P#@@G@X(/T(IX\3:$VJQZ6NLV!OY &2V%PID8$9&!G/(Y^E %*W\&:
M9#X8U'P_(T\UE?R3R3;V ;,K%FP0!C!/%94GPY6\@L(M3\2:Q?)ITT4UFLAB
M01-&05)"H-YP,9;/!.,'FM^_\6>'=+E:*_UW3K:19/+9);E%*M@'!!/!P0?Q
M'K575/$4MGXH\,Z9;+#+;:N;C?+DD@1Q;U*D''/X\4 5=3\*30:/XE_L2\NX
M=2UB43K(DHC,4NU5&UL<+\HSU.,X[5U03]T$<[_EP<]ZQ[CQ?X;M-3_LVXU[
M38KW=M,#W*!PWH1G@^U/EU5[?Q#<6]Q=Z9%80V N7#38N$.X@NP/ BP/O>H-
M '/+\-+46B:4^N:K)H"2B1=*=HS'PVX(7V[R@/\ #NJ_?^!+#4-:U2_EO+Q8
M=6M1;7UFK+Y4P"%%;IN# 'C!K2M_%7AZ[U-=-M];TZ:^896WCN49SQG@ \\<
MU0T3QMINM^*M:T*">U,NG,BILN%9I\KER%'92=IZX(.<4 9LOPV2\L[.TU+Q
M)K-Y#82Q26:.T2"(QD%2=J#><#&6SP3WYK2?P38R:]J^HR75T]OJ\(BOK!BI
M@EP@0-TW [1C@UO_ &VU^W_8/M,/VSRO.\C>/,\O.-VWKMSQGUJ%=9TM[2ZN
MUU&T:VM&9+B83*4A9?O!SG"D=P>E ',VWP\BCDL(KW7M6U#3=/D66UL+EX]B
MLOW-S*H9PO8,>W>MK3;'4+?Q)K=W<7,[V5SY MH9)=RQE4(<H/X021QUR">A
M%8?B#QTOAO2M>U.YGTJYALWB2S@@NL2NSH&VR9SACRP ZJ,U)<>/=/MO%-M:
MR7^G+HLVEO??;S.-I82J@ ?.TCD^^10!V-%5=.U.PU>S6\TV\@N[9\A98) Z
MDCJ,BK5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7"?$_RA:>'GO\?V.NLP'4-_W!'AMID[
M;-^W.>.E=W3)H8KF%X9XDEB<;71U#*P]"#UH \\U673Y_BMX<.B/;O<+97?]
MH-:D'%OL'EA]O;?C&:L_!_3+&T^&VB7,%I"EQ-;LTDP0;WRY)RW4]!^0]*Z_
M3=$TK1XY(],TRSLDD.76V@6,-]=H&:LVUM;V=NEO:P1001C"1Q(%51Z #@4
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M(XH \:LY-!3X+^(X-;:T&KA[W[<DQ7SC=[W\LX/)/W-IJY#_ ,ANR_[$!_\
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M/M&RUA7[0<SXC \TXQEO7CCFH+G1M+O-.33[G3;.:R0 );20*T:@=,*1@8H
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M7'S*5&WV!XK!T7P;J">)+'5]4CT6SCT])?LUII$#(C22 *TCD@9.T8 QWZT
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MF^0-PP8XR<]\]:L_V7I_/^@VOS0?9C^Y7F+_ )Y]/N_[/2@#S'4],L;'X<^
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M]O BQPKJB.L:#"@M A8@>YKN*BBM;>"6:6&"*.29@TKH@!D(& 6(ZG QS4M
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M]N"@5V! *  YX.><8.TUDNNI>+?&>E:JNC7VG:?I%M<_/?((Y)Y94";53).
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M:TN@FY5FB7&2O=2,@CWI+'1/$=]J1N/$>IV;6@MW@%AIT;I%+O&"\A8DDXX
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M/\1?&2ZU?2KM;K2[*".>Y\OF(WVUXEP>A81YSZ'%>HU'%!% I6&)(U)+$(H
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ML(&UI6P&.>PH Y6#P7XET[29/#>EZ[:VV@M(WE3B)Q>6\3,6,:,&VYY(#'D
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MSX[%KJ0VJ29SN$.[9UYQC'M6];:/96FKW^J0Q%;R^6-;A]Q.X1@A>.@P">E
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M3_\ $R@M42>UZ;8W=#M(8GIP<C..*Q+OQ1I$_P %]&T.&[635(C90SVB@^9
M8YH]QD7JHR,9.,DCUH [D_$&STKQKXCTO6[U8K>S^S&TCCMWDDVM%ND)" G
M)')&!FMNZUZWN)/#]QIVLVJVFH7!5?D,GVI=C':A'W3QG)]"*Y.R\1Z%X?\
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M7*!Y=P"2').  !R6SD8 SP>*@M/&_AV]T^^OH=1_<V";[H/#(DD*XSN:-E#
M8[X[5Y&D-Q!X9\,:B+M[#3;#7M0\^Z6 3+;%I)%CD*$8V@Y&3TW9KJ_#D-CK
MWCN[F/B*;Q%MTIK6YN(;2)+7RW8'RV=#\S]3C!P">10!Z%=:UIUE:6EU/=(L
M%W)'%;N 6\UY/N 8'.:O.ZQHSNP55&2Q. !7D7@V&]U'Q/IWAJ^5VA\&>;YC
MN.)G8E+8_A$6-;GB#P[XTE\,:]%+XFCU(3V$T<5I%IRPLS%> '#$],C&.<T
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MT"[%IJ-\4N#'YIBB@DF94_O,$4[1P>3BO-K.")?V9;_$:C?!=NW'5O/?D^_
M_*KNM7-C8>*9+F#Q5+X7U633[<R27T,;VE^@!QMW'EER0<$'G@'K0!T?B#XB
MZ=I-[X<6WGBGL]5D+/.D;R 0[&(9=HY)8 8ZCGBM35O'7AS0[V6SOM1*W$*A
MIDB@DF\H$9!?8IV<<\XXKSW^W%31/A[K>K6MKI5I%J4XD:&(Q0!2DJHX4_=#
M_>Y]:GF\2;M=\2PMKUAX:\F\:/[%!9))>7_R#$HWYWE^@VJ>,4 >@7WC+P[I
MUG97=UJL"6]\ADM9!EA,  3MP#D\CCJ<X'-/TCQ;H6N6EW=6&H(\5G_Q\^:K
M1-#QG+JX!48!.2,<&O+?!T:30?"42(&\M=0X8?=94;]01^E7/&.GWFHZS\1+
M33HF>YETBQ;RX_O2!6<L!ZDJ"/TH W]3^)6FW5]H%KX?U%)9+S588)ED@=?,
M@8-N9"X&X9"_,N1S[UM6WBFPL(-4N=7URU:WAU1K-7$31BW.%Q$Y/4C.2W3G
MVKC_ !'XJ\-:_>>"(-'N8;B9-8MY D0YMDVL"K_W#G VG'3VK)O8DFL-6BE0
M/&_Q B5E89!!,60: /4-%\9:!XAO9;+3-0$MS$GF-$\3Q,4SC< ZC<N>XR.:
MHS_$OP?;2SI-K4:B%F5Y?*D,99>JJ^W:S>P)-97BJWFG^)6BQ6K".YFT?4(T
MDZ8;$>WGV)S7#ZWXDT&+X#MX:D0IK-M:1V\VG&$^;#,C+N=AC@9!;=T.?4T
M>XW=W!8V,]Y<OLMX(VED?:3M4#).!STJI/K^E6VCP:M+>(+"X\OR9@"1)YA
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MI8!U*+GH1D$@5S5A>VUM;7IO;-KP2>/6AB'GM'Y3EUVOQ]X+_=/!H ]:6-$
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M28)Y4T>?-WN 1M4#.0#D$<<\4=!O=5N_C%=IJ]@EE<1:"BE(I_-BD'GDAT)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5S'C;1+_5K+3;K2UBDO\ 2K^.^AAE;:LVT$,A;^'*L<'UQ73U
MF:]X@TWPUIAU'59VAM@ZQ[EC:0[F. ,*">M '):QI?BCQUINJ:=?V::'ILUD
M8HX998YI)+C<&5R4R%0;<8SDYJ/4;3Q9XOM=-T;4]"CTRWBNH9[^\-VDBRB)
M@VV)5^;YB!RV,#UK8LOB5X5OK^&R74)(+B=MD2W=I+ ';L SJ!GVS764 <GX
M;T._TX^+/M,03^T-4FN+;#@[XVC10>.G*G@UB:'X2UFRM_AXD]LJG1DG%[B1
M3Y9:%E&.?FY(Z9KN=8U>QT'2;C5-2G$%I;KNDD()QDX  '))) Q[TNDZI!K.
MFQ7UO'<1Q29PMQ"T3C!QRK $=* //Y_!FMF'5+RWAA^W0>)SK-C%)* MQ&$5
M=I(SMR-W7H0*MG3O$7B3QI8:CJFB?V9I<.GW5JRM=1R2[I0H).TD8.,#&>AS
MC(KT*B@#Q:T^'U[8:/'H@\ Z)=:A$?*76YGC,+IG_6/'_K"VWJN.O>N^T;0;
MO3_'FKZ@T*)83V%I;P,A !:/?N&W.0!D5NZQJ]EH.DW&IZC,8;2W4-(X4M@$
M@= "3R15BYN8K2SFNIBWE0QM(Y52QV@9. .2<=A0!YI<>$=?B\+W*06*37L7
MBAM7AMS.J^=$)MX ;HI(]:GU;PYXHU&?Q9?:>G]G7>J:99QVQ^T+N61-QDCW
M*>#ABN[ISD5IGXL^$5G6!KJ^$K@LL9TRYW$#J0-E=7I6J6NM:;#J%D9#;S9V
M&6)HVX)!RK $<@]10!Y;'X+O'U?P]>:;X)M]&2QU&*>[EFNXY;F10"#A@3E1
MG)RV2<<<5HGP?K9MW3[,NX^,QJP_>K_Q[;P=_7K@=.OM7IM% '':'I6J:?XU
M\3"ZTU9-)U61+B.[$RD9$:H8VC^]V//2N?\ A?HD\.LZM<7$PGM-&:31M,<'
M/[I9&D8_7F-,_P"QBNZO+G2-8O+WPS=?OI3:K+<6Y5@#$Y*@[A[J>AS5S2]+
ML=%TZ'3]-M8[:TA&(XHQ@#G)_'/.: ,'X@:5JVK^&UMM(#2.MU%)<6R3^2US
M #\\0?\ A)'?(Z5RVC>$+NW\=Z%K%EX1M=#TVU2X2=1/&\[LZ8#.5)R,@ ?,
MQY).*]0DD2*-I)'5$0%F9C@ #J2:X]?BEX3:12;VX6U9]BWKV<JVQ.<?ZTKM
MQGOG'O0!E6_A/6(_@A=>&FME&JR0W*+%YBX)>9V7YLXZ,.]6_P"S->\->*+G
M6-,TD:K;ZG9V\5S EPD4D,T*E58%R 5(.#SD$5W8((!!R#T(I: .3\ :5K&E
MZ?JS:W!%!=WNJSWFR&0.H5]I&#^!'.#Q4NG:/>V_Q%UO5Y(@+*ZLK:*)]P)9
MD+[ACJ/O"NGHH \O3P;KUK:C4;6WA;4K'Q'=:G;VTDP"W$$I8%=PR%8JV1GH
M1S6DVEZ_XF\30:SJ6E#2K?3K*XAM;:2X266:690K,2A*JH"@#G.:[ZJUE?VF
MI6YGLKB.>$.T>^,Y&Y2589]B"/PH X.Z\*:Q+\%;'PXELIU2**U5XO,7 *2H
MS?-G'13WJW]B\0^&/%&MW>E:,NK6.L2)<*%NDA:WF"!&#;NJ' .1DCG@UW5-
M=UCC:1V"HH)9B<  =Z /,M'\(>(+?2/"<5[;Q?:K#6[B]O/+E7:J.9B&7GG.
M]>.O-9^O^#]:U>2Z5O"=I'KQG8VWB*QNUME52V5D=0=Y8+P1ALXZUZ5X>\2:
M5XITS^T=&NOM-KO,9?8R$,,9!# 'N#^-:M '"?V?XA\,>*M5U/3]*_MNVU:.
M!I!'<)#)%-&FPDAR 58 '@Y!SQ4(\->(M4UOP_>:Z89&2SOXKUH&4+#YVT(B
M]"V ,9QU&:[A+^TEU":PCN(VNX4626$'+(K9VD^F<'\JLT >7#2O&:>!3X&&
MC0$?9SIXU?[4GD^01MW^7]_=LXVXZ\YJ;Q#X6N);I+.[\'6GB+3(;6*&QGBG
M2WN;<HN"KNS D$\@J>/2NZ_MRP-_]B$K-/Y_V?:L;$;]GF$9QCA<$GH,@=>*
MAU?Q/H^A7^G6.I7BP7&HR^5:H58[VR!U P.649..M '#P^&/%6C6'@W4/)&L
M:AHWVE+FV^U .T<PP LCX#% %'.,XJ*\\,^*-8@\=W5UID-M-K5A;PV=NMRK
MD% X*LW SR#GIS@$XS7JE% '"^-O"%QKVAZ(T5E;7USI4R3-8W3 1W*;-KQY
MZ \Y!/&14'A/PT]MXG_M*/P;IGAVSAMRB@>7)<RR,>2&C)54 R.Y-=I?ZK9Z
M9)9I=2,C7EP+:#",VZ0@D X''"GD\5=H Y7QEHVI7MQHNLZ/%%/?Z/=&9;:5
M]@GC="CH&Z*V#P3QQ63)I&O^)O$!UG4=*&EPV6G7%K9VKW"22RRS !F8H2JK
MA0 ,Y[UZ!6)=>+-&LUU5IKIP-*>..\VPNQC:0*5' ^;.X=,XH X./0_&&I>
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M+!0=LJ,>3QT4UTU4KO5;.QO[&RN)&6>^=D@4(Q#%5+') P. >N* .6O;#7-
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M-WV+V&<UHT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %<-\5_\ D5;+_L+6?_HU:[FL+Q;X
M:7Q7H@TXWDEFRSQSI-&@8JR-N'!XZB@"C\3+:TN?AMX@%XJE8[*26,M_#(JD
MH1Z'<!7%W/BK4[_5=.T>ZNM=M8+?1[:YNFT>S::>6>1<_,P5MBC![<DGTKJ)
M/A]=:HT<7B/Q5J>KV*.LALFCBABE(.0'"*"PSSC-:.L^$Y+S6X];TG5IM)U-
M8/LTDD<2RQS19R%=&X)!S@C!YH \V\176LZS\-=6BU.?6(DT_4K=+:XN;7[,
M]Y"\L>TR*R<LI)Y&,D FMG6M;O8_%S>&6U/Q']@TVSCDEN--M/.N;B60D@NZ
MH0J@#L!DY]*Z:3P##<>%[W2+G5;RXGOKI+NYO9<%W=75\!?NJOR  #H*M:SX
M3EO-=77-)U>?2=3\C[/+(D2RQS1@Y =&XR"3@C!YH X:;Q-XJ'A$Q">_MKN/
M7;>SM+^^LC"]Q!(PP71@ 2,D' &<>];37.I^#_&MK:3:W?ZM87NG75S)'>["
MR20[6RA51@$,1CI6J/ ,+:1%9W&JWES<?VG%J<]W-@M+*C!L8Z*O &!T%:]]
MX>@O_$NFZU)*VZR@G@$.T%7$NW.?IM_6@#ROQ)9:[J_P:N?$UWXCNWGOK9+F
M:QVI]E$3,I"*NW<"HQ\V<DCGK7MB_<'TKSV\^%TEUH4WAU/$]_%H!.8;(11D
MQ_-N"^9C<R ]%/H.3BO0@, #TH X?5O^2S^&_P#L&7?\TJ+Q0VLZC\0M,T"P
MUNYTRSN--FGN&MU7>2KJ!M+ X/(&?3-=+=>'HKKQ;I_B!IW66RMI;=8@!M8.
M022?;%.FT"*;Q;:^(#.XEM[.2T$6!M(=E;.?7Y: .&UJ_;^W[O39_%FN22VL
M420V>A6ADE0[.7G81L-S'G&0 .U5=(\4:]XET/P7IC:E+9W6KF[:]OH8U67R
M[=BN%!!"LWRY...:ZMO!5W!K&IW>E>(KO3K;5)1-=01P1NV_:%+([ E"0!V.
M.U5[?X;VUCX>TK3K'5+JWN](GEFL+]54R1^8S%E8'AE(;!!ZX% '+W%S?>"/
M%OBW4)KZ;5'M/#\4UJ]T%WX\R0*KE0-V&SS@'%16NOZ_9C2[^UN?%FI7TDT7
MV^UNM)=;62-B _EXC&S;G(.>W.<UV=CX!C6_U6]UC5+C5I=5LA9W0EC6-2@)
M^Z%^Z,'&/QSDU':^ [U?L%K?>*=0O-*L)$D@M&C1&;9]P22*-S@>G&<<YH Z
M+Q%!977AO4K74;M+2RGMI(9KAW""-64J3D\#KWK@;D>+_#OA9]+UC0]+\2>'
MH+3R9'L9C!,;=5QDQMP3M'13]*]'U'3[75M-N=/O8A+:W,;12H?XE(P:XP?#
MW5_L']D'QQJQT4IY1MC#%YOEXQL\[;NQCCZ4 8FK^+5O-8T;1M)N-9M=".D1
MW^_2;1IKAU8[8T)VL44!<D]2>,TQ?&'B.R\/:I:+_:'F_P!H6MEI>I:I8F&1
MDG(!+*5 9D(89QS\N1787_@B$W&G7FA7\NC7NGVHLHI(HUD1K<8Q&Z-]X C(
MYR#3!X!M;C0M2L-4U*]O[K495GGO68(Z2)C88P!A N!@ ?7- $$NC:]X>CNK
MN#Q-=W]F+"=IX[_:TBRA<H\151CG.5/%<G_;'B/0_AM8>)9M>O;W4M:CM8(H
MS KQVQE(PZ1J,L^WMSENW:NPC\#W%U=_:]<U^YU2>*VEMK4M D2P"1=KOM7[
MSD<9/'7BKLO@RPN? ]IX6N)IF@M8(HHKA#LE1HP-DBGLP(!H X_2M4U>+Q)I
M]C97/BV\T^^62&]DU33FC-LVPE)8W,8"\\8.1S69X;@U_3OA9+<:+=ZG=22:
MK(LZ0B-YHH%N)!(T"E0#(PYYSSTQ7?:=X3OTUFTU+6?$=WJCV2LMM$84@C4L
M,%F"??;'KP/2J,/P[:WTVZT^'Q!?1P?;?MU@41 UG+O9S@X_>*2QR&R,4 5_
M 6LPWNKWUG!XBU&]1(5<Z=J]N8[NW;.&;.U=R'(['![U-\5]:_LSP:]C'(Z7
M.K2K8HT:,[*C?ZQ@J@DX0-T'<5J:-X4FLM>DUW5=7EU34S;?9(Y&A2%(HMVX
M@*O<D DDGI5N[\.17WBW3M>GN'8Z?!+';V^!M5Y,!I,^NT8H X'P?KNCZ=\2
MIM)T@7,>E:M9QM D]K+ $N(5VE5#J,YC )([K5S1(?$GC+P_+XGMO$UU87<\
M\QL+153[+$B2,BK(NTE\[3DYSSQTKL/$GAJ+Q$NG.;F2UN=.O$O+>>-02&7.
M5.>JD'!%8<_P[D,-[IMGXAO;/0;Z1Y)].CB0XWG+JDA&Y%8DY'/4XQF@"AX?
MTVX7XQ^(KB74[LLEG:R/"&7RW+B0;?NYVJ>5Y!]2:[G1[&YTW2H;2\U"74)X
M]VZZF4*SY8D9 XX! _"LBW\(K8^+EUO3]0EMH&M8[6XL1&K1RK&&$?S'YEV[
MNW7%:^CV-SINE0VEWJ$VH3Q[MUU,H#OEB1D#C@$#\* *'_"'Z)_;/]K?97^V
M_:?M?F><^/-V;,XSC[O&.E>5>)=5TGQ)XA\7&]DO UO;#3-+>"RFF5)8V\QW
MW(I /FJ@ZYPM>WRJ[PNL;^6Y4A7QG:>QQ65X7\/6_A;P];:1;RO,L.XM-)]Z
M1V8LS'W))H X:^\8ZGK?@#PGJ6DWIL;_ %'5+>RNG\L-Y;G>D@*GT89P?:M;
M2CJ>@_$>+0I=;O=3L+W3)+H"^V,\4J2*ORLJCY2&Z8J?_A7=JM[++%?S);OK
M46M+;A!M250=P!]&)S[8K=FT"*;Q=:^(#.XEM[.2T$6!M(=E;.?7Y: ,SQGJ
M=[IU[X62TN&B6[UJ*WG"X^>,QR$J?;('Y5R5NOB+7-,\7:F?%6H6ATK4;V*Q
MAMUC" 1$D>9E27'08R.!ZFO0-<T"+7)](EDG>(Z;?)>H% .]E5EVGV^;]*K:
M?X5@T_2M;L%N9'75KJYN78J,QF;J!ZXH Y.TUK5_&6I>'M*&ISZ7%-H,6KWL
MMD%625W(4(I8':H.XG ]!6!<7&K^&--^)$R:I++J-O>6(2\*J'966(#( QG8
M0"<<G)KNG\!B"UT1M*U>XL-3TFR6QCO%B5_.A  *R(>",J"/0U6_X5K%)HVO
MV-SK-Y<RZU-#/<7,B+N#H5/ &!@E>G8<=J $N?%,_A?Q'XH@U>X:6SCL1JM@
M&QD(!LDB!_WPN!_MUF6^MZ_HEYX8CU>]EGEET>]OK^(@#?(H1PO3C;N*CZ5U
M'BOP58>+;G2IKR62,V$XD*ITF3*L8V_V244_A5V_\.0:AXET_6996W6=O/;^
M25!619=N<_\ ?/ZT >5^)K#7=3^#DGB6\\1W<LU]!#=3V15!;"-W1@B+MRI4
M%><DG!SUKT/2-3O;CXC^)=.EN&:TM;:S>&(XPA<2;B/K@?E6-=_"^2ZT)_#P
M\3Z@F@@@P67E1DQ@-N53)C<R ] ?0<G%;.J>#[FX\1RZWI&O7.DW-S EO=B.
M&.5954G:0'!VL,D9Y^E '+1^);^3P;//>^)/[.+:]<6K7/D^9.T*R,!'"H4Y
M?  !P<#)JOI.N7A\0ZQHR7VN76ERZ#-=Q_VS;^7*LBL$RA*JQ0ANXZBN@C^&
M=O::196MAJ]W!=V&H2W]K>.JR,K29W*P/##!QV-6K?P)(-=FUJ_UV[O;Z?3Y
M+"4O$B((V((V*H&W!&>^<G)H M_#K_DF_AO_ +!T'_H K@M3UW5]/U74&U[7
M=<T&\6\864[6@DTLP[OD!VJ2<KU)(()[5ZEH.DIH/A_3])BE:6.SMT@61A@L
M%&,FN8N_A]=7$%_IL7B>^AT.^D=YK$Q1NP#G+HDK#*J<GCG&: ,EM+N];^+6
MMI;:U=:?;?V7:/(]B4$DI)?;AF#87J>!SQS44'B34E\#3IJ/B5;*:TUN73)-
M0,&^>>)'(Q&BJ092,#[IZ$X[UV^F^&;;2_$-WJUO(X^T6D%H(,?*BQ;MN#U_
MB_2L6?X=0M:_Z+JMQ;7L>KRZM;W(C5O*DD)RI4\,N"1ZT <YHNN78\5W^CQ7
M^NW>ESZ+-=+_ &U;^7()%8+E"55BI#=QUJ'P;_R$OAK_ -@"Y_E%77VW@:4>
M(#KM_KMU?7SV4EE(7B1(_+8@@(J_=P1GN3GDU-I/@BVTFX\/3)>2R'1;*2SC
M#*!Y@?;\Q]#\OZT 0_$74-4T_2M)72+W['=7>KVMIYNP, LC%3D'J.GY5D/>
MZGX-\8&TFUF_U?3Y](N;UH[TH722$J?E95& 0<8Q78>(- B\01Z<DL[Q?8K^
M"^7: =S1-N"GV-,O?#EO?^)K369I&)M[2:U,!4%760KG/_?/ZT <'(_B:W^'
M:^.CXFNGU'[*NHM9%4^QF,@-Y03;D?*<;MV<U;T*V>[^,>H:BNHWPC?2;:Y\
M@LFTAS( A^7.U>HYSGN>E7_^%;.=-70I/$=^_AI6&--,:;B@.1$9L;BF>W7'
M&:VG\+%/&<7B*SU&6V!MEM;FT$2M',BEBO)&5(+=O04 8OQ3@N;FP\-PV=P+
M:Y?7[41S%0WEMA_FP>#CKBJMWJ6I>!/$D-K/JU[K&G7NG7=R$O"AEBEMU#G#
M*H^5@<8QP>E=/XL\+Q^*["SM9+VXLS:WD=W'-;XWAT!Q@GIUS^%5=.\',FK2
M:KKNJRZS>&W:TB,L*11Q1-]X!%XRV!D_AP* /.;?Q3XC?P_;:_:W/BF\UN54
MN#8C27^P2(Q!,2XCZ;3PX;)QGO7KFN/YGA?4GVE=UE*<,,$?(>M<Q'\.KB.Q
MBT;_ (2C43X>B<%+ (@?8#D1^<!NV \8ZXXS797MHM[I]Q9LQ19XFB+ = P(
M_K0!Y!IT>N>'/AIX9\21>(KV1E6R1K JGV8P2,B;-NW.0K#YLYSG\+VI>);S
M5_%VN6DE[XDL[+3)EMK=-$L#+N?:"SR.$;/)&%XX^M=E<^"[>Y\$6'A@W<HA
MLUME68*-S>2RL,CISM_6HK[P==#6[S5="UZXTB:_"_;(U@2:.1E& X5ONMCC
M(ZX&10!R5KJFJZM??#^?6K:>&_CU*[B<S6Y@:4+"X6381\NY<''KFJUTFN>+
M/A=K?BI_$%W ;FUO&BT]%3[.MNN]?+8%<EBJGYLY!(]*[BV\#6EI_P (_P"7
M>W3G1YY9P\S;WN'D5E8N3_O$\?2LV[^&\DMCJ.D67B.]LM"OC([V$<2-L9\E
M@CD;@A8Y*_49&: .H\,_\BIH_P#UXP_^@"N'T*'Q+XQ\.-XHMO$US8WEQ+*U
ME:!4^RQ1I(RJDB[2S9"G)SGGCI7H>G6:Z?IEI9(Y=;>%(@QZD* ,_I7'S?#I
MS;W>EVGB&]M?#]Y(\DVFI$AP'.71)"-R(Q)X]SCK0!4M$U[7OB/KUI)X@NK*
MPTE[.1;:U5<2,\09E)8$[.#Q_M>U8=IKWB/5+3PO;1:U-;RZAJ^H6T\ZHK-Y
M49DP ",9 7@XZX/->BZ1X:MM&UO5M1MY&QJ MU\G "Q"*/8H'X5EZ?X!M=/?
M1F6^F?\ LN]N;Q,J/G,V_*GT WG\J ,#3-.UZ_\ %?B#PT_B_5DL--6":&=?
M+^TLTJD[6DV<JI4G  SGKQ3/#_BK6=1MOAW)<WA+ZC+=Q7NU0!/Y4<@4D8XY
M0'CO7=6.@16/B;5];6=VDU)($>,@83R@P&#[[JQ]+\ VNEP^&XTOIG&A2W$L
M990/-,H<$'TQO/Y4 <9!-XFOOA[J_BIO%5_%=:=)>/:P1I'Y16*1^) 5)?.T
MCJ,#'OG:\0:\;F]TJ.Z\0WUC%<:<ES_9^BVS2W<DC?Q$A'VQ@<#IDYYKH;;P
M7;VW@G4/#(NY3#>BY#3%1N7SF8G Z<;OTJK)X'N+?5HM3T;79].N?L45E<'[
M.DRS)']UL-]UN3[>U '"-K-_JW@B6+4)[J=K#Q9;6L,EY$(YS&)(F42  ?,-
MQ!XK1NKG5-/D\?ZII,KK<:=JUO=O&H'[Z)(8S(A]BF[\A71V_P -;:WTVZLO
M[5O)EN=5BU5Y9@K.94*D@D8!#%/08SQ5^:TTWPBGB#6KU[BXM]3G66:*.W,I
M7Y%CVA5!)!P/SH @L]<GU_Q[##IMV?[(L=.6YN-F,323\Q*?H@+<?WA2^,]2
MU$:MX?\ #VF7C6,FL3RB6[10SQQ11EV"9! 8\ $@XYJO\*_#3^'?!Z>?#+%=
M7LAN'CG.9(TP%BC;_=C51CL<UN>)/#47B&&T874UE?64WGVEY!@O$^"#P00R
MD$@@]: .1O+[5_">MWVBG6;O4+6YT:YO;66[VM-;S1#GY@!N4Y!Y'!%;'P]M
M=6ET"QUS5M=N[^;4K*&8P2*BQ0[E##: ,YP1G)Y.33[;P.SSZA?:OK%QJ6IW
MED]@MPT2QK!"W4(B\ D\DG).!70:+IB:+H6GZ5'(TB65M';J[#!8(H4$_E0!
MRE_+J7B3Q]?:##J]WI>G:99PS2FRVK+/+*6Q\S X4!>@')-5YI_$6CZWX1TG
M4-8^U?:;Z[BEFC4*T\*PLT>_C <8&<<9%;FL>%)KS7%UO2-7FTG4C!]FFD2)
M)4FC!R R-QD$G!'/-5;#P!9V%SI%RM]<RW-C>3WTTTH!:ZFF0HS-C '7@#T
MH YP^*-:C\&S:$;UCXI75O[&2X*C<2S;EFQCIY)W9QU%9_CG4+V?1?B3IT]U
M)-;6,>GK;H^/DW*A;\SS7>-X*L'\?)XM,LGVE;?R_(_@+X*B7_>V$K]*K:OX
M!M=73Q.LE]-'_;XMQ+M4'RO)  V^N<=Z .=U*/5'\6?$)M$N'@U*+3["6W9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/LT.NK-J/E7@7,T2B1U.QNJ@+DX'<DT >PQ:C97%U):PWEO)<1_?B252Z_4
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MB566/9$=HP.%SSCIFM_6?#VD>'KOP%<Z5806ES_:D5N\\2!9)$>&3<'8<MG
M)SF@#T:?4;*VN([>>\MXIY?]7')*JL_T!.35FO#=*TN^URQ\57E]IOAFZ<W]
MU'>W.J32">W520HR$.Q54 K@^]>I^"3<'P3H_P!KOH[Z;[*@-U&6*S#'# L
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MS([=L9*L<C) Y(4$BG7_ (_T:RFTV&%+S4)-3MC<V264/F&91C@<C!P<\X
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M2; &!ZY-=)<-J&E?%&.XEL[FY:[T!+2*XC@9H6N%D=BKL!A <@\XZUZ%1TH
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M,3"1RTDFW"XR<@C'KQ7J-% %#1$>/0-.CD5D=;6(,K#!!"C((J_110 4444
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M4?$-QH.BII27&FV\+ZC=W22-'YLBY"1HK XP,Y)X!%9-U\1-:32;:*#2[/\
MMT:X-%N8'D8PARC,)%8<[3\IY&<9'6M(Z-XHTOQ!<Z_I<&F7$VJ6T*ZC937#
MQJDT:[0\<@0Y7!P05'0&J</@'51'I]U<W=I+J3>(5UF_9=RQ@!&3RX^"3@%0
M,XSS0!--X@\:0^(=.\-^1H;ZE<V,MU-<J)1#%MD"@A<[F^4@8XY/7 Y@;XBW
MVD^']=DUJTLVU;2KU+$+;R%()WD"F-LMDH,-DY)P :Z270KJ3XB6OB /%]DB
MTR2S9"3OWM(K @8QC"GO7/ZI\/;O55\4![FWB?4+^WOK!R"X1XD0#S%(Z$J0
M0,\'\* &Z;X[O8_$6FZ7J6I>'-074RT<4ND3%C;RA2P#J6)93@@,,<]N:F7Q
M]>CP#/J4EG!_;\5Z=,-DN=AN_,V*HYS@@ANO2IM)T+Q#+KMC=7VG:!I-I:!C
M*FGH)9+IR,#YFC7RU'7C)[9K%M-)MM6^-%S/87D5SI-M''J5S'$P9%OBK0IR
M.,[/F^H% 'H5J=8_M6=;M;+^SA"GDM%N\TR?Q[@> OICFJ7B?4=7T^UM_P"R
M;>S+RR[9;J]EV06J8)WL,@MDX  [GJ*DM=0U&7Q;J&GR0P?V=!;12Q2H&W[V
M+ JQ/'\.<#L1GJ*QO'/AB^UV]T2]M+>QOXM.FDDETV_<K#<;EV@DA6&Y>HR"
M.30!DZ?\0-0W^)K.XGT74;C2M,;4(;K3'8PO@-\CKN)# J.C=#VI8_&/BRVL
MO#^MZE9:2-)U:>W@-O"9//A$V CEB=IY()7'&<9/6F1^!]=FU#7[R=-'M$U/
M0WTZ"UM"P2W<EMH)V#</F)+8'ICC-;&I^%+^\\'^&])CEMQ<:9<6,LS,QVL(
M2N_:<9).#C('X4 0?\)%XGUO4M9/AZUTPZ?I5PUHRW9?S;N5 "ZJ5.$ S@$A
MN:F^$W'PL\/Y_P"?<_\ H;5"FA>*- U36%\/G3);#5KEKL/=R.KVDS@!SM"D
M2+D9 RO/'O6SX(T.Z\-^#-,T>]DBDN;6(I(\1)4G<3P2 >_I0!D:'.=8\7>*
M]7E =-.8:5:JW1 J!Y?^^F9<^R"LGPOK<-U-\/PNC:?!]MT^[D0Q(1]E"A,K
M'SP#GG.>@K6\/6[:7XO\6Z*_R_;Y!JEJ3_&LB!)/^^749_WAZU7\/>"-3TJ7
MP4T\UJPT.RN;>YV.QW-(%"[,KR/E.<XH N^&)3IOC;Q+X=7BU4Q:E:K_ '!-
MGS%'H/,4M_P(TSQGXPNM"UK2]*M[C3-/%[')(=0U3=Y"E2 (QM*_,<YY8# [
MT[PS$=2\=^)]?7FU!BTRV;^_Y.3*1[;V*_\  35SQ1IVNW=W;RZ?#IFI:?Y;
M1W6E:B J2$D%9%?8Q##D8(Q@^M &;<^,-;L/#=F]QI]A-K-_J L+'[/<;K:?
M.2)LC)5-H)(Z\>]20:_K^F^([30O$D>G2C4X)FL[JP5T >-=S(ZN3_"<@@]N
ME8MG\-M2M=#9[::PL=4CU<:M9VL.YK2W(7;Y70':PSD@#D\#BMJWT+Q!K7BB
MQUOQ EA9QZ9#,EI:6DS3%I)%VL[N57C;P !WZT <EX:\8R:%\/\ P9H]E-IT
M%[?VKR&YU*79!!&C')/(+$D@  CO3_$/C&36O _C/1;V?3+F\L[ 3+=:9+O@
MGC8XR!DE6!&""3U%:%M\.M5T[1?"\L"Z7=ZKHUO);3VUUDV]S&YR0&VDJP(!
M!V^N:M7/@[7]5\-^)+>Y31[&?4K806EG:(/*@ ZEY0@9B3[8&.E &UI7B.:+
MQ1<:%J"0Q0)IL-]9S#(+Q_=EW$G&5;'3L:N^#]:N_$7AV+5[J".!+J21[9%!
M!\C<1&6R?O%0#^-<9\3=/%]_PCNG:?J$46NR3'3S'&P+FVFB*S$CK@* V3Z>
M]>EVEK#96<%I;H$@@C6.-!T55& /R% 'D%IJ%WX=\4>._$^K6FF7<EA-"F8H
M6$Q=HD6-(W8G:IW -]3]*ZN7Q%XK\/W6E3>)+?27T_4+F.T?[#Y@DM)).$R6
M)#KG@D;>N:2^\!3ZK'XSM[FYCBBUR:&6VDCRS1-&B %@0/XT!P#TI)]#\6>)
M;C2;?Q"NE6MCI]U'=S/9S/(]W)'RH"LH"+GD\D\8H D\.^(O%'B'Q%J*I;:5
M!HNFZG/8S._F&>79T*#.T=5SGKDXQCFO\3VU99O"8TZ6U17UR%<3*YS)M<IG
M:1E.#D=<XQTK>\)Z%=:$-;%T\3?;M6N+Z+RR3B.0C .0.>.>OUJ'QOH>IZU9
M:7)I!M?MNFZE%?)'=,RI)L# J2H)'WO3M0!RUBWB=OB9XSBT,:6DFVQ:>>]$
MC)N\CA552#SSR3QCH<U._P 3IV\+:%<""PM-7U6XFMO],GV6T!A9A([-P2OR
MC SD[@,UTN@Z%?6'BKQ#K%X;?9J@M2B1.6*&.+:^<@<9Z>WI7+K\.=3@T#1S
M&^G3:MI-_=7,<5P"]O/',[%D8[<@[2O.#@COUH UO"WC2;4?$L_AZ_N](OKA
M;7[7!=Z3+NB= VUE92S%6!(/4Y![5=\8>(=6T:]T*RT:TM;FYU2Z>WQ<,P5,
M1LV[([#&3Z@$#UIGAK1M9AUNXU/4[72=.@, AAL-/17P<Y+O*45B>VT<8]ZS
M/B+_ &A_PD'@PZ4T"WHU&0Q?:,^6W[E\JV.0",C(Z9S0 ^;Q?KFBS:WINM0Z
M?+?VFD2ZK9SVJNL4R(""K(S$@AL=&Y![5>U+Q9>67A;PWJJ00--JES90RJP.
MU!/C<5YZC/&:J+X3U?7M0U;4_$+6EI/=Z7)I5M;V;M*L$;Y+NS,%W,3CH  !
M68WA7QIJ&E>'M)OCHT%KHMW:3-+#-([W2PL.Q0!/E!..<G'04 :>F>)/%.L^
M)M6M[6VTJ+2=)OVMII9?,,LJA0V$ . PSR3P<CCBLFR\<>,)/ \'C2YT_21I
M@C$T]E'YGGM$#AI%<G:#U8*0>.^:ZKP_H5UHLOB6:Y>)EU'49+R'RR20AC1<
M-D#!RIZ9K@/"&D^+/$7PFTO0=^FQ:1>6X1[[S'\]("QW((]NTMC(#;L8[9H
M["7Q)KVN>(K_ $SPLFFQP:='$UQ=WZNXD>1=ZHBH1T4@EB>_2LF\^)=[!X>@
MEDMK*PU%=5?2KZ:Z9FM;61 27)&"58;<=/O<GBM1_#^O>'O$>H:EX:AT^ZM-
M2CB$UI>3/"8I(TV*ZLJMD%0,@C.1UJO;>$?$>E:&S6E[I]UJ5WJ,M_J=M<1X
MMKKS!@Q@E2RA0%P<=N1S0!)_PFVH:/X4UG6]933+VVL@AM;O2YP8KLM@!<%F
M*$,5!))'.1TJC9_$"_M-7TF#5=1\-7T&IW"VOEZ3<%I;61_N9!8[US\I("X)
M%5X?AC/J%EXD6[@T_15U>&%(K+327BA>-MZRME5!8MC@ # ]ZU-/\/\ B6;5
M---[I_AS3+>SD$MQ/8QB62Z('"J&C'EJ3R3DMQP: .C\5^($\+^&KO5F@:X:
M$*L<*G!DD9@J+GMEF'-<_-X@\5Z!>Z7_ ,)##I$EIJ=PMFKV(D5K:=P=@;<3
MO4D8)&VM_P 7>'QXH\,W>DB<V\LNUX9@,^7(C!U..XRHS[5@2Z)XJ\2:AHZ^
M(4TJTL=,NDO'^Q3/*UU,F=F RKL3)R1R>@H S?A?87IUCQ3J-_%I;S?VO<PO
M<0PL)MX*9 8DXCQT7K6OXA\1>)$\:6_AKP];:8TLVGF],]\7VQA9-IR%.3G(
M&/4YSQBM3PGH5UH7]N?:GB;[=JUQ?1>62<(^W .0.>.>OUI&T*Z/Q&C\0[XO
MLBZ2UB4R=_F&97SC&,8![]>U ',77C[4;G6-2L;#4O#.GKID@MY6U6<JUS.%
M!<(H8%$!.-QW<]J<OQ$U36+/PJ^@6%F;C6VN(I5N7+);O$/F.Y?O*"&/^T,=
M,U)/X0UC2=<UBYTC3-"U2UU2<W0&I$I);3, &Y"-O0D9QP1S69K.FZYH^M?#
MZSM;JRN-7C>]9W>$0P2GRMS+A!\HQD X)Z$YH UY_'E]X;.N6GB>WM9+O3K%
M;^"2Q#(ES$S% -K$E&WX'4]<T^;Q)XM\/_V;?>([726TV]N([>9+/S!+9M(<
M*26)#@$@' '7C-0W/@74?%/]NWGB26VM;O4;%;"VALV:1;6-6\P$LP7>Q?!/
M X&*DN=!\7>)%TS3O$']E6]A9W,5Q<S6DSN]X8SN4!2H" D GDGTH CMO$7C
M+7M4UR#2H-%M[#2[V6S::Z$K/)A01M"G (R,G/.>,8YP/"FH7EKX!\ G4;:P
MO1=:I%%;NZ.7A4I(=^2?]9D'GI@]*[[PSX?NM';Q%]JDB8:EJLUY%Y9)VQNB
M* V0.?E/K]:YC2/!/B&W\/\ AC2;UM- T'5([A9897/G0*KC."O#Y<<=..M
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M2IR ,8(Z\UC+\-]2/@[Q)8Q#3=/NM6N8;F"QMF8VML8V0@9P#EMG)"@>@XH
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MR/+< '<HP1][<>3P,=:YS_A6WB(^"KKPU%8>'()Y(V5]9W.\]U\VX;ALRI/
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M/2#<:G#!'/\ :)HU\@,$=%<JK#=S@@9SWZCB@#9HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHKCOB#>WL4&AZ79WDMD-6U..SFN86VR)&59F"-_"QVX![9H [&BO.WM7\'>.
M]#T_3;^^ET_6(;I)[6ZNGG"/%&'61"Y)4GH><<BCX3:5-+X6TSQ'?ZOJ=]J%
MY:E7%Q=,\07=\N$/&0%'/7EO6@#L]9UFWT2R2XN%DD:25((88@"\LCG"JH)
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M@$@#)R#A3W/-X3:YI,7B.*TL==T[1VT*YF1=2O5ED@N%4X:)A([@$9[\$9H
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M[:\M)/+FA)&&P<$8(X(((-9\7@#25TO5[2XN+Z[FU>/RKR]N)@T[J!@ '&%
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M;W4;A=(F>6S^TS!_+#1^7L^Z/D"]!VK1G\,Z;<ZS>ZG<1M+)>V0L)XG(,;1
ML<8QU.X]ZAU+QKX9T?4?[/U#6[.WNAC=&\G*9Z;CT7/OBK.J>)M$T79_:6J6
MMKOB,J>9(!N0$#(]>6 X]: ,.T^'&F6\UD)M1U>]LK"19;2PNKK?!"R_=(&
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MN;?#O#)-;F!BC.Q7Y"3@8/'/3%='=Z;87[(UY96UPT?*&:)7*_3(XJUC P*
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M[6QC->GW&F6%W<1W%S8VTT\?W))(E9E^A(R*G,,1F68QH95!4/M&X ]1GTH
MRO%,5F_A'5H;Z.X-DUG*DRVJYD\LJ0=H]<5YOH^KRV>N>%+5=9T3Q59RR>59
MM' J7MDAC/SX4D;0HPV0#7L%5;;3-/LYY)[6QMH)9/OR10JK-]2!S0!X9I$D
MEIX(UO3]7\7:7ISB>Z74M/N=.62X=V=N1F0&0L""I ] .E="FHS:=KNBZ5#>
M:9IU[;Z!"6UG6H2)98R<;$CW@ C&6RQ.?I7J4NF6%Q=I=S6-M)<Q_<F>)2Z_
M1B,BEN].L;_9]LL[>Y\LY3SHE?:?49'% 'A5O<+<>$?%#K>I>AO%-H_VA(A$
MLN7A^<*.@/4>HYYKW.+4[*?4[C3HKF-[RW17FA!^9%;[I/UQ4ALK5M^ZVA.\
MJS9C'S%>A/KCM3U@B69YEB02N &<*-S =,GO0!)7EZ)K_B?XCZMK6A7>GP6V
MCK_9,+7L#RJS\/,5"LN"#M7// KU"HXH(H%*PQ)&&8L0B@9)ZGCO0!X;>F\\
M/>"O'G@S5)(6FAMSJ5F84*1M#*P+!%))"J^1U/6NU\56EO:7'P^6WA2(0ZK%
M%'L7&U# ^5'MP/RKNIK.UN'+S6T,C%-A+Q@DKUQSV]J>\$4AC+Q(QC;<FY0=
MI]1Z&@#DOBM_R2WQ!_U[?^S"J6AV\+_%_7;AHU:6/2;-4<CE0Q?('UP/RKNY
M8HYXFBFC22-AAD=00?J#0L,22M*L2"1@%9PHR0.@)H \1@$-E965S=JJZ'8>
M-+PW((_=PC<ZQLPZ!0Y'/09%=!/J.C:G\7+F;2KBWN9%\-7"7$UNP92?,0J"
MPX) /Y$5Z9]EMQ%)$((O+D),B;!AR>N1WS45OIMC:*%MK*VA55*@1Q*H /)'
M Z&@#R6SE7P]X \!^,PK>7IMLEO?;!DFVF 4D^NU]A_.I)M/GM?!?A>^O5VZ
MAJWB>TU*Z'HTLF0O_ 5VKCVKULVMN;;[,8(C;XV^5L&W'ICI2R012A!)$CA&
M#*&4':1T(]"* /+]%U/0M(M/'%AXDGMH;V74KF6>&X(#W$#C]UM!Y<%<  9Y
MXK*\/7MMI</PKOK^>.VLQI]W"9YF"HKLB;06/ S@XSZ5[!-I]E<W$5Q/9V\L
M\7^KE>,,R?0D9%$NGV4]H+2:SMY+88Q"\2E!C_9(Q0!Y#?\ B+37N_B=JT%M
M%J]@MOI\>P,?*FX="=PZH#G)']TTFIZC//XK\$I<^)-%U!UU)"EMI-L%C@4H
MP^_O8X/  .,XZ<5[#'9VL2,D=M"BLH1@J  J. #[#)XJ*#2=.M8Q';Z?:PH'
M$@6.%5 <=&P!U]Z .6^&_P#Q[^)_^QBOO_0Q7,>.XIK'QA<Z1 K"+QE!;VQ9
M>@DCD"2GV_</_P".UZS'#%#N\J-$WL7;:H&6/4GWI'@BDDCDDB1GC)*,R@E2
M?0]J /)/!MO+/XU@\,R1L+7PC-=S#(X;S6_T?\HW?'TJM8V=LO[-.IL((]TL
M5W*YVCYG$[@,?<;1^0KV1((HY9)4B19),;W"@%L=,GOBFBTMA;&V%O$(""#%
ML&TYY/'2@#SK2=0L=(^)FJ7&O7,-L]WI=G_9UQ=.$5HU4^:JLW&=Y!(Z]ZT/
MAJ8YG\3WM@,:/=:O))9%1A'&U0[I_LEP>1QUKLKK3[*^A6&\L[>XB4Y5)H@X
M!]@14Z(D:*D:JJ*,*JC  ]!0!Q*_\EEU+_L78?\ T?)7%>$A*UO\,%@($QTO
M4@A/9MJX_6O:O)B\XS>6GFE=A?:-Q7TSZ4Q+2VB\KR[>)/)!$>U -@/4#TS0
M!X#IQ4?"F32M1\7:=:1X>"ZTMM+$EXLY<Y&/-#-)NY#8]#VKK+__ (EWBFY>
MP\66^E:S_9UL+V+6K9?(OE52%=26##'S!MI.#7IS:98/>B]:QMFNUZ3F)2X_
MX%C-%YIMCJ&S[;96USL.4\Z)7V_3(XH P/AU?C4_ FFW*Z=!IZ$.JP6P(BP'
M8;D!YVMC<,^M<--KQG_X2T0:EH?A^V2]GAGMI+?S[R[<#;N(9P/GX"@*?QKV
M%5"J%4  #  [56;3;%KT7K65L;L# G,2^8/^!8S0!SGPP;?\,?#ISG_0D'Y<
M5P=QJ46FZ7X@,EG93F?QJT4<M^3]GMG*H1+)@C@$>HY(KV:&&*WB6*&-(XUZ
M(B@ ?@*C>RM)(987M86BF):5&C!5R>[#OT[T >3VEP=2^+NE6]_KNGZR[Z9=
M13?8;<1Q(#M/E[@S;CC)P3QQQS7.-:W^HZ9<V.)&NO -HYB8\;IDN-T9'K^X
M@ _X'7O,&G65JL2V]G;Q+#GRQ'$JA,]<8'&:D%M K2L(8P9?]80H^?C'/KQ0
M!Y XT[6/!][XJU.\N=.76-<BN;.^2(/]E6)O+MVD5N-GRDG/'SU(NHW]]>>)
MM)GFT?7;Q_#TY75M+BVR8Y"PR@$C))) ![=*];^S0?9OLWD1^1MV^5L&W'IC
MIBF6=A9Z?&8[*T@MHR<E88P@)]< 4 >1:EXET:^\!>!+"SU&WN+O[;I@:"*0
M,\>QD#;P.5P>.>Y%1>)_^1?^*1[+J-JQ]@! 2:]?CTK3H7D>*PM4>1@[LL*@
MLP.03QR<]ZF-K;D2@P1$3?ZT;!\_&/F]>/6@!+2\MM0M([JSN(KBWE&4EA<.
MC#U!'!KQJ]C9_ GB-WC>6QA\8RS7\:J6W6RW"E\@=1CD^PKV>""&VA6&WB2*
M)!A4C4*H^@%$<$40<1Q(@=BS!5 W$]2?4F@#SO7]4TG7/&7@M/#]W:WE]!=M
M,\EHZOY5IY;!]Q7[JDE0 >IJY\(K2WA^']K/'#&LLMS=,[A1ECY[KR?HH'X5
MV=IIUC8%S9V5O;&0Y?R8E3<?? YJ:*&*",1PQI&@R0J* !GD\"@#A_$MM!<_
M%GP6)XDD$=O?NH89 8+'@_K7.2M=Z;\4_$Q?Q'INA/-%;-:M?VBNLMNL>"(V
M9U "L&RH[\UZVT,32I*T:&1 0KE1E0>N#VJ&\T^RU!56]L[>Y5#E1-$K@'VR
M* /&D%IIO@G0+T:G]HTW_A+X[D74EM]EA2,NVXHI8@1[MQ!R!S6W<^(A)XU\
M0BPU30- 2&.W\^^O$\V>\0Q[E9 75=@!P,9S7ILMK;SVQMIK>*2 @ Q.@*X'
M08/%12:5ITTT,TMA:O+  (G:%28P.@4XX_"@#Q?PLX?PYX$PQ8#Q-<CE-A_Y
M;G[O\/7IVJ==433])FC-M8-+/XSO%ANM1S]GM) S$2-@C)Z@#(Y/6O9A9VJD
M$6T((D,@(0<.>K?7WILEA9S6\EO+:0/#*Q:2-HP5<GDDC&": /+= O);OXS-
MYVN66KSC0I8WFLK<1Q*?-0^6"&;<1G/7C-96AWMK<_#SX:PP7$4LMMKUO'.B
M."T3[9CM8=C[&O9X;"SMA$(+2"(1 K&$C"[ >H&.E(FG6,;%DL[=29/-)6)1
ME_[W3K[]: /-/"^K^'M%\/\ B>Q\2W-I!?C4+M]1AN6 DG5F)0A3RX9"H&,^
MU9_@[3[B/7/AY%JL)-U;Z'=.JS#YH_F39UZ$(0/:O6I]-L+JYCN;BRMI9X_N
M2R1*S)]"1D5.88FF68QH95!57*C< >H!H XOPFBQ?$;QXD:A4^T6;[0,#<;<
M$GZDU1\2WNDZ?\8?#EQJTL,,8TVY$,LY 5)2Z8))X'&X ^IQWKT)88DDDD2-
M%DDQO8* 6QP,GO4=Q96EV"+FUAF!4H1)&&RIYQSVX''M0!Y8NCP^,KSXA#2'
M1K&Z%L+2YB/[MKV)"Q=".#AO+!(ZUI> -2E\;:_<>++B)HTM+*+3H$9<;9B!
M)<'!]&*KG_9KM=1L[Z/1FM?#[V=C<K@0F6#=$@SS\JD=LX]ZC\,Z#'X:T"WT
MQ)3.Z;GFG88,TK,6=R/=B?ITH YWXBZHMA/X>A%OIPGN+\^1>ZEG[/:.J$AR
M 1ECR%&1S7'P7KW7C_Q$9=;M-7E'A:97GLX!%$&#_<&&;<0",G)ZXKV.YM;>
M]@:"ZMXIX6ZQRH&4_@:;'I]E$JK':0(J(8U"Q@!5/51QT]J /*K^TM[?X&>%
M#%"B%'TR92JX(=I(RS#W.X\^]>A^,(;VX\%ZW#IP8WLEC,L(3[Q<H< >_I6J
M;6W:!8#!$84QMC*#:N.F![5+0!X.&AU#P+H6GCQIIQC,ELMK86>DJ;N&964@
M "7<&4@[F('?UKKM'M+=]0^)LKPHTDDYB=BN24%LIQ].37H$>F6$5ZUY'8VR
M73?>G6)0Y^K8S4RV\*F0K%&#*<R84?.<8Y]>* /(Q;00?"GX<F*)$(U/3) 5
M&/F9LL?J<G/UK0\.:WX:TGQ9X]75KRRM;EKX-(;EE7S(!$O S]X [L@9^\/6
MO2_LMOY4<7D1>7$08TV#"$="!VQ6!I?A&VL]3UF\O4MKW[???;(ED@!,)V*N
M 3GGY<Y&* /.?#-M>0/\-XF1X9&AU9[9)!@I&PS$#G_9*_A3K#5?#EM\";O1
MKV6W75%M9K>>PD(^T->DL!\GWBQ?!!QZ'M7LK0Q/*DK1HTD>=CE02N>N#VS4
M#:;8->B]:RMC=C@3F)?,'_ L9H \NUZ\O_ 0T+Q/-%)+<W.CC2[Y,;BUTL>^
M$G'4EPZY_P!JJ>MZ%=>%W^'\,NI06$-L+C[1?W4'G0I>2*&W."RC+,9 K$\5
MZ#K7AV_UW7]/>ZOH!H=G,EU]D6$^9+,F=NY\XV X;&.HKHIX(;F%H9XDEB<8
M9)%#*1[@T >,7Z+<1^/+Y?$4&KSCP^\-TUE8B*#=ABF7$C!I -PQZ'KQBO5/
M"UI;V?A;28K:%(D%G",(H'\ _P 3^=7H=/LK:T-I!9V\5L0084C"H<]?E Q5
MA55%"J % P !P!0!Y[J$=U+\3?$4=D2+M_#"+ 0<$.9)=OZXKF;C5?#DGP%A
MT6"2W.I_9([9-/4C[0+X8!_=_>#>9DYQ[U[,(8A,9A&GFE=I?:-Q'IGTJ :;
M8+?&]%E;"[(P9Q$OF?\ ?6,T <-X0LE;XD^+YKR*.2]C@TY&D8 D'R26P?<@
M'\!7H=,6&))7E2-%DDQO<* 6QTR>]/H **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ K!\6>*(/">EP7T]K/=+-=1VRQP %RSYQ@'KTZ5O5RGCO3+S5+70TL[=IC
M!K=G<2A<?+&CY9C[ 4 0R^-KZ%+&SD\,W8UZ],C1Z8+B,E8TQF1Y =JKR/?)
MQBF3?$.WL]"UN]O],N;6^T78;RP=U9@'(VLK X92"<'V-9OCKPP]UXNTWQ!)
MI-WJUA':/9W-M93M%-'E@RR+AEW#.01GN#@US.NZ,MA\//&>IQ>'9=(@GAAC
MMQ=W+RW,RJX),@9V"C)X YZYH [ZT\;3?VGIUMJN@7FF6^IMLL;F:1&#O@L$
M=5.8V(!(!SZ=:KS?$&=UOKS3/#=]J.CV$CQSWT4L:[BGWS&A.7"X//&<'&:J
M7S:SXQU3P_:R^'[S2X=-OX[^]GN639OC!VI$58EP6/WN.![XJEI+:_X1\.7O
MA:/PU?:A.DMP+"[@,?D2I([,ID8L"A!;!!';C- &UJ/Q"CBOM.LM%TBZUF?4
MK'[=:BW=45H\C[Q;&WCGGO@=36#:^*=8NKSQ\FL:??6]A96H;;'=1A[4?9]Q
M52I^\V2P89QQGI5WPOX2U#P_XH\/I)&9;:Q\.M9RW*_<\XRHQ4=^QQ["J^I:
M9JZZK\0[--(NI8];L=]G<Q[3&S+;>7L/.0Q;IQ0!JCQN;6XTK0],T6_U.]N-
M)BOH5,R#]V?E_>.Q !&!D]R1Q4T7Q%LO^$<N]2NM.NX+RUO?[.DT[Y7E:Y)
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M:'+LN <?,DAWK@@]"01BF66E>*M$/A;Q#J=I<:M>VEE/9ZC#"ZO.J.X9&&2
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M3)^Z.&YY/S#TKFQXG\:CX=-XV.MVY%O.5&G_ &--DZ"?RCO?[P/^[C@#ODT
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M?)BBD*X2/A=Q) Y&!R<&@#U>BO,]2\2^(?#7_"2Z/>:BE]=6NBOJMA?FW5'
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M&-=-V?;"V?W.\ KN^H(KBK/Q9KGB^ZT'3--F_L2>ZTQM2OIC )'0!Q'Y:*_
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MNYIFFFN)N!N;^%%R=B#LHZ5FZIH/B%M9NKW1M>ABM[R-4FL]0MFN(HRHQNC
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MK0!A:MX;_M3Q-HVKFZ,:Z=%<Q&(+S)YRJN0V?EQM]#U[5R1^&NMMX,E\'_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %<A\1;BS30K2SNQJ$QO;V*"*TL9!&]VW)\IF.-J$ [CD
M<#K77UFZYH&F^([%;/4[<RQ)(LL95V1XW7HRLI!4CU!H \S\/VDFB_%.UM8=
M!M_#\-WI4[2V=O>>:)=K+M=U "J1R 1G//-8$/AW3[7X#6GBJ-9?[?MXHYX;
M\RMYD9$P4*ISPH7C'3\:]<T_P1H&FZE%J4%K*VH1*Z?:IKF665E8 $,S,2PX
M& <X[8J<^$M$/A4>&39?\2<((Q;^:_W0VX#=G=U]Z ./U[65\ >,]7U&7)LM
M8TUKF)#T-Y ,;!Z;U9?J175^"]&FT+PE865TQ>]*&:Z=CDM,Y+N?^^B1]!63
MXGT34/%/BC2+*YTB--%TV[2_:^>96,S*IVQJ@^8?,>2>,+7:T >3Z9H&E^*K
M#Q;K.N[GU.'4+NW2X:5E>QCBX0)@_+@8;WSSFL_PU:PZ_P#\(+X?U;<^D#P^
MUX+8L0ES.K*H# ?>VJ2V*]$U+P'X=U;4IKZZLG\VXQ]I6.XDCCN,=/,16"OC
MW!J2Y\$Z!=:/8:6]DRV^G "S:.9TE@P,?+(#N''OSWH \T\0W$W@_P#X372/
M#UQ+;:=%9V<RI&Y(L7FE\N39_=RGS8[=1BNS3PCX6\,ZMI-UI\S:9=R;X$2*
M4G[?E"=LF<[R,;L]<CK6]IOA/0]*TV[L+>Q5H+S/VKSV:5KC(P=[.26X]35?
M2/ V@:'?QWMG;3-/"AC@:XNI9A AZK&'8A!VX[<4 ><RW&W]ER.1I<,;5%#;
MN<_: ,?6MR/PSI?B?XI>+HM9@-W;0067EV[NPC#-&V6P#]X!>#VR?6MR3X7^
M$9O/233':"9F<VWVJ7R49N2R)NVJ?< >U=';:18VFJWVIP0[;R^6-;B3>3O$
M8(3@G P">E 'B,&C6L?P8T_Q6S3R:_;W$7DW\DS-)&JW0B" YX79QCIWK:O[
M:\\2_$3Q+#>>&X->ATXPP6\%SJ'D+;(T88LJ;3DL23NZ\8KT8>$=#'AE?#OV
M+_B5*P80>:_42>8/FSN^]SU_2H]9\&:)KM^+^Z@GCO!'Y1N+6YD@=T_NL48;
MA]: /,C9WE[HGA/2=4O!)&/$<ML/LU_YS+ (Y,1-*N"2!E#T.!6N_A[2M)\;
MZYH-C:+#I%YX<^U36:L?+,JRE0P&>#@#I7>1>$]#M[72[6#3TB@TN7SK-$9E
M$;X(W<'YC\S9SG.<]:M-HVGOK+:NUN&OFM?L;2%C@P[MVW;G'7OC- '.?"JP
MM+'X;:(;6!8C<6R3S;?XY"H!8^_ K&TS0-+\:>)_%LOB.#[9+97HL[:&5R!;
M0B-2&0 _*6))W=>*[;0/#FF>&+!['289(;9I#)Y;3/(%) &%W$X''0<52UCP
M1H.N7[WUW;3+<RH(IGMKF2#SD'19-C#>/K0!Q&G6.E^)O%^G:'>:C+K>AV6B
M+<6@N),K=2><T;2/C <J%"\COGJ<UC>(8VTW1/'7A[3KF:/2[&]TQK0+(2;9
MI9$+HC'H 0"!VS7J>H^"]!U*VL8)++R!8+LM)+25X)(%QC"LA! QVZ41^"O#
M\6@R:*FG@6,LRSRKYK[Y9 P8.SYW,<J.2>V.E ')7?AK2O#7Q%\*1Z1;&VCU
M);RWOE$C'[2JP[AOR3N.><]:P-'L]$T;X>:X3#>0->ZY+8!--8)-<8N"(X0Q
MX (R">.">:]=NM(L;W4[#4;B'?=6!=K:3>1L+KM;@'!R..<UCR?#_P ,RIJ:
M/I[&/4I1/<)Y\@7S =V]1N^1LG.5Q0!PFEV+Z'\4O#$=OX;@\.1WT-VDL$%Z
M)6N%2,,"ZJ-HP<8.23D^E9NF6::KH?@.QN9)O(GUK45E"2%2Z!IR5)!S@@8/
ML37J%CX%T"PU*UU-+:>74;8DQ7=Q=RRRC*E2"S,25P3\O3G.,U8M?".AV::<
MD%EL73IY;BU'FN?+DDW;SR><[VX.1SQ0!Y[J&F6GAO5_'&DZ1&;33I?"[79M
MD8[%EQ*A91V) '2DT[1;/Q#XQ\.66J(]Q9KX0AF:W+D)(P=0-X!^8#<3@]\>
ME>DW?AS2KZ\O;NYM=\][9&PN&\QAO@Y.W .!]X\CGGK2VGA[2[&_M[ZVMMES
M;V2V$3^8QVP @A,$X/(')Y]Z /)92^EZ/K'AVUN)[;1SXK@L'VRL#;VLBHSJ
MK9RJDG'_  (UT%SX<T;PW\5?!\6C1"S6=+PRVL3G8VV'A]N< \D9[_A72>(/
M#870]671])LKR?49UGO+6]=MEU]T, <_(VU1@] 0#7-^&_!DR^--.UD>'&T.
MUTZ&9<7-]]JGN'D4*!NW-A%&[ W=3TH T/B_I]I?>#(VN8%E,5_:A"W\.Z9%
M;\P2*S9O">C:G\6Y=.N[02:=:>'X!':;B(^)I N0#\V!G&?6O0=9T:P\0:5-
MIFIVXGM)L;TW%>A!!!!!!! .14.G^'-+TN]2\M8'%RMHEGYLDSNQB4DJIW$Y
MY)YZ^] 'C]U<7NG^$KK0-/,S6/\ PF+:6L/VHQ8ML!A").2BD_+GT..]='X?
MTJ^T3Q]I:VVBV'AZSNH)DN;*+5!+]JVJ"KK'@?,IZL.S<UW$GA+0IM.U'3Y=
M/22UU*X:ZNHW9F#RMC+ DY4_*,8QC'%1Z-X-T70KY[ZT@GDO&C\K[1=7,D\B
MIUVJ78[1["@#G?BQIEEJ&EZ$;NW2;&M6D0W?W'D <?B!6?I_A32-8^*?B.*^
MMC+;:7#IYM+?S&$<;>6V&P#R0$ &?4^M=_K>A:=XBTQ].U2W\^V9E?:'9"&4
MY!#*000?0TW3/#^FZ/=7%S90.D]Q%##-(\KN76)2J9W$\@$\]3WS0!XWK5I9
M:QX7\0:_I_AR>_C_ -)FC\0:E?K'*K(6P854%@JE<*N%S@ UT5A:P^,?%VF6
M/B(&\M(/#MM>0VTK'9++(</*1_$1@#GIFNI;X;>%G:X5["5K:=VD>S-W+]GW
MMU81;M@/?IP>1BKE]X*T+4+33[>6VE3^SHQ#:307,D<L2  ;1(K!B, 9R3F@
M#R>Z,N@>'?%FG:--*8)?$\-DS_:2K)$R1AD\TY*_W-QS@5T.DZ/?:%XVT-[/
M0=/\.03F6&Y@35A)]M0)D8C(&YU.#N'.,YKM[/P1X<L-(OM)@TN(6%\V^YA=
MF<2-@#)W$G/R@Y'?GKS2:/X)T+1-06_M;>>2[2,Q12W5U).T2'^%-[':/I0!
M4^(EC-J7AA;*WOK6VFFNH56*ZF,4=W\V?(+#GYP,<<FN&M[[_A%4\1QVWARZ
M\.:W_8LMU#:0W*SV<OE_\M4QT<$CJ!Q7J^L:-I^O:;)I^IVRW%K(02A)!!!R
M"",$$'N#FJ&D>#]&T6XFN;:":6YGC\F2>[N)+B0Q]=FZ0DA?8<4 >3PZ/J-E
MX>TC6K#0[+3K\-;S?V[-K@+7)8KN$F5&\2 D;2>XQTKI](\/:5XSU/Q;>>)(
MC<W-MJ<ME!YDA'V2!%788QGY"<EMPZUTEI\.O#%E>P7,-C)BWE\ZWMWN97@A
M?KN2(L44^F!QVJ?5O OA_6M0EO;NUF6>=0EP;>YEA%PHX D", XQQSVXH X2
M+0=&\5^/]-LKN]GUG28_#,<B223,/M+"=E5W*XR<$_CS5*VTZ[\3ZYXGFO/"
MT&M&UU*6R@>;5/(-I%& $6--IV\?-N'4GVKUFVT#2[/4X]1MK1(KF*S6Q0H2
M%6 -N"!<[0 ?;-9NK>!/#^LZA-?7-K.EQ<*$N&MKJ6 7"C@"0(P#<<<]J /.
M;'2DU;6/AM+KIM=2O'CO8I;F.<3+,L2DQ?.O#$=2?7.:[_XFEA\,_$)4D$63
MG(J[?^#=!U&TTZUFL D6FG-F+>1X3#QC *$'!'4=ZV+JU@OK2:TNHDFMYD,<
MD;C(=2,$'\* .&\73KCP JR#=)K%N0 ?O+Y+Y^HY'YUSVF^$](U^Q\=7VJ0/
M<W$&K7R6S/(W^C[5# H <*<G.?8>E=M8_#GPQI]Q:SPV,SRV<BR6K37<LGD;
M<X";F.%Y^[T/&<X%;-IH6FV-OJ$%O;[(]0GDN+D;V/F/( '/)XR .!@4 >8:
M,H\8:GX.TSQ"S7=A_P (VM_Y,KG;<W&Y4)<?QD+S@^N:R]4#>$['XD0Z!/)&
MB76GPJXF.8$D558!SG: &*@_PC'I7JEWX)T&\TK3M.>S=(=-4+9/#/)'+  ,
M?+(&#=!@\\]Z73O!7A[2K34+6UTU/(U$ 7:2NT@FP",MN)R>3D]23D\T <#9
MZ)?:%XE\/W%AX>L/#H>Z$%PXU@2?;8F4[D*%1YC_ ,0/)XK1^%WAO39+:;Q%
M-$\VJ+J%Y'%.\C'RH_-<;%&< ?>/3JQKJ-*\!^']&U"&^M;6=Y[=2EL;FZEG
M%NI&"(P[$+QQQ6MI6D6.B69M-/A\F RO,5WEOG=BS'))/))H Y'XBZ5<ZO>Z
M)%;+8:@8GFE?1+RY\D7PV@;AZE.O(Q\U<1J&J?V?X4U'1-*T[4='N6UBTM[_
M $V:\79;QS#.(9ER$1]N,]MQXKUW7/#>E^(HX%U&!V>W<O!-%*\4L3$8)5T(
M(S]>:K6W@OP_;:/>:7_9ZS6M\=UU]HD:5YV[%G8EB1@8YX[8H X?2M+O/#WC
M;1I;;0]/\-VDRS1W=NFJB7[8@3((CVC+(0#N'."<URFNVMO<^ M0\1Z;X=N7
M'S7,/B34M05+ICYG#JJ GKP%^48Q7L.D>"="T2_^W6UO/)=B,Q)-=7,EPT:'
M^%#(QVCZ51_X5CX3-O+:OI\SV;[L6;W<Q@C+9R4CW;5/)P0 1VQ0!G:=&FH?
M%#5HKD;TN/#UJL@!QD,\F>1TZUVVFZ?;:3IMOI]E&8[:WC$<2%BQ"CH,DDG\
M:HMX:TQ9+JXBM<W,]B+%V>5_FB4':IYX^\>1SSUJ;P]I/]A>'=.TKS/-^R6Z
M0E\$;B!@GF@#S;5+'3_$GB'Q!+!X9E\0&"<VTUYJ5\L$%HZ(-T<( + #.20N
M<D\UE:1"?$NE?"RVU.>>:*X2]6?]ZP,JHAPK$')'R@'U'%>EW7@+P]>:E<WT
MMI,'NV#W4,=U*D-PW3,D:L%;WR.>^:LV/A#0].&E"TLO+&E&4V0\UR(O-SOZ
MGG.3P<X[8H \SUG?X+;X@6?AP/9V\6F6MS%#$QVP.[,CN@_A.WGCTJ_XB\'^
M'O#]SX*NM(3R97UNU1G64G[4"&.]^?F;ON]SZUZ0=!TQM1O;][17N+Z!;>Y+
MDLLD:YPI4G&/F/;G-8MI\./"]G=6MQ'8S-)9RK+:B6[F=;<J<@(&8A1[#@\>
ME "_$NXGM?AKXAEMR1)]B=<CJ >"?R)KG?B'9LOASP19:;<_9676K&*WG5 _
ME81PK!3P<<<&O0]1L+?5-,NM/NEWV]U$T,B^JL"#^AKF+/PE'K?@ZPT/Q9:-
M.^FR!8Y$G9/-\L%8Y048$$J<D'H2?8T <QXDL-<\.ZUX:U?7/$"Z_:IJ<=O'
M926B6Y223*B5-A^9ER>&!X)Z5T/B F#XK>#9(>'N(+Z";'\481'&?8,!^=7M
M+^'?A;2-1BU"UTPM=PG,4MQ<2SF,^J^8Q /N*D@TBZN_'EQKE[%Y<%G;?8]/
M0L"6W$-++P>,X51GGY3ZB@#+^(F;J?PUH\\CQZ;J6J+#>%'*^8H1F6(D=F8
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M"L+1?!^C:#>R7UG!,]Y)'Y1N;JYDGD"9SM#.Q(7V%;M !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 5;73[>SN+N>%3YMW())F9B2Q"A1UZ  #@
M<?G5JBB@ HHHH **** ,BZT"*Z\5:=KS3NLME;S0+$ -K"3;DD^VW]:UZ**
M"LCP]H$7AZUO((IWF%S>S7A+@#:9&W%?H,UKT4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!RWC+7-7TF71+31EL?M.I7W
MV7=>([(@\MFSA6!_AJI;Z_XDTKQ3I.D>(HM*FBU7S4@GT\2(8WC3>0RN3D$
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7*7_@*QOYKX'4]6@LK^0R7=A#<!89B?O9RI90W<*P!KJZ* &11)#$D42!
M(T4*JJ,  = *?110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
; 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>separationagreement006.jpg
<TEXT>
begin 644 separationagreement006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHJAK6K0Z'H]SJ=PDCPVZ[F6, L1G'&2/6@"_1
M7/>&_&-AXGTJZU"S@N8XK9BKK,JAB0N[C!/K3_#/B_2O%EO++ISR!XB/,BE7
M:Z9Z'TQP>AH WJ*J3ZG86UP+>>]MXICC$;RJ&.>G!-6Z "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>A(J:F(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *RM;\1Z1X=BADU6]6W\YBD2;6=Y".H55!8X]A6K7G?BJ2]/Q.T0
MZ!!%=ZQ;6$SSPW3;($MG8#?O&2K[EP,*<C.<4 =MI.LZ=KM@M]I=W'=6S$KO
M0]".H(/((]#S5ZN"^&YD2\\40:BGD:V=2^T7UL@_=1[T'EF,Y^92JYR<$G.0
M*[V@ HHHH **** "N0U7XH>#-$U.?3=1UN."\MVVRQ&&0[3C/4*1WKKZ^>SJ
M>HZ3\6O'5U8>%$\0JGEM-&TBJ85"@Y *DMGT SQ0![9X?\5:'XIMY)]$U*&]
M2(@2;,ADSTRI (SSV[5L5X-X%OC::?XP^*,4-A!#-;E8=+M'RL;J!_K.!@D@
M'WW$]Q572OB/XCMSHNKOXCFU=[V=%O\ 2!I+QI!$W=)=@!*C'0\D]Q0!]!T5
MY*=4\7>.?&WB73=#\0+H=EH3+"BK;+*T\IW<L6Z#*'IVQP:D\2^)/&FFVOA3
MPN;JPM_$FLRO'<7\*;XXT4CYE5@!N((R,8R#CJ, 'JU%>6:1KGB;PQ\1XO!^
MO:PNM07]D]U:79MUBDC90Q*L%X(^1O7M[BLO2?''B.X_9_U+Q+-J1;6(9&6.
MY\J,8'F*OW=NWH3VH ]GHKQS4_$_BZ[\0>!-)TO64M'UK25FN99+='&\Q[FD
MQCJ,$@ @9QVIL7BOQ3X>U#QIX9U/5QJ-UIVCR:E8:CY"(ZX4<,H&#RPZYZ'L
M<  ]EHKP"[\5?$#3O"'A?Q8?$D,[ZG<):_8'LT$7S!L,S#DD[<G&,9XZ5TNG
M^(O$GA?XE7N@ZYK9UJR_LA]1#&V2%D9<DA0O;Y6X]Q0!ZU17SE;_ !/\3S:2
MOB6+Q$\UZUQG_A'TTIS"8=^-HF"XSCG.[/OGBNTU'7O%.M_%;_A'-'UO^S-/
MGTE+LEK5)'BR025!'WCD#DX )XSB@#U6:>*V@>>>5(HHP6=W8*J@=R3T%);7
M,-Y:PW5M*LL$R"2.1#D.I&00?0BO =3UGQ)KGPK\;:9JFL":?0M0\B2X%NH-
MU$&*["!]WY@&R.>,5ZM\,[2^M/A]HPO]1-\TEK%+"3"(_*B,:[8^.NW^\>30
M!UM%<Q-\0O#,$\D,E[<!XV*L!8SG!!P>0F#6MH^N:?KUL]QITSRQ(^QB\+QD
M' /1P#W% "Z9K>G:R]VEA<B5[.<V]PFUE:.0=00P!_'H:6WUK3KO5[O2K>Y$
ME[9JK7$:J3Y8;E<MC&2.<9S7">/4OO!VL)XST*.-Y;L+87]H[;4G9OEAD^JL
M0#ZJ<<58O(+GX<_#V5[.1+K7;VYC$UW,,B6ZF<*9&_V1G@>@ H ]"HK@+R37
M_!NKZ#)=>(+C6++4[Y+"YBN8(T*2.K%9(RBC !7E3G@T:;XBU6?X;>)]5ENR
MU]9R:B+>78HV"(OLXQ@XP.HY[T =_16;X>NIKWPUI5W</OGGLX9)'P!N9D!)
MP..IKR[Q!XJO[>VUJ\A\:73ZI9-,\-CI6G^?:1*F2$E<Q'G ^9BPQD^E 'L=
M4[O5;*PO+*TN9Q'/?2&*W0J3YC!2Q' XX!/-<2-8UGQ7X@L-'L]3DTBW&CPZ
ME=S6L:-+(\IPJ*7#!5&"2<9[5B^++S6/#%UX4N=>D.KS6NJW'V=K.+]]<1F!
MA&&0  /DX..._K0!ZY17EEYXD\1+\+7\56^LP27NH7%L]M%%$I@M4>9$\KE=
MS'!(8GG.<8Q6IY^N^&/'&AV5[X@GU6RU:*Y\Y)X(T\IXD#AH]@& >1M.?QH
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MP);  (X'XUS,7C[6I/"WA.VO-1FM[W5FNWO;^ULO/DCCAD8;8XU4C)RHSM.
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MC'^D2/&8\  X10,8 STKJFOK1+M;1KJ 7+#(A,@WD?[O6EGO;6U5VN+F&$(
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M\"1'[V(PQRQS]XG/IBLJ3X=ZK=6FG:?>>+)Y]-TVXAGMH39JKL(F!59'!^?
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M<,'I@AJ[>6^M(+B.WFNH(YI/N1O( S?0'DT^:ZM[<$S3Q1X4N=[@84=3SVH
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M/IXI\-7FC27#VPN N)D4,496#J<'KRHXJMIWBRVNM7URRN_(LTTRZCMUEDG
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M<R3V.L7LD\J+;LQ'FHJ>6 N2<[>O'6D^%OAZ?P[X'M([U9!?W7^D7'F_?!(
M16]U147Z@UUD-Y:W$TL,-S#)+$<2(C@E#[@=*:VHV*78M'O+=;END)E4.?\
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MTFBDB\U)4:/GYU8$<=>:5'21%>-E9&&0RG((H =1110 4444 %%%% !1110
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MK;I%+=,KSNO61@H4$_@ *HR^%-!GT*/1)=*MGTV-MT=NRY"-DG*]P<D\CUH
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ML-3TR[N49[9-0MO*^T!1EMAR1D#D@X..U6(?%^F3^%+OQ(GG_8+43&3*?/\
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M 0MY_GYQY/E]=^>WX].:XWQ!IQTKXCZIJFIW?B"STW4K:#R;O2 [*KQ@J8Y
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M@ &QTSCM6K0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?'OC"/P]H?B*;2=)>QU22&W2SCED6;?(,(V\Y4*6QQ@D CDF@#U)F5%+,0%
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M6S.91N&?G)XY&" .F<=J .IHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%N?#O@S2M(O&B:YM(!'(8B2I.3T) _E6]10!S&M^';W4O&&DZK;SI#!:6=W
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM)35[#Q1I2:=IGBFWT^X+PZBNKWBRHZE3B13YK,KAL9VXR#4 UK5AX8/@O\
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M9K./]\Q:1,')."$.T9))/S4[PMX%M-/^&D'A?581,)X#]M&[[TC_ #-\WL<
M'_9% '.>%;N/3O%FFV=Z/$^C7L\<D<EIJD[75O?.%SE)2S ,,$\8STKU6N6T
M[P-;6>IV=_=ZOJVJR6(;[(M_.KK"2-I8!57+8R,MDUU- !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ03J[ #@G /2FW'BSP]::LNE7&MZ?%?L0HMWN%#Y/08SP3Z5S7B&RMK+XB^
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M.LV)NGA.X/;J(Q(1CJO!R1VSVH ]5@\7Z)J=I?/HVKV%_/:PO(T<,RN1@=2
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M((+H#AL$ C- '%R^$=5T[P5X:GM;?[9J^F7ZZK>6^X*UQ(^XS $\;@9#C/\
M=J^$U'Q=XVT;4SH]]I>FZ1%<$O?HJ232RIL"J@). ,DD]:[ZB@#Q2>T\2_\
M"I#X'3PMJ)U&W58I+@[/L[(LH;<C;LL2 ,#'?GI7M+HLD;(ZAE888'H13J*
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M$]JO44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?9IUDV_7!XJ!?%OAQW9%U_3&98Q,P%VG"$@!NO3)'/N*X:Q@N&^)>@RW.LZ
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MZ#'0![51110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%9?B#
M7[+PWIGVZ]$KAI%ABAA3?)-(QPJ(O=B: -2BN4M?'ED)[RWUFPO=$GM;0WK)
M>A"'@!P65D9@<' (Z\CBH;3X@P2W%@+[1-6TRSU&18K.\NXT$<CM]U2%8LA;
MMN S0!V-%<C>^/(HK^^MM.T/5=6CTY]E[/91H4B<#)0;F!=@.H4'%%]\1-)M
MTT,V5O>ZFVMQ226*V<8)DV;<@[B-I^;OP-ISC% '745R]IXZTR2RU:;4H;C2
MIM(4/?6UVHWQJ1E6!4D,&P<$$Y/%1V/CJ.>_L;;4-$U724U!MEE/>H@25L9"
M':Q*,0"0& SB@#K*I:GH^F:U;K!JFG6M]"IW*ES"L@!]0".M<[9?$&SU#6;R
MQM])U1H+&XGMKR^,2B"!XMV<MNR00N>!W'K4"?$B#997D^@:Q;:1>RI%!J,L
M<8C)<X1BH<NJDD8)'<4 =7_9>GG3?[-^PVWV#;L^R^2OE;?3;C&*M*JHBHBA
M548  P *X;2O%M_+\1/$^G7UK=1:780PLDL@B$<"A79G8AMV'P".O Y"U-;_
M !&M)5M;N?1M5M='NY%CM]4GB00L6.$) ;>JL<89E Y'2@#M**S?$&H3Z7X?
MOKZVMI;F:&%F2.+;N)]?F(&!U//0'KTK@_AWKQM-%T'^U#KLU_X@;"RWTZRH
M66(R%T&X[(R,@# / R!0!Z=17(>+/$R0Z?XGTFT-Q#J-EHDE\LZX 7*N%VD'
M.X%<]/2L&S\37MAX@MKBZEO+NTA\'QW\MM&VXR2"0;G ) +8SS0!Z;7FVKZ'
M\0]:7RM1LO -] K$QK=VUQ)M_/H?I7677BS3K?3=&OD$MQ'J\T,-HL0!9C(-
MP)R1@!<DGL!5G7M>MO#UK;75W',T,UU%:EXP"(S(VT,V2,+D@$\]>E '&V.F
M_$W3+5;6P@\!VENOW8H(+E%'X#BJB>&/'L6IG4X]*^'27Y.[[2ME.),^N[KF
MNS3Q=ILGC:7PH/-_M".T^U%B!Y>,@;<YSNP0<8Z&L2+QA8ZMK.C7=F-8/GPW
MYMK:(H(KH0D*2P+<DD?(<CJ<XH SM2T7XCZS (-4L_ %[$IR$N;:XD /J <U
M2U;PG\1M5\+7/AS'@JSTZ=/+*6<5Q'L&0?E'('(]*H+XZUFX^'&CZS>C4()A
MKL233HJC[1%]H<,B*A)("@(00,D=^M>@:/XRCU+7?[%O-(U'2KUX#<P)>*F)
MHP0"049AD9&0>>: .-TGP=X]T9;-[:Q\ F[M+=+=+Q[6<SE54*,N,'.!5G4_
M#?Q UJ2.35--^'E])'PC7-I/(5^A;-;GQ%\1:EX>L=(?3;:YE:YU.WAE:%4.
M4+C,?S$8+C@'ZY(ZUE+XOU&S^(NLV:Z9JVH;["TFAT^'8?()#ERQ9@BGE0<'
MD],T $^D?$FY%J)[3P!*+1@]OYEM<-Y+#H4S]TC Z>E,U/0_B-K421:K9?#^
M^CC.Y%N;6XD"GU&[.*Z!?B#I#^&(-;6*\/GW!M([(0_Z0UP&*F+9G&[(/?&!
MG-6M&\61ZGJLFD7FF7NE:FL/GK;W80^9'G!9&1F4X) (SD9H Y6'0OB+;/,\
M%C\/HFGC$4Q2UN%,B 8"MCJ .,'M5>'PGXY@M!:0Z/\ #A+82B<0K8SA!(!@
M/CINQQGK72>.=9U&UDT;0]'G%MJ&M71@6Y*AO(B52TC@'@L .,^M5+GP9K6E
M>1?>'?$VJW%_'*AE@U:\,L%RF1O##!V'&2"H_"@#-U/0?B)K<:)JMC\/KY$.
M4%S:W$@4^V[.*?)HWQ(ETP:9)9^ 'L  !:M;7!BP#D#9TX//2NBU/QI'::S<
M:3IVCZCK%Y:HLEVMDJ;8 PRH9G906(Y"C)Q5:X^)&BPZ-I>IQ0WUQ'J-R;2*
M&&',JS -F-D)!#97;]2.W- &/+I'Q)N6M#<6O@&7[(P:W+VUPQA(Q@IG[IX'
M3TKTBN(B^(XFO+G34\,:V=9MP'DT_P N/<(R,B3?OV8[=<YXQ4LOQ)TB/0='
MU:.TU">/5IFM[>"*$&42C=E&7/!W*5],^W- '945S.G>-+2XN+^TU*QN](O;
M&W^US07@4DP<_O%9&8,HQ@X/!XJC#\186?3I;KP_K%GINHS)#:WTZ1[&9_N;
ME#EE#=B1WH ZY;.U2\DNTMH5N9%"/,$ =E'0%NI STJ#4]&TS6H%@U33K2^B
M4[E2YA60 ^H!!Q7.7?Q BCU;4],T_0=7U.ZTQPMT+6--J@J&!!9AG()  Y.#
MQ5NP\<Z3J4^A);K<&/6X9);29D 7*#+1MSD-C/&,<'F@#;33;"/3O[.2RMEL
M=FS[,(E$>WTVXQCVJO8>'M%TORSI^D6%H8BQC,%NB%2PPQ&!QD 9]<4VQUZV
MU#7-4TJ".4R:;Y8GE('E[G7<%!SDD#!/'&165J&M6FG^-)TEGU%I+?1)+QK9
M&7[.8UDY;&<^;V],4 =#>V%GJ=H]I?VL%U;/]^*>,.C?4'BJMKX>T>PCB6QT
MNRM#"'\EH+=$,1888K@<$X&?7%<S:_$VRN$TV[?1=7@TK4)(X8-1FB01;WX4
M$;MP&>-V,9Z<<UU4&I&?6+O3S8WD8MT1Q=21XAEW9X1L\D8Y]* . N_ &OZO
M;OIVJR>'V@G95N]6@M"E]<Q*P;:0 %4G !.2/:O1TM+:*ZENH[>)+B556254
M =PN< GJ0,G'UKG?&^IW-K8V.E6$S0WVL7:644J'YH4.6DD'NJ*V/<BA)+67
MQI>:(+S5/-&D1DQ>=^Y5"[J'4YW"7@Y;T [T :EYX;T+4;Y+Z]T;3[F[3&V>
M:V1W&.GS$9J?4M(TW6;<6^IZ?:WL(.X1W,*R*#Z@$5C>!]6N=0T>YL[^0RZA
MI5W)I]S*>LI3&V3_ ($A4_4FG:MXN%CK#Z3I^CZAJU]%$LTR6@15A1B0NYG9
M1DX. ,GB@#=L[*TTZU2ULK:&VMX^$BAC"(OT X%1W>EZ??SV\]Y8VUQ-;/YD
M$DT2NT3>JDCY3P.1Z5S,GQ)T>+PY::TUKJ'EW%]_9YMA #-%/\P*,N>N5QQG
MJ*DM/'<<UW?6-WH>JV.H6MDU\EK.D9>XA7@E"KE2<X&"1R: .C73;!+*2R2R
MMEM)=WF0")0C[L[LKC!SDY]<U6OO#FAZH(!J&C:?="W&V'S[9'\L>BY' ]A5
M&;QEID?AO3-<C6:>#4W@CM8HP#([RD!5P3C(Y)YXVFE\;WT&F^#-4O+FYO[:
M&*(%YM/8+.HW#E">,T :3:+I36]Q;MIMF8+G'GQF!=LN  -PQAL  <^@JO#X
M=L+?6K74K>&.$VEFUG!%%$J*B,RL1P,X&T8'0<^M9.H>.8;/7;C0K/1]4U+4
M;>&.=H[9$VE&SR69@!C'?DDC&><87B'XAS2^'-"U/0;._(N]7BM;B,QQB2/;
M(%>!@S<.W(&..O(H ]#N[.UO[62UO+>*YMY!AXID#HP]P>#5&[\-Z'?V5O9W
MFC:?<6MN L$,MLC)$.F%!&!^%9=_XT6WU$:98Z)J6I:BD"7%S;6PC!M5;H)&
M9PNXX.%!).*KW?Q(T:U\/V.KK!?3)>7GV%;>.']^EQAOW;(3PV4*X]2.W- '
M66]O#:6Z06\,<,,8VI'&H55'H .!5>?2M.NKZ&^N+"UFNX 1%/)"K/&#U"L1
MD=3TKEF^(B)>6VFGPWK?]K7-L;E+'RX]X4.R'<=^U1\N<DXP1W.*LV_Q!TN7
MPY=ZO+;7T#6=S]CGLGAS<+/D 1A02"3N7!!QS0!T)TK3CIHTTV%K]@ "BU\E
M?*P#D#;C'7GI46IZ#I&MB,:KI=E?"/E/M,"R;?IN!Q6/IGC,76O0:+J.B:EI
M-Y<Q/+;?:A&RS*F-P#(S , 0<&HOAE?7>I?#[3;N^N9;BX=IPTLK%F;$S@9)
M]  /PH ZF""&V@2"WB2*&,!4CC4*JCT '052U/0-&UHQG5=)L;XQ_<-S;K(5
M^FX'%<S/XPTOP])XJU"[GU2>'3[RWBN(WVND1D5 /)&<[?F!.><YQFKEAXYC
MNM;M]*N]#U73I[R)Y;(W<: 7 098##':V.<-B@#H1IM@);:465L)+52EN_E+
MF%2,$(<?*"..*272M.FEN)9;"U>2YC\J=VA4F5/[K''S#V-8?_"=:4? _P#P
ME?EW/V/&/(V#SM^_R_+VYQNW<8S3;_QJMOJL^FZ?HFIZK=6B*]XMFL>+?<,A
M268 OCG:N: -:;PYH=QI<>F3:/I\EA$<QVS6R&-#[+C ZGIZU*FC:7'IRZ<F
MFV:V*D%;80*(P0<@[<8Z@'ZUA2^/],;3-*NM.MKO49]59UM+2!%61B@/F!MY
M 7;C!R>OK6)XL\>WD7P^UR_TW3M1L-5L6$$L<\2;K9C@B0_,59<'@KGDCB@#
MT"2TMIKB"XEMXGG@W&&1D!:/<,':>HR.#BHK;2]/L[RXN[6QMH+FY(,\T42J
M\I']X@9/7O7.1Z];OXLL_MAU33YVTB6Y>TN'C$"(LB@NX5C\X[$$C:35";XI
MV5OI\6J3Z!K4>E7#JEK>F%-DQ9@%.-^Y0<Y!8#(]\"@#3OO!MMJOC:;6-3M[
M*]L)--2S^RW$0D^=96?=@C'1L>M=%'86<5@+".T@2S";!;K&!'M]-O3'M6!J
M7C+[-J]UI>FZ'J>KW-FJM=?9!&J1;AE1N=ERQ'.!FN>U_P"(4\VF>%-2T"SO
MY;74]26*55CC#D+O#0$.PPY9?I\IYZ9 .WTS0-'T4R'2M*L;$R??-M;K'N^N
MT#-2_P!DZ;_9O]F_V?:_8,8^R^2OE8SG&S&.O/2N97Q3I>DZEXLO+Z\U%8]/
M^S&XBG(:.(O$"JPJO.6R,CNQJQI_C>.?5K33M2T74]'EO@?L;7J)MF(&2N49
MMKXYVM@T =)):6TUS!<RV\3SP;O)E9 6CW##;3U&1P<5#+I.FS_:?.T^UD^U
M%&N-\*GS2N-I;(^;&!C/3 KCY/BC9_9+V]M] UJYL+":2*]NHX4V0%&(8\OE
M@ -WRYP",XZ5U*ZU'+?Z?;P6EW/!>P-.EY''F%% ! 9L\%@>!B@"Q)I>GS:E
M%J4EC;/?0J5BN6B4R(ISD!L9 Y/YFH8M!T>"UN;6+2;&.WNF+7$2VZ!)2>[#
M&&/UJKXNUW_A&O"NH:LL8DE@CQ#&?XY&(5!^+,*R4_XDVJ^$-*OM3U2>_F6X
MW,L@,5Q((]SF7/. 22@'3@=!0!T>F:)I6B1/%I6FVEC&YRZVT*QACZG:!FJX
M\+^'UNIKH:'IHN)F#2R_94W.00P)..3D _49KCWU67_A6<?B71[W5)SIEQ-=
M$7L@,D\:2NLL;[>"NW=M]-JGM7>K>)-IHOK9'N(WA\Z-8\;I 1D 9(&3[F@"
M>2-)HGBE17C<%65AD,#U!'<5G6WAO0[._6^M=&T^"[5 BSQ6R*X4#  8#(&.
M/I7EK>.=9N?AO#J]X-0M98M<C22=0H\V+[2P,:B,DG"C:01SVSUKOM*\:1W^
MNKH][H^I:3=RPM<6XO50"9%(W8*LV",C(/(H ;<^']4U7QK9ZEJ<UB=*TLO+
M800JWFO*RA=TA/'R_-@#U![5U-<2?B78^0VHKI&JOH*2&-M76-/(X;:7"[MY
M3/\ %MQ7:!E9-RD%2,@@]10!0N- T:ZT\V%QI-C+9ES(;=[=#'O))+;<8SDD
MY]Z?9Z+I6G-&UEIMG;-%&8HS# J%4)R5&!P"><>M<7I/CW3M/\/>'(88M=U6
M;5HIVL_-5)+B4QMR'.X 'YNO0!>2*OK\1["/2M5O+W3-1LYM)EB2^M)40R0K
M(1MDX8@I@YR#T!XH Z<:3IJVUS;C3[407;L]Q$(5VS,WWBXQAB>Y/6J^JZ#9
MZMI]M8R(L=O;SPS(B(O'EL&51Q\HX XYQD#%-U#Q!::?K&E:8RR2W&I&0Q>7
M@JB(NYG8DC"\@=^2*Y__ (678FW.I#2-4.@"3RSK'EIY'WMN_;NW[,_Q;<4
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MZNW4-6E?4;H'J'E.X+_P%=J_A65XBTN_N/'6I74-G/);OX5GMED5"5:4R9"
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M5JU]I=W:*P5IX7B#'H"RD9_6@#RG1-5\5^'/AWX9UR2]T^32PEG;MIPMCO\
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MN.Y"1CG!'%;?Q<\S_A6VH>2@>7SK78I.,M]HCP*N6&F>+[C5[*XUK5["*TM
MQ,&FQNOVIB, R%SP!UVCOWJWXU\/3^*?"EUI%M="UEF>)EF(SLV2*^<>ORT
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M/(OC>ZS%.EU&5.25,I)D!^8%1GK6]\7%_P"*'$D@)LXK^UDO!V,(E7=GVZ4
M.?XD-!:#5+GPKKL&B8#&_>)/E3^^T8;>%[YQT[5VMO/%=6\5Q!(LD,J!XW4Y
M#*1D$'T(J#4+JQ@TBYNKUHC8) SS,X#(8]N3GL1BO/\ _0/&?C:STKS)E\.0
MZ)%?VMG"SVRSEW*AF"[3M50,+T&: /1X;>&W4K!#'$K,6(10H)/4\=ZDKQ/7
MY[[2=$\:^'K'4KL6NFWFFFRF:9GDMQ-(A:,.3D@=@<\'%;%]X2LK'XBZ-H]M
M>:FFGZE97$E_#]OE/VIHRA4LQ;(.6YP1GIT)H ]4HKQ/43<:=X.\7:19ZC=6
M]O8Z_;06DIG9GMXW>$D!B<X!8\$UT]YI<'@SQEX8.D3W:IJ4TMK>P37+RB=1
M$7\T[R?F4KG</4T >BT5X)K;QW?A#5/$.EV/B"]N(_-N(O$=Q??9E&'.#''Y
MF2@^Z $&:ZV33E\4?$M+34[F[>Q/AVWN)+6*X>)))#*XRVP@]SQ]/2@#TZBO
M'(UU&T\%Z[/975W,WA7Q#++:H\S,S6T>UFB8DY9=COU]!76Z!?\ _"3^/-1U
M>VN'?2=.M8[.VVL=DLL@$LCX]0IC7\30!T.HZ];Z;K>CZ7+%*TVJ/*D3*!M4
MHA<[N?0=LUJUY]\0--BU?QCX)L9[B:"*6YNM[0R&-F @)*AAR-V-IQS@FLZ?
M06A\3:]X+TF\NH;"]T,7L*-<.WV2Y$A52C$DJ#@$C/8T >I45YCH_B&Y\;:G
MX2M1))$;.W;4=616*GSHR85C./\ IH)&P>RBNF\?WEO:>&"EQ>W]J+FXBMT&
MGKFXG9F_U4?(P6P1G(P,T =16?K.LV>@V O;YV6(RQPC:I8EW8*H_,BO,]$2
M;1_B=H5O::+J&AV>H6UT);>ZU#S_ +1L565B@=]I!/7.3FMWXNZ?;7WA.U:=
M7)CU&U5=LC+PTRJ>A&>#^':@#JHM>MYO%-SH"Q2BYM[1+MI"!L*NS* .<YRI
M[58U&_?3TMF2RN;OSKB. BW4,8PQQO;GA1U)KSR3PMIVJ?%FZTZY-U_9]KH5
MLHMTNI$$F)'"[V#;FP,]3UY.:R8;J\M= M[!;VZ>*P\<QV$+23,S^0)1A"Q.
M6')'/:@#V:LKQ)KUOX9T"ZUBZBEE@M]NY(@-QW,%&,D#JPKS_2=-%UK/C/Q!
M<SWMS<:/J4QL+?[2XC1EA5ON@X.<@8.>E86N^&[6?X*)XFEU"]EU>[M[>ZN;
ME[MR)B[H3&R9V[03@ #@J* /;+FTMKR,1W5O%.@.0LJ!AGZ&I5544*BA5 P
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M/P_HUKI5@KK:VR;(P[;B!DGD_C5:+PQID.GZS9(DGDZO++-=@N<EI5"M@]N
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MVLN=LD9R#C@CV(]#R*I:WXKT/P[+##JE^L,TP+1PI&\LC =3L0$X]\8H Q?
M/AZ733K6M7FGBPO=:O6N6MBP9HH^=BL1QN)+,<=WK?U[0+#Q)IHL=020HLBS
M1R12%)(I%.5=6'((]:KR^,O#L.B6^LR:O;#3;A_+CN=Q*EL$X/H?E/7IBK>D
MZ[INN:0NJZ=<^?9-NQ+Y;+G:2#PP!X(/:@#*LO NE6>M6FLM/J%WJ=J'5+J[
MNFE8JRE2ISQMY/  YYK4U[0K'Q)I$NF:BKM;R%6S&Y1E96#*RL.000#7%^$O
M&\FOZ[KU]<ZY;PZ1I\LL<=H;0H!$FW$S3-C&<GY:ZC1_&GA[7[S[)INI++<%
M/,6-XWC+K_>7>!N'N,T 3:=X;L=,U+^T8WN9;LV<=FTT\QD9XT)(+$]6R3D]
MZK'P7HYC=#'+AM5&KG]X?^/@$'/TR!Q65XJ^(VB:1IFM0VFJP?VM9V\OEJ8V
M:-9U0E49\;-V0/ESGM6DWC#2]*T+2;O6KY(;B^MTD6-(V=Y&* MM1 6(&>PX
MH T]-T6RTF;4);5&#:A<FZGW-G+E0IQZ#"CBN;N/A9X<N8)+1SJ(T]G,B6"W
MCBWB<G.Y$S@<YXZ#)P!6VOB[P^VAKK0U6#^S6D$7VC)PKE@H5N,J<D#G&.]5
M$^('A:32%U5-7C-FTYMT;RGW/( "55-NYN"#P#0!N:C$\VEW<4:[G>%U4>I*
MD"N#\'?#6RM?#6B+JZW_ )MO''++ILMXS6R7 Y+>7DKG/..F><5I:QXZL;CP
M/KVK^';Z.>YTV!F*R1LK1OC(W(P##\1S766,K7&GVTSXWR1*[8]2 : ,"]\"
MZ5>:O=ZBMQJ5H][M^V16EX\,=Q@8!8*>N.,C%.L? VAZ;;Z;;VL,L<.FW<EW
M:Q^8<1N^[(_W?F/% \?>%CJHTT:Q";@S>0#L;R_,_N>9C9N[8SFGZMXY\-Z'
M?O9:AJB1W,:AI46-Y/*!Z%RH(0?[V* )]0\,V%_X@LM=9KJ+4+-#&KP3M&)$
MSNV.!PRYYP:Y_P +:-<7WC;5O&.H:/)I<MQ!'9V\$[*92J\O(VTD DA5'/1/
M>NK_ +;TPW6GVRWD32ZBC26@0[A,J@,Q4CC&"#^-07?B;1K!M16ZODC.FI')
M=Y5OW2OG:3QWP>E &C<V\-Y:RVUS$DL$R&.2-QE64C!!'H17,6'P[T2QN[.7
MS-0N8;%P]G:W5X\L-LPZ%$)ZCMG..U96M_%G0;1; Z7>Q78FU..SN'\J0K''
MU=E(7#$#&,9SG(SBN^BD2:))8SE'4,IQC(- %+3=%L])N-0GM5</J%R;F?<V
M<N5"\>@PHJ#Q%X9TSQ3906FJQR20PSK<($D*$. 0#D<_Q&K&KZUIN@V/VS5+
MN.V@W! SY)9CT50.23Z 9JAIGC/P_J\-[)9:BK_84\RY22)XWB7!.XHP#8P#
MSB@!FE>%;#P_<76IPM?:AJ+P^7Y]Y<F:4H.1&I;@#/YGK63X-T2=_$VO>+K[
M2GTRXU,QQ0VTK*9$C10"S;20"S ''^R*T;7XA>%+W4+>QM]9ADGN2%APCA'8
MC(4.1MW?[.<YXQFMFQU:PU(W@M+E9#9SM;W P1Y<BX)!S[$<]* );ZQM=2L9
M[&]@2>VG0QRQ.,AE/45SVF^ ='TZ_M;MIM1O6LO^/..]O'FCMN,?(I. << G
M)%;VFZE9ZQIT.H6$PGM)QNCD (##.,C/TK&'C[PNVIC3QJ\?GF;R WEOY9DS
MC8),;"V>,9ZT :FD:+9Z)#<Q62NJW-S)=2;FSF21MS?AGM4>O>'M/\1V<=MJ
M$<G[J030S0R&.2&0=&1AR#6)I?CFUU#Q[K/APLB"R2/RFV/EWPYDR2, +M&/
M7GDU8M_B'X4NK^&RAUB-I9Y/*A?RG$4CYQM60KL8Y]#S0 ^Q\$:391:CN:\N
M[G4(#;W-W=W#2S-$01L#'[HY/ Q5NX\+Z9<Z%I^C2)(;.P,#0*'((,.-F3W^
MZ/K63HGCFUU?QKKV@[D5=/,:PML<&0[29"Q(P,' 'KC/-7+#Q[X7U/48["SU
M>*2>5BD7R.J2L.H1R KG_=)H V=2T^WU;2[O3KH,;>ZA>&4*<$JP(.#VX-<]
MI_P\T/3KNSF1KZ:&Q;?9VEQ=O)!;OC&Y$)P".<>F>,5U,DB11M)(ZI&@+,S'
M 4#J2:Y[3?'OAC5]0CL+'5HY+B7(A!1T6;'78S *_P#P$F@"+4_ >DZEJ-S?
M)<:C8S7@ NQ87CPK<X&/G X)QQD8-7H?"FCVMQHTUM;>1_8\<D5FD;$*BNH5
MLCOP!R:A/C?PV-<31?[4C.I-.;<6ZHY8. "0<# Z]3P?PKH* ,&_\':+J<NK
MO>6[2_VM#%#=*7(#+'G9C'0@G.1WQ5&/X>Z1]KL;NZNM4OKJQF6:VFN[UY&B
M*]@#Q@]^,G R:ZRB@#GG\%Z/)8W5FT<ODW6H_P!IR#S#DS[P^1[94<5T! ((
M(R#U!I:* ./3X:>'T=8_].;3DE\Y=+:[<VBOG=_J\XQGG;T]JZ"/1;.+7Y];
M57^VSVZ6SMN^78K%AQZY8UH44 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<1\5G6'P;'<2'
M;#!J-G+*_9$$Z9)]A7;TC*KJ58!E(P01D&@#@M&FM-0^,&HZA;/%/')H5JT,
MZ<@HTCG(/H<"N&U*WN!H=_<PS-;V5AXYGGN94@$H@C' D*="JL02/QKW5(T0
M#8BJ ,# QQZ4H50" H /)XZT >7:%);ZM\2--N8_%K>(+BSLYB\EE9Q+!'&^
M!MDD1NI(!"\G@]*WOB58W<VBZ9JEG;274FC:G!J+6\0R\D:$APH[G:Q/X5V$
M,$-NI6&)(U)R0B@#/X5)0!PNI?%7PZ-',NAWL6JZI.NVST^#)EDD/0,N,J/7
M.. :H6^JVWA[XFZG>^*9;?3WU'3;46EQ-)B%=@;SHED.!G<0<=^#7HB6UO',
MTR01K*WWG" ,?J:=+#%<)LFB21,YVNH(_6@#Q"6.+42-0@A_XDNI>-[22T#)
MA9E"[7D /568'GOBNY$,9^.CRF-3(OAQ<-CD?Z0:[C8N -HP.@QTHVC=NP-V
M,9QS0!X9=SV=EX;BGOH]UE!X^E:10NX!0\AZ#J!UQ73:GK-CKGCVTU/P]Y6K
M1:7I%XU\UJ0Z2APIB@W#(+%E)V]J[/Q#X=77O[*Q<"W^P:E%?\1[O,*9^7J,
M9SUY^E;$4,4"[8HTC7.<(H S0!\^Z[KWV[X;6G_%3:85<VT@T+2[-%%JHD0D
M2$EG0)Z_+S@=^?3?#<49^*_C>;8ID$6GJ&QR 8F)'Z#\J[-;:!"Y2"-3(<N0
M@&[Z^M2!5!)  )ZG'6@#QNQL)6^$IU2PCS>:%K%SJ%LB\9$=P^]/H4+C'TKL
M?AZ#JD6J^+)%8-K=T7@W#!%K'\D(QVR S?\  JU_$^BZCK>E'3].U8:9'-N2
MY=;<2,\3##!22-K<_>YK5L;*#3M/M[&UC$=O;Q+%$@_A51@#\A0!P?C/6VL?
M'6F68O-*T,O82R#6M0@#G[X!AC+,J@]&.3TQ7"A9]6T_QX\%U-K*)?Z=<SN+
M<1M=P)M+E44 %<(<8^\%[YKWJ6"&X4+-$DB@Y =01G\:I:UI;ZKI%S9V]]<:
M?/*%V75L=LD;*00?<<8([@D=Z //=9\4^'O$?CKP.-'N8[V6*\E9IHE.(E,+
M?(3C@G .WK\M<U?>(FO_  5X@7^V].T8R&\B_P"$=L[)&NF;+#$FXELMU9@H
MP#G(QQZ58^$M4EU^PU;Q!K<-^VG;S:P6UF+= [KM,C_,Q8[21V S75"WA$S3
M"&/S6&"^T;B/3- 'D=JXDU73G4[@W@%B#Z\I3]0@BB^ GAGRXU7;_9D@P.C&
M6,D_4Y/YUZV(T'1%Z8Z=O2C8NT+M&T=!CB@#R'7[VRTOQ%XEET_Q5'H=VS![
MS2]9MXY+>^_=@!XP3N*L!@[<G(/'2K5AK$<7C'P-?ZI;0Z/]MT26".WV[$65
MFBVQJ.W;"_05ZE);P3.CRPQNR'*LR@E?IZ4YXTDV[T5MIR-PS@^M '*?$G4?
M[+\$W5P;"VO%,L2,MW&7AB!=?WCJ.2J\'\!7$#4S>?$[P:7\66^O;)KD,]G;
M(D$!:!L+O4MEFQT+'@=*]C(#*58 @\$'O3([>&%%2*&-$4Y"JH !H \HTF"(
M? _Q<1&N9&U1WX^\P:0 GWX'Y4:_?3^#[+PUXRM86F\W2!IMRBC)=FBWP''_
M %T&W/\ MUZSL4*5VC:>HQQ7.ZSX:NM;US3Y;G4P-&LY$N/[.6W&9)D)*EI,
M_=!P=N.HH L>#]$/AWPGI^FR-NN(X]UP_7?,QW2-GW8FN&O[ZUMO%7Q,L9YT
MCNKO3(I+>)CAI56U<,5]0.]>JTQHHV<.T:EP,!B.<>E 'EFK0Q0_"#P4(XU4
M)/I3K@8PQ9,GZ\G\ZR/%4:36'Q$BD4,CZUIRLI[@^1FO;"BE0I48'08Z4AC0
MYRBG/)XZT <)XPFM]'\=>$]9U(K%H]NMS T[#$=O,ZJ$9CT4$!E!Z"J_A/4]
M+U?XK^)[S29(YH&L;16GBY29P9 65NC#@+D?W37H;HDB%)%5D88*L,@T)%'&
M (T5 !@!1C ]* //?'6I:;I/Q%\#WFJND=L@OAYT@^6)BD8#,>PYQGMFL'6M
M8MY[_P ;>)=(L8-7TF/2[>UERN^WNIPYRW'WU1&&2.PZUZ/J?AU=3\3Z+K+W
M 4:8ERA@,>X2B557KGC&WT.<ULI''%&(XT5$ P%48 _"@#Q74=6-YXC\&!O%
M]EK>W5HF,.GVJ)!;Y1@,L"Q!.<!2PR,\<<=5X)MU.F^.6CC!FEUV_!('+<
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MKB"+6C/&T A#??,9._=MXVXQGG-5/'&@S7WQ"TJPM9%^S:_"(M5B'!:*V=9
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M?%*)/-DEQY7EO@95L]2 1@Y'%<Y>> ;J-_#>IW?ARWUW[+HL.FWNG22H'B=
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M$*R\D$9[9&:S8O"GB>[TR\>]T^*&[N?%5OJGE1W"L$@7R\_-D9("D>IQP.:
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MFR-O?F2.5DQE')0%.HYP157Q!H&NS_#K0M,LHG>:T^RC4+.*Y$+W$*)B2)9
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M#U*BO,X=;UWQ=XKTZSL-7ETG3;SP]!J<BPQ1O*KN[#"LRG'49.#]WC&<UO\
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M;2QP!2Q*+U8X&%';)QD\"K]>?: )=)\+:OX_U5%GU6_LVOV0'(AMU0O% I]
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MV.HZ1)#K.MZS)<W,<.H6ESHDD,2H_!DC;REV;2<X).16SX=G\2:WK^O7TWB
MQ:?I6JW%K#9>1&%E55!Q(^,@#<.1SP>N: /1*J2:I8Q/=HUU%YEG$)KA V6B
M0@D%@.1D*V/I7CM_XSU"PTR+5K7QC=ZKJ$=Q$+FWMM.SIQ5I K*LGEC  . V
M\DGZUMVEO?V7Q#^(%]'J]SFWL8)1$8X]K9BE* _+G"8X]?XLT >E6%];:GI]
MO?V<HEM;F-98I "-R,,@X//0U8KS#2M;U[Q3+X<T6+5Y-/,F@0ZIJ%[!%&9I
M6?"A$W*57D,2<>@&*JZUXJ\1^']#\7:8=2%SJ.CFSEL[]X4#2132*-LB@;<C
M##( R#G@T >LU3U75;+1-.DU#49Q!:QE5>0J3@LP5> ">2P'XUQAD\0>'/&O
MAVUN_$,VJ6VL-/%<0S6\:+&Z1%PT>T @9&,$GCO6M\1=5O=%\#WM_I\WDW4<
MMNJOM#8#3QJ>"".C$4 =317GN[Q%XA\>>)M)@\13Z9IVG"U,0MH(FDW21;B-
MS*?ER"2.ISU K;^'VLWVN^#K6[U.1);U99H)944*)#'(R;L#@9"@T =/1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5C>(_#Z^(8=.C:X,'V+4(+X$)NWF)MVWJ,9]:V:
M1F"J68@*!DD]!0!SOB#PO+JFJ66L:;J3Z9J]FCQ).(A*DD38+(Z$C<,@$<C!
MK$UCPPUIX1\03:[=:GX@GO0CS+:((VC"$;3!%DA2OWNI)(YS7;VM[:WL9DM+
MF&X0'!:*0. ?3(I(;^SN+B2"&[@DFC^_&D@++]0.10!Y)9&?Q'XV\+M;>([[
M7TTZ=YYY&L?L\5NGED#?\HW2,2!^!X'-=-<?#N^:/6;"S\336NBZM++//:"U
M5G5I?OA9">%)[8SC(!'6NTFU&QM\>?>6\67V#?*J_-Z<GKSTJ66X@@_ULT<?
MREOG8#@=3]!0!R8\ 6SR6_GWLCQ1: VANBIM+HVW+@YX/R].>M9EQ\.-6O\
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M-K&M/>ZIJ=@VGBY6W$:6\)R=J1@GN<G+'.!TKKK&U%EI]M:!]X@B6/=C&=H
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M\BKM'//W<_C6DE_9R7#6Z7<#3JN\QK("P7UQUQ3K:\MKR,R6MQ#.@.TM$X8
M^F10!YUX0T^QUWXDZSXOT\3G3!&L5LTL;1K)<,JB:1%8 CY412<<G-=EIL>K
M+XEUM[N=WTQO(%E&R*OED(?,VD<D$[3EN^0.!SHV]_9W;NEM=P3/'PZQ2!BO
MUP>*L=!DT 8VJ>'UU/Q#H>K&X,;:4\SB,)GS/,C*=<\8SGO6;;^"8[?P!?>%
M1?,R7:W*FX\KE?.=F^[GG&['7G%=';7UI>[_ ++=03[#AO*D#;3Z''2ECOK2
M680QW4#RE=X19 6*YQG'IF@#F?%/@.V\4>'=/TF6]EMFLRH6XB7YF388W7KP
M&4D'^M6_$'A2/5TTV6QNWTS4-+<M8W,48<1@KM9"AX92O!''0<UO3W$-K"TU
MQ+'%$OWGD8*H^I-);W5O>0B:VGBGB/1XG#*?Q% '+V_@Z]G74Y-;\17E[=7U
MM]E#VP^S);IUS&@8X;/.XDGMTJ&V\%ZG/JFE76O>(CJ<6E2>=:QK9+"QDVE0
MTC!B6P">!M!/6NJBU&QG,HAO+>0P_P"MV2J=G^]@\?C6!IGC#^WM T_5M(LT
ME2YO!!)%-<I&T4?F,A<]<G"Y"CDYH S!\.91I>H:4=<=M/N-134((C:KN@83
M>:R[@?F!/'.,5AZU>6>C>*];$>N:MX>:Z97G@2P$ZWIV >9;MM.UR/E/N.E>
MGSW]G:RQQ7%W!#))PB22!2WT!ZU)+<0P?ZZ:./@M\[ <#J>>PH \Q\*^ M1'
M@[PE<I>OI.M:4MP\8GMQ, D[$E70D'."O<$'-=!9>!)4U;5]1U'6YKZ;5;#[
M%<@PK&%ZX* 'Y0 <8.>><G-=;!=6]U )[>>*:$])(W#+^8IEK?6=[O\ LEW!
M<;#AO*D#[3[XZ4 <II7@:YLO^$:-YK9O#H#2+ ?LHCWQ-%Y2H<,?NCG/>JI^
M'=]#IMSH5AXFGM/#MPSYLA:JTL<;DEXTE)X4Y/520#UKNI98X(FEFD2.-1EG
M<X 'N361KOB*#2O">HZ[:>5?1V=N\P6.4;7*C.-PSB@"&Q\*6VG>)X]7M9?+
MBBTJ/3([4+PJ(Y8'=GT.,8[5FWGAS5-'T'Q&= OY!JFIWYO876%#Y3-Y:[?F
M."N%Y;L"2!D5TEAJMK?QQ!)X?M+1+(\"R NF0#R.O>I;C4;&TE2*YO+>&1_N
M))*JEOH">: +->0>!_!FKZO\-['3[O7[FWT>Z\PW.GFU42[?-;*+*3E5;&2,
M$\GG!KT*_P#$1LO%NFZ&+8.+VUGN/.WXV>7MXQCG.[U[4_PEKQ\3^%=/UHVX
MMC=Q^9Y0??MY(QG ST]* &V/AN*P\4WFM1386XLX;1;<)@1K&6P0<_[73':L
M63P+J5J^HV^B>)I=-TO4)7FFMOLBRM$S_?\ *<D;,\G!!P3Q72V.H3S37RWL
M$-M'#<^3 PN%?S5P,,0/NDDD;3SQ[U:M[VTNVD6VNH9FC.'$<@8J?0XZ4 <M
M/X"CM!I$WAW4&TF\TNV-G%*T0G66$X)2121NY&[((YS4$GP[%SITK76M74FN
M/>KJ"ZHJ*ICF1=J[8^0$"\;3G()R:Z\WUF+P6ANH!<D9$/F#?C_=ZUDZ-XE3
M4]1URUEA2W72[P6HD:3/F916!Z#'WL8YH I6?A*^GO;BZ\1Z[)JPEM7M%MHX
M?L\"QO\ ?)0,=S$<9)X[50M_ >K16=KI$GBZ[?0K5DV6Z6XCG:-#E8VG#9*C
M '"@D#&:[AI8UD2-G4.^=JD\MCK@=ZQ/$_B:V\.Z'J5\K07%U96[3_9/."NP
M _$@>^* ,^\\'W\>N7VI:#K[Z4-1VF]A-JLP9U&T2)DC8^, GD' .*@TGX>Q
M:58>&K1=2EE&AW4]RKO'S-YF_@\\8\SKSG%=3_:-M%80W=W/#;1R*K9ED"@$
MC.,FK2.LB*Z,&5AD,#D$4 <S9^#4M/".KZ +UF74FNV,WEX,?GEB>,\XW>O.
M*Y7Q!!:>&-:T@C5K[1KF#2TM/[56S$]M<HAQY3KSAQC<#QU(R:]1KG?"?BRV
M\2Z#87\OD6ES>>85M3.&;"R,F1T)^[GI0!Q7A73==3P=XMOM)NK\7VI7S3:=
M=7,*B6;"H!(4< *K$-U PO..E>JH&"*&.6QR?4T"6,RF(.ID R4SR!ZXK%U_
MQ38>'[>TEG82_:;Z*R4(Z_*SL%).3P%SDT <^?A[?P:?=:)IWB::S\/7+/NL
MQ:JTL2.27CCE)^53D]5)&>M;=CX3M=-\30:M:RF.&#2DTN*U"\*B/N!W9_#&
M*Z!65D#JP*D9!!X(JN-1L6GC@%Y;F:5=T<8E7<X]0,\B@"EXGT"W\4^&[[1;
MJ62**[CVF2/JI!!!]^0.*YZ?P1K&IW>D7.L>*#<MI5W'<PQPV*PQL5Z[AN)+
M$<9! &3QS7875[:62JUW=0VZL<*99 @)]!FLS7_$UEX>_LP7/S'4+R.TCPX
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M>HYH CMO!4=OX$U'PN+YF2]6Y!N/+Y3SF9ONYYQN]><5IVFDWEG=:?Y>J/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<2:3%<#PQ/KVF:Y]J;'AJ>V:YM78R9)4E-JHW+;@P H ]Q9E12S,%51DDG
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MI&<$#..H!YQ7>>+;>63QCX)DBA=DBOIB[*I(0&!QR>PS0!(_Q'T))B6CU#[
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M,=D4!YD)A&3R5V@\Y/->NT %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !117%?$Z\NH= T_3K2XDMFUC5+;39)XSAHXY&.X@]C@$?C0!U,>KZ;->
MFRBU"T>Z7K LREQ_P'.:N5Q^H?#+PM=:)_9]GI=MI\L8!M[VUB"SPN.5</\
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M+V^AO+6W%JWE2@)<1 DA9!CGDD\8H X#PSJVJ6GA_P ">(KK4KR>VN9)=.U
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MO$.%/SE>^.N.]>-SWUQI\6@:KIG_  EQEDO[6.?4M2N"D%VDC@,/):0\,#D
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M9[B)+2./S3*S@)MQG.>F*X:'XG0WN@>&=7MVL4BU*_6UOE>;<+0&-W(+ C#
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MN5"L"X#,#SG:"21[=J\^T6&)O#7@":UUR#2M:BTZ;[(;VW\RVG4E=Z$DC:W
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MD1?:"GEF78-Y3.=N>N,\XKG-.\7RS:VNCZOHMSI-[- UQ:K+*DBSHN-P#(2
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M[6_I0!Z!J.C:7JZHNIZ;9WJQG*"Y@60+]-P.*MPPQ6\*0P1I%$@VHB*%51Z
M#I7(7/CR4SZ@^E>';_4]/TV1HKN\ADC4;T^^(U8@R;>^._ S74:;J%KJVFVV
MH64HEM;F)98G'=2,B@"1[2VDNHKI[>)KB($1RL@+H#U /49I([.UA:=HK:%&
MG;=,5C ,AZ9;U/UKA8?&NGZ#I=[="WU6\$OB*;3O+>02R><2>(QQA,KA5[9K
M2LO&E[/J=UI%WX:O+/5H[0WEO:M<1,+B,,%.'#;002,@F@#ICIUBUB+$V=N;
M-0 +<Q+Y8 .1\N,<$ U%J.BZ5JXC&IZ99WHC.4^TP+)M^FX'%>6^ O$3:1X.
MBU[5+/5;O5=8N!# &N_.-[(7? C0MB,*!@DA>!]*[*V\<%+J\L-8T:ZTO48+
M-[V."21)%N(D'S;'4XR.X.",T =.;&T98%-K 5MR&@!C&(B!@%?3CCBG?9H/
MM7VKR(_M.SR_.V#?LSG;GKC/.*X1/B@!X;?Q%<>'-1@TC; 89V9"9O,<(=J
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M!:6Z06T,<,*#"1QJ%51Z #@5)7-6WBTW\-S-I^DW=W%!J9TXM&5^;:</*/\
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M+MGU^:NCU&-Y=,NXXU+.\+JH'<E34LUO#<>7YT,<GEN)$WJ#M8=&&>A'K4E
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MM'M]=TR2PNI+F.&0@LUM,T3\=MRD'![U3\/:IX<</H>@WEI(-,01-;V[[O)
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M,R(2 )),Y#/CC' R*ZB+Q-K'B[6;6P\/W<6E6XTN'4;FXEMQ/)F;.R(*2 ,
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MXVTR[^RNS$$.=BMD>GWJ\NNW9[;5=S$[?B! !DYP,P\5VG@;_D8O&W_89_\
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M(94#HZG(92,@@^F*Y:T\6Z?IVEWUYJ6M&]1=4FLXO+LV5PX8@0*B@F1EP1N
MYQF@#3F\):'<6NJ6T]@DL&J3>?=H[,1(^  PY^4C:,8QC&:AT;P9HVB:@=0M
MX[F:]\OREN+RZDN'1/[JEV.T?2BS\;:!>:=J%Z+QK>/3@#>)=0O#)!D9&Y&
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M&=(NIM5EGM!(VK0K;WNYVQ*B@@#&>.&/(P:GT?2+30M+ATVQ$HMH<A!+*TC
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M\$K_ ,(7T4BZ_;6LUO+I_DL9#)N8^:..4_CW=/QKV?3!_P 2BS##_E@@(/\
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M"T; #*K]\\X!8G ->U4  =* /,_#]OM\#^/P8L&74]5)&W[W4#Z\5UW@<$>
M/#@8$,-+M@0>O^J6MZB@#P6_UV?4_!NNV\^M2:=?.MW'_P (SING(KJ<L/WA
M*%B"/F9A@8)YKV/PJP?P?HC Y!L(#_Y#6M? SGO10!X1+J<>C6,T/AO5KM+H
M79'_  A^J68N"7,N2J<95<_,""1[UUEGXBT_PK\0/%R:T\EK)?R6UQ9KY3.;
MD"$*1'@'<0PQ@<UZ7@9SCFC% 'A.A7L.D:1\-;_4[:5(()]3,W[HL8,LX#,
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MI[YQ5SPOK-Q)XUTJRTSQ)_PE.FO%,9I;BT GT]=N5)F '+$!2",UZN!@8%
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M#_5UW%% 'C+VY7]E^*)82&^RQML"\Y\\'./7/->S444 %%%% !1110 4444
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M?H\?AN58[FWMFTFXD=@I-G(@5F]RI56 ^M:VI^%Y'\2>$&LH%&EZ3%<PRC>
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M6'2NHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(%56QT'.#@"FZ;XBU.UN_%>GP7VMO:P:$]_:-K$.RXBD&\97(!*\ C<.H_,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MSOC1(RCXX5% VX(SGDG//;&QX:T*+PSX<L=&@F>:*TC\M9' #,,D\X^M:M%
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M]3TU]/N))50 *>A15 "X!Z?B>:[.B@#G-+\(6VEZOIVHQW,KO8Z0NDJC 89
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *YSQFGB"71WBT*ZM[(&.1KF[D!:2)0N1Y:]-QYY)XZ\FNCJKJ43S
MZ5>0Q+NDD@=5&>I*D"@#S<ZO?V7P,T%K2ZDBO[^&SLTN<Y=#*RJ6!]<$X/K5
MZ;3(O!'C'PT-*N+P6>J2R6=Y!/=23"1O++I)\Y.&RIR1U!IQ\):I=?![2M%$
M:0:S8P6TL<<C@J)HF5MI(R.<$9]ZF2+6O%?BO0[V^T*XTBQT<R7$@N98W::=
MD**J!&/RKDG<<9XXH [RBJ.F7=[=B[^VZ:UB8KEXH0TJR>=&,;9!C[H;GY3R
M,5>H **** "O(_BY<ZGX@UW1? VA73P7ERLE[<21N5VHJML!([$AOQVUZY7C
MEI\,]5\5^,_$'B/Q)=:KHKR3"*P6QNT1S !@;B-V!@+QQSF@#?\ AUXS;4?A
M2=3NPTM]H\$D-W&S89FB7(R3W*[>?4FL@_&YXM&T_7KCPC?1Z%=2^0][]H0[
M9.<A4QE@-IY.WD$55T;P#K_A#6_%>EZ;#<W^@ZOIDGE7,\\9D^T[#@-R#DDL
M,X[KGH:KZEX%\23_  +\/^'H],9M5M;T2S6_FQY1=\ISG=M/#+T/>@#L-$^(
M\]]XR3PWK'ARZT:XN+8W5HTTZR>9&,_>"_<. >,G&"#64_QD)@N-8M_"]]/X
M6M[CR)-6691SD#<(L9*Y(YSW['BK^N>&-3U#XS:/K*6C-I,6ERVT]P'4;&82
MC&,Y_B'0=Z\XLOAKK>DV,N@2^!X=6N/M/[K5)-4DCMFA+ Y>-9%((&??V..0
M#T[7?B5_9GBRT\/:;H=QJUU>V*WEJ;>95$F2V =W"C"D[B?PJ/1OBK97F@>(
M-0U?39]+N-!?9>VI<2$,20H5A@$E@1]>^*K1^$M2M?C#HFJ06(&CV6ABR,R2
M#:C@N H#,6/!'//UK$;X=:UJJ_$RTG@%JFM7$,NGRO(I64H[N,X)(&=HY'>@
M#%\?>.];USP]X?EF\/7^B076IP3VMS]I#+/%M;AMN"I.Y2 1R,GM7<:C\4;R
M'Q'KFA:7X5NM3N])59'*7*HC1[=S,21P1D  9)Y]*Y#7-)^(/BCPOX>T>?PF
MMHND74#32&\C8S%%*[E&>% R3R>2,=ZZ[0_#.L6GQ$\<ZG/9%+/4H8UM)=ZG
MS2$P> <CGUQ0!F-\;\Z';:_'X3OSH9D6&YO&G0>5(>H5>K@>O [5T7B#XA2V
M'B*/P]H&A3Z[JIM_M4L4<ZPI%$>A+,#R<CCW'K7"MX#\3']GU?#0TMO[8%WY
MAMO-CSM\W=G=NV]/>K/BOP'J,7CL>(AX<D\06%W8QPS6L%\;:6"5550<AAD8
M4>O4^@H Z.Z^+NGP> 3XHCTV=C%>"RN;*1PDD$O<$X.<<'\>U2V/Q,N9/%^G
MZ'JOAB\TM-41GL+B:9&,H )^9!]PG'3)()&:X_5OA[KD_P (I=.L_#EK9ZK=
MZBEU)8VMTSX4#&6>5R"WK@XZ5V'BWPYJNI?$?P5JEG:&6RTYIC=2AU'E[@N.
M"<GH>@- &)\,O&/B77O''B:VU73[K[.MQL^>92NG[=^(MH')/3<.NWFN\\5^
M(KOP]9V[6&A7NL7=S,(HX+8853ZN^"$'N?\ &N1\%:1XA\._$GQ2ESHK-I6K
MWC7<>HK.FU!\Y V]23NQVQBK/Q4TCQ%JBZ(=)MKF^TR&X9M3L+:Z\A[A/EVC
M=D<##<9[CZ@ ET?XF/>CQ':ZGH,VFZKH5JUU-:&Y64.H0MPZC&>G;N*QF^-<
ML>BV&OR^$+Z/0;B0127QN$^1\D':F,L!@C)P"0163X>\#:[8ZIXRFC\,#2[/
M5=%D@LK9+I)=LFS:$8[L[B>2>F2>:L:MX(\17/[/^F^&X=-9M7AD5I+;S4!4
M"1B?FW;>A'>@#K_$/Q"FT[Q5%X:T+09]<U0P?:)HXYUA6&/L2S#&>GIU'/-<
M_P#!_5KC5_$?CJXG%U&IU%2EO<L=T&3)E,9(!'0@>E2:MHOB;PU\3G\6Z)HO
M]M6VH6*6ES;K<+$\3KM .6XQ\B_KTXJW\+O#_B'2-:\6W_B"QCM9-3O$N(_+
ME5T.2Y8#!S@;@.0* *FN7<WA_P"/FB7,ES(FG:O820.K.=@D0$YQT[1_G7$^
M O$6JCXGVGB&_NIAI/B6>]AMTD<E$"$,N >!R%7\Z[WXT>$-7\4:%ILV@6[3
M:G8W195614(C92&(+$#J$K)\6?#C57^$?AS2]%MRVM:0T<H5)%4[F!\W!) ^
M\V>O:@"/X?>(KZT\*^)?&;V.I:M+J6K.+6SMPTC; 3C'78H+,"?;Z5UGA[XA
M7>I>+7\,:YX<FT74S;&ZB4W23JZ9]5 P>OKT-<[JG@[Q/IWP7T30M"65;ZW:
M.34+:"X$4DJMN:2,/G'WF]>0._0U?"/@W5;#XH66N0^$FT72&L9(&0WBS.K\
MG=(2Q.3TXSQC- !X3\?V'AGX>66J1:?J4VF3ZLUK<2WEZ)9+?./G)"#*]>./
MKS7>7_CBWM/'5OX8CM3,39M>W5UYH"6T0SR1@YS@>GWA7(>#?A]J#_!S5/"V
MNVGV6ZNI9GC5G5MK?*8VRI(^\H/X4OPW\!ZU%I&OW7BQ&AU?5+<:>"75V2!8
M@@.5)&3]?X10!/'\9";>/69?"]]'X5DN/LZZN9E/.[;N,6,A<]\_KQ5W7/BC
M<Z?XPO?#.E>&+O5[ZWB29?(G"AT90Q)X. -P'?)(KSS3?AQK=KIT'AZZ\!P7
MEREP1)JD^JRBU>'<3N\M)%((R. ,\=,UZ+H?A?4M/^,^MZTUD4TF;3(K:WGW
MJ0S*(@5QDM_">OI0!Z#&SM$C2)L<J"RYS@^F>].JGJFEVFLV#V5]&[P.065)
M6C/!R/F4@_K6!_PKCPO_ ,^=U_X,;G_XY0!OZIIEKK.FS:?>+(UO, '$<K1M
MP0>&4@CD#H:\NLO NB3?$[5M&D_M V%OIT$\<7]HW'#LS G._)X [UZVB+'&
MJ*,*H '.>*Y6QTB_A^*.KZN]N183Z;!!'-N'S.K,2,9SP".U '.0W^IZ+\2]
M7TK1-)GU-8]+LUBBEO/+CB1=XRSMN.X\#H2<'/2K]QXNLM;TCP]>W.GW<$S:
M_'8O;"XVFWN%+J=Q'#J,'COD5KZ;I-]!\2->U26 K97-E:Q0R[A\S(7W#&<C
M&X=1WKEX_"FMK:6B&Q.Z/QF^IL/,3BV+.1)U]"..OM0!L-X^U&XFU*72O#,V
MHZ=IUT]K/)#=+]H+(<.4AP20#TR03Z5VLC;K9F&1E"1D8(XKR3Q'X9U&_O=4
M=?!TT?B%Y7^P:WI-VMM&5/W'E_>!MPXW J<XXZUZI:PW,>DPPW4HFNE@5)9
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MD=DCN+0(I8D+FW4G [<UG>)=5U+3_BMH\>FV,VH2S:5.JVPG$4>?,0[W8Y
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MBQJ"BD?+@,..Y'O5#4QXNUO1]#T=_"TUO+8WUG)>W+W$1B98G4DQ8;+9QNY
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M@(RV[<=VT*1UP20* .NO?&U\/$<.@Z5H#WUY+I\=_N:Y$4:(S,I#,5.,$#&
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MVD\KV<YM[@"\G&R0 $KRW/##IZUV/@NWFMO!FD)/>2W;FTC822*JD J"%^4
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M-_UXP?\ HM: .&TWX3?#?5[9KBPM)YH4E>%F%Y.,.C%6'+=B"*N?\*1\"?\
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MHMGKDFF:<FEP7;>1!&\H=F<85F4X!P,Y!^Z,8R:Q9/%7BA?"L4$>I1'58/%
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M>V@N[>XFB1)5#E@RML !Y7(.* .HN-5LK74K+3IYPEW>B0V\9!S)L +<XP,
MCK5RN6US5;RU\?\ A/3H9@MK>I>FX38IW[(U*\D9&"3T(K@X-8\8R_#!_&[^
M)W%Q;"21+,6D7E2HDI4B3Y=Q) /((QQQWH ]EJ">\MK:6"*>>..2X?RX5=@#
M(V"<*.YP"?PKS?Q9XCU*S\18U#5=5T+0S:1R6MY8V*SQM*<[O.8HQ7'&%P,C
M)S5/61J.MW?P\NAXE226:XE3[7IT<9B9Q%)F10RGD@;2#P.> : /6Z*\[T6X
M\2ZWXC\0W#^('@TW2-3D@BM([:,^:H16VLQ&<#(QCGD\],5YO%6M+\![?Q&+
MW&K-;PN;CRTY+3*I.W&WH2.E 'IE%>?S2>(M>^(&OZ+:^()=,TZQM[:5#!;Q
MM)OD5N 64_+\I)[\#!'.>;B\0>+S\.+?QO/X@_>P3)&UC':QB&9!.(6+G&[<
MW+9! '0 4 >R45Y9KGC">Z\:ZMI+:WJ6D66F"*-#IVFM<O/*R;R6;RW"J,@;
M>">3FH3XO\47_A[0$@N39ZA<:Z=,ENI;(H)XMCD2B)P",C:V..1CIQ0!ZPS*
MB%F8*JC)). !4=K=07MK%=6LR302J'CDC;<KJ>A![BO-[M]>LM9USPO<^(;F
M]@FT)]0ANI8(A-"P?8R\*%*D>HX[5O?"^WFM_AOH?G7DMSYEI%(GF*H\I2BX
M0;0,@>IR>>M '1VVJV5YJ%[86\X>ZL61;F, CRRZ[E[8.0<\5<KROQ-XLU[3
MSXX^P7:)+IUYIL5GNB4A!*(]X/&2#N/7D9XQ6LDOB#P[XZT#3[SQ!+JMIK"W
M"S1SV\<?E21IO#1[ " >F#GZF@#OJ*YCQSJE_H6DV>K6D_EV]K?P&_7:#OMF
M;8_4<8W!LC'2N:C\>7MKX_UH7\P_X1V*"Y2T7: ?.M4C:;G&3G>XZ_P4 >F5
MFGQ!I*OJ2/?PQ_V85%X9#L6'<H89)XZ$&O.;2^\::KJ7AS1WU]K&:_T:2_O)
M5M8V=&,BE0H(P" RI],]^:S_ !Q=ZK?>%_B%I]QJDC1:6]FJ$0Q@R*8D+!L+
MW8[N.1C P.* /7&U6R76(]),X%]) ;E8<')C#!2V<8ZD"L)OAUX5>]:Y;2\[
MI?/,'VB3R#)G.[R=VS.>?NUE7.I:MI7BV'26U.2ZC3P]<W32RPQAWE610K':
MHQ@'&!Q[5SZ:MXNL_ 6B^-+GQ(\\DIM3/8?98EADCD=4/(7<'^;<2#C.< "@
M#UZBN"BGU[Q9XDUZ.QUZ72++29UM(4@@C<RR[ S/)O!ROS !1CZUI?#G5=3U
MGP=#>:Q.DU_]IN(Y'10J_),Z@ #L  * -Y=)L5UI]8$ %^]NMLTVX\QABP7&
M<=23G&:AUWQ#I?ANQ6\U:Z%O"\@B0[&=G<]%55!)/!Z#M7*PS:]XO\0Z]'9Z
M]-H]AI-R+.%;:"-WEE"!F=RZGY<L %&,UR-_>ZQXG;PF]UJLEI?6NO3:;,;:
M&,H9HED'G*&4\D <'(Y/% 'LMK<Q7MG#=0%C#-&LB%E*DJ1D9! (X/0C-35D
M>(]7;PYX3U'52//>RM7E ;C>RKQG'J?2L#2-+\8HNDZH_B5;UIRCZA93P(D(
MC89/E%%W!ER,9)![XH [:BO,-.O/%?B7PC<>,;3Q$UDS"::RTY;:-H!'&S +
M(2-S%MO)##&>!2V_B#7O%_B31[33]5?2;&^\/IJ4XBA1Y%<R;2$+ XZ@9(/
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MMA;I"D@P[  L2Y  SG'M6/<?#+5+SP@/"MQXK;^R8HUC@6&P5),*04$C;CN
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M..XEM\28R3&Q4G@]"0<5I22QPJ&ED1 3@%F Y]* "**."%(8D"1QJ%11T '
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MQ?(B7D<MJ+B.4H,*X&Y2K <=<'CBFIX'Q::)%-K%U<SZ=J/]HRW%P-[7$A#
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M12.Z)*C.G#*K E?KZ4 >7:]>V>B^,M8>/7M1\.2W2QM.IL!<17N$P)(#@[7
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ML<04I+L'&[)8 XYZ5Q.M6*6O@2QURP\+VFFQ^?;7%MJ]U?!]0G+RJ0QVIRS
MDD%N!GCBO9](\(Z#H?VDV&GHC7*[)GE=I6=/[I9R3M]NE9R_#3P@L+0G1D>$
MC"QR32.L?.?D!8A/^ XH Y[3?"^CZ_\ %3QG<:M91WAM9K(P)-DK&Q@4E@O3
M)VK^5<M'I6GV'PLUF6TLX()'\1K$[1H%)1+U0BG'8 G [5[5;:796=_>WUO
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M.C:?%8:;:QVUK$#LBC& ,G)/N2><]Z@/A_26.I;[&)QJ9!O%<;A-A0HR#QT
M% 'F]MH%UI'B[P\\.B>'_#Z2N]O+%:7[.;Z$H=R%/*4.1PV2<\>]<[>>'M&B
M^$'C*>/2[1)H=9G6-Q"H*!+C:@![85F ] 37KFC^"/#N@WPO=.TX1W*H8TDD
ME>4QJ?X4WL=H]ABE_P"$*\.;M5/]EQ8U;/VY=S;9B3DDKG .><C!S0!P7B'3
M'G^)5EX?M-!TN^TNQT@3VFF7<_D6X=I6#.%",&(  P1QG-8NI:==6_AC6=)F
M>RM;0:[8"&QL+QIOL)=UWJ&*KMR<, .F37JMQX&\.76F66GS::#!8Y^RL)I!
M)#GKMD#;QGZU+!X/\/VVDII<.F1)9K.MSY8+9:52&#LV<LV0.23TH MZ+H.E
M^';$V6D645G;%S(8XA@%B "?KP*T:** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L[6M;L/
M#^G-?:C*8X0ZQJ$0N\CL<*JJ,EF)["M&N.^(VH:AIVBV,MB#'&U_$MU>+:_:
M&LXN<RJF#R#@9P<9H OZ/XST[5]5?2_L]_8WZP^>+>_M6A9XP<%ESP0"167<
M_%7PU:VTM[)_:']G(Q1+\64AMY6!P51\8/(..QQP37'6UM)JWCZV%EJFM:E!
M<:/>6R:E?PE(Q*P7B/"* !U) Y]3BJGB/Q!%;?!"3PQ<:1J$6JVEI#:W$#V;
MB.(HR@R&3&PJ2,@@G)(H ]+U+QYH^F:Z^BNE]/J">66AM;5Y2JOT<X'"CC)[
M9%1WWQ#T.QN[N$I?SPV3^7>7=M9O+!;,.H=P,9'?&<=ZKZ);2+\5O%=P\+A'
ML[%4D*G#<29 /?MFO/;&WC\/Z7JNC:SK'BFUU!;BXV6%E"&COE=F*M$?*;.X
M$ Y;@YSB@#U?5_%^E:1]B4M/>7%\N^UM[&$SR2H!DN O\.".3Q4!\>:"OARY
MUR2XEBM;298+I)8626WD+*NUT/(.6'X<UYY=:&_AS7=!O;R[U[2-*&A1V N;
M4K-);2*^[RY2(V&""!D #*U#J&F)=^"?%=_8QZY>I?WM@HN=14;KL1S1@ND8
M12% .,D<A>V* .\7XF:#]I-J\&JQ7+IYEM!)I\JR7:YQF)<9;]..>@-7[/QQ
MH5UH%[K3W$EI:V,C17:W431R0.,?*R'G/(P!G.1BL_6;>1_BOX7G$+-''97H
M:0+D*3Y>,GMGFN,\0:'J5_:>,FM;:[8P^(+:\*6Z_O)8DCCW>7D89AR1P>5[
M]* /1-(\::9JVI)IWD7]C>2QF6"*_M'@,Z#J4W=<=QU]JRV^*GAP0-=*NHO9
M1R&.XNTL9&AMV#;<2.!@?KP1ZUSVDIIVM^,M#DLM6\3ZTUD\EPTUVJQ0VGR%
M</F%22V<;0?K1I]C<+\ =;MC:RBX>/4"(O+.]B99,<=3D8Q0!T?_  F<Q^*0
M\.+;7+6/]G+,)$M6(,C/]_?T\O;QNZ;LBM?Q5?C3M/M)3J4MAOOK>+S(X1*7
MW.!Y9!Z!NA/:N4LI_P"S/B;HTMW%<)%>>'(;.&00NRF82EBA(&%.#GG%:WQ)
M@EGT/3%AB>1EUBR8A%)( E&3QV% %C4OB#HVF7=Y"\6HSQ6+;+RZMK-Y8;8X
M!(=P.H!!.,X[UT\,T=Q!'/"ZR12*'1U.0RD9!%>/>();;3=:U^:PO]>\/ZRT
MS.EG';M=6VI-M&V14V%27X!Y!&.:]4T*6^G\/Z=+J<"P7[VT;7$2# 20J-P'
MI@YH X'PE\3K4>&8YM=DOYI(KB:*[OULF,$'[U@@=U&T?+L^F1FNGN_$%KI_
MB;46GU64V]IHXOI+-8 45 SYE#CDDA<;?;/>O/=&UZ"U^%5]X9DTN_.LW*WD
M%O:?8Y/]),LDFUPV-NT;N22,;3[5;O\ 1[ZQN=9LY(I99(? B6AD521)*OF
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MFP+A8)$7(20.<D'LP].@J.[\9WEO\-])\3+;0&YO19EXCG8OG,BMCG/&XXH
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MCF#&*1'"L5)5@<$=1]:XI/$GB?3O$6BVVNV.F+9:Q(T,0M'<RVT@0N Y;A^
M1D <UB#QN=$T&>:SL=-L#<^(KJQ:XG+K;1$,Q,LI'.6V^H&3U% 'J=%>::_K
M'B6\^&_BB27^RCY-HS0:C83EH;B,H2^P!BRNON<'(I4\1^++,>&?#]C::1-J
M%_ISS>=*TBPQ!-F"<?,?E."!_$1VH ]*HKB-5U[Q3:W#Q?\ %/:7#!#&6N]3
MG;R[F4KEQ& P*HIXRW/M7+:OXGUKQ3X?\"ZOIZV5LUUK(CDC=W9#,GFJ.5ZQ
MG83Z_=H ]@K*@T&WM_%%YKRRRFXNK:.V:,XV!4+$$<9S\QKGF\0^)M9UK4['
MPY;Z4D.E.L%Q<7YD(FG*ABB!,8 R,L<]>E9DGQ%U>^M]!ATC2K5=4U&ZN;&X
M@NI&V6\T(.[YEZJ,$],D>AH ])HKSB^\:>(+;7T\/RW'AO3]1BM(YI)+Z218
MKIV+?+#R#@;>223D].*[G1KJ^O='M;C4K(65[(F9K=95D"-[,O!!ZCZT 7JC
MDGBB>-))41I#A%9@"Q]!ZU)7F7Q6TB;7-:\'Z?;7;VES)=W#07"=8Y%A+HWT
MW*,^U 'I4DT4(4RR(@9@H+,!DGH/K3Z\DUOQ*_B+PAHXO8A;ZQ8^(;*VU&V_
MYYS+*,D?[+=0?0^U=,_B'Q+K>M:M:^&;;2TM-*F^S2SZ@9"9YMH9D4)C:!D
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MY/E,:E023V/S#B@#C-'\%ZLGB.\UN&QTOPQ*^GR6J1:<_G"25B")7!14(7'
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M#PA?>'DTKP^M[,DJOKLDC//<[B2,@IN5CP"2Q YP#TKN-)\.W]IXS_MF<P"
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MINCV[26N^S\22:I)AS@PLTA ''WOG''UYKT6J4FIPQ:Q!IACG,TT3S*XC)C
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M0*I=B3DYX':NHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA<=*Z-/A]I2:,-/-Q>NS7\>HSW4D@::XF1@P+DC&. , #CIBM=]!MI/%,/B
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ UY]X5>[UK6M#\)7VY_^$2DEDO68<2-&?+M3^*MO_X#76_%E _PNU[*AML
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M@>-\8X]".Q!X(]17/7GCL)J%_;:7H.J:O'IS[+V>T$>R-P,E%W,"[ =0H.*
M.IBM;>"6:6&"*.29@TKH@!D.,98CJ<#'-<]X@\/WT]I9PZ"=-AM[=G\W3;NV
M#6MPK=F"C*D'D$=R<YJM>?$72H8M#>QM;W4SK<<CV26D8+.4VY4[B-I^;G/
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M6D<<KH0"P9RR_49&17944 >90>%KR_\  WC"PN(9+6YFUB\O+*20;<,'#Q2
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M9S)-=ZEJ4D",A!E5R=A7U![5LZ9X(T[3M4@U*6\U/4;JV5EMFU"[:80!A@[
M> 2.,G)QWKI: /+K.RU/1[GX;WDND7\T=II)LKM8(=[6\CQQ ;UZ@ JV3VQ7
M4?$'1[[6/# 738A/>6EU!>1P%@HF,;ABF3P,@''OBNIHH \\OKF^\;:]X<CM
MM#U2PM=-OA?W=QJ%OY.TJC!8T!/SDEN2.,#K46F:-J,7PB\3Z<]C.M[<#4_*
M@*'?)O:39@=\Y&/K7I%% &;X?ADM_#6E03(T<L=G"CHPP58( 0:TJ** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K#\6:A?Z;H37&GSV%M)YB*]U?R!8K>,GYG.2-Q
M Z+D9-;E<SXU\,S^)K"P6UN((KFPO8[V)+F,R0RLH(VNH.<<_I0!S7AGQI=7
M/C1=$'B*R\06<]E)<+<V]KY)AD0J-N02K @]N?ZYD'BWQJOPXM?'=QJ&G&!%
M1Y=-6T_UL?F!"?,W9#'.0 ,#@<UU-IX5UV7QA8^(=5U*Q8V]I-:_8[6!DC17
MP05))).1SG'&,#UC;P%<-\)%\%_;HO/$"Q?:=AVY$@?..O;% %Q/$\^G>,-=
MTS6)(TLX+)=2LY N#Y !$H;U*L!^#"M#P=?ZEJOA6QU+5E1+J\4W C1<".-B
M2B_4*5S[YKC/B39V/B;Q)H&@V=[_ ,3<W#17D41RRV+INEW^@(5,9[FO3T18
MT5$4*JC  & !0!P-IJ7BSQ7-JU[HNI6.G65E=RVEK!-:><;EHSAFD;<-JEL@
M;1D"N>?5]2\7>)/AUK-K=1V!NDO086M_,\J5$*R\[AD'&!Z8SSTKJ!X6\2Z-
M=:I'X:U;3X=/U*X>Z*WENSR6LC_?,95@&!/(#=#3'\ 7.F6OA5?#]] DV@&4
M WL;.LXE7$A.T@AB22/<T <_H47BAIO&]QHNJ6=C!;:U=2*LMKYS3R!$)5CN
M&U<!>@)Y/I4^H?$V6:S\,PK?V6B2ZKIXOKJ\N(S*L*\#;&N>6+9ZG@#O78:+
MX9ETJV\11/<I(=6OY[M"%(\L2(J@'U(VUBV_@/4M)L?#MQI&I6T>L:19&Q=I
MXF:"ZB."58 AEP0""/UH Y]_B;J$/AGQ.;6_L=5O-(%O);7T$12.XCDD"D,F
M3AAR#@XY!KT?P_;:[;6DO]OZC;7ER[[T^SV_E+$I ^3J=V#GD]JYS4?!NO:[
MX:UJSU?7(I+S4FA\N.*-A;6JQNK812223CDD^GI7=4 <*NI>)?%&NZU!HFI6
MNEV&DW'V0/):>>]Q,%#-G+ *HW <<GGFLZ#QWK6LVFB:59QVEGKU]>75I=3,
MADBM_LW^M=5R"V?EV@GOSTK9F\->(-*US4[[PSJ.GQP:HXFN+>_@=Q%,%"F1
M"K#.0!E3W'6JB_#N;3M+TA]*U0#7-,N)KH7ES%N2Y>;/G!U!&%;/8Y&!UH ;
MJNN>+?"NFW,5ZUCJ4]Q<V]II5WY?E!Y96VD2H"<!>N1U'I6I9Q^,M+OF%[>6
M6LV3VTC^8(1:M#,HRJ]2"C<C/48K/N_!&L:]:WTVN:XJZC(\$ED+-&%O9/"V
MY&5&/S,3]XG&1P,4^Y\*>)/$"W"^(=<@AB:RFM(H-+22-&:5=IDDW,=Q Z+T
M'K0!R\WC_4].N-,FD\6Z)JES/=PPW>E65ON6$2,%;;*K'E<]6Z_I5W7?&NJV
M_BG5=.D\0:?X?DMF T^WU"S)BO5V@[VF)  +$KQR,=ZLS> _$M[X?T[1KC4]
M'MK73I8)8UL[1U^T&)@1ORWR\ G"CKCG'%:FL^&O$UW+JEM:ZGIEUI>H$MY6
MJ6S2M:$KM(CP0"O< XP: *^H^*9M*\4QS7MM9LD/AF;49V@4,VY'0E4D/)0\
M_7@U1N=>\9:/X3@\9W][83VA2.XN=)CM2OEP.1PDN[)=0P/(P>:U+3X=06]S
M91271GT^#0'T62-QAY S*2V>@X!X]ZJ/X(\27VA6_A;4];LI?#\7EQO)%;,M
MU/"A!6-CNVCH 6 R<?6@"3^T_%6O>,O$6D:5JEEIUEIGV=HYWM/.D<R1!MN"
MP&,Y)/7D 5N^!==NO$GA"SU*^CB2[9I8IA%G87CD9"1GL=N?QJ32/#\FF>*?
M$&KF='CU1K<I&%P8_+CV')[YZU1T+PUJ_A[PWIVEV6HVP>'4'GN9'A)$D#RN
M[(HSPV& S[4 =91110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% #!#$LS3"-!*PPSA1N(],T^BB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%% !1110 4444 %%%% !1110 4444 %%0M=6Z726K7$2W$BETA+@.RCJ0.I
MR.?>IJ "BDW#=MR-V,XSSBEH **** "JFJ(\ND7L<:EG:!U50,DDJ>*MU#;7
M5O>0^=:W$4\6XKOB<,N0<$9'<$$4 87@&TN+'P!H-K=P207$-E&DD4BE61@O
M((/0U4\/6-W!\0_&5W-;2QV]R;+R)60A9-L)#;3WP>#7744 4=,U(ZD+LFQO
M+3[/<O;_ .E1[/-VX_>)R<H<\'OBKU%0VMU;WMLES:3Q7$#C*2Q.'5OH1P:
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M2$?,0!]2!FND\7R:S#X2U.3P^F_5E@)MEP"=WL#P3C.!ZXK;HH \5N-/GO\
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MP^6,;>1G   SWZX% &M<ZUX@UGQ3J.B>'I=/LHM*BA-U<W<#3%Y9%W*BJ&7
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M'4O+>=]X4!I)'!*KUVANI'&!6?JDNOZ/X)\;6YM[S3+&&&":PAGU&.XFMF+
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M6A7F5SIUI:_&75=22&9[BWT%+Q%\^3#2>9(O3=C& !MQC/.,\T >C6EE:V$
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ME2.5"J&QC(.<@]<=ACIGUR3PYXDT[7-2N7_LS6M&W3Y;Y8[F&/S,@=!NC+C
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M/U#6K2WNAC?&[_ZO/3>1PN??%6]7\0Z1H-I'=:IJ$%M#*0L;.W,A]% Y;\*
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M6TJS6MH]Z[0VS*P8;%/3TYSP2!C-=I10!GZ];RW?AW4[:!"\TMI+&BC^)BA
M'YUR'A/X<V%IH6@G4O[0:6T@AF.GS7;/;PW(4;F"9QD-D]P">!7?T4 <O=>
MM*N=3O+U+G4K9;Y@]Y;6MX\4-PV,$LHYR0,'!&:ET_P1HNEQZ/':QS+'I$LT
MMFID)"&4,&!]1\QQZ5T=% &+?>&+"^\1V6O-)=0W]HGE!X)RBR1[MVQP.&7/
M.*7PWI$^C65U%/.TK37DUPH,K2;%9LJNX\].W;.!TK9HH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *XCXK2)#X.BGE8)%#J5G)(YZ(HG3)/H*[>F2Q1SQ-%+&LD;##(XR"/
M<4 >2WMY)'\5=1U!/%&G:3!?:=;MIUY=6ZS13P@'>L<A=0/F.X@$Y!![5E?8
M;2?PW8E+_P#M2QOO&ENYD-F((9"6P_EKN8-&2#ST)S7M,VFV-Q;);3V5O+ F
M-D3Q*RKCI@$8%2_9X/+CC\F/9&047:,*1TP.V* .(OK6!_C5HQ:%"8M&N)(_
ME'RMYJ#(]\,?SK%TNSMAX:^*;B",,]_?*QVCD"!2 ?Q9C^)KU(Q1F42F-?,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC/)SGI0!WU%%% !1110 5S%AX]T34/&E[X3C>:/5+0$L)$ 23 !(0YY(!SC
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M />:*X#X577B*32=1L]>BU$I:W16QGU%0)Y(3T#D$Y88YY/7%9'BRXU+Q/\
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M6.2>23Q@=!0!]-45XQ;QZMX8^*WA&#_A(=4OTUNVD>^CNY]\;.$)RJ]%&<8
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M)%KMZC3OC=(0_+''&3U-9_B6:VU'QA>V3R^)-6:WAB4:=HS-!':,P)W22"1
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M](B$$"VLNU7ARI\MP0=RG:,]SZU9L_&7AO4=7.E6>MV4]]SB%)022.H'J1W
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M8)=LK/L4Y"[MH))QE@,<GD5-)\0?"$5E!>/XBT\07#%8V\T<D=>.HQD9SZT
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M(64$L@B0A3[?,>/>N9\*W=MIDWP_U/7)HXM,_L*2WMKB<@1PW193RQX4F,$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZD.NZGHVGZ#JNIWVFE#<+;(@55= X.YF Z' '4D'CO6[H&N6?B30[75[ O\
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M=VT]O/) I=9]NYC@?-\I(P>H^O:M>L3PC=O=^%=.:2RO+.2.!(7ANX3'(&4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KE+_P%8W\U\#J>K065_(9+NPAN L,Q/WLY4LH;N%8 UU=% #(HDAB2*) D
M:*%55&  .@%/HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
:**** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>separationagreement007.jpg
<TEXT>
begin 644 separationagreement007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHJAK6K0Z'H]SJ=PDCPVZ[F6, L1G'&2/6@"_1
M7/>&_&-AXGTJZU"S@N8XK9BKK,JAB0N[C!/K3_#/B_2O%EO++ISR!XB/,BE7
M:Z9Z'TQP>AH WJ*J3ZG86UP+>>]MXICC$;RJ&.>G!-6Z "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>A(J:F(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<3 87(+ [R<\;>,#B@#VBBN*N/%G_%873B^,?A_2-.2>]>.+S/,EF(,8X!;
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M?WQC'3J<UOM-$D)F>1%B W%RP"@>N?2@# T[PU<6WB6/7KW4_M=Y_9BZ?)B
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M H,';(O3GL1P:]*MKRUO%9K6YAG53M8Q.& /H<=Z;'?6DMT]K'=0/<)]^)9
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MZ;<ZC)X+M+J5"=3;3TD=2.3-Y8)&/]ZJ\O@7PO/JIU.70[1KMI/-9BGRL_\
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MQQP2.>E>H5BZ+X2T'P[-)-I.F0VTTBA'E&6<K_=W,2<>W2MJ@ HHHH ****
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M0&- 6"CDX[XYQFL'Q!H^H^/3XLU/2;2YAMIM*AL;3[1$T+7CI*96(5@"!CY
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MP9)E5&);=D8+*!6?I>B:@OP35VM)[76-%O9M1@CN =ZO'.[X)/WMR%AGH=U
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M3;Y]?C/\.UQ^[C'^[,TC8_V:U-'U8>!]3\2V6K:?J3M>:I-J%G-:V<DZW*2
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MY:-M=65R3NY!!S7+>+]4\6ZMX"M=2U"QTR+2[^YLY5AA9_/MD:9&0NQ^5\\
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MWC=O*F$I78Z$\KN5N <X(YS0!V=]H-K?Z]I6L2O*+C3!,(54C:WFJ%;<,9/
MXP16C#-%<1"6&1)(VZ.C @]NHKD+?Q!XATOQ-IFE>(X=-:+51(MM/8;QY4J+
MN,;AR=P*YPPQR.E<?X8\7OX>^'7A73;1K%+_ %.6[$<VH2^7!"B3.6=SU/4
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MWSM2)"RLW R23QD5$?BF!X7:Y,-@=6&I_P!D@"Z'V4RXW>;YG_/+;\WKV]Z
M/2JS=5T6WU6:PN'=XKFQN!<031XW*<$,O/\ "RDJ1[^H%<GHWCFZ;Q)%H>IW
M>AWTEU;R36USI$Q90T8RR.I9B#@Y!SS@\5C0_$+Q?_PB.E^+)=)TEM.NY(XF
MLTDD$[%VV!@Q^4 MC@@\'K0!ZO6;?Z+;ZEJ>G7ER[L+!VEBAXV&0C:'/J5!;
M'^\3Z8YB'Q;K6C>(KC3O%,6FB :9+J4<VG[_ )%B(#HP?J<'((QTZ5@CXI:A
M;Z5;^(;R?PX=,E*/)IT%V6O88G( ;.<,P!!*[1WYH ]7HKAIO$7BK4O%VNZ'
MH5MI*1Z6(&^U7ID(;S(PP7:IY.<\Y& !P<US.M^(]<\2Z%X(U.TCL[26;7!#
M-#(79?/3S5'((S'E&..OW?2@#U^BJE_=R:?H]U>M"T\EO;O*8HNLA52=J_7&
M!7$>$_&6N^(9M.N4D\/W]E=#-S!83E;BQ!7(+AV^;!P"  >> : ._BFBF#&*
M1) C%&VL#AAU!]Z?7D'A_4/%=A8>,;S1K;2C9V6MW\SB\:0R3D-N95VX"\#@
MG.3V%=9=^*-8O=+T:]T>WT^SM;^S6[EOM4E_=0;E4K'M!!9CD\Y P* .PFFB
MMXC+-(D<8QEG8 #)P.3[T+-$\LD22(TD>-Z!@2N>F1VS7C_B'Q9<>)?AIXIM
MKQM/EN--OK6%KC3I"\$RF:)@RY)(ZD$9/(KKO#7_ "5#QS]-/_\ 1+4 =K17
M(>)?$6MV7BO2= T6TLI9=0MYY3-=LP6'RRO)"\D8)X[G'(YK,'Q U'2=-\1I
MKEA;2ZKHTT$*)8LRQW33@>5C=DKR>>N* /0J*X=_$/BG0M1TJ/Q';Z2]KJDX
MM(Y;'S ;>=@2BN&)WJ2,9&/I5;X6/K$D'B%M2EM9$&LW:YBW[O,$F&^\?N=-
MHZ@4 =]YT0G$'F)YQ7>(]PW%>F<>E9'B7PXGB:Q6QGU&^M+8DB>.TD"?:$(P
M48D$[3[8-<EXA;65^,.G+HD5HUR^ARJTEV6\N)/.0EB%Y;D  9'WNO%/G^(U
MUHVD:XFM65M_;6E7$-MY<$I6"<S &)PS<HI&<YSC:: /088HX(8X8D5(XU"H
MJC 4 8 %/KS[2_'5[%XDTS2M6OO#U\FI%HXI='G+&"4+NVNI8Y4@$!ACGMS7
M0>,_%">$]!%]Y4<MQ-/':VR2R"-#*YP-S'[JCDD^@H Z&JAU73A// ;^U$MN
MN^:,S+NC7U89X'N:X?3_ !QJ7]OVNB7=]X<OI]1AE^QSZ9,S)%,B[MDJEB=I
M'1@1T(Q7F[Z;J[_#C4;QK?0RMYK1BN9O)?SYB;P JS9Y3<!P>P]: /H6VNK>
M]MUN+2XBG@?[LD3AE;MP1Q4U>;W'BJZTC5$\*Z<_AG2IK&V2:\FNF,5NKN20
MD,892<\L3GC/J:?!\2YKGP\&M[.TGUQM5&D)%%/NMGF(W"0..?+V_-Z]O>@#
MT6HWFB61(6E19) =BE@&;'7 [XKSKQ5?>-H/"?B.UU"VTW:-*EGCU&S\Q$7
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M74_VBX2W MXM^PL<;F]$'<]J .3DT;Q3XEU31CX@@TRQL=+NEO&%G.\S7,R
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MY-6M5\%VNH:Q+JUIJ6IZ3?3QK%<2Z?,J>>J_=WAE8$@< @ CUH \^;5-;O\
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MH-D9>*)R<1DY.,8ZFNZO/"UA>Z3I6FRO.(-,FMYH"K ,6AQLW''(XYZ53N_
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MN35M.ATM=3DOK9+!D5Q<M*!&5;&T[NF#D8^M</?R:9J'Q4\,KHS6L[)970U
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M(R"#W!%>,6=]X=M/A!XAT_7I;-=:W7HOH)BOGR7)=RC 'DGE"I']*]0\'?\
M(CZ!_P!@VW_]%K0!'I_B&%-.:XUC5-'CS=S0QR6]Q^[(0L0I+'[X53N';!]*
M?#XQ\/7>E7NHV>LV%S;6:EIWCN%(3TW'/&>V:\JMK6"]TKPY;W,22POXUN=R
M.,AL-,>1W'%==>VL,7Q;OTAA11-X78R*J@!V$^ 2.YQQ0!N^'?&^E:WX.A\1
M3WEG:0% ;G=<*5MW.#L9CC##(X..O2M;2->TG7H'GTG4K6]C0[7:WE#[3Z''
M3\:\@TFYTU_#?PPFO)K9]%MY'2])8&..Y\D^3YG8$-GKTR*ZZWFLKKXT)+HK
MPR*FD.-3>W(*9,B^4&(XW_>QWQ[4 ;7BOQMIWA2]TBVO)K9#?W(B=IIQ'Y,>
MTDR'/49 '89852A^(&G6OB#7['6]0TZPM[&XAAM7EEV-*'B5R3D\X+=ATJ#X
MBR6UOJ?@VYNWBC@36E#R2D!5!BDZD\"HO"NGV-S\0_'ES+;0S2-/;1;W0-\A
MMU.WGL<_C0!V5SK.F66EC4[G4+6&P*AA<O,HC(/0ALX.>WK1I6M:7KMJ;K2M
M0MKV -M+P2!P#Z''0UX;8?:D\._#=_M5E:V,=Q?H)M0B,MNDPD81;QN7G 8*
M2>#7=>$8G;XDZM<R:WIM[<_V?&EW%IEFT<6[>2C.Q=@9,;ACK@CTH [;7=7@
MT#0;_5KD_N;2!I6&?O8' 'N3@?C6%X#\47_B*QO(-:M8;/6;&54N;>+(4*Z!
MXV ))Y!QUZJ:ROB2U[K=_HGA#2_LYN+R;[;<BXR8Q!"0P#A>=K/M''I6<[>(
M/#'Q+TS6M>;3/LFMJ-*G-@LBJ)1EH6;>3R3E<^E '5^)?&^CZ'9:I%'JNG'6
M+6SEGCLY)QN9U0L%*@YYQTZXJRGBO3++PWI>J:YJ%GI_VVWCD_>R!%+,H8A<
MG)QFO-+2XT&'X,>([36Y+1=7#WHOHYBOG-=%W,9P>2?N;36IH$MG:^-]#FUE
MX8XW\+VZZ=)<$!-X/[T*3QOP5SWQ0!NVOC2[U*UU^:SN=&CBL-2BMK:YN)2(
M9(F$9)+ G+'>0N."<5.OCZRNO$'B+0[6[TZ*[TNW#0R7%R-LDFUR^X#D*A4!
ML<CGI7G5PVFOX4\;/I'E&Q;Q-:F,PXV']Y!N*XXQNSC'%=#J4MK#XF^)\#O"
MEQ-H\30HQ 9P+>7<5'4^^* .\D\2:;I>A6-_KFJZ;;?:(D;S5F BD<J"?+)Y
M9><CVJTFNZ3+I<>IQZG9M82,%2Y$RF,DG:!NSC)) QZ\5YIX8ELK7QAX>EUE
MX8T?PK:KIKW! 3>/]:%)XWXV^^*Q->CL[S2_'?\ 9P1]!GUC34B\K_5/+OC$
MY7''7;DCO0![!IGB?0=:NYK72]8L;RXAYDC@G5V Z9P#T]ZAN/&?AFTU/^S;
MC7]-BO=VPPO<J&#?W3SP?8USWB"UMK'XF>!WMK:.']W?1$1(%R@A!"\=@>@K
MSO5M4^W?"34KFVD\.Z3I%R)6BT_8]Q>/(7/#,SC#D\DX.!["@#V"'7KF3X@W
M7A\QQ?98M,CO%D .\NTC*0><8PH[54\:^(-7T:;0[31DL6N=3O?LNZ\5RB#8
MS9^4@]JRM <R?%-G)W%O#-H<^O[UZ;\3K(:CJ?@VT-Q<6PEU?;YUM)Y<B?NG
MY5NQH ?JGB/QCX4^R7VO0:'=:7+=1VTQL/-26/>VT, Y(8 GIUKJ]7\3:%H,
MD4>K:O963R\HMQ,J%AZX)Z>]>;:YH$?@_P 6:-JNN7^IZUX=>=8]VI7CR_V?
M<_\ +.4C(4J>F2/E/.>U)&VHQ?$GQ?NU;0K&X<Q%/[6M3(7M?+&/+;S%&S.[
M(&>>M '=ZUXDDL=6\,V]E]GGMM7NFB>7.[Y!$SAD(..<#GGBKEYXL\/:?J:Z
M9>:WI\%\Q $$EPJOD] 03QGMGK7E^A01P0> UM[];VU;7+M[>2.W:&,(8Y#M
M16).P'=@YZ5G:/\ :1X-\0P:IKGAVSS<W0U6&_L6DN=Y=N2?-&XD8VX7T R1
M0![1J^OZ1H,"3:MJ5K91N<(;B4)N/H,]?PI(/$&C7.D-J\.JV;Z:@):Z6=?+
M7'7+9P*\U@O9H-:\/Z;:'2SJMMH$<AU?6ED7=$3C"1;A\_RY8DY[&L/3?[-O
MO#GBY+_6X883XA@>/4;2U'V=9L1[7,9)'EEAR2<'KF@#V72/$6B^($D;2-4M
M+X1D"3R)0Y3/3('2HK;Q9X>O-6;2K;6]/FOU)!MTN%+Y'48SR1Z5YM+J&L'4
M]<TYH]'U'7)O#]PUMJFC[ED"K]U)$R0"6.5(/45CA/M7P[T*W7Q+X>@M]]M]
MC2STUVNXYPRX  E)\S.0QQ_>H ]X)"@DD #DDUCZ=XM\.ZQ?-8Z;K>GW=TN2
M8H;A68@=2 #S^%3>(TM9/#&JI>M,MH]G*LS0*3($*$,5 Y)QG%>7:5?2:5?>
M$(9;O0?$>G23I;Z=/;1^3>VX9"-Y525*A1\W3WH ],O?%GA[3=273KW6]/M[
MUL8@EN%5^>F03QGMGK6?J?C?3=,\;:;X;FGM4EO(G=G><*4;*B--OJY8X^G&
M:\PTC[4OACQ-!J>M^';,F\NO[4AU"R:2X)+'!)\U=V5QMP/0#)KH-.\C3_%?
MP^6]O5ESHL\4=Q<IY33-^ZV<-R&QC@\T =IXY\4P^#O"=[JSM 9T3;;13/M$
MLAZ*.Y[G YP#4.E^*[6T\+VVJ>(_$&A%9W81W-G)L@?!QM7<Q+$$$'![=*J?
M%I5;X6Z\2 <0 C(Z?,M9]PUA9?&*W?5S!# VBA=-:?"QB3S"90N> ^"OOB@#
MM(]>TB72TU2/4[-K!R%6Y$RF,DG:!NSC.2!CUXKF;_XH>&K?6-(LK;5M-N8K
MV>2*>=;Q,6X5"03]6 4=.M>?^(4M+W2_'YTX(VA3ZIIJ1F'_ %3S;XQ.4QQU
MVY([UV?BV#2]'\8^!G,5G96:WER&;:L<8)MV"YZ#T _"@"_8_$+38M0UNVU[
M4=.TX6>I-9VWF2A#(@1&R=QYY;J,#I791R)-$DL3J\;@,K*<A@>A![BO//".
MEV%SJWC^:>TAEDEU22!V= 2T8B0[>>V6/YUK?"QF?X7^'BQ)/V0#)] 2!0!I
MV>N(C:BVJ:CI*0PW_P!E@,,_W<A=J2;NDI)Z#L14^E>)M"UV>:'2M7LKV6'F
M1+>=7*CIG /3WKR75X(KK2O$MO.@>&7QM CH>C*?)!'Y5VFK6MO:?%OPDUM!
M'"9+&]C?RU"[E41E0<=@2<4 =E>ZA9:;$DM]=P6T;N(U>:0("QZ#)[\&JND>
M(]%U[S?[(U6SOO*.)!;S*Y7TSCM[UR?Q;:P70M$;5-G]GC7+0W&_[OEY;=GV
MQU]JJ:U?Z<WQ)TB\T<QW1M-*O)-2^Q,"3;[5,2DKW+CY10!UP\9^&3JHTL:_
MIIOB_EB 7*[M_P#=Z]?;K4]]XFT+3+K[+?:Q8V]QO2/RI9U5MS<J,$YYKQ#Q
M!J#R_"6VDBN/#>G:;*89+/3+1&FN0?,5L&1GX91DL=O8CO7HNCZ=97GQ?\6W
M%S:PS2PVMB(FD0-LRKDXSTY5?RH Z.]\9>&=-U'^S[W7M.M[O(!ADN55E)Z
MC/'XU;U;7](T&WCGU;4K6RBD.$:>4)O/MGK7C=_JWV[X?^)+JT?P]H^E7#W8
M:TF1[B]FERP^;+@*[,,C@[<@]JW-!N[&S\8:!=Z[/!%!+X7METZ>Z8"/?UE
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M,,2I&ILI0BK@!FB4LV/4]2:]=@UC26:R@@O[1FO%=K5(Y5/G!>6*8ZX[XZ4
M:%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&7 VGD8)'!Y^AKI[/QK<OKEMI6I>'+[3IKZ*26P,TL3>?L&YD.UCL;'.#^=
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MDO(^FZ79632??-M;I&6^NT#-<U<?$BPM/#DVJW&GWL<MK>I8W=B5!FAE8@=
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MI6JZ6=3L-0M[FR )::)PRK@9.<="/2K-G>6^H64-Y:3+-;3H)(I$/#J1D$4
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MR]6ZAF\O=E>0\9&1PP.#6,W@G7;*'4=+T3Q!#9Z+?S22LCVI>>V\PY=8G#@
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M!2,GYL%,]N#CWJYIVA^)I-9M+[7/$,4L%HK!+73X&@2=B,;I<NV['91@9YH
MXB'Q'XVE^&S^-CKEJHMO,<6'V)2DZ)*4.]^H)P<;<=O<UT\NJ:[XE\77VDZ/
MJB:1::9;023R_9EFDEEF!95^;@*%'..23UJ6+P(\?PNF\&_V@I>2*6/[5Y7
MWR,^=N>V['6I;SPIJMKKC:SX=U2VM+JXMH[:\BNK8RQ3;,A' #*0P!(ZX(H
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M:?J-K'E+= 94(B.&/KN8-GKQCI7<CP9<&'PXMQK5Q>3Z3>-=S7%R"SW#%7!
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M55#-M)!S@X /J,BKFL&3P4?']EX<,EI;1:=:7$,,;$K;O(S)(Z GY?EYX]*
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M9=.AF$S"22V6-\*7!R>"5SGH*Z[0])L_#7Q:GTK1XC:Z?<Z(+J2V5R4,JS;
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MU19 %+@Y(QE<YZ"K^KZ0!X\A\+67AY=1T73=+6XM],DOS#'N>5MTIW9WX^Z
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M^8@X]>];M% 'D>G^!I[S6]">/PE)H<6G7:7<T]QJ7VD?(#B*!=[;5+$$_=X
MX[5ZQ<6\-W;2VUQ$DL$J%)(W&592,$$=QBI** .:TKP'H&C7\%[:V]P\MLI6
MU%Q=2S); C!$:NQ"<<<=JAD^''AB6[>9K&7R9)O/>S%S(+9Y,YW&'=L)S[8K
MJZ* *,>CV,.M3:ND.+Z:!+=Y-QYC4DJ,9P.2>U9UQX*T"ZT^ZLI;$F&ZO6OW
M(E<,MP>3(K Y4_0BM^B@#G+;P+H-M9ZC;FWGN#J,/D7<US=22RR1X(V[V8L!
MR> 14FI^#-$U4V;S0SQ36<7D0SVMS)#*L?\ <WH02OL:WZ* .>MO WANUT&[
MT.+2X_[-NY3-- SLP9\*-P).0?E7D'J,]:71_!FC:)?M?V\=S->&/R1<7=U)
M<.D?]U2[':/I7044 8J^$]$7PM_PC)L5;2-AC^SN[-QNW?>)SG/(.<BJ-O\
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M"S%VE<]6=F)+$^I-0Z;X4T71_#\VA6%D(--F$@DA5V.[?G=R3GOCKQVK9HH
MYZ^\$Z%?V>G6SVTL1TV(0V<UO<2130H%"[1(I#8P!U)S3X/!GA^#P_=:&NG(
MUA=DM<I([.TS'DLSD[BV0.<Y&!Z5O44 <UIG@+P_I6HVVHP6]Q+?6NX0W%S=
MRS.H*E=N68_+@GCIWZU"OPX\,K<^8+2?R/.\_P"Q?:Y?LWF9W;O)W;.O.,8]
MJZNB@#$N[(:&NJZQH^D/?:G>M&\T"7 0SE0$&"YVKA?IG'K5'P!X:;PQX;\B
M>&*&]N[B2\NHX3E$D<YV ^BKM7\*ZFB@#.UK0M-\0Z?]BU2V$\&\2+\Q5D<=
M&5@05(]0:S].\%:)IB7WEP3S37T1@N+BZN9)I7CQC;O8D@<]!BNAHH R9O#.
MDSZ'9Z+):DV%GY/D1>8PV^404YSDXVCJ>>]077@_1;S6;G5I;:3[7=6YMKAD
MG=5EC*E<,H."0"0#C(K=HH P)_!FAW']C;K61&T952Q>.>1&C0!1M)!RP^5<
MALYQ2R^#- GT:;29; -9RW+794R-N69F+%U;.Y3DGH1BMZB@#"T;PAH^A7%Q
M=6T,TUW<((Y;F[N'N)60=%W.20OL.*S1\,O"H9,V,YACE$T%N;N4Q0.&#9C3
M=M3D=ATR.A(KKZ* *-OH]C:ZQ>:K#$RWEXL:3N9&(8("%PI.!U/0<U>HHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***1F"*68@*!DDG@"@!:*
MAM;JWOK6*ZM)HY[>50\<L;!E=3T((ZBFK?6C7[V*W,)NTC$K0!QO5"<!BO4#
M(ZT 6**** "BBB@ HHJEIVKZ;JZRMIM_;7@A?RY3!*K[&]#@\'VH NT52AU?
M3;G4I]-@O[:6^MP&FMDE4R1@XP67.1U'7UJ[0 454@U73[G4+BP@OK>6\M@#
M/ D@+Q9Z;EZC/O5N@ HHHH **;'(DT:R1NKHPRK*<@CU!IU !1110 445136
MM*DU>324U*T;4HUW/:"93*HP#DKG(X(/XT 7J*** "BBB@ HHHH **;'(DJE
MHW5P"5)4YP0<$?@:=0 4456AU&RN;VXLH+N"2ZMMOGPI("\6X97<O49'3- %
MFBJTFH645_#827<"7DZL\4#2 .ZCJ0O4@59H **** "BBJ6JZQINAV?VS5;Z
MWLK?<%\R>0("3T SU/M0!=HK$E\8>&X+E+>77=/29X/M"HUPH/E;=^_KP-O.
M?3FMF-TEC62-@R, RLIR"#T(H =1110 44C,J*68A5 R23@ 5 ;^S6[@M3=0
MBXG1I(8MXW2*,9*CN!D<^] %BBBB@ HIJR(Y8(ZL5.UL'.#Z'\Q3J "BBB@
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MTPT;5+:^,&TRB%]VS.<9^N#^5<UX[LIM"OK?QYI:9N-.3R]2A4X^U6><L/\
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MG:4/Y:[5^65U&!]%%9]QX:\1V/BG5M3T#4M.BM]7\HW"WD#N\#HFS='M(#9
M'#=Q6KX*\/2>%?"5EHLUP+A[8R9E QNW2,X_'#4 <SXE\3:I8ZO?12^*M"T&
M.' L[:>,7$]S\H.YP'!4$\  $]ZY[4M1U?QG#\.=66ZL[0WL['R7M#,B3K')
ME^7&5P.%[=<FNI@\'^(-+UG6Y=*O=*6#5KIKEKNXMV>ZM]P *K@@,!CY<D8]
M#2Z1X"N]-TOP?9O>PN= N)978*?WJLKJ,>A^<?E0!R4$>J:3)\2M3N+K3KUK
M-?WD<FG +,PMU*]7.% X*\Y]1TKHY=;\5:EXJM]!T2YTZQA&CV]^\TUL9-I9
MF4HJ@C@X'T /K6E>>";FYLO&D"W<2GQ!_JB5/[K]R(_F]>1GBKVE^&)[#Q9_
M;#W$;Q_V3!I_E@'.Y&9BWT.: .6F\1>,KZU\67]C?:;:VV@7=Q'''):&1KD1
MH'*L=PVC!'(R23VQ5B'Q+XIMY/"VL7UQ8-INOW$4!T^*W(:V$L9=")2WS$8Y
MX ]*VK7PC<6^B>+; W41?7+JZGB8*<1"6-4 /KC&>*+GPC<3Z+X2L1=1!M#N
M;::5BIQ*(HRA ],YSS0 WXHI</\ #37OL\Z0D6CE]T>_<F#E1R,$^O./0URE
MY;Z^/%G@:WM=0LSJ+Z7=!KN2V(2-#Y9R(PW) P/O8)Y]J]%\2Z/_ ,)!X8U/
M2!-Y)O+9X1)C.PL, X[UAZ;X8U@:SX>U35;JR:?3+.>UE6U1PLF_:%(W=,!.
M??I0!3T_Q'XDAB\5Z7<G3[[5=%\HP7+#[-%*LJ;@9 20NWG.#SC\:R;#QQ?1
M>+M'TM?%>C:_'J+O#,ME;;#:N$+*RLKL&&1C!YK6U[X?7&M-XMQJ$<0UHV;0
M@H6"& #AQW5B/RH;PGXCU#6- O[^[TBVBTFY\U;*P@<(X*%6.YCUY&!@#KR:
M (?A5!J44/B1KR_AN(_[;O$VI;>6?,$GSOG<>#V7MZFKNMZOXBG\?P^&M&N;
M.TADTLWLES/ 96C(EV?*NX DY Y.!R>:O^%O#^I^']1UM);FTFTV]OI;Z *C
M+,CR-N96.<$#MBK)T"4^/U\1^>GDC2S8^5@[MQE#[L],8&* .23QUKEEHFH6
MES'9W>O0:TFC6TJH8X9GD"E)'7)(P"20#VK4CU7Q'X<\3:/IVNWUGJ=EJ[/"
MD\-J8'@F52P!&Y@RD CU!J.[^'TMY#KA_M!8+J[U:/5;&=$W?9Y450NX'[W*
MG/L:M6WAS7]4\1:;JWB:]T\II>][:UT^-PKRLNTR.7.> 3A1Z]: +WC/Q!=:
M!I-L=/ABEU&_O(K&T68GRQ)(>&;'.  3QZ5CR:EXHT'7]-TG5=3LKZ+6%EAM
M[R.S,36MPJ%EW)O(=#@]P>.M;WBSPZ?$FDQV\5T;2\MKB.[M+C;N$4T9RI*]
MQU!'H:R[7PYKVI>)--U?Q+>:>5TL.;6UT^-PK2.NTR.7.>!G '3/6@#S6SCU
M:'X1Z#(MS;W,K>(XC:1-"8PKB[D^^P8[@6YZ# XYZUZ!#KFO^'O%L6E^(+^S
MU"SNK">\2:WM3 T+1;2RXW-N7#<'K56S\ :Q!H5KHDVH6+V=AK,6H6DB1N)#
M&)FE97YQN^; Q71ZKX:.J>+=-U:22,VMM9W-M+"0<N)=O0_\!/YT >;?\+:N
MO[&_X2(^(]!W9\S_ (1_RSYOE9^[YN[/F[>?NXSQBNK;7?$VN>-[W2=$O+&U
MTZVM;6[\Z>W,CL) QV8W#KCKVQ[TEIX2\7Z=H\7ARRU^QATF$B.*^$#?;8X0
M<A!SLW ?+N].U=%IOAZ6Q\8ZOK;3J\5];6T*1X.Y3%OR2>^=U $7CW6[[PYX
M,OM5TU(WO(6B$:2#*L6E12/R8UEOJOB;PYKFB)KM[8WUEJ]Q]D86]L8C:SE2
MR!3N.]#M(YP>A]J7XNAC\,-6".48M;X8=0?/CYJ6+PUX@U36]+N_$FH:?+;:
M3(9K>*RA9#/-M*B23<3MP"2%7N>M &#IWC'Q*-!U;Q9J4]C_ &1ILEW$+**
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M&PN8+5;/SK*Z:)I(5^ZKXZX]>OO3$^)/A"2&:1=9C_<LJM&89!(2V2-J%=S
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M<)#/?-J&^.=EDCG+;MZ,.1STJWI7B[0=:LKN[L=2B>&S_P"/DR!HC",9RX<
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MELI+R.$@DE%XW>F-Q H YC2M'N=9^),_BN^T:33DL[/[#;"=E+S/N8M)A2<
M*=HSR0QKM+VSM]1L;BRNXEEMKB-HI8VZ,K#!'Y&N!T;QOJ$\OA5]0DB6VO\
M1)M0O66+D,@0Y&.0,,>!793>(-*@T*+6I+V,:;*L;QS@$A@Y 3  SR6'&.]
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MT&KJ@O!)<.[2,N</N))W9.2<\FK>D^-O#FN:D=.T[5(YKK876/8R^8HZLA8
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MA[GO0!YYX?6*;XHV,^%=AX2MRC]< RGI]:YJ[B\JTUJ\:)GT[3_'*W=\B)N
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MB-U)Y//+#@<UD+;>)O#WB_Q#<:=H2ZE:ZQ)%-!.+I(E@=8PA$@;YL<9RH/%
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M"3(2ZDGD?,..O/2M.#PC--X4\:Z;JRI;1:GJ5W=02LX(5&"F.0X/&"N>>>*
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M\[[%:R7'E;MN_8I;&<'&<=<5RWA_5-9T#PWX6TG4= \BX,D>F2 WB,55(O\
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M)K]QKEI':W&H:J]VD<<HD C:., 9'<;2.W3- '7T444 %%%% !1110 4444
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M(J$-@]R"0/6J]CXPU6&U\:6UOJ]_>Q:?I!OK"[U"R$$R-M?^$HN]<J""5]:
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M<]NM=-+?V<%LMS-=P1P-TE>0!3^).*D-Q"(DE,T?EOC:^X8;/3![YH P]?\
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MH,=B#6CXF\+SZWJ.DZK8:E]@U+2WD,$KP":,K(H5PR$C/ '((Q7244 <5#X
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MDG@<DYX%3V?AW2+">SFM;"*.6SMS;6[C.8XB<E1GM0!J4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M89G@D*?PR*<,I]P:\XUG3?$-AXO\%'5=<358'U%LDVJ0M')Y+\+MZJ1GKDC
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M6Z^6$^SLKN5((Y)W@-D]* /5Z*Q/!^K2:[X-T?5)O]==6D<DG^^5&[]<UMT
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M>,X]3CWK5\*>(XO%'ANPU=8?LQO$9E@:0,1ABO7 ST]*V7D2-=TCJ@Z98XH
MXZ7PGKFFZKJ=SX9URVLK?5)3//!=V9F$4Q #21D.O)P"0V1D58@\&R0ZAX7N
MGU:XNGT1;@/)=9DDN6E3:26)XP><<\8':NKKFM?\6G2]5M]%TS3)M6UF>(SB
MUCD6-8X@<;Y';A1G@<$D]J (-1\$C4K_ ,3SR7Q1-<T^.QVK'S#M5QNSGYOO
M]..E;'AZQO\ 3-#M;+4KR&[N($\OSHH?*#*.%^7)YQCO6/I'C"ZE\01Z#K^B
MOH^HW$32VN+A9XKA5^\%< ?,.I!'3FNJ\Q/,\O>N\C.W/./I0!P^D6!T_7_%
M?AN1O+CU5GU*SD(SN$JA)0/=7 ./1QZU;T7P2VD7WAVY-^)?[(TIM.*^5CS<
M[/GZ\?<Z<]>M=8[1H-\C*H7^)CC%*9$#*I=0S?=&>3]* ./O_ $&IR>*#<WK
MA-;DMY8S&F'MGA10K YY.Y0>WI3H?"_B"]OH;C7O$$-PEK#)'!#9VS0+(SKM
M,DH+G<0"<*, 'FNN>1(U+.ZJHZEC@4&1 ZH74,W0$\F@#A1X!O[#3_#+:3K$
M,.IZ%;O;++/;%XKA' #!D# C[H(P:(OAP]S;>)$UG6'O)M=\AY)HH1$8)(A\
MI09/ .W _P!GDG-=T\B1@&1U4$X!8XYIU '#CPAXBO\ 6]$U#6_$5M<+I,YD
MCBM[$Q";*,I9R7/S<CIP.>.>%3X?ND5NG]I ^3XC?7,^3U#%CY7WO]K[WMTK
MM4D20$HZL <$@YYIU ',ZOX9CN_$4NNW!:XMQH\VGR6*1Y:578,<'(Y(7&/?
MK7D]]<'6?"^F^&]+\6R:B#<6\=MI)L0EW$JR*=MRP)P(U!R<+RHY/?W[-,C:
M.0&2,HP/&Y2#G\: %=!)&R'HP(-<'I7P^O[+2- TRYUJ&XAT/45NK9EM=C-$
MJNH1OF//SYW>W2N[\V/S/+\Q?,QG;GG'TKF;KQO:V-UXH2ZM95A\/PPS2NC!
MC*)$+X5>,$8QU_*@";4/"4.I^*9M5NI@]M/I$FERVNS[RNX8MNSZ#&,?C61:
M^#O$T-C9Z+)XLQHUHR!7@MC%>21H1MC:4/@#  +!02![UN/XGC3Q'I.D_9C_
M ,3"SENQ,7 $83;P1CG.[KGM6ZK*ZAD8,IZ$'(- %?4+"WU33;K3[M/,MKF)
MH95SU5A@C\C7%0>$/&=CIRZ-9^,X1IB)Y4<LVGAKF./& H;<%) XW$5WCNL:
M%W8*HZEC@"LOQ)KT'AOPU?:W/&TT5I"9-B$9?T /N2.: .?N? 4EC'X>D\-:
M@EC<Z) ]O%]JA\Y)HW W!P"ISE0<@]<US7C#PI>Z)X#\<:E>ZJ=0N]6CMWD9
M8/+",A"X4 GC!  Z@#DFO2M#O-2O],2XU73$TZY8G_1TN1/A>QW #GVQ6!X.
M\?0>+=7UG318O9SZ;*4&^3=YR!V3>.!@90C\: &6_A+6;[4M+G\0ZY#?6>ER
M">UAAM/*:64*0LDK;CDJ">% &>?:N8\*Z'XCU+3_ !);Z?KT-E87>M7T<J26
MGF2Q#S""8FW #(]0<'D5ULWCJWC^)-OX-CLWDDD@,KW6_"QL%+;-N.3MVGK_
M !"NJ,L8D$9D4.1D+GD_A0!RD7@&QAU2U=)/^);!HCZ/]D9<EHV926+9]!CI
MWS5*V\&>)8-/M=#_ .$LVZ+:L@1X+8QWC1(1MB,H? & !N"@D#WKN7D2/&]U
M7)P-QQDTKNL:EG8*HZDG % &)IGAXZ?XFU_6#<B0:L8"(MF/*\N/9USSGKT%
M8J> &3X<:?X3_M(%K22%_M/D\-LF$F-N[C.,=:[4$,H92"#R".]-26.3/ER*
M^TX.TYP: .2NO"NLV6O:AJGAK6+:S&I[6N[:\M3,GF*NWS$PRD' &0<@XIT?
M@N=3X;>XUJXO)](N9+F6>Y!9[AG1E('/R ;N!S@ #WKK#(@D$9==Y&0N>2/I
M6-IOB.+4-=US3&A\G^RIHHC*T@Q*9(PXP,<8SCO0!7NO"HN_%-_J[W6([S21
MIIA"<K\[L7W9_P!O&,=JYZ#X?:W:V/ATIKME+J/A\O'9O+8GRG@:-4VN@?.X
M;<[@1]*]$HH X-O .I7=YK][J.O1SW.LZ2^G.$M-B0$[@"@W$[0&Z$DDY.><
M#K+.PFL/#UOIT%POGV]JL"3,F1N5-H8KGID9QFKRR(Y8(ZL5.& .<'WH,B"0
M1EU#D9"YY/X4 8WA/P['X6\-6>D+-]H>$%I9RN#+(Q+,Q'/4D]ZX37?#%IX2
MT_SI=5N+2W_MHWNG7D-J'33&D4[EE!;F$\CMC<*]"?7;5/%$7A\K(;N2S>\W
M8&P(KJF,YSG+?I1H.NVOB+3&O[19%@$TL/[T $F-RA/7IE3^% 'F_AR"Y\3?
M$'4K]==36+;^PWL7OK>V\JVCD>0$1QC)W$ %B=QZCITKL)/!$5Q\/K'PO->N
MLEE#"L-[$FUDEBP5D"DGN.F>G%=3$T;Q@Q,I3L5/%/H Y2PT#Q)+J]K=Z]XB
MBGM[16"6MC;M;I.S#&Z;+MNP/X1@9YK,@\#^(=-TM] TKQ0MIH19O*(M2;NW
MC+9,:2[P.Y 8KD9]J[[-17,DD5K+)%$9I40LD08+O('"Y/3- &-9^&_LGC"?
M71=LZR:?%8B)P2PV,S;BY/).[T_&LD^ V/@+6/#/]HC=J,UQ(+CR?]7YLA?&
MW/.,XZBMB+Q(BZCHNF7MG+;:CJ=L]P8=RN(-@4NK,.I!8#CKS2^'?$<6OV]Y
M+Y/V<VU_/8A6D!WF-MNX<#KZ4 9E]X4U.WUYM;\.ZK;V=W/;1VUW#=6QEAG"
M9V/@,I5@"1UQBHW\$WMSI>GP7VO3WEY;ZQ%JLT\J$JQ1L^7&F[]VG8#)QR>]
M=@[K&A=V"J.I8X I000"""#T- &+<^'S<>,[#Q!]I"BTM)K;R-F=V]E.=V>,
M;>F.]<L=+U'P+\/+_1UOH]0:4M:Z1&D'ER;YF;:K'<=V"V2>,!2:]$K*T+7+
M3Q%8R7EHDBQ17,MO^\ !W1L4)'MD''M0!)X?TE-"\.Z=I,;;EL[:.#=_>*J
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M+*#3=/MK&U39;VT2Q1KZ*HP!^0JE?>&](U'6K/6+JTW:A9#$$ZR,A49S@[2
MPSV.10!XQ9^%M('P&N?$'V4'6(DGN(;W<?-A9)VV[&S\H&.@XY)[UN:C'?\
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MIG@_1-%%TUC9GSKF/RI9IYY)G9?[N]V+!?8&K'AO1D\/>'+#24<.+6()N4$
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ML^H7)8;-I($A5?\ QT #V% &GJ'Q#T'3KV[MV^W3I9-LO+BULY)8;8]P[J"
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M=E=RXWKY28QZCK7,^'';PT/!6OZK!.NF#0#822B%F^RREE<%P 2H8 KG'UH
MZ_P;XJD\2^*_%$<<\KZ?9FU6WAE@\IX6:,^8K @-G<#D'TXKM:X#P->QZIXX
M\9:G;6T\5I<M9^3)+"T?G!8V4N P!P<<>V#WKOZ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC#9_9],GM;B%+@2[79U*X.!D$+GVSBNTJEJVKV&AZ;-J.IW4=M:0C+R/T'H
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M?7[QS:I'JKM+('<S(5)RQ'(8H"?J<8H VO%NKRZ!X0U;5H$#S6EK)+&K#(W
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M/O!%JVOZ[<EY+P^=<7FZ1=L6[@X&,]#[<5TEM\.-,M=*?3TO;YT?5DU9I)9
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M06-;U+=8F678-JD;T;:V.,B@#B+'5/%>J_#RW>W?5KHVFL36U]Y#HE^]JC,
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MQ;:0_B_X=+HFO1W%K=!%MKED&UEEB8?O$)'()4,#Z&I;CX>Z-<W'AF9C,O\
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M81\KR$$@8'3CBL[5?!_VO6I-8TS6+[1[^>)8;E[41LLZKG;N5U(W#) 8<XH
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MZ)_MP8VY<.YB$N.J[NW3.,T >S_\))H[Z/=:K;:G9W-G;*6DEAN$900.A8'
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M5QVKP:;:?$[P>-#BMHKR1;@72VJJH:U\O(WA?X=VW;GOTKC[70]+'[.-[?\
MV"W-ZT<\YN#&/,WK.P4ANHP% 'L* /4!XI2+QAJ>D7AM[:SLK*"Y^TR2;>9'
M9<$G@=!CZUOSW5O;>7Y\\47FN(X_,<+O<]%&>I/I7G#:5#XB\<^)M+N^8[WP
M]:QLQYP6:3#?4'!_"JGA'4;KQCK^A6U^IW^&+5SJ /.;[<T"Y]PJ._\ P(4
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M&!'%?;F*-@<!@ I./3FCPWJU[XYUJUU(QD3>'M+9'1AC_B92 HX_X"$/_?=
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M(U[+$JPJZ$@IG=DGZ9'/UQ:\1^,+7P[J6FZ<]C?7M[J0D^RPVB*Q=DVY!RP
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M"T4\8=21T.#WK%T#QG;:[K5[HYT[4+'4+*));B*[11MW$@ %6(;IG(XP1SU
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ML7D<LEO;[-RP@%CN8*,9('5AWHU+7K;2]6TG3IHY6FU25XH60#:I5"YW9/3
M[9H -(\-:'H!D.D:39V+2_?:WA5"WL2!T]JF&C:8NDG2AI]J-.8%3:B)?*()
MR1MQCDDFN2D^*-G]EO;VWT#6KFQT^:2&]N8X4V0E&(8\OEA@;OES@$9QTK5U
M/QI:VEW966G6-YJ][>6_VN."S"Y6#M(S.RA0>@YY- &K=6/D)=7NEV=D-5>
M1I),NT/MSM5V49V@D^N,UF^#_#UQH=I?7&HO;R:KJ5T]W>/;@B,,> BYY*J
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M\2G5;G2-0N['4M*M(6>SMS-);30J049%^8 ANN.HKTNH);VUAO(+.6YB2YN
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M'*IR"KIDX92.QP01TK5LOA]J6D:-X;?3-1M5UG1(9+??-$S07,;G+(P!##D
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M2(Q[2&5<\\$C&>I%+J?CJ]M_$4_AZY\4:1HTNF6\/VJ\N+;>;J=UW$1H6 5
M",\D\U;\$^$[U='\ ZA<,+=M)L;@2V\BD.?.5<?0C'.:V+[PUK=CXHOM=\-W
M>GAM2CC6\M=0C<H7C&U9%9#D';P1T.* .7;XL2/X2M9EGTV+49M4?3'O6+&T
M78-S3@9R5*E2%SU;KQ4VF_$2==1O]+&NZ;KI_LV:\MKRTA\LI)&,F.1 Q&.X
M((Z$5MW7@K5;O1;!YM=\WQ!8WK7\-Y)#F(.V08MF<B+:=N,Y[^U3QZ!XFU$Z
MA)K>JV:+-8R6D%G8(PA5G!S(Y;EF[ < "@#F#XH\<6^A>&=>>YTF9=<EM[9;
M VS*L1F4[)#)NR><$C ZX'K6JOBK6?#.LZW8>(;JVU**RTC^UHIK>W\AL!F4
MQE=S#JHP?SK1F\&W$OA?PEI(NXA)H=S932/M.)1 N"!Z9[9J?5/!R:QXGO[^
M[F4V-[HITN2%1AQF1F+ ].C?G0!PL7Q2NK2TL=7NO$NA7PGDC^TZ/;0E9($<
M@'9)N)9DSD@C!P>E=*NI^+]>\4>)-,TO4=/T^UTJ:-(I9;0S/(6B5MI&X #)
M.3R>1Z<RV?AOQDEK8:1<:]8)IMHR!KNV@=;N>-,80Y)5<@ $C-;FB:!+I7B#
MQ#J+SHZ:I<1S(B@Y0+&J8/Y9H \ZOM7UKQ;:?#O5XKNVL;BYO9%9/LQE5)E2
M52X^<97"GY??K78:A*=(^*^C-%Q'KEE/;SJ.A> "1'^NUG7Z5G1^ -6L?"GA
MNRT_4++^T]$O)+E'GC8PR[S)D$ @CB3]*T9HFUOXIV,BX,'A^SD,KKT^T7
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #(XHX8Q'%&J(
M.BJ, ?A3Z** "BBB@ HHHH **** (I[>"ZB,5Q#'-&>J2*&!_ TZ**.&-8XD
M6.-1A548 'L*?10 4444 %%%% !1110 4WRT$ADV+O(P6QSCTS3J* &O&D@
M=%8 AAN&<$=#3J** "BBB@ HHHH **** "BBB@ HHHH *@ELK2>=)YK6&26/
M[DCQ@LOT)Z5/10 4444 %%%% !1110 4444 %,2*.,N8XU4NVYMHQN/J?4\"
MGT4 %%%% !1110 4444 %%%% !1110 CHKHR.H96&"I&013888K>)8H(DBC7
MA410H'T I]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV][$(W*8.)%P2" >.O!ZU4TCQK%8^#O##7RWNI:OJ5A%*MO:1>9-*=BEW(R
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M$<0/R[VE<%A]0!0!UE%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6J:,RB%OLTFG>2;AFD7)15SN("<_A4GBW2+^7P]\,(K?3KEWM+NS,ZQPL3"
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M<1Q[W"[W/11GJ>#Q[4 >,:CHS7O@GQE>:=IVO3_;6M(HI]1=I)[Q8Y%^81%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M016RQX .WS5W.3\Q+ CD59$OB'6[OP!IVLW]]83WD%\NHK:W'EM.(PFTDH<
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MLQQ)(^.A(!1<_6@#L:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;4[%;VWLC=1?:;F-I88]W,B+C+#U R/SJ.36]+B>_66_MXSIZJUWO<*( PW
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M'?NPSL^0PY9B%&,5]#U272-,26:5-.M%DG!$SB!09 >NXXY_&@#ROQ6P>_\
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MBXD\76.KWEO9W!9-,TX*ODLH&)9!*P W;2H(Z@^N:]-6V@19%6&-5E):0!0
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M @O)(&55V^S;U(]C7#6OA5+JPT[27\":FNI*\27DMYJ,QLD"D;I%(F^;IE5
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ML=/MVN+J4P[(TQEL3(QZ^P)HT/3+RV^(7BS4)K=DM;Q+(02G&)-D;AL?0D4
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MF%P3S5Q!JGA3QSKEU'H&H:I::K#:_9I;/8=KQ(4*R;F&W/!W=*PX-!\0:?X
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MC4,P)'R_*<D=JBC\,Z[91KK$.FR3W.G>)KR_%GN56N+:7<I9,G&[!R 2,XH
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MAMEBD7<KJ?3@@^A%8D?Q$BN],TJ?3](N[J]U8RFRLE959XD.#*[$X1,8//\
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MA+6)/%]EXDU;6X)YX+:6V-M;VACB57QC;ER<Y&223GC &*C3P R_#C3O"?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5BOF,^X*"O.,$D_]\FN/U>W\5_$2T\/^'+GPI=:/%8W,4]]>W# (/+4KB/\
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M3X!L+/4[8V]XDMP9(CVW3R,/P(((^M=;0 4444 %%%% !1110 4444 %%%%
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MN9PH9\C< J#<!QD^];?@SQ!/XC\/BZO($@OH)Y;2ZCC)*"6-BK;<\X.,CZT
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M $&_$G_@R;_"KWBS_DH/@3_KZN__ $F:N,/Q5N;W3[O6[;Q-HMGY3R-:Z+/
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MLD,:J6QS@9S^%3WMIXBM/B9X(76=2M=1A,EX4EBMO(9'^SME2-Q!7T/7@YH
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MESZ 4 =EK.G6VM6,FESW5Q!YH#9M;@Q2X!&2"ISCH#]<=Z3P_'I,.@V<.AM
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M*VM?,+Z=<?9IRRX&_:&X]1AA6C0!S7@OPN_A?3[U)I8'N+Z\>\F6VB\J&-F
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M5 Q7(SGJ.1TK*U'P1HVI:M)J;_;;>ZG18[AK2\E@%PJ\*) C#=@<>N* /-=
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MFBL6OA;QEG&#*0?OD8VCL/QKL/AQ'J-I!J^GWBI%;6]YBTMOMRW3VJ%03$S
MY&#R ><&M?4_!>C:H+)I([B"XLHO)M[FTN7AF2/&-N]2"1QT.:O:'H.F^';
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MV\442!(T0*JJ,  #@5Y=J'B+RO&_B&W?7=,\+>0T(+-:(]UJ V<."YPP'W0
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MWAAN)40X+K&4( X) )R1]:L7WC:_?Q!9Z-H>BK?3WFF+J,<L]SY*1H6V_/\
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M#BOHMTRV.H_:T2-(Y&9@95/S97<?N@YQ7>Z=K%CJLE['9S&1K*X:UN!L*[)
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M+<C(+8 '/:K&B>$O$7AW6;/Q"L@OM0U1\>(+<2!4PW*-%DX_=?=QW&:])HH
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MO(O$%NUI$T#6CJ+62*1#),7QM"_*Q# \[O>NT\*031>)_&+R1.B2ZE&T;,I
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7*7_@*QOYKX'4]6@LK^0R7=A#
M<!89B?O9RI90W<*P!KJZ* &11)#$D42!(T4*JJ,  = *?110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
&1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>separationagreement008.jpg
<TEXT>
begin 644 separationagreement008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHJAK6K0Z'H]SJ=PDCPVZ[F6, L1G'&2/6@"_1
M7/>&_&-AXGTJZU"S@N8XK9BKK,JAB0N[C!/K3_#/B_2O%EO++ISR!XB/,BE7
M:Z9Z'TQP>AH WJ*J3ZG86UP+>>]MXICC$;RJ&.>G!-6Z "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>A(J:F(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@X&2#Q@\#GK0!W=%><ZH/$TWC;3O"UEXGN+>$Z2]U<7;6T32NRRA01\H /S
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:%<,U[.&50N6C8M@G."0YP,T <]\3O!D7AV_T.6QUS7<ZMJ@@G5[TD*K')V
M 8Z\=:],M=,T[X8>$=7OEO\ 4+R")&N6-]<>8Q8+@*IP,9.!]369\4_#NK>(
M)O"[:79M<"SU5)[C#JNR,8R>2,_A3OBQH>N^*=-TOP]I5LYLKN\1M1N5=0(8
ME([$Y/)W< _<H X#X9ZOKV@>,]*?Q%>32VOBZT:XA\QR5CEWL5 R>,C'3_GH
MOI6K\7[R:V\::4OB"76(O!QMCO;3&VYGR?OGZ;>/3IWI/%GP7NK/18+[PYK6
MN:CJVG2QR65O>W:.B@,,[,@!2, ]<?+BNAURX^(-CK5CKMAI9U33+FR5+W0W
MF1#!*0-V#SGGN-W?CG- $'PF^Q_VAJAT+Q<VKZ"RJ8;&Z+FXM6XY.X#"GYAP
M,'CWJ'X[F^?1O#]I87<UM-=:HD :*0I]Y2!G';)H\ >%=:;XB:EXPU#0;?P[
M:S6OV>+3X75BY)4EFV\?P^@R2..YVOB?X?U37F\,'3+1KC['K$-Q/AE79&.K
M<D9_"@#S36_%VH:S\'?"NE6MW/%JMQ-)#<NKD2!+93NR1SG&QC5;7=3N%^"'
M@6>XU*\B66_=;F>.9A(8]\F>1R<#Z]*WK#X8ZW:_$+Q/>&S8Z5]GO9-,/F+M
M::=-NT#.1PQ&3C[HINI>"/%(^%/@S3K?17N-2TN^:XN+7SHQA=[L,L3CG(Z9
MZT /\(CX<77BS3(M(\8^);O4!,'@@N)9/+D9?FPV8P,8![TS0?"R^-_B+XZA
MU#6M:MDL+X"!;.[,8 9I,\$'^Z,5V6F>)O&TVJVD5S\-4L[>29$EN1J43>2A
M(#/@#)P,G'?%<YIMMXY\(>.O%VH:=X-;5+;5[P212&^CB 52^#@Y)SO]NE %
M.PUC6=)TSXC>#+_5+F^.D:?)/97DKGS0A3."W7C<F/3GVQ!+XBUJ3X>?#[PW
MIVHS6UYX@<Q3WP8F1(PX!P>N3NZYS\N.];FG>!?$<NA^.-<UFWA'B#Q!:20P
MV4$@(B780J;LXR?E'7^$<\\0W'P\\02_#SP=/8Q1P>)?#K>=';3.-KY;)0D'
M&?E7OCJ.,T :T'PKU#P[K6FZCX6\37Z>7*/M\.HSF5+B/OP .3[^N01CG$@O
MKP^-OBO&;J?9!IK-"OF'$9\H\J.WX5K+??$OQ9KFE0G1V\+:=:S"6]G^U)*T
MX'5%&.AYXP1T.>*CA\):ZOBWXD7AL&%OJU@T5B^]?WS^61@<Y'/KB@#E/A=X
MUU&'PWJ/AO7)IO-N=.FO=*N)7),B[6W*&Z\%6(^C>U9VLZG=+\ _!5Q/J-Y'
MYNIR+<3I,WF%/,FSSU. /TKJ[[X8ZGJ?P;T2T%N;7Q1I".\"AU#'+L6CW XY
M&".>H'J:S]0\#>*1\'?"&E0:,\VJ:;J+W$]KYT8*KOE89;..0R],]: '^%!\
M-[KQ7ID6D^,O$MU?BX5X()Y9/+D9?FPV8P,<<\U[M7G.G>)O&\NI6L=Q\-$M
M('E59+@:E$WE*2 6P!DX&3BNA\/>(M0U7Q-XCTJ]T^.VCTN6-8)$DW&97#$$
M^AP <>] ')?$:[N8/BA\/(8;B6.*6ZE$B(Y"N,Q]0.M<1:^--3\*_&3Q!?7<
MT\OATZC]BO-SED@W[BC =L;6Z=LCTKT7QUX=U;5OB%X(U*QLVFL].N)'NI0Z
MCR@2F#@G)Z'IGI5'1? 5Q?ZQ\1+;7K%H]-UNXC-M)N4E@/,.]<$X()4C- &9
MIWB:XT;Q5\4]4\Y[B.PBAEMXG<L@.QL8&> 3CI5?P]\.+WQEX/A\2ZEXIU@>
M(+^,W$$L=R5B@)SL&T#ITSC'MTI/AU\,]<L8/&6C^)(G2WU&WCM(+L.K^8JA
MU#*,Y& 5(!QVJ;39OBAX6\,?\(C:^%XKV6%&@L]6BO%5%0DX8J>XSQDCH.#W
M /4O#5IJUCX=L[77+V*]U&)-LMQ&"!)SP>>^,9/<\UK5Q=J?&/A[P[X?LWA&
MOZ@\RQZE<O*J>2A.2PZ;MH./4XS7:4 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5#;V=M:&4VUO%"9I#++Y:!=[GJQQU)]:FHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** /,3=ZYK'CGQ/8KXT?1K33IH$@A%O P(>(,>77/7^=7O#7
MC66UT76+CQ%?I>VFFZB+--6@APDZMM 8A>!AFVDCBN8N/^$0MOB1XO?Q;I/V
MDRSVYM7DTZ2X&T0*&P50XYQ6KX0T&/6;/Q?I]O97=EX2U )%IUO=1LFUBA$K
MQHW*KN*D>X[4 >AWFLV5AJ>GZ=.[?:M09UMT52=VQ=S$^@ [GU%+I&K6NMZ>
MM[9B40EV0>;&4;*DJ>#SU%>??#5M1\0:Q-J^L1,L^BVJZ(@;G=,IS/)]21&,
M^QKT'2-6MM;T];VT$PB+L@$T9C;*L5/!YZB@"]6)XOU671?"6I7]O_Q])"4M
MQZS-\D8_[Z9:VZY7Q2K:CK_AK1PI,;W9O[CCC9 NY0?K(T7Y4 -N?&>GZ"PT
MNZ.HZC>6-O&;Z6TLWF$65SND*C"Y +8ZXYQ3O$6O&X\/:7)H=X-^LW=O!:W$
M8S\C'>[ 'TC5S7)>*'T^Q\8ZI<_VMK7AC4G2(K<0PFXMM1 3 /E[2"R_=QD&
MM#PM/JNO:SX<;6K,6MSIFEO=SQ+'L"S3,8X\K_"?+20D=M] '2>/M3O-&\!Z
MUJ.GS>3=V]LSQ2!0VUO7!!%;6GRO-IMK+(=SO"C,?4D FN<^)L4D_P -?$$4
M4;22-:,%5!DD\=!5;1?B+X<GBT[3TFO?M+K' %;3KA1O.%P6*8'/<G% #[?Q
MGI6CZ9=WNJZU+<P'6)K%)&M2GE."2(0%&6"A2 W4UI:+XRTO7-0N-/B2\M+V
M"(3M;WUJ\#F(G&\!@,KGC-><I97#6MFK6LIQ\07F(,9^YN<AOITYKH_$^F7>
MI?$.6"U5E>X\+7ENDV"%61I%"@G\<T :T'Q'\/7%Q$JO>"SFF\B+4'M)%M9)
M,X"B4C;R> >A]:MZMXUTS2M2DTX0:A?7D*+)/#I]F\YA5ONE]HP,XX'7VKR:
M&"SO/!EGX;NM5\73:D8XK270(XHTV,I /S&# 1<;@Q;H!SFNFU/6+A/&>LV.
MI:SJ&AP1^4+6+3K /-J"[!\_F^6Q8YRN!C% 'H^C:Q8:_I-OJFFSB>TG!*/@
MCH2""#R""""/:N;\?ZMJ\*:9H?ARY%OK6J3,(I2BMY44:EW;# C^ZO/]ZH/A
M'%-!\/X(;B&>&>.[N0\=P,2*3,Y^;WP16;'I.K>+/B#K.M6NK7>D0:8!I=H\
M=O&YEQ\\S8D4C&XJ,CKB@#I= \7V=_X"M_$NH2K;1);EKPL/]5(GRR#'7A@0
M!UZ4_2?&NEZMJ<>FB'4+.[FC:6".^LW@\]!U*%A@XR..OM7 IIMQX:E\7>%]
M3M+W7]/U&V_M2'RT$;S.QVS*-H"A\@. /3@<U9\,:E<CQ?I-GH>OZEK^E.LO
MVM-2M#YEBNSY3YQ53DMA=IS_ %H Z6+XH^&IH1<QO?&Q#^7+>_8I/(A?.-KO
MC"]OID9Q6KK/B_3-%O8;%UN[R^FC,RVMC;-/)Y><;R%'"YXR>O:O+= \2V#_
M  :N/#<5E=2ZO=17=M;VB6KGSVDDD =6QMV@GDYXVFK4^ES>&/%[S:WKFL:7
M:W&EVD,5_I\:O&TD2;7C<F-R#GYATSD]: /1&\<:"- BUE+J22VEF^S1QQPN
MTS39(\H1XW;\@\8[>E4Y_&>G:CH&NM!=WFDW>GVK23_:;)EFM@5)63RV'S#@
MD=0<5Q*:;IB^#[B^NK7Q.]E=:W]J&HNP6Z@(7:+M42,%5.,8*D\YQ3#>ZI?Z
M!XRLK;4KG7]'71)/)U">R\J7SB&'DA@H\WCG.."0* /7M/E\_3+67SC-OA1O
M-*[2^0#NQVSUQ5FL_0E*>'M,5@0PM(@01R#L%:% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !5/5+2YOM-FMK2_EL+AP ES$BNT9R#P&
M!!].?6KE% &7X?T.V\.:-#IUL\DH0L\DTIR\LC,69V/<DDFM2BB@#GKG0M<F
MNI98?%U];Q.Y9(4M+9A&">%!,9)Q[G-59/">KW+ W'C?7!M''V>.VB_/$7-=
M710!R/\ PA5]_P!#QXF_[^V__P 9H_X0J^_Z'CQ-_P!_;?\ ^,UUU% '(#P9
M>,2!XY\2G!P<2V_'_D&@^#+T,%/CGQ+N/0>;;\_^0:J_#[_D-^-_^PZ__HM*
MOZO>6T/Q$\/VSV$<MS)9W;QW1<AH@OEY4#H=V1U]* (_^$*OO^AX\3?]_;?_
M .,T?\(5??\ 0\>)O^_MO_\ &:YR#XC^)7\&V_C*70=/31/E\^/[4WV@KOV,
MZ#;MP#T!.2!VS6YJ_C*^/B:ZT'0X]+$MC%')=W&IW)B0,XRJ*%!+'')/09%
M$_\ PA5]_P!#QXF_[^V__P 9H_X0J^_Z'CQ-_P!_;?\ ^,U!9>-M0UCPU]KT
MK1EGU5+YM/N+?[0/)MY%^\[2 <Q@8.0,G<*=X?\ %NHW7B^?PUJ\6F-<K9_;
M(Y]-N#(FT.$*,&&5;)!^E $O_"%7W_0\>)O^_MO_ /&:1?!EXX)7QSXE.#CB
M6W_^,UI^,=>'AKPEJ.J@;I88B($Z[Y6^5!^+$5Q7@*S?P/XI'ABXN?-CU:Q2
M^C<ON!NT4+< ?7Y7_"@#H_\ A"K[_H>/$W_?VW_^,T?\(5??]#QXF_[^V_\
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MVH_^ 5K_ /&Z/^$>\0?]#MJ/_@%:_P#QNNFHH YG_A'O$'_0[:C_ . 5K_\
M&Z/^$>\0?]#MJ/\ X!6O_P ;KIJ* .9_X1[Q!_T.VH_^ 5K_ /&Z/^$>\0?]
M#MJ/_@%:_P#QNNFHH YG_A'O$'_0[:C_ . 5K_\ &Z/^$>\0?]#MJ/\ X!6O
M_P ;KIJ* .9_X1[Q!_T.VH_^ 5K_ /&Z/^$>\0?]#MJ/_@%:_P#QNNFHH YG
M_A'O$'_0[:C_ . 5K_\ &Z/^$>\0?]#MJ/\ X!6O_P ;KIJ* .9_X1[Q!_T.
MVH_^ 5K_ /&Z/^$>\0?]#MJ/_@%:_P#QNNFHH YG_A'O$'_0[:C_ . 5K_\
M&Z/^$>\0?]#MJ/\ X!6O_P ;KIJ* .9_X1[Q!_T.VH_^ 5K_ /&ZD@T'78[B
M.23QC?S(K M&UG; . >02(\C/M7144 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ><V%EXS\.:[XADT[0;"_M=2U!KN.2
M74/)8 JJX*[#_=K4&E:YJ?BGP[KE_96]HUK:7D5U#'<>8$:0J$VG W9"Y/'&
M:?=_$?1[75+W3DLM8NIK.7RIS::?),JM@'&Y01T(K9T+7[?Q!;RS6]IJ%LL;
M["M[:O QXSD!@,CWH XX^#-7/P/'A/;#_:GV81X\SY,^;N^]]*-:\&SP>,=0
MUR'PSI'B*WU**(207I19+>6-=H*,ZL-K*!D<'(KT>B@#RV^\#:U+X7T^ Z;I
M#[-2:]O=&L@+6WFC(PL>Y5 <K\IRPYQST%7O#?A34K#Q[%KG]A:7H^FG39+0
M6EDZED8R*P9R% ).#TSC Y->B44 <EXO\-7'BK5="LKB**30;>=KJ_1VYE95
M(C3;W&22?H*RO$'PWL+2.QU/P?I-C9:SI]Y'<1E!Y8F0'#QL?0J3^5=OJ>IV
M>CZ=-J&H3K!:P@%Y&S@9( Z>I('XTW^TX/[;&D[)OM!M_M.[RSY>W=MQNZ;L
M]O2@#SKQ1X2UO77U*UN_#.CZE/.[_8-9,XMY;5#]P. NXE/8D'':D!\0:-\4
M$@T^"+6)H/#=M%=+-/Y+S$2N/,#$$9SDD'U/->IU7%A:+J+:@+>(7C1"%I]H
MWE 20N?3))Q[T >;WOPZU/5=#N[V]73WURXU=-6^R2YDMOD78L#$CYALR"V.
MIK0T/PW?GQ!%?KX5T#PW!;P2*IMH8IIY)6&T,'5%VJ 3WR<X/%=^QVJ3@G S
M@=36=H.N6/B/1X=4TYV>VE+ ;U*L"K%2"#T((- 'G$W@K7=5OM.>Y\/:3I^K
M6UU'+/XALK@(TJJV6(C502S#C#<<FNU\+:)>:3J?B2>Z"!-0U(W,&ULY3RT7
MGT.5-3'Q?I?VZZM(_M,KVM[%8RM%"642R#(&1V&1N/;-;U !1110 45S.N>.
MM*T'6ETB>WU*YO3;BY\NRLWGQ&6*@G:#CD&IM \9:/XBNY[*T>XAOH$$DEI=
MV[P2JA. VU@,C/<4 =!1110 4452M-3@O;Z^M(DF$EDZI(7C*J2RAAM)^\,'
MM0!=HK/O-:L[#5]-TR=G%SJ)D%N N0?+7<V3VXK0H ***J:EJ=GH]B][?SK!
M;H55G;/5B% X[DD#\: +=%%0W=W;V%I-=W<R06\*%Y)9&PJJ.I)H FHKBU^*
M&@8CGEM]6@TV1@J:E/I\B6S9. =Y' /J0!71C7+%O$ T178WC6GVT +\IBW[
M,Y^M &C15+5-3@TBS%S<),R&1(\0QEVRS!1P.V3R>U7: "BLCQ%XDL?#-E#<
M7JW$K7$RV\$%M$9)99""0JJ.IP"?PJW_ &C$NC_VG+'-#"+?[0Z2IMD1=NXA
ME[,!V]: +E%<-'\5M DM%O#9:XEDR>9]J;2YO*"==VX*1C'>NRLKVVU&R@O;
M.9)[:=!)%(AR&4C((H GHHHH ***SVUJS7Q#'H99_MTEJUVJ[?E\M6"DY]<L
M.* -"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFZ"ZCJ,6HRD%?ED0H0HX^[\@Z\\GFB_\%&76+O4])US4-'GO@HO%M1&R3$#
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M @.%3:3M8#/0U[<#D X(SV-<1'\-8!:P:7+KVK3:!!(KQZ5(Z;,*<JA?;O9
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MVX9#;3C)&=N1G@XK%> S:;X3V:YX8A@6\MVT[^S;"7[02/X1B1B 1D-D8]:
M/5V\1:(FH1V#:O8B\DE,*0&X7>7&,KMSG(R./<5IUY]X$TNPE\2>,M0EM(9+
MM=<=%F= 64+&A&">G+'IZUZ#0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &9J7
MAO0]9F2;4]&T^]E085[FV21@/J15W[';?8S9_9X?LI0QF#8-A0C&W;TQCC%3
M44 5QI]D'M7%I!NM 5MSY8S""-I"<?+QQQVI!IMB(;B$65N(KEF>=/*7;*S<
M$L,?,3@9)JS10!1TS1-*T6-X]+TVSL4D.76V@6,,?4[0,U#:>&]"T^_>_L]&
MT^WO'SNGAMD1SGK\P&:U** (8+2VM6F:WMXHFF<R2F- ID<@#<V.IP!R?2IJ
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG_ !IXBE\+
M>&)]6AMTG>.6&,1NQ .^14ZCTW9KH*X;XO\ _).+S_KYM?\ THCH [FN5\)^
M-[#7]!TV[O;JQL[^^#E+,W"[SAV4;03DYV^E=57A-KH&DI^SA=:B-/M_MQBE
MN/M/ECS1(LQ"D-U&  * /:[_ %73M*C634;^ULXW.%:XF6,$^@+$4^34+**W
MCN)+NW2&7_5R-( K\$\'.#P"?H*\JGAU34_BOJB>5HD\T>G6QLX]85V_=,I,
MC1 <??R&/TK&_LN"?0]'TV>ZL+[3W\9JGD62N+>)3&^^%=X&4SNZ9'S$9H ]
MF;7='33EU%M5L5L6.%N3<((B?0-G'ZUF>*?%":)X1EUZP\B^020JA63*.'E5
M"0P]-Q/X5Q'B#3)8OBKI>F:=9:'%9Q:4\EA:W\16W\XRGS3&J#'F8V_@2:P=
M;M$M/!'CJ&YOM--H;^Q,]KI:R+#:N98_,VEAC)&TD*3@YSB@#VNUUC3+Z2:.
MSU&TN)(/]<L,ZN8_]X \?C4PO;1K+[:MU";7;O\ /$@V;?7=TQ[UY]K5CH^G
M^,O _P#PCL%I#=232(1:*H#V?E,6W;>JYVX)[]*Y]HI(II_A6H81S:N)$QP!
MIK9G8 ^Q5H_QH ]G5E=%=&#*PR"#D$50CU[1YM0.GQ:M8/>@D&W6Y0R C_9S
MFFZ]=V^F>&]2N[A)3;6UI))(L!VOL5"2%(Z' XKQ;6X);3P?X:NUTOPYI-D]
M[9R6"02-->'+J<^9A1G&2QYSS0![?>:OIFGSQ07NHVEM+,<11S3JC/\ [H)Y
M_"B35],B@6>34;1(6WD2-.H4[?O<Y[8.?2O/]&M]"NO%'C<^*([%[Q;L+B]"
MG;9>4NS;NZ+][.._6N1\+Z=IVK:9\,[.:%;G3WO-481S#<'56D9=P/7D X-
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MQ]TD9.,<U<\6^)K7PCX>GU:Z42"-D1(O,"&1F8+@$^F<GV!KD-8L/#]E\4_
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M-KJ&KII+VM[9WSV8O!%=1A"8]Y0]">0>H]Q0!N.BR(R.H9&&&5AD$>AK M_
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M>H"1HE1<A5C +,QSP.0/J13=>U^Q\.:<+V_:0J\BPQ10H7DFD;[J(HY+'TH
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M&>348],DM9H=LL$[\J'&>!CG()'I6CJ'B2UL-8&E&WNI[QK*2]2.! V]$(!
MR1\Q+# _6@#16QM$OY+Y+:);N5%C>8*-[*"2%)]!D_G4!T/2CIDNF'3K;[#,
M6:2W\H>6Y8[F)7H<GFN \/>,[G6O!OAO4-5GU&SNKG5HX#)# BI<LS/A.O\
MJ\#!/7*]ZZ&_^(.G6E[>P6^FZMJ,=@Q2\N;&V\R*!@,E22020.2%!Q0 NO\
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ML7E(05<;(U4=!N &>PZ]JV+30;BW\=ZGKS2Q&WN[*"W2,9WAD9R2>,8^8=Z
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MKK >-48)A9HF!&\%1AAZCJ*T?A)%.O@83SRM,;J]N9TF9-AF5I6P^.V[K^-
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M%'8^);6*"WN;GSWMT,D+>7OR<@$GN:]PN;F&SM)KJX<1PPHTDCGHJ@9)_(4
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MQ5T    8 [5Y!JNJ7'B;QA:V$5GJ>N:-#H\%Y'#:7BVOGM(3B:3+H2,   <
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MW)#A2=SG/ XQGU(KS/6K+4KV]TR[GTZ\U_2DTF /966I&":WE/)E*!E,A88
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M2^TR\AN[5\A98FW#(ZCV/M6?-K/V/Q#?17>H6$=A:Z>MT\1W":/YFW2,>FS
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MZ[C_ +/'7I6C<:OIUKI\-_/>1):3%!%*6^5RY 3'KG(Q]: ,?5?!&F:IJ_\
M::W&H6-TT(@F:PNF@$T8Z*^.N,GD8/O35\ :!'X<30H[>6.TBN3=0-',RR02
MEBP9''*D$G'MQ723316T$D\\J10QJ7>1V"JJCDDD]!6'I?C?PSK6H+8:=K-K
M<73 LD2L07 ZE<_>_#- %+_A7FBR:?J=K=RW][)J4:PW-U=7)>9HU.0@;^$
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MH6H:-&LOV2_:=IP7^8F;._![?>.*JWW@?2KV+3=DEY9W.G0"WMKNTG,<RQ@
M;"P^\.!P0:Z2B@#ET\ :"NA7&E/%<2K<SBYFN9)V-P\P((D\S.0PP,8IUCX&
MTFVFN9[N6]U6>XMFM'EU&X,Q$+?>0=  >^!DUTU% '*:?\/M*L+NRF:[U2\C
ML&#V=M>7C2Q6[ 8!53W .!G..U=7110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7#?$S;%;>'KR[7.E6FLP37Y(RJ1X8!F_V0Q4FNYIKHLB,CJ&1A@JPR"*
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M9#/;%!Y;*[2+N4#(V@'!!]:;X=TRU74_AG#YLE[:JNIS6[W-MY)VD*5PA+8
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MMV0#]0% _"O;1#$LK2B-!(P 9PHR0.@)IGV2V^SFW^SQ>0>L>P;3SGITZ\T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNR7]I/8RV&I:=*L5W:2LK["R[E8,O#*1R#^E &[1110 4444 %%%% !1110
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MHW>#9 V.=NHPD9]J .GHKF?[=\3?]"=-_P"#&#_&C^W?$W_0G3?^#&#_ !H
MZ:BN9_MWQ+_T)TW_ (,8/\:/[=\3?]"=-_X,8/\ &@#IJ*YG^W?$W_0FS?\
M@Q@_QH_MWQ-_T)TW_@Q@_P : .FHKF?[=\3?]";-_P"#&#_&C^W?$O\ T)TW
M_@Q@_P : .FHKF?[=\3?]"=-_P"#&#_&C^W?$W_0G3?^#&#_ !H Z:BN9_MW
MQ-_T)TW_ (,8/\:/[=\2_P#0G3?^#&#_ !H Z:BN9_MWQ-_T)LW_ (,8/\:/
M[=\3?]"=-_X,8/\ &@#IJ*YG^W?$W_0FS?\ @Q@_QH_MWQ+_ -"=-_X,8/\
M&@#IJ*YG^W?$W_0G3?\ @Q@_QH_MWQ-_T)LW_@Q@_P : .FHKF?[=\3?]"=-
M_P"#&#_&C^W?$O\ T)TW_@Q@_P : .FHKF?[=\3?]";-_P"#&#_&C^W?$W_0
MG3?^#&#_ !H Z:BN9_MWQ-_T)LW_ (,8/\:/[=\2_P#0G3?^#&#_ !H Z:BN
M9_MWQ-_T)TW_ (,8/\:/[=\3?]";-_X,8/\ &@#IJ*PM/U;7+F^CAO/#4EG
MV=TYO(G"<''RJ<G)P/QK=H **** "BBB@ HHK&U34]9M+ORK'P])?P[0?.6[
MCCY],,<T 9/Q3M+J^^&.OP62LTQMMVU>I56#,/\ OD&M_2-2L+_0K34+&:,V
M$D"O&X(VJF/TQT/IBL:77/%A7%OX-4OGGS]4C1<?50Q_2N+G\%75Q<22M\-]
M/197WR01>(Y8X7;U,:QA#^5 &3;R-=Z'-Y4LD6A>(/&K(7C8H);9NN".0KNF
M/S]:Z?Q+X2\):18ZY:V2I:S7.BSR'2XN(91%\RS%,<,K  -D?C5V\3Q)J&BG
M1[GX?:.^G% @MAK&U% Z8 AXQ@8QTJCI>C:WI NOLW@&P=[N+R9Y+GQ"\[O'
M_<W/&3M]AQ0!EV.D:?<?\*]\.SP+'HM[IKWL]LI*I=W BC(#X^]C<6QWJ+Q)
M9VWA^[\:Z%HZ^3I,GAE[V6T0_NX)]S+\HZ+N7D@>F:TQX;U1=#BT8?#VP^Q0
MR^="I\1R%X7]4?R]R_@14UIHFM66E7^FQ?#[3C!J"E;QI/$#O).",?-(8BQX
M)[\=J *&H^'](\,Z#X2UO0D$>K27MG$+I')DO5EP'5SGYP5)/MCC%9MIIUYX
MIU+Q/>W_ (7LM9ECU.>U6YNM4,#VD<9PBHNP[,##;@>2<UN:=X=U72=1BO[/
MX>:>LT&?(#^(9'2#/7RT:,JF?8"DU7PYJVLW\U[>?#^Q\^X4+<&'Q')")P.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY5E(R"*FKFOA_IRZ5X%TNS2"]@58V=8KXJ9D#.S8;:  ?FZ8XZ5TM !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!6U"PM]3L)[&[0O;S
MKLE0,5W*>H)'.#T/J*L@8&!THHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBLG7M"77K>*)M3U.P\MMV
M_3[HPLW&,,1U% &M17E7@7P]<:M-K,]YXH\2N=-URXM(4_M-]K1QE=H<=^O/
MK717/Q"B22_EL-!U74=-T^1HKN^MECV(R_?VJS!GV]]H[=Z .SHJO8WUMJ=A
M;WUG*LUM<1K+%(O1E(R#7FGASQW?65IK[W.DZSJMO8:M>"XNXRK+;Q"0X50[
M!FVKSA0<#% 'J=%<QJ'C:S@?3H-*M+G6+S4;?[5;6]GM&8>/WC,Y"JO(&2>3
MQ5[P]XCMO$$5TJ6]Q:7EG+Y-U9W*@20OC(S@D$$$$$$@B@#9HKE-?\<1:)KZ
M:'!H^I:GJ,EJ+M(K-%.8]Q4DDD8QC]0.]-N_'.V_N[73- U35?L&!>R6HC"P
MMC)0;G&]P",JN>M '6T5YWK/CNYEUOP;)H-M=WNEZHTLC^0(QYX$3X3YV!4J
M1N/3IC)/%=9IGB*UU5M86&*9?[*NGM9MX'S,JJQ*X/3##KB@#8HKAY?B;8_8
M]#EM-(U.\N-:MGN+.VA12YVD9#?-@<'.>F :D?X@E]3N-*LO#6KW>I6T,,T]
MN@C7RED0-AF9P 1G&,Y)!QG&: .THKDQ\0M)?PS8:S!!>3-?S&WMK%(A]H>8
M$ADVDX!!5LDG  ZU-IWC2VGN+VSU:QNM&O;*V-W+#>%"# .LBLC,K*.AYR#0
M!TU%>5^)_'M[>Z/I,UGI6LZ9;7VI6@M;Y]JK/&9%R"%8LH9<D!@,BO1M;F2W
MT'49Y'GCCCM979[<XD4!224)Z-Z>] %ZBN&M_'5K8VF@:;:6&L:K>7^E1W=L
M#L:61<*/WCE@ V#DL>.O<@5N^&O$T'B2WNRMI<V5W93FWNK6Y #Q. #V)!!!
M!!!YH W**P-;\4?V7J4&EV>E7NJ:E/$TXM[;8H2,'&YG=E4#)P.<U)X:\2P>
M)+>[*6ES9W5G<&VNK6Y #Q2  ]B000000: -NBN'N_$NK0_%NTT*.QNY-.;3
MFD;9Y6TL9$'FY+;MJ@E2.N3P#UJKIOCO3M*T+2@D6N:D^I7EU!;B7;+.TB2-
ME2<@;<C"^@QG&* /0J*X:'XC/<3WEA!X5UF35[(@W5BHBS$A *OOW[2"#P 2
M3@\=ZNO\0-+?0M(U*QM[N]EUC(L;*%!YTA RV<D!0N/F).!0!UE%<#KOC%[S
MP;XJ@6WOM&UO3M.DF:"9E$B HVV1'1B&&0>0>"*VO#_B2&\O(]#F2=;^'3K>
M[\R7!$Z.,%E.<G##!SW- '245E:#KUOXAM+BZM(I5MXKJ6V21P,2^6VTNN"?
MER"!]*PM0^(*6VK:MIECH.JZE<Z45-W]G6,*B,@<,"S#)P2 HY.T\4 =E17#
MV_Q-L;D:;=QZ1J@T;4)H[>'4WC18_,<X *[MX&[Y=V,9]1S5_4/&4L.J7EAI
M?A[4]6>QV_:I+?RT2,D;MH+LN]L8X4'K0!U-%<=-\2-*73-"OK:SO[M=;WK:
M101 R;U'*L"1@YXSG P23CFG6_C^V-GKKW^E7^GWFBVWVJYLYMA=H]I8,C*Q
M5L[2.O6@#KZ*XNU^(L$]UI?GZ'JMIIVJR+#97\Z((Y'894%0Q90W8D<U/>^.
M1'J-]:Z7H6IZNFG-LO9[01[(FQDHNY@78 C(4'&: .MHKC;_ .(^FVZZ.-.L
MK[59-8MWGLDLT!+A=N0=Q&T@,2<]-I[\5U,-X'TR.]N(I+4&$2R1S8W1<9(;
M&1D=\>E %FBN''Q(C6"UU&X\.ZO;Z)=2I'%J4@CV_.VU69 ^]5)(Y([BK6H>
M.Q;7^HP6&@ZGJ<.ED+?7%KY>V)MH8JJLX9R 02%% '745#:745]907<.[RIX
MUD3<I4X(R,@\@\]*Y'_A8D3"2\AT'59]%CN#;-J42QLFX/L)$>[S"H;C.V@#
MM**YG5/& M-:ET?3-'OM8OK>-9;E+4QJL"M]W<SLHW$ D*.2*YSQ%\0+B2Q\
M-7F@6=]+%>:LMM=1A8UD!7=NMV#L-KDCZ84\\C(!Z316=K%_<6&@75];V<T\
M\<)=;>,KOS_P(A>.IY[=Z\Y\#^)3HW@NPU+4HM>O]6UET6&":X$[7;[2Q:%=
M^(TP3G.W  SVH ]7HKD[;QW;E-5BU'3+[3=1TVS:]ELI]A:2$ G?&RL589&.
MO!ZUR_B'XE:E<^&X=0T70-8M[>>YM1%>RI$JS1O( 0H9L_,,J#CN#D=: /5*
M*\VE\6:G:?$FZM8]+U6]:;1[>:/3(G3$+EWWEB6"*1P"03DXQFNQ\->(K7Q/
MI37MM#/ T<SV\]O<*%DAE0X9& )&1[&@#8HKFM7\7K8ZT=&TW2;W5]12(3S1
M6I15A0]"[NR@$X.!U.*IS?$G1X/#T&KFVORLE^-.DM1#^_AN.?D9,]>.V>HH
M [&BN9T;QB-2UY]$OM'O]*O_ +/]JBCN]A$L6X*2&1F&02,CKS6?\0?$>J:!
M+X=33;2ZF%WJD44WD>7^\3!/E#>1AFQP>F%.2,\@';45YK;^+=3L_B#XKLHM
M*U;5C&MG)%:0NFVV4PY;EV"@DGH,DD'TK>_X6#I3^&].UBV@O+A]2D,%I8QQ
MCSY)02&3:3@;2K9).!CKTH ZRBN?T/Q4FJZE<:5=Z==Z7JL$0F:TNMA+1DX#
MHR,589X.#P:YKXH:IJ4,^@:39V^J^1?7RK/+ITZ1/*H5SY2L6!!. <\# Z]J
M /1:*\^@\5:7X5LO$-U<2ZW<0Z9<VMO.EU*)C&72-1Y?.<?,"V3DG)YJ^?'T
MBQVD3>&=734[Z61+73Y!$DDB(JLTA)?:J@,!R<YXQ0!V5%><>+O'=_'\/M3U
M#3-,U&QU*UN4M9DF2,-;DLN6R6*LI!P"N>6'3!([^QN)+NRBGFM9;21URT$Q
M4NA]#M)'Y$T 6**X*'XHVUQIDNKP^']8?2+>1H[J]"1[82K$$[=^YU&,DJ#@
M>X(K8U/Q>MMJ$.G:5I5[K-Y);BZVVIC5$B)PK%W95Y[ 9- '2T5R,?Q#TMO#
M4NKR6M]')%>'3VL#$#<&ZSCR@ <%CGUQBET_QRMQXCMM U#1-1TS4)X9)U6X
M\MDV+CG>C$'.>@Y&.<<9 .MHKB/^%E6AMCJ@T75#X>$GE_VOL3RL;MN_9NW^
M7G^+;7:/-%' T[R*L2J79R> H&<Y]* 'T5PZ_$NU^RQ:I+HFJP^'Y7")JTB(
M(L$X#E-V]4)QABO<5E&^U'6?C+)8SP:W%8Z=;Q/$D%TL<.=[GS9%5\NK;0 ,
M$^H% 'IM%<5\0_$>J:!_PCZZ;:7,PN]5AAF,/E_.G)\KYR,,_8]/E.2.^5;^
M+=4M/B%XHLH]+U;5"L5E)#9PNFVV!B)?)9@JDDC@$DD>U 'I5%<2_BS3-;M_
M"NHP3:K;QWVH&&.*(B/]XJN&CG4]5!4\#N!3F^(D1\V[AT'5;C1H;@VSZE$L
M;)N#["1'N\PJ&XR%H [2BH+QBEC<,I(81L01V.*X+PSXS:Q\!>%EN(K[6-;U
M*VS%!$P:67;RSLSD *,C))[T >B45YWXE\?W*^"?$,UA87UCKFFQA9K>98R]
MMN!*R_>*LG!P03]*9<>,=<7Q;X1LAHVHQ6][;SO<0,8"TA 4!B=YX7.X\\AA
MU(P #T>BN.N_'\<=Q?FPT+5-2L=.D:*\O;58]D;+]\*&8,Y7OM!HU/XB6-I>
M6%IIVG7^KSZA9"]M5LD4B2/.,Y8C''//TZ\4 =C15:6^BMM,>_N@T$4<)FE#
MC+1J!DY SR/;-<I#\0QYFFRWOAS5K'3=2FC@M;V<1;2S_<W(KED!]2.] ':4
M5R=]XY2#5+ZST_1-3U2/3B!?7%HJ;(6QG:-S NP!!(4$C/K5%_BAIS:9H5W:
M:7J5W)K:SFRMX8U+L8B 0?FP.N<]  <T =U17)3^.&^U16%CX?U.^U/[,ES=
M6D?E*;17'"R,SA0YYPH)/%/;X@:0/#L.KI%=R/-<_8X[%8O])-R"082A/##!
MSDXP,YH ZJBN8L/&<<]W=6&I:5>Z7J-O;-=BVN"C>;$.K(R,5.#@$9R,BL9/
MBO8FPL-4ET+68M(OBL<-ZT2$&4@D)L#%SR"H.,$],CF@#T"BN7TKQK#>ZK>:
M9J6EWNCW=M:_;=MX4P\&<%PR,P&#U!Z52A^(]N\5M?SZ)JEMH=U(L<.JS*@B
M.XX5F4-O5&)&&*XY'2@#M:*Y"]\>"+7M3T73M U34[[3O+-P+<1A%5T#@[F8
M#O@#J2#Q6)K/Q"NKD>$+[0+&_GLM3NF$J(L2O)M5P83O888,N3T'R]>Q /2J
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X_P"'^GWF
MGIXF^V6TL'VCQ!=SQ>8N-\;%=K#U!QUK!T:\U7P;H%_X;D\-ZI?723W!LIK:
M#?!<K*[.I:3.$QNPV[ICO7IU% &#X*T6?P[X+TC2+EE:XM;94E*G(W=2 ?0$
MXKB-(U+6-!TGQ%I4GA75I[J[U*]DL6BM\Q3"21MI=\X09/5NV",UZK10!XS-
MX(N?#U]H%S?VNKW]E#HL>G7+:-/*LL,RL7SMC8,R'<1QG& <5V'P^TI;2;6-
M131[_3X[R6-8VU&ZDEN9T12 SJY)3DD 9SCKVKMJ* .2&GW?_"WCJ7V:3['_
M &"(//V_)YGV@MMSZXYQ7%/X?_L+7O$(U/2O%-V+V_EOK.;1KF<12+)@[&6-
MP$8'(RP&1CGBO8J* /*CH]]X=L/ EY'X>NQ%IMQ<R75E9.UU)!YR/CDG+?,W
M)[<^U6[6XU3PWK'BRP_X1_4[R35+UKJQGMH@T#[XU7#OG"8*\Y_#->E44 >5
M^$="U2TO/ #7.GW$0LM(NHKDO&1Y+MLPK>A.#73Z!I]W;_$7QA>S6TB6UTEB
M()67"R;8W#8/?!(S76T4 >*OX1U3_A'=%O9M-U&0:;K%]+<6EK(T-RT,KN \
M9!!)'!P#R":O6_A-/$$FM+I^D:U9QRZ3+9PW^M74YD:23^!8Y&)"< ECCGI7
MKE% 'DVK:AK.L^&-$T-/"FK17MK>61O6D@Q%$L4B[F1\X<9'\.>,DXQ7HWB.
M&6Y\+ZM!!&TDLME,B(HR68H0 /QK3HH \X\+:/J-KXE\*SW%E/'%;>%%M9G=
M"!'-NB^0^C<'CVK:\*V%W:>*O&%Q<6\D4-U?1/ [+@2*(4!(]1D$5UM% 'GG
MC$ZJWC"WCNQXA_X1TV>4_L,/N:XWG(E*?.!MQCH*=\,=+N]+N?$HN=+O=/AN
M+Y9K=+N0R.T9C4 ER6W-QSR<'BO0:* .)U5+RQ^*^DZH--O+FRGTU[ S6T6]
M89&E1@7_ +JX!YKF_#F@:M;2^"#/IUQ&+34]3EN-T9'E*_F["WH#D8^M>M44
M <EH-A=V_P 1?%][-;2);726(@E9<+)MC<-@]\$C->>V_A'4H/"_@F_O=,U6
M1-,2ZAOK2RD>*ZC65R5=0I#'&!D Y(->WT4 >/MX?:]TCQ;=Z9X?UJ+S='DL
MK:;5+F:2YN6(+%%BD)*J#C!."23CO5WQU#J>A:+X<\0:5$1JT$ TMHB=K.)X
MPJCW*RA#CZUZG6+>^%['4?$-GK-W+=RR6>#!;-.?LZN,XD\OIO 8C- $_AW1
MH?#WAW3](@Y2T@6/=_>8#YF^I.3^-<]HNFWD'BCQU<2VLJ17DL!MW9<"4"W5
M3M]<'(KM** /+%T/5!\(/"NG?V?<?;;:ZLFF@V'?&%F!8D=L#DTFHQZK=>)M
M:BUVS\4W:>?C3+;2Y'AM)(=HV[I$*@-G.XNW':O5** /(_">@:O:67PXBNM-
MN(GTZ>_^UAD.(=RR!23Z'(P>^:TO$^C:E=:WXVE@L9Y([OPVMO;LJ$B67][\
MB^IY''O7I5% '!:_I5_/X9\%P0V<SRVFIZ?).BIDQ(@^8MZ =ZY@^'_[!UGQ
M FI:3XINS=W\U[9S:-<SB*59#NVL(W 1@<@E@,C'->R44 >:>'_#=YI>O^#,
M:0UG;VFG7HGC25IDMWD96"F0]2<M^N.*] U4WHT>].FA#?B!_LP?[IEVG;GV
MSBK=% '@^JZ5JFK^%+<-I?C"_P!=22"6\:_>188F5U,GEQY"/R" %4X'/&*W
M_$^FH?$6K73:!XCLM68C['J6@,Y6Z7:-OFX^4,#P=P''>O6:* ,OPVNJKX:T
MU=<96U06Z?:BN/\ 68YZ<9]<<5Y3J6F7\,M])HF@^(]%\4O<L4_LYV;3[AB_
M$CEOW>TKR00#G/%>U44 >2:IX?DTWQOK&HZOI_B"[M=32"6*?0YIALD2,(Z.
MD; ]0"I(Q@XS39=#OM-\*:)?V_AR_B,/B-=4N+))FNKGR]KKO;<22YRI(!.,
M_6O7:* *=X6NM%N#'&X:6W;;&RX;)7H1ZUYK9Z/J^D:!\/M9_LJZN)-$MY(;
MVQC3]^JRQA2RJ>I4J..N":]6HH \OU.UU/Q7JNM:W!H]]:6D/AZYT^V2[A,<
MUS-)SQ&>0HP!SC)/%6_$&E:B?A%HEM!I]Q-=V2:?++:Q)F7$31EU"]R,'CVK
MT6B@#B]&ANKKXD7VM-875O9W6C6RHUQ$4(?>Y*$=F (R*G\"6%W8+XD^UV\D
M/GZ]=SQ>8N-\;%=K#U!]:ZVB@#@I7O?"?C[7-5ETC4+_ $[68K=DEL(#,T,D
M2E"C(.<$$$'IUK 'A[6KB"WU2;2YX9=0\7V^I&TQN>WMU 4-)C(!PN3Z9%>N
M44 <E>V%V_Q6TK4%MY#:1Z5<1/,%^57,D9"D^I /Y5#\1;>\:TT&]M+"YOAI
MVLP7<\-JF^3RU5P2J]_O#BNSHH X_P ,VEVGCOQ=J,UI/!;7HL6@>5"N_;#A
MA]0>#Z&N$_X1'5!X;\.7UQIFI2#2]2OWNK2TD:&Y,4TCX="I!)'RG /()KVN
MB@#SOP;I,#>+I]5M=%UJVMHK/[.EYK-U,9I&9@2BQ2,2$& <G'/2M?QC87=Y
MK/A*6VMY)4MM6$LS(N1&GE2#<?09('XUUM% 'DNOZ!JUS;>-EBTZXD-WK%A+
M !&3YJ*8=S+Z@;3GZ&NC^(-C!>OI9O\ P]>:G8QM(6NM.9_M5F^!M9 A#%3R
M#CT'!KMZ* /'KC2?$M_\.?%5DL6L7=FTL#:3#JF#>,B,C29[XR#M!YXKU?3;
MW^T=.@O!;7-MYJ[O)NH_+D3V9>QJU10!XOX:UK4)_A9=>'[/PYJ5S=W9O+:U
MFCB!MW$DL@+O)G";23D'GCCK6E>Z?JVFZK9:1JG_  DDVAVFEV\%H=#W@2RJ
MNV3S63# G QD@8KT70]%L_#VE1Z;8*ZV\;NZAVW'+N7//U8UHT >*Z7X<UBR
MT"2Y71[B"YL/%9U.#3[B;=)/"8PNU78D.^"><G)4\UK7NHW/B?XF:+;OI-]I
MD!TN^C1[Q%21BP0,=H)( ^7!/4D^E>A:[H-CXBT[[%?I(46198WBD*212*<J
MZL.0P]:I:+X1L-&U&34OM%]?:A)%Y/VJ_N#,ZQYSL7/"C// YH \IL_#3VOA
M>/P]=^&?%%UK"+]E:);^X73Y1G&_S ^Q4*\XQGMBO8=0TG[9X5NM&C81>=9/
M:JV2=F4*@YZG%:E% 'DMU/K>H_#>/P.OAC4HM7-K'I\DLD.+1 H"F7S<[2N!
MD <YXQ74Z/I5W9_$G5;EH)?L9TJT@CN&7Y79&?(!]>1^==C10!QOQ&M[R2PT
M2\L[&YO1I^LV]Y-#:IOD,:[@Q5>YY'%+X9M+L>/?%FI2V<\%M>QV#0/-&5W;
M8FW#Z@G!'8UV-% 'DNE:#JT5AX5233KE6MO$EU<3 QG]W$QFPY] =PY]Q5#4
M],OHI]0ET70?$>B^*7N7*'379M/N6+_+(Y;]WM(P2" <YXKVFB@"K,DS:5(D
MF&G,!#;!P6V\X_&O'(?"=_::3X,U._TS6)8+33&LKVWTZ62*Z@8L&5@J$,PR
M""!['!KVVB@#R!_#,VH>&?&,VF:#JMN]W8BVM7U.ZE>YNMH)(V2,2@!X&>3G
MM6O=W5[-KO@CQ FA:O\ 9H(KJVN(3;?OH&<(JETSD+E2<^E>D44 >*0>'6T!
M=6T[4-%\57ETUU-+9R:9=SK;7*.Q9=VQPL9YPV0.F>:Z?PYX=N])\::&?[,:
MUM+;PX]NP1VECAE,R-Y>\]3C/Y5Z)10!F>(FU1?#>I-H@4ZH+9_LH;'^LP=O
M7C.?7BO(KW2KW4K30IX-+\7WNH6VH6D]]-JCRA(@K@OLC)"MS_=4@ 'FO<**
M /.M+NM3\(ZKXBLX]"O=5CO]1EOK2XL]C)ND"YCE)8>65(ZGM6#X!L+RYL_A
MI?I:NUO;V^I&>55^2(N1MR>V><5W6H^ =+O]0O+M+S5++[<0;R&RO&BCN#C&
M64=R!@D8S70V%C:Z9806-E"L%K;H(XHTZ*H& * /,-<\/_V?\0-9U34=/\0W
M6GZHD#PS:+/,#&\:;&21(F!YP""1CDU0NO!EVWAG3=1@T'4;<0:Q)?W&GQW\
MC7DD+KL+[]V1+@*VT-ZC.<U[-10!Y7I.BQ7FLW=[8:#KT<,&FS1)=ZS=3F1I
M'&/+CBD8DC Y/'.*FDT34S\,O!%B+"?[5:7NG/<0[#NB5&!<L.V.]>G44 <!
MXC\/7VM>.-02.*2.VN_"UQ8"Z*G8LKR< GUP<X]*XZ#PZ+G0++0I_"_BB;5,
M16]S%<ZA<+8*%(#/Y@<H4P,@*">@Q7N%% ')>'-/N[;Q[XRNYK:2.WNI+0P2
MLN%E"P -@]\'BN*M-+U?1_"?@^[ET;4)VTS6;F>YMH(=TRQNTP5@G&1\RGZ&
MO8J* *%KJ3W.JWED=/NX4MEC9;F5,1S;@3A#G)*]#5^BB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N4
MO_ 5C?S7P.IZM!97\ADN["&X"PS$_>SE2RANX5@#75T4 ,BB2&)(HD"1HH55
M48  Z 4^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
7 **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>separationagreement009.jpg
<TEXT>
begin 644 separationagreement009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K:A?VNE:?
M<7]],L-K;QF261NBJ!DGBJVAZ_I?B73%U'1[Q+JT9B@D4$<CJ,$ BO-OCMKT
M,&BZ9X::[6V_M>Z47,S'B*W5AN8_B5^NTUE?"37-(TKX@^(/"FCWR7.CW;?;
M-.=22 P WH,\YP?_ "'0![/%J%G/=7-K#=0R3VH4SQJX)BW9QN';.#UI;*^M
M-2M1<V5S%<V[,RB6)@RDJ2IP1UP01^%?/WA;1O$4E_\ $M8O%#1/;O(EV_V)
M#]J?]Y\V,_)P&&!_>]JU? =QK.A_ G^THO%%C8QS,PM&O8 $LP)I ^" 3(S'
MD @X]* /=**\3\'^-]7B^(L&CS>(+S7-(N;&2X\Z[T[[*P90QR@(!*_+UZ<^
MU2^&[SXB^.M#D\5Z5XEM;(M=,EKI4ELI@\M6 (=\%L]>Q/';/ !ZH?$.E+XB
M7P^;M?[5:#[0+?8V?+SC=G&.WK6G7BNNVNM7_P ?;.WT_4(M,OI-" FN4B\[
MRQN;=L#8!.< $]CG%0Q>-_%-EX$\>PW.JB?5/#UXD%O?^0@9E,NWE<;>@/8]
M?:@#W"BO#+[7?B!IEYX-G'B:"=_$Z",P/8H(K4L$PPQRQ'F9ZC)7T.*T=.\9
M>(?"VO>-M)UK4_[;31K!;VWFDA6)BQ52%(7MEP/PXH ]BHKYZTSXD>([=-'U
ME_$<VK27=PHOM'&DO''#$Q/*2[ "5&.A[]\5U3:EXQ\1_%'Q3X:T[Q(-,L+*
M.&2-Q:)*Z$HORKG'!+$DG)XP,4 >IWU_::99R7E]<Q6UM&,O+*X55_$U8!R,
MU\S>*->U[Q9\$8;_ %345:2RU=K2X585'VD@ HQ(QM*Y(X'.>:^B=#M+ZQT:
MVMM2U$ZC>(I\RZ,(B\SDD?*.!@8'X4 5?$/BS0O"D,$NN:C'9I<,4B+*S;B.
M3PH/YULJRNH92"I&01T(KYW^(FJ:%XN^)FIZ;K.K0V=AH^G2V]JTA.'O&'7C
MT) /^Y7I'P9\3_\ "2?#RS663==Z?_H<V3R=H&P_BI7GU!H ]!HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ6.A+I($TUM,XD)!D"D[0<DD+DXK;\.ZGX]T'P[I^DGX9+<?8X%A\XZE"I?
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU]_X'2__ !5>AT4 >>?\*4\%_P#/M??^!TO_ ,51_P *4\%_\^U]_P"!TO\
M\57H=% 'GG_"E/!?_/M??^!TO_Q5'_"E/!?_ #[7W_@=+_\ %5Z'10!YY_PI
M3P7_ ,^U]_X'2_\ Q5'_  I3P7_S[7W_ ('2_P#Q5>AT4 >>?\*4\%_\^U]_
MX'2__%4?\*4\%_\ /M??^!TO_P 57H=% 'GG_"E/!?\ S[7W_@=+_P#%4?\
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MA1)YL[R9VYQC<3C[QKHZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+#4=;LK6ZX)BEE *YZ;O[N??% &Y16;JWB'1]!M8[G5=2MK2&4XC:60#>?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF%BP,G^\<<_C5>'PC\0K>-8X+KP=$BR>:JIII4!_[P '7WH 3X4_\CK\1O\
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M-(03\SH"-R!MA(SVKO'@ADFCF>)&EBSY;E063/!P>V:>Z+(C(ZAE88*D9!%
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M6=<=,,1D58\B'[1]H\I//V;/,VC=MSG&>N,]J )**** "BBB@ HHHH ****
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MSTK3\.>(K7Q+ITEU;Q302PS-;W-M.NV2"5?O(P&1GD'CL17*0W&HZ!XOU/Q
M= U2[T_7K:VDV6\2M/:RQH5\N1-W<$<@D Y^M:W@72]0M4UK5-3M39W&KZ@]
MVMJ6#-#'M55#$<;L+DX]: +$_C.RM1XE^TP2Q-H""28$C]ZC1[U*_7!'U%1V
MGCFRO=*\.WL%M.S:Y/Y$4'&^,@,7+>R;#FL#QOX9U34/&6G/I]LTFG:JD5KJ
MS+P$CAF656/U&]/QIOA7POJEG\1-1>\MBFC:8]Q+I;G[K-=,KOM_W<,O_ J
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MM[?[1]H%L2+RS<R,49,,"01UP?3K0!Z7X?UM];MIVGTR[TZYMIC#-;W*CA@
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M5CV*#))(Y &6X[DFLO4;#5?%6I:WK:Z/>6-O'H%QIUI#=*$FN)9/F)V@G"C
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M_M. 7NHM"D*2",K*JR!DF'\2@J>/7!J2Y^(3*;^YT_P]J.H:3ITKQ75]"T8
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M&/0,3G/;H*R=,\72^'/!&BV%O=PV,VIZK?HU[-"95MXTF=F8(/O-RH Z<\T
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M/K62*VD%E,!/KCZ*!N'#J6&_Z?)TZ\T .LM"\53:G8S:UXC@DM;)BPBT^V:
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M;633]+NH)XO+LBLLXB8$"5MY'08X R<$],5Z%10!!>VJWUA<6CL56>)HB1U
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MR27EX%VM)(YSO YP1A<?[HKLJR/$>OQ>'--CO9H'F62YAMPJ$ @R.$!Y],T
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M7D=S&L%D4:X*@C=(2Y^;![ #D^U=Y5);V=M:DL38S+;I LHNR1L9BQ!0#KD
M _C5V@ HHHH **** "BBB@ HHHH **S]<UBU\/Z)>:M>[_LUI&9)/+7+$#L!
MZU>C<21JXSA@",T .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XOXCR-':>'&5RH_X2
M&Q#$'''F<Y]J[2L_6M$T_P 0Z7+INJ6XGM9""5W%2"#D$$8((/<4 <OJ\Q_X
M6[HL(D/_ ""+MF0'_:3!Q^!KSN'0+.U^!-IXM1K@Z_;Q1SPWQG<O'B8*%'.
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M%M=>&/%:RKIEOX;TF2PG>\M5U-)]^P;A,D77*\@D Y!&:[J7P=H,^EWVFS6
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MP_N_[0]:R+&YU'POH_@[2]2N;;P]FRGD;5;JT662$M)N6W4MPAVD9S_=QVH
M]*M_'7AZYT:_U5;UX[;3CMO!+;R)) ?1HRNX=?2DT[Q[X=U35XM,M;V0W$X8
MVYDMY$CN-HR?+=E"O@>A^E>274C7.B?%%UO;W4!-:631W5U"(WN  P+*H51M
MR, @= *]%\80A-2\""./"QZLB@*/NKY$G'L.E &E9>*+"QTG5M1U378I[:UU
M&:W,GV8Q>20V!"%QEV'3(!W5;TCQ?HNM27$-M<213VT?FRP7<#V\B)_?VR '
M;[]*\GOK.\.DS:@DMS;VMAXTN[BYFMX1*\"9($NQ@00I(['KFMK3#8ZYXK>[
MBUO5?%0M-,N$E>*W@CA*.,>2714W.V,@9XQVYH [33_B!X<U._M[2WNYPUT2
MMK)-:2Q17! SB-V4*WX'GM73UXEHVKBSNO#MEX>U^;6;=KJ&-M!U*S5[BP3H
MS>8 "AC&1SQZ>_KUCK-AJ5[?V=I,7GL)!%<J49=C$9 R1@\>F: *>M^+=%\.
MW5O:ZE=/'<W*,T$,<+R/+@@$*%!R<L..OY&H8O&_A^70[O6/MQCM+)Q'=>9"
MZ20-D##QD;@<D=JYOQ?J^G:'\4_#%[J9V6ZV-VOGE"5A),8W-CH.JY_VJY7Q
M4ZZYHOQ#U[3D=])NK>RMX9@A"W4D;_.ZYZ@;@N>^/:@#TB+X@^&9=)GU07[B
MSBF$&]K>0&5SRHC&W,F1R-H-7='\5Z/K@NA:7+I+: -<0W4+P21 C(+*X! P
M.O2N1^)MI/!>^%=4CNKBPTW3KF07%S;0+*;;?'M20HRL-H.03CC=7/M8'Q1<
M^(I-'U_4M?O/[!ELUO3!#%;DN<B$,BKN?C/<#)YH Z'7_B=I\D&G)H%])YUS
MJ5O"LDEHZQSQ-*%D\MG4*W!ZJ?>NEU?QOH.B:@]C=7,[W,2"2:.VM99S AZ-
M)L4[1WYKS[7/%6A:OX6\+:58AGOX-1T\26@A8/9%'56W@CY,?=]\\<5'Y[>'
M/%WBE-6\77GAYKJ^-W!BTBD2ZB*@+M9XV)9<%=H/;@=: /3;_P 6Z'IVCVVJ
MSZ@C6EV5%LT*F5IRW("*H)8^P%16?C7P_>:7?:B+\006!Q=BYC:%X#V#HX##
M/;CGMFO.--MH?#,7@;6[J/48]$MC?>9)?0@/:M/RCNJ#"*?F XX##.*L>-+^
M#Q=HVI7GAW3Y)+6RO+.:YU2U@5FNT1B65 5_>>6,'G(H [_1_&FB:Y??8K2>
M>.Z,?FI#=6TD#2)_>0.HW#Z56MOB'X:N[Z"UBO9<7$WD07#6LJP329QM24KL
M8Y&!@\]JXO3Y[+7_ !EH<EOXIU3Q++9B:?\ =6L$<5N#&5(E8(I&[.W;G.>H
M%8UGJL>E6NGVOAG6KBZ(NXXQX3U6T$LT!\SY@&QNCV#)!.0,=: /3]2\?^'=
M)OKBTNKJ<M:D"YEAM)98K<D9 D=5*KP1U/'>K6K^+M%T3[*MU=/)+=KOMX;6
M%YY)5Z[E5 3M]^E>:Z_?6.D:QXC?3_$5WH.H/,[S:3?VJW$&HL4 #QH021)@
M#Y3GU Z5I6.KC0/&5IKWBFW72X=2T&WACD9"(K:526> G^#J" ?3'44 =H/&
M_AP^'SKAU-%TY9A!)*R,#'(6"[77&Y3DC.0,=3Q51?B/X:DLH;F*XNY//D>.
M&%+&9II"H!8K&%W%0&!W8QSUKSK6(QJ^F^*M:MK>3^Q]4UK31:[XRHG",BR2
M!3_"Q[]\5UOQ!;3(->TFZN]3U#0;I895M]9@"F!<E<PR@@CG&1G XZT =EHN
MNZ=XAL/MNF7'G0AVC;*,C(XZJRL 5(]"*T:\[\(>+/L7AO6-5UZY@DTZVOMD
M6K0631"]#;5\PQJ#D[CMW#@X]LUZ%(S)$[*A=@I(4'[Q]* .5G^)/A>WG=9+
MZ;R$E\E[Q;25K9'SC!E"[.O&<XJWJ_C;0=$U%M.N[J4WXC646T%M)+(R-G!4
M(IS]TYQT[XR*\:U?7)=6^&>H0OKIM[MHI-WAG3--2,6V&)99/E+A0,L6RHKT
M?0E63XK75P%# ^'K0+)CL9')P?P% '0IXT\//X:/B$:E&-,!VF4JP(;.-FS&
M[=GC;C-85CXY36OB'8:5IT\JVC6$\MS;W%JT,JR*R;"0ZA@,,<=C^%<>89+>
MVN]4>WEDL-,\<SW=VB1EBL6,>9M')"E@>/KVKHK77M*\1?&'2KG2)!=0Q:3<
M1O=QH?+8[XR$#8Y(ZG'3=0!V^M:]IWAZS2ZU*<QI)((HU2-I'D<]%55!+'@\
M =JSH/'7A^?2M1U'[9)%#IH!O4FMY(Y8 >1NC*[N>W'-9OQ(731I^F3:E+J-
MFD5X&CU.QQFQ?:P#OP?D.=IX(YYQ7%2W>K:]X8\;:=;7L7B.W73E,.K060A>
M9^2825XD*J,Y'KCO0!ZW>ZUI^GM8+=3^6=0F6WMOD8[W*E@.!QPIY.!6/J7Q
M \-Z3?SV=S>RE[8@7+PVTLL=N3T\QU4JOXGCO7'ZKXLTCQ)J'@:#2)WNC%JL
M,D[)&VV ^4X"N2,!CD\=?E-+HGB+2/".E^(M&\0(?[2;4+N;[&\19M065B4*
M#!W[@0O?&.: .WU;QGH>C3P07%S)-<3Q>='#:0/<.8_[^(P2%]SQ23^-O#T&
MAVFL'45DL[QMEL88VD>9N?E5%!8MP<C&1CG%<?I>K6/A/QKJ=[X@@71;;5-/
MLC8^8O[N$1H0\ 8# *DCY>_:L?6KCS]5\-^)X([KPSH@>]C%W#:(QC:0C;,Z
M,A"B4 \D9&1D\T >EV7C'0;[3+W4$OA%!8?\?8N(VA>WXS\Z, PXZ<<]LU'I
M/C;0]9OQ8VT]Q%=-&9HX[NUEMS+&.K)YBC</I7GD,&F:M%XMU*2ZUSQ/:-I\
M=M<7$,$42S@-NQ%L5=[IR<X/ISP*FT/699/%&FV.FZ__ ,)AITD,_FK/:+]H
MLD\OC,P Y8X7#8)_D =M9_$+PU?7UO:P7DW^DR>5;3O:RI!._P#=24J%8\<8
M//;-2:KX\\/:-?S65U=3//;J&N1;VLLPMU/(,A12$XYYKS#3=6334T>T\-:Y
M<7Z_:XH_^$7U6S$D]J-V&P^ T?EC)!.0,=:Z70/$6D^"[WQ18>(YC9WDVK7%
M[%YD;'[7#)@H8\#YSCY=HY&* .MU;QQX=T6VL;B\U)?+OXVDM#%&TOG@;<[=
MH.3\ZX'?/L:KW/Q$\.6HCS<7<A>!+EA!8S2&&)AE6D"H2F1S\V#7">%M)NK#
M4?AG#?VCP2(FJS+#(O,"OAD4^A"L..W2KWBBYT[3?&NJ7$?B6]\*ZG)%$7DG
M@6:UU!0N 50@Y*_=."#Z#O0!Z?97MMJ-C!>V<R3VTZ"2*5#D,IY!%+=W=O86
M<UY=S)#;PH9))'.%51R237*>$?$JCPWX:@UJW33M3U1)%@M8K=D1MF3D#&$R
M@#8..M7?'][/IW@35KJWTZ'498XABVFB\U&!8 EE_B"@EL?[- #=-\?>'M4U
M*VL(+BYCGN@3:FYLYH5N !D[&=0&XYJ"\^)7A6QFNHI;^9VM)7BNC%:32"W*
MG:=Y52%&0>3P>V:X"[U1=1\2>#Y$\63>(%358RY@LTBMK?*, "57(8DX +$X
M!XKI/#, 'ACX@9BYDU?4LY7[PVX_&@#K-5\7:+H]O937-VTGVX;K2.VB>>2<
M8SE%0$D8(.>G-97@WQ4WB;7O$HANA/IUI/ EI^[V%0T0+@@@'.[.0>1C%<=X
M?O(?#=[X.UW66,&ES>%HK%+IU)2"<%7(8_P[EX!/]W%=%\/[ZUU3Q;XUO[&-
MUM)[NV:-FC*>8/) +@$=&()![@Y[T =/K?BG2?#\L$%]-*;FX!,-M;P//*X'
M4A$!.!Z]*Y[7O',-QX4CU7PY>Y8:G;V<WF0E7C+2JKHR. 5.&[CO5'QCKDEA
MX\MK274[3P[;-IQ==7DLTEDG;S.8%=QM4# ;'.21Q7%0LTVC>(SYUY<EO$NG
MR":[A\N65"T>'*A5P#C(X'&* /5O#FL7NH^*/%5E<RAH-/NXHK=0H&U6A5B,
MCKR3UJ]KGBG2?#SV\5_/)]HN<^1;P0O-+)CJ0B G ]<8K$\'JP\;>.200#?P
M8)'7_1TJEJU_:^&?BM_;6M-Y&FW>DK:07KJ3'%(LI9HV;^'<"",]<4 2>*_B
M+8VGP]O]=T*Z\Z=2;>(FW<F*;N)%VY0@<_/@=/49Z+PM-._AN&YNM4N=39]S
M_:)[+[,Y )&/*VJ1C!QQD^]>6:\3JOACXDZ]8Q2?V5J!M$M'*%1.T>U7D4'J
M"2!GOBO;5^Z/I0!Y5=?$ZZO/ WB75+)S;7>G:B(87>T=%$'GI&"?,&-Q4MD=
M1GD"NSTKQSX?UG54TVSNY?M,B&2$36TD0G4=6C9E <?3Z]*\PU.ZMW^'_CS1
M7)^W1Z^TTENR$-Y3W<>UNG((KO?%<?\ Q7_@0JOW;F[&0.@^SM0!=N_B'X9L
M;^:UFOI/]'D\JXN$MI'@@?\ NO*%**?7)X[XJ6\UZWT_Q+<BYUE$M+?2&OI;
M,6Q8JBN<S^8!R,#&P<]Z\CTR1=&\'WWA_6?%FJ65^C7$,^BQ6$+O<EV;_5EH
MRSAPWWL]^H K;U6Q>QNM0M-EQ^Y^'LD/[_!D!!88;'&[UQ0!Z1H'B[1?$\ER
MFD7+W MPI=_(=$(;."K, &Z$<>E0:OX[\.Z'JATR^O9%O@$8P1V\DC;7SAL*
MIR/E.3VXSU%6_"4:P^#-#C1 BKI\ "@8Q^[6L'3(1_PN/Q!,4Y&E6BJ^.Q:3
M(S^ H T-1\?^'-*OY[.YO)2]L0+EX;666.W)Z>8ZJ57\3QWJSJWB_1M'-JD]
MQ+-+=1^;!%9P/</(G'SA8P3MY'/2O)[*?_A'H-?TS6?%VH:1=&^N96L$L89/
MMBR,2KQEXR7W@@=>#QQ6C<VFF:%;^&5GU;6_#-[%I7E6^J7"1LA3<#]GF7E=
MPX.#CZYXH ]"E\=^&H="M];EU1$TZXF^SI,8WXDY^5AC*GY3U J?1O%NCZ]=
M36EG-,EW"@D>WN;>2"38>CA74$K[BO*[W7)YO"6BZAK$$=S;6_BZ,I=6UF8O
MMT05SY_E#J2<].NVMS5KJ/QSXMCE\+3^>EGHU[!/>Q@B/S)E BCW=R""V.U
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MZ#2  #   ]JQ/#FIZQ?BZCUC3H+=X67RKFTG\V"Y5AG<A(!&.A!'XFMR@!,
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M'@544'MDD<]A3-3N_$<OC_P1%KVFV5N#=SR1RV5PTB@^0^4;<HPP]1D'GTH
M]0  Z "C SG SZUYV_Q"U6[MK[5])TW3)M'LY)$"W%]Y=S=+&2':-=I &0<!
MCDX[9JQ>^.]3O=7TW3O"^E6]\VHZ6NI12W,YB5$+8^; )[@<=S[4 =X0"02!
MD=*4@$8(R*\]?QSKMYJVJV>D:9I,LNE2>5+97%\4N;A@H9C$NW&WG"D]<=J[
MZWE::VBE>)X6= QC?&Y"1T..,B@"2@@$8(R*Y_QIXCE\*^''U6&R-Y(LT,0@
M#;2^^14X/KSQ5"U\3:W8^(=.TOQ'IEG;IJ@<6DUG<-*$D5=QCDW*.=N<$<$B
M@#I=1T^WU2PDLKI6:WDP'56*[@"#@X['&".X)%6J\YUCQWXDT729-?O=#T^U
MTN-^;.XO&6],>[;NV[=N>^W)X[UH:CXMUU_&,_A[0M'M;EH+:&[>XN;DQJ$8
ML".%)W<#'XYZ4 =K@ DXY-+7DNC^*?$&B:5X\UG4;>UN([#492$%T[$.%B'E
MKE>$"G(/7/;O71Q>+=?M-:T:+6M%M+;3]9E,-NT%T7F@?8742@J!R ?NDX]Z
M .WH  & ,"O/9/'VK7IU*\T73M,FTS3YI(2+J^,4]T8^',:A2 ,@@;CSCM3K
MCX@:CJ.I:59>%])@O6U+3!J,<EU.8EB7=@A\ _3CN?2@#T"@  8 P*\^?QSK
MMWJ^J66DZ;I,LVEN(YK.XORES<,$#-Y2[<;>< GKCM7>6TK3VL,SPO"[H&:)
M\;D)&=IQQD=* )0 .@I, D''(K \:>(Y/"GAJ75H[3[6T<L,?DAMI;?(J<'U
M^:L"3Q=XNMO$,&@W/A_3?MU_ T]F\=\QBB"D;A*2F> 1]T')('N #OB 1@C-
M+7 I\19K3PYJ=UJFF(NK6&HC3/LL$^4GG;;LVNP&%(8')' !JSIOC#4HO$5A
MH^O6VF*VHJ_V6?3KLS*'1=QC<,H(.,D$<'&* .U  & ,"D  S@ 9KRZ/XF^(
M#X3MO%TGARU&B&58I46[)N&S)Y>Y%V[<;N,$Y/M71:=XFUQ/%EOH>OZ79VOV
MZUDN;62TN6EV["NY'RHYPPY'% '7C:?F&.>XH(!QD=*\;\#^)?$6@?"K3=5.
MB6LNA64;><?M)%R\?F-ND5=NW R>"<D#/%=AJ/C6\N-?ET?P[#ILKVUO'/<W
M6H71AB7S!E$4 $LQ7G/0#'K0!VM(0#U .*\\G^)ER=#L+BRT99M3FU<Z/-9_
M:!MCG"L<B0#!7A3G'0Y[5+=^,_$%KJUCH$MGH=KK,UJUU*UU?.EN1YA14C.W
M<[$#)';WH [6YT^WN[RSN9E9I+-VDA&XA0Q4KNQW.UF S_>-6JS="OK_ %#2
M8I]3TUM.O,LLEN9 X!!(RK#JIZCIUJSJ%]!I>FW6H73;+>UA>:5L9PJ@D_H*
M +   P!BEKSA?B+JEMIUIKVI:;IL.AW+QY2*^WW=O'(0%D=-NT]1E0<C/L:N
MW?B[Q'<^(=?TG0]%LIO[&,;23W=TR"0/$'"J I^;DCG &!ZT =T0",$9%%><
M6_Q%UF?2M'\1/H5M#H&H3PVYW71-RAD;9OVA=NW=VSDC!XS@:#^*?$FH>)M<
MT?1-&L7727C#W-Y<LBR;XU<*H52=W)YZ  >M ';'!P#CVS2UYC)X@C\3>(_A
M[J:0/;NUW?1S0.<M%(D#JZD]\$'GN,5=3QQXAO\ 1[GQ+I6@VD_A^ R,@DNF
M6YN(D)#2(NTJ!P< G)Q[T >@T$ C!&17+Z-XQBU;Q&VG"%4MKC38=3L)]W,T
M3<-D=BI*\>AK&_X6//<:;I\EEIT#7>L7EQ%IJSW'EQFWB.#/(V.!@9P <Y&*
M /0:*X:V^(/V%M8MO$4-K#=:;9?;]]A/YT5Q#DC*Y (8-A=I]1SS5>'Q[JUH
M=-O=:T[3(=,U":.$"UOC+/:F0X0R*5 (R0#M/&>] 'H-%>?R>.M:O=7U>WT3
M3-,N5TJX:![*>^,=Y<%0"6C3:0 <\$GG':N]B<R0I(R-&64$HW5<]C[T .P,
MYP,CO2UFZ[J%WI>DRW-AILNHW8*K%;1MMW,2!DM_"HSDGT%<W8^+]6M?%UGH
M&OVVE*U]#++#+I]VTGEF,!F6164$<'@^U ';45YM<_$'Q%_PBUUXMLO#]I+H
M*([PJ]TRW+Q@D"4KMVA21G&<XYK2O_&M]-J\.CZ+:Z>;P6<=W=3:A<F*&$/]
MU!@%F8X)] * .V(!() R.E! (P1D>]>?3?$N:/PX;Q=)674H-5CTNYLX[@,O
MF,1@H^,$$$$$@=>>E7;;Q/XEA\0_V#JNDZ;%>W5E)=6$D%V[1,R$ QR$H"/O
M#D _2@#=U_0(]>.E&2=H?[/U"*^7:N=Y3=\I] =W6M@ #H,5Y#X6\::OHGPN
MT*[OX[2:XU"[-M;7-U>,J#<SL7G<K\O*D8&<\<UZ!X<U36;][J'5].MH?*V-
M#=V4_FP7*L#]TD!@1C!!'?@T ;N!G.!GUH(!ZC-+7!:=XYU>^N]7NY-)M;?0
M-'NKJWO+M[@^81#N.Y$QSP%SD]3QTH [VBO.%^(NJ6^G6FO:EINFPZ'<O'E(
MK[?=V\<A 61TV[3U&5!R,]\&M&3Q3XDO_%&MZ+H>CV+C2FBWW-Y<LBR;XPX4
M!5)W<GGH !ZT =M28 )( R>M>?3_ !(O)]-T&32M%$M_JMS-9O:S3[?L\T8.
MX,P'(!4Y/I[\5/<>,=<&IPZ#!8Z2FLQ6JW%_)<WC+;0;B0JJ0NYF.,]!@4 =
M+XFT-/$OAJ_T:6=H$O(O+,BKDKSUQ^%:<48BC5!_" ,^N*\_F^)IA\-R73V-
MO%J<6IKI<T<ET!;Q2MR)#*!_JMO.<9[5J6WBS4=/TS5+_P 1V%JEG8VWVF.^
MTZX\Z&X7G*KD A@0!Z'(YH Z[ SG'/K00",$ CWKSZ'Q[JUH=-O=:T[3(=,U
M":.$"UOC+/:F3A#(I4 C) .T\9[U*?%_B?4=0UZVT30["1-'N6A>6ZNV3SL(
M&"H I^;D]< <=<G !WM%>5W7BC6=>\3?#_4-)A@CLM1@N)O(GN77+B/YPX52
M#M!^4]R3TZUNZSXG\3VG]IW=IH^G0:=8,RAM2NVADNPHR6C 4@ ] 2>?:@#M
M@ ,X&,TH(/0UY?>>(M9UGQEX"O=+B@2PU&RGN1!-<NN<HA?> I!*AOE]23TJ
MSIGBJ'26N)+?2(K>QG\47&GWDJS,Q$C'"S'/3<V 1P!D4 >CT 8&!7(:OXZA
MT?5M;CFM]VGZ+IZ7-W.K?-YKD[(@.F2!G.>XJA!XYU>RN]+?7=/TR&RU*=+=
M/L=\99;61_N"52H!!/!*G@T =-JN@1ZIK>B:F\[1MI4LDJH%R)-\93!/;&<U
ML  # &!7GJ^.];U#4=571=+TVZBTR[>VDLGOBE[-L.&=4V[0.N,GD#M7H*MN
M16*E<C.#U% "T@  X %<[XS\2W'A?2[.ZM=/^WS7-]%:) )-A8N2!@^N:HP>
M)-8M]<CT+Q%I]G;RW]M+-9SV4[2(Y0 O&VY00P!!ST(H [ 8/S#'/>@@'&0#
MBO,_!6IZQ9_#/PE:Z+I<=U-<6S%[BYE,=O;*N3ER 22<X  ]:M+\1;VWT?Q4
M][863ZCX?CCE<6ER9()U<$KAB 0>"""* /0Z*X:/Q?K]IJNB_P!L:+:6^FZS
M,(+=H;HO- Y0LHD4J!R ?NDX]3W[F@ I, D''(Z4M% !1110 A /49I2,C!H
MHH  ,# HQD8-%% %>]LH=0L)[*;>(9XS&^QBIVD8(!'(X]*FCC2*)(XU"H@"
MJHZ #H*=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5S/C30K[5[/3KK2S%_:.EWJ7MO',Q
M5)2H(9"1TRK'GUQ7344 <):6'B?5?'ECKFIZ7;Z=8VUA/;+ +H32!W*'<2 !
M@[< #ICGK5+PSX,UC2SX#^TQQ#^QK6\BO-L@.UI  N/7I7I%4=9UBRT#29]3
MU&4Q6D&#(X4MC)"C@<]2* .$UOP9+#XSU+7(_"VE^)+;4XXM\-T8TEMI47;E
M2ZD%6 &>^10O@K6+;1-*OK2RT>VUG3]2?4%L+1!#;LC*4,6X#EMF!O(ZCTYK
MTFB@#A;_ $_Q=XITO7H+Z&WTNUNM,DM+6P,RS%IF!_>O(HX'10 3W)[54BT?
MQ1:W.A>(X-)M_P"TK.Q;3;S36O!^]ARI5TDQ@'*@X/8XS7<6^JVESJMYID3L
M;JS6-YE*$ !\E<$C!^Z>G2KM 'E^L>#O$/B/3/%6HWEM;6VIZK9Q65G9+.'$
M4:-N^=\ %B23QP/>NJ\66&J7>G6:6.GV&J6Z/_IFG7H4"X3;CY68$*P.#R.:
MV=.U6TU471M'9A:W+VLNY"N)$.& R.1[CBK-Q<0VEM+<W$J101(9))'.%10,
MDD]@!0!YOH6D:CX+LO$^O0Z5;:7:- LEMH_VS?&KH"6=F^ZI;(&%]*]%LYI+
MBQMYI8C%))&KO&?X21DC\*=;SPWEK%<0.)(9D$B,.C*1D'\JEH \CUWP7KVM
MB6WG\.:6-9\\F'Q+;7 @9%WY5RBC>7"\8Y&>]=!?>&-4G\8ZQNMTGT?7=*6Q
MN+H3!9+<JD@SLQ\V=XZ'BNSO-0M-/$!N[B.'SYE@BWG&^1CA5'J35F@#S&YT
M3QGJG@Z+P5=Z=900>5':3ZNET&5X$P-RQ8W;RHQ@\9)YK4&E^(/"WB35[S1-
M*@U6PU4QR^4UT('MY50(<[@0RD 'CD<\5W5% 'F[^ =0UW6]-N/%PM=31=)N
M+>YD554)-)("/+&!]U"0&Z\9ZFGKX;\3SZ9X<L-1,5Q)HNMQS?:S*,SVJ(ZJ
MY']_# $>V<UZ+10!QFN^$KC7/&%S<R;4TVY\/W&F22!OF5Y)%/ ^@)K%NM$\
M9:SX1A\&7NG65O;[([:YU9+L,KPH1DI'C<'8*!@\#)KTVJ8U6P::]B%Y#OL0
M#=#</W(*[AN/;Y>?I0!PNK>!-1U.[\7O$\,#7T]C<Z;(S9'F6Z+]\#D#<N/H
M<U/):>+M>\5>&[_4-&M=-LM+GDDG47@F>1FB9 RX PH)[\\]!BNYM+J"^LX+
MNUD66WGC62*1>C*PR"/J#4U 'D$/@"^T6UO-*MO!?A_5V>61K+5KORP8U=B1
MYRLI9BN>V<@ <5UVE^&+W3O&VGZALMOL5MH/]GLT""-?-\U6^6,?=7 /TZ5V
M-% 'F/BOPMJVLW>IPWGA32M8,S$Z?J8G6VEME(PJOQN.T\Y!.?05TVG7.IZ+
M=^'/#EP4OBU@WVF\,A\S?$JC=M[@D]3W(KJ*,<Y[T </\6C.O@1C:E!<"^M#
M$7^Z&\],9]LTR32_$OB;Q!I=YJMA;Z/;:3YLL82Y$[33LA16& ,(N2>>3QQ7
M97VGVFIVWV>]MX[B'>K[)!D;E(*G\" :LT >(3_#G7+GP;=Z.?"VE?VW(C";
M7+F[$KW!W9W(2I<,W3D@#/X5Z-I6B7]OX[U'69XT6VN=.MH$PX)WH7+ C_@0
MYKIW<(C.WW5&35;2]3M=9TRWU&R=GMKA-\;,A0D?0@$?C0!YUJ7A/Q%-I?CK
M18;&W>WUF9[RTN_M(&781CRV0C(QM)SG%=1XDT.]U.\\+RVRH5T[45N+C<V,
M((W7CU.6%=110!Y(/ 5YHS:G96_@O0=;%Q<2S6>HW9C#1"0DA90REFVDG[I.
M1CI73:/X5OM,\8:9?,EH+6VT(V,AMD$2><95<[8QT7@UVM% 'F7BOPOJVLWF
MI0WGA32M9\YB=/U(3K;2VRE<!7.-QVGG*DY]JZ33;G4]#N?#7ARY*7S/8L+J
M\,AW[XE4;MO4@DXR?4>M=31CG/>@#FO'>BWFO^&&L+!4:<W5O+AVVC:DR.W/
MT4T7VBWEQ\0]'UF-4^QVMC<02DMR&<H5P._W372T4 >9ZK\/M0U6P\1HR6AF
MGUN/5+%+CYXI0B(-D@]&PP(]ZLZ#X:NO^$ELK[_A"]!\/VMHKM(T212SS2$8
M78RJ-BCDD]3TQ7H=% 'FJ^"]8'P8MO#'EQ?VG')&S+Y@VX%R)#\W^Z*Z74]%
MO+KQ_H>L1*AM+.TNHI26P0TFS;@=_NFNEJC-K%E;ZS:Z1)*1>W44DL,>TG<J
M8W'/08W"@#S33O#OC>/X=Q^")M-L8TEA:WDU,7898H6)W QXR7 ) P<=#D5;
MU/P&VG^*+G5+;PQIGB.RN[:"%H+QHUEMWB38"K.I!5E R.#D5WVMZW8>'=*E
MU+4IC%;1D E4+,6)  "CDDD@8%5]'\2Z?K<SP6HNHYXXEF>*XMGB958L!D,!
MS\IX_P : ./MO!>JI8^'R;#2;.6WUT:C<6UA&L4<,6QU"Y &]@"H)QS^%:?C
M'2-1U'4H]_AW3?$6CM!M-K.R1S02Y^^KL.A&!@$$8KI]2UBRTE[);V4QF]N5
MM(,*6W2L"0..G"GD\5>H \]T.VU?P'X0M8)+>&62YU=4CLOM+.+2":0*(T8C
M+E!S_P!]'H,UV>MZ7'K>@ZAI4KE([RVDMV<#E0RE<_AFK^,U2U+5;325MFNW
M9!<W"6T6U"V9'.%!P.![GB@#S"S\#:D+&QTA_!'AB">%HTN-9:.*59(U(RRQ
M%-V]@._ )/-=GI&A7MGXF\77TJH(-3>!K8ALDA( AR.W(KJ:* /.5\':N/A9
MH&@&.+[?93VLDR^8-H$<H9L'OP*K:;?^(K+X@^-_[(TB#4H&N;?*/="!HY/L
MZ8)R""I'7'(QT.:]"@U6TN=5O-,B=C=6B1O,I0@ /G;@XP>AZ=*DM]/M+6ZN
MKJ"WCCGNF5IY%&#(0-H)]<  4 <'I7@74],N?"4DDD,\EE=WEYJ4B-A?,G1_
MN \D!F ^@S4%GHOC'0O"EQX.T_3;*YMMLL%IJKW801PN3@O'C<64,>G!P*],
MHH \H\>>'I=(\-^%;+1+Q4U:V*Z/ S?>ECFB,;G ],!_0;:U_%/@-9H?#<VF
M:98ZBFA(T TV^QY=Q"R*I&2" XVJ02,=:Z*WM?#^H^++J_BLH9M8TY5MY+LQ
MY,>X%M@;ID!N<<@,/6MZ@#S.#P'-J]CKT$^@:/X<M[ZR^R6\-G%&\P;.XO)(
M@ QD+\H]*KZ?X/U%YM,M9/ WAG3GMY4:[U-8XI1*J]?*38&#-CJV-OO7JE%
M'EOBKPIK&MW&IP7?A72M3GF=O[/UA;A;>2V4CY!)@;R4/H3G':NML+S4=+U7
M1/#D^R\']FEKB],A\PR1[%+%?1BW4GK6OJ&L66EW%C!=RE)+Z?[/;@*3NDVE
ML<=.%/)J]CG/>@#EO'^BZGKWAG['IA#N+F*6:V:8Q"ZA5LO$7'W=P[UR^G>"
M[T>,=#U.#PMI>AZ7:)<13P6\J-,_F1[=SE0 1G  R3R37HE]JMIIUQ907+LL
ME[-Y$ "%MS[2V"0.. >35V@#P_4[C6],^#6H:79-I5WH<5O)!;ZN+H[I(2Q
MC\K;_K.=G7%=#J/@FXBU^+7!X:TWQ!%<V$%O<6=X462"2,8#H7!&"#@C@\ U
MUX\#^%QJW]J#0;'[;YGF^;Y0^_\ WL=-WOC-6;SQ1HUEI=SJ4MZC6EM<"VFD
MC!?;*7";>.^Y@#Z?A0!Q:^"M5?0+*,:9I%A<?V];Z@]I8(L:0P1N#M+ #S'
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M,>;L?#Q[5!4?>&WD<CTK?\/:QJ%WI/C.6XNG=[+5;R&V8X_=HB*5 ^A)I%\
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MW*/WHD"@EO3&WM0!S$/BG6;[PEI.AK=M'XFFU0Z3=3H!N3R6W2R@8QS&H/\
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %-DECAB:65U2- 69V.
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M^C^*$O\ 5];LKKR+9;"_6RA9I,&9FC5P.?XN3P/2MY[F".>*"2:-)IL^7&S
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M29_&=F_B70=,TRXL[^#4I+A)9H)P_E&*/>!\I(R?>NFDD2&-I)75(T&69C@
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MMA;Q7R-87*W*Q@2B1IH\MNZ]&(^E;ERRZKXQ\32:9H^AEK0QP7]_KDK..$R
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MZXA^T);:?$)'$73S&)(55SP,GGM0!9O_  CX=U2VM+:^T6QGAM$"6Z/""(E
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M1(RPWLB'[S!<D"N$M;9KGX@>$[^P;Q3J=G!/.+B^U2.58XRT+!0J,JXYZL%
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MSVY$K+A(D#@%CUSV&!S7-Z&MW>V/PV5=,U")M*E:WO!/:O'Y3+:E23D?=R<
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M!(!YX^E>QT4 ><'59/$WQ*\+7]CI6IIIUG#>+)=7-H\*[W1<+A@#QMZXP2<
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M@R^7(B[0Z,JG@C&5([=:=#X.U8MX;FO=1MKBYTZ_EO+IEB\M3O1E"1J!T&X
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MUB?]1?ZO9VMQ_P!<VE!(^AQC\:9XFN9XOB+H$,<\B1/IM^S(KD*Q CP2.Y%
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MT4R*-884B3.U%"C)SP/>GT %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH-+896Z,HV'G& ?7/&.N>*IV7C?PWJ-I>W-GJ]M*EDGF7 R5:-?4J1G'OB@
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MOK>F:#:"ZU6^AM(2P16E;&YCV ZD^PH @LO#MA86NJ6\"R"/4[B6YN,ODEY
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M,WF!A+GH%Q]X_2I-/\1:-JNERZG9:E;3646[S9A( L>!D[L_=P.><4 9.I^
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M#5-#\-+;RQI=37<'FW5WB,8< NHVX.% #?K7I:Z;8I>->)96ZW3=9Q$H<_\
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M>&/"^LV$_@!KJR:,:7IUW#>$NI\IW";1P><X/3- %R+XAZS<QZG%;>#IWO\
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M-7:I:1=W=]I4%S?Z>VGW4@)DM6D60QG)XW+P>.>/6KM !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ,:*-Y$D>-&>,DHQ4$J2,'![<4^BB@ HHHH **** "BBB@ J.X
MMX;NVEMKB))8)4*21N,JRD8(([@BI** .:TSP#X<TB_@O+6RD,UMD6_GW4LR
MP9&/W:NQ"\>@KHDBCC>1TC16D.YV50"QP!D^O  _"GT4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%<GK'BFYA\>Z)X6TV.%Y;E'N[Z20$^3;KD#&"/F9N
M 3T].: .LHK@)_%GB+^Q/%UW;)HLUQH\[_9HH)?-+1(26$H5LJ^U3QQSVKKM
M!UFV\0Z#8ZO:$^1=PK*H/5<CE3[@Y'X4 :-%!( ))P!WK%LO%_AO4=1_L^RU
M[3KB\R0(8KE&8D=< 'G\* -JBL:^\7>'-,<I?:[IULZR&$K+<HI#@ E2">"
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M5Q''<"=?+9B<!0V<9SQB@#2HKGX/$MMJFJZ8ND:II%UI]P)Q*5N-TK,@7 C
M."!GYL] 1ZU8M/%GAZ_U-M-L]<T^>^4D&WCN49\CJ  ><4 ;%%8EEKBJ=0;4
M[_2DBBU VL!AGZ9"[4DSTE))^4>HJ?2_$FAZY--%I6KV5[)#_K$MYU<K[D ]
M/>@#4HK$E\8^&H+V>RFU_3([F $RQ/=(&3'7(SQCOZ5M @@$'(/0T +16/\
M\)7X>_M?^R?[;T_^T=VS[-]H7S-W]W&>OMUK1CO;66\FLX[F)KJ%5:6%7!=
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#R#0!Q_A/2M/N]<\?37-G!-)+J;0.TB!B4\E#MY[98USNE%M,^&O@/Q>"?\
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M]_;\OZXK@KSP#X@U:UDTO5+K0Y+:<A+G58[,K?7$08':<?*"0 "<GZ5Z6
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MF.1Y-HW%C>!<YZYV\?3BO9].T+1]':1M,TJQLFE^^;:W2,M]=H&:E_LO3_L
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M8CZUF^'7M+?0/A5<7C0QPBXNU>28@*,I+@$GCK7M<5G:P3SSPVT,<TY!FD1
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MHN(+ZR^+8O\ ^S+N>POM*2T%S"H9(9%D=COYR!@CG!ZUS_\ PCNK_P##._\
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MNE[(-P.WKG/K7(SZ#=7TWARYLM \32W=IJ=K<7UYJ]R[%55AN"(SD'GDE5
M'O6IJ7AS6)K7Q$J:?,QN/$]M=Q #[\*F+<X]AM/Y4 ;W_"PKM-6&CS^$M4BU
M6:+S[.U\R%O.CS@DN&VICN"?3KD5-'\1;0^'GU"33+R.]34?[*.G$IYGVHD
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M6[,"-IW9<_,",D< XQBMJR\7RV>C^'=,M;"[UG6[K2X;IX8Y%4K'L4&221R
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M@'J?:I*\G\46GBJ6[\'1ZGJ=M!>IK+PI-;VX99/W<FR8J3P2N04Z9.:]7&0
M"<GUH 9+/# 8Q+*D9D8(@=@-S>@]3[5%;:C9W=S=6UO<1R36CA)T4\QL0& /
MX$&N$^(]K?W'B+P;]CU+[)NU(HG[A9-K^4YW\]>,C'O5'2[#Q#?^.O&Z:1K4
M.EQ)=P$N;19GDD\A, [C@*/89.>HQ0!ZE17DLWQ-OIO#/A0R7=MI=YK"S&ZO
MC 95@6$[6*)W+-C&>!S6YX)\7SZIXCOM#EU--8ABMENH-02U,!(W;6C=< ;@
M<$$=0: .]) !). .I-4]*UC3M<L1>Z7>0W=L6*B6%MRY'45R_P 4]>70_ ]R
MBW*6]QJ+K80RNV ADX9R>P5-QS[5SG@'6?#^E^/;WPWH&I6UUI5]:1W5J(7!
M$<T:B.1?JRJK_@: /6**\RBUKQ?KGAG4_%NF:M:VMI$;@V6G/:!UDCB++EW)
MW!F*DC' XZU4O?B%>.?#FFRZS#I$EWHT.I7M^;3SF9G  1$P0,D,22#QC% '
MK%%<7X \57&OOJ]A<W4=^VG2QB/4(H#"MS&ZD@E#T8$,#CC@5VE !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P"1T\=_]A&'_P!$K7<UR5_\-_#6I:K=:E/;WBW5VP>=H;Z:(.0 ,X5@.@%
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M@B*W>H>7]I?<3OV+M7@\# ]* .;^%L\\W@&S6>>2=H)[B!7E;<Q1)G503WP
M!^%<^FGZY?\ Q<\6C1M>32BEM8^:6LEN/,RCX^\1C&#]<UZ)I&CV6A:>+'3X
MC%;B1Y I8M\SL68Y//4FL35OA[X>UK6)]5NX+H7DZJLDD%[-%N"C"Y",!P*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$L08"I&48D8W$<54T'QBOVS6(M:NPH'B%]+L?W1Q_JT9$)4=22W)KBQ&XL5
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MI1::.+3;I6NO*95<DH=H+ 9V]\=-U>FT %%%% !1110 4444 %%%% !1110
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M >1D9KCX=<U%_ WC2Y\2Z8E[9P:PZ&)=1?=N$T:^6&"@A$X((ZXQ@4 >RT$
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MOEU&_P!!\-I?Z38320L[792>Y,9P_DQA"#@@@9(W8XK:TCQ-_:OB34M)%D\
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MMMY/&>* +0 '08I:\^^&]O>VFM>,+?4=1DU"ZCU&,27+KMWDPH>%'"@9P!V
M%5-2M]=C^+?A2XU34HGMII[U;6RME*QQ(L#;68GEG((SV'04 >F45R.N^$M.
MU/6+K6/$UX+C28+95@M)7:.&WQDO(Q#88GCD] *P_".OOH7P^NM0G6[N;234
M)8]"@F8F>XA9@((QNY.3G&>B\]!0!Z2 !T&*6O+/"$^IZ%JWQ!NM7N?M=_;1
M6]W-C[@;[.TA1?\ 9'W1[ 5S6F3Z)<:%I>M7X\06^J7$D4TOBD1L88YF8$IR
MW^JR3']W9_.@#WB@@$8/2BO.?C&;,:'X?&HAVL#KUL+E4#$M'M?<,+\QXSP.
M: /1J*\IT&U^%DNO6*Z5IMVNH"97MV>VO% =>027&T=._%;FI_$8:-?:GI=]
MI;C5XI$73;2.7=_:*R'"%#@8Y!#==N.] '=8!ZCI17(:AXKU5=9AT'2]*M;C
M5EM5NKPSW9CM[8,<!=X0LQ)!Q\HX&:J_\+&5-%DD?2I/[;34%TO^S%F!W7##
M*XDQC85^;=CH#Q0!W-%<3<^,->T:RU>36_#B1O96#WT4UI<-);S!>L9<H-C^
MV#D9(Z5IZKXI.FV'A^Z^QB3^U[VWM"OF8\KS5)W=.<8Z<9H Z+ SG'/K2UY(
MFM:JT'Q(;7-/CNM-M=^Z%;]\@"%2(D^4;5())88P3T/6NTT/Q(L^MOH,ED+4
M1:=!>VK^;O\ -B8;6Z@8VL .ISD'B@#IZ  !@# K@H_B-+=Z9ITMAI FO-7N
MIXM,@>XV+)#$3F=V*_(N!G !/(QG-:^@>)[J^UNZT'6+"&SU6W@6Y46\_G13
MPDE=ZL0I&&&""/2@#IJ0$'."#CK7#^.)[G4O$7AWPE#=36MMJC3S7LL#E)&A
MB4'RPPY&XD D<X%9OBKP+I7A?PW>>(/"L)TG5=+A:Z26&5]LRH-S)(I.'! /
M7G- 'I=97B#1Y=:T](;?4KG3KF&99X;BW/*LO0,IX93D@J>#7+7'CW5KG5K'
M2]"\/I?7-WI,.J;I;L0HB.2""=IYX4#USVQ3KSQ?K6HC6O[%T"*[T[36DMKB
M9[O9)+(J_O!"FTAMN<<D9/ H UM'\*W5MKQUS6=8?5-06W-M 1 L$<,9(9L(
M">20,DGM735Y?X6\4W&F>!?!VD:;9+?ZO?V.]$FG\J..-!\TCO@D#)   ))K
M2N_B-/I6C:])JFDI%JNC1Q2RVT-SOBGCD;"NC[0<=<@KD$>] '?45C^'K_6=
M1M99]8TB/326!@C6Y$K%",_-@ *W8CFMB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOB=S+<VD=JT1 VJ$9F!SZ_-4/B7PM9>)-"GTN0+;K*\;&6.-=PV.K_KMQ^-
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M69 '[,#C/7KBNLB^'-O:Z!HEC9:I=6M_HI?['J"*I<!R=ZLI&UE(/(]A3I/
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M3,%OJ3QJ9X;81EV#<;3)P0&QT.>M:S^ E@M-$.EZM<6&I:19BRBO$C5_-BP
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M&52BA@WS;CQSQVKW6B@#SW0-%N-,^(&D+]@G@M;;PLMKEF,JQ.)E_=^9@!B
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-;O#/++($54<;3ECP.M 'F:_%6\MM+MM?O-7\,2VDK(TVD6T^;N&)R!D-O\
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MF[!NC<;5"JH!QUR"#SFN_H **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLTMI.6,[E5!Q$1P0ISDGMBK5QX\\*6M]/93Z_81W$&[S4:4?*5&2,],CTZT
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MPW<>H&3U/3.": +&L?\ ($O_ /KVD_\ 037BUAJ-QX.\,^&->LHF=M7T+^S
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MX>+!"D8BU;3 FU0-N>N/KDY]:Q=-FN;#6?&<5]XJTC1Y7U*:6>#4M/$KS6Y
M\M@QE7<FS@* <<^M>R-;P.D:/#&RQD,BE00I'0CT(J&ZTO3[Z6.6\L;:XDC^
MXTT*N5^A(XH P?AS:K9_#[1X([J>ZB6$F*6> PNT98E?D+-@!2 .3P!74T44
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7%WYL<1.S[YC1CN<#GGC..*Q[+POJMK<^!9I;9I+B*[NKW5)!C]W+-&Q;/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQR,D;AC@4 >A45XFGQ+U#4M*N==M_$L=I.&D>TT7^S&DC=%)"J\NW.Y@.JL
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MJ&;[H)Y/TK&A\1Q2>+;_ $)X?+^QVD5R;AG&&#LPQC'&-O7/>@#+D^'>A_\
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MW$<RR-9G[9($;<JM*7(SP 6"Y/XUUOAS6%\0^'-.UA8# MY LPB+;BFX9QG
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MSVR[F'EO']P\'G'O69JW@3PWK5_+?7NG$W$RA9FBGDB\X#H) C /Z?-F@!/
M$E[+X%TDZA?07UR(BK7,$OFK( Q"G?\ Q':!D^N:\XM/^)5K&I^*5X73O&%Q
M!=-V%M.D4;$_1MC?A7LUM;06=K%;6T*0P1($CCC7"HHX  ["LUO#&C-8:I8M
M8H;;5)7FO(RS$2NX 8]>.%'3'2@#S&$?VAXM\->)7Y.L:[.\)/\ S[1P/'%^
M84M_P.JVKV5AKNE^*-6LO"\6HP>9<EM;U>]5'C* @^2JJ65%(^4?+TYKUO\
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M (^A+(\CS<8&YV)8X[<\=JFTWPOH^D7%M/96A2:VMFM(G:5W*Q,^\KEB<_,
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MY+0+)<22)"3W1&8JI^@%-E^'GA:>_DNY-*!:67SY(O/D$+R9SN:+=L)SSRM
M'21RI+&KH<AE##Z&N%^)K"T;PMJES_R#;'6H9;MC]V-2&59&]@Q'/O77IH]@
MFMR:RMN!J$D MFFW')C!W!<9QU]JLW%M!>6TEM<PQS02J5DCD4,K ]00>HH
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M9")'4$^N  *[ZN4\$Z-+HZ:@LGAZUT99Y1(([;4'N5=CG)PRJ$^@X.?:NKH
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M7V!KRUEM+MVA)#!=DF5W*<D'(!XKG_"7C'4]%^%VAW%]%!>7^HS_ &>P#W3
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,#GFLJ#P#KLW@C2-*O=,TV6\\/WGF6\5Q*)8-0B.[<K K\F0W&0>0/P]<HH
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M_MC^P['^T-_F>?Y(W;_[WIN]^M7='UBRUW3EO]/E,ENSO&&*E?F1BK<'W!H
MR=7T6\O?'7AK5H50VNGQW:SDM@@R(H7 [\@UGWNFZ_H7C#4M;T/38-4M]6AB
M%Q;O<B!XIH@55P2""I4@$=>*[6B@#@;+PWXHT'PU;R:9=VLFL/J,FHZC;D[8
M;LR,2\2N02N,C#?[//6I;?1==USQ,VOZQ8P:<+6PEM+*S2X$SLTF-SNP  '
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M0!T%A<-=Z=;7+ !IHED('0$@&N.^+'_(GV__ &$[/_T<M=+!I$UO?V4T>I7
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MAM/M\WZ4 <Q)->>'O'VIZ\NC7VKZ;K5I;""XT^,2O"8P1L*D@A6W!L]/Z/\
MA7+=2V_B@W5N+8G7[AA &#>5N5&*9'&02<XXSFMG5O"ES=:TVKZ1KESI-W+
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MZN+B&U@>>XFCAA09>21@JJ/4D\"L\>(M&DTJXU.#5+*>S@!,DT5PC(I]"P.
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M7"1E_H"1FO+;W1-,TWX7^";VSL;>&[2ZTR47"1@2%W9-Y+=3G)S3;&UU*_\
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M+;)51PQC;KA@.A^M '.^*_$E]I&HZ-I6F06C7NJRR)'->R%(8]B[B#MY+'.
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M&!2D5T8QYB*000&ZXY/YFN0M_BMIMQIUIJPT764T6=D0ZC) @BC9CM^8;]V
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M@"Q*_P N%89QU'IQ7<G6['PKH^E6<%QJ?B&>_9OL6V19YKD8WEMY*KM (Y)
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M8E8,,J01TR#2T >2Z[8ZGXID\6:];:1?V]N_A]M,LX;B I-=.69RPC/S #(
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MF1GCMT9L-*ZKR54=A6-I7C*\M]*U?5+[4]'UO2K&S-REYIA\MRPSF)XR[8/
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MH_+AE:0@[U"*=I7&!\IX]ZU/#/A?5]-\4:QK&JW%A*NI6\$?D6J,JP^7N&P
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MXD<;#'&W1F()SW//;.*]$H X+4/%^C:7/J*6_A>YNM-TF3RK^]MH(O+@; )
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M\%Z;)K;*VHA&29UE23?M8J&W(2I)4 G!ZDUT- !1110 4444 %%%% !1110
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MDC/W6D<,-NX8.%!P#6[IGB<IX5&K>)[==#EA9H[E+AMJ!@<90G[RMU'KGO0
M'P7IG]I:O>Q3W\+:M$T=U%%=,L9) 7S%7^%\*!N%;EI;)964%K&SLD,:QJ7;
M<Q &!D]SQUK$3Q?I.J:%JE[H>H6]W+90/(R#.48*2NY3@@''XU7L/&>GV_@O
M0]:\07UM9RZA:0RD<C>[(&(1>2>O09H Y7QSI^J^(+?5-(U+P>^H7.]CHFI6
M115B! V^8S/N4@_>XPP[5Z5IT5Q!I=I%=NCW*0HLSH,*SA0&('IG-1:3K.FZ
M[8K>Z7>PW=L25\R)L@$=0?0^QJ]0!P\/PLT:V>=K;5-?M_/E::40:I)&&=N2
MQ /4^M=A8VBV%A!:)+-*L*! \\A=V [LQY)]ZX+1=5\;^)9=8FL=2T6UMK/5
M+BRCCFL9)&*QM@$D2#MCM6OX2\47U]-KVG:^+**]T294GN;9BL#HR;PWS'*D
M#.03Q0!NZ'HMGX=T:WTJP5UM8-VP.VX\L6//U)J#7_#6G^(DMOM9GBN+5S);
M75M*8IH6(P2K#U'!'0U%I'C+PYKUXUII>KVUS<!2_EHV"RCJ5S]X>XS5V'7=
M+GT1M9BOH6TU4>1KD-\@5<AB3[8/Y4 5=!\+Z?X>:ZFMFN)[N[8-<7=W,99I
M<#"@L>P'0# %69M%LY]?M=:=7^V6T#P1D-\NQR"<C_@(J[!-'<V\<\+!XI%#
MHP[@C(-<_P"-_$D_AC0$NK6*![JXN8K2%KABL,;2-@/(1R%'4T =)6=J&BV>
MIWVFWERKF73IC/ 5; #%2ISZ\$US27'CG1M0T][Z2PUO3[J=8;@65HT4EL&Z
M2#YF#(.^>:LZ+X\T_5_&6N:"LT"G3B@B8.<R_+F4GL I^7\#0!<UKP;IVM:D
M-1^TW]C>F+R))["Y:%I8\Y"MCJ!DX[CUJKJ7P[T'4=*TK3 MU:6NE-OM%M+A
MHRC?WLCDMU.>N2?6K-EX]\*ZCJ4>GVFN6DMS*Q6)5;B0CLK=&/T)JKX<\=6/
MB'Q/K>C0RP;]/D"P[6):50HWMTXPS;?PH LZ3X,M-'N)9H]4UJY,L30E+O49
M)E ..0&. >.M37/A/3;SPD?#-PUS+IY18V+S$R, P;ESR>16[7GNH^(O$U[X
MOUK1]&N],M+C3(8Y;:RNX"TFH;DW$AMZA5S\N1G!ZXH ]"Z# KF?&>DW-[:6
M&IZ=$9=1TB[6\@B!P9E *R1@_P"TC,![XK?LI)YK&WENK?[/</&K2P[@WEL1
MRN1P<'C(K@;WQ7XFNW\37VDOI%M8>'YGA:WO(W:2X*('8E@P$8(/RG!SWH Z
MC7O"VE^*$M9KQ+B&YMSOMKJWE:&> D<X8<C/<'BHM#\%:7H>HR:FLM[?:DZ>
M4;S4+EIY53^ZI/"CZ"M31M2&L:'I^IK$T2WEM'<"-NJ;U#8/TS7(Z]XGUX>,
M;G1M&NM!M+>TM(99Y]55SF21GPBE77^%<T 7)?AKH,KRQ[]033II3-+ID=VZ
MVKN3DYC'8GG ./:ME_#6ER:I=7\EN'DNK);&:-N8VA!)V[>G\1JSI']I_P!E
MP_VQ)9R7W/F-9JRQ'DXVAB3TQWZYK"\<^+YO"^D3M8:;<7^H?9I9XT2,^5$B
M#+22/T"CTSD]!0 VQ^'>BV5U9RF;4;J"Q<26=I=WCRP6[#[I53W';.<=JVK'
M0-/L'U1HHV8:G.9[E9&W!F*A3QV& .*P]4\67>G^"='U&&"*?5=5^S6]M$V5
MC,\P')QR%'S'Z#\:33=;UW3?%EMX?\1R6%S]OMY)[.ZLXFB!:/&^-E9FZ!@0
M0?PH @?X5^'YM+.E7%QJL^F 8ALY;YS%!Z;![=LYQ6KJW@S3M6U%=1^TZA97
MWE""2XL;IH7FC'17QU^O4>M8Y\=7=U\0M*T.STV:/2[AKF.2]N8RGG/$F2(@
M>=H.,MC![=,UW5 '+Q_#[P]%X<_L*.VE6R6Y-U$5F820RDY#(^<J0>G-6=%\
M(Z?HFH2ZBLU[>ZC+&(6N[ZX,T@C!SL!/"KGG '/>@>./##:Q_90UNS-[YGD^
M7OX\S^YNZ;O;.:I6'CJQOOB!J'A82P![:)#&0Q+2R?.77&,#:%'YT ;.NZ!8
M>(M/%GJ$;E4D66*2)RDD4B_==&'*L/6LW2? VDZ3JTNJ^9>WE_-;-:S3WMP9
MC)&2#@YX_A P,#KZUKZMK.G:%8F]U2\BM+<,%WRMC+'H .I/L*@TOQ+HNLV,
M][I^IV\]O;Y\YP^WRL#)W@X*\<\XH Q+?X;:%;RP+YFHRV%M*)H--FO'>UB8
M'((0]@>0"2!Z5NVV@6-I>ZM=Q*XEU1E:YRV02J!!CTX%5M(\9>'->O&M-+U>
MVN;@*6$:M@LHZE<_>'N,TR\\;^&=/U*33[O6K2&ZC_UB,_W#C.&/0'V)S0 O
M_"'Z3_PCNG:%LE^Q:?)%) /,^8&-MRY/?D57U3P-IFI:I/J4=UJ6G75RH2Z?
M3[MH?M  P-X'!('&>#[UT-M<PWEK#=6\BR03(LD;KT92,@CZ@U7UC5;;0]&O
M-4O&VV]I"TTF.I &<#W/04 8USX"T*73M,L[:.?3_P"S PLI[*9HI80WWL-W
MW=\YS2)X"T3^P]2TJ9;FY34R&O+BXG9YIF&-I+]?EP, <#'2J%_XJUC2?#FB
MI):0W'B7691';VA)2.)F!<[CUVQK@$]21VSPR>X\>Z#);7EXUAKEF\R)=6UC
M9O%-"K'&^/YFW@9R00#CTH W++PGIUG>Q7CR75W<QV)T\R7<QE,D)?>0V?O'
M/<]JH67P[T2QNK219=0FM;*7SK2QGNW>WMW'0JA],\9SCM6CK/C#P]X>N$M]
M5U:WMIW7>(V)+!?[Q R0/<\52U?Q,\&K^%8M.EMI[+5[EXWE7YPR")G!0@XZ
M@<\T =16%H?A'1_#ND7>EZ9;M%:W4CR2KNR27&#@]@  !Z8IE[XY\+Z=JATV
M\URSANU8*Z,_",>@9NBGV)%3:SXM\/\ AY]FKZK;6CF,2!9&Y*DX! [\_P J
M *4_@/1IM-TJSB-W:OI4?E6=W;7!CGB7&"-XZ@@<@Y%(O@#0QH.H:2Z7,J:B
MZR7EQ+.SSSLI!!9SSQ@<=!4^I^.?#&CSK!?ZS;0RE!)LR6*J1D%@ =H(]<5<
MOO$NBZ9I,6JWFIVT5C-M\J?>"LN[D;<?>R/3- %+6/!FG:MJG]J+<W^GZ@8Q
M#)<:?<M"TJ#HKXX..QQD>M+!X)T.UL-+LH+=XX=-NQ>PXD)9IL,"SD\L3N.<
MU0\/>-(=?\5:S:VEW:3Z39VEO-%/'UW/OWAB3QC8.,#'.:T=,\;>&=9U 6&G
M:U:7%T<[(T?_ %F.NPGAL>V: +LFA6$NO_VU)&S7?V-K$Y.4,18.05^HK$L_
MAUH=E<VSK)J$MI:2^=:V$UV[VT#CD%4/IG@'(':NL=UC1G=@JJ,EB< #UK"T
MOQKX:UK4/L&G:S:W%R02L:/]\#KM)X;'MF@"C?\ P[T:^N[V9;C4K2*_8O>V
MMI>/%#<L>&+*.Y'7&,]ZZ:TM8+&SAM+6)(;>!!''&@P%4#  _"LB_P#&?AS3
M-3.FWNL6L-V,;HV?[F>@8]%)[ XS5RWU[2[N2RCM[Z&1[Z$SVH4_ZV,8RP]N
M1^= & WPVT-ENK?SM2&G7,CR2:<MXZVQ9CDG8.V><9QGM6KI_A33-,O-.NK<
M3>;I]A_9\!>3.(<J<'U/RCFKO]LZ:)K^)KV!7T]5:[W. ( R[@6)X QS6=I7
MC?PUK=^+#3M8MI[IE+)$"07 ZE<@;OPS0 Z;PAHUTFM1W-L9H]9=7O$=SABJ
MA5(_NXV@\=QFJ6G^ -*L=9LM7>[U.]OK+<+>6]O&E**RE2H!XQ@GWSU)J?P;
MKEWKUAJ,]XL0>WU.YM$\M2!LC<JN<D\XZU/JGC+P[HMS);:CJUO!<1[=\))+
MC<"0=H&<8!.>U %[6-'L=>TN?3=2@$UK, &7)!R#D$$<@@@$$5BVO@+2H&NI
M+FXU'4)[BU>S\^^NFE>.%AAE0G[N?7K[UJS>(]%@T1=:EU2T73' *W1E&QL]
M,'N>V.M5+'QKX;U*UO+FTU>WDBLD\RYZAHDZ[F4C('OB@"2Y\+Z;=:!8Z+*D
MAL[(P&$!\,/)(*9/?[HJ:V\/V%I<ZM<1+()-5</<Y?.2$"<>G J>XU?3[6PA
MOI[N)+6=HUBE)X<N0$ ]<Y&*R?'.N7?ASPI/J=DL33QS01@2J2N'F1#P".S&
M@"7_ (1#2?[ TS1=DOV/39(9;<>9\P:(Y3)[\BJNI> M*U'4;J^CNM2L);P
M7:V%VT*W&!C+@<9QQD8-7-9\8^'O#]RMMJFK6]O.5W^4268+_>( ) ]S5NVU
M_2;V6SBMM0MYGO(6GMO+?/FHN,LI[XR,T 3Z;IMGI&FV^GV$"P6EN@2*)>B@
M?YZU:K.BU[2IHM0ECOX&33F9+Q@W$!498-Z8%9G_  D+Q>*]/LWDCETS6+4R
MV$RC!$J#<RGU#(0P_P!UJ .DHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *\@\5I=Z5XCU;PI8ATC\8O%
M);N@XB8G9=G_ +]@-^->OTQHHWD21HT9X\[&*@E<]<'M0!Y3XJTZ<>*=?TW1
MXF65?!GDV\4?7 E<!5]\<"M6Q\1>#;K1/"=E;I!J$_FP+9V=J5:6VD5>79<@
MH$YW$_K7H/E1^=YWEIYNW;OQ\V.N,^E116%G!<R7,-I!'<2??E2,!F^I R:
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M".-(HUCC1411A548 'L*X[6/"_B*XO-5&F>((4T_54V36]_;-<?9_EVL8?G
M (YVD$9H U?!<FK2^#=*DUMP^HM #*^02PR=I..,E=I..^:\P>R\(ZLWBR\\
M;7R6VN1WDL962X,+Q0I_J#&@($@Q@@D-DUZ_HNEQ:)H=AI4#N\5G D",Y^9@
MJ@9/Y5+/IUC<W$=Q<6=O+-']R22)69?H2,B@#B='3Q]JGA;0[N+4]/L)WL4-
MS%=V)=S)S\W#+MRNWC'!S4%Y_P ( _C'6T\2:?8PZJ(8C+/JI79<1[,!H0Y(
M &,';@Y%>C56NM/LK[9]KM+>XV'*>=&'VGVR.* /-O!5EXKF\&VW]@ZG;66G
MBZN39KJ%JTSM:E_W./F! QG&>Q%=;XM6X3X9:XEW(DMRNCW FDC7:K/Y+9('
M8$YXKI0,# Z4UT61&1U#(P(96&01Z&@#S3Q"#;_#_P $:LRL;;2KK3[NZ8#.
MR$1[&; [#>#]!5VXU&R\3?%/PXVCW<%[#I-I=7%U-;N)$3S55$4L.,G!..N!
MFN^$:"/RPBB/&W;CC'IBHK6RM+&,QV=K#;H3N*PQA 3ZX% '(^)?^2H>!O\
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MI(2Q>]N3<S,V.7*JO& . JJ/PR<DDU>H **** "BBB@ HHHH **** "BBB@
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M?6Q\!0^)DL9&EFD6W2PW@2&X,GE^5G'4-GMT&:PO#_AN)_%6G7EIX&_L:WM
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M/F'?WKRKQ3X>70/"-]K>K:W?R^*9'<V=S;74JYG9CY4,40.TKT!7!XW&O1-
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MG##"D D#BHI/#^H^--<U;4M0TV;1[2;19-)@CN60S.9&W-(P0D *0 !GGDT
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M7![9P/RI]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 445R.L>)[M/B#HOA;3!$7EB>\U"1UW>7 N0H'/5FXSV_&@#KJ*
M\]D\7ZVNC>+;D7_AL3:9>>3:,96\N)/,VXN.>&QZ8YJQ<^+]0TOQ%X3BOS:2
M:9KML(FE@!PEW@,I5L\HV< ?CF@#NJ**HZKK.FZ'9&\U2^@L[?<%\R9PH)/0
M#U/L* +U%<K?^-M-N/!NN:SX>O[2^ETZTEEV@[@KJA90Z\$ X]LTS1_$]]?^
M+K72I8X!;RZ##J3,JD-YKN5(SG&W';&?>@#K:*J:GJMAHUB][J5Y#:6R?>EF
M<*N>PY[^U5=-\3:'J^GSW]AJMK/:V^?.E60 18&3NS]WCGF@#5HK%T?Q?X>U
M^Y>VTK6+2[G0;C'')\VWU [CW'%0'QWX56\@M#K]AY\[;(T\X9+;BN/8Y!'/
MI0!T-%8VF^+/#^LZE-I^FZQ:75W""7BBD!. <$CU /I5?_A._"OVRWM/[?L/
M/N&VQIYPY.2N/8Y!'- '0T5C:9XL\/ZUJ$UAINKVEU=P@EXHI Q !P2/49[B
MHIO&WABWU?\ LJ77;%+[?Y9B,HR'_ND] WMUH WJ*Q]6\5Z!H4CQZIJUK:2(
MJN4EDPV&) ('4YVMT]#5W3=3L=8L([[3;N&ZM91\DL+!E/8\T 6Z*YNS\0SR
M^.-;TBX\B.RL+.WN%D((;+[]VXDXP-H[#O4NG>-_#&KZBNGZ?KEE<739V1I)
MR^.NW^]^&: -^BLM_$FBQZ+_ &R^IVRZ;NV_:C( F=VS&?7=Q]:MR7]I%?PV
M+W$:W<Z-)%"3\S*N-Q ]!D?G0!9HJEJNKZ=H=DU[JE[!:6P(7S)G"@D] /4^
MPKFM>\=6L?A,ZSX=O+.^"WD%LQR6"[Y51@0""#AL\^U '945B:QXQ\.^'[E;
M;5=8M+6=EW>4[_,%]2!R![FBYUD27FAMI^HZ:UG?R-DR.6:X386'DE>"<C)S
MVS0!MT5STGCOPK#=Q6LFOV"SRN8T0S#.X,5(/I\P(Y[BK&G^+/#^JZK+IEAK
M%G<WL0)>&.0%N.#CUQWQTH V:*P1XU\,MK']DC7+'[=YGE>5YHSO_N9Z;NV,
MYK7O)6AL;B5'C1TC9E>7.Q2!U;';UH GHKG(?%VEV.B6%SK>M:9'//:+<-)%
M)MBD'R@M'NY*Y88[\BM'3O$.CZMI;ZG8:E:SV,>?,G60;4P,G<?X<#GF@#2H
MKGK7QIH.KP7HT;5[.\N;>!I?+1\G '7'=<]QQ3?"GB=-9\/Z%/?S6\6IZE9B
MY$$>1NP!N*@DG R._>@#HZ*IC5M/,U[#]L@$EB%:Z!<#R05W MZ#'-<G<?$7
M3;S7=!L= U&PODO;UH+H*Q9D3RW8%>1U*]>1UH [BBN=LO$EM;V5Q<ZSJ^E*
M@U":UBEAD*HNTDA'+?\ +0*IW=N#5O1?%&A>(C,-'U2VO&AQYBQ/DKGH2.N/
M?I0!KT5SH\>^$S=36P\0Z?YL1VNOG#KD# /0G) XKHJ "BN7\6^*&\-7^@B2
M2UALKV[:&ZFN#@1QB-GR#D <J.N:T-.\5:#J]A=7MAJMK<6UJ"UPZ/\ ZH 9
MRPZ@8!//I0!L452DUC3H;&VO9+V%;6Z:-8)2WRR%\; #WSD8K!T3QSI^M>,M
M:\/Q36_F:>46+;)EICMS)QVVG"_6@#JZ*S]4US2M%6-M3U"WLQ(&*&>0*&"C
M+8SZ"H]'\2:-X@M9;G2=2MKN*$XE:-_N'_:'4?C0!J45A:;XT\-:OJ)T_3];
MLKF[YQ%'*"6QUV_WL>V:H^&O'.G^)/$6M:3;S6_F:?*$B"2;FE0*NY\=@&;;
M^% '5T5SNJ:[=67CC0-%B2$VVH0W4DS,IW@Q!"NTYP/O'/!J/3O%EC;^';&]
MUW6M(66X61A/;R%8) C'.S=SP, ^] '345S3?$+P@NGI?MXAL!;/(8U?S>2P
MQD8Z\9&>.X]:L7NN)%J.CO!J6F+IUW'-+(9')DF18]P:$C@@=6)[=* -VBN2
M\)>/=,\3:+?:BUS:6Z6<TBS#SAB*,,P1V)QC<%S6KHWBK0?$,DL>D:K:WDD0
MW.D;_,!ZXZX]^E &Q17$>+_B/H^B:/JZZ=JVG3:U91,R6LC[@7'52 1DCG(!
MS77->16^FF]NI$BACA\V5V.%10,DGV% %FBN1\)^/M+\1>$WURXNK2T2%G%R
MIF&V !V";F..J@'\:V-%\4:'XB\T:1JEM>-%CS%C?YE!Z$CKCWH UJ**QM:\
M6:!X>ECBU;5K6TED7<L<C_,5]=HYQ[]* -FBLUO$&CKH@UHZG:#3"NX7?FCR
MR,X^]TZ\?7BL/4_B+H%MX3U/7=/U&TOA91G]TLNTF0@[4/&1N(XXH ZZBN9T
MWQ,NL76A2V6H:8UI?6TLDD6YC+(Z;<^7VPI)#9]JL?\ ":^&/[8_LG^W;'[=
MO\KR?-&=_P#=STW>V<T ;U%8NJ^+O#VARRQ:GK%I:RQ;=\<DF&&[.WCJ<[3^
M52R^)M#AT--:DU:T73),;+KS1L;/& >YR",=>* -6BL[1]?TGQ!;O/I.H07D
M:-M<Q-DH?0CJ#]:BN]0GA\2Z?9+=V"6\T$SR02%O/<KMP4[;1D[L^HH UJ*Y
MV/Q[X3EO+>TC\0:>T]SM\I!,/FW?=&>@)[ \FNBH **X3Q=\2](TG1M1_L?5
M=.N=7M611;,^X$F158<$9(#'@'C'-=)K7BG0O#KQ)J^JVUF\H)1)'^9AW..N
M/?I0!KT5POCKQ];Z%I&EOI>IZ:)]4N8XX;B=M\20G[TV%(W <=^]:DGC/1-#
ML;)-=\0:>+R6!92R?*) 1]\)DE5/;/YT =-165/XET.VL+:^FU:SCM+H$P3M
M,H20!2QPW0\ G\*S_P#A87A#^SC?_P#"0V'V82>46\WG=C.-O7ISTH Z6BLR
MX\1Z+::-'K%QJEI'IT@!CN6E&Q\],'N3Z"LN?Q]X>/AO4]:L=3M+N+3XRTBK
M+M(;'RJ>Z[C@#B@#IZ*Y'1O%PUZW\,W=G?:6L>H(_P!J@9F,AD$08I%CC*L?
MFSVK0N/&WABUU;^RI]=L8[X.$,32@%6/12>@/L>: -ZBLC5O%6@Z%(T>J:M:
MVDBHLA260!BK$@$#J<E3T]#5S3-4L-9L([[3;N&[M9/NRPL&4XZ_C[4 6Z**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M([1<>=;RK(@D++U4_?!)ZD^]>S1ZE92ZG-IJ7,;7L,:RR0 _,JMT)'H:XAO
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M6\&DM%\)<G/^CZ@.?^N=>R+!$DLDJ1(LDF-[A0"^!@9/?%,2RM8O)\NVA3R
M1%MC \O/7;Z9]J /#+J83_"Z6U@NH1]A\2M)JB%/-\B#[2YW2Q@@E<[3@XR
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MH<GG-:^J3:QXVNM"L1X=U#2XK/4(;Z^GO0BJGE'.R,AB7)/&1QBL?5='UM]
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MV?PQXTTJZC:U;5=2U PN_>.485^.U $D7Q%/V6VU6Z\/:A:^'[IT2+4I'CP
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M;<YR <]*Y*U\'ZA=:AXK2QT*\TVSU/03;6C7MP9'DERW^L)9BI.1P3TQTZ4
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M"QU+6H9IKJ[\G>(4AX8HAXW,2,9R!S53XA67BF#X>ZW;ZIJ\-S;17%J]O=+
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
B**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>separationagreement010.jpg
<TEXT>
begin 644 separationagreement010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K/U#7-.TN\T^SO+C9<ZA*8;6((S-(P&3P
M< #J3P*T*\R@D.K?M#W23\QZ+HX$"]@\A4LWUVN1^ H ZQO''AM+/5KMM300
M:1-Y%\_EO^Y?=MP?EYYXXS5C_A*]$&H:78?;U^U:K%YUE'L;]\FW=D'&!QSS
MBO(KCQ/JJ^$_BA<"6W\S3]5$5N?LD6%7S\?,-N'..[9-;C:]J'_"=?#:U\R'
MR;_3#)<#[/'DMY)/RG;E.>RD"@#TK1M<T[Q!8M>:9<>="LKPOE&1D=3AE96
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M<YW'KG&>,58OHO%FF^,=&T0>+9IH]:@G:>5[2+=;M$%8F$!<#.[;AMV.O)H
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MH+,<DX..U5O'VD>(K7P3>0:CK[75K'J-H;2<1H)I$:5 5E&S;E6.05ZXY]*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY$&C3P6TFIJ%!PUUE(@21E=K*3P1UYJOJGCW5HK-YXKXP0:KK<ME8SK:>?\
M9[6$;7D5%4EV9E;&<CGT% 'K5%>7:/XMU"/5KW3X-4U#5[%M.FN(KR\TQK>2
MVF09VDF-%92.1QD$8K=^'9\0ZAH5EKVMZZ;S[?9QR+:+;)&D1(!#!@,DD=>V
M2<#I0!VE4[W5++3IK.*[G6*2\F\BW!!.^3!.T8]@>OI7+ZS?:OJWCI/#&F:F
M^EV\%@+ZZN88D>5RSE%1=X(4?*23@]A6-K5OKEI>^#[?7;R"]EC\18@N8UV-
M)%Y,FTR*  'Z@[>.E 'IM4WU2RCU:+2FG47TL+3I#@Y**0"<].I'YUY?XB\4
M7]O-K;KXU>/4+-Y3:Z=I-A]JB15&569C&3N./F^8!?PK8M?%6IWVL:"_F)''
M?>&9-1DC6-2!-^[(()&<#<>,XH ]$HKQQ-:\:Q>"?#OBD^(TEN=0FM[=K.2S
MC\C;*=@8X ;=DAC@@=0 !71VU[XDT7QG=Z')JK:UYVC27]L+B&.(K.KA0@*
M#:=PZ]/6@#T"HKFY@L[:2YN9HX8(E+R22,%50.I)/05Y7X6\57]SK6E6]]XK
MN(M5F8"_T?5]/6V!R#D0,$'(;I\QR.M=-\6(99OACKGE7+P;+<N^U5/F*.JG
M(. ?4<T =DC*Z*ZD%6&01W%+7G?VC7KC6M(\'VFNRP%-+_M"\U'R(C-(I?8D
M:#;L7OD[3P!WZZOA35-53Q'K?AK5[P7\NGK#/;WGEK&\D4@/#JO&Y2I&0!GT
MH ZE[NVCNXK5YXUN)59HXBPW,%QD@=2!D?F*ATW5++6+3[583K/!YCQ[U!'S
M*Q5ASZ$$5P^MV-Y+\:= DBU6>%#I\[^6L49 57CW)DKG#=SU&."*Y?0H_$EC
M\-]8U[3_ !"UI'I]Q?7$%FMK&\<@25V82%@6))##@C Q0![917E>M^.KB[\0
MVFEC5+O1K0:;%>SS6-@UU+)))RJ#Y'"* ,Y(R>E='\/_ !!?ZU:ZE;W[S7!L
MKGRX;Z2T:V-U$0"K%& PPY!P .* .QHKA-8N?$&I?$L^'=/UIM-T\:0EY(\4
M$;R;_-=/E+ @9&,YS]WC&<US*ZOXSE\$:WKK^)@D^@W%Q D<=G'LNQ"Y!:7(
MR"PXPNT#&>M 'L-%>>>)O$,JZC81S^*DT2TGLEG6WLH/M%Y+(3_=,;XC Z$#
M).:I:+K_ (GUOP'J]W9:GNU+1M2ECCEN;58?MD,85MDJ,!Y996(R-I! Z<T
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M+3(X@7L=-:ZDGED7?R?+<*J@KQ@$DGF@#U"H[BXAM+>2XN9HX8(E+O)(P55
MZDD]!7FMMXF\37W@*YUJWGQ>:)>2>=Y]K]G34K:,!B=KC,99#G(QA@1],W6=
M5U;QC\+?%'B/^T&M-)G@<6%DB1LWE)D,9&P2&<@\ _*!ZT >O(ZR1K(C!D8
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MIP!DA@",Y/S5N>#Y=5N/">GW6MR[]0N(_/E&P+Y>\[E3  ^ZI _"@#<HHHH
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MO9Q?>*EM8K6SE$;7,C)$1$S'@(V#NZ<9KV.L2[\(:!?6=]:W.G1R0WUQ]JN
M68%IL ;P0<J<*.5Q0!YK::.+7XF:3I\GAW3=!@U/3;R&XL["Y\PS1[1@R (J
MCG.",YYYXK#O+O4;[0M-TZ.1S>^"(9;NY _BDMYUCC!^L22'\:]AT_P3X>TN
M_M[^UT_%[!NV7,DTDDOS+M(+LQ+#'8D@=JN0^'-(@N]4NHK&-9]5 6];G]\
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MM8;,S6M[YMO -J8"( ^T< GD$]]H]*[=_#6C26NI6LFGQ20:G*9;R-\L)7(
MR<G@X4=,=*IZ7X&\.:-J$-_8Z=MO(0RI/)/)*X5A@C<[$XQT'0<XQF@#H:**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&L/&4>JLLM]HTN^T 0+YT4H_T<8'4[CL/N*[#36O+7P_;/J\PDO8[=6NG50
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MR+RW$0N;BXCM87F4LD;.?OL!R0 "<#KB@#J:*\PT'QM<+XMTS2_^$A'B"UU
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M4PV$5ELN4C1P2;D[CC8H.>%R0#S7O%-"(K%@JAFZD#DT <A/X6US3M;U*_\
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MP?6@#-3PGKVJ:AI;^)=<M+NTTN=;F&*TM#"T\RCY'E)=NF<X4 9K9\-^'VT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>+W&BZ=:0?%JX@M5
M2:*"2-&!/"O;*[#KW;FO:*YZZ\$Z%>:EJ5_+;2^=J=N;:\"W$BI,A4+RH.,[
M0!D#- '!7/AO3_#>G^!M9TT31ZI/J-C;W-T9G9YXY5PZODX(/IVQQBJ-O97O
MBO6/$UY?^&/[9D@U.>SAG?51;FSCCP%6-<?*<?-N'4FO6;K0--O;33[6>W+0
MZ?-%/;+O8;'C^X<@\X]^M9FJ> M U?4+B]GAN89KI0MU]ENY8%N0!@"148!N
M..>: '^ YM0N/ ^E/JEU#=7@B*R3PS+,LFUB V]>&. ,GUS6+\/"MOKOC:QN
M"!J UR2X93]XPR*IB/TP#7;6=G;:?90V=G"D%M @2.)!A54= *QM<\%Z)X@O
M8[Z\MY8[Z--B7=K.\$H7^Z60@D>QS0!B>.O%=OINF^([;2B?[?LM*^T-+''D
MQ(6P,MV(R6"GZUA>(/#FE>$/#>D^(=!>1-72ZM5%R)V9[\2.JNLF3\^X,3[8
MXQ7?:-X3T30;"YL[&Q01W63<M*QE>?(P=[,26X)X/J:HZ?\ #WPYIM[;7,-M
M</\ 9&WVD,]W++#;-ZQQLQ53Z<<=J .!/AO3]:TWXBZEJ*S3W%EJ%Y]C)F<"
MV9(E<,@!P&R1S[ 5*ND6VF6'P]\20/.=:U&^M$O;QYG9[A9H69U;)P1G&!VQ
MQ7ID7AS2X;35;6.W(AU6626\7S&_>,ZA6.<\9 '3%$GAO2I;'2K-[8F#2I(I
M;-?,;]VT:E4.<Y. 3US0!Y_X?\)Z)XDO/&5SK!>XDBUFYBB+3,/LB@*=R<_*
MW.=WL/2LRRU(>)_#WA"UU2RU+7M3DL99VTY)EBAF17\L3SLQ&>@QUY8\5T6D
M_#>UN[_Q'<ZY;7,9OM5FE007KQK<VQ"[1(L; ,,[N&YY/K73ZGX,T75&LI&A
MFM9K&/R;::QN'MGCCX&P%"/EX'% 'D<[7.G>$OB9IL=M_9D-F+1X;&*Z,Z6S
M. 6"M@8S@$@< \5UNH^'-/\ "OBSP?>:2)HKJ\O6MKR9IG9KI3"[$R9)W'(!
MSZUT\?P^\,Q6.I6<>GLL&IHB7B^?(3-L)());.[).6SD]\UL7VCV.HW-A<74
M)>2PF\^W.\C8^TKG@\\$]: /++F\N](TW7/A];S.M[=:DEOISY.5M+K+LP[X
M0+,,]L"O4[A!I>@2I9I@6MJ1"O7[J_*/T%<Q8Z)?:O\ $@^)=4T=;"/3;5[.
MR+3+(\Y9CF7Y?NKM) !Y^<UVQ&1@]* /'[D"W_9OT]X9&#/%:2LX/)=[A&8Y
M]RQK3M_#.F>)_B9XSBUJ)[NVMQ9"*W:5A&K-#RVT$?-P,'MSCK6WHOA%$\/7
M_A/5K4RZ1!=;[)Q)C?"7$J*<'(*-\ON /6NDM='L;+5;_4H(2MW?^7]I?<3O
MV+M7@G P/2@#R+2)9]6T+P3X=U"[N'TR[U&_@N296#3) 9/*B9@<D' &.^VK
MWCO0]$\.>$O$UEI%VT)FM[69]*$F8XA]H5?-53RN[H<<'%=[)X*T"70ET9K$
M_8TG:YC E</'*6+%U?.Y3ECR#WQTJ&/P#X>32[ZPDMIKA+\H;N6XN9))IMA!
M7=(6W8! P,XH H^'I&/Q2\:1ER0(=/*J3T^23.*X72Y3JVE>&]&N;B3^R=4U
M_4!=,DA7SE1I'2,L#]UB!QWQ7INL>"=$US4QJ5W#<)=^7Y,DEM=20&6/.=C[
M&&X?6@^!_#O_  C_ /82Z<J:>)C<)&CLIBD+%MR,#E2"3C!&.G2@#AI="T[P
M[\0M:MM*!A@;PI-(+<2$K"?-Q\H)^4'&<#OD]ZIZ/I<'B#4_ =CJ+32VC^%_
M,FA$K*LV/*P'P>1D@X]A7H6G>!- TRYN;J&WGDNKJV:UN+BXNI)9)8VQD,S,
M2>@Y[8XJ[9>&-(T^YT^XM;8I+I]G]AMCYC'9#\OR\GG[HY//% 'E5\\OAW3_
M !AH.F7,]GI<>L6-NK)*<VD,ZQ^;L8GY1R1[9K<U+PQHWACX@>"ET9&LQ<7-
MPLMLDS%)0L#8<J2<L,XSU.[FNIU_PZHTK79M(TRSN[_5/+:YM[UV,5R% 7:>
M?E.P8!'&<$UR>@^#)9/&6CZI'X:N-%M=,$K.][J'VJ69F0HL:?.^U%W$]1GC
MB@#K?']Y:6?@^Z%Y<7\*3O' O]GD">1F< (A/3=T)XX)YK@M/LGT/XF>%5M?
M#0\.1WWVJ.:);\2M=*L)8;T7(^4X.<DY->J:SHNG^(-+ET[4[<3VLF"5W%2"
M#D$$8(((ZBLFS\!Z%9ZE::EY=W<:A:L6AN[J\EFE7*E=NYF/RX8_+TH I_$V
M\N;3PB$M[B2U6[O;>UGN(VVM%%)(JNP/;@XS[UG:GX5\.>&&D?3)VTVXN=.N
MHOL22DK>XCR68-G++UW#GGDUW&HZ=9ZMI\]A?VZ7%I.NR2)QD,*Q=/\  FA:
M=+-*D5S<2R0-;>9=W<L[1Q-U1"[':/IB@#SZV%CJ>A^"M(DTR_URZ30HKG^R
MHYTBM@A55\V4L1D@Y '/?BLF=[BQ\#_$/35@_L^&SO+0PV45T9EMMYC+*K\=
M^2!P#D5ZM<^ ]!GCTY4BNK633K<6MM-:7<L,JPC'R%U8%AQWS21_#[PS%I^H
MV,>G%;;4?+-V@GD_>F,Y5B=V<YY)ZGOF@#F4\-:;XH^*'BZ#68Y+JUMX++R[
M=I6$89HVRV 1\PV\'MDUR,&D01_!K3_%SRW,NOV]Q#Y-]).Y=%%T(@@YP%V<
M8[]:]LMM(L;35K[5((2MY?+&MQ)N)WB,$+QG P">E41X0T0>%U\.?9#_ &4K
M!A#YKYR)/,'S9S][GK0!>UFRMM1T:[M+N(2P21'>A) ..>WN*\;\/Z;:MX6^
M'FBX>WT[7&DEU+RI&3[0T<19$8@]&/4#&<5[@Z+)&R,,JP((]JPY?!N@S>&[
M;0)++.GVNTVZ^8P>$K]UE?.X,,]<YH X75;&W\*>)M2TC0]UOI][X=N[F>R1
MR4BD3A9%!/RDY(..#BNB^&GAO3M,\+:9J\*2/J.HZ?;R75Q)*SM(2@8#!. !
MG P!P!6MIW@O1--AODC@FFEOXC#=7%S<2332I@C:78E@,'H"*V+"QM],TZVL
M+1/+MK:)88DR3M10 !D\G@"@#SS5_#MAXG^,%S9:LLL]C%HD,PMA,Z(TGG2
M,=I&2!G'UKG+6QO?%6H>([V^\,?VO+#J4]I#<-JHMS9)&<*L:X^0@8;=W)S7
ML"Z18IKDFLK"1?R6ZVS2[CS&K%@,9QU)YQFL?5/ .@:M?W%Y-#<Q2W0 NA:W
M<L"7( QB148!N..: . T_3!JOB7X=7.N?9[[4)+*[$US#/YJRF+;Y;;U.">^
M1W)S5;6;2QURQ\2:M9^'KS5Q')<D:WJ%^L MR@/$(&6"(1Q\HSCDUZC?>#M#
MU!-+62S,7]E'_0C;2M"81@ J-I'! &0?2J4GPZ\-RW%R[VUS]GN9&FFLA>2B
MV>0]6,0;83^&* .0TFZGO==\)7=Q*TEQ-X/DDDD8Y+,1$22?7-9NG/::IX4\
M$:5/8ZCK=X=-:Y_LN*=8X'7(7S9F8C.#P!D\D\5ZA:>$]&LGLG@M65K*R-A
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MIDDEM965Y9-:1JY(@,GE,VW)X&3G%>Q7.D6-YJUAJ<\):[L!(+=]Q&SS  W
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M2R;B=OE[64%=IW$D\@<9(KDO$5Y8:5XB\02V?B.\\.:B[[Y;&\MEN+;4?W8
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M/3M8\,0VCFXL=6+R//%;2RYB\MBI3:#DE@,CD@<D#K7,7'B&236_$=I<:X=
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ML3+)8^6ZEV<$?(%"L,^_&: .W;QWX>&O_P!AK>R2:B)_L[Q1V\C>6^ 1N(7
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MTM?\+Z/XFLK:SU:T$]O;3+/'&&*@,H(&<=1@D8Z4 >8:K<Z[/I]IJ2I=)?\
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MS2OC.>68DGT'H,"N%\-_#>VN=%>X\0V]U;ZG?W$\]_#!>NBS!Y694D\MMK@
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ML?G.PFMTB+,\FXG)#;2&/.37)3Z.MY\*7\1W$MU)KFLZB)=.+3N!;/-< )L
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M:YMIK;:T5@R(5BW'LQ)P%Z]<B@#9O/'OABPU"2QN=6C2:*012L$=HXG/\+R
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M*PX)&-QQTXH ZV7QYX8AU-M/?5HA.LH@9@CF-9#QL:0#8&SQ@G-3:SXQ\/\
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MI*W'F*T30X&?G5P"O'.2*\KTV72] \0> ],UJ2."WTK16NWFFXCCN9\8WL>
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M7[);2K#.[QNC1.Q 4,I 89+#J.]:=YJMC875G:W-PL<][(8[>/!+2,!DX [
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR%0 AQC)88') Z5>A\=7ML_B.'6])AM)]&L5OB+>[\U'1E8A2Q5<-\F.AZT
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MW^D-& S,S%F;'.,DGO61:^+M9M_$.E:7KVAVUF-5,BV[6U]Y[1LB%RLB[%[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.T30S;1R!P<W+E5?C.?NIUZ<UFZQX0US5+3Q</LH$VN:G;0C]ZO%E%L!?KW
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M,J&0YD6.4GY 3G^$D9X-;5MX7@M?%,.LI.VVWTP:=!;D9"*'W%MQ.23A1^%
M'%R>*M7\+-XSBEU";65TP6B6;72(KFXG'W"4505!9#TX%=)I^A^++#4]/NIO
M$IU&%]PU&WN(41!E>#!L3(PV.&)R.^:2X\ 6MWI7B"SN+V5I-7OOMOVA%"M
MR[/+ ZYV[!]>::NEOH%U)XI\5:^]^UE 8HC':&**!6(#,(T+%F)P"?3L* ,*
MS\6ZU<^"M-TV&Z$GBJ_O9]/68QK^Z\J5A),5 QA4 /3J17<:]J@\.>%;_4Y6
M,QL;1Y<OC,C*O&<<9)_G7)?#KP\/[3UGQ=/#/$=3N96L()QM:&W9]Q;:?NF1
MOF(] M=#X\TV;5_ 6NV%NI:>6RD\M1U9@,@?B1B@#CKO5+SP3X*T*SAE8:YK
MT_FW5Y]F:=D=U\R:7RU!+E1A0,8P!V%7_"^N7S>+DTR'4M8U;2[BT>22?4=.
M:W>WF4K@!O+0%6!/&#@KUK8O-&'BW0] U6ROGT_4+94N[.Y6,/LWQX960XRI
M4X(R#[TZT\+:I!%J5U-XCFGUJ]B$*WAMPL=L@Z".$-@=2<DDYQGTH YG1-?\
M3ZSKD_A!;\+<Z1=LVI:LJQEI+?.8E1<8#L#AN/EVGN:N64GB3QM#JNJZ;X@E
MTFVAN9;;3((88V24QDKYDQ96)#,#P,8 [FM;2OA_8Z#JNE7^E7$D$EI!);W1
M9=[7RN=Q,C9^]O\ FS[D=*IGX>7 @N=)B\0SP^';BY:XDL$MP),,V]HQ-G(0
MMGC;G!QF@#&U+Q=J%SXEDT&]U.]TM--M8?MT^CV#W+3W+H&*HWEN$0 @\C)S
M3'\6>))/!B06]Q*NK3ZZFEV-]=69A:>(D/YK1LHQ\FX' '0XP:ZB]\'7\>N7
MNJ>']>.DM?QQI=QFT6=6*+M5TR1M8+QW' XKGM8\*R2^(_"GANPOKZ---AN-
M2>_D/FN9@55&8MPQ+,Q*^G' H N7%WK'AWQ=#I=WXCN;VSU'3;J=Y)(8E>S>
M(*?,3:H&WYN%8'D=ZL?"33+NS\#VU]>7L]Q+JA-\R2*@"-(Q;(PH)W @G.?;
M JTO@66[CU>?6-9DO=5U&Q?3Q=I (EMX6!^6-,G')R222<#I6[X=TRXT70+/
M3;F]6\DM8Q$)EA$0*KPHV@G&  .M '#QQS/\6?$>N3:M<BTT*PCC:+9'M*NI
ME:/.W.!M5LYSD]<<5SVEQ^)?#_PPTG7(];E@O;R[BEAL(X8S%,;F<$B0L"S$
MJY/!&, 8XR>XG\!W,O\ PE42:XR6WB!6WH;8%H690A(;=\PV@@# QFM;4_"T
M&HPZ#;B<Q6VD745RL03/F&-2J G/ !(/X4 <SXBUV2X\476GIXFOK2WM8U M
MM$T][J?S3R?-;RG5<<84<GJ:YF:^U;QQX<\"V]SJL\<VHZE*S/%#&OG10,S+
M*RE2 PV*<?=^8Y!XQVQ\#:A#<:Q%I_B26STW5KB2YG@2U5IEDD #[)2> <?W
M21V(ZTEIX DT^3PI)9ZP8SH,#6Y#6P87"/MW\;OD8A>O/6@#J;Z*[70[F*UN
M'^V"V98IB 6\S:<-C&,YYZ8]JX2T\7:EKNA>$K#3[OR]5U*UCO-0NE13]G@0
M#S7P1@%W&P<=SZ5VVN:[8>'=-:_U*21( P0>7$TC,QZ !03S7*?"_P )-H6@
MRWM]#(E[J3%S#-RUO!DF.'VP&)(]6/I0!0MKSQ'XC\)7OC&+Q#/I<7ERW&GV
M44,1B6),[3-N4LQ8+DX(QGBM#1?%.HZ_XH\.0HWV>WFT'^U+V!5!#-(45%R1
MD8.\CGGO2)\.;M-(_P"$='B2<>&=Q'V);=1-Y1.?*,V<[.<?=SCC-7[OP9=+
MXD.K:-K1TM9;..RFA6U67]VA)7RRQPA&2.0P]J )?"VK7NL>(?%+R3[].M+Y
M;*UCV@;&CC7S3D#)RS=_2LWQ?KCIXAM]*C\13Z?"L'FSPZ79O=7CL3\H($;B
M-,<Y(R?I6]X2\,P^$]$.G17,ER6N);B2:0?,[.Q;GDY(&!G/.,U0N/".H)XF
MU'5](U]K!=36(7D1M%E8F-=JM&Q/RG;ZAAWQ0!R6F^-]=D\,2V\%RUSJ%SKY
MT?3KR\MA&X3 )DEC '*#?Q@<@9'6NBN8O$/A&WU+5+KQ ^J:5!ITLTBWB(LL
M<ZC*E-B ;3R,'IQBFP?#B.T\+6.E6^K3+>Z??M?VM^T09A*68_.I/SC#D'D9
M]J6\^'TVJZ9J\>JZ[+<ZAJD<<$MRL 1(H4<-Y<<>X[0><DDGG- '-_#/4KO5
MM/TK0M,NWT^QTFTAN+QVB_?7KR[F(3>,"+=NRXY)Z8')'UGQ+J/@?Q%XK;Q'
M-8V=M/=RZ9';P1$R)&Q5!(64Y4E<8&#R22<@#O+WPN)?$UMKEE>&SGCL9+&1
M%C#"2,\IW&-C<CZXXJC)X#MW^'EKX/6\=;:)8EDF\OF4(X=AC/&X@_G0!G1:
MEKWBC7ET2'4)-)CL+"WGU.>VC0RO/*N1&F\,%4 $DX)Z"LN7Q1KVG6>H6DNI
M&Y?1_$%G:27AB0-/;2E,JX QN&_!( Z#I75:CX4OO^$AN=:T+6_[,N;V%(KM
M)+47"2[,A& ++M8 D9R1[56N/A[:R>"+WP[%?W"37LPNI]0<!Y7GWJYD(X&<
MJ!CL * .=3XAWD/C/5KZZGQX8AL+DV<2J,S2021HSAL9.YW9 ,XX%5)]5U'3
M]>TO4?$<AN+S0M"NM8N450H669MB1# [*&4$^Y[UU5U\-M,N+GPP5G=+308R
M@M@N1<<HR[SGL\:L>#DU?N/!=G?:CXCN;Z9YX];MH[1HPNTPQHK#"GU)8MGU
MQ0!P,7B[7%T^SU=-6UF[U>26)IM(&BR):>6S#=&K&+(*J2=Y<YV^]=3%<:YX
MOUS6OL&MS:/IFDW)LH?L\,;M/.J@NS[P?D!8#:,9YYJWI_@W5$N=._M?Q/<:
MA9Z:RO;6R6X@W,HPK2L"3)@=N 3R0:AN? E]]HUI-,\1S6&G:Q(\UQ;+;*[K
M*Z[69)"<J&P,C&>N".M ''>#]4UJZTG2K"SN4M-4\47EYJMY>I&&\B%6"_NU
M;(RV$"YS@5I7OB37/!_B#6XKW5Y=5TK2-(^V*)8T662:5PD<<C*HZ%6P0!PW
M.<4_Q!8Z=X8F\,V8OM0TF;2K$Q6VL1V?GPR#"J\4B 'EL!AG\#FE\(^$O^$A
MT?Q9<:U)?2PZ_,(XY[E/+F>&-<)(%P-GS%BJXX '% %.U\3ZU"^E7B:QK.HZ
MC/<PI>Z<^BR16HC=@'$;&(%=F<ABYSMYZUW_ (VO9--\$ZS?0W<EI+;VCRI-
M&%+!@,@#<".3QT[U1T_PIJO]I65WKGB6;4TL>;>".W%NI?&-\F"=[8^@[XK2
M\6^'E\5>%[[16NFM1=*H\Y4#;<,&Z'J.,$>AH \S?0-2L=(^'GA*VOV:Z>X_
MM%WGB5A;"*(,0%4#(#OD;LDG&36];:YJFA:IXPL[KQ EU;:9:V\D5UJBHBQ3
MRACM)C497[IP!GD =:Z>T\-3)XEM-=OM1^U75OIQLMH@$:EF<,T@&3C. ,>@
MZUF7_P /HK^UUI6U*1+O4=1CU".Y$0/D/&%$:[2<,!L[XSGM0!S%CXDU.W\1
M>'(;?Q#K&J2:E=>3=Q7NE&VMV38S,T1,2$;<#C)XZUK?#RPNKCQ-XKU^;5;J
MX2747L51TC"R+" JMD*#P2ZC! QUR>:U[?P=J$GBC2O$&KZ^U]<Z>DR)"EJL
M4.)%VY5=Q(/7)).>!QBKGA#PS/X5T^XL'U,WMNUQ)-#N@"-'O8LP8@G><MUX
M^E $.NZM>:;XV\,VZW&S3KX74-PA P76,.ASC(X5^]<L_B_7]2=)]+N%BCUZ
M_P#L.C"2(,L4$:L9;HC&6+;254G&-M6/B!%#XTU?3?"%@]TMY;7BSWUQ'&RK
M;6YB8,-Y&"763: ">3STKI];\)0ZE9Z6FGW)TRZTF0/8311AQ%A=A4H?O*5.
M",CZT 8J7FI^%?&FF:7>:[<ZK8:E:7$KF\2,26[PA6+ HJ_*02,$<8ZU0_X2
MK6X?@DWB*6X)UB\0M:L47Y3++MA &,'"LO4'IS6]:^"6ENK^_P!<U634=1O+
M-K$3)$(4MX6ZK&F3@D\DDD\"LV'X<WDECHECJ?B22[L]&N();:".T6)&6+[H
M?#$L> ,YQUXR<T =I+.--TE[B[E+BV@+RR$ ;MJY)_0UY.NJ>-X_!7AO7YM?
M)U34[R"*WL?L\8@D29B0)/EW'Y.<J1@#UR3ZCXATEM=\.ZAI*W)MOMD#P&95
MW%0PP>,CL35&[\*P75SX<83E+;1'\R.#9D2$1F-,G/&W)- '/V=_JVB_$"XT
MZ_\ $+WUDFC-J%TUU''%' _F;5*E5!5<!N"3P,Y-<O=>+]6M[&TU2V\3:C?Z
ME/>0Q+;1:2R:=('D"[%D>('[I.&WY.*[[4/ ]KJMUXDFO+N5EUNUBM,*H!MT
M16^Z>^68M5%_ NJ7TFBOJ_B9KM=)NXKF&**R6&-]@(&\;B2W3G( Y^7F@!MQ
MXPET'7/&0U29IK73XK6XL80H#,)$*^6N!DDR+@9S]ZNC\,Q:O%X?M3KMP)]3
MD!DGVJ%6-F.?+7 Z*#MSWQFN(LK&R\>?$V/Q+:K<-HNF6T<8>2)HTNKE6=E(
M5@"1&')S_>QZ5Z9(&:-E1MK$$!L9P?6@#RHZMXCU7POXI\1MXBFT_3[&YNVT
MY;:"(LZ195=Q93E2RG@8.2<GH!J6NK:_XHU.QT2*_?2_L^EV]YJMS;QH96EE
M'RQ)O!"CAB3@]A6F? 4/_"MT\&K?R+#L5)+GR_F<>9O?C/&[D=>]3ZEX4O&\
M02:WH6L#2[NXMTM[E7M1/'*J$[#MW+AADC.<8[4 <%XHU/69_#/BCPO-K$UQ
M<VVH6MA;W8CC#W*7(7]U( N,@,<E0"<#IS7K.DV!TG2+:Q>[EN1;IL\Z8*K$
M#ID* .!QP.U<E<_#=3HUK;6>L31:C%JBZM+?SPK*;BX (RZ9 QR, 8Q@5V%_
M:27FDW-FMP8I9H&B$P7)4E2-V/;.<4 >5P^*/$<'@>?QW>ZK(]OYTIL-+C@0
M+.KR%(1(<;C@E2 N#A>I)JQI_B/5;?5M%,.M:UJ\UW=)!J%M<:,\%NB/D&2-
MC$I0*<=6.1UKLKGP98W7@2'PH\LJV\-O%#'/'@.K1[2KCWW*#4>F>&-436+?
M4]=\0RZG):(RVT45N+:)2PP795)WMCU.!S@4 8=E)XE\;6VIZOIOB"72K>*X
MFM]+@BAC9)/+)7S)BRL2&8'@8P!W-3077B#Q1XAN](_M5M*@TB"!+Z;3U5GG
MNG0.P1I%.V-1CMDYI_\ PKNX%O/I$7B&>+PY/<M</8);@289][1B;.0A8GC;
MG!QFKUUX0OX=;OM2\/Z[_91U!4%U$]HLZED7:KIEAM;;@=P<=* .;C\5Z[;Z
M0#/?B9M*\41Z7=W0B4?:;<E5RPQA6S(N=N.5]ZM>(_&]_8W6NZM9,7TC08OL
MIB"@B\OI"JA,XSMCW+G&#ECZ5M3^ K(^!9_#%K=31>:XF:]D DE:;S!(96Z9
M8L :F?P-ILG@0^%&DF\AD&ZX4XD:7=O\W/\ >WC=0!QUCXDU>WU+19(M:UK5
MKFZNXH-0M)]&D@MT1S@O&QB4IL)!Y8Y YK9\/3>(O$^N:M?'6Y+31[+5W@MK
M>&%"9UBVJP9B"=A8-TYR3SP*UM-\+ZJNKVVHZYXCEU-[-6%M#';BVB5B,%W5
M6.]L>N .<"M'POH*>&?#UOI2W#7!B+N\S+M,CNY=B1SW8T 9_CC69-)TJW2W
MU:WTRXNIUC$KPM/+LZMY42JQ=\>HP,\UR>D>+KS3M>UFW.J:IJ.EV6BOJ+OJ
MUE]GECD5L +\B$JP#=1VX-=CXC\,W&KZII6K:?J?]GZCIOFK%(]N)XV20 .K
M)D?W1@@BL6?X;RW</B/[7X@N)[G78(()IW@4&)4)R$ ( 4@XQV]2: ,,WOC"
MQ\*^%M;OO$,K:E?W5I!]A6WB$,BRL,A_EW;MN22" ,<#O6[/XPFT+5O&8U*5
MIX-.%M-8P!0&?S4PL:X&23(I'.>M=!JWAR+4[_0YVG,5OI-P;A8 F1(P0HO.
M>-NXFN-TZPL_'7Q,'BBU6X;1=.MXHT:6-HTNKI2Y5@K $B,2'DC[Q&.E '<^
M&X=5@T"T&N7(N-3=?,N&"A51F.=B@#HN=N>^,UJT44 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %12W$$!Q-
M-''\I;YV X'4\]A4M>>7FDV?BKXO31W\*W-EHFEQAH)!E&FF<M\PZ,-J X/?
M![4 =PVJ:>MO%<-?6P@E.(Y#,NUSZ YP:FN;JWLX3-=3Q01#@O*X51^)KPU-
M%T=?A!XD\0G3+::34KFY&G(\8(MTDF\J,1*>$YPV5QGCT%==I.DVNK_$#4=/
MUM([V'P_86D%E;W #H2Z$R3;3P6R N>V* /1!<P&W%P)H_((R)-XVD>N>E)'
M>6LMS);1W,+SQC+Q*X++]1U%>)3)'?:!J>AZ4QAT76?%45G8B$X58UVO,T78
M)NC;&..M=%JFGV.B?$2T.A:;!!-I>@WE]+Y,>&N"Q"HKD<N=RL><G.30!Z2U
M]:)=K:/=0+<L,K"9 '(]EZUF7WB>RLO%&FZ </=WJ22$AP!$J =>^6+* /KZ
M<^/1:->S_#FUO;J#PR+K6/+ECUF:ZF:\:YD(*$;82=X; VJ<#!'3-=:D.FCX
MD>)?$.I65O,WA_2K<2R+ K,TVUI6<9'WPJJ >H&!0!Z,^H64=VMH]Y;K<M]V
M$RJ'/T7.:?/>6MJ&-Q<PPA5W,9'"X&<9.>V>*\(\1:;(/ D5TNA:):RZY<1&
MTN9KIKC4'DF<,K;]@PP!SPQ  Q7;66@:?XK^)'B.]U:W2^M--CM].@BG&^-G
M"&1V*G@D&3 STR: /0XYXIH_,BE1TY^96!''7FG1R)+&LD;JZ,,AE.0?QKQZ
M*><W6O?#[3G,-Y?ZW.TCQ_\ +M8R(DLCCTSO*+[M[5Z=?RVOACPI<S6\2Q6N
MFV3-'&.BK&A('Z4 4O#7BNWU]+EG$-L5OI[:U0S M<)&VWS .#R0W STZUMW
M5[:V48DN[F&W0G :60("?3)KQ2;P[HVG_!/2)[.""7Q%J)MI+.[ !G:[DD5L
M*W4;<MD#C -:GD:EKOC7Q5J5SIWA^_ATV86<<>LW#J+6)4#%E3RV4!\DECSQ
MCH* /6VFB1%=I$56("DL "3TQ]:9!>6MR\J6]S#*\1VR+&X8H?0XZ&O&[;39
M-1T/P1X;ENXY+2^U2?4(S9R2!4M(@SK&K.JO@%U4' [8JSK8B\.>(_&.H>&K
M&"R_LCP['"5MH@B^=([.'( P2JJ#DT >LK?6C7;6BW4!N5&3")!O ]=O6N8U
M/Q?=KXSA\.:-:V-S*L N;N6XN_+$:ERNU0%.7X8XXX%<$WAR\LM*\.VJ6_A>
MSOKBZ@EM-3BNII+NXD!#N^1#EMR[LY.W#<]JGNH].M(?B9XMBT^U6>&9K&SE
M$*[DE6((S*<9!:24Y(Y/>@#NU\9BWN-$L=2M8H-0U6:5$ACNDD6.--Q#LP]5
M P!W;%=$]_9QW:VCW<"W+#*PF0!S]%SFO,=)\/:5#X^L;:ZL;66+PWX<A$KM
M '(F+<,>,DA8R1W&[BLJ^TZQ@@EU6\LK+6_#6OZBL\.K6_[J_M&E<;.6&2%.
M ,$$#/':@#VNLS2M2FNK$3ZA%!:2.\GEQK<+(&C4G#;AQR,$@=,U4\9:G_8G
M@C6=0#D/;V4A0G^_M(7_ ,>(K@]+\,6M]XL\.>'KZ$2V?A_P^DD\#?<>>5@I
M5QW'[LM@\=* /5;:ZM[R$36L\4\1. \3AES]11<7$%I"TUS-'#$O5Y&"J/Q-
M<3\.;6W2_P#%UU901VUE)K#P0P0J%C'E(J,R@<#+ _E4=Y:6OB/XL36.L11W
M%AI6F1SV]I. T;R2.P:4J>#M"A1GIF@#NTN(9+<7"31M"5W"16!4CUSTQ3+6
M\M;Z,R6ES#<1@X+12!P#Z9%>4-9^'KW5/#FAZ/,[>&-7U&\NYX>5AEDA48B0
M8'[LOEMHR#M.*GU>YL/#/C?7+O0H(+6"P\.2R:@EL@2/SMV8 P'&_ ;WP: /
M3O[0LO,BC^V6_F39\I?-7+_[HSS^%.GO;2V61I[J&)8P"YDD"A<],YZ9KR"\
M\'Z=HW@'PA8+9Q'6KZ_L8VO'4&>-LB1]K'D!0K  <8^M:VE:=I.K:YXX\5ZS
M:0WEM;736T45PH>-5MH@&8*>,DEAGMSCJ: /3#/"+?[098Q#MW>86&W;ZYZ8
MI+:ZM[R$36L\4\1Z/$X93^(KP[3['5;K3? 'AL065Q;/ITNIM::A,\<-PQ8,
MB':K%M@?(7&..>E6KZ;4M!TSQQJ>G/H]@4MH+2:VTB21D@N"^TRY,:*&"/SM
MSC:,\T >R1WUG+<R6T=W \\?+Q+("R_4=16':>,+?5%U\:;$DSZ2YA7?.J+/
M*$#8!_A7)5=Q[Y]*QSX9\$:+J>@64<<=KJ=NKW$$ENG[R9$0B0S. <J0>=QY
M/2N(LM)LS\*])CAL+>WNO%>L1I*8HE5O)><R;>!]T1ITZ#- 'LHU&*VL;:75
M);:RFE1=T;SC <@94,<;L'O5MI8T"EY%4.0JY.-Q/0"O.?#UEH^NW_BW7?$L
M%I=26NHSV0%XJNEK;1   !N%R,L3WS7,Z)9OX@TWP#X?N_/^PO/>:EY;,0XM
M8RRP*3UP1(!_NT >TV]Y:W>_[-<PS>6VU_+<-M/H<=#4AEC618V=0[Y*J3R<
M=<"N"\*Z=96_Q0\4'3+."RM+.TM+1HK:,1H\A#2$D#C(#**C^(^JQ^'/$'A;
M7YD+QVKWD11>KE[=BJ#W+(H_&@#OQ/"QD"RH3']_##Y?KZ5CZAXA&FW$TTT<
M']D06+74MV+A=VX'A G4Y4$YSCM7DFG6.I6NKZSX-DG<ZOXA:UGOIE/,<;H[
MW3#V'^K'^\*FU^UMKS2O&YAMX2ESJ-EX?T^-D!$9CV(=N>F"[X^E 'HA\<))
M:^%IK>T#-KTH C:89@C\LR,Q(!!*@#(]^M=/;7=O>1>;:W$4\><;XG##/U%>
M<WGAK2-3^)FE:$+&!=)T32Y+HVL:!8VDF?8%91P<A"Q!Z]\YK1^'=I;1ZMXP
MN[&"*VLGU8VT,$*!(QY,:HS!1P,MG/TH [:XN8+2%IKF:.&)>KR,%4?B:1+N
MVEMOM,=Q$]OC/FJX*X]<]*X+Q*!XB\<)I=KHUGJ,VD6XGE_M.Y*6T9ER%(C"
M-O;"GD\#ZFN'A#W7@7Q1;VHM+>/7?$,6EVT5AD6Z\QJ[QCT8!SGOC- 'NB7M
MK)=-;)<PM<*NYHED!<#U(ZXIZSQ/#YRRHT6"=X8%<#KS7GESH&EZ=\3_  E9
M:390P2VUO=W=U,B_O9$V",;WZMEGR22>16!I;2ZE:S_#>T9D5=6O!?NIP8K
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MH$C\PD?9PP7C?G=CO@^E=9X"\&:;X9\/Z:PLXCJOV1$N+MUS*Q(!9=QYV@@
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MNU<_0<5;K"USQ79:)>6]@;:\OM0N$,D=G8P^9)L'!<Y("KGC)(YH M?\(]I
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MH;^ 1F9 <$J02#C(R,Y&>E1>'_'.F^)[B)-+M-1E@<.3=FWQ A4XVE\XW'J
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M,E\?,0HZ+G./;%:&IZG9Z-IEQJ.H3K!:6Z%Y9&Z ?U/MWH JZ5H<.FZEJVH
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M[MG"K\V,]>&P#@T =/1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$P-S&P5HN/O D$ CKS5'PYH%EX>TYH;2::Y>XD-Q/=3N'DN)&ZNS#@\8''&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#< %/#$$YSD>BW/AKQ'K=W?:UJ)L;;4$TZ:STJSAF9XX'D&&D>3:"6. .%P
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MK;*006,FU6=B2,C@<4 +8>(/&M];:=K2Z/I[:5>R1G[$C/\ :XH'/$A8G82
M0Q7'3C.:YVTUO6;"Y^(/BN^-A-:V>ZQCB DYDA4!57)X4M(0W<GIBNJT?3_&
M+S:1;:E)8:?8::H$WV*9I'OBJ[5!#(/+3N1R>@K%M_ _B"7PA-X>O?[/"S:R
MMW<7"3,3<0F?S7)&WAN% &2#CK0!H6&JZQ)<)X:\,6&EV?\ 9=I";Z6X1S##
M(Z[A#&BD$G'))/ (ZFH)_B'J,'A@S_V9"^N1:TNC/;1N3')+N&2A.#@H<C/3
MOTJ\VC^)="\1:U>Z#!IM[;:O(DQ%Y</$UM*$"$G:C;U( ..#573_  !>65YX
M=:6\BNEM;ZYU34Y6RK3W4B$*57&, L>IZ 4 :&FZ_P"((_'*:!K,.FE+BP>]
MC-D7W0[75=KEOO [N" .G2M+Q)KL^B7F@I'%&\.H:BME*SYR@9'((]\J!SZU
M'9Z%=)X^U3Q!<O$89+*&SM%5B6559G?<,8&6(Q@GI5?X@>'=3\2:!!;Z/<0V
M^H6]Y%<PRS$A4*D\\ G.": ,:U^)R/JWB8W-O&FD:7;?:+6=2=]R%=HFQVYD
M0JN.O'K52]\2ZK]KDN+W3=+CU71O#[:E)+(KD6TLA.8AS_<0Y]2!VJS/\-"?
M%&@/;RPIH.G644$\!)\R=HG9X\C&"-Y#')Y(IVN^"-8U.Q\;M#/:K>:X8([;
M<[;5@C51M8XX)_>=,]: .5-OK=MX*\!:%-'!>:A?:E'?+'O9=\:J9V\UCGD.
MV6('0< FO0?#FO:U<^*=7T'68[!Y;*&&=9[%750)-WR,&).?ESGN.U%OH.IW
M7B_2-:OXK2""PTR2!;>&5G\N>1EW8)494(H&>#[5:\/:%=:=K_B/5;UXFDU.
M[1HA&Q.V&.,(@.0,'[QP,]>M #O%>L:CI-M:C3HK$//+L>ZOYQ'!;*!G<W(9
MB>@"_B17-:?\0[E;3Q2+Z72;Y]$LUNEN],D)@EW*Y"$$G#93'4]>U7_$_AK4
MKSQ?8:Y:Z?INK006CVWV+4)2BQ.6#>:AV.,X&T\9P.*Q7^'NNW.C>);6YETP
M7&MWULSM;[D1+9-F4 V]0 P'KG)QF@"\OBWQ7;#PS>ZEI^F0VFL7,-JUHA<W
M$;2(6WYSM &"2N#@<9S5]/')M=$\2W^HP()-(U"6SBAASNGX4P@ Y^9MZBK^
MN:)/?^*?#VI-)!'IFD_:)YE=B"7:/8A QC !8DDCM7(Z-I">(_BKK.IPW*7'
MA^RN8KA53F.6^$*ID'H=@&?]YAZ4 >C:2]_)I-J^J)#'?M$K3I#G8CD<J,D]
M.F:X/2/''B+6YGN=/M])N(X;PP7.CAV2^@C$FPNQ9@N<?-C:!CC.:[_4;>XN
MM,NK>UNFM;B6%TBN%4,8F((#8/7!YK@5\*>(M6US0;W5K+2+2[TJ=)9]6M)V
M:>\55(*;=BX5NX)..U '2Z+XBEU/6?$D4D<2:?I5PEO',,[F81AY-W;@L!Q7
M.:;X\UK7-.T*VTZQLQK6K02WK><6\FUME<JKL =S%LJ  1R3R!4#^%?&4&D>
M)M%L'TN.+5+JZN4U!YG\P^=_ 4"X4@<;LG Z UH'PKK&@:OI6J:!#97AMM'3
M29K:YF:$;4;<KJP5N^<@CI0!D>-]4\1O\/=7TK5]/B34;F\ATZUDLR1'>+*R
M\H&)*G&X$'OWK?TW6]?L_&5EX>U2VTL6]U927$2V1<M;",JNURW# [L9 7D=
M*C'A77[VY\.RZQJ4%W]DU&74;P#*JC;&$4<0QRJENK'/&>^*UK?0KK_A85[X
M@N'B-O\ V='96JJQ+#YV>0L,8&3MQ@GI0 [Q7XBFT*"QM[&V2ZU34K@6UG"[
M[4W8)9W(Y"JH)..?SK#U+7_%&AZ-X@DUZUL3';::]S;7]CN6,R8($3*Y)#9P
M01QBM3Q7H>HWVI:'K6D"WDOM(GD=;>Y<HDR2(48;@#M;'(.#61JOACQ3XCT.
M_MM5O+1#J-W;%K..1C%:VT;AG56V@N[8YR /I0!F>'-0\2>$M&\%Z==66G)8
M7K16/V92YN49HRQD+?=Z@DKCC.,GK6CX@\8:YI]YJ9CN/#FF6UEGRHM4N<S7
M>%SN4(XV ]!G)]A6_JVA76I>,_#^I[XA8:6MP[(6.]I74(I QC &[OWKA?\
MA7_B:/PEJ7AZWL]!6YN/.#:W*[-/<AV)^9=F58@[2VXX[ T ;T_CG5KT^%8-
M%TN![S7+%[QX[ER%ME"*0S$<[<MZ9.,<9R'6?B#Q=K-W=V.E1:+YFED07UW,
M)?*FN<;FCB4'("@C+,3R>E:>D^&;BR\7?VI*81:V^D0:;:1HQ++ABSD\<=$
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 444C,J*69@JCJ2<4 +10"",@Y!HH **** "BBB@ HHI ZE
MBH8$CJ,]* %HI REBH8%AU&>12T %%%% !114<=Q!+(T<<T;NGWE5@2OU% $
ME%%% !1110 4444 %%%(64,%+#<>@SR: %HI"0 23@#J30"& *D$'N* %HHH
MH **** "BBD+*" 2 3TR>M "T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 444A902"P! R>>U "T4 @@$'(-(&##((/TH 6BBB@ HHHH *
M*C:>))5B:5%D?[J%@"WT%24 %%%% !1110 4444 %%%% !112;ANVY&<9Q0
MM%%% !1110 45''/%,6$4J.4.&"L#M/H:>2 "2< =2: %HH!R,CI10 444PS
M1!MID0'TW"@!]%%% !1110 44C,%4LQ  &23VID4\4ZAHI4D4C(*,"#0!)11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%]MK&CP6VK>';9KAHX9BT<HV%@,XR.@_.JVLZ6+[Q1X#U"'4M+,&BHPNR;Q
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M4'MDD<]AFLB+Q%XBTF=F\3:1:1Z?]EEN6O-.E>5;?RUW%) RCDC.".I&*O\
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MQYH.[Y8QPJX'0=.E !#X[\00:!IWB?5-$LH-!NO)\T1W+-<0)(0JRD%=I7+
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M.&.!D\YR..<=LUVM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLYA\\<A ^;:"3GKP*F'C>]T_Q[K&HWMTS>'3%=V]I#GY1+:(CN1_O9E'_ :
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MH+/(W\3$G@'@#'!S7=^![[6-0\)VLNO6\T.HJ7CD\Z+RVD"L0KE>Q9<$^^:
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MO:Z?J?BCQEXNM)_$>K6=E8W,*6T5E/Y11FA5B2<$D9Y"],DYS70?#G5KW6_
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M6NUB8>/W;JX(=>,\\YYJ]X=\-0^'UNY/M=S?7M[*);J[N6!>5@,#@ !5 X
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M")IK[1[R._AB3[TH7(>,>[(6 ]\5J6'B70M4O9++3]9T^ZNH\[X8+E'<8Z\
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M Y[X70I!X*C2"_BO;7[3,8)(87CC5-Y^5 _)4'(!R>*A^+7_ ")2?]A&S_\
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MVUGH\15"\H >1V(7)PH &/QKM+6SMK&V6VM+:&W@7.V*) BC)). ..22?QH
M\AEMWD;P@RZSX6AB6^@;3O[*L9?.<=T&';"%<AB1@=ZH:1'>RZ3XL%_>^%X2
M;^Z_M)=4M9'N ,G!)$@^7;C;@?3FO7['PUH6F7KWMAHVGVMT^=TT%LB.<]>0
M,T7WAK0M3O4O;_1M/NKI,;9I[9'<8Z<D9H \WT/38+KQ=X&BOI%U(6_A^:2*
M::$KOPR!6VOR#M/?ZTNEZ'I9TCXG.=/MBPO+J-28A\JB!6 'I\S$\=S7JIL[
M9KM+LVT)N8T,:3%!O53R5#=0#@<>U,73[)$N42SMU6Z8M<*(@!,2,$OQ\Q(
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MW,BA'F" .RC. 6ZD#)X]Z )J*** "BBB@ HHHH **** "BBB@ HHHH ****
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M/-//]G26]I;^&([3(8R1QR";)C$A'S$#].:ZZRUJ*]UW5-)%M<Q2Z>(6:25
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M[;&_W3QSZ5S-OHJW^EZ=HTF@^,)M0W0QW5O>W]PEE#L(W/O+%&4;<J%SVXH
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MMGOY;?1]5O=-TZ1HKS4;>)#%$R_?P"P9PO<J#C%==:W"W=I#<H&598UD ;J
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MMVNC:%+;Z'J%KYOBN*_EBN9WN)Q$%9?.E)R4) &1DXXYS7KE !1110 4444
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M-XHLQJFAV"Q3,^LP23V[X&%5%5CNYR"0PZ9K;H Q?".B2^&_"6F:--,DTEG
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M^-RJ/&NU70H<_=P"I].M=E10!Q-IX%N$U30[O4=3.J?8K2ZANFN@6:=IR"<
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MH:/KUOK-UJMO!%*C:;=FTE+@89@JME<'IAAUH U:*** "BBB@ HHHH ****
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M5??Z1='#.R+&-THX!8$'/XUU6I>!M,U#4YM1BNM2TZXN$6.Y.GW;0B<*,+O
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M;P/<LR0RJ20$!Z+EB2.]:5]X7TK4?$>G:]<V^_4-/5U@?=P PQR.^,G'IDT
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4R!E-H.[[PX')S7$^&O$&A>%H?%.G^);NWM+\ZI<W$T5S@-=12'*,@/^L!7
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M&,K*P,:D'&#R3CB@#8LOB-'KGA[7[JVU"TT^:POC#%/-!(R"'S51688Y+<C
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M8<_*,\XYX&<9K5O/&LT]WING^'M-&H7U]9+J&)Y_(C@MVQM9VPQR2<  'H:
M.M\M/F^1?G^]QU^M)%#%!&(X8DC0?PHH _(5A^&O$C:XU_:7=D;#5-.E$5W;
M>8) NY=RLK #<K Y!P#UXJ#7/%%W:Z]!H&BZ8FH:I);FZD$UQY,4$6[:&9MK
M$DG(  [&@#HD@BC"B.)$"YQM4#&>M/VJ&+;1N/!..:XD_$2.VT;49;[2Y8M8
ML+J.R?38Y0YDFDQY01\ %6# Y(& #QQ65/J>NW/Q0\'6^LZ2FGL$O74V]WY\
M4H,0X)VJ0RXY&,<C!H ]*\M"&&Q<-]X8Z_6N<UCPO<ZSK.GM-J*)HEG(EQ_9
MR6X!DF0DJ2^?N@[3MQU6N!;Q!J*Z'X.?PYIAM[2YUJ>-K>34F_>.KS?(S%"=
MK%2_M@#!ZUOWOB^T\-2^-=432)'GT^YLUN0+HG[09$C4%01A-H;H.N.V: /1
M**XZT\7:O%XFTW2=<\/IIZ:HLALY8[P3$,B[BD@"C:=OH2.WO6=/\1=5.B7W
MB/3_  R+OP_;>;LG^VA)IE0D&18]I 3(/4YQSCM0!WHMH%G,XAC$S#!D"C<1
M]:D"JI)"@$\G ZU4L+U]0T6UOXX0KW%NDRQ%^ 64$+NQ[XSBO&;S6]=N?A9X
MCNM3A;,.N*(WCNS*Y(NU!B *C 4 *#GGT% 'MLEM!+#Y,D,;Q?W&0$?E3O*C
MQCRT^[M^Z.GI]*Y*S\7:M%XEL-(U[08].74HY7M)8KP3<QKN9)!M&T[><@D5
MG_\ "P]3ETB7Q);>'/-\-1%F^T_:P+AX5)#2K%MQM&"<%@2!F@#OPBAMP4 X
MQG':@JI8,5!(Z''2N*U#QQJ+>)O[#T#0%U23[%%?"=KP0Q^4Y8=U//"XZYR>
MF.7ZIXK\1V_]IW-AX6633].9U>6]O#;O/M&6,2E#E?1B0#VH [(*H8L% +=3
MCK33#&T1B:-#&1@H5&,?2N*N?']Q-/X>M]%T1KZ77;)KN#S;@1+" $/[P[3@
M88\C/(  .:S_ !!XPCN/!WBBUU_1&2\TI8OM=C%>$+*CL-CQS!0<'![9&,&@
M#T6.*.&,1Q1HD8X"J, ?A38[6WA39%!$B[MVU4 &?7ZUS&H^*M2D\0W6B>'M
M'BU"XL8TDO);BZ\B.(N,H@(5BS$#/3 XYJA/\28QHEE<0:;MU*ZU!]-:TNKA
M8DM[A 2X>7!&!CC .<C H [D(H! 4 ,<G ZTJJ%4*H  Z =JQ?#^K:KJ#WEO
MJ^C'3Y[9EVR1S>=!.K#.Z-]JDXZ$$<<5SOB75==MOBAX6L;*W22RFAN69#>&
M,2D!0Q9=IY0'(ZYW'IUH [G[/!Y_G^3'YV,>9M&['IFG+'&N-J*-HP,#H*XA
MO&^LWHU"]T+PVM_I-A+)"\[W@BDN#&</Y2;3D @@9(SCBNJTC5K;7-$M-5L"
M7M[J$2Q;N#@CH?0]C0 :O:W]SITT>DWL5A?/C;<R0"4#!&<KD9XR.M0^&]"A
M\.:%;Z9#*\QCW-).XPTLC$L[GW+$FO/-$\;ZUHOA?Q;KFLZ<+B.QUB5 BWQ=
M@3*D9B7*<*@(P>_H*Z&7QIKEJEG:77AE8]:U&=UL;$7RL#$JAFDD<+A N<$
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M-3OXV9+?6)IHQ"Z%CM>520^0#RH!SC@UTFJ^ ;W5-1U:T"0P6-SX<ATV&:/
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M=C9VYR >3@C/-7-:\)^(?$.A^+]1FTY;?4M8AM[:ST\SHS1QQ-G+OG;N)).
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M:HTD<LJX60+@94J1D 9%=/<S>(/">NZ ]]KTNJVFJW8L;F&6"-!%*RLRO%M
M(4%<$$G@]<U)<_#=;_0-<M+_ %B:XU+6WB:[O_)"X$; HB(#A5 !'4GDG)JY
M:^#]0EUFPOM>\0/JD>FDO9P?9EA <C;YDA!.]@"<< <YQ0!R?_"3^);K1](6
MTU18+J]\37&G/,UNC!8090!MQ@D!01ZD#.>:T)=?UCP9KNN6-_JDVM6MOH3Z
MM"US&B2*ZN5*90 %3P>G%:]MX CMX=-C_M%F^PZS+JH/DXWE]_R=>,;^OMTK
M2O\ PE:ZEXEN-5NY3)#<:2VERVI7AD9]Q;=G\,8_&@#D-1O/%7AOP?;^,KKQ
M$]ZZ+#/>Z<UO&L!B<J"D9"[E*AN"6.<<CFK\(\2>(O&GBBQC\23Z;IVFS0I;
M+;01,^]X48[BZG*@G..IW'D 5*/A]J%Q86FBZGXFFO?#]JZ%;,VJI+*B$%$D
ME!^91@=%!..M9UCHVO77Q#\:W&E:T^EAY[9&\RS$Z2#[.OS*"1A@<C.2/4<4
M 1_\)AJ-WX0TZ:_U^TT:9;^:QO[J.+?-,8BR_N(]K EB 3QQSBJ%MKFHZI;>
M,=#77-2NK.+21=VUY>6*P3@'>'7#1KN4[<;MO<XZ9KIW^'*6=OH+:)JKVE_H
M[3-'<W$(G$QF_P!:9%RN23SD$8J>R\"S)K&JZGJ6MS7TVJ6'V*X'D+&%&3@Q
M@'Y0 <8.>><T </%8:G_ &;\*H+76)%NIXW:.YEA1C;H;0955  .%R 6SSC.
M:V[K6->\/_\ "::3-K,NH-8:+_:-E=3PQB6-BL@VMM4*PR@(R/:MO2? MS8C
MPU]LULWAT!I!;D6HCWQ-#Y2H<,>5'.[O5O5O!::KJ&O79OFC.K:5_9A41Y\H
M?/\ /UY^_P!..G6@#C]0\:7EUJ^GZ1+J^H:9;QZ5!=W5QI^GFXFFED'"\1N$
M4 9SCDG%.C\5^*KCPAJ(M$U"YFLM1CA_M!--*3RV;8+2I"Z@&1>01C'?%=/<
M>";F"\L=1T36CI^I6]BEA-(]L)HKF)/N[DR,$')!![XYI1X*O#HDD#>)M1.K
M/>"^_M <!9!T419V^7CC9T- %+P'KJZGJ=];P>*GU>WCB5A;WUN(;RW?.&W
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MMQ'';PL#PD8)[G)RW.!TH YJ>\\965IX3U$>)S)-KTT5M/!):1^3!YD1<-&
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M0!YVP"1D#<,\5)>ZYID>NWVIZ#K^KZ7_ &B%^VQ-X>N)E9U&T2)E!L;''<'
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M71Z3XKM[^^UFWN1#9C3K[[&KR3C]\=BMGD#!^;&.>E8_@?\ Y''QW_V$X_\
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M-]!WI\MQ! "99HXP%+'>P& .I^E>6>&="\/>(/"_B'4_$MM;3ZBU[=K?W-P
M9+78S!55CR@5 I&,5F>';,>*-9\!GQ%#]L9M FE=+@;A+B1 A<'[W&&Y[X-
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MEA3M^Z-V=W7C&*[.O&_!G_'S\+/^P3??RCKV2@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J
M"\L[;4+26TO+>*XMI5VR12J&5AZ$'K4]9^M:WI_A[3'U#4I_)MT(7A2S,Q.
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M&X:YO0YMH;>!I7E*[<J O?YA^OI0!I6FF65C<W=S:VZ137D@DN'7K(P& 3^
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M>1SR:2Q\)Z#INF76G6NEP):78(N4(+><",?.3DMQZFL=?B7HC3RVAM=734%
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MFT]K:PBC.G1O%:%<_N4;&X#ZX'Y5IT44 %%%% !1110 4444 %%%% !1110
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M*]Q<7,Y!DGE<Y9VQQZ#CH * /--.UF'1_A7-X+NM-O3XACM9K$6"6CMY[MN
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M%%I!*L+,C3"<MM+ $ XYYQ7.6MC<+^S;=VOV647#6US^Y\L[R3.Y''6O7J*
M/*]6U:ZA\6RV6HZK?:#IZV-N;::PL!)+?,0=X,GEN05/ 4#/.:P+6"ZA^'&I
MS2V>I?Z/XK6\D6YB9KCR1+&V]@!DG')P.N:]SHH @M+J&_L8+NW8M!/&LB%E
M*DJPR,@@$<'H>:\H\/Z7=_\ "=1>#I8F_LGPY>3:K$Q^ZR2 &W3ZJTDO_? K
MUR12\;*&*$@@,.H]ZQ/#?AI= ^VSRW]QJ.H7TBO<WER%#OM&U5 4 !0.@'J:
M ./T'7K7P0=?TO7+:\6\DU.XN[?R[627[<DIW*4*@@M_"03QBL;2;2Z\%0^
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M\DC[ESD#G'6@#!^)$FLIK'A%-,DM%5]5  G+X:3RW(W;>JX!]\XK.TV7Q/\
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M+:646M7E_)IWERS[+:.2-F#R,YYV +G'7D#WKI(=#NX_B+=Z^6B^QRZ7%:*
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M2W P: +7Q;_Y)?K/TA_]')4_B#6_$-KJDT%D-&TZQAC5OMVKS$+.YSE456!
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MU->SCR+(H2&W$8+Y887&,YR<51N?!VIZ5K^L7>FZ'H6LVNJ3_:0-0;9);2D
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M8R %X#$=:MQ>'/$VI^*;[7-5CT^V6XT273HK6"=I#&S.&!9BHSGG) XXZ]:
M-/P/K7B3Q%IT&KZK::;:Z?=VR2VT<#NTP)QDOGY<'J .0",U7\3^,[C3_$L'
MA[39M*MKHVWVN>ZU28I%&F[:J@ @LQ(/&1@"MWPII<^B>$=(TNZ*&XL[.*"0
MQG*EE4 X/IQ7/>)O"=Y-XMA\2:=IVF:HQM/LES8:A\H8!BRNC[6PPR0<C!%
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MSCOF@#HZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *ANK:*]LYK6==T,T;1NOJI&"/R-35EZY?
M7%A%9-;3:?$9;R*%S>R% R,V"J8ZR'^$=S0!7\+^%;#PIX=CT2T:6>W4NSO<
M$,\A8DDL0 #UQTZ 56T#P1IGASPI<^'K*6X:UN/,WR2,#)\XV]<8X& ..PJY
M?>+O#FF.4OM=TVW=93"RRW**0X )4@G@@,"?3(]:UXY$EC62-U=' 964Y!!Z
M$&@#EG\"6@'AQK74;^UFT*$6\$L3)F6+"@K("I!R$'3'>KMGX4LK+1-6TJ.:
MX,.IS7,TS,1N4S9W;>,8&>,Y_&IM3\6>'=%NUM-3US3[.X8 B*>X5&P>A()X
M'O6M'(DL:R1NKHX#*RG((/0@T <K<> [7R=)?3]2OM.O]+LULH;V H7>$ #9
M(K*58< ].#R*%^'NDMX?U32KN>\NWU5Q+>7LL@\^1UP5;(  V[1M &!CI5>Z
M\2Z]K/B&_P!(\*6VGB/366.\O]0WM'YI&?+1$(+$#&22 *O>'-9UV?4[W1_$
M.F1PW=LBRQWEHKFUN$;(^4M]U@1RI.>_2@"O8^ TAU[3=:U#7=5U.^T[S! U
MRZ!0KH4(VJH'0YSU) R>U:&@>%X?#M[J<UK?WDEO?7#7/V65E,<,CL68I@ \
MD]"34]EXJ\/:EJ+:?8ZWI]S>+G,$5PC/QUX!YQ3;[Q;X<TR0QWVNZ=;N)3"5
MEN44AP 2I!/! (/XCUH BU'PG9:EJU]J,LUPLMYI;:7(J$;1&69MPX^]\Q]O
M:DTWPC8Z7JFG7\,UPTMCI:Z7&KE<-$"IW' ^]\H]O:K:>)="DU<:3'K%BVHD
M9%JMPID/&?NYSTY^E17OB[PYITIBO=>TVWD$IA*2W**0X )4@G@C(_,>M $$
M7A"QBT?Q!IJSW!AUN:XFN&)7<AF7:VSC@ #C.?QHM/"-A::I:WZRSN]OI0TI
M48C:T08')P,[OE^GM6I?ZOIVE6'V[4+^VM;3C]]-*%0YZ8)X.:QM9\<:-IO@
MZ\\26E[9WUM C>7Y5RNV60#B,-S\Q].OM0!4TSX>V>FV6DV?]J:C<P:3>?:[
M-9F0^7A"HCR%&5 8GUSWK2L_"EE9:-J^EQS7!AU2:YFF9B-RF;.X+QT&>,Y_
M&J\/BJ"ZETR[AU/1O[*N+.:XG=KH>9E,9*<X*+\P8GIQ6?HOCQ/$GAW3=3TZ
MXTF"6?4%M[B"YNLE$,C*%7'_ "U90"H/7- &7XBT>#1;K08H[3Q!%%8:>+2'
M6=('FS*%P/*EC"-E2 &SC&[L*N_#/1+C3AKVH307T$6I7HE@74&S<.BH%WR#
ML6;<<<8]!7:6^HV-W:R75O>036\997ECD#*I4X8$C@8P<^E4KWQ1H.G:?;W]
MYK-A!:7(S!-)<*%E'JIS\WX4 5]4\+PZEXCTW78[^\L[RR4Q_N&7;-$6#&-P
M0>"5'3!J.W\'6%MX1O\ PVD]R;2]%P))"5WCSBQ;!QCC<<<?G6Y:7=M?VL=U
M9W$5Q;RC<DL3AU8>H(X-<UXA\3:C#K]MX;\/6EO<ZO- ;J62Z<K#:P@[=[[>
M6)/ 44 .O? ]O-/87FGZG?:9J-E:K9K=VQ0M)".BR*RE6&>>G!K0\.^&[7PY
M;7"0SW%U<74QGN;JY<-)-(>,D@        5DZ=K'BJQ\16NE>(M/L[B"\1S#
M?Z7'((XF49*RJV=N1T;.,\5L3^*_#UKJHTNXUO3XK\D*+=[E ^3T&,]3Z4 .
M.@VQ\5#Q"9)?M0L38^7D;-A??G&,YR/7I7.-\,[/[+)I<>M:K%X?DD+MI*2(
M(L$Y*!MN\(3_  AJZ74O$>B:,774]7L;1D5699YU0@,2%."<\[3CZ'TJ!_%_
MAN.2TC?7M-5[Q0UN#=)^]!. 5YY!/'UH ?:^';.S\1W&M0M(LTUI%:&(8$:I
M&25P,9S\WK6-=^ (WN]0?3==U72K;4I#)>6MHT>R1V^\REE)1F[E2*W-2\2Z
M'HS.NIZO8VCH%9EGG5& ;.TX)SSM./H?2I_[7TTZ5_:G]H6O]G[=_P!J\Y?*
MV^N_.,4 <-XHT:RT>?0HK33-:M;6QMWA@U/1<RS6XX_=R1[6+HP&<D'D>^:J
M^$O!46J6GBIM5M=233]9N(3#_:#E;MO+4?OF[HQ?) P,8' '%=UI?B?0=;68
MZ7K%C>>2-TOD3JQ0>IP>![U'%XO\-SW\%C%KVFR74ZJT4272%G##*X&><CD>
MM %#3_!*P:O::GJFM:EK$]B&%F+PQA8<C!;"*NY\<;FR:+7P'IMI%ID:7%T1
MIVH2ZA%N9?FDDWY#<?=^<XQSTYKH;>^M+R2>.VN89GMY/*F6-PQC?&=K =#@
MC@TMI>VNH6XN+.YAN("S*)(G#*2"01D>A!'X4 8VJ^';>74M0UU;=KV\ETI]
M/^Q.X6*9,L^TG'!8G&>F#TKS#^P9=930M*L;?Q<OV:]MYFMM50K;:?&C L Y
M4>80 57EN#QBO7SKND+I::H=4LQI[D*MT9U\HDG;@-G'7CZU9>^M([Q+.2YA
M6YD1I$A9P'9%QE@.N!D9/O0!FV-AJ$/BK5KV6ZG;3YXH%@@DEW*CJ&WE%_A!
MRGN2#VQ69\1)R_A.\TI-(OM2GU*%[:&.VA+*LA'RL[=$ .#N/I6KI_BKP_JU
M\]CIVMZ?=W29W0PW"NW'7@'G%7H=0LKA+AX;N"1;:1HYRD@(B=1EE;T(!&0:
M ,&S\%:>/ %OX5OE,T"P*LKJQ#-+G<9 >H;?EL^M,T_P2L.KVFI:IK>I:Q-8
MAA9K>&,+"2,%L(J[GQQN;-23>*-WB[0=-LFMKBPU.TN+C[0C;L[-FW:0<$'<
M?6J7B_XA:7H6BZH^FZEIESK%D@/V)IPS9W $%0<\ GCM0!#=?#*SN(M2LDUO
M5H-(U"22:;3HI$$8D?DD';N SSMSC/7(XKL;*T2QT^VLXRS1P1+$I;J0H &?
MRJP.160OBGP^VL?V0NM:>=1W;?LHN%\S=_=VYSGVZT <W_PK"U_L:?0O[>U=
M=!DW[-.1XU6/<2<!]F\J"<A2V/7(K0NO T3365WIVKZAINHVMHED;NW\LF>)
M>@D5E*D@Y(.!C-:FI>*= T>\CM-2UJPL[F3!6*>X5&(/0X)Z58OM;TK2T1K_
M %*TM5=&D4SS*FY5QDC)Y W#\QZT 8MCX"TO3YM)FBFNVFTZYFN_-D<,US-*
MI5WD..20>V.@J*Z^'NEW,.L6RW5Y!::K<Q7<MO&R[(YD96+("O&XJ-W7/;%;
MMAKVD:IITFH6.IV=Q9QY\R>*961,#)W'.!@<\U7LO%WAS4HKF6RUW3KB.U0R
M3M'<H1$@ZLW/"^_2@"34-!MM1US2-6EDE6?2VE:%5(VMYB;#NXSTZ8Q7/2_#
M:T:&YT^WUO5K70[J1I)M*AD01'<<LJL5WJA).5#8Y-&B^/$\2^'=+U33KC2;
M>2XOUM[FWN;K)C4NPV+CK*R@%0>N:M:-\0-%U;4M=M3?6,*:5)@R&Z4[XPJE
MI?90S;<],CK0!9UOP3I&NRZ&\ZR1+HTRRVT<) 4A=I","#E<HO'^R*?9^#]-
ML?&FH>*8C*;^]A6&121L4 *"5&,@G8N>>U:\VH6=NMNT]W!&MS(L4!>0#S78
M$A5]20"0!Z5@^&_&^F>)-7UG3[:XM=^G3F-0EPKM+&%7,F!T7<VWOR.M $+_
M  ]TMM#335N;V-X;Z2_M[N.0+-!,[%B5.,8^8C!!R.M3:;X*MK>]N[_5=0N]
M9O;JV-H\M[L 6$]45$55 /?C)K1T[Q3H&KWLEEINM6%W=1Y+107"NP ZG -:
M%W>6UA:R75Y<16]O&,O+*X55'3DG@4 <6?AC;26]G93^(-9FTZPFCFLK-Y(]
ML)1@5&=FYP -H#$X!]>:Q]?@CMO%6K2O8>++!KD)EM#4RPZDH4 %B$/E./NG
ME3@9SWKOK'Q+H>J7\UA8:O8W-W#GS((9U9UQP> >U,O?%/A_3=133KW6M/MK
MU\8@EN%5^>G!/?MZT <EX:^'W_%O?#^GZB]QIVJZ<SW$$]K(/-M7=V8J"001
MAMI!R#BNDT+PI%H^I76JW.HWFIZI<QK$]U=E05C4Y"(J *JYYX')J]J?B#1M
M&R-3U2SLR$\S$\RH=N0N<$],D#ZFN3TKQX_B#XA76CZ5J6A-I=FJ9/FF2>[+
M(68Q%6VX4X!X/>@#?\0^%H]<OM/U&'4+O3M2T\O]GNK;82%< ,K*ZE6!P.H[
M5E'X;:?(=8DN-4U.YGUBR^QWDTTB%F&3A@ N%(!P !MP.G>MVR\5>'M2U%M.
ML=;T^YO%SF"*X1GXZ\ \X[TY_$V@QWZ6#ZS8+=O(T2P&X7>77!*XSG(R./>@
M"+4?#5IJ=OH\,TLRKI5U%=0E",LT:E0&XZ<G.,5DWOP_M[FZU$VNLZII]EJ;
MF2^LK9T$<SL,,P)4LA;^+:1FM:+Q?X;GO8;*'7M-DN9U#Q1)=(6<$9! SSD<
MU)8^)-&UA;I=(U:PO);<'S!%.KA/0M@\#WH GT328="T.QTFV>1X+.%84:0@
ML0HP"< #-<W_ ,*[@47]I#KFJP:/?RR33Z=$\80L_+@/LWJI[@,.M:EEXFLH
M=!L;S6]7T>&>>W,S2070\AP,!FC+')497GW%:&G:WI>KV#7VG:C:W5HN0TT,
MJLJXY.2#QCWH X+7M!M] C\.VL5MK_DZ=;-!#K.E8DN(1P/+DC5"&1@.N#@K
MT&<U7\,^!QK.G>+DU!=6M;#7)H!&]ZP%VZQ 9D8$?+N;. 0,#L.*[NQ\7>&]
M2E$5CKVFW$AD$02*Y1BSD$A0 >20#^1J7Q%?7&FZ%<7=I-80SQE-LFH2&. 9
M< [F'3@G'OB@"+Q%X:M/$=O;K/-<6US:RB>UN[9PLL#@8R"01@@D$$$$51T[
MP3:V]U>WNJWUWK-[>6QM)9;W8 (#UC54554'J>.:U-6\1:+H/E_VOJMG8^;]
MP7$RH6^@)YK+\2^+$T:WT&[M9;26SU'48K:2X9\HL3([%U8''\/7I0!1@^'%
MNBV=G<Z[JUYH]E(LEOIL\B&-2IR@9@H=U7C )QP.M==>6D5_8W%G."8;B)HI
M #@E6&#^AJKI.OZ/KT<DFDZG:7RQG:YMYE?:??!XJQ?ZA9:79R7FH7<%K;1_
M?EGD"*OU)H YS2O EMIO]A;]4U"[.B-(;0SLG"/'Y>PX49"KT[U8U7P1I>M7
MFK7%ZT[C5+)+*:,, %1&+!EXR&RW?(X'%5;'QQ9ZEXOGL+2\L)](BTD7YO(Y
M0P#>:R,"V<  +GVKHWU33XK."\DOK9;6X*"&9I5"2%\;-IS@[LC&.N: .6?X
M>B\DTV35?$>L:@^FW,5Q:>:T2*C(<C(5!O)Z$MDX)QC-:VF>%X=)\2:GJ]M?
MWFS43YDUDS*81+A1Y@XW X4#KCD^V,V'Q[8WVN>)-&M+K3DNM*A!A>:Z&V5]
MC,Y8#D*A #8SCGI6NWB+3]-T"QU'6]4TVU$\*,9A.!"[E03Y9)^9>X]J (?$
M?A:'Q!/87B7]WI^H:>[M;7=J5W)O&&4A@000!P1VK*3X;:=]AU^WGU+4KB37
M8HX[VXFD4R$INPR_+@'#8QC  & *Z9-:TN72?[534K1M."[C=B9?* ]=V<5'
MI'B'1M>21](U2SOA&</]GF5]OIG!XH BU/P[:ZJVD--+,ITNZ2ZAV$?,RJR@
M-D=,,>F*Q+WX=VUS+J,=MK.J6.G:F[27EA;.@CD=A\Q!*EDW=PI&:ZJ]OK33
M;22[OKJ&UMHQEY9G"*OU)XJI8>(]$U33Y[^QU:RN+2W!:::*=66( 9)8Y^7@
M9YH QI_ 5F;/1EL=0OK"^T>V%K;7T#)YAC"@%7!4JX. <$=>F*C/P[TZ71]1
MLKN_O[JYU*>&>[OI77S9&B960<+M"C;C '0FN@T_7M(U:XGM].U.TNYK?'FI
M!,KE,],X/%1:MXFT+0I8HM6UBQL9)1E$N)U0L/7!/3WH K^)O#$/B6&RW7MW
M8W-E<"XM[FU90Z-M*_Q @@ACVK-;P$B7^H2V>O:K96FI2F>\M(&C"R2$ ,P8
MH73=CG:1[8KHKO6-,L--&HW>H6L%B0&%Q)*JQD'IAB<'/;UJ*U\0Z->Z5)JE
MKJME-I\0)DN4G4QICKN;.!CWH Q]*\ Z9I">'DM[B[9=":X:U#LIW"8,"&XY
M #'&,=!G-1W'P]TN:#5+9+J\AM-1O(KY[>-EV1S(RL2F5XW%1N'/MBMBU\4Z
M!?7QL;76M/FNQ(8_(CN49]P!)& <YP"?P/I2:YK$>GV5Y';WVFPZE':M<1QW
MTVQ H.-[XY"9X)H =IV@VVFZUJ^J122M-JCQ/,KD;5*($&WC/0=\UQ6N^&+3
MP[H^@V5O9ZW/;V5Q/(FJ::P:[LFD);[BH=Z-N*D8X &0:[2^\1Z3HMC;3ZSJ
MMA9^<HVM).%5S@9VY/(J:?7=(M=)759]4LX]/8 K=-.HC8'IALX.: .)^'VC
M7$?BG7M>>/5A:W<4$$4VK#;<7#+N+.4P-J\J ,#@=*Z;7_"J:UJ-AJ<&HW>F
MZE8AUAN;8(QV/C<K*ZLK#@=JT;'6]*U/3FU"QU*TN;-<[IXIE9%QR<D' Q[U
M#I7B?0M=FDATG6+&]EC&72WG5V ]< ]/>@#!7X<:?MULS:GJ=Q-K5F+6]FFD
M0LV,@./EPIPV, ;< <5LZCX9M-2M='MY99U72KJ&ZA*$99HP0H;CISSC%:T]
MQ#:V\EQ<31PPQJ6>21@JJ!W)/ %9EAXJ\/ZI;W-Q8ZWI]Q#:J7G>*X5A$HY+
M-SP.#R>* .3N-+7Q3\5[#4CI5];VV@QRK+<7,1C2YEW8B"9^^%R[[AQR/6O0
MZXCP%XPO/&-QJ-V;K1S812O'#:VS,US& Y57D.[&&"DC %=)J_B/1= $9U?5
M;.Q\S[@N)E0M] 3S0!A+\.],B\/Z7IEM>WUO-I4DDME?Q.HGB9V);^':0=Q!
M!&"*5?AYI]Q::LFKWU]JMUJD M[BZN&576,<JJ!5"H >>!UZYKJ+.]M=1M([
MNRN8;FVE&4EA<.C#V(X-4=5\3Z%H4T<.K:Q8V4LHRB7$ZH2/7!/3WH P'^'@
MO)--DU3Q'K&H/IES%<6GFM$BQLA!&0J#>3C!+9."<8S4U[X"M[B_OYK/6-3T
MZVU)M]_9VKH(YV(P6!*ED+ 8)4C-:]SJ<@UG1X;:ZTTVEXLK.))OWLH5 5,(
M'##G+>@Q3(_%_AJ6]M[./7]->YN ##$MTA:3/3 SSGMZT 9;?#[3TT?1;.TO
M[ZTNM&0QV5_"R^<JD88-E=K \9!':F_\*\L9])UFUOM1O[V[UB-8[N^E9/-V
MK]U4 4*H'/ '>MW3?$>B:S<3V^F:M97DT'^MCMYU<IVY /3-<]9>+-0?4?"-
ME.VEW']L17;W$]C(TD0,2@KY39Y!SSG- &OKOA:#6TL'6\N[&]T]B]K>6S*'
MC)7:PPP*D$=0165)\.K&[TK6+74-2U"\N]7$2W5](4$A6,Y15 4*H'/ '<UL
M3>,/#5OJG]F3:]IL=]NV>0UR@<-_=(SP?;K4VI>)-#T>0QZEK%C9R#;E)[A4
M(W9V\$]]K?D?2@!-4T&VU;4=)O9I)5DTR=IX0A&&8H4PV1TPQZ8KB/%/@?R[
M/0M.TXZB\4OB0W\\\)_>6^\2,7# ?*%8C!/MG-=EXK\1VWA7PS>ZS<>6PMXR
MT<;R!/-?'" GN?QJ71_$6EZU!;FSU&SGFFMQ<>5#.KG;G:2 #T# KGU&* *>
MB^$X]+U6;5[S4KS5=4DB$ N;O8/+BSG8BHJJ 3@GC)(JYK&@VVM76ESW$DJ-
MIMV+N(1D ,X5EPV1TPQZ8J6?7=(MI98Y]4LXGAD2*17G52CL,JIR>"1R!W%-
MTGQ#HVNB7^R=5L[[RCB3[/,K[?3.#0!0USPG%JVJP:O::C>:7JL$1@%U:%"7
MB)SL=74JPSR,C@U2'P]TO^Q+C3I+J]FENKR.]NKV216FGE1E89., ?*!@  #
MI6NOBKP^^KG2%UO3SJ(;;]E%POF;O[NW.<^W6M>@#EM1\%+/K-UJNEZUJ.CW
M-ZJK=BT,92?:,!BKJV& XW#%:^A:'9>'-'@TNP5Q!#D[I&W.[$DLS'N222:T
MJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "N*^)7_'AX=_[&&P_]&5VM17%K;W2H+B"*81N
M)$$B!MKCD,,]".QH \^\)Z3I]WJ_C^:YLX)I)=3>!VD0,2@A0[>>V6-:_P +
M'9_A?X>+,2?L@&3Z D"NIBM+:!IFAMXHS.^^4H@'F-C&6QU. .32VUM!9VZ6
M]K!'!!&,)'$@55'H .!0!Y)-J8N_^$PGLAX>TBQ2\G@OI-15[BYN'10I;864
M 'HJ\^PYKL_A>Y?X8^'26S_H:#/TXK<DT#1I=3&IR:38O?C!%TUNAE&.GS8S
M5NUM;>RMTM[2"*"!/NQ1(%5><\ <"@#@/"6HV7AGQ5XJT+5[J*SN;K4WU.U:
M=PBW$4JK]TG@E2I!%1^+?%K^(="\6Z3X:B:[6RTQC)J%M)N3S3]Z%<?>;9DY
M!XZ=:[S4M&TO68EBU33K2]C4Y5;F%9 I]MP.*ELK&TTZU6VL;6"UMU^[%!&$
M4?0#B@#R_P 43^')_ _AN+PV]FU_]LL_[)6V*F16#KNX'(^7=NS^-3:;IEC<
M-\3KB>UAEF>YEB+N@)V"W4@?F2:]!M/#^C6%\]]9Z186]W)G?/%;(CMGKE@,
MU:6RM$%P$M85%P2T^(P/-)&"6_O<<<T >2C3[2U^'7PSF@MHHY3J>FN9%4!B
MSC+G/7G)S6CX8N?#-OXA\?\ ]JRV*7!U%OM'VDJ,V_EKCKU7._/_ .JO1SIU
MD;>WMS9VYAMF5H(_*7;$5^Z5&,*1VQTKF],\#6$6HZS=ZM9V&H&\U%KVW\ZW
M5S""B+CYAP<KVH \NTU-5B@^'AN+BRM+?[-=_8Y-6A:2%7+YB!&Y<-Y6W:2?
M7%7]3MBVF?$29M5TV]F.EK]JATVS>.%)0&*ON+,"^W.<'/ S7LU[I]EJ5HUK
M?6D%U;MUBGC#H?P/%,M-)TVPL6L;/3[6WM&!#00PJB'/7*@8YH X.&2TNO'G
M@IK5X)K9M'NP#$0R'_5 ]..N:Y;1Y;9OAEX*BA>$S1>)H%F1"-R'[3+@,!R#
MCUKV2TT;2[#R?L>FV=OY 98O)@5/+#'+!<#C)Y..M-CT+2(G=X]*L4>287#L
MMN@+2CHYXY89.#UYH \N\2FZT;6]<\'66]!XLGBFLF4<1^8=EV?P52W_  *I
M+ZUN]/\ BQ);6MWH]@D.D01:;_:ENTB>4I(=8L.H# XSU.,=J]6DM+::YAN9
M;>)[B#=Y4K("T>X8;:>HR.N.M0:EI&F:Q"L.IZ?:7L2G*I<PK( ?4!@<4 <C
M\,84BM=<:#4K6]@DU)V_T*V:*WCDVC>(]Q.5SSD'&2:@O;RW\,_%]M0U65+>
MPUC34MX+J4[8UFC<DQECP,J<C/6N]MK6WLK9+>U@B@@C&$BB0*JCT ' IMY9
M6FHVS6U[:PW,#_>BFC#J?J#Q0!S]QXUL7\3V&@:5Y>I75R'DG:WE#+:1J.'<
MC(Y. !QUK@=%F\.1_!+4X-9:T&HB.Z&HQSE?/-WN?&0?FWYV[?PQ7J^FZ-I>
MC1M'I>FVEDCG++;0+&&/OM S3)?#^C3ZDNI3:1827ZD%;E[9#(".GS$9H \[
M\(:>UQ\0+*36;<2ZA!X3LPYG7<RR%V#YS_%Q@_C6*FDZ?%\$/&+QV4"O]LO2
M&$8R-DQ"8/;  QZ5[4+6W%VUV((A<L@C:8(-Y4'(4MUQDGBHO[,L/L<MG]AM
MOLLQ9I(?*78Y8Y)*XP<GDT >>VUQH\7QFDDU26W2[.@6_P!F>X8#^-]^">^,
M>^,^]<X+ZQMM)U!;?3[.[TN^\6!-*-S*T=I&^T$R$KP8]ZM@=":]%G\%VE]X
MQO-6U&VLKRQGL8;9;6>$.%9'9MV",=&Q6_-I6G7&G?V=-86LECM"_9GA4QX'
M0;<8H \G2XN6^*JK>ZAI%S=_V%=+*NEPE%C&5(5B68L>,]L>G-5YM,L;;]G/
M2[B&UA2=19W"RJ@#B1IX\MGKGDC/I7K=MH6CV21):Z58P+"&$8BMT78&X;&!
MQG SZU,=-L&L%L&LK8V:@!;<Q+Y8 .1A<8X(!'TH \U\::A=>"?%.HWMA&S-
MXDL1!;JH_P"7]"(XS^*R#_OBO0?#NC0^'O#FGZ1!REI L>[^\P'S-]2<G\:R
MM0\/ZGK/C"QO-0GLO[$TR7[3:6\:-YSS[-H:0GC"DL1CVSTKJ* /#=1T:35M
M5O\ X:*&6"*]N]4C(X"P/%NB ]A--_X[4+WVH^,?!'BCQ/"DWVB#2+?2T"@A
MOE"R7>!]6(_X#7N0L[47IO1;0BZ9/+,^P;RF<[=W7&><4EM9VME$8K2VA@C9
MBY2) H+'J<#N: /-?%D_AZ?2?"4?AI[)KW^TK4Z8MH5WK&#\_ Y";,[L\>M+
MHFLZ;I-A\0H;^]@MYDU:[E\J20*Y5XDV$*>3N[8ZUW]EX?T;3;N2[L=)L+6Y
MD^_-!;HCM]2!DTL^A:1=:BFH7&E64UZ@PEQ);HTB_1B,T >3Z$+@K\/19G%T
M?#5YY/\ O[(]OZXJAJLWAC_AG>"!FM!?)%&#&<>>+P./,R/O;L[L^V>U>VQ:
M;8P-;M%96\;6R&. I$H\I3C*KQ\HX' ]*JR>&]"FNYKN71=.DN9AMEF>U0O(
M/1CC)_&@"UJ N#I5T+3_ (^?(?R?]_:=OZXKS#0+KP9%\)-&CU.**=U:$26T
M)Q=&]WC. "'W[\GKG'M7K-9RZ!HZZH=472;$:@>3="W3S?\ OO&: ."\*3Z#
M;_\ "9IXC>R2^.JW!O1>%0S6YQY7WN2FS&.W6L#PM8_:[CX7QZG 952WU*2%
M+A<D1@J820?1-A'X5ZY?:!HVJ7,=SJ&DV-W/']R6>W1V7Z$C(JV]I;27$-P]
MO$T\(812% 6C!ZA3U&<#./2@#R;6K+2AJOQ,M+Z9[#3I;?3GEEMXMWEL0WS[
M!U&0N[U&<^M7='O;FW\>:+8:LOA_69+JUGCM=2TP%)8X@H8^;&"5V-@ 8XS7
MI?V*T\V>7[+#YEPH6=_+&90 0 Q[@ GKZU5T[0='T>2233-*L;)Y/OM;6Z1E
MOKM S0!Y!HLML_PS\!QPR1--'XDMUF5"-RMYTN P'0X]:N:@+<Z3\6+2/ROM
MFYY!"N/,\O[.F2!UVYKU2/0M(A=GBTJQ1GF%PS+;H"THZ.>/O#)YZ\U*-+T\
M:@^H"QMA>NGEO<^2OF,G]TMC)' X]J /.?$6NZ7?P_#VVL[^WN)GU:TF"12!
MB$$; D@=.6 K%U<LOA_XIVNG,BZC]LW^5'CS?(V0^80!SMV[J]8M?#>A6+%K
M31M.MV,@E)BM44[QG#<#J,GGWJRNF6":B^HK8VRWTB>6]R(E$C+Q\I;&2.!Q
M[4 >32Q-<3^$,>(?#0C2^A;3TTG3Y!,R@?,@Q(VU"N0Q(P.]=A\6,?\ "K=?
MW9QY SC_ 'UKH;+P]HNFWCW=CI%A:W,F=\T%LB.V>N2!FJGC/0IO$WA#4M&@
MF2&6[C"+)("57Y@><?2@#C]>FT*XNO <7AE[1[E-2B:V%J062T"-YN<<A=N,
MY[XKE=(6[_X1OQ/%J.K^&K7-Y=?VI%J-F[W&2QP2?,&1MQMP/3&37L]CH>E:
M;<2W-GIEG;W,W^MFA@5'D_WB!D_C3;OP]HNH7J7M[I%A<W:8VSS6R.ZXZ88C
M- 'F^B:5;7?C;PC!J!74EM_##O'+<0%=Y\Q%5BC<@[6[\\U%J]I.L_Q732H
MMRMM:B(0KA@/LPW!<=\9Z5ZT;6W-VMV8(C<JAC$VP;PI.2N[KC(!Q1':V\-Q
M-<101)-/@RR*@#28&!N/4X' S0!Y7XHG\.3>!/#D7AQ[-K_[79_V2ML5\Q6#
MKNX'(^7=NS^-:?@S3+&34?'.H26D+W8UJ=%F9 655B0@ ]N6;\Z[6U\/Z-8W
MSWUII%A;W<F=\\5LB.V>N6 S5N*TMK?SO)MXH_/<R2[$ \QB,%FQU. .3Z4
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MZ>TB\1?%.%FA2X?3HGC0D!V'V1MQ ZD9ZUC6G]H+XH\),E[I5H#X6MQ8R:I
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MH *XOXEZYJNA>'[6;2H9FDEOH(GDB9 54R*"OS'^+[N1TSVKM*Y+XCV%[?\
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ME/B/=Z-(%.C^&IIKJS .0'N@&1"/]@&7'^\* /5Z*** "BBB@ HHHH ****
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M901N;:OJ,D\T[QG;^+K?P/XHM-1U&TN[(:<TL=\EL(W;@[XFC#8Y&"''3T-
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MB?1].UO4;75++5V>%)H[7R'@F5"X& Q#*0"/4&G_ !1_Y%BS_P"PM9?^CUH
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M6+I=OXE?Q[XW?0;_ $^)&NX$DCO86<*?(3#J5(Y]CP<#I7J--"*K,RJ 6Y)
MZT <*/AY-INFZ&^BZFJ:QI#S2"YNHMR7)F.9A(H((#'D8/&!5U?#6NZI8ZXF
MOZS$SZE9/916UG&RV]LK*P+@,<LQW=3CIBNOHH X%/!NOQV>A7L>IZ>FO:-$
MUM&X@<V]Q;D ;)%W;@?E!R#U[5/=^$O$&M:!K]MK&M0/=:I;^1##;QLMM:J!
MU )+,3U)-=O10!SFM^&I=5C\.JEPD?\ 9-_#=OE2?,"(RD#T)W5'H/A[4M$\
M3:Y<_:[672M3G-V(O+831S%44C=G!7"GMGD5T]% 'G]S-9ZM\98[2">.?[/H
M=Q#=B)P3$6E3"MCH2.QYJB_P]\3S^%+?PM-KNG?V59O$8)$M7$TJQN&59/FV
M@#'8<D#WSW&F:IIU]JVKVEG%MN+&5([I_+"[G9 PYZG@CFM:@#!TK0)-/\6>
M(-9:='CU3[-LC"D&/RD*G)[YS6)9^#M=T?1[:+2=:ABN[>_N;HQRQL;>X25F
M.R100>-PP1T(Z5W-% 'GD?PUDOK77Y-4N[6WO]7\@C^S8#'%;-"=T;@$Y9MW
M))QGIQ5H>&/%.I>(="U/7-6TUH])F=Q!9V[KYQ:-D+,68X;D<#@<UW-% ' C
MX?746F*;74HHM5M=8GU2SN#$60>8S9C=<@E2K$'!'J*L3^$M=URSUH:]K,0E
MU#3VL8;>R5Q;P Y/F%6;YWR1SQ@#'>NVHH XJU\'ZE<7V@W>M75E,VG65S9S
MI;QLJS+(%52,DX^5>?<\5G_\(-XE/AS_ (1$Z[9_\(]M\CS_ +.WVS[/G_59
MW;,X^7=CIVKT6B@#GM*\-?V7XLU/5HY4^S75I;6T4 !S&(@PZ_\  A^5/\*Z
M!)X>L[^"6=)C=:A<7@*@C:)'+!?J*WJP/%'B8^'8K!(-.EU"^O[D6UM;1R*F
MYMI8DLW  "F@"E?>%;R?QM-J\5S:MIM]8"PO[6:-M[("Y!1@<#._!R.WY8S>
M!O$LWAU/"4^NV3>'E583,MNPNVMU/$1.[8#@!=V.G:O0+:266UADGA\B9T5G
MB+!MC$<KD<'!XR*EH JW=DLVDSV,6(U>!H4]%!7 K@;?P#XCE\,V'A/4]:L9
MM!@6)9FBMV6XF1"#Y62VT+D8W8S@#WKTBLTZW:#Q*N@_O#>FS-[]WY1&'"=?
M7)Z>U '/W'AK7M,\0ZEJGAF^T](]3V/<VM_"[*DJKM\Q"A!Y &0?3K6_H&FW
M>E:/%:W^I2ZC=@L\MS*,;F)SP/X5'0#T%3:3>SZAIL=U<V,UC*Y8&WF(++AB
M!G''( /XT:K>SZ?I[7%M8S7TH9%$$) 8@L 3SZ DGV% ',W7AGQ#9^*M4U;P
M_J=A##JRQ?:4O+=I&A>-=@>/:P!X[-QD55T?X?7&E6'A6U;4$E_L2\N+AW*'
M,PD\S ]B-XS]*Z=?$%M-JFK:9;1337FF0132H!@-Y@8HJGN?D/YBKNGW,MYI
MUM<S6LEK++$KO!(06B)&2IQQD=* .:UGP/%KNO:K=WDX^QZAI"Z:T:CYT(D9
M]X/3^(8]Q4-IH/C)WTZTU'Q!9BPLI%=Y;.!TN+L+T5R6*J#_ !8Z^U=I10!S
MVA^')=)D\0N]PDG]JWSW2;5(\L,BK@^OW:R-)\"W&G6_@N-KV)SX>$HD(0CS
MM\;)QZ8W9YKN** .''A;Q+HUUJD?AK5=/AL-2N'NBMY;L\EK*_WS'M8!@3R
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M%9V:,EO HY)&XDLQ[D_2G:OH$FI>*/#VKI.B)I3W#/&029/,CV#![8ZUO44
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M. 3%Y:AG#D'&1D#CUH R;7PWKNI>(M-U;Q-?V#KI>]K6VL(756D9=ID<N2>
M3@#IGK6GXMT"3Q'I,%G%.D+1WD%R69201'('(_'%;U(3@$^E '&2>&?$.D:Q
MJEUX9U'3X[75)?M$T%] [^3,5"LZ%2,YP"5/<=:9IWP__LJ;PNT-_P";_9$]
MS<7,DJ?/<R3(P9N.!\S9QZ<5T'AC7HO$_ANRUF"%X8[I2RQN02N&(YQ]*UZ
M.'\3>%K::?Q-J^IM+-IU[I"6LD%M'NF41EV++ZGY@0/:N*N=1O?$%[X/L(_%
MNFZYY6J6UPL.GP;96BC^9I9_G;:5 QC Y/M7JVNZ_%H3Z4LL#R_VC?QV*;2!
ML9PQ#'V^6H?#FJV.KR:N]I8K;/9ZA+8RMM4&1DQEN.QW=Z '>+_#_P#PE/A3
M4-$%RUL;J,*)0,[2&##([CC!'H37.3>$/$FIW.A2ZA?Z1;0:1>QW*6EA;.J2
M;00223P<$@ # R<Y[=/!K\4_BR[\/B!Q+;6D=T921M(=F4#'K\M:] '(_%'_
M ))AXB_Z\V_I5*U\,>(-7?1/^$@U6RGTW39([N);:!DEN9$'R&4EB!C.2%ZG
MTKNF574JZAE/4$9!I>E '"IX4\3:*^I6GAO5M/ATV_GDN%%W;N\MF\AR_EE6
M 89R0&Z>]:5CX4GL_%&FZM)J+W0M-*:P=I^997+JWF$]/X3Q[UU%% '#ZA\/
MSJ4OB21]0\F34[NVO+26-,M;2PHH5B#PW*]/0U+#X:U_5=<TN_\ $VH:?)!I
M;F:WMK"%U$LQ4J)'+$] 3A1W/6NSHH \WG\!>(X?#5_X4TO6K&'0;A95A:6W
M9KB%'))BR&VE<DC=C."?:N_T^V-EIEK:LP9H(4C+#OM &?TJS10 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5Q7Q'FF>WT#2Q<2V]GJFK16EW)$Y1C&59MFX<C<5 X^G>NUJ
MCK&C:?KVFR:?J=LMQ:R8)1B1@@Y!!'((/0CF@#@KOP_IGAWQ]H6D:3"8=.UN
MWNX=0L%D8QNJ1AEDQGY6R=N1US5KX.:796/@."ZMH!'-<S3B9P2=^R>15ZGL
M*Z/1?!^D:'?27]NMS/?/'Y1NKRYDN) F<[ SDX7V%:&CZ/9:#ID>G:=$8K6-
MG94+%L%F+'D\]6- '"0Z+IP^-&M78MAY\>DQ7"ON/$C-(K-U[CBN8T.Q37+7
MX76%]+.UK/I]\;B-967S@HC(5B#DC..._2O5[KPOI5YXB@UZ2*5=1AB\D21S
M.@=.?E90<,!N/44VQ\(Z+IQT@VMJR'2(I(;+,K'RUDQN')^;.!US0!YUI?@O
M1KS4O&VEW,4\FG:9,OV"U:X?9:EX [,@SP=Q'TQQU.<U;_5?$%MX%TJYLY=7
MMIM&:[FM6O/(%W(NU1O8_?VCG;WSD]*]AM]#T^UNM3N8H2LNIL&NCO)WD($'
M?CY0!Q6=<>!]!N=&T[2VM9(X=- %E)%.Z2P<8^60'<..O//>@#!\ 6NH:9X@
MUK3Y+2+3]-"12P::-06Y:U<Y#8 Y5&X(!XR#BG>)+:+Q#\2]+\.ZHSMI"Z9+
M>_9@Y5+F82*@#8(W!5)./>NGT+PUIGAV.X&GQ2>;<N'N+B>5I99F P"SL23C
MMZ4:[X:TSQ$MN;^*3SK9B]O<03-%+"2,$JZD$9[CH: /)?%B-H%AXY\/Z3<3
M1Z;!;6-U#'YA86DKS ,JDG(! #8_*O6O#_AK2_#%I+;Z9"Z+,_FS-)*\C2/@
M L2Q/)Q5./P)X?CT.\T@V;O;WSK)=O).[2SL"""TA.X\@=ZZ.@#S73-"T_QK
MXI\52^(HWNWL+X6=K;/*RK;Q"-6#J 1AF+$[NO'%8FD7]Y9:=H7B.:\FN;;2
MM7N-'GN)'R9K-Y/+21SWVL$Y^M>AZOX(T76=1?4)DNH+N5!%/+9W<EN9T'17
MV,-P^O-77\-:._AIO#OV&-=):$P?9DRH"GT(YSGG/7//6@#RK6-2U*?PKJ_B
M:TEF7_A(-9AL8&27RREDC^6I5C]S>0WS?[8-:FD:3?Z%XTT1['08/#]M.9(K
MN ZNLHO%V9!$9.6=3@Y'."<UZ$_AW29/#B^'Y+&-]*6!8!;MDC8H&!GKD8'/
M7//6J.D>"-%T;44U"%;NXNXHS%#+>7<EP84/54WL=H^E '+?";P[8-HD'B28
M33:J\UU$LTDSG9&)G78JYV@<9Z=2:G\:Z+IVH_$SP0UW;+*96NT<EB,A(2ZC
M@]F)-=MH^CV6@Z:FGZ=$8K9&=U0L6P68LW)YZL:K:[X9TOQ']D;4(I3)9R&6
MWEAF>)XV(P<,I!P1P10!PWA_PYIGC4>(=4\0^;/?1ZI<VL;&=D-C'&V$6/!
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M8%N HP!($8!L#CZ4ZT\$>'[&VM+:VL?*@L[XW]O&LC!8YB",@9Z?,?EZ<]*
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MK;PS'J6EV:,JI97'V6ZM6P IB?>@V8&"N1T'6J7A;X?PM8>(TUC218V6M21
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MMGPK\.=*TS2M#EO;6<WMG;PN;:2[>2"&Y"#>ZQ[B@;=DY Z\BNKLM'LM/O\
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M1H=^^H6ZW4]\\?E?:;RZDN)%CSG8I<G SV%;] !1110 4444 %%%% !1110
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M]: /5+_QIX?TVUL[BZOBHO5WV\:P2/+(O<B-5+X'TXJ>/Q5H4GA]]>75+?\
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M>@H [+3O$J:M?Z ]OJ<*17UI-(UHULZO,R;064D?*%)/!ZY&*E'Q \+'4_L
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M0&=$?444!+UPF"5/\07A<]/2NDH **** "BBB@ HHHH **** "BBB@ HHHH
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MYR.2>.]:?B'Q7J&F>)M/T#3-'2^N[ZVDFC>2Y\I(]A4'?\I.W!/(R<X&.<@
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MHU]+'&LL=[YD]OYA 1I4V@ $D9PQQFNPU;4[;1=(N]3O&*VUI"TTA R=JC/
M[F@"X0",$9%! (P1D&N#C\=:O:QZ?J.M:#!9Z/?RQQ+)'>^9-;^8<(94V@ $
MD9P3C-.?QGX@OM5UNQT/PW!<_P!D3^5++<7WE"7Y P" (?F.3P>!QSSP =ND
M<4,>Q$1$]%  IX  P.E>.^+=7N?&T7@=[72;>ZTK5)3,;6YO&B$LBQN3&^U#
M\JXR&YR>,#K74Q>)]8GEO;/PKX<MKK3]'?['(\UYY/F2(!NCB&PYV\#+$#-
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MROD[@#C R>G)'XU:^#VF+9^!K2];3;>VN+Z))9)XYVE>ZXR)),@8;+-QS]:
M._VCT'7/2C SG'/K7-6?C"%CXE74;<6;Z#(QF'F;M\&S>D@X&-PSQV(ZFLN+
MQQJ^HG2[#3-!B;6+NP74+B&XNRD5I$QPNYPA)8_W0OK0!W(  P!BL2P\-Q6?
MB36]8>83?VH;<^2T8Q$8D*CG/.<YZ#%8$GQ%DM=&U"6\T@PZKIM];V=W9&?*
MCSF4+(KA>5(;(X!XQQUKH-3\0'3O%.A:+]F\P:J+@^=OQY7E(&Z8YSG'48H
MVB 000"#U!IJ11Q1[(XU1/[JC K&\3>(3X;@L+I[42VDU[%;7$OF;?LZR':)
M#P<@,5!Z=:R?%/B:*.;6]$;3OMEM:Z'/>WK>>8\*0P6+(&06 ;G(P!F@#L<
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MWE8$XSST).<"M&3Q[>:=:Z]!K&CI;ZOI-B;\017.^*ZAYPR/M!'S @Y7CWH
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MR,%( 4* "!R*]GHH \RU#PYJ<NDZ'9:IX1LM>L(-+B@DM_-C2XMKA5 8K(S
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M3$I^XTG(<LG? 8'%>KJVY0PR,C/(Q2T 5+"WN;;2+6VN+GSKN*!(Y)R/ON%
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MKDU]:22"VM]#LR]O:A1\JS,8RK-G[V6XZ<5Z#JOAN'58]$1[B2/^RKR*[3:
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MJ6NJ:??2/'9WUM<.GWUAF5ROU /%8'Q&O+&S\$WHU"">X@G:.#R()O*:5G<
M*7_A4GJ?3-<.;*YTOXG>"Q/I&@:/+*]R@@TMR9&C\EN)#L4%<XQP>: /5WU7
M3HY(XWO[57E8K&K3*"Y!P0!GDYXJPLT32O$LB&1 "R!AE0>F1VKQC3_#.C7?
MPK\8ZC<Z=;SWOG:G(EQ)&&DC*,Y3:QY4 C.!W)]:UKS4E\*77A?QG=NQM+W2
M5LM2<GDL(O-B8^I)#KG_ &A0!ZBDT4K.L<B.4.UPK [3Z'T-$<T4V[RI$?8Q
M1MK [6'4'WKF?A]IL]AX3AN;Y<:CJ<CZA>?]=)3NQ_P%=J_\!KD?$VI7'@G7
M_$5G9 B3Q);I-IBCC_32RP.![_-&_P"!H ]$74II=;@MK>.WEL)+=Y3<K<*6
M#A@-H3J1URW8C%6EU&Q>]:R2]MVNEY: 2J7'U7.:\MU'39?"_B"TT_1\FXL/
M!UVEN5'+2*R8;ZEN?J:IZII/AVS^!]EK6FPVZ:JL%O<6M_$!]H>[)7/S_>9B
MQ8$?7TH ]+TOQ VH^*-?T=K<1KI1MP)=^?,\V/?R,<8Z=ZT;75-/O97BM+^U
MGDC^^D4RL5^H!XKRK6+ZTLK[XDR:K!/+#*-,A>&WE\IG9X@H7?\ P@DX)],U
M'/8W&E?$+P5Y^C>']&DEN)HT@TQRTK1^4V0YV*"N<=CS0!W,'C5-4TK6KC1H
M()[G3;QK58I[I(UEVE07W<A5.XX/?'O717>H66GJK7MY;VRN<*9I0@8^@R:\
M3O=/T^T^&7Q%:UL[:&1-<FA!BB52(Q-%M3@?=&>!TKL-+TW3-<^)?BY=>M+:
M\N;86\=I#=H)!';&/)**W&"Q;)'>@#T%[B&-49YHU#G"$L!NXSQZ\<U':7]G
M?HSV=W!<(IVLT,@< ^AQ7B$5I;:CI&C:6V9]$3QK+;62EB5:U"280'NF=R_3
MBNWT[3+'1OC/);Z9:065O<>'_-EAMXQ&CNLX4,5'&<$C- '>RRQPQ-+*ZQQJ
M,L[G  ]2:K#5M/>PDOHKVWEM8P2TL<JLHQ[@XKC_ (@)#=^(?!VG:G@Z+=7\
M@NDD_P!7)(L1,*/V(+=CP2*S;[2M*L_B9)IFFV-JMK=Z)-)J=G'$ODDJZ^4[
M)C;NR2 <9Q0!TG@7Q-J'BS26U:ZM+*VM)L-:QP7)ED"G/$HP IZ' SUKH+G4
MK"SFCBNKVV@DD^XDLJJ6^@)YKE?A/9VMK\--$DM[:&%Y[99)6C0*9&_O,1U/
MN:YG7-#ENO$_B>^L+/0?$<+[$O[+4,Q7-KB(#;'(00%(^8'CD]>* /5S-$)E
MA,B"5@6";AD@=3BA9HG>1%E1GCQO4,"5R,\^G%>7Z!J5EJ'C'P1>6<<MO:7&
M@7"6\5PY9QM:/Y=QY8@#KW'-8?B*\2:?Q^8;C_0)=7TVWO98GQM@VHDHR.@Z
MJ?QH ]>EUJR;3KVZLKJWNS:Q,[K%*&P0"<'&<=*J>'/$UIKNC:7=/+;P7E]:
MQW/V3S@74,H. ."1[XKG=;TCPCHU[";*"&PU2;3;N.VBLH]BSQ"/+>8%&"!@
M$%N]<?)X>TG3?@GX>UBTL+>+4T;3[A;Q4'G;VEC!._KC#$8SC&/2@#VUF5%+
M,0J@9))P *K1ZE82W(MH[VV>X*AQ$LJEBI&0<9SC'>J_B'_D6=5_Z\YO_0#7
MD<^EZ'8_ S1=6TF&W&LJEI):748'GM=ET#*&ZDYW*5]!CM0![*^H644RPR7E
MNDK/Y:HTJABV,[0,]<$<4'4K%;T61O;<79&1 95WG_@.<UYWH>A6%]XX\<:G
M-8076HVMY$;-ID#^4X@1@4S]TDXY'H*P[72?#DWP'GUNYBMSJAM)+F34' ^T
M"]!)'[S[P;S,#&?:@#V9)HI'=$D1GC(#JK E3UY]*S[C4IAJMA;6D=O/;S/*
MES+]H4-"57( 7JQSP1VZUYSJ.M7'@?4+;Q+?(<ZWHBI<H1C=?PQ[D!]V!9?^
M BI+317\.ZW\-K*X):[S?S7;]2TSP%Y#[_,3^0H ]+74K!KTV2WML;L=8!*N
M\?\  <YJ&RO;J?4M2@GMX8X+9T$,B3AVD!4$EE_@P>,'J.:\9BLH?#OAVTU:
MXTW1]?\ #\5ZL\6LV4C0:@&,W#/D9=MQP0",]ZM^*)7CN_':-(\5E-K&F17T
MB,5*V[1QB3D=!C@^QH ]BM-1L;\N+.\M[@QG#B&57VGWP>*:VJZ<DD4;W]JL
MDI*QJ9E!<@X( SSSQ7!>(-+TC0O%W@N3P]:6MG?3WI@=+1%3SK3RV+[@OW@,
M*03T-<U8^&M&N?@]XJU*XTZWFOM^HRK<21AI(S&\A3:QY4 C.!W)]30![)=Z
MA9:>JM>WEO;*YPIFE5 3Z#)JPK*ZAE8,K#((.017DUWIEUJ^N:=?V!T36-17
M0[<7.EZPC$A&R?,C;! +$D'CMS74_#S4],?P?!';6ATN*"ZEL_LLMSYH24.<
MJCD_,,YQCZ#I0!V-<WXI\42>%9]-N;FS#Z//.(+N\#X-H6X1BN.4)X)R,>]=
M)574=.M=6TVYT^^A6:UN8S'+&W0J10!CZ]XG?3=8TK1M.M5O=3U!]WEF3:L,
M"_?E<@' '0#N>!6S/J5C:W$=O<7MO#-+_JXY)55G^@)R:X#X0Z6D>E7^IW$\
MUW?_ &E]/%Q.<LL$#;(T'H.,GU)R:J>%M'\/:WHWBF]\2VMI<7QU&[COYKI0
M7MT5B$ 8\HH0 C&/6@#U S1+,L)D02L"50L,D#J0*%FB>1XTD1GCQO4,"5SR
M,CM7D'@N\NY]8^'D^IR.;B;1;Q%>4_-( Z;>O4[ #74>#[B&Y^(OCUX)%D07
M%FA93D;E@P1^!!'X4 =I=7=M90F:[N(H(AP7E<*H_$TMO=6]W L]M/%-"W22
M-PRG\17!^,#!J/CG2]*M]#M]7U6*RDND34+CR[6&,L$+E=K;WR,<#@5P3R7%
MCH'Q"M(S9VL"ZC9)=)I1800H^Q9MG0CC(;@=^E 'MLNM61L;VXL[JWNGM8V=
MTBF5L$ G!QG'2H- UZ/6/#.DZO<".U.H01R+$T@P&<9V@G&37,:WH_@_1I[)
M[.""QU&6QNHK-+)-HGC\HE@^T890 ""W?OFN1^'/GP:GX7;Q4L<B7&E1CP^Z
ML?)@*K\Z$'_ELR[6W>F0* /8I=5TZ!E6:_M8V=S&H>9068<%1D]?:I;F[MK*
M SW=Q%!$.LDKA5'XFO)M)\,Z+J7AWX@WM]IMM=71U74E6::,,T84DJ$)^[@D
MGC')H\/QP:[XD\'6VOJEW;#PK#<VD5T R27)VB1L'AG"8^@)- 'K"WMJ\44J
M7,+1S$+$XD!#D] #W_"I!-$9S )4\T+N,>X;@/7'I7C&I:8D=QX[M] C5;71
MI;+5;6&+_5PW<8+R*@' )5<$#H35:;Q,NG^(Y_B8KLVFWDESID0ZJT<<"M%C
M_>FBD'_ J /5)_$JQ^,--T*&*.:.\MYYFG63.PQ%1MP.OWO7C%:W]HV/VW[%
M]LM_M>,^1YJ^9C_=SFO*;/2[SP[K'A.TB4MJ<>@7\SY&2UP^QV^OSL:YRSTB
M[N?A5!JA3PM:JZK<'6Y;B;[9'<;LEV81D[]W! )].E 'O5U?V=EY?VN[@M_,
M.U/-D";CZ#/6LCPUXE77-)O+^XBCM$MKRXMF+297$3E=Q)QC.,^U<II&FV&N
M?$3Q0GB6UM+VZM[:T2WCN8PRI T679%8< ONR<>U<CH\6GMH/AS3Y763PQ+X
MFO$E+MF.4 N8%<GJI8#KP<"@#W"VU"RO IM;NWG#J64Q2!L@'!(P>F:1-1L9
M+UK-+RW:Z49: 2J7'U7.:\KU6VL-%^)FKGPQ#!!J">%+J5H+50 LP=-AVC@,
M<#ZX%<_'HUY_PK;2M2@3PG8?ZB>#61/,;KSRP.6(C)9V;(9<GJ1VH ]XN;B*
MTMI;B9PD4:EF8D  #ZUR$7Q!M[O2?#.HVELK1:U>+;,KS#=;@H[9;&><*./>
MNHU.WBN])NH+F&.:)X6#QNH96X[@]:\8L]'TR\^'?PTM'M(/(N]4B:Z5% \X
M^5)G?CKD  Y[<4 >UVE]9WZ,]G=P7"*=K-#(' /H<4R+5-/FO&M(K^UDN5SN
MA692XQZKG->:ZM'I'A3Q]K3P6GV+3F\*R7%S#IZB(N5EVAE"X ?!(![5SVJV
M,FG:9X/O$T#0=&@.J67V1H)S+>N"PSN<(H.5Y;ELT >M:9XHL=4\1ZOHL! F
MTPQ*[%U/F%UW':!SA> ??-&N>*+'0=3TFQN2/,U*<Q*Q=5$8"%BS9[<8^IKF
M_"6G:?#\4?'$L5G;1SI+:%&6)0RAX SX.,C<>3ZGK1X^T[3[SQ=X*-[9VLX>
M_DB<S1*VY?)<A3D<C/./6@#<TWQ?:W.IZW:7S6]DFG7BVJ22S@><3&KYYQ@_
M-C'-=!-<06\#3SS1Q0J,M([!5 ]23Q7G'ASPQHNM>,?',^J:9;7KF_6 &XC#
M[%\E"=N?NDYZCG@>E<9IS:CJFB?#2P:.QN[:2WN62#4Y&%O--&=J!L Y*KG:
M"* />;:ZM[R!9[6>*>%ONR1.&4_B*QO%'B>/PY;VJ1VDM]J-]-Y%E91,%:9\
M9.2>%4#DL>E<QX)T^[TSQWK<,CZ):K):Q23Z9I3R,L<N3MD(9%52R\$#DX!Q
M4_C66/2_'W@O7+UA'IT,EU:RS.<+#)+& A)[ E2,T 3OXK\2:+=V9\2Z!:PZ
M?=S+ +G3[IIC;NQPOF*4'!/&X<"NNNM1L;%HUN[VWMVD.$$LJH6/MD\UF>(O
M%5AX<M[1YP]Q<7D\<%M:VY#2S,Q ^4$C@ Y)Z5R/AO2=&UWQ#XUF\16=I>7\
M6HM 5O$5S#:!%,>T-]U2"QR,9- 'HLUU;V^/.GBCR"PWN!D#DGGL*KG6-+6T
M2[.I68MG;:DQG78Q] V<$UXOH%G!KMQ\/;/45-[IJW.JK;K/\PE@CQY6[/W@
M-HQGLHKH=$\)>'Y_&?CRVFTBSDMH&@$$#1 QP^9;AG*+T4L<9(YX% 'ITUW;
M6ZAIKB*,%2P+N%R!U//846UU;WD"SVL\4\+=)(G#*?Q%>*Z/;V&K0?"6#6MD
MT+VEV!'.<K(RK'L4@]>@P#W K0UJ?2?#FM>.8H8)%T,:7;M>VU@PCVW,CL@"
MXX0LI7)].30!ZK;ZII]Y</;VU_:SS)]Z.*969?J <BB;5=.MV59K^UB+.8U#
MS*N6'51D]?:O(=0L+C2?$_@AY-#\/Z(S:DL<,6GRE[AHRC!@[;%!7D ]>2.:
MO:+X9T75-)^(-YJ&FVUU<G5;^-99HP[1JHR A/W>23QCF@#U@31&8PB1/-"[
MBFX;@/7'I0LT3R/&DB,\>-ZA@2N>1D=J\FMKHZ'HOP_\:7$I\D:?%IVIRL<D
MPR("CL?19 .?]JNM^'5K,WAZ77+M"M[KEP^H2!NJH_$2?01A/UH NKXK@C\6
M:IH]YY%K!8VT$_VJ68*&,A88.< 8V^O>MW[1!]F^T>='Y&W?YNX;=OKGIBO/
MH]"TO6?C+KLFIV-O>"#3+7RTN(PZ*6,F3M/&<#&?<^M<S:O86_A7^PGTQM01
MO%=S:Z?IYG\J ['9E60D$>6.3MP<G'% 'L=GJ%EJ",]E>6]RJG#-#*K@'WP:
M2#4K"ZN)+>WO;::>/[\<<JLR_4 Y%>0PV[6'Q'U*UOTTC1/-\,W#7(T8L1"N
M]<2/\JY<#)&!T%+I%F/#5UX2?4M"T6ZM'N(K;3M9T:0PRLTB%5,J$ N&'+<D
M=Z /9Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "JU[IUGJ*PK>6Z3K#,D\8<9VR*<JP]
MP:LUF:]KUCX<TPWU^TFPNL4<<2%Y)9&.%1%'5B>U %F73;*?4(;^6VC>ZAC:
M..4CYE5L;@/8X'Y5AI\//"$?G;?#UCB4$,ICRH!Z[0>%S[8J/3O'=AJ&N1:'
M+I^J:?J4L+SB&\MPA"+CYLAB#G/&">ASBH/"/BO3[NRT/3Q=W]U-?V3W-O=W
MD:JTX1\,#@_?&0<>E &IJW@WPYKMPEQJ>D6US.B>6)&!#%?[I(Y(]CFMBVMH
M+.VCMK:&.&")0D<<:A551T  Z"L&[\;Z-8C6&G>98]*EC@F=8]PDE< B.,#E
MFY QCJ:-(\8VFIZJNESZ?J6EWTD1FAAU" 1F9!U*$$@XR,C.1GI0!+JO@KPU
MKE]]MU/1K2YN<!6D=.7 Z!L?>'US6@FC::FH0WZ64*W4$'V>&0+@QQ_W5]!]
M*Y*/XL:'+I\>IKI^L?V46"2ZA]D_<0L3M^8YSP<9(! Z=:[:XF$%K+/L>01H
M7V1C+-@9P/>@#D_%?@FWU:VB33[.TC:;5K:^OA(,+.J-\^1@@L5X]^];6C>%
MM"\/-,VDZ7;VCS#$CQK\S =!D\X]NE57\9Z2OA"V\3*TTEC<B/RD1 9'9V"A
M N?O;C@C/8U6U#Q[86>HWEE;:;JVIM8X%Y)86WF);G&=K$D9;')"Y(H U[7P
M]I%E]@^S:?!%_9ZNMIM7_4A_O!?3-1:UX5T+Q$\3ZMI=O=21 A)'7#J#U 88
M./;I44'B_2+NYT2&UF:==:BEEM)8U^0K&H+;L\@\],=<]*MVFN6EYKVHZ-$)
M/M5@D4DQ9<+B0$K@YY^Z<T #>'M&?0_[$;3+0Z7MVBT\H>6!G/3Z\Y]>:@TC
MPGH&@SB?2]*M[6;8T9E1?F*D@D$GD\J.OH*9KOBBUT.ZM++[)>WU_=AVAM+*
M(/(57&YCD@ #(Y)[U5C\>:*WAVYUF8W-M':SFVFMYH2)UFR (]@SECD8QGK0
M!NZAI]IJMA-8W]O'<6LPVR12#*L.O-0R:)IDUQI\\EC TNG BS8KS!D!3M].
M !^%8]AXWM+N[DLI],U73[X6[7$-K>6X1[A%Z^7AB"1QQD'GI4TGC/24\(VW
MB56FDLKH1>2D: R.TC!50+G[V3@C/8T :C:/ISW%[.]E"TM]$L-TS+GSD ("
MMZC#'\ZJZ=X6T/2?LGV#3((/L?F?9]@_U7F8WX^N!FLW4?'5C9:E=6-MINJZ
MG)9 ?:VL+82+;DC.&)(RV.<+DT7_ ,0-#LK?1YXS=7J:PCM8BSA,C2E0"5QU
M!^;OTP<XQ0!NC2K!;J\N?LD)FO45+EBN?-500 WJ "1^-9VD^#/#>AWQO=,T
M:TMKG!42(G*@]0N?NCV&*/#WBNS\137MM':WME>V+*+BTO8O+D0,,J< D$$
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M-A?3"&TU":VVP3,QPN#G< W8E0#3M0^(>FV%Q?A=.U:ZM-.D,5[>VUL'A@8
M%@3D$[0>=H.* -.;P?X=GN+^XDTBU:74 %NVV?ZX AAN]>0#^%.UKPGH'B*6
M.75M*M[J6-=J2.N&"_W<CG'MTK6AFCN((YHG#QR*'1AT((R#7G/B[XDVZ^%=
M<ETBWU4)#%+##JT5MFW$XR!ALY^]QNQMSWH [G^P]*%O8VZZ?;K#82"6UC5
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M?0[)KTR>:9#'P7_O%>A;WQFL3PAXQCD\->%K6]EN+_6M2M%E9(E#.%_BEDY
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M3Q"\+ZKIT-T\&?*=@0R9Z@,,'!]*=9>&M$TZ.YBL]*M((KJ-8IXXX@$D500
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MK L=S]K18TP%FQMW@=C@XJEJ?CS2M.U"TL(H+W4+J\M1=VL=C#YOG1DXR#D
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M=U97"D;2!M[G\* .?\)^-M=\12Z=<Q3^'KVVNB/M5E:2LEU8J03EM[?/M/!
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MU2+PYX1M]#TC2X9=8N+R$0_.D4/ELYW#!)[%B._(&,UZ5I=J]EI%E:2E3)!
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MF2WMHXG*G()50#CVXKD]/\!RO\*IO!^IW$:RRB<&:#+*I:9I$(R!G&5R/8T
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MRL6+&0/&R%MPC49&1A<=SSVKT:@ HHHH **** "BBB@ HHHH **** "BBB@
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M>2, Y QP.35?1M1O_&;>#M(U/4+N*VGT5M0NVMYFA>[D5EC"LZD'')8@$9H
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M(Y<!!CA2S$D=_6NEL=1L]2A>6RN(YXTD:)F0Y =3AE^H/%0?V[I7V.^N_M\
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M]* -RN+O?ACH]['>VOV[5;?3;UGDFTZ"ZVV^]N2P7&1S\V,[<]JGT+QI:MX
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MD&2N'#L'<*<''3BO0+BW@NX&@N(8YHFX:.10RGZ@TEM:V]G L%K!%!"O2.)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5BZ[XIT[0);:WN1<
MSWEUN\BTM(&FED"_>(51T'J>*VJRM0MXVNI)].73AKXMMD,ERN6$98$@[?FV
M9';O0 _1-=T_Q#IYO=.E9XUD:*170H\4B_>1U8 JP]#6E7 _#=IK:]\4:9J:
MC^W(=0%S?R1-F*3S4!C:,8!4;5 P<D8ZG-=]0 4444 %%%% !7!ZQ\7O"VAZ
MW=Z1=O?&[M6"RB*U9P#@'J/K7>5X/I[>+5^,WC;_ (1--):;=%Y_]HE\;<#&
MW;WSGK0!ZQX5\::%XSM9I]%NS-Y#!9HW0H\9/3(/K@\].#705X1X4O+W2==^
M(]OK*_9_%KZ>]ZTMJP\D(L>5*8Y!RZGGG\0<RZIXGUN+]F_3=:CU:[75))0K
M78E/F-^^<8W=>@Q^% 'N58WB;Q/IWA+2/[3U1I5MO,6/,49<[CTX'TKR[XA7
MWB:U\3P37;>)E\,_8D,<OA]PKK+_ !-)QSWX) Z8[U3UWQA>CX&PZCI'BJ\O
MKN+4$MWO3$;>=>IV. 3D@$<YYXH ]V!R,T5Y+K\VN:O\:H_#=KXAO]-TZ72!
M-,+5P&X8Y*9!"L< ;L9QFN<M_''B+PSX,\=VS:G/J%UHVHK9V=W=?/(H=V3<
MQ/7 7(SW/IQ0![[17A_A?4O%&G>*= -M+XOU.PO<1ZH-7LW$498#$D;8^502
M3]!UYXQ-8UKQ+I6LZC)XJU7Q=H]P+LFUO+%1+IZQ;A@&/@-Q[D\C(SG(!]%T
M5XU\0-4\12WFAW]I/KMUX4EL%EEN?#Q\N9Y3D[R,$A<;3@\<GFNI^%&N0ZSX
M;N%3Q!>:N]O<%6-];^5<0 ]$?D[CU^;/KZ8 !H>*_B+H'@R_MK+5GN1/<1F2
M-883)D X[?2H?#?Q.\/>*M773--^V_:&1G'G6S(N!UY-<1\2O[7_ .%T^$/[
M!^R?VI]DE\C[9N\K.'SNV\],_CBNX\.P^/IKNXB\5OHBV#V[*C:6TJS"0D '
M+=!C=R.<XH [&BOGJVU[Q5-X[3X;2^*V$46HL[:JLW^D21!=WD[O[W48_O<=
M!BNFU3^V]:^--YX7MO$NHZ;IBZ6DS+;R_/QM'R$YVL202W7 /K0!Z_17S]-X
M_P#$OA?PKXTTE]2DO[W1[^*TM-1F&Z0)(7&6SU("'&<\M[5K>%;_ ,3Z9XRT
M:*W?Q?J6E7BF/4CK5FX2%\?*\;$?*N>WIZYX /:Z*\ TYO$WB'PUXWU23Q?J
M]L-%N[I[2*WFVY**6VLW4K@ !00!R:O:OKGC/5_A_P"#M5MCJTUE+$YU9]&(
M2Z<CY5((!P."3@8]<<4 >XT5X=H_C]M+^'_BN\T_7]4U&\L0C06NLVX%Q:;V
M" LV2)!D@]L8Z<U4\.:OXLM-3\-W]I/XPU1;V2,:K'J%DYM0CXR\1Q\H7.0>
M^!VXH ]\HKY[\4ZMXETSQ+K,GB34/%NF0"Y;^SKS2L/91PY^7>G ;C&?FSZB
MO<O#U_%J?AW3[V&^6_2:!&%T(_+\TXY;;_"2<\=J -*BO O&FM7LM[XDO=,\
M5^)[R>P=O+328##966WJDS$X?&.2.OIVJ_JGB+Q)JUQ\,H;;6[BPEUFT;[9)
M#C#DJF6V],\L1Q@$T >W5D>)O$NG>$M%DU;56D6UC948QIN.6.!Q7E-IX@US
MP7XF\=:0VL7NKV^F:5]NM&U!_,=9-J$9/IE^1TX[5S'B[2M:F^"MOXEO_%>H
MW\FHO%+<6EPX: !FRH08^4@XSCCKQ0!])12++$DB_==0P^AKSC_A>?@S>ZJ^
MHML8J2MFQ&17H-A_R#[;_KDO\A7@/PGN/'\7AW45\+6>A36/]I2EVOVD$GF;
M4R!M(&,;?UH ]?A\>Z)//H4*-<A]<5FLPT)&0O7=_=KIZ\S\4:SK-G\2/ %B
MUX\"WBR_;K>!R(I'"KQCN <XS7,V*>(_%.J_$&-O%NK6-MI%Y,;6.UEVG<#)
MM!;J$ 0?*,9S[4 >Y56U&^@TO3+O4+DL+>UA>>4J,D*H+' [\"O&X?%M]JGP
MA\-7.I>*+S3KZ]N7A=K&V,MW>A)&79'@_*V ,MCKCUP<[1=:U?=\0/#]U>:W
M-80Z%-<01ZV0;F,F/^+'0'=G'IC@4 >VZ%K5GXBT2UU;3V=K2Y4M&77:< D<
MCZBL?Q7\0_#W@Z:&VU.YD>\F&Z.UMHS)*1ZX'0?7K5+X1?\ )*= _P"N#?\
MH;5S'@A4G^._CB6^ -_$L:VV_P"\L7 ^7VQL_/WH [GPGXZT'QI#,VD73-+
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MD0+#RO+QC[HQN^]GG- 'LUO.ES;13QYV2H'7([$9%25YM9K>>*/$QT5]5O\
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MY5+F!9 I]0&!Q0!XIJ%^]]X8TI8[+2M,L[7Q.\-\R[IM/DE )63&1^Z+MTR
M"*VKBWU-_%5]+;ZSI$VMC0;I1;Z/9R)Y@*_NS(V]@"'QMS@\FO55TRP33O[.
M6QMA8[=GV81+Y>WTVXQBH],T32M%C>/2M,L[%)#EUMH%C#'WV@9H \?UJ3PJ
MWP5\/I;&R^UJ]D(%7;YHGWIYN1UW??W5[!K?_(!U'_KUE_\ 034!\,Z ;J:Z
M.B::;B<@RRFU3=(00?F.,GD \]P*TW19$9'4,C##*PR"/0T >'N_A]O@#I4.
ME&T.K,MN+18MOG_;MZY(Q\V[=G\/:MCQ;>7GA'Q'K-K8*?,\5VL:V6WHM]N6
M%L>GR.KY_P!@UZ/;^'-#M+Y+VVT;3X;N- B3QVR*ZJ!@ ,!D#''TK)N/#^IZ
MIXUM-3U.:R.EZ87DL((4;S&D=0I:0GCY1NP!ZY[4 ;>C:5;Z)HEEI5L,06D"
M0IQU"C&3[GK7C6J?8_\ A6GQ&M4,*SC7IMT:D!PAGBQQU ]*]SK/DT'1Y9KF
M:32;%Y;H 7#M;H6F ((#G'S8(!Y]* .0\2:;8Z9XT\!?8;2&V\N[G@7RD"XC
M^SO\O';@5P6CQW;^!M>CU/5?#-L#<70U5+^S=[I9-[<DB09;&-N!Z8YKW:6T
MMIYH9IK>*26!BT3N@)C)&"5)Z'!QQ5*Z\.:'?:@NH7>C:?<7J8VW$MLC2#'3
MYB,T ,\+)+%X3TB.:Y>ZD6SB!G="C2?*/F*MR"?0\UQWPTU73] T2Y\+:I>0
M6>IZ5=SK)'<2",R(TC.LBYZJ0PYKT>LW4_#VBZTR-JFD6%\R<(US;I(5^FX'
M% 'G7C/Q5%XH\):S]BMY)-!L=0M8KF^C;*74.]3-MP,[5X!(R",]JO\ B632
M)?%/@@>'VLVU$7V0;,J<67EMYF=O\'W<=O2O0HK2VM[1;6&WBCME78(40! O
MI@<8JIIV@:-H\DDFF:38V4DO^L:VMTC+?4J!F@#R!M+L?^%(>+[HVD)N)+V\
MD:4H"VY9R%.>O&!BNKU+3K+3?&WPZ6RM8;<+]JB_=H%^3[,3@XZC(S7=?V7I
M_P!BELOL%K]DE+&2#R5V.6.22N,')Y-2O9VTLT$TEO"\MODPNR M'D8.T]LC
MCCM0!X[H,_A5/A3XJ2]>R^T-<WPNTD*^8TF]_+P#SG&S;COTYJW9WE\VM:-9
M"TTJ'Q!:^'K=KN_UF1SA6ZJD8(!(8$LV1Z5U_ACP)I^D62?VE8Z=>:A%=3SQ
M71MU9T#RLX 9AD8W5O:EH.CZP\3ZII5C>M%_JVN;=)"GTW XH \.A6&_\!^(
MK=Y[6[@E\70JSVL?EPR!GA#%%R<*><<FO1-9L;2R^*O@[[+:PP>;:7\3B) H
M9%2,JIQU ).!78?V/I>UU_LVSVR.LCCR%PS+C:QXY(P,'M@5/):6\MS#<R6\
M3W$(812L@+1[OO;3U&<#..N* /'[2"5M3@^%[*QM[35FNWSR#IRXFC4_5V5/
M^ UZ=XL1)/!^M*ZJP^PS'!&>=AK.\.>']3M]<U#Q!X@FLI=4NHDMHULD81PP
M(20 6Y)+$D_05T\D<<T3Q2HKQNI5D89# ]01W% 'D.EI8P:C\-7U584TUM#S
M;F4 1_;#'%@G/&XIG&>_2J?BUK1[SXAOHQB.G_V'$+PP8\LW>YL=.-VS&?UK
MV"XTC3;O3ETZYT^UFL54*MM)"K1@#@ *1C [4V#1=*MM-;38-,LXK!@0UJD"
MB)@>N5 P: (?#^EV.E:-:0V-I#;IY$8/EH%W87J<=3]:X2ZU W'CCQ-_9L6@
M:=):+#%?WVKL\KR#R\@K'N4*@!]0">:].50JA5 "@8 '05G7GA[1=1OH[V]T
MBPN;N/&R>:V1W7'3#$9% 'CWA-U?PW\/=CJZ+XAN@I5=HQ^_(PO8<].U=]\,
M_P#D$:U_V';[_P!&FNI32=.C*%-/M5,<S3H1"HVR'.7''#')R>O-36]I;6BN
MMM;Q0J[M(PC0*&8G)8XZDGJ: //;)]#C^,_B=M3:T6[^P6OV<W!4?)M;S,9_
MX!GVKE;26"UTC1KQ'6+0T\<2/8R'Y8DMBL@4@] F\MCMS7L%]X>T75&=M0TB
MPNVD*ES/;(Y8KD+G(YQDX],FK$^FV-SIYL)[*WELBH0V[Q*T>T=!M(QB@#SG
M5=0TK4OBAJL?VSS+6+PG/'=26AWM&#*"P&W/S!3G YY%9.EW+Z/+X/CFET#Q
M!I;W,5OIMQ:H8+V#<I <H"00!][I[UZQ8Z+I6E[/[/TRSM-B&-?(@5-JDY*C
M Z$@''J*BL_#>AZ=?-?66C:?;7;YW3PVR(YSU^8#- 'D5Q:P7NFBUN8UE@E^
M(CI)&PR&4NV01W!KI?$%H]I\27.C0+#>S>%[L1^2H4LZNGE].X)XKT#^RM.P
M!]@M<"X^U#]RO^N_YZ=/O_[76I3:6S7:W9MXC<JAC68H-X4G)4-UQD#CVH \
M%@A:?X4:=$^N^&[2TQ#L,-A(U['<[ATQ)DR[\Y(7GGC%=/JUN\?BGQ+<:3J^
MB2W$D<0U73=;@**0(@ 4DR#M*^Q .:]&7PYH::H=471M/74"=WVH6R>;GUW8
MSFEU'P[HFKSQSZEH]A>S1C"27-LDC*/8L#0!Y?!/;:N/"6IZ+=V>A:K_ &2X
MM=/U.$RVSP;@"JN2""-H((.XJ1QBNM^&NH1WFE:I$NFV5E+;:E+%.;"0O;3R
M84L\9/0'/3MBNGU#1=*U:V2VU'3;.\@C^Y%<0+(J_0$<58M+.UL+5+6SMH;>
MWC&$BA0(JCV X% 'EE^-2'QAUS;>Z+:RFQM_L1U:W:3=#@^9Y1#J!\^=W7M5
M"*/2H?A;KT-S>Q:DESJLBZ:FG0-"%NR1L2VW$\"3)!4D?>]Z]:U/1-*UJ-(]
M5TRSOD0Y1;F!9 I]MP.*>-*TY5M56PM0+3FV A7]SQCY./EX]* /'H-UO\-/
M'EGK.[_A+5AE?5'D8$S J?*=" /W>W@ ="#6KK$N@RZ!X%B\./:->C4+0V*V
MY4R+&/\ 6DXY"[=V[/?KS7<>*_#4/B#0M4MH(K:+4+RR>T6[>,;E4]BP&=N>
M<59TGPYI6DE+BWTRQBOC$J37,-NJO(0!G+ 9.<=Z /)])6^+^,EO=1\,V['4
MKC[?'JUH[S&+^ Y\Q<Q[,;<#Z5=T/3+>?7?AQ!=S#4XX-*NWAFF@*;P-FQMC
M<C"D8SZ UZ=?^'=$U2Z2ZU#1]/N[B/[DMQ;)(R_0D9JZUI;/<Q7+6\1GB4I'
M*4&Y%.,@'J <#\J /(]7LM*%[\2[&]N6TW3GDTYVEAAWK$Y4'<4'!!8+N[$9
MS5BWOM4M?%,-E<1:%J6JW.EW2V&IZ02DB*JA@)4R0%9MN"#C/2O4C869>Y<V
MD!>Z 6X;RQF8 8 ?CYL#CFJVF:!HVBM(VEZ38V+2??-M;I&6^NT#- 'AUK"T
M_P )+6*?7/#=I:%4#;;&5KV*YW#/23<9=_<+^&*ZO4[:5/%NNW&E:SHKWSV\
M"ZII^N6Y1' CP&1^"%(ZC! .<UZ)_P (YH?]J?VI_8VG_P!H9W?:OLR>;GUW
M8SFEU+P]HNL31RZGI%A>R1C"/<VR2%1[%@<4 9O@&_@U/P)H]W:V']GP/!B.
MVWEA&%)7@GDKQD'T(KS.ZM8;W39K6YC66";XB%)(V&0RE\$'V(KVY$6-%1%"
MHHPJJ, #T%5O[*T[&/L%KC[1]J_U*_Z[_GIT^_\ [76@#@M>M&M/B9$=(@2&
M\F\.7BIY*A=S*R;.GH3Q5'0I_!4?PK\/+?10SNIMAY$!Q<F]W+G&"&W[\D\]
M,]J]0:TMFNTNVMXC<HA19B@WJIY(#=0#@<>U4T\/Z+%JC:I'I%@FH,23=+;(
M)23U^?&: .!T36-.TK3?B%%?7L%O,FK7<ABD<*Y5XTV$ \G=VQUK)\/:?::C
M?_"Z.\MXYXTT2XD"2J&7<$BP2#P>M>JW&@:-=ZBFHW.DV,U\@PMS);HTB_1B
M,U/%IEA UNT-E;1M;(8X"D2@Q(<95>/E' X'I0!POAO1]/D^)_C:=K&V>6W>
MQ2W+1 ^4!;J1MX^7D#IZ#TK@M(BN9?A?J46J:OX:MHRUP-26[LW>\2?>V2Q$
M@)DS@K@?W<5[W':6T-Q-<16\233D&:14 :0@8&X]3@<#-4I_#FAW.I+J5QHV
MGRWRD%;F2V1I 1T.XC- ' ^&OLMMX^O5\1W,,MT=$L18SWB[/,B"-YQ ?H2_
M+#KSS6C\)?L']BZ[_96S^S_[=NOL_E_=\OY=NWVQT]J[+4M%TK64C35--L[Y
M8SN07,"R!3ZC<#BI[6RM;%'2TMH;='<NRQ1A S'J3COQUH \M\9?\A_Q_P#]
MBJO\YJGUO2[#3_#?P\>TM(87CU;3U5XT ;#*=W(YY[^M>D2Z;8SO.\UE;2//
M%Y,S/$I,D?/RMD<KR>#QS3I+&TFC@CEM8'2!U>%6C!$;+]TJ.Q'8CI0!SOQ*
M%ZWPVU\:?O\ M!M&QL^]M_CQ_P !W5F37'@OR/#"Z=';371<#1Q9D;XSY;?,
MVT@[ /O9R.F17>UG6/A_1=,NY+NPTBPM;F7_ %DT%LB.WU(&30!Y1I\GAI?@
M+>Q:@;7[?]GG%TDN/M'V[+8R#\WF;\8[].U;'AO3S=?$JVEUFW6;4(/"UGYA
MF4,5E+L'//?((S]:[Y_#NB2ZH-3DT?3WU '(NFMD,H/KNQFK@M+9;MKL6\0N
M601M,$&\J#D*6ZXR2<>] 'C$44=O;I;PHL<,/Q%"1QJ,*B]< =AR>*Z7P]K&
MG:1J'C]-0O8+:2/4WG*2N%;8T*;2 >3G!QZUM:]X6N]4UK2/LBZ=::5:Z@FI
MW)1")YIUW=@-I!R,L3GBMZYT'1[S4(M0NM*L9[V+'EW$MNC2)CIAB,B@#R/P
MU96U\GPDBNX$FC6TO7V2+D;@BD'!]#S]14OBRWEMKGXH0Z5$8R^GV$DB0+C*
MG?YAP.Y0-FO7(M+T^ VWE6-M']E#+;[(5'DANH3CY<]\5*EI;1W,MREO$L\P
M5990@#.!G 8]3C)QGUH X]Y_!#WGA>.UAMKB=G*Z6+(@E$,9W$A2/W>W@YR.
M1Q7"6+VO_"K])AA:'SXO$\8F1"-R?Z:^W<!R..F:]@L/#^C:5<RW.GZ186D\
MO^LEM[=(V?ZD#)I5T'1TEFE72;%9)Y5FE86Z R2*<J[''+ DD$\C- '"^%I-
M$BU7QNOB%K);\ZG*9_MI7)M-J^5][^#;GVZUS'AJR2^?X9PWT!FM//U.2VCN
M%S^Y +0Y![ !2/H*]?U#P_HNK3QSZEI%A>31?ZN2XMDD9?H2#BK;V=K)/!.]
MM"TMOGR9"@+19&#M/;(XXH XWP_!#:?%KQ7';Q)%')964CJBX!;]X,X'?%5O
MB-?CPIJ>D>,@I*6R3V5R .622,M'GV\R-1_P*N\2TMH[J2Z2WB6XE4+)*$ =
MP.@)ZD#)Q]:2[LK6_MS;WEM#<P,03'-&'4D'(X/'!YH \,L])N=(N8?A]-YC
M'Q ]C?SYS]T*6N^?<P@?\#J]XK1&T+XIEE4[+ZT89'3Y(>?RS7LKV5K)>1WC
MVT+74:E$F,8+JIZ@-U -,;3;!UNE:RMF6[_X^08E/G<8^?CYN..>U '"O:Z9
MJ?QFTV98K6Y@B\/R2V[*%= WGA=RXXZ$C\:N> H8[;7_ !K;0(L4":N&6-!A
M06AC)('N:ZRTTC3; Q&ST^TMS%&88S#"J;$)W%1@<+GG'3-30VEM;R3206\4
M4D[;Y61 ID;&,L1U. !DT 34444 %%%% !1110 4444 %%%% !1110 4444
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MLACO;NT1-D3J,LJAF#.5[A0<5FZAI.H2:%\/(DLYFDLKZT>Y4(<PJL#JQ;T
M) KEX= ;P_-K-EJ&D^+;J>2\GN+-])NIQ;W*2,64-L8+&V3AMP'KS0!WM_\
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MGH3D@?C5754AUC3/#T^J>$]=$$-JT0N[2.2.^LYEVC&Q/FV, >>1P.* /0-
MUV+7[![F.UNK22*9H)K>ZCV/&Z]0<$@CIR"0:H:MXM-EK#Z3IVBZAJU]%$LT
MZ6OEJL*L3MW,[*,G!P!D\53^'B:VFE7PU6347M?M;?V<=3 ^U>1@8\S'?.[&
M><=>U8GB$ZI+XVU"'5D\3MHPAB_LV/0PXCE./W@E>/!#;N!N(&* -B;XE:1#
MX:L];-GJ!2YOCI_V5809X[@;OD*YZY3'!/)%2/X[*BRM5\/:L^LW:/*NE@1B
M6.-6VF1V+[54GH2>:XC1O#VKP^'=&MI=&O+>2W\9"[>%\R&.'YCO+\[E&0-^
M3D]ZV?&.@R1_$"+7[FTUNYTR?3Q:.VC32K-!(KE@66,AF0ANV<$4 =KX>\1V
MOB&WN#%#<6MS:RF"ZM+E0LL+X!P0"0000002"*K:YXLBTG58-(M-.O-4U6:(
MSBUM H*1 XWNSL%49X'/)K+^'VEBU;5]072=0L$O9D$;:E=22W,Z(N [AR2G
M4@#.< 9[5#J@O/#GQ$F\0'3+Z_TV_P!/2U=K&$S2021NQ&4'S%6#=1GD<T 7
M;?XA:7-%;%[6]MYI-133)X)HU5[6=@2OF#/W3QAAD'(J]:^,-,N_%^I>&D,B
MWNGP+/,[ ",J0I(!SG(W+GCO7%R^'-4\0Z3XVUAK">QN=4>";3;:9<3*UL@\
MMF'\)9ATZ@5BZCX>\3OX>L==LM-GCUW5[J]BOH-IW0170VJ6]!&(XNO2@#O$
M^(EG=66EOINE:C?7NIQ//;V42H)/)5MOFN68*BGC!)YR*L)X_P!)70M1U.\B
MN[.33I!#=64T8\])&QL0*"0V[<-I!P<]>M<KXD\*+I7BS3-1%EK5QHL6DIIG
M_$FFD6: QME25C(9D(..,X(JG_PBMY>:'JFIZ7H>HP3KJ-I>6\6IW;O<WR6Y
MSAQ(3LX+!03DX&<<4 ;$WBS4;[XB>$=/ETW5='$QNWEM[DKLN$$!*G*,02I&
M=IY!(K9^)NNZAX=\"7^H:6DOVH%$66,(?)!8 L0QZ=N,G+#CN,F74K[Q+\0/
M"=W;^'M6M;&Q:Z:XN+VU,.QG@90N#SC/?H21@FMKXEZ=>:M\.]8L["W>XNGC
M0I$@RS[75B .YP#0 Z^\:BTGLK"+1-2N=9NH3<?V;'Y?F0Q@XW2,7V*,\#YC
MDUH>'?$MIXC@N3##<6MU:2^3=6ER@66%\9P0"000<@@D$5R;7UWI_C-/%O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
..444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>separationagreement011.jpg
<TEXT>
begin 644 separationagreement011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M66/( R0P!&<GYJQM/U3Q5J\_A_P_/JKV%[>:?)JU_=1PQF1(RX"0Q@KM!&X
MD@GY: /3Z*\GUWQ-XA\,Z;XNTF356NKO3K&&^L-0>%!)L=]I5P!M)!!P<<@U
MUOB?5[[3]6\)PVLYCCOM1\FY7:#YB>4[8Y''(!XQ0!OZKJEEHFF3ZEJ,X@M(
M%W2R%2=HSCH 3WJX#D9%<7\6O^25^(/^O<?^AK5&63Q'X:\1^&C>>(9=1AU:
MX:UN[62WC2.-O+9@T6T!E *XP2<B@#T*BO(/$/B>]A.N31^-+K^TK-Y3;6&D
M:?\ :+>)4!*K,YB/S<?,2P Y]*Z/3?$^H_V]X;GU"=1IFOZ0LB1[0%ANE02-
M\W7#(3P2?N4 =Y17D5WXZUI?#UC>_;98!XAU65;*5+/SGM+) <%8U4EW8+GD
M'[WH*U_"7B.^?Q=_9*WVK:MI4UJTJW6H::]O);RJ1\A;RT#*P)(XR"* /1J*
MXOQ[J&M6UYX<L-%U 6,FI7YMI93$LF$\MB2 PZC&1[@9XKG-8\0ZCI_B2'PK
M=>(]5CALK(3W.H6>F^=<W+N[;5(2-E10HZ[<G\Z /5Z*\E@\;^('T4Z;'-,;
MZXUF'3++5;NP:$O%(I;S3$P4%U"L,8 )P<5NZI-XB\"Z5JVKSZR=:TR"Q:14
MO459DN 0%P8U4&,YY!Y&.* .]JG8ZK9:E->0VDXEDLIOL]P I&R3 ..1SP1T
M]:\JM/%VKV<FE7D6LZUJ]S//$E_8S:))% $<X8Q-Y2E=F<C+'('-:%[XFUZU
MM?$NJ17C-;Z'KR"6$1)\]F$C\Q.F>-Y;/7CK0!ZC17G^M^,;RTUO7;RRE$FD
MZ!I/GS1J 1/<R#=&I;&<! #P?XZYJV\8ZQ:P:;J46LZUJM[++%]MTU]$DCMR
MCD!A$WE J5!R"6.<>] 'LI.!DU3TK5++6M,@U'3IQ/:3C='(%(W#..A /4&N
M*M)?$7B[4_$%S8Z_)I=OIE])86EM'!&Z2/&!N>4L"6!)Q@%< >M7OA,"/A=H
M(;J(6S_WVU '9T5YW8IXF\2^(?%$*>)KC3K/3KWR+-;>WB9MWEHWSEE.Y1GI
MP3D\]*HGQE>ZCX0T&\OM?M]#:>:>"^D@B\RXF>)BF($VL,$C).#@$8H ]2HK
MR72M?\1:C:^,-+TK6+^YGT^VANM,NKZQ$,[$AB4961=P;9@$J/O5T$'BVX\1
MZOX4M]&G\J&[M&U2_P!JABL(&U8^0<9D;!QS\AH [JBO%8-<\9CX9Z=XU;Q*
M9+MIHT^Q-:QB"1&F\KY\+NW'.<@CT [UTLNJ:SX0\6K;ZCK<^L65QI5S>NDT
M,<9CDAVD[-BC"D$C!SCUH ]%HKQ&'QSK9T&W\00ZQJ]WJT@2=M(719/LCHQ!
M,2OY6<A3P^\Y(]#75B;Q!XD\=^(-*M_$%QI>FV4%I+&L$$9EW2(3C+*<#()(
MZ].1S0!WES>6UD(C<W$<(EE6&/>P&]V.%4>I/I4DLJ00O+(VV-%+,?0#DUXQ
MJ5WK'B3PMX0GO=7EBO8?$PL9)H(HP)'61U6;!4@, O3[OS'(/&/7KUI;71KA
MUE9I8K=B)& R6"]2,8ZT /T[4+75M.M]0L9A-:W""2*0 C<IZ'!YJS7E&GZY
MXFUL^"+&'6VL_P"U=(EN+V=+>-G++L.Y05P&Y(Z8P3QG%=-X,O\ 5%UWQ)H&
MIZ@^H_V5-!Y%U+&J2,DL>_:VT $CIG'- &QKWBK1O#/V8:K=F%[IBL,:0O*\
MF!DX5 3@9&3CO6R#D9KSCQ-IMY<?&#PP\6L75NKVMTR)''$1&%$>X#<I.&[Y
MR1CC%6=+\0ZK<?#[Q5J<MV6O+&?45MY=BC8(B_E\8P<8'7KWH ZZXUS3;346
MT^>Y"72VK7ACVL<0J<,V<8X)Z=:L6%_;:II]O?V4HEM;F-98I "-RD9!P>>E
M>7?:I[_Q%97ER_F7$_@:265\ ;F9D).!QU-=I\/?^2<>&_\ L&P?^@"@"Y#X
MJT:X\1RZ!!=M+J4(S+&D+E4XSAG V@X[9S6S7BVFWNJ^$M-\=:M#JL][<QZP
M;.**YCC$;S2>2JS/M4'(W= 0N!TSS747[^(?!M_H=U=>(I]8M=0OXK"\@N8(
MD"M)D+)$44%0&'W3G@T >@T5Y_X%E\1Z[>7>KZAX@D-G;:A=VL=@EO&%D179
M5+-C.0<8QCA1UR:U?'6J2Z996.W7H-%MYKC9/<&/S)V7:?EA3:P+$XR<' YH
M Z2]O(-/L;B]NI!';V\;2RN03M11DG YZ"JEKKVF7M]!96]T'N9[,7T:;6&Z
M D /DC'4CCK[5Y<GB*\N['QMHK:GJ&I:?'H$MU;3ZC9_9Y@2LBL/N)N7C@[?
M45K>%/\ D?M!_P"Q,A_]&I0!Z;17'?$'4=9TZST]].^W16+W!74+G3[=9[B&
M+:<%4((P6QDX.!7,CQY-IG@;7=3L/$4>O-;S10V9GMREQ TA"XF0*N<$DC"\
MX(H ]7HKRG2_$^HVGB'1XK?6-;UR&\G$%]%>Z,]NL6X'$J-Y2A0&P"I)X/MF
MET3_ (3;Q%X=U76(/%$L5Q%+>065K':Q;7*.P3>2IYR-O'8#ODT >JU3TS5;
M+6;,W>GSB> 2/%O"D?,C%6'('0@BN-@\7W7B.Z\'0:1-Y!U"(ZAJ&U0QCAC&
MUHSD'&92%R.?E-8^G^*=?U33-"TJ#4!!?ZOJE]"]]Y*%H8(&<D*N-N[ 4 D'
MUYH ]6HKSKQ#J/B7P%X=U:\EU5=6@/DQZ?+<Q#SXI7?8P<1J ZC(88YSQ6?I
M7B?4;3Q'I$%OJ^MZW;WLWD7L=]H[VXA)!Q*C>4H50P *DG@^V: /5:*\</BK
M6+;4Y%UOQ+>:%JXO2L5I?6"C3I(?,P%64(2<I_$7!S7JNM7$MKH.HW,#[98K
M621&P#A@I(/- %ZBO(CXA\3Z)\.K'Q->ZZ]Y>ZS':PP0FS4QVS2X_>!4&YVV
MY..[=N@J[H7B6_@\6:796^J:UK5C>[X[HZAI+VYMG"Y5U?RD&TD8*G.,B@#U
M"BO'8=3\877PXO?&!\42QSV37#PVJVL7E2)%*P(D^7))"D9!&!CODUT9U'6/
M%OBR?2['5IM'LM/L+>XF:VCC:6668%E&75@%4+V')- '9Z?JMEJANQ93B7[)
M<-:SX4C9*N-R\CG&1TXJY7B=GX@U7PGX6UQ#<JVJ7OBV2Q:\2V,FPLBEI1$N
M=QVJ2%&>36_X=\2WZ>+[+3(-2UG6--O8I?-EU'2WMVM947<I#^6@*M@C!Z''
M/- 'IM%>.Z;XF\4:?\+G\=ZCK;7TTMMY4%@;9%B5VE$:2$J-Q/4D#&<X[5:T
M[Q1J5GKNC);ZSK>MI>7*6]_#>:,]ND8?CS8V\I=@5L94D\'VS0!ZG=7,-E:3
M75P^R""-I)'P3M51DGCV%-LKR#4+&WO;6026]Q&LL3@$;D89!P>>AKR^63Q'
MXN\&:_XAAUZ2T@87<5IIRP1F$PQ[T(D)&XLVT\@C&1]*[GP1_P B%X=_[!EM
M_P"BEH TM-U6RUBWDN+"<311RO"S!2,.AVL.1V(-7*\D_P"$G\2W6CZ2MIJB
MP75YXFN-.:9K=&"P@R@#;C!("@CU(&<\UT>A7&L:5\0KGPW?:Q-JMI)I@OXI
M;F-%DB82[&7** 0>O3B@#N**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K&\3^'U\2Z.-/:X-N!<0S[PF[_5R*^,9'7;BMFD9@JEF("@9)/0
M4 <MK'A._N/$W]OZ+KATR[DM1:7"O:K.DJ!BRD D88$GGGZ50M/AQ'::7;V1
MU:>8Q:ZNLF:6,%Y&!R5."!R>_OTKLK6\M;V,R6ES#<(#@M%(' /ID4D-_9W$
M\D$-W!)-']^-) 67Z@<B@#%UWPS/JGB'1]:LM4-C<Z=YB,# )5FB?;N4@D8/
MR]1TS3+#PBECX=UO2!>,ZZI/=3&3R\&/SR<C&><9]LUN3:C8V^//O+>++[!O
ME5?F].3UYZ5#<WMW%K-A:16L<EK.LIFG,X5HBH&T!.KYR<XZ8]Z .;?P)-;+
MHUSH^LO8ZIIFGIIQN6MQ*EQ"H'RO&2.XR,'C)ZTEQX"GO_#NHZ?J.O7-W>:A
M<PW$UT\>%7RW5E2.+.$7"8ZYYR2:Z\7$!@,XFC\D9S)N&WCKS39KZTMD9Y[J
M&)54,Q>0* #T)SVH GKBH_ ^HV=WJZ:;XC>TTS5;J2ZN(!:*TRO)C?LE)^7.
M.,J<=J[))HI(1,DB-$1N#A@5(]<^E9NH>(=-L-"OM8%S%<6UE$\LGD2*Q.T$
M[1SC)Q@"@#F[?X=M8:+H,&GZS);ZGHBR1VU]]G#!XW/S(\9.&!&.XY&1BG2?
M#Z2\M;A]2UN6ZU&ZO;:ZFN?("IB!@4C2,'"CKSDGG)S6W9Z]+J)T2:SM8I+/
M4(6EFE-RH: [ RJ%ZN220<=,5J&_LUNQ:&[@%R1D0F0;R/\ =ZT <W?^"$N-
M4UN[M+]K2'6K%K6]MQ%N5Y"I59AR,, <'U_6I[[P@E[X;T31C>,BZ7-:2B7R
M\F3R,8&,\9Q^%;T][:6JNUQ=0PA "QDD"[0>A.>E2QR)-&LD;JZ,,JRG((]0
M: .1N/!NIVNJ:C=^'O$3:5#J4GG74#VBS@2D &2,DC:Q &<Y&>U0ZK\-=/OO
M -OX5M;R>U2V<21W>-\F\D[V/3)8.X/^]79B:)O,Q*A\LX?##Y?KZ4GVB'RT
MD\Z/9(0$;<,,3TP>] '+77@&PN/&.C:^LS1KI=N(%M OR2;0PC8G/5=[8X[T
MV]\ 6>HCQ$MS=S8UF>&X5HQM>VDB50K*><D%0?TJ:3QDNGVVC_VO:QVUWJ=X
MUJL4=RDBQ@%\.7XXVKVZ$XJ>P\66UQK>NV%WY%I'ID\4"S23@"8O&'[XQUQC
M)H KZ?X8UK^V+.^UOQ/+J"60;R;>"V%LCL1C=)M8[SCH.!GG%9%U\-[UM'O_
M  _8>)IK/P_=^85LQ:J[P[R2463/W-QSMQG&1GFO0 00"#D'H138Y8Y0QCD5
M]K%6VG.".H/O0!YGXC6T\.^)+"5=6OM#NETU+8ZD+(7%M=HIQY;+SB1?O \<
M-CGI4/A#P<=<\*:T+VXU"/[;K3:A87TR;+C*A-D^T@8RRL0"!P>U>FR7]G#;
M?:9;N!+<\>:T@"_GTI_VF#R%G\^/R6QMDWC:<],&@#G-,\-:PFMV^IZWXDEU
M%K6-D@@@MQ;1988+.H8[VQTSP.PJ[XL\._\ "3Z$^G"\:SE$L<\5PJ!_+='#
M*=IX(R.E;+2QK(D;.H=\[5)Y;'7 [U%'?6DLPACNH'E*[PBR L5SC./3- &-
MI?AN:R\13:W=:C]JNI["&SEQ"(PS1EB7P"<9+=.U8US\.1):R_9M6>"]&MR:
MU;SF .L<C?P,A/S#!/.0?I7:S3Q6T+33RI%$HRSNP51]2::EW;26PN4N(6MR
M,B57!7\^E '+V'@Z^B\76WB34M>>]O(K:2U:);98HMC$$;%!)4@@DDELY[8J
MYX.\,S^$]*?2SJAO;))&-HC0!&A0L6*E@?GY/7BMI;^S>2:-;N!G@&95$@)C
M'^T,\?C2QWMI-;"YBNH7@)QYJR KUQUZ=: /.O'UC8^+_%VA>'X!</>VESYM
M^RQ,$2S*[G5F(P=Y"  $\UU/B#PO)JFI6.KZ9J3:9JUDCQ1SB(2H\38W(Z$C
M(R 1R,&MR&]M;F62*"YAEDB.)%CD#%#Z$#I61X8\2+X@T.74YH4M$CN9X&!D
MR (Y&3<20,9QGVH RE^'L-WIVNQZUJ4U_?ZU$L-S=B,1!$4?(L:#(4 G/).3
MUJ.+P-JUQJ>C7VL^*)+]M)G\V"-;-8E8;"IW8))8Y'/08/'-=?%?V<]L;F&[
M@DMQUE20%1^/2I7ECC0.\B*I( +-@$GI0!D^*] 7Q1X7O]$>X-NMW&$,H3<5
MY!Z9&>E)K/AY=8O]$NFN3$=+N_M(4)GS/D9,=>/O9S[5HOJ%E')'&]Y;J\C%
M$4RJ"S#@@#/)IT=Y:RW,EM'<PO/&,O$K@LOU'44 <1'\.[^#2;_0K;Q-)!H5
MV\S&!+-?/42$ED\TGE<D_P .<<9J[K'@&/6/ 6G^&7U&2&6PCA2&^CCPRF-=
MF[;GNNX'G^*NIDOK2&Y2VENH$N)/N1-( S?0=33IKNVM@QGN(H@J[V+N%PN<
M9.>U &#K/@ZUU+1M,LK.XDTZ?2GC?3[F%0Q@9%VC@\,I7@@]:71O#NIVNLOJ
MVLZ_+J5SY/D1110_9X(USDGRPQW,?[Q/M4_B+Q38>'?#,^NR,+BVC"[!"ZGS
M"S!0 <XZG\@:VHY$EC62-U=&Y#*<@_C0!D:UX?76-3T6]:X,1TNZ-R%"9\S*
M,F,YX^]G\*HZUX5NKK7X]>T75CI>IB#[-,S0">*>+.X!D)'().""#SBI?"WB
MRV\1:-;7DWD6=Q<2S1I;&<,S>7*R9&<$YVYZ=ZWUEC>1XUD5G3&]0<E<],CM
M0!R#^ ?M6A2VM_KE[<ZF]ZNH)J) !AG7[ACCY55'3;W!/-"^!IM3GNIO%&L-
MJS36;V21Q0"WCCC?&XA03ES@?-GC' KL$ECDW>6ZML;:VTYP?0^]<O=>.;.)
M/%2V\0EG\/VYF=#( )B(C)A<9( X!..N>* *MIX,UH-I]MJ'BZYNM,L)$DC@
MCMQ#++L^XLLJME@.X &>]:NF^%;>R/B!9Y?M,.M7+SRQLF H:-4*=>>%Z^]7
M=)UJUU2RLY!- EU<6T<[6PE#.@90W3KWZXJU<7UI:21QW-U!"\APBR2!2Q]@
M>M '->&_ -AH7A"[\/7$\FH17N\74THVM(&4(!U.,(% ^F:K6O@C64CL+"\\
M774^D63HT<$=N(II%3[B23*V648&< 9[UVU<CJ/BW49M?N="\,Z1'J-W9JIO
M+BXN/)@MRPRJ9 )9B.< <>M #;GP9?Q:KJ-SH?B&72[75'\V\MQ;++^\P%9X
MF)&QB ,Y##/.*V/"N@+X7\,6.BI<-<+:(4$K+M+98GID^M4?#OBB[U'5KS0]
M9TLZ;J]K&LQ1)?-BFB8X#H^!QD8((!%;T=_9S7+VT5W \\?WXED!9?J.HH \
MWT?0]>NO%GC.?3-=ETI)=15&5[-9E<>4F'3)&UN2,\CIQQ6R_P .UL5T*3P_
MJC6%UH\4L,<D\ N%F60Y<NN5^8MSD$=3772ZA96Y FO+>,E_+&^51EO[O)Z\
MCBG"\M3=FT%S";D#<8=XWX]=O7% '*Z?H*^$=2UGQ3JVN37ANK>/[6SVV GE
MYP45,D+AL;<$\9R:S?A;H,-G%K.MQ131V^I7<GV".=2K1V@=F0!3RH+.[ >A
M%=U+J-C RK->6\99_+ >51EO[O)Z\CBI9[B&UA::XFCAB7J\C!5'XF@#D5\
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MWV#R-G&/,W[LY_#&*V:YWPIXLMO$>AV=]+Y%I<732A+4SAF(21DR.A.=N>E
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M;A\+]>1Q[ULP:)INM?%C&IV<-Y%#X=MG2*= \>XR.-Q4\$@9 )Z9-=5-\/\
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M4=[>!!<3J/FD"C"Y/L* /%]-TW3[WPOX -Y96TX?Q!<PMYT2MN0O<':<CH2
M<>H%=5HGAC1-:^(GCF;5-,MKTI/;11K<1AU13;IG:#P">.1SP*["Z\(>'KW1
M4T>XTFVDTZ.4S) 5X5R22P[@Y9OS-:%GI=C87%S/:VR12W15IG7K(54*N?H
M!0!RWPG=W^&6CAW9]@FC4L<D*LSJH_  #\*YKQ%J5SX*U[Q+IUB")/$4*7.E
MJ./],=E@D ]\LDGX&O3].TZSTFQCLK"W2WMHRQ2-!P,DL?S))_&N:N]"U/7/
M'>GZAJ5I9Q:5HQDDLV60O+<2NH +# V!>>,G)P: .=L?#>EQ?$33_#>IP0W-
MCIF@QG3[>X4-&\F\K+)M/!?@?3-<[K:6^G:=XWT_3BL>AV6KZ8\*(?W4$C2(
M9E7L #@D#@$FO7]:\-Z/XBCB35M/ANO)):)FR&0GKM88(S[&B#PWHMMH;Z+#
MI=JFF."'MA&-CYZY'<^YYH YKQ)<1-\5_ T D4RA+]R@/(4P@ _0X/Y&J'P>
M\/Z5!X.L=:6RB.ISM<![MES)M\YE"@]AA1Q75:5X*\-Z)<17&G:1;V\\))25
M02XRNT_,23C'&.U:FG:=9Z38QV5A;I;VT>2D2#@9)8_J2?QH \[^(4=[J'C_
M ,,:8MKI]W:/#<31VNI2,EO-.NT<X5MS*I) ([FN6U^PO-*\/>/H&;1K2-K*
M"673-+F=U@EWC#X**$W+V'7:#7L^L:'I>OV8M-5L8;N$,'59!RK#NIZ@^XJI
M;^#_  ]::-<Z1!I-LEC='-Q%@GS3ZL3RQX[F@#AM<\&^'[3QSX'L8-+MX[>X
M%W'=*J ?:52(.HE_YZ?, ?FSDU@^)[.STS2?B;IUJBV6G1W.F2+% -B1%_++
MLH' SC/%>T3Z;9W-[:7LUNCW-GO^SR$<Q[AM;'U'%<WXU\(KK?AK6;;2[>W3
M4=3:W,TDAP)/+="-QYZ*I H Q-:TG1]!\3>")/#EK;6MW/>& BU !GM#$QD+
M8^^!A3DYYYKEM+CAO;7PIIFI8.BW?B#4OM,;G$<LBO(84?U!;/!ZD5ZOI/A#
MP]H5[)>:9I-M;7#KM,B+RJYSM7/W1[# J67PQH<VD2:3+IEL]A)(TK0,F5+L
MQ8M['))S0!Q%UH&E+\2Y] TVVAM['5-"F&IVMLH6,?,%CD*C@-RP!K.\.WMS
MXFOO#/A:^RT_AUY)M5SWDMV\J#Z[B=__  &O1-/\.Z;X:L;O^P-+MXKB12V"
MQ!F< [0[G)QGCOC-9_@_0+S3[K6-;U>&VAU;6+A9)HK9MR11HH5$W8&XXR2<
M<EJ /-V\.Z3<?#/QWJT]C#+J":A?M%<N@,D6R4E0C=5 .3QCDFNAGT/3=%\2
M?#VZTZSBM[F>66.XG1<23AK=F/F-U<DC.3GFN_\ [ TH:;=Z=]AB^QWCR/<0
MX^61G.7)^IJ:72K">6REEM8V>Q8M;,1_JCMV\?@2* /$-)TF_P!<\(ZYJ5_I
MGAJ::2YNC>ZAJ%S(MS;.K,.HC/E[ !M /3'K70Z;I,&O>/?#<6O?9]5,?A43
ML[ O%/()44.0P&[(8GD=3FNYO_ OA?5-2;4+W1+2:Y<AI'93B0CH74<-^(-:
MPTRR&IKJ0MHQ>) ;99@.1%N#;?ID _A0!XKKVFV-MX(^(=A':0K9V.LPR6L.
MP%8"WD[M@_A^\W3L37M]K:VUE:QVUI!%!;QC"11(%11Z #@52E\/:1/!J$$N
MGP/%J+;KQ&7(F. ,M[X _*K.G:=::1I\-A80+!:P+MCC4G"CKWH \:T70?#$
MOP8UO5;F"U-^C7LCW; >;!,DC^6%;JI^X0!U+>];%UJ\W@V^T7Q=JBLL>JZ(
M+?4@>/\ 2HHO-C)_VF_>)^5=D/A_X2%U%<C0;/S8FWJ=G!;);)'1CDGD@XJK
MXLT+4_%&IZ=I<MI9C0(;B*\N;AY"979"2(E3' )VY;/0D4 6O >D3Z1X1M%O
M1_Q,+LM>WK$<F:4[VS],[?\ @-<+<Z9I\%Q\798;*UCFCLB$=(E#*'L]S8(&
M0&;D^IYKU^L>Y\*:%>:G<ZE<:7 ]Y<V[6T\Q!!DB8;2K>O''TH \XO?#ND:+
MX3\!:CI]A!;ZA_:6G![M$ ED\S DW/U8-DY!JM8Z9J&O^(?&4USHWAS4I(]1
MEMW;5YW62"!0/+"@(P1-OS!@1DY/:O6IM&TZXM+2TFM(W@LWCDMXR.(VC^X1
M],<5GZOX*\-Z]>_;-3TBWN+G:$:0@J74= V"-P]CF@"I\.?M \ :4MSJ$.H.
MB,BW,#LRN@=@N"P!.% &2.U9/@:6+3O&'C+1KMU34)=3-_$K'!E@D1=I7U P
M0<=*[N""&UMXX+>)(H8U")&BA551P  .@K+USPIH/B7RO[8TNWNVB_U;N,.G
ML&&"!^- '-^,_& _LWQ/H^B^?)J=AI+W,EQ!@I 3D!20<B3&6 QT%<]XCT7P
M_HOP\T35O#UM;0ZHD]F=.NH% EN)'=0P+#E]RE\@YKTO1_#^D>'[$V>DZ?;V
MENQRR1)C>?5CU)^M4;#P-X7TS4EU&RT2TAND)9'5>(R>I1>BGZ 4 <#!X<TC
M58_B7>ZAI\%U<)=W"1/,@8Q8@5LIG[IR>HYX'I4"Z+IUAX3^&^L6UI&FJ7&H
MV#3WH7]]+YJ$R!GZL#GH37J\>CZ=#'?)':1JM^[/= #_ %K,H4D_4 "FMH>F
M-96%FUE$;>P>.2UCQQ$T8PA'T% 'GOAG0?#.K:OX\FUBUL[F9=5E27[2 WDP
M^6I##/W,G=\PQ]WVK$T>Z.L:%X)T^YT?^W-6%I<7%O%J%QY=L(5<HDL@*MO;
M;MQP3R378Z=\-],N-3UV\\0:99W;W>IR7-NV23Y15 %?ID94G:<BNDU;PMH>
MN16T>HZ;!,+7BW(!0Q#&,*5P0, <#CB@#QJXC>TT3XKV+0Z=;"*WM&:VTUB;
M>)V5MVW('/ SP.177ZSX>TGP_JO@2[TJQAM;IM36WDGB0"29'A<MO;J^2,Y.
M:[*+P;X<@M+JUAT>TCM[N)8;B-$VK*BDD!@.O)//7DUHW.F65XUHUS;)(;.4
M36Y8?ZMP" P]\$C\: /)+PS:<-7^&=N61M2U-/L6W^"QN-TDV/9-DJ_\"%>P
M0?9K<)90F-/*C 6%2,J@X''IVKEM-T+4[WQW-XDUNTL[?[+;-96$<$AD9E+D
MM(QP,$C "]LM6RFA1+XLEU_<OG/9K:!0F#@.6))SSVP,#'/7/ !@?$7[WA+_
M +&2T_D]<WHGA?1-8M_B!=ZEIMO=S_VM>0H\Z!S&H16&S/W3EB<C!Z>E>GWN
MG6>H_9_MENDWV:=;B'</N2+G:P]QDTVWTJPM([R.WM8XTO)7FN H_P!8[ !F
M/N0!0!Y/X>2+7M1\ 66O*MU8_P#"/M<017'S)-<KL7D'ABJ9(SG&2:M>(+3P
M_IMW9V&@N4,?BW3GNK5 1#;R-SA!C:,C!(!.#Z5Z#=^$]!OM(MM*N=+MY+&U
M %O$1CRL<#:1ROX&EMO"NA6=A;V-OI=O';6UPMU$BKTF4Y$F>I;W- '*^%KF
M"U'Q":>5(Q%J\\LA8XVJ8(\$^W!_*N5\*VUKJC?#K3=8BCFTPZ--/!!, 8Y;
MD%1RIX8A"2 >F37I]]X+\-ZGJXU6]T:UFOOES*R_>V]-PZ-CC&0>E277A/0;
MS1;?1[C2[=["VQY$)&/*(Z%3U4^X- 'DVL6&F:9;_%NUTE(HK9+.S)AB^Y&Y
M60LH X')SCMDUTMGH6F:U\5K_P#M2R@O$@T6T*17"!T#$N-VT\$XR >V3ZUV
M%MX-\.6=A>6-OH]K%;7D:QW,:KQ*JYQN]?O'GKS6E#I=C;ZA)?Q6R)=21+"\
MH'+(N=J_09- 'C$,,$>D6NB7/R>'5\9W-I-$6Q&L2EC'$W^P7QQTZ5U$6EZ)
MI7QOT^+2+>VM97T>=KB"V4(J_.@5BHX!(!^H KHO$/AV5M#GM=#L--D^T7AN
MKRSO$_=7@8YD!.#M8G!#8."*QO"/@N>P\4?VW-HVFZ)!#:-;06-E+YK,SLK-
M)(^U<G"@ <\4 .^*\%G<Z9X=M]1<+9RZ];),2VT%"'!!/8'H?8U2U6'2O"WQ
M&L7TJWCLH'T>[EU2&R0)B&,*8WVKQNSN /7M72>-O#<OB>VT>V6*"6"VU6"Z
MN8Y_NO"H8,,8.<[NE:&C^%="T%9UTS3(+?[0,2D#<SCT).21[=* /%M<LQ;_
M  [T_5[3PYH^E6K3VTUG>R77FZC*6E5@VX(/F())RQXSZ5V'B?5I/ 'BO6KR
M!"8]>L/-M4 SF_CQ&% _V@Z'WVFNJC^'7A"))$70+/9("-K*6"@G/R@GY.?[
MN*KZQH6I^(?&&EF]M;./0](N!>0R^87FGF"84;<?(%8D]3G"T <G;>#=/M?&
M_A+0=0MX[N*TT.>25)1N26;S$+,P/#99F;GO@]JJ:?X3T&;0?B,9=+MI!9W=
MW%:*\886RB%9 (@?N?,Q/RX[>E>N/IUF^IQZDUNAO8HFA2;'S*C$$K]"0/RJ
M./1M.BAOX4M(UCU!VDNE XF9E"L3]0 * /( -3UOQ#X.M)+73-10>&(;J"WU
M:5EBDG.!(X 5M[A<<$< DU6U>PN;'P5XXL7GTR"#[98LMAI<SNEE(TJ;P"R+
MMS\K8'0YZ5Z[J'A30=4TVTT^]TN":ULU"VR$$&$  #:PY7@ <'M1#X3T&WT1
MM&ATJV33G<2/ %X=@0P9NY.0#D^@H Y#5?#VCZ#\0O!0TG3;:R%P;NVG$$87
MSH_()P^/O<@'G-6?A7I]A9Z?KKVMG;02?VU>1%HHU4[%E.U>!T / [5VMQIU
MG=WEI>3VZ27%FS-;R,.8RR[6(^H.*K6'A[2=+U.]U&QL(;>[OCNN98Q@RG.<
MD=,Y).?>@#D-4TG3I_C7IDTFG6DLS:1-.6>%23(DD81R2/O < ]17-Z-HWA_
M4?@SJ&N:O!;OJ[Q7,]Y?R@?:(KE6;'S_ 'E*D* !CMQSSZXVG6;ZG'J36Z&]
MCB:%)L?,$)!*_0D#\JR+GP+X7O-5;4KC1+22[9Q([,G#N/XF7[K'W(S0!P&@
M:/;>*?'%G+XFLTO9QX6LI9(KE=R^:S-EBIXW=?IDUW7Q O;'3O NJ3:@ER]J
MT8B9+63RY'WL%"AOX020"?0FMQ=-LTU.34EMT%[)$L+S ?,4!)"_3)/YTZ^L
M;34[&:ROK>.XM9EVR12+N5A[B@#R&YT^?2/&_@IWT#0=">2\:*.+3IB\[Q^4
MP8.0B@KT]>34</\ QZV/_91)?_0Y*])LO WAC3I(9;71K=)89%ECE.6=&7.W
M#$DX&3QG'-71X<T=511I\("7IOU&.EP229/][D_G0!0\>:1)K?@G5+2WS]J6
M+S[8CJ)8R'3'_ E _&O,#XG2Z\26OQ,:1AI5O+#I;J#P(WMR[G\)9%'_  &O
M<JQO^$3T#^PI-#_LJV_LN1][VNSY"V[=G'U - 'F<-G$ND^$K"\T5=6UW59+
MG5S:7-P(K;S'&]FERK;BH< #!Z&LJY?4='/Q(@L8-/L;I--MI)+?2&8Q0DE@
M[#@8<(220!7LNL>&]'U^&"+5-/BN%MVW0DY5HST^5A@C\#5-O"=CINGWG_".
M6=EIVH2VQ@CF\G*GDD;Q_$,DY)YY- '"^*-"\):7_P ()/HMO903/K-FMO);
M !IXLY)8CEQ]TY.>?K6=IVEW^OZAXPN;S1_#>HNNI3P3RZM<.LUO"O"*N(VV
M(%Y!!&>3VK9T_P  W=SK.E33>&-#T**QNTO+B>QF\Q[ET!VJ@V+L3<<D9["N
MTU;P3X:UR^-[J6CVUQ<D!7D((+@= V"-P^N: /-[?2KW5=.\'E-3T+7-5M;"
M8K9:B)'@NHMX E1BN=X 49*]S]:Z[X=WUA!I>KV:Z6NB26.H.EU;?:1)#'(P
M4_NVX 4Y'R@#!/2NBU7PMH6M6MM;:AIEO-%:\6X"[3",8PA7!48 X'I5/4/!
M6DW'A&X\-V5K;V=E.065(\\[@Q;J,OQPQ)P<'G&* .CKPW1M"\,-\#=5U::"
MU_M"-;N4WAQYT,Z2/Y05^JG.S &,Y]Z]RKFD^'_A*.[AN4T&S$L+;T.SC=DD
M,1T)!/!()% '(^'[2+Q'X\N4\66L-U=VVBV+VEM=H&4;T)G<(>,[P 3C(Z5S
ME[:V\NE7^B6S,="B\96MM:JCG;&K%?,C0CHH9FQCIDUZ_K7A?1/$1B;5M.AN
M7ASY<C95T!Z@,"#@^F:>GAS1HM.M-/CTVV2SM)5F@A1-JQR*<JP [YYS0!QL
MNC:=H/Q6TB/1["WL4N])NDGCMHQ&LFQHRN0."1D\]:YB>Z@3]ER#=,@+6\<2
MC=U?SQ\OUX/'L:]CDTZSEU*#49+=&O($:.*8CYD5L;@/K@?E6&WP\\(O<W%P
MV@61DN"3)\G!)ZD#HI/<C% '(^(-"GOO&^N7FGV6@^(SY$$5YINI92:U&PX$
M3D%5# [NW-83W?\ PD5QX#M=,TZV?2FLKA[:PUFX8Q/-&P3:S!6\PJ 2N1C!
MS7JFL>#?#NOW:W>J:5!<7 39YIRK%?[I*D9'L:GOO#&AZEI4.EW>EVLEC!CR
M8=@418Z;,?=Q[8H \MDTA[>U\:Z;>ZIHFA6EQ;0&:VTZ222*TE9L!F4HH42#
M ('4<UK:!"=!\>:/::OX8TK3[^\MYH;6^T27;!,JJ'8218!Z $$YP37=V'A;
M0M,TNXTVTTJVCL[G/GQ%-PFSP=^<EOQS46C>#?#WA^Z-UI>E06]P5V>8,LRK
M_=!8G ]A0!LQ313QB2&1)$)(W(P(_,4^LGPYH47AW1UT^%E*B:68[$VJ"[LY
M &3@#=@<GI6M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5FZ[KMCX=T[[;?M)L,BQ1QQ(7D
MED8X5$4<EB>U:5<A\1+S5;+1;)],\^.)KZ);VYMK?SY;:#G=(B8/(..<'&<X
MH MZ3XTLM4U=])FT_4M-OQ ;A(;^W$9EC!P64@D'!(XSFLF#XK:#<65MJ"6>
MK#2YF5#J+69%O$S'&&;/J<$@$ \9KG=%MWE^)NFWMH_B*_L#IUS%_:&J1N%:
M0[3M4%5VC Z[0">F<4UM*OQ^S4FG"PN?MOV1!]F$+>9GS@3\N,Y[T =WJWC.
MQTO5FTN.RU+4;V.(33Q:?;^:8$/0OR,9P< 9)QTJE\-M;G\0>&KC4)[I[D-J
M%RL,CC!\H2'8,8&,#%9JWW_"'^/O$=WJ=G?26>L"WFM;FUM7G!:./8T3; 2&
MR,C/!SUJ]\,(KF/PQ=O=V$UC)-J=W-]GF3:R!I20,?CU'% &CJ_C.RTK56TN
M*QU'4[](A--!I]OYIA0]"Y) &<' SD^E0R_$'0QIFFWEH;J^?4MPM+6T@+SR
M%?O_ "G&W:>#D@"L9;\>#O'WB2\U6TOFLM7%O-:W5M:R3@F./8T3; 2K9&1G
M@YJB+S4;'Q-HWC'5- N;2PFL;BSE@MX6EDL]TH>.1T49!91S@'!/- '3I\0-
M&.BZIJ4R7EL=*Q]MM)X=D\.?NY7/((Y!!(/K50_$[1DNHH);'6(C<H7L6>Q8
M"^QCB(=2>0>0.#GI7&^);6^\2V/CC7K'3;U+.YTR"RM$DMV26[9'+,XC(W8&
MX 9'-=CKUE/)XY\!RQVTC0V[W?FNJ$K%FV(&X]!SP,]Z +"?$31AHFJZG<PW
MUF-*D2.]MKF#9-$7("DKG&#N!R#TJ#_A9ND+=I:2Z=K4,\\9DLHY+%@UZ,C_
M %0ZD\@_-MP.3@5R?C'2K^Y7XE"*PN91=?V9Y&R%F\[;MW;<#YL=\=*Z_7[2
M>7XF>#KB.WD>""*^$DJH2L9:- ,GH,\XH @U+QKIVI>#=6O8[G4](DL9XX+D
M&W N;=RZ8&PG!#!ASGH36AJOCJPTS4;RRCT_5=0>Q56O'L;;S$M\C< Q)'.W
MG R<5P_BC2]0FL/B0L5C<N;F]T]H L+'S0HAW%>/F P<XZ8-6O%$=E;^+=4N
M7_X230-298S#>Z4DEQ#J.$P-R*A7<OW=IQVYH ["\\<Z7"FG?8H;W5)M0M_M
M5O!80[W,/'SG) 4?,!R1SQ5.[\6Z=JFE:5>VU]?V2OK,5D\8@Q)YVX@P2JWW
M0>Y'X5RVHBXNK#PW>^,+'6=.U+["V_6M'+B2"0L/W4D<:M@,,'D$9R,"HU'B
M/4_#^CF_6^O8H/%5LUI<7%J8IY+53_K)$ &!G/) XY- '::AX_TVRO[RU@L-
M5U 6)VWDUC:F6.W.,D,<C) Y(7)%/U#Q]H=BFDLC7-[_ &M$\MBMG"93,%VY
M  YS\PZ],'.,5SFAZS_P@\FOZ9JNFZG)/-J=Q>VCVMG),MXDIW* R@@..A#$
M8XJCX6\.:GH^I?#V"]LY%>VM=1>?:I9;=I2KJA8< X;'X&@#L+7Q_HLVE:K?
MW*WE@=**B\MKN I-$6^Y\HSG=GC!.:FTGQE9ZGJZ:5-I^IZ;>R1--#%?V_E^
M<BXW%2"1QD9!P>>E<IJNGROKGQ">XT"XU6TN+:P ME)C-P%5MWEMCEEZX'.0
M!UJ/PG<7T?B^PM=!U3Q!J&A-%*;]-9MG'V4A?W822158MNXV\\9H ]2KBD\6
MWK?%.Y\.FSN_L4>GI(K" 8$A9LR%L_<P H/KFNCT36K?7K%[NVBGB1)I(&2>
M/8X9&*GCZBN7GDDL/C&9IK6Z-O?Z-';0SQP,\?F++(Q5F PO!!Y]: ,;P;\3
MX$\$Z3=:W%JT^0([K53:DVZ2%R!N?CU R 0#QFNPU;QE9Z9JKZ7!8:EJ=]'$
M)IH=/M_,,*'.TL20!G!P,YXZ5PG]E7X_9H&G"PN?MOV/'V;R6\S/G9QMQG/>
MM#7;^]_X3?4K35K[7M-TU88?[/71[-F-X2IW[I%C8[@W 7*X'- %KQ!\1PND
M>'M0T.WO9HK_ %5+:<"URZ*K$21%3]V0D8 ]CCUKNY[V.VTR2_F21(HH3,ZE
M?F  R1CUKQBQL]0T_P #:=<7&EZHOV#Q?]LN(7B>6=80[$N<9+_>&6&<UZWK
M+&]\)Z@\"2,9[&0QIL(8[D.!MZYYZ4 8%K\3M%NC82BSU6.POW2*#4);0K;F
M1NBELYSGC.,9!YJYJ7CK3[#4[K3[>PU34YK, W9T^U\U;?(R QR.<<X&3[5S
M&I:;>-\%?#=FEE.;F(:9OA6([T*O&6RN,C'.?2K&DZJ/ ^L>);35[#46%]J4
MFH6<]K9R3K<+(J_NP4!PRE<8;':@#N]*U2RUO2[?4M.G6>TN$WQR+W']#G@C
ML16%J7CO3[#4[JPM[#5-2ELP#=MI]KYJV^1D!CD<XYP,FF?#C2KW2?!L$6H0
M&VN)YYKDVY/,(DD9PGU (S[YK#TC5AX'U7Q+9:OI^I.;W4Y=0LYK6SDG6Y60
M+A 4!PZD8PV.U %G7?B!Y6H^$WT:.YO=-U61W>2VM]_FH(VPBYQA@PR1U %5
M;#Q[+I_B'Q7:7EKJVIBSO_DCLK7S1;P^6IY/ QG=QDG@\5B6VFZCX9T7P3J&
MI:==A;;4[JZNH+:%IFMEF60HI503QN /H379>#K2>#7?&<LUO)&L^J;XF="H
MD7R4&1GJ,YH O77CC1K?2-,U"%KB]&J#-C;VD1>:?C)PO&,#J3@#O4*^/]'&
MCZKJ%Q%>VKZ4H:\L[B#9/$&^Z=N<$'L02.*\SL-!O[+P[X#U2]BUJUM+.SN+
M:\.GHRW%J7;*N4 +;3C!P/2K.IZ4-2\.>,;_ $NT\0WOF:<EK#>:BS%[K#[B
ML<10-A?[QZY.!0!ZIX?\1P>(X9YK:RU"W@C8".2[MS$LZD9#QY^\I'?BJFK^
M-+'2]5?2X;'4M3OHHQ+/#I]OYIA0]"Y) &<' SD^E;]LNRUA0+M"H!C'3BN!
MCU >#?'/B6YU6SOFM-6:"XM+JVM))PQ2,(T1V E6!'&>"#0!M3?$#0QIVF7=
MF;K4'U,,;2ULX2\T@7[_ ,IQMVG@Y(P:;_PL+1%T+4M4N!=VPTQTCO;6>'9/
M 7("[EST.0<@D$9KFDO-0T[Q1I'C#5M!N;2QN--FLI8+:%IGLB9A(CNBC(W*
M.< X/!K&\3V=]XDT_P 9Z[9Z9>K9WD%C:6D<ENRRW7ES!GD\LC=M&< D<@&@
M#M?^%FZ0MXEI+INM0W$\9DLHY+%@UZ,C_5#J>H/S;<#DX%6%^(FBCP[J.M7$
M=[:Q:;.L%Y;W$&V:%V90,KGI\X.03Q46O6D\OQ-\'W,=O(\$$-\))50E8RR(
M!D]!GG%<5XR@N+71?B5<2VDACEO]/>+>A"S >0#M)X(R,4 >@:9XXT_4=5MM
M.DL]2L);M&>S:]MC$MR%&3L.3SCG!P<=JK77Q'T>VENF6TU2XL+.0Q7.HV]H
M7MX6'#9;.2%[E00*R;_4CXU\2>&H=,T_485TV]^W7L]U:/ (-L;+Y66 W,2V
M,+D8&:XW3],&A>&KKP_JK^,&U2)IHDL+'?\ 9[U79B"C!"H5@WS$GCG(H ]1
MU7QSI>EZI!IBP7U]>W%J+N"&Q@\TRQDD9!SCL3DX&,<\TR+X@:++X>EU?%X@
MBNOL3VCVY%P+C( BV?WCD?GUK'T#1I]-^(>FK]BGBMK;PK':AG/F!'$P_=F3
M #, /;.,XK'N=.(L/&']HZ!?WUI+XA6;%MNCFCCV1_OXL#+%2.B]>?>@#MM-
M\:Z=?SWMO<V][I=S96_VJ:'4(?+80\_O 02"O!Z'BJ-O\1]+GGL/,T[6+:SU
M"5(K6_N+39!*S_<P<Y&[L2!FN5TF^\102:U'X<N]7US2HM*DD@;6;5E<7>?E
MC5G56D&,Y!&.G/-8NH?:-4TW0I8;OQ7JU[#J%G-?1SVCPV]J Z[OW815)!X
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,1S1J5#1R;#E<'!! Z UJ^#_  _>:);:A<:G/#-J>IWC7ET8 ?+0D !$SR0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[&@";Q]XKUR+Q/H_@SPO)#;ZMJ:M-)=S('%O$,\@'@GY6Z^GOPFBV/Q'\/\
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M18W"ZOITFG3 @JP9TW1,1_>'!Q_TSQ7IW@+PZ/"O@C2M)*A9HH0T_O*WS/\
MJ2/H!0!TE%<S=>&];GNYI8O&FJ6\;N62%+:V*Q@GA03&20.G)S6GHVFWVFQ2
MK?:U=:HSL"KW$42%!Z#RU7]: .<&O:AX=\>2:7KMV)-(U4&73+J15002*,O
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M6,45L[_:E:)% 0J",Y7!R1C\Z .AN?B-X=M=+TO4&GN'BU5'>R2.W=WFVX!
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M)]>..^*GT+Q+IWB#[2EH9XKFU8+<6MU"T,T1(R-R,,X(Z'H:\<T_3+NS\->
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MXLT_6YX+:.^O;R\BF,G$:LV^-_J" <>U:'PQLKR/PFNKZISJFLR&_N21C&X
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M74)3,T4I=TQN/)7(!P:SK34/$-K%I>H6$?C.]U)I8FO4O80;2>-B/,VKG$>
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M\(2Y%M*"Q)[%UVLN[W!ZUW6M^$DU/5X=9L=3O-*U6.$P&YM0C>9%G.QT=2K
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M*^@GEW03I,0K!(\80@MD$>G.:V/&/A96T;Q3J=F+FXO[W16LEMT&[=M5RNT
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MSR;\AN/N_.<8YX% '+7NJZEX%UKQ'9PZG?:E:P:!_:D":A*9FCF#LF QYVG
M)%1:WIVLZ%X9T;6H?%FKS7=S=V:WJRS@Q3"21=P1<809/\/\.0<UV^K>'+>7
M4]0UT6[WMU+I+:?]A=PL<R;F?:3C@L3C/3!Z5YA_8DNLIH.E6$?BX_9;VWE:
MUU2(I;Z?&C L/,*+YA !5>6X/% 'N%>?_$2RGU'Q%X+M+>]ELI)-0E'GQ8WH
MOD.6VY! ) (![$YKI[&RU"+Q5JUY-<SMI\\4"V\$D@*HZAMY11]T'*=>20>V
M*@\3>$[;Q/)ITLU[>6DVGS&>"6U<*P<J0#R#TSG'0]\CB@#CM3N]3\*ZCXAT
M2#6+^[MG\.7&I6TEU,9)K:5,J<.>2#D$9Z$<5H:UJ^H0>"/!EU%>3)<7=]IB
M3R!L-*KE=X)[YYS6UIW@JU@?4;C5+ZZU>]U&W^RW%Q=;5/D\_NU5  J\DG Y
M/-9D/PSA\K3+>[\1:Q>6FE7$,]A;RM&%B,; J#A 7X&W)Z G&* *O@W2Q!\3
M/&T_VV]D\N>W&R28LK;X5;D=\=!Z#BK?C5]2N/%_A+2++5;K3X+][M;EK9@&
M94C#8&00#P0#VSD<UMVOA>.R\77WB"WU"[0WZ(+FSRIB=D4*K],@@#UJS?Z#
M;ZAKVD:O++*L^EF8Q(I&UO,38=W&>!TQB@#SG4->U;P0OC:T@U*[U".PL[6X
MLGOY/->%YF9#ECRR@X;!]*TM9L=3\$0Z3K$/B/5-0D>^@MKZ"]F\R*X65@K%
M$Q\A!.1M],'-=3=>#],OM2UB[O!).NK6D=I<0,1LV)NQC R#\QYSV&*S[3P"
MJW6GMJ>O:IJMKILBRV=K=&/8CK]UF*J#(5[%C0!E_#W2Q:^+/&<WVV]EV:D8
MMDTQ96S'&VXCNW;/IQ5[7./BUX6_Z\+[_P!I5L:;X7CTKQ/J6LVU_=B/42'G
MLF*F+S,*-XXW X7'7')JQ=Z!;7GB/3];>647%C#-#&BD;6$FW)/&<C:,<T >
M8:1J6N:YIOPYM&UV_MSJD5\;V>*3]Y*J#(Y.>>, ]1DXYK1TS1M4O]<\5Z%+
MXKUU;+1WB-HZ7.)MTL(D.^3&YPIZ \<G.>,=5I7@/3M)'AT0W-T_]@I.EOO*
M_O!*,-OP.W;&*T[+P];6.L:UJ<<LK2ZN8C,K$;4V1B,;>/0=\\T <%HNOZMK
M7_"NQ<W\Z?VI87GVPQ-L\UEC4*QQW!R1Z$USVEWU]X;^&UDNG7FIM/J^NR6+
M-&1+)"@FF+&%3P'8+^9S7INF>!M/TH^'##<W3?V##-#;[RO[P2  E\#J,<8Q
M5./X;:<NEWNF/J.H/9S78O;5=ZJUC-O9]T3!<@[F/7/\Z .?TS5]8T77-]I9
M^*9]&-E/)=#6T+>5)&F]&1R2?FP5(Z<C%8OB/2=3U#X--XEN_$>HS7E[;P75
MQ;M*/LQ5W1O+6/&%VY&".<CGK7H^F>#1;:PNK:MK%[K-['"T$!NA&J0HWWL(
MB@9. "3DD5CW7PKM;K27T0Z_JZ:'NWPZ>KQ[(CNW !BNXJ#T4D@<>E '<W4'
MVJTFM_-EB\U"GF1-M=<C&5/8^]>,>%I+^P^''A/3=.U2[MY->U%[>6X+AC;Q
MJTI819&%9@O7GDDU[;7%6_PUT^#0&T8ZGJ+VL5T+JP;>HDL) S,#&P7U8_>S
MUH KP+>^%/'^C:1'JU_J&G:Q!<9BOYO.>"2)5;<KGG!!P1TS7>US6D^$!8ZS
M_;.HZM>ZOJ:PF"&:Y"*(4)R0B(JJ"<#)ZG%7/"MEJ&G>'+6UU2YFN+Q#(6DG
MD$DF"[%0S#@D*5!QQQQ0!S/DWOB_QMXAL9M9U+3[#1S!!!#I\_DL[O'O:1V
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M?B-M9@:1)#81V"PC'EK&C%ACC.><=: -D#  ]/6BBB@ HHHH **** "BBB@
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M![B[GE&5)(+ *6(^5><9&!5KP_8VFJZ]\.Q?01W21^&&D"S*'&X+$,D'KU-
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M!(QVKVFWU*TN+DVJ7$0O%B662V+CS8U;H67J* +=%%% !1110 4444 %%%%
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M1SM&30!K:=X=T31YY)],TBPLI9.'>WMDC9A[D 5;M[.UM(6AMK:&&)F9F2-
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MDDD "@"^=*TXV<UF;"U-K.S-+#Y*[)"QRQ9<8))Y.:;IVCZ9H]LUMIFG6EE
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MNKE8E\F%@,@EMW(/MSQTY&7>/==OM%T>S@TID34]4OHM/M977<L32$Y<CO@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2#Q#XSU'PC+XUM+G3HK,1O=0Z0]L27MTR?FFW9#E03P,9Q5S0-0BU;XI3:C
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M!ZY<GCT-6].TSQ;/K-K=ZYJUC':VJM_HNFQNHN7(QND+D\#J%'?O0!3^*?\
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M1(H!)QR&&.#64_@;6[R[\17FH:I9O-K.CMIX2&%D2W;Y@NW))*@-DD\YSTZ
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M-!\-75Q/%I4UM<7<\4,K1_:60J%0LI!P-Q8@'FN5\1^;X8/C/P_I=W=#31H
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M>"[-Y)^[VS;0@7=MVX'((YR:ZY=)LV^-&H7F6BG70XKE96F?:DAD=2Q&[&
M.#QWQGF@#TJBO$M*B?P[<:/=>(;'5[6Y^U1AO$-CJ)NK>^W' \T%OE1\C^'C
MC&*]MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/(\K2.#@*"Q^5>@'%;\7BO0I]+M-3BU*%[.[G2V@E7)#2L=H3&,@YXP<8[T
M4;+P#X>L=-U33Q:R3VVJ$->+<S-(96 QN+$YW'KG.<\T:7X%TK3-3M]0:XU&
M^N+52EJ;^[><6X(P=@/ ..,]<=ZUK[7--TV[6UN[D1SM!)<K'M9B8X\%V&!V
MR..M8W@'QA'XS\/"_(1+A99%EB1&"H [!.6ZY4 G'?TZ4 2R>!="ET/^R&@E
M^SK=->1.LS++%,S%MZ..5.6/3Z4_2O!FE:7-=W+-=WUW=P^1-<WUPTTC1?W
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M=U':VL>-TDAXR> !W)/H.:Y73/'5OKOQ M]*TJ[2:P.FRSS(T+)(DJR(!D,
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MZ@L<5[D0*(G,DI'WML8&\X/M0!5T_P"'VC:??6=R9M1NUL3NLH+R\>:*V.,
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M+NX[FV8E=Z9&&'4$'D$>AYH H:OX1TG6(;%'CEM);#BSGLI#!);C&"$*] 0
M,=*JIX!T)="U+2GCN)DU,@WMQ-.SSSD="SGGC' Z"KNM^+-#\.S0P:I?B&>9
M2T<21O(Y4=6VH"0ON>*Q/"WCBWU*QU"]U"^@-L==DTZPEC7*R*2OE#(SDG/6
M@#I+O1+*]U73-2F5S<Z:9#;D-@#>NQLCOQ7+^._")O?"OBEM(M9)M4UB.$2)
MY@PYC*A<9( ^4&NMFU6Q@U2#39;A5O)XGFCBP<LBXW'TXR/SKE-0^(OA^^TC
M4!HGB.TBNX+47/VB2WDDCB3<HW-@<_> QU&1Q0!HZ7X%TC2]2M[]7OKF6U4K
M:)=W;S):@C!$:L>..,\G'%56^&N@NMS;E]1&G7+M))IRWKBVW,<DA ?7G'3/
M:M#5/&_AW1+N2SU#4UCNHE1F@6)W?# D$*H)(P#TZ=\5.WBW0%\.IX@.J6_]
ME./EN<DACG& .I;/&,9SVH 33_"VF:;>V%Y;K+YUC8#3H2TA.(<J<'U/RCFH
MKFTB\-1:MJ^FZ7=:A=WTR2S6\+KND8 ("-Q    S^-.T?QEX?UZ^^PZ;J*S7
M8C:5H&C=)%4$ EE8 C[R]>N:T;K5;&QOK*RN;A8[B^9DMD(/[QE7<1GH#CGG
MK0!@?#OPP?"OA..UF@C@N[B5[JYBC.5C=SP@/<*H5?\ @-:^O>'M/\1V<=O?
MI(##()H)H9#'+#(.C(PY!J2?6],MM0EL9[R**XAMOM<JN<".'.-[-T R#U/8
MUG:3XY\-:Y?I8Z?JB27,BEHD>-X_- ZE"R@./]W- #-*\#:-I5]=WJBYN[J\
MM_LUU+>SM,9TSGYMWMQZ8&*K6?PYT*SN;1]^H3VUE();2RN;QY+>W8="J$XX
M[9SCM6[!KFFW-G>WD-TKV]C)+%<N ?W;1_?!X[>U9>H^/O"^E6]M/>ZO%%'=
M6ZW4'R.3)$W1@ ,GKTZ]^U #=5\"Z3JNHW%]YVH6<UVH2[^PW;PK<J!@"0*>
M>.,\''>B_P# >BWHT\P"ZTZ73X?L]M-I]PT#I%QE,CJO'>NCAE2>&.:,[HY%
M#*<8R",BGT <O;_#[P_:V$ME#!,L$M['?N#,S$S)MPQ)Y.2H)SU.?6MA]%LW
M\01:XRO]MBMFM5;=QY;,&(QZY4<UH44 8$O@S0Y]-U33Y[4RV^IW;7EPK.<^
M:=OS*1RI&T8QTIFD>"]-TG4QJ9GO[^^6(PQ7&H733M$AZJF>!GN>I]:Z*B@#
M '@W1QX-/A7RI?[*,9C*>8=V"V[[W7K3[OPIIMYXAMM<<W"7D,'V8^7,RI-%
MDG9(O1ADDX-;E% '(VOPXT*TEMPLFHR65K*)K?3YKUWMHG!RI"$]CR <@5JZ
M3H\UAK>MW\DQ:._EC>./S&<(%0 GG[N3G@<< ]ZV:* "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "N*^)G_(*T/\ [#UC_P"C17:TA4-C< <'/(H X7P7!$WB#QX[1J6DU38Y
M(^\HA3 /MR?SKBO"MS!I.G?#?6M6<1Z3%8W5O]ID_P!7;S.1M+'HN0"H)KV\
M* 20 ,\G ZTUHHVB,;1J8R,%2."/I0!Y/XKUC1M;M+NZT:T1T&M:8DVIQ >7
M=N)!PK#[VP8&>G-:.E^(])\+^-O&D.LWB6DT]U#<V\<G#7"&%5'EC^,Y!&!D
MYKT=8HTC6-8T5%Z*%P!^%#0Q/(DCQHSI]UBH)7Z'M0!XAX5GBTC2/AQK6J_N
M=*MXKV"2>0?);32.0C.?X<X9<GI5K5=3TS5]1^)=YI,D<UNWAY%:XBY29PLH
M+*>C#@+D?W37LK11M&8V12A&"I'!_"A88D7:L:*N-N H QZ4 ><^'(HV^)UA
M(R NGA&V"L1R,RG.*YRXA:.VUF],+R:?IWCG[7?1QH6Q"$3<VT=0&96(]L]J
M]K"J#D* <8SCM67KVDW&JZ=Y-CJ<^F722K-'<0#/S*>CKP'4]"IZT <-)XBT
M3Q#\7_"\NCSQW?E6=XLMU$"4.54A-W0D<DCMN'K7H.EZO8:U:M=:=<+/"LKQ
M%P",.IPPY'8UA:3X5OX_$,>N:[J\=_=V\#V]K';VOV>*%7(+MC<Q+':.<_A6
M]IVFP:7;R0V^\B29YG9SDL[L6)/Y_@,4 <'?:UH^A_&RXGU>XAM!)H4,<5S.
M0J*?.D)4L>%) XSUVUR]VX;1-3\201R+H3>+;74(W"'!A0H))@/[I8$Y]LU[
M;)#%,I66)'5A@AE!S3MJ[=NT;<8QCC% 'G \0:7K_P 8-!;2;R.\AATV[#3P
M'='N)C.T,."0,$@=,CUJW\(KZUF\#QZ?'.C7EC<7"74&?GA9IY" P[9%=S'!
M%"JK%$B*OW0J@ 4Y8T1F94568Y8@8S]: .)L8HV^->KRE 9%T6W56QR 97S_
M "'Y5Q#*MM:S:A/$S:3IWCJYGO J%A''R!(0/X59@37MVT;MV!D\9H"J 0%
M!Y/'6@#SFXU/3_$_Q0T"X\/7,-\FGVET;^ZM6#QJDB@1QEQP3NYVYR,$U<^$
M%_:W7PWTNU@G1[BS0PW,8/S1/N)VL.QKN(H8H$V0Q)&N<X10!G\*58T0L415
M+'+8&,GWH \=\9?Z_P"*G_8+L?\ T%ZZ708HV^+6J2E 9%T.S56QR 6?(_0?
ME7>E$.[*J=W7CK2A5#9 &>F<4 >*-!%'^SQXBV1HNZZNF.!U(NB ?R _*MC7
M$>7Q#\0HT4N[^&(PJ@9))2;BO4MB;2NQ=IZC'%+M 8M@9/4XH \2O=0CN#X
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M*SU3P=I,]C<QW$2VL<;-&<@,J@,#[@UN!$7&%48&!@=O2A(TB7;&BH.N%&*
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MNZ!FC\&1LA(^Z=T8R/P)'XUZH8(FE$IB0R ;0Y49 ],TX(H((4 @8&!T'I0
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MZL2!^-::>,=:T^\TW_A(_#T>GV6I3K;PS0WGG-#*_P!Q)5VC&>F02 :R=6\
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MEG*.I?RFW$Y;!/S%>,BO1] T>]L?&GBS4;B(+:ZA+;-;/N!WA(0K< Y&#ZT
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MO-\J*95*^:FT;=P]"<' -6].\"#4FU>,>$]/\-6-UITEG&1LDN6D?@OE&*A
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M6Z*I:19W.GZ7#:WFH2ZA/'D-<S(JL_)(R% ' P/PJ[0 4444 %%%% !1110
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M@T2UGMXX6&XR^;MRS-ZY4GIR3VKH;^U%]IUU9E]@GB>(L!G&X$9_6GS7,%O
M9YYHXH0,F1V"J!]3Q2PW$%Q )X9HY(6&1(C J1]10!QP\ RV=MH<ND:R]EJN
ME6*V NC;B1+B$ ?*\9([C(P1@TY?AW:W.E:S!J^H7%]J&L-&US?!1$R&/_5>
M6HR%"$9'7G.<UU=K?V=\&-I=P7 0X8Q2!]I]\4D>H64UT]K'=V[W"?>B60%U
M^HSD4 <I_P (/?:E<+)XD\12ZG'#;RP01PVRVP'F(49VP3N;:2!T SG%9]Q\
M-M4OO#$/AV\\6.VG6JQK;)%8I&W[L@IYAW'>!@=-N3@FMG5_%EYHUI/<7&F1
M%1JL-A"%N@V])&5?,. =I!8_*?3WKI+>]M;OS/LUS#/Y9VOY4@;:?0XZ&@#F
M[_P=/=>)K[5K?5VMX=0L?L=Y:FW#B0!7",&R"N-^<=\56_X0*6SAT2;1]9>Q
MU32[!=/^U-;B1+B$ ?*\9([C(P1C)ZUJ^%O$\?B#P?9^(+F..QCG5V97ERJ;
M7*_>('I^M;<%Q#=0K-;S1S1-]UXV#*?H10!Q<WPY6\T+6;6]U>6XU/6)89;N
M_:$#_5,I150'"J N ,GJ3DUOZKX?75-=T/5#<&-M*EEE6,)GS-\93&<\8SFM
M6>XAM86FN)8XHE^\\C!5'U)IJ7EK):_:DN86M\9\U7!3'UZ4 9GA^/5HWU8Z
MI.\J-J$K66]%4K;X7:N%[!M^">2,$]<5D>)K=]-\7:#XG128(]^G7I SMBE(
MV.?99%7/LV>U=7#=6]PTBP3Q2M$VV0(X8H?0XZ&H[C4+*T5C<WEO"%(5C)*J
MX)Z Y/>@#F;OP=J,6KZC?>'_ !"^E+J3![N%K19U,@7;YD>2-C$ 9ZCC.*S]
M5T"(+X6\%V'FR6MK.E]=R2'<?)A.X;CZO(1^3>E=X\T20F9Y46(+N+E@% ]<
M^E59=6L4TN?4DN8IK6%&=I(I%8<#D YQF@!NMZ6NMZ-=::]S<6PG3:)K=RDD
M9Z@J?8@5S]GX/U*77M-U77]?_M-],#FT2.S6W 9UVEG(8[CCL,#VK<\/:W;^
M(] LM6MAMCNHEEV%@Q3(!VG'<9JKI'B+^T]9U^QD@6!-)G2'S3)GS T8?)X^
M7&<=^E &##\-]FC7FE2:U.UM]M^WZ:R0*DEA-O9]P;G?RW<#C/K5^Q\(7TFN
MVVL:_KAU2YLXWCLTCM5MXX2XPSE03N8CC.<#GBND>_LHXO->[@6/9YF\R #;
MG&[.>F>]20SPW$"SPRQR1,,K(C J1[$4 <S;>!;%/AW'X.N[B2XM4A\KSU&Q
M\AMRL.N"#@CKTIEEX5ULZE87&L^*I[^WL&WPP0VPM_,?& TI5COP">.!GM72
M6^HV5TDCV]Y;S)%_K&CE5@GUP>*E-Q $C<S1A)2!&Q88<GICUS0!Q%U\/;W[
M+J>EZ;XDFL=$U%I'DLQ:J[1F3)<1R$_*I)/&#U.",UUVD:>-)T6PTU9#(+2W
MC@#D8W;%"YQVSBK$ES!$Q62>-& #$,X! )P#^?%-AOK2YFDA@NH)98CB1$D#
M,GU Z4 <-'\.;^#1;WP];^)Y8=!N6F/V=+1?.59"2R>:3RN6/\.<<9K9TGP>
MNEZOI6HF^:5[#1QI07RMHD 93OZG!^7I[]:O>*/$=KX5T"?5KM6D2(HHC5@&
M=F8* ,_7)]@:T9;^SM[9;F:[@CMVZ2O( I_$G% '.2V>E^$(_$6LZI=.]EJ=
MPLLR?9V?9E%CVX7);./3O5#X4>'7T'P>LEQ',ES?2>>5G_UD<0 2%&_W8U7C
ML2:[B.1)8UDC=71AE64Y!'L:QF\3V2^,1X:)Q=?8_M9<NH7[X4)C.=W4_3'K
M0 SQ+X:_M[[#<V][)8:GI\QFM+M$#["1M964\,K X(X^M8\GP]&J6VIGQ!K$
M]_?WR1H+F&,0"V$;;D\I 3@AN223FM/PKXMM?$6@6&H3F"SN+PR!+5IP6.R1
MDXS@G.W/2MRZO+6QC$EW<PV\9. TL@09],F@#E[7P?J-QK&GZAXA\0-JHTUC
M):0I:+;H)"-OF/@G<P!..@&>E<IX2\)ZWJGAS5+4>(+G3].O=1O%N+7[*K2;
M3*P/ER$Y0,OL>I(QFO65970.C!E89!!R"*YGQ!XKGT_6+;0=&TTZGK5Q$9_)
M,HBC@B!QYDCX.!G@  DT (? VG'5A<9_T$:*=&^Q;?E\G=G.[.>G']:S[;P+
MJ\=M9:7<>+KN71;-T,=NENL<[HARB/,IR5&!G !('6K6E^*M6C\16^A>)-&C
ML;F[C>2TN;2<S03;!EER5!5@.>1S73-?V:7BVC7<"W+#(A,@#G_@.<T <KJ'
M@W5YYM4BL/%,MMINILS3VT]JMPT9<8<1NS#:".Q! [5TVE:;;Z-I%GIEH&%O
M:0I!'N.3M4 #)]>*DN+ZTM%=KFZ@A" %C)(%VYZ9STS0VH622PQM=VZR3C,2
MF0 R#_9&>?PH Y6S\ 16<.D1C47;^S=4FU$'R@/,,F_Y.O&-_7VK9'A]1XT;
MQ']H.]M.%AY&SC D+[LY]\8Q6C<7]G:!C<W<$(3&XR2!<9Z9SZXJ4S1"'SC(
MGE;=V_<-N/7/I0!S_B;PO+KE]I.I6.H_8-2TN21[>5H!,A#KM<,A(SD=\C%9
MB> ;F34M5U&_U^6[NM3TM].F)MU1$!)P44'@#)^4DY))S776M_9WL;26EW!<
M(APS12!P/J0:1=1L6N(X%O+<S2+N2,2KN8>H&<D4 85[X/CO/"VC:(;UE73)
M+1Q+Y>3)Y!7 QGC.W\*YGQ#8V/B_XHZ+;VBW#-I&]M5?RF6,HK(\41) #9D
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M8\@9^;H0"<;NAH OT5'!/#<PK-;RQRQ-RKQL&4_0BI* "BBB@ HHHH ****
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M(+&&[G3P]92/#<QAT$K%]Q*'C(Y'3C)]:[-_ OA>35CJCZ'9M=F3S2Y3@O\
MWROW2WOC-:Z:=9QZG+J*6Z"\EC6*28#YF122 ?8$G\Z /';?28;KPO<Z+!>V
M-J+3Q?<1Z?9WZ,UM/L8E;=@/X>20/45U/@=X[#QAJVDW7AVVT?5GM8KF4:?/
MOM9HPQ4,$P-C9SU&2*ZRX\+Z'=:?=6$^EVTEK=SM<SQ,N0\K')?V;/<4[1?#
M>C>'4E72=/AM3,0967)9\=,L<DX]S0!RGCG3-.O?'?@@WEE:S^9=3QN9HE;<
MH@=@IR.0&Y ]:S_#WA;1-;\0^.[C5-,MKR0ZDT"F>,/L7RD/RY^Z<GJ.>!Z5
MWVM>'])\16L=MJ]A#>11N)$60?=;U!ZBK%KIME9274EM;I$]W)YLY7_EH^ ,
MGWP /PH \=T>YBU7POX TV325UO5#9RSP07ESY=JJI\F^0%6WD# 48..3Q5"
M:R1++XIV-S9:3%Y%A;S_ &73QN@AF\N3YER!A^!D@#FO7;GP5X;O-.LK"?2+
M=K:RS]E494PYZ[6!R,]^:EM/"?A^PBN(K72+2&.Y@^SSHD8"RQ\_*P[_ 'FZ
M\\F@"7PY:VMGX<TZ&S@A@@%NC!(4"KDC).!QR23^->.ZK!;:OX(\2:W8>&](
M&FS&ZD.JZM<[[N1P6&4 3*G<,*I88XKVG2=(T_0M.CT_3+5+:TC)*1)G"Y.3
MU]S62W@+PJ][-=OH5FTTS,\FY,J6/5MOW=Q]<9H X:RTBP\3>.?#*:S;I?1#
MPDEP8YQN5WWH-S ]?O'KWYJI8Z3?ZUXI\7[]&\-Z@UM>&U":O*ZO;VRH/+"*
M(V"H1DY!&3GTKU>UT/3+*YM[BVLXXYK>U%G$XZI"""$'MD#\JI:QX,\.:_=B
M[U32+>XN NPRD%69?[K$$;A['- %#X:K.G@+3HY]0M]0\OS$CN+=W=&C#L%
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M3U([5U-[!!KOC#Q$]AX;TK4)+4QV]Y?:Y<?NHB$SMBCV,0H!R3E<G/UKL8/
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M'-HS:/+I=L^GL[2&W9,KO+%BP]#DDY'K3M'\-:+H$$T.EZ=!;+.<RE1EI/\
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MIY3%MZKU (7!/>N'O$O]0T2'PU!(YO/!:75XQS]]H)%%M^<9;%>SZ-X0\/\
MAZX>XTK2K>VG==AE4%FV_P!T$DD#V'%7(M%TV"_OKZ*RA6ZOU5;J4+S*%& &
M]<#B@#Q[Q#/'XG\$^,O%<;,(+VYLK*S<'!$,4T>2I]Y'?\JZG4] TGP]\1?
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MR#;R3C@XH ]$HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVUS):7*P2>9'YB'DHW\2D$$'T- &Y<W5O90-/=3Q00K]Z25PJC\326E[:W\
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M 523CKVJEXTNO$X\"^*;'7[.R>(::98;^PW+&QS@QLCDL&'7()!'I0!Z:""
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M,_.3QR,$ =,X[5U5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM1;RVBD1=H='V-P5QD8'(KH_"FDWVD:-Y.I26;W<LKS2+9P+%%'N/"*  2
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MG[2@V2[<['5@RG'<;E'%;=9FIZY::5?Z79W"RF74IS;P%%! 8*6^;G@84^M
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MEO9+><QO.L8&W)'?Y?O=>3@@G-=Y+X!L6U&_N+;5-6LK?4)/-O+.UN D4SD
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MJ,O.0,D8!R._3C- '0/PC?0UXOHL^J:[IWPTLYM;U.)-0MKXWLD5TRR3A I
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MGVZS*\MSEAD,Z!#MXX& .N: .#MWO_%6N^#8+S5[Z"WO/#8O;R*VN&A^T/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;F/&W$J;'&X9!XW="#CT]>HH \;O_"=Q?>$O%<FE>%KNQ:[AA@M$N[F26ZN
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MW7KL:?K5UIBO$=*TZ_F5[O&,2<DG"Y(P"<X4^M>BT4 (I+(I(*DC.#VI:**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.$KR>I!)Q0!ZM/=6]J$-Q/%")'$:&1PNYST49ZD^E$ES!#-##)/&DLQ(B1G
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M4\.QR0B>P2([O/4F5F#%E5>OR;1GZ]JZ&O/_  Y'8CXN>+'\F&.=[:QDB#(
M_P R2;R.^>F?UKT"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ3J,GD11V^Z[&.8Y5.UUQUSO! '?(H T=3\)^'M:O$O-3T2PN[E  )9[=6;
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M9:AXCM-9NY[R5[3#06K3G[.D@! D\OIOPQ&: ,L?#^W&BZ5IL.M:U81Z?;+
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M^&%\.:E>:M;33K9R1VY:VN0\C.CM*/E4?-\P)!&*]0IKR)&NYW502!ECCDG
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M=X@00A,K9 (X.#D9]JJ7<-]:^._%L9TN_EBUC2XEM;F* O%NCBE#*S#[I)(
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M7M-T&&WM8YYKJ^B\UY'D&51%W*,!<$G/<53'Q)U:\\*Q3::=.N=4378M):9
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M9M>\)Z3JK@"2[M(Y7 Z!BHW?KFG>)+V_T_0+NZTQ+1KM%&PWDOEPIR 6<Y'
M&3COC%9&F6.I^'G\*Z%9[)-.@LWBO6\HDY2-0K!^@RW;J<\=#5KQMX;E\5>'
M&TZ"XCAE6>*=/.3?$Y1@VR1>ZG'- '*:+XWNSXYTK1/^$GTGQ#;Z@LPD>RM_
M+-LZ)O&&5V# X(]:JQ^*/&UWX+U'Q7%>:5#!ITER19M:,QN4B=@2S[QL.!@
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MHU*&1IK52<[ 5.' SQG% "WJMX$TO3/#GA@[[G5=0>*T^VMOCM%(+O@#!*J
M<+GOUILWB#Q#X:UA])UFZM-0^U:?<75C>16YA(DA4%D=-Q!&""""/2E'PXDM
M-"LUL=5)UZUU!M3_ +0GCRL]PX(DWH#PC XP#D #\9O^$2UO6-3FU7Q#>V)N
M8[&:SLK>R1Q%#YHP\C%N68X QP !WH P/^$J\<0>'O#?B%Y])E7698+8:?\
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M'9I<G'<+7J5 #8XXX8UCB14C4855& !Z 4ZBB@ HHHH **** "BBB@ HHHH
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M&*(['$<C_P!U9"-C'V!-.U+QYX9TC4)+&^U6.*>(@2XC=EB)Z!W *IU_B(H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5P_Q/ACN--\/PRH'CD\06*NK#(8&3!!KN*1E5L;@#@Y&
M1WH \P\=BXL?B1H>IS:PNC6!L9K>*_EMUECBG+ E6W<(67HQ_NXJOH>A6?BP
M>-(DUN75EU"&*VDOEM$BMVF124:,J3O9<KDX[#DUZM)''-&8Y45T;@JPR#^%
M$<:11B.-%1%X"J, ?A0!Y-X8FU3QP^IZQ-&\-[IFDMI$ ?C%ZRYG<>AR$7/U
MJC<:[H$_P0B\,P-&VMFSCLETD#_21=C /[OJ"'!;=^.:]H"JN=H R<G [TP6
M\(G,XAC\XC!DVC=CTS0!XGKGAW6-5\9>(Y+>87,NF6NF7,^FNN8]1=%8['/T
M#X'0DC/2K_B#6HM5\3>$_%-IK2Z5H\]C-##?2VZRI;3DC*.&X1B 5SZJ17L
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M+%IIRN]W+;VBHB?>?_1N5'N1D?C7J\<4<0(C14!.2%&,GUI0JABP !/4XZT
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M1U"_%_Q/M &[3K)FQW.9!G\J/$@,?Q0\$S2?ZDK?1*3T$AB4C\2%:NUVJ&+
M#<>IQS63XCT,:[I\423?9[NVG2ZM+C;N\J5#D'&1D$94CN&- '.^/E_M;6?"
MWA=O^/?4;UKBZ7L\-NOF%#[%ME;_ (OEA@\%:[)/CRET^<MGT\MN*V-H)5F
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M*UO)-)EMM(NHK"ZP!#*T D2/D9^3(SQD=>]5O#.@Q^'-%CL%G:YF+O-<7+J
MT\KL6=R!TR3T[# H UZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P/%WB=?"FF6UZUC+>>?=Q
M6JQ0L Y+G QGJ?;CZBM^N6\<:3?:O:Z*EC 9FM]9M+F4;@-L:/EFY(S@=NM
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MD$;LNX%U5S]UBNX ^] %"#QCJUOKVEZ;KWAS^SDU-FCMIH[U9\.JEMK@*,<
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MDO\ [+B#S,%//*@?-CG&[TYQ56?QIJLWB;6-#T;PTU_-I9C\Z:2\6&-@\8<
M$J?FY(QTXR2*Y273_%U]X&T7PO\ \(O+!+IDMFMQ<R741CD2%UYCPV22!NY
MP 1R<"K]CK&K:7\2?&XLM N-5@>:T_X]I8T9)/LR8#!V'RD=QG&.G- &K/\
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M,C>=J=_J"21,V[.8LR'DC@#:H&>3Q0!Z)I4\DGQ:UZ/S7,(TNT94+':"6DY
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M,=Z]?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\CL:Q_ &K3ZYX!T34;EBUQ+:KYK'JS+\I/XD9_&N%\,Z7XBET3Q+J.G>(I+
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M#5--TOQ)+8:+J3R22V@M5=XS)G>(Y"1M4DGC!QDX(KMHIX9U+0RI(H."48$
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M(719;^$H[*0' @3H>XSFN(\,6]WH.C>!-?N["\DL;&&]MKI(X&>2V,LA*R;
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M!P=IR0,D"NCM+N"_LH+RUE66WGC66*1>C*PR"/P->3>()]/M_$6K7MOJ&O\
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MMU:%)H%*,1($;AAP2/I[UP.GW>J:/X+\*0,UQI5E)>W_ -LU)++SI;7]](4
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MW_7./_T:E '4_P!N:1_T%++_ ,"$_P :OUY5;_\ "%2O%'_PJS4E+D+O?PZ
MHSW)]*W;OQ%XGO/&.K^'M!M-*5=/@@F^TWID(^=2=NU>I)'7C !ZYH [BBO+
M8OB%XHD\(VWB]M+TN+2%E2*YMS([3M^]$3NA^Z ')P#G@=:W)_$'BB_\9ZQH
M.B6VEQQ:='!(;N\\Q@3(I(3:I&22#SD8 Z'- '9R311,BR2(AD;:@9@-Q]!Z
MFL?Q!X=.MR65S!J=YIM]9,S07%L5. PPRLK JP.!P1VKA[[Q#)XB?P?-<VRV
MU]:>)6L[R%6W*DT<<@;:>X/!'UK4A\4^+-<M;_5_#]AI1TJUFEBABNFD\Z\\
MLD,5*_*@)! R#TYQ0!T7A_PQ'H=S>WTU]<ZCJ5\4^TW=SM#,%!"JJJ JJ,G@
M#O6[7&:/XY_M;7-$C6!$TS6]-:ZLY#GS!,A'F1-VX4YX]#67>_$'5Q8QWNFZ
M=:7$-WX@_LBQ$CLOFH%8&0MV'F(>W0'@T >CT5Y[%XB\;OXFNO##6FA'4$M4
MO4O091 (BQ7:4SN+;AZ@8R?8PGXEW,?A.PN)K6QAUJ[U"33=DLY2VCDC9@\C
M.>=@"YQUY ]Z .ITWPNMEXCO-=NM1NK^[F4PP"?:%MH2V[RT"@=\<G).T5OU
MY]IGCV[&JW>DZA<:+>W(L)+VUN=+F+1-L^]&ZDDJW(/7!&>E4H?'/BR/PUI/
MBJ]T[24T>[:W6:WC>0W"K(P3S 3\O5@=N.A'.: /3J*\]\/2:T_Q?\5I-+:-
M9I#:!E&_<J%9#'MR< ]=W;TK?\=Z^WAKP;J&HQ$?:MGE6HSUF<[4_4@_0&@#
M?AN(;A"\$L<J@E248, 1U'%25Y9X CM?!OBU_"D%]#<VFH6,=Y"\<H<?:8U"
M3CZMA7_.M<>)O%>M2:M=>&['2VT_3KF2U1+MG\V\>/A]A7"H,Y )SDCM0!WE
M%>;6=UK]U\9HGD2VMX'T&.5[64L7B1I?F7@[?,WC!(XP!7I- !17)^(M9U^T
MU,V]@-(T^Q2$.VH:M*=DCDGY$56!X R23WZ5SG_"T+MO"-KJ'EZ9#=2ZJ^F2
MWCRLUE$5R?-W#DH0!CD=>M 'I=Q!'=6TMO,NZ*5"CC.,@C!KCX?A[D65K?\
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M6.2N.%^4=\Y.> *UYO%NK:OJMAI?AJWLEFFTZ/4KB>_W,D,;\(@5""6//<
M=Z .S2:*5G6.1':,[7"L"5/H?0T^O(=&\577A?3_ !GJ>IV<(U)]<2W6W6;$
M33-'&JG>1PG\63T%;NE^.[N+Q'I^E:O>^'[U-1#B*?2)RWDR*N[;(K$D@@'#
M#'(Z4 =])+'#$TDKK'&HRS,< #W-.!# $$$'D$5Y!XH\1>)_$GPOUK6[>QTY
M=!NK:410LS_:O)R5\TG[O;=MQT[YKU72_P#D$V7_ %P3_P!!% %B*:*>,20R
M)(ASAD8$''!Y%/KQOP;K'BS1?AH-5M+#3)=(L'N97AD=Q<3QK,[.RD?*N.0
M0<[?<5W.D^,!>^);S3[E8HK-M/AU.PGY!E@8?.6R< JV.G8B@#JZ;)(D4;22
M.J(@W,S'  ]2:Q/"&M7?B+PY!J]U;I MVSR6\:@Y\G<?++9[E0#^-><74FM.
M/BP+R6T>V2U=6";]P/V4% N3@#:>??I0!Z(OAJ.Y\5Q^(;G4KF[6%#]BM6V^
M3;EE"LRX&22 >23C<:Z"O--+\2>*-%TSPI-J=EI?]D:B]M8K%"[FXA,BX1F8
M_*>G( XSU/6I+OQ_J%YJVK0:1=^'+2WTRX:U*ZK=%);F5/O[0"-BYX#'.2*
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M%'B]/%.GV]S>'693$TFF27)$>U>-RHP'.>,T >V(Z2HKQNKHPR&4Y!%<O?\
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MF:)7\L95T<*>021@CD>]=]10!YB?A[K>IZ)KJ:K<Z>NIWFJQZI:M&&DA1T5
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M'?7!E#2>5(0ZY^[T8$#CD<<5U5IX"TQ+35H]2GNM6GU9!'>7-XPWN@&%50H
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M7/.:]BCA%SHR0&22,2VX3?$VUURN,J1T/H:X^\^%MA=Z==:0NM:O;Z'.S/\
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MN-/-R0 9Q&V YQQG! /N*Y?6=9U>PF\4>&H]1G74+S4+4:5.SDM''=$ [3U
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M71\[65L>AS7 ^+K>7PCXBB\<V",;1E6WUR!!G?#T68#NR=_]G\: ._+*" 2
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M J0PP0?4&@#OJ*\X?QYXHMDT2[N/#ED;37&6*RBCO#YR2,FY/-RNT*0"3C)
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MY1R,?C747O@?PKJ5[+>7OA_3KBYE.Z262W5F8^I-2:#X0T#PP\[Z+I<-DTX
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M63WE]<1V]NA :1S@ D@ ?4D@#W- ' 7O@;5KH:]/ ]O%>-KL.KZ:9&RC&-$
M#XY .&'XYK073?$7B7Q-HU_K.F6^DV.D.\XB6Z$[W$Q0J.0 %4 D\\GTKJ7U
MFQBU:339)2EQ':_:WW(0BQ;BN2W3J#QG-6+*\M]1LH+VTE6:VG0212+T=2,@
MB@#"\:Z!=Z]I%K_9TL4>HZ?>Q7]KYV?+:2,_=;'(!!(S[UEIIOB+Q)XIT;4=
M9TVWTFRTAI)EA6Z$\D\S(4!R  J@$GU)[5W%% 'EMEX0\1Q^%['09[*V5=-U
MV*]BN5N0PGA^T/*QVX!4@$#'>NGUSPY<:MXTTF_*J=/AL;NVN#NPP,H0# _
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MQE?F5E484ACD=*XK5_%-[9>'I-=T_P 3>(-3U*"57>:"R*Z6P\P H-R ;<'
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M]/P"=L7"?,"!@OG.3GM7LL#2ZIH<3R">RFNK8%@ORR0,R\XR.&4GN.HKDO\
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MUL)<P2SRP1S1O-#CS8U<%DR,C<.V1ZUY!IK)H'@[X?>,2=D%G;I9:@W;[-,
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MCM^PW]K=;D\Q?(F5\KG&X8/3((S[5XQX>%LVE?#J#5]AT1+O44(N#F+SE=Q
M&SQP ^W/<5U?AZ/18_C5K:Z*+8+_ &3$;E;?&P3>8<].,[=N: /0;N\M;"V:
MYO+F&V@3[TLSA%7ZD\5!::UI5_927EGJ=G<6L0)DGAG5T3 R<L#@<5R?CZ>"
M37/#6EKI5MJ&I7$\TMF+Z=H[:,HGS,X .\X;Y1@\\\5Q#>;#JWQ'MYFTI9O^
M$<)GCTM"L2N%DX.3RX!&3QU'% 'L4.N:1<7_ -@AU2QEO,;OLZ7"-)C&<[0<
M]*2^UO3-/G6VN=1LX;N1<Q02SJKR?12<G\*\UU/1-,TSP?X NK*Q@@N5U/3?
MW\<8$C;\;\MU.[)SGK5G0K30;Q?'DGB6*T>[74K@73W07?';!1Y)!/(7;RI'
M>@#MO"&N2>)?"6F:S-"D,EY")&C0DA3D\#-266K,TU^-0EL(8XKS[/;F.X!+
M J" _P#=<DGY?I6-\*_^27^'O^O0?S->?ZQ;17L6MVEPF^&?QS:Q2+_>5EB!
M'Y&@#V"UU[1[Z.XDM-6L;A+8$SM%<(XB ZEB#\O0]:SO"WB[3_%'AT:Q%)%!
M&&D$B-,K&(*[*"Y[9"[N?7OUKG[S2=.L/BWH<=G8VUO%=:3=Q3QQ1*JRHICP
M& &".37 JB+\(?#$5L+%()=<V:B9QB(KYTVP3[>=FX)G/M0![EI^KZ9JT3RZ
M=J-I>1QG#M;SK(%/N5)Q42^(=%>ZAM4UC3VN)P&BA%RA>0'H5&<G\*\_L["[
MM/B-I[W%UX?M;IM/N!+::3#*&N(<#:7X*@*V,$XSD@9KFUT33+;]FZWU&*Q@
M6^6**X%T(QYHD\]?FW]<XX^G% 'JL'B_3[CQK<^&5DA%Q!;I-N,RY=F+90+U
MR N3]:W9[B&U@>>XFCAA09>21@JJ/4D]*X6PM[*/XV:NS0VZSMI5N\9*J&+%
MY Q'?..":7XBB"35O",&J;?[$DU,B[$G^K9Q&QA#]L%^QXH ZV#7M'NK"6^M
MM5L9[2'_ %D\5PC(GU8' K ^'_BG4/%^ER:K<KID5K*0;>"UF:2:(9;B;/ .
M ",>M8]W9:9'\6[2UTNVM@LVDSG58(D784#+Y)=1QG.<9YQ[5H?".W@A^&&A
MO%#&CRP;I&50"YW'D^M %U_'-BVMZ_I$+0&YTFU689G7]\Y5V90HY^78,_7M
M5CPWXNT[6]*TIYKZQAU.^M(K@V*W"^8I9 V I.['/I7)&WLHO'GQ!/DVZ7!T
MN!X_E4-DQ2[R._/?]:Q;C0]+T_X(^&M0M;&WBO4?3KA;E8P)!(\D>YMW7G<1
M0!ZK;:E*=2U:.[:RCM+,QF-UG!<*4W,91_!ST]1S4^G:SI>KJ[:9J5G>K&<.
M;:=9 I]]I.*\LUVVL;S4?B-;:AJ0TZ"2[TP"Y>(R(K^6A4.HZH6 !SQ@\UJ^
M'9+C3/B':V.LZ-HRZG=V$GD:AHTC*C1(RDB2(],G&&YYX% 'I=%%% !1110
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MRSZ6\:3,X&UBZ!QMP<G@]P* ,77?!5MJE[X>2"TL$TO3[F:6XM'C^619(V!
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M?QZ3JLNA12&.35XXE, P=I8#=O* YRP7'!H ZU;&T2_>^6VB%W)&(GG"#>R
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MH5$D)WL<D'' '<U5.A:I_P ,^S:5_9MU_:#2N?LOE'S"#>EON]?N\_2O7**
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MTMUXI\+7NGV7BV\BMM0#7=WK!EQ&"C  1MC SU8* .!GFO8U96&5((Z9!I:
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MPRG:%FQOV\\'GC.?QK U#QUK#>)-7TZVU70M+N;";R[73=3B97O5V@AQ*74
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M*1R>V>F#ZFN?LIK[Q7#X!T_4=3O&BN)M2M[F:&9HVNXX<A264YY"#)Z\GUH
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M7I6/4RD,<-U)$L;>2A\P!2,MTY.>GUH ])N;]K?4[&R%E=2K=>9NN(TS'!M
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M'K@T^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$/<;N,_6IZR++5-3NKVUCFT*:UMIK4S232SH3#+NQY14$Y..<@XK7H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#0!W%%-7<L8,A7<!\Q' SWK"LO&WAC4M3&FV>N6,]VQ*K&DH.\CJ%/1C],T
M;]%8FJ^,?#FAWJV6IZU9VMRP!\N24 @'H6_NCW.*KWNOW*>.='T.T$+P7%I/
M>7;L"65%VJFT@X&6;G.>E '1T5D+XIT%K5+H:M:?9GF:!)O-&QG4$L W0X"D
MGZ&G:/XET7Q L[:3J=M>"W($OE/G9GIGV.#@]#B@#5HK#L/&7AO5-2_LZQUJ
MRN+LYVQQR@[\==IZ-CVS5N37](BTZZU"34;=;.TD:*XF9P%B=3M96/8@\4 :
M-%9]SK>FV:P&:\A4W$3RP+NYD1%W,5]0%YK T/QK;CP1I.N>)[NST^;4$\Q4
M!*A@22H5222=NW.* .OHJA:ZWI=[I/\ :MOJ%M)I^TN;D2#RP!U)/08[YZ5S
M%]\0+&\N=%MO#5_97\U[J:6TP!+>7%M9W; ((.U>#T^M ';45A3^,_#5MJDF
MF3:W8QWD>=\32C*D#)![ X&<=:EU#Q7H.E65K>7VJVL$%VH>W9GYE4C.5'4C
M!!X]: -BBJ]A?VFJ645[87,5S:RC,<L3!E8>Q%<WJ/CK3[/Q[IOA99K<SSJ[
M7!:3#1' \M /[S%@?H#Z\ '645PNC?$C2I9]176M4TZRVZG-:V2%]K/$A"!V
MR3U8-SP.*Z36?$VB>'A$=7U.WM#+GRUD?YGQUPHY(]Z -:BN1\4?$'2-!\'-
MK]K=VMZLHVV:K,-L[Y P",],Y/I@UT*:K9_V*NJO=P_8O(\]K@'$>S&=P/IC
MF@"[17FK?%#[?X%O=;TK[']K&H+96L3L77YI0BL^".J[GQQQBNSTCQ3H6O7,
M]MI6JVMY- ,R)#("0.F?<>XXH UZ*PX?&7ANYU?^RH=:LI+[>8Q"LH)+CJH/
M0M[=:W* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "N+^*UU)#\/-1MH#_I&H-'8Q#U,KA"/^
M^2U=I4<L$,X431)($8.N]0=K#H1GO[T 1VT$.G:?#;IA(+:)47/95&/Y"O)+
M(Q6'P3\1^)?(7^T-?^TS,Q7YF\^0QQ+],,I ]S7L3*&4JP!4C!![U$;2V-NM
MN;>(P)C;%L&T8Z8'3B@#R*:UN-(^(5O:RZ]INDKI6A6\.GR:C;^8CJ,B5D)D
M0!@5 )Y./:JLEE_:VAB#[>UW#XK\0P*YCLS:H\40W221KO8[6$0.[C/7%>R7
MFG6.HJBWUE;W2H=RB>)7"GU&1Q4IMX6:)C#&6B_U9*C*<8X]..* /+_%\!MO
MB1X>MX[_ $W1K"UT^62R>[M@\'GA@I4#>@#!,$'/'.*P]7NI/^$3\;:]%JHU
M)]26#2EDM+ P17#[MA:/YV,G$A7(Q]W S7M%Y8VFH0>3>VL%S%G.R:,.N?7!
MIWV2V$447V>+RXB#&FP80CH0.V* /-]2?0]2N_!/A_PM+:W/V*]BO=UJP<6]
MM$IW%B/N[R0.>I)K-NC=S>+_ !+X#L#)&=8OTO;B=!CR;1X4\X@^K,-@_P!Z
MO4UTZ"RM[K^R[6TM;B8%MRPA59\<%MN">:R/#/ARZTNZO]6U>[BO=:U!E\Z:
M*,I''&HPD: DD*.3R<DGF@#3O9K;P]X;N)XXUBM=/M&=8UX"I&F0!^ KQZUN
M-&?X&1:%8M;W6O:P/+-HI!G:Z=\LSKU&WKD] H]J]8\6Z+-XC\*ZAH\%T+9[
MR/RC*5W;5)&[CW7(_&KUOI6GVLXN(+*WCG""/SEB4.5 P 6QG'% '%>&-.BU
M+Q[XFUF>-;J2P$.E6TD@S@I$&EQGN6?'Y^IKGM!UO1-/^#]\+^6"?7+\7"7M
MFV#<7%X[,OEE/O$Y( XX S7K\<,4._RHD3>Q=MJ@;F/4GU/O5<:9IXO_ +<+
M&V^V$8^T>2OF?]]8S0!Y7J%S=> ;GP=>W,3W-^VA2:485Y,MP!$T<>>^7R,_
M4U<;0'T[5?!.@7,@GOKG4)M:U.<?\M)HXR<_3>ZJ/917I\MO#,\;RPQR-&VY
M"R@E#ZCT-!@B:=9S$AE52JR%1N /4 ^E 'BMOK^B6'P;\0/J4T$FO:@]XE[;
M,09VN6=U4%>H"C:1V &:G>PN-$\;:)82ZSIVD)I?A^)+*34;?S(F?.)F7+H
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M/>O7[33;'3XGBLK*VMHW.66&)4#'W '-/^QVOD1P?9H?)C(*1[!M4CH0.V*
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MN$B%VY4O\QXW!",9]37/ZA>6>K0?$+6]'5=NJS6FB6LJKCS7;:DC#USY@/N
M#WKTC6O#VMRZ@LVC7^FK9>2L1T_4+,RPQLI.)(PK+@X.,=.*N^&O"\&@:/\
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M2!S5J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6UN+QI46$-M;:IX&%/;MF@#IM3\720ZU-H^C:-<ZQ>VL:R78AD2-( W*@LY
M+D<A1V]*RD^*>FR:)'JJZ=?^5+J@TR*'8/->3;DX3V.5QZBL^+4-2\'ZGXNN
MHM'DU2UNKE[Z*^@GC\N/;& \<Q+ ILVGH"<'IFJ?@S0=0N8? MQ<VS&"*&[U
M>ZF(PIN)^8Q]0)&/X4 =.?&][Y\&FKX9O&UR96F_L\7$7[J$' DDDSM4$]!R
M<BI4\?:<GA^\U*]MKJUN+*Y^QSV!4/-]H.-L:!3ARVY2"#@@YXYKF?$/AXV_
MC[5-7U#0M8U:SO[:!;9]+N71H70$,CA9$X.003D#FJFH>!;S_A$].N#H3>>F
MKKJ-]IMK?2O*\85D $K/EI54J>& )!Q[@';:;XLN)M;M])UC0[G2;F\B>6T,
MDT<JRA,%ERA.U@"#@]N]8<OQ5B72;K68M OY='L[IK>YO=Z*J@2;-R G+\D'
M '&>N<@4])T1QJ-YKMAX8O[1+"RE-A_:-W-)=2W#*0=L;2LJKCCGDD]J?)X4
MOXOAOX1\,I:.^;NT;4QQB- WFR[O^!C'XT =!9^-7F\266E7FAWEA'J$4LME
M<3NG[P1@%MR [DX(/S<\\@&J<GQ'7[%+K,&A7TWAR%RKZHKH 5!VF18R=S(#
MW],D T:QH.H:WXZO)?+>&TBT&6TMKANGGS,=Q'T55_.N-TOPBT^C:;X?;P=J
MD=ZBI!J$]YJ,PL@BX#L@2;Y]PSA0 .>>!0!Z%JGC1+/Q*F@6.EW6I:A)9"\1
M;=E"[2^T;F8@*."<GVQDFN8\2^/]3O/!$CZ-IMU:ZM-J7]CLOFQEK>XWA2 2
M<-D$@$=.IQBN@\.Z5<VWC#Q1J]Q:/%"_V>TL@>2T,4?)7V+,?RKD+/0]:L=)
M\&27NCWDY&KW&IZG' %9XYGWF,D$C@%QD]L4 >KVDDCV,,MQ"UO(8U9XG<,8
MSCD%AP2/45PNE>,;>#1=/N].LM2O[OQ%>7$UI:W%RN<*3NPS8"1A5!"C/4>]
M=5XI:]7PGJW]G0//?-:2+;QIU9RI"X_$BN(U'1'LM)T70-6\,2ZMH-MIT2I-
M8*3=6]VHP3PX(!'(*]\YXH [7P]KS:W%=I/IUSIUY9S>3/;SX.#@$%6'#*0>
MHK)UG7K&T\63><U[G1=(EU&7RIML)5B1M=?XFPA(ST_&I_ -MK5IX;,6M/=,
M_P!IE-JMXX>=+?/[L2L."^.O)ZBN3\0>'];U*+QQ+%8S";5[FTT^VZ<6R!0\
MG^[\TAH W;;XB--_8ES+X?O[?3-7EBMX+R5T'[V1<J/+SNV\$;L#IGI@GH?$
M^KRZ!X:U#5HK5KIK2%I3&'5> ,DY8@<#)QU..*Q]?TBYO?%7A"W@M6_LK3YI
M;J9Q]U&2+9$/S8_E4OQ$L+_5O!=WI>G0O+/?216[;/X(VD7>Q]@NZ@#F/A[>
M2Z0FB6VJ6NIMK6OQ2332W-[YRE8T#^9MW$("9 H  / S73:GXZLM+?Q();:5
MDT&WBFG<$8D:12RHOO@#_OH5F:M'?Z3\2K35(]#OM0L%T@V=M]C5#Y<IERP;
M<PV@JJC)XK!'AO7]2T/48]2TUDN=<\2QO>(IW".SC9<<]UQ'@>N[I0!:\5^.
M/$4VF64.E^'=0LQJ=Y!;VMTT\*/*K'<P5"=R$JK8+8P#DXJQ-XDU5_BE>0V6
MF7UZ]EI$*/813JD<<LC;RSLQ" A0JCJ3DXXSC5\5V]])XX\(7*:;=7>G6LL[
M3-;JK>7(R!(V8$C"C<YS3- LM4T^W\9:S+8R#4;V]GDM8B!NDCCC"0C\=O'U
MH FB^(=C<>&],U."PNY;S4Y7M[73DVF5Y49E<9SM"KM)+9P!^53VOC15_M6#
M5],GTR^TVT-[)!)(D@D@PWSHZG!Y4@],&N'E\$W&FZ9X*GO-)O\ 4+;3["2&
M]MK&9DGAFE"N77:REOFW @'OGFI;CPI?7/AG7Y['P]<6-QJ:Q:?:I<7<D]R+
M9I%\QI=\C*HP6(4<C'/6@#NO"_BBY\31QW::'=V>G2VZ30W5PZ#S&.,J$!W8
M&?O$ '''&#3=7\6/9ZS_ &+I.DW&KZFL(GFBBD2-((R<*7=R "<' Y/&>E=#
M!#';01P0J$BC4(BCH !@"N"+ZMX7\9^)KU- OM4&K^1)9RVH4KE(]GER$D;
M#SGI@GOQ0!H#XA6LNF:?);:7?3:I?RR0PZ7M590\9Q)N).U57NV<<BIK;QQ$
M(-:75=.GTV^T>V^UW%M(ZOOBVDAT=3A@=I'L>*QYX?$.E^*='\3:IIC:BYTE
M[*\CTM-QMY3('W*C-EE(&TD'MFLG7- \0^(;'Q%JKZ;-;7&LK;:9:6A93)!:
M"3,DDF#@$AF.,\"@#H[;XAM,VB7$OA^_M],U>6*""\E=!^]D7*CR\[MO!&[
MZ9Z8-2ZAXZE@O=5CT[0+S4K72&"7T\,L:E&VAB$1CN?"D>GH,T_7](N;[Q9X
M1A@M6_LO3Y9KJ9Q]U&6/9$/S<_E7&:OIVN:A+)=0^'-0T[QNLNQ-3TUA'9SH
M'^5I"7(9-F,A@6XQ[4 =??>)=);Q/:2SW%[!#8:0^JO()"D/E.0H$B=6; )
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MM90PR/7!KSJ/0=;MO@A=Z;'92'7=361KB(8W!YY3O)^B,<_2O1X+-+738K*
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M!A0LQ4;<YYQSQ6GXTM+^+7_#.O6NGSZC;Z7/-]HMK< RXDCV!U4D;MI[=>:
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M>3<Q+,FX8.U@",CZ&K%1V\$=M;16\2[8XD"(/0 8%24 %%%% !1110 4444
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M.OUO7CV9,K(K!1G/&"V>_2MRB@#B9/"&O6-]JPT#7X+&PU6X:YF66T,LL$K
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MYC F'GY1@_+]X\C!H Y+X0Z#8V'@VVU>.S6&\U/S+B1AG.QI&9%^@7;4Z_\
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MGBF4V4)8D0V:R.65>>FV,_\ ?5>S6>BV%A+J$MM"4DU"4S7+;V)=]H7/)XX
MX&*S)? WA^73=*L!:210:4VZS,-Q(CQ<8/S!LG(/.3S0!Y_]AFUSQ3K<#>&8
MM6T?1I$T^SLY;\0Q6X5 S/L(.YFW<,>@%1QQ:AJ/ASPAX>:^*K?ZU)/!+;7?
MG,EG#OD"B4=2ORJ#["O0]6\":!K6HS7UW;3K-<*J7/D74D*W*C@"148!\#CG
MMQ6BOA_2TO\ 3[U+1$FTZ%X+382JQ(P ("CCHH'3M0!YGJ7V?P9XJ\57WAZW
M\B/3O#HDG0,S+)<O(QC=\DY(5<Y/)!-5_%7@O2K7PQH-NLTLFMZQ>VUM<WAG
M8R7@<AI=_/S)@9QT&!7J@\/:5]HU6=K17?5E5+W>Q82JJ; ""< ;21@>M96G
M_#WPYIMW974-K/)-8MNM'N+N67R!M*[5#,0%P3QTZ'J!0!?\6SVUGX.UFXNH
MU>WBLI7=#P& 0G'X]*\O7PI;VWAWX?\ A:!7M;C4KB/4+Z2)BKGR8C(_/8[F
M4 CH<5Z]J>FVFLZ9<Z;?PB:TN8S'+&21N4^XY'X51L/"NDZ=/83PQ3//80/;
MV\DUP\C(CD%AEB<YP.3R ,=* .!!TCP;XU\4WEDLMEI>G:-"+M;<EV>XD=BC
M88D%]H !/][FL2_T:?2;CPUY?AY].U:\U6",:G<:IYU[+\VZ0N%&""H.X9P,
MXQ7K4WA;1KD:N)[)91J^T7P=V/F[5"KWXP ,8QZ]:HVG@'P_:7EG>>1=7%W9
M/OMY[J\EF>/@C:"S'"X/W>GY4 8'@;1--NO&OB[Q&EH@E&J-:0/DY78@$A'^
M\[-2^-M'T_Q'\0_"6EWELLZ(ES=W )/^K10%''8NX_*NNTCPUIFA7=_<Z=%+
M$U_*9IT,SLF\DDE5)(7))S@#/X"B^\-:9J&N66LSQ2B_LU*12QS.F5)SM8*0
M&7(!P<T >=V.B:/K5UXZ\3ZU";FPAN7MXK9G81;+6+:6P#@G.[!/3G'6HM!D
MFC_X5W9ZA=-LT_29]8O'E<_*FP+'N/HOF'_OFO1T\+:/'X=N=!2U8:=<^9YT
M7FOE_,8L^6SNY)/>I(_#VE1ZB;Y;13.;-; EF)7R 20FTG&,D]N: /*7TB&R
MU*WGUNUDE&J:BLFG>+--N-TH,C[HD=6^ZI&%X!7';O7M5<O8?#[P[IUU;306
M]RR6LGFVMO+>2R00/_>2-F*J1GCCCMBNHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
5HH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>separationagreement012.jpg
<TEXT>
begin 644 separationagreement012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAU[5].?=)_9EC::-)-"RJ2%,K^2V\OCG:P SZT >RTV21(HVDD=41 69F.
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MLR@E3GT)Q0!<HKQO7?&-V-/UG6;;Q=>F2U,C6<&EZ6TMD%7A5DF:(AB3P6#
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M\PVT6TDR;!EN0,# (ZXKC?A%IMY;>#8]4O-0N+B35G:^:*5$ 1G=FW JH)+
MJ3DD<<8J5/\ B:?&R5OO1:-HX7_=FGDS_P"@)0!W5%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !61XE\/6OBC0Y=,NI)80S+)'-"</%(I#*RGU!%:]% '#7'@?6M:BBLO
M$GBM]1TI9%>2UBL$MS<;2"!(X)R,@9  S5JX\&W_ /PDNJZGI_B"6RM]6$7V
MN%+=6DRB;!Y<A/R9'L3Z$5=U[Q7;Z5:V3V0AOYKO48=/5(YAA7=L$DC., $X
M]JVI+ZSAN4MI;J!)Y/N1-( S?0=30!Y=+X+FM]9\(^%-/O[B%-$L[B_^WK$,
M&8NH0E3D')9\KGD$_6K?BWP[?:7X4\0:K<WTFK>(-2M4TV.5(/+6.*1PNR-
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M/.[+>F,^U=5<WUI9[/M5U!!O.$\V0+N/H,]:=<7,%I"9KF>.&(=7D<*H_$T
M.6(10"*$!%5=J<<+@8%>?V?PSO+/0AX>7Q1<G0Y>;NW%LHEE+<R!9,Y17.21
M@GD@'FO0(I8YXEEBD62-AE70Y!'L:IWEY=P:EI]M;VL<T4[OY\C3A#"@7((7
MJ^3@8'3.: ,+4?!UPNLQZMX=U8:/<_9%LI4-J)XGB4Y3Y21AER<'/3C%-G\!
MQ3>&4TPZK>-?I>+J"ZE+AY!=!MP?;]W;VVC QQ[UTO\ :%D98HOM=OYDPS$G
MF#+C_9&>?PJS0!R">!C?_P!IR^)-4DU2XO[0V),<0@CAA/)"("<,3SN))X':
MHHO ^H73:=!KWB)]2T[3Y$EAM5M5A\UT^X9F!._'7 "@D9.:ZR*_LY[E[:*[
M@DGC^_$D@++]1U%++?6D%Q';S74$<TGW(WD 9_H#R: .=B\'>3H?B2P346$V
MN3W$SW/E<Q>:H4 #/.U0 .:ENO"$%Q;^&K5;DI:Z'-',D03/FF.,HF3GC&<]
MZZ+S8S*8MZ^8!N*9YQZX]*;Y\(,@,J9B&9!N'R#KSZ4 <A<>"=2AOM4;1?$L
MNF6.J3&XNH%M5D=9& #M$Y/R%@!U!P>174Z=80Z7IMM86V_R;>,1H9'+,0!U
M)/)/O4EM=VU[%YMK<0SQYQOB<,,^F13?[0LO-BB^UV_F3#,2^8,O_NC//X4
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MKNK-<F>?5IHY&!3;Y:HFQ4'/..>?>MNB@ HHHH **** "BBB@ HHHH ****
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MX>T.STBP39;6L0C3U/J3[DY)]S0!S/Q GCO9-'\-#3_M]SJ4S2I!+<F"!EA
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MK^-&71]5@DB@U"TMI ULS!=R21X &2K<\9Z9KH[WPGH&H:;;:=<Z3:M:6O\
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MC_A)_#__ $'-,_\  N/_ !J/_A$/#/\ T+ND_P#@%'_\31_PB'AG_H7=)_\
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M?^-1_P#"(>&?^A=TG_P"C_\ B:/^$0\,_P#0NZ3_ . 4?_Q- $G_  D_A_\
MZ#FF?^!<?^-'_"3^'_\ H.:9_P"!<?\ C7"1^(/ \[3?9? -[=Q0RO"TUMX>
M$D>Y20V&48."*TX+KX>W6FZ7?VVBZ9-!J5Z+"$KIR!EF(8[7!4%<;3G/MZT
M=1_PD_A__H.:9_X%Q_XT?\)/X?\ ^@YIG_@7'_C4?_"(>&?^A=TG_P  H_\
MXFL7Q+;^#/"MC;W5[X8LYA<7*6L4=KID<DCR,"5 4#G.#0!O?\)/X?\ ^@YI
MG_@7'_C1_P )/X?_ .@YIG_@7'_C7&VFK^ I]1MK&]\)?V3+=/Y=N=3T,6Z2
MN>BABN,^QKKO^$0\,_\ 0NZ3_P" 4?\ \30!)_PD_A__ *#FF?\ @7'_ (T?
M\)/X?_Z#FF?^!<?^-1_\(AX9_P"A=TG_ , H_P#XFC_A$/#/_0NZ3_X!1_\
MQ- $G_"3^'_^@YIG_@7'_C1_PD_A_P#Z#FF?^!<?^-1_\(AX9_Z%W2?_  "C
M_P#B:/\ A$/#/_0NZ3_X!1__ !- $G_"3^'_ /H.:9_X%Q_XT?\ "3^'_P#H
M.:9_X%Q_XU'_ ,(AX9_Z%W2?_ */_P")H_X1#PS_ -"[I/\ X!1__$T 2?\
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M_"3^'_\ H.:9_P"!<?\ C4?_  B'AG_H7=)_\ H__B:/^$0\,_\ 0NZ3_P"
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M_"3^'_\ H.:9_P"!<?\ C4?_  B'AG_H7=)_\ H__B:/^$0\,_\ 0NZ3_P"
M4?\ \30!)_PD_A__ *#FF?\ @7'_ (T?\)/X?_Z#FF?^!<?^-1_\(AX9_P"A
M=TG_ , H_P#XFC_A$/#/_0NZ3_X!1_\ Q- $G_"3^'_^@YIG_@7'_C1_PD_A
M_P#Z#FF?^!<?^-1_\(AX9_Z%W2?_  "C_P#B:/\ A$/#/_0NZ3_X!1__ !-
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M%Q_XU'_PB'AG_H7=)_\  */_ .)H_P"$0\,_]"[I/_@%'_\ $T 2?\)/X?\
M^@YIG_@7'_C1_P )/X?_ .@YIG_@7'_C4?\ PB'AG_H7=)_\ H__ (FC_A$/
M#/\ T+ND_P#@%'_\30!)_P )/X?_ .@YIG_@7'_C1_PD_A__ *#FF?\ @7'_
M (U'_P (AX9_Z%W2?_ */_XFC_A$/#/_ $+ND_\ @%'_ /$T 2?\)/X?_P"@
MYIG_ (%Q_P"-'_"3^'_^@YIG_@7'_C4?_"(>&?\ H7=)_P# */\ ^)H_X1#P
MS_T+ND_^ 4?_ ,30!)_PD_A__H.:9_X%Q_XT?\)/X?\ ^@YIG_@7'_C4?_"(
M>&?^A=TG_P  H_\ XFC_ (1#PS_T+ND_^ 4?_P 30!)_PD_A_P#Z#FF?^!<?
M^-'_  D_A_\ Z#FF?^!<?^-1_P#"(>&?^A=TG_P"C_\ B:/^$0\,_P#0NZ3_
M . 4?_Q- $G_  D_A_\ Z#FF?^!<?^-'_"3^'_\ H.:9_P"!<?\ C4?_  B'
MAG_H7=)_\ H__B:/^$0\,_\ 0NZ3_P" 4?\ \30!)_PD_A__ *#FF?\ @7'_
M (T?\)/X?_Z#FF?^!<?^-1_\(AX9_P"A=TG_ , H_P#XFC_A$/#/_0NZ3_X!
M1_\ Q- $G_"3^'_^@YIG_@7'_C1_PD_A_P#Z#FF?^!<?^-1_\(AX9_Z%W2?_
M  "C_P#B:/\ A$/#/_0NZ3_X!1__ !- $G_"3^'_ /H.:9_X%Q_XT?\ "3^'
M_P#H.:9_X%Q_XU'_ ,(AX9_Z%W2?_ */_P")H_X1#PS_ -"[I/\ X!1__$T
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MU[5XK>59DMK^[5H=Z\J2JJN<'UXK?T_0;73=9U;5(7F:?5'C>=7(*J40(-H
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M&?SX)K*14=6VE>K*W8FJ=CX)FLKZ"Z/B_P 3W(B<.89[N-HY,'[K 1@D'ZT
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M6N4U?PFXTWQ+)HUY>0:GK)23S4G$?E2*JJI5@,A<*,]21G'6NI12L:J6+$
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>separationagreement013.jpg
<TEXT>
begin 644 separationagreement013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF9AS<Q7BR-P1M^4'O5CQ<=17XM>#3I.F6VIWO]ACR[6Y8+&_RRYR3QP,G\*
M/5-$^(OA/Q'>O9Z1K"7-PD33,@BD7"+C)^90.XK.3XQ> '<*/$<()./FAE _
M,K3/#A\3.VH'7?">E:/"+1_+FM)4=F;^Z<=L9/X5S?P3T+2=7^%(CU'3K6Y6
M6XF1S+$K$C([D9H ](U3Q7H>C:''K5]J44>FRE0ERF9%;=TQM!SFI=;\0Z5X
M<TK^T]6NUMK/<J^:49N6Z<*":^:6GFD_9YU&V+M);6GB#RK=B<X3:#@>V6)_
M&O5/CJ1_PJ0\]9X,4 >@/XDTB/7+317O4&HWD)G@@VMETP3G.,?PMU]*MZEJ
M-II&FW&H7TPAM+=#)+(03M4=3@<UY3J Q^T)X+!Z_P!BO_Z!-7:_$W_DF7B+
M_KQD_E0!0_X7+\/_ /H8HO\ P'F_^(KM;6YAO;2&[MWWP3QK)&^"-RL,@\^Q
MKP_P7)XV'@S218> ]#O;3[.OE7,UQ&'E7U()SFO<H5*P1J46,A0-B]%XZ"@#
M(\0>+M!\*_9O[;U&.S^U,5AWJQW$8ST!QC(Y/K6T#D9%?-_Q U30O&'Q#U^V
MU?5H;2UTC3WM=/WDX>[SDGCL&R#]!7JWPB\3_P#"4?#RPFEDW7=F/LEQD\[D
M P3]5*GZDT =U1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268268302848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Oct. 27, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EDITAS MEDICINE, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4097528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11 Hurley Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">401-9000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EDIT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,673,688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001650664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268268664928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 82,537<span></span>
</td>
<td class="nump">$ 141,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">267,080<span></span>
</td>
<td class="nump">202,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">2,422<span></span>
</td>
<td class="nump">5,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">6,564<span></span>
</td>
<td class="nump">7,335<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">358,603<span></span>
</td>
<td class="nump">356,754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities</a></td>
<td class="nump">96,797<span></span>
</td>
<td class="nump">93,097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">11,559<span></span>
</td>
<td class="nump">15,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">31,936<span></span>
</td>
<td class="nump">43,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Restricted cash and other non-current assets</a></td>
<td class="nump">5,755<span></span>
</td>
<td class="nump">5,253<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">504,650<span></span>
</td>
<td class="nump">514,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">10,411<span></span>
</td>
<td class="nump">9,511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">30,278<span></span>
</td>
<td class="nump">31,296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue, current</a></td>
<td class="nump">8,221<span></span>
</td>
<td class="nump">8,221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">9,693<span></span>
</td>
<td class="nump">11,082<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">58,603<span></span>
</td>
<td class="nump">60,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">24,918<span></span>
</td>
<td class="nump">32,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">60,667<span></span>
</td>
<td class="nump">60,667<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">144,188<span></span>
</td>
<td class="nump">153,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value per share: 5,000,000 shares authorized; no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value per share: 195,000,000 shares authorized; 81,668,796 and 68,847,382 shares issued and outstanding at September&#160;30, 2023 and December&#160;31, 2022, respectively</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,574,382<span></span>
</td>
<td class="nump">1,442,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,452)<span></span>
</td>
<td class="num">(3,601)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,212,476)<span></span>
</td>
<td class="num">(1,078,131)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">360,462<span></span>
</td>
<td class="nump">360,680<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 504,650<span></span>
</td>
<td class="nump">$ 514,321<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268265476880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">195,000,000<span></span>
</td>
<td class="nump">195,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">81,668,796<span></span>
</td>
<td class="nump">68,847,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">81,668,796<span></span>
</td>
<td class="nump">68,847,382<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268269802800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration and other research and development revenues</a></td>
<td class="nump">$ 5,336<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 18,074<span></span>
</td>
<td class="nump">$ 13,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList', window );">Revenue type</a></td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 40,512<span></span>
</td>
<td class="nump">$ 41,326<span></span>
</td>
<td class="nump">$ 108,095<span></span>
</td>
<td class="nump">$ 122,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">14,987<span></span>
</td>
<td class="nump">16,236<span></span>
</td>
<td class="nump">55,198<span></span>
</td>
<td class="nump">52,720<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">55,499<span></span>
</td>
<td class="nump">57,562<span></span>
</td>
<td class="nump">163,293<span></span>
</td>
<td class="nump">175,680<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(50,163)<span></span>
</td>
<td class="num">(57,520)<span></span>
</td>
<td class="num">(145,219)<span></span>
</td>
<td class="num">(162,504)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(1,590)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Interest income, net</a></td>
<td class="nump">5,144<span></span>
</td>
<td class="nump">1,793<span></span>
</td>
<td class="nump">12,464<span></span>
</td>
<td class="nump">2,806<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income, net</a></td>
<td class="nump">5,144<span></span>
</td>
<td class="nump">1,794<span></span>
</td>
<td class="nump">10,874<span></span>
</td>
<td class="nump">2,810<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (45,019)<span></span>
</td>
<td class="num">$ (55,726)<span></span>
</td>
<td class="num">$ (134,345)<span></span>
</td>
<td class="num">$ (159,694)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (0.81)<span></span>
</td>
<td class="num">$ (1.81)<span></span>
</td>
<td class="num">$ (2.33)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (0.81)<span></span>
</td>
<td class="num">$ (1.81)<span></span>
</td>
<td class="num">$ (2.33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic (in shares)</a></td>
<td class="nump">81,648,250<span></span>
</td>
<td class="nump">68,736,125<span></span>
</td>
<td class="nump">74,029,645<span></span>
</td>
<td class="nump">68,621,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">81,648,250<span></span>
</td>
<td class="nump">68,736,125<span></span>
</td>
<td class="nump">74,029,645<span></span>
</td>
<td class="nump">68,621,574<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268271227872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (45,019)<span></span>
</td>
<td class="num">$ (55,726)<span></span>
</td>
<td class="num">$ (134,345)<span></span>
</td>
<td class="num">$ (159,694)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on marketable debt securities</a></td>
<td class="nump">833<span></span>
</td>
<td class="num">(904)<span></span>
</td>
<td class="nump">2,149<span></span>
</td>
<td class="num">(3,798)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (44,186)<span></span>
</td>
<td class="num">$ (56,630)<span></span>
</td>
<td class="num">$ (132,196)<span></span>
</td>
<td class="num">$ (163,492)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268265762992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Gain</div></th>
<th class="th"><div>Other Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,435,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 553,642<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 1,411,827<span></span>
</td>
<td class="num">$ (493)<span></span>
</td>
<td class="num">$ (857,699)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Statement of Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">11,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted common stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted common stock awards</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on marketable debt securities</a></td>
<td class="num">(2,016)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,016)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(50,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,515)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, end of period (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,602,664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Mar. 31, 2022</a></td>
<td class="nump">512,760<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">1,423,476<span></span>
</td>
<td class="num">(2,509)<span></span>
</td>
<td class="num">(908,214)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,435,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Dec. 31, 2021</a></td>
<td class="nump">553,642<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">1,411,827<span></span>
</td>
<td class="num">(493)<span></span>
</td>
<td class="num">(857,699)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Statement of Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on marketable debt securities</a></td>
<td class="num">(3,798)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(159,694)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, end of period (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,761,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Sep. 30, 2022</a></td>
<td class="nump">414,745<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">1,436,422<span></span>
</td>
<td class="num">(4,291)<span></span>
</td>
<td class="num">(1,017,393)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, beginning of period (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,602,664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Mar. 31, 2022</a></td>
<td class="nump">512,760<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">1,423,476<span></span>
</td>
<td class="num">(2,509)<span></span>
</td>
<td class="num">(908,214)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Statement of Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">6,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted common stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted common stock awards</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on marketable debt securities</a></td>
<td class="num">(878)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(878)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(53,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,453)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, end of period (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,718,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Jun. 30, 2022</a></td>
<td class="nump">465,414<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">1,430,461<span></span>
</td>
<td class="num">(3,387)<span></span>
</td>
<td class="num">(961,667)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Statement of Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">5,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted common stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted common stock awards</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on marketable debt securities</a></td>
<td class="num">(904)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(904)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(55,726)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,726)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, end of period (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,761,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Sep. 30, 2022</a></td>
<td class="nump">414,745<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">1,436,422<span></span>
</td>
<td class="num">(4,291)<span></span>
</td>
<td class="num">(1,017,393)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, beginning of period (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,847,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Dec. 31, 2022</a></td>
<td class="nump">360,680<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">1,442,405<span></span>
</td>
<td class="num">(3,601)<span></span>
</td>
<td class="num">(1,078,131)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Statement of Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">4,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted common stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted common stock awards</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on marketable debt securities</a></td>
<td class="nump">1,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(49,036)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49,036)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, end of period (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,993,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Mar. 31, 2023</a></td>
<td class="nump">317,473<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">1,446,912<span></span>
</td>
<td class="num">(2,279)<span></span>
</td>
<td class="num">(1,127,167)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, beginning of period (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,847,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Dec. 31, 2022</a></td>
<td class="nump">360,680<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">1,442,405<span></span>
</td>
<td class="num">(3,601)<span></span>
</td>
<td class="num">(1,078,131)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Statement of Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on marketable debt securities</a></td>
<td class="nump">2,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(134,345)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, end of period (in shares) at Sep. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,668,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Sep. 30, 2023</a></td>
<td class="nump">360,462<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">1,574,382<span></span>
</td>
<td class="num">(1,452)<span></span>
</td>
<td class="num">(1,212,476)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, beginning of period (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,993,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Mar. 31, 2023</a></td>
<td class="nump">317,473<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">1,446,912<span></span>
</td>
<td class="num">(2,279)<span></span>
</td>
<td class="num">(1,127,167)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Statement of Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock from public offering, net commissions, underwriting discounts and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock from public offering, net commissions, underwriting discounts and offering costs</a></td>
<td class="nump">117,079<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">117,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">5,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted common stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted common stock awards</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on marketable debt securities</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(40,290)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,290)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, end of period (in shares) at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,616,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Jun. 30, 2023</a></td>
<td class="nump">399,917<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">1,569,651<span></span>
</td>
<td class="num">(2,285)<span></span>
</td>
<td class="num">(1,167,457)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Statement of Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">4,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted common stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted common stock awards</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on marketable debt securities</a></td>
<td class="nump">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(45,019)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,019)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, end of period (in shares) at Sep. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,668,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Sep. 30, 2023</a></td>
<td class="nump">$ 360,462<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 1,574,382<span></span>
</td>
<td class="num">$ (1,452)<span></span>
</td>
<td class="num">$ (1,212,476)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268271122816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flow from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (134,345)<span></span>
</td>
<td class="num">$ (159,694)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">14,453<span></span>
</td>
<td class="nump">23,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">4,598<span></span>
</td>
<td class="nump">4,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of fixed assets</a></td>
<td class="nump">1,583<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Net amortization of premiums and discounts on marketable securities</a></td>
<td class="num">(2,720)<span></span>
</td>
<td class="num">(226)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">2,723<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">771<span></span>
</td>
<td class="nump">307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_edit_IncreaseDecreaseInRightOfUseAssets', window );">Right-of-use assets</a></td>
<td class="nump">11,712<span></span>
</td>
<td class="nump">3,641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="num">(502)<span></span>
</td>
<td class="num">(719)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">1,102<span></span>
</td>
<td class="nump">1,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">22<span></span>
</td>
<td class="num">(485)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,333)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(9,335)<span></span>
</td>
<td class="num">(5,078)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(109,938)<span></span>
</td>
<td class="num">(135,076)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flow from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(3,412)<span></span>
</td>
<td class="num">(3,494)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfMachineryAndEquipment', window );">Proceeds from the sale of equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(219,764)<span></span>
</td>
<td class="num">(209,782)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from maturities of marketable securities</a></td>
<td class="nump">156,605<span></span>
</td>
<td class="nump">354,854<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(66,571)<span></span>
</td>
<td class="nump">141,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flow from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from offering of common stock, net of issuance costs</a></td>
<td class="nump">117,079<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">435<span></span>
</td>
<td class="nump">367<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">117,525<span></span>
</td>
<td class="nump">665<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(58,984)<span></span>
</td>
<td class="nump">7,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, beginning of period</a></td>
<td class="nump">145,399<span></span>
</td>
<td class="nump">207,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, end of period</a></td>
<td class="nump">86,415<span></span>
</td>
<td class="nump">214,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash and non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Fixed asset additions included in accounts payable and accrued expenses</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid in connection with operating lease liabilities</a></td>
<td class="nump">9,103<span></span>
</td>
<td class="nump">11,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange of operating lease obligations</a></td>
<td class="nump">$ 1,069<span></span>
</td>
<td class="nump">$ 4,708<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_edit_IncreaseDecreaseInRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount represents the increase (decrease) in right of use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">edit_IncreaseDecreaseInRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>edit_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfMachineryAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sale of machinery and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfMachineryAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268274282384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Business</a></td>
<td class="text">Nature of Business<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Editas Medicine, Inc. (the &#8220;Company&#8221;) is a clinical stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The Company was incorporated in the state of Delaware in September 2013. Its principal offices are in Cambridge, Massachusetts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its inception, the Company has devoted substantially all of its efforts to business planning, research and development, recruiting management and technical staff, and raising capital. The Company has primarily financed its operations through various equity financings, payments received under a research collaboration with Juno Therapeutics, Inc., a wholly-owned subsidiary of the Bristol-Myers Squibb Company (&#8220;BMS&#8221;), and payments received under a strategic alliance and option agreement with Allergan Pharmaceuticals International Limited, which was terminated in August 2020. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks common to companies in the biotechnology industry, including but not limited to, risks of failure of preclinical studies and clinical trials, the need to obtain marketing approval for any drug product candidate that it may identify and develop, the need to successfully commercialize and gain market acceptance of its product candidates, dependence on key personnel, protection of proprietary technology, compliance with government regulations, development by competitors of technological innovations and ability to transition from pilot-scale manufacturing to large-scale production of products.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, the Company completed a public offering in which it sold 12,500,000 shares of its common stock and received net proceeds of approximately $117.1 million after deducting underwriting discounts and commissions and other offering costs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company entered into a common stock sales agreement with Cowen and Company, LLC (&#8220;Cowen&#8221;), under which the Company from time to time can issue and sell shares of its common stock through Cowen in at-the-market offerings for aggregate gross sale proceeds of up to $300.0 million (the &#8220;ATM Facility&#8221;). As of September&#160;30, 2023, the Company has not sold any shares of its common stock under the ATM Facility. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred annual net operating losses in every year since its inception. The Company expects that its existing cash, cash equivalents and marketable securities at September&#160;30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> will enable it to fund its operating expenses and capital expenditure requirements into the third quarter of 2025. The Company had an accumulated deficit of $1.2 billion at September&#160;30, 2023, and will require substantial additional capital to fund its operations. The Company has never generated any product revenue. There can be no assurance that the Company will be able to obtain additional debt or equity financing or generate product revenue or revenues from collaborative partners, on terms acceptable to the Company, on a timely basis or at all. The failure of the Company to obtain sufficient funds on acceptable terms when needed could have a material adverse effect on the Company&#8217;s business, results of operations, and financial condition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268274369536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Interim Financial Information</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) have been condensed or omitted from this report, as is permitted by such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 (the &#8220;Annual Report&#8221;).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Editas Securities Corporation and Editas Medicine, LLC. All intercompany transactions and balances of the subsidiaries have been eliminated in consolidation. In the opinion of management, the information furnished reflects all adjustments, all of which are of a normal and recurring nature, necessary for a fair presentation of the results for the reported interim periods. The Company considers events or transactions that occur after the balance sheet date but before </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The three months ended September&#160;30, 2023 and 2022 are referred to as the third quarter of 2023 and 2022, respectively. The results of operations for interim periods are not necessarily indicative of results to be expected for the full year or any other interim period.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Significant Accounting Policies</span></div>The Company&#8217;s significant accounting policies are described in Note 2, &#8220;Summary of Significant Accounting Policies,&#8221; to the consolidated financial statements included in the Annual Report. There have been no material changes to the significant accounting policies previously disclosed in the Annual Report.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268274312288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash Equivalents and Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Cash Equivalents and Marketable Securities</a></td>
<td class="text">Cash Equivalents and Marketable Securities <div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents and marketable securities consisted of the following at September&#160;30, 2023 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents and marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">171,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasuries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">447,866&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,474)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">446,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents and marketable securities consisted of the following at December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents and marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,556)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(694)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasuries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(229)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">440,972&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,620)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">437,371&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, the Company did not hold any marketable securities that had been in an unrealized loss position for more than twelve months. Furthermore, the Company has determined that there were no material changes in the credit risk of the securities. As of September&#160;30, 2023, the Company holds 29 securities with an aggregate fair value of $96.8 million that had remaining maturities greater than one year.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no realized gains or losses on available-for-sale securities during the nine months ended September&#160;30, 2023 or 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268274568160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets measured at fair value on a recurring basis as of September&#160;30, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasuries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and other non-current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">450,291&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">229,685&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">220,606&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets measured at fair value on a recurring basis as of December&#160;31, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasuries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and other non-current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">441,248&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">195,192&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">246,056&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268269601120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text">Accrued Expenses<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">External research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property and patent related fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional service expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,278&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,296&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268274337504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, net</a></td>
<td class="text">Property and Equipment, net<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,940&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,407&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computer equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,565&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25,006)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21,526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,569&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268361958128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we entered into a license and service agreement pursuant to which we will lease manufacturing space for our continued research and development activities. As of September&#160;30, 2023, the lease has not commenced for accounting purposes and it is not expected to commence until the second quarter of 2024. The license and service agreement provides for total remaining lease payments of up to $87.8 million over a 10-year lease term. The Company may terminate the license and service agreement in its discretion upon twelve months' prior written notice.  </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to a number of license agreements under which the Company licenses patents, patent applications and other intellectual property from third parties. As such, the Company is obligated to pay licensors for various costs including upfront licenses fees, annual license fees, certain licensor expense reimbursements, success payments, research funding payments, and milestones triggerable upon certain development, regulatory, and commercial events as well as royalties on future products. These contracts are generally cancellable, with notice, at the Company&#8217;s option and do not have significant cancellation penalties. The terms and conditions as well as the accounting analysis for the Company&#8217;s significant commitments and contingencies are described in Note 8, &#8220;Commitments and Contingencies&#8221; to the consolidated financial statements included in the Annual Report. There have been no material changes to the terms and conditions, or the accounting conclusions, previously disclosed in the Annual Report.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensor Expense Reimbursement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is obligated to reimburse The Broad Institute, Inc. (&#8220;Broad&#8221;) and the President and Fellows of Harvard College (&#8220;Harvard&#8221;) for expenses incurred by each of them associated with the prosecution and maintenance of the patent rights that the Company licenses from them pursuant to the license agreement by and among the Company, Broad and Harvard, including the interference and opposition proceedings involving patents licensed to the Company under the license agreement, and other license agreements between the Company and Broad. As such, the Company anticipates that it has a substantial commitment in connection with these proceedings until such time as these proceedings have been resolved, but the amount of such commitment is not determinable. The Company incurred an aggregate of $1.5 million and $6.1 million in expense during the three and nine months ended September&#160;30, 2023, respectively, for such reimbursement. The Company incurred an aggregate of $2.2 million and $6.1 million in expense during the three and nine months ended September&#160;30, 2022, respectively, for such reimbursement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268271325712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and Profit-Sharing Agreements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_edit_CollaborationAndProfitSharingAgreements', window );"><strong>Collaboration And Profit-Sharing Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaboration and Profit-Sharing Agreements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaboration and Profit-Sharing Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span>The Company has entered into multiple collaborations, out-licenses and strategic alliances with third parties that typically involve payments to or from the Company, including up-front payments, payments for research and development services, option payments, milestone payments and royalty payments to or from the Company. The terms and conditions as well as the accounting analysis for the Company&#8217;s significant collaborations, out-licenses and strategic alliances are described in Note 9, &#8220;Collaboration and Profit-Sharing Agreements&#8221; to the consolidated financial statements included in the Annual Report. There have been no material changes to the terms and conditions, or the accounting conclusions, previously disclosed in the Annual Report. <div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Revenue</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, the Company&#8217;s contract liabilities were primarily related to the Company&#8217;s collaboration with BMS. The following table presents changes in the Company&#8217;s accounts receivable and contract liabilities for the nine months ended September&#160;30, 2023 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2023, the Company did not recognize any collaboration revenue that had been allocated to deferred revenue from BMS.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_edit_CollaborationAndProfitSharingAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">edit_CollaborationAndProfitSharingAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>edit_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268274316304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-based Compensation</a></td>
<td class="text">Stock-based Compensation<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total compensation cost recognized for all stock-based compensation awards in the condensed consolidated statements of operations was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,803&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,731&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,881&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,930&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Unit Awards</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of restricted stock unit awards activity for the nine months ended September&#160;30, 2023:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock unit awards as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,499,070</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issued</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,331,578</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(262,588)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(462,777)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock unit awards as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,105,283</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restricted stock units issued in the nine months ended September&#160;30, 2023 include 437,842 units granted to certain employees that contain performance-based vesting provisions. The Company recognizes the fair value of the performance-based units through the expected achievement date if the performance-based vesting provisions are deemed probable.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, total unrecognized compensation expense related to unvested restricted stock unit awards was $13.2 million, which the Company expects to recognize over a remaining weighted-average period of 2.54 years.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock option activity for the nine months ended September&#160;30, 2023:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Remaining<br/>Contractual Life (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,276,148</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,195,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,467,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,000,626</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.83</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable at September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,449,032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.34</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, total unrecognized compensation expense related to stock options was $28.1 million, which the Company expects to recognize over a remaining weighted-average period of 2.70 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268361940528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss per Share</a></td>
<td class="text">Net Loss per Share<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and potentially dilutive securities outstanding for the period determined using the treasury stock and if converted methods. Contingently issuable shares are included in the calculation of basic loss per share as of the beginning of the period in which all the necessary conditions have been satisfied. Contingently issuable shares are included in diluted loss per share based on the number of shares, if any, that would be issuable under the terms of the arrangement if the end of the reporting period was the end of the contingency period, if the results are dilutive. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of the diluted net loss per share calculation, unvested restricted stock unit awards and outstanding stock options are considered to be common stock equivalents, but they were excluded from the Company&#8217;s calculation of diluted net loss per share allocable to common stockholders because their inclusion would have been anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders were the same for all periods presented.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents were excluded from the calculation of diluted net loss per share allocable to common stockholders because their inclusion would have been anti-dilutive:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock unit awards</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,105,283</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,503,682</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,000,626</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,216,124</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,105,909</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,719,806</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268268483936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (45,019)<span></span>
</td>
<td class="num">$ (40,290)<span></span>
</td>
<td class="num">$ (49,036)<span></span>
</td>
<td class="num">$ (55,726)<span></span>
</td>
<td class="num">$ (53,453)<span></span>
</td>
<td class="num">$ (50,515)<span></span>
</td>
<td class="num">$ (134,345)<span></span>
</td>
<td class="num">$ (159,694)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268266206544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=edit_LindaCBurklyMember', window );">Linda C. Burkly [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">During the quarterly period covered by this report, Linda C. Burkly, Ph.D., our Chief Scientific Officer, entered into a Rule 10b5-1 trading arrangement that is intended to qualify as an &#8220;eligible sell-to-cover transaction&#8221; (as described in Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act). This sell-to-cover arrangement, which was adopted on July 3, 2023, applies to restricted stock units (&#8220;RSUs&#8221;), whether vesting is based on the passage of time and/or the achievement of performance goals, granted on her start date, July 24, 2023, and any RSUs that may be granted from time to time thereafter (other than those which by their terms require us to withhold shares for tax withholding obligations in connection with vesting and settlement). This arrangement provides for the automatic sale of shares of our common stock that would otherwise be issuable on each settlement date of a covered RSU in an amount necessary to satisfy the applicable withholding obligation, with the proceeds of the sale delivered to us in satisfaction of the applicable withholding obligation. The number of shares that will be sold under this arrangement is not currently determinable as the number will vary based on the extent to which vesting conditions are satisfied, the market price of our common stock at the time of settlement and the potential future grant of additional RSUs subject to this arrangement.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Linda C. Burkly, Ph.D.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Chief Scientific Officer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">July 3, 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=edit_LindaCBurklyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=edit_LindaCBurklyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268274316304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash Equivalents and Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Schedule of Cash Equivalents and Marketable Securities</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents and marketable securities consisted of the following at September&#160;30, 2023 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents and marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">171,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasuries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">447,866&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,474)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">446,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents and marketable securities consisted of the following at December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents and marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,556)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(694)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasuries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(229)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">440,972&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,620)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">437,371&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268274316304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Assets Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets measured at fair value on a recurring basis as of September&#160;30, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasuries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and other non-current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">450,291&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">229,685&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">220,606&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets measured at fair value on a recurring basis as of December&#160;31, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasuries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and other non-current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">441,248&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">195,192&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">246,056&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268269641328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">External research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property and patent related fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional service expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,278&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,296&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268269554624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,940&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,407&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computer equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,565&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25,006)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21,526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,569&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268274326608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and Profit-Sharing Agreements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_edit_CollaborationAndProfitSharingAgreements', window );"><strong>Collaboration And Profit-Sharing Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock', window );">Schedule of Accounts Receivable and Contract Liabilities</a></td>
<td class="text">The following table presents changes in the Company&#8217;s accounts receivable and contract liabilities for the nine months ended September&#160;30, 2023 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_edit_CollaborationAndProfitSharingAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">edit_CollaborationAndProfitSharingAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>edit_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of account receivable and contract liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>edit_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268274860816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total compensation cost recognized for all stock-based compensation awards in the condensed consolidated statements of operations was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,803&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,731&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,881&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,930&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of Changes in Unvested Restricted Stock</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of restricted stock unit awards activity for the nine months ended September&#160;30, 2023:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock unit awards as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,499,070</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issued</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,331,578</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(262,588)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(462,777)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock unit awards as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,105,283</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock option activity for the nine months ended September&#160;30, 2023:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Remaining<br/>Contractual Life (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,276,148</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,195,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,467,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,000,626</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.83</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable at September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,449,032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.34</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268271215984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Anti-Dilutive Common Stock Equivalents</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents were excluded from the calculation of diluted net loss per share allocable to common stockholders because their inclusion would have been anti-dilutive:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock unit awards</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,105,283</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,503,682</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,000,626</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,216,124</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,105,909</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,719,806</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268271031904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">29 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>May 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Liquidity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,079<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,212,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,212,476<span></span>
</td>
<td class="nump">$ 1,078,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=edit_FollowOn2023JuneOfferingMember', window );">June 2023 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Liquidity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued (in shares)</a></td>
<td class="nump">12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of shares</a></td>
<td class="nump">$ 117,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=edit_AtMarketOfferingMember', window );">At The Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Liquidity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued', window );">Sales agreement amount of aggregate sale proceeds of common stock agreed to be issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of proceeds from common stock agreed to be issued or sold under the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>edit_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=edit_FollowOn2023JuneOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=edit_FollowOn2023JuneOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=edit_AtMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=edit_AtMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268265403712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash Equivalents and Marketable Securities (Details)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>security</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Cash Equivalents and Marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 447,866,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 440,972,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,474,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,620,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 446,414,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437,371,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of securities in an unrealized loss position for more than 12 months | security</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_edit_MarketableSecuritiesNoncurrentNumberOfSecurities', window );">Number of noncurrent securities | security</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Noncurrent marketable securities</a></td>
<td class="nump">$ 96,797,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,097,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss', window );">Realized gains (losses) on available-for-sale securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Cash Equivalents and Marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">171,404,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,902,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,197,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,556,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">170,207,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,357,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Cash Equivalents and Marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">143,261,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,019,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(12,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(229,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">143,271,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,793,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Cash Equivalents and Marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">82,537,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,522,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">82,537,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,522,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate notes/bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Cash Equivalents and Marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">38,066,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,575,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(254,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(694,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">37,812,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,883,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Cash Equivalents and Marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">12,598,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,954,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(11,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(141,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 12,587,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,816,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_edit_MarketableSecuritiesNoncurrentNumberOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of noncurrent marketable securities held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">edit_MarketableSecuritiesNoncurrentNumberOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>edit_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268261561280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">$ 446,414<span></span>
</td>
<td class="nump">$ 437,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">170,207<span></span>
</td>
<td class="nump">159,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate notes/bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">37,812<span></span>
</td>
<td class="nump">56,883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">12,587<span></span>
</td>
<td class="nump">29,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">143,271<span></span>
</td>
<td class="nump">49,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">450,291<span></span>
</td>
<td class="nump">441,248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">170,207<span></span>
</td>
<td class="nump">159,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Corporate notes/bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">37,812<span></span>
</td>
<td class="nump">56,883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">12,587<span></span>
</td>
<td class="nump">29,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | U.S. Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">143,271<span></span>
</td>
<td class="nump">49,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">82,537<span></span>
</td>
<td class="nump">141,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and other non-current assets:</a></td>
<td class="nump">$ 3,877<span></span>
</td>
<td class="nump">$ 3,877<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList', window );">Restricted cash and cash equivalents, statement of financial position [extensible enumeration]</a></td>
<td class="text">Restricted cash and other non-current assets<span></span>
</td>
<td class="text">Restricted cash and other non-current assets<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">$ 229,685<span></span>
</td>
<td class="nump">$ 195,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate notes/bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">143,271<span></span>
</td>
<td class="nump">49,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">82,537<span></span>
</td>
<td class="nump">141,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and other non-current assets:</a></td>
<td class="nump">$ 3,877<span></span>
</td>
<td class="nump">$ 3,877<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList', window );">Restricted cash and cash equivalents, statement of financial position [extensible enumeration]</a></td>
<td class="text">Restricted cash and other non-current assets<span></span>
</td>
<td class="text">Restricted cash and other non-current assets<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">$ 220,606<span></span>
</td>
<td class="nump">$ 246,056<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Significant Other Observable Inputs (Level 2) | Government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">170,207<span></span>
</td>
<td class="nump">159,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Significant Other Observable Inputs (Level 2) | Corporate notes/bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">37,812<span></span>
</td>
<td class="nump">56,883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Significant Other Observable Inputs (Level 2) | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">12,587<span></span>
</td>
<td class="nump">29,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Significant Other Observable Inputs (Level 2) | U.S. Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Significant Other Observable Inputs (Level 2) | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and other non-current assets:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Significant Unobservable Inputs (Level 3) | Government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Significant Unobservable Inputs (Level 3) | Corporate notes/bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Significant Unobservable Inputs (Level 3) | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Significant Unobservable Inputs (Level 3) | U.S. Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Significant Unobservable Inputs (Level 3) | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and other non-current assets:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes cash and cash equivalents restricted to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268268507216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent', window );">External research and development expenses</a></td>
<td class="nump">$ 17,135<span></span>
</td>
<td class="nump">$ 16,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee related expenses</a></td>
<td class="nump">9,536<span></span>
</td>
<td class="nump">10,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_edit_IntellectualPropertyAndPatentRelatedFees', window );">Intellectual property and patent related fees</a></td>
<td class="nump">1,385<span></span>
</td>
<td class="nump">1,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional service expenses</a></td>
<td class="nump">943<span></span>
</td>
<td class="nump">1,260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other expenses</a></td>
<td class="nump">1,279<span></span>
</td>
<td class="nump">1,635<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 30,278<span></span>
</td>
<td class="nump">$ 31,296<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_edit_AccruedExternalResearchAndDevelopmentExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents information pertaining to accrued external research and development expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">edit_AccruedExternalResearchAndDevelopmentExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>edit_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_edit_IntellectualPropertyAndPatentRelatedFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for fees associated with intellectual property rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">edit_IntellectualPropertyAndPatentRelatedFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>edit_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268268384896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 36,565<span></span>
</td>
<td class="nump">$ 37,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(25,006)<span></span>
</td>
<td class="num">(21,526)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">11,559<span></span>
</td>
<td class="nump">15,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=edit_LaboratoryEquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">24,940<span></span>
</td>
<td class="nump">24,407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">9,648<span></span>
</td>
<td class="nump">9,761<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction-in-progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">623<span></span>
</td>
<td class="nump">1,573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 215<span></span>
</td>
<td class="nump">$ 215<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=edit_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=edit_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268268502704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Lease Agreement (Details) - License and Service Agreement<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Remaining lease payments</a></td>
<td class="nump">$ 87.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=edit_LicenseAndServiceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=edit_LicenseAndServiceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268274797120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Licensor Expense Reimbursements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=edit_LicensorExpenseReimbursementsMember', window );">Licensor Expense Reimbursements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalAndContractServicesExpense', window );">Expense for prosecution and maintenance of patent rights</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="nump">$ 6.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalAndContractServicesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalAndContractServicesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=edit_LicensorExpenseReimbursementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=edit_LicensorExpenseReimbursementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268268470464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and Profit-Sharing Agreements (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_edit_ReceivablesNetCurrentRollForward', window );"><strong>Receivables, Net, Current [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Accounts receivable, balance at beginning of period</a></td>
<td class="nump">$ 5,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_edit_AccountsReceivableAdditions', window );">Accounts receivable, Additions</a></td>
<td class="nump">2,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_edit_AccountsReceivableDeductions', window );">Accounts receivable, Deductions</a></td>
<td class="num">(5,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Accounts receivable, balance at end of period</a></td>
<td class="nump">2,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_edit_ContractWithCustomerLiabilityRollForward', window );"><strong>Contract with Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue, balance at beginning of period</a></td>
<td class="nump">68,888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue, balance at end of period</a></td>
<td class="nump">$ 68,888<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_edit_AccountsReceivableAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of additions to accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">edit_AccountsReceivableAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>edit_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_edit_AccountsReceivableDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of deductions to accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">edit_AccountsReceivableDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>edit_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_edit_ContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">edit_ContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>edit_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_edit_ReceivablesNetCurrentRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables, Net, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">edit_ReceivablesNetCurrentRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>edit_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268268276672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 4,731<span></span>
</td>
<td class="nump">$ 5,881<span></span>
</td>
<td class="nump">$ 14,453<span></span>
</td>
<td class="nump">$ 23,930<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">2,571<span></span>
</td>
<td class="nump">3,045<span></span>
</td>
<td class="nump">7,182<span></span>
</td>
<td class="nump">9,803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 2,160<span></span>
</td>
<td class="nump">$ 2,836<span></span>
</td>
<td class="nump">$ 7,271<span></span>
</td>
<td class="nump">$ 14,127<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268264098576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Restricted Stock and Stock Options (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Unit Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock unit awards, beginning of period (in shares)</a></td>
<td class="nump">1,499,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Issued (in shares)</a></td>
<td class="nump">1,331,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(262,588)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(462,777)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock unit awards, end of period (in shares)</a></td>
<td class="nump">2,105,283<span></span>
</td>
<td class="nump">1,499,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance, beginning of period (in dollars per share)</a></td>
<td class="nump">$ 18.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Issued (in dollars per share)</a></td>
<td class="nump">8.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">19.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">18.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance, ending of period (in dollars per share)</a></td>
<td class="nump">$ 12.20<span></span>
</td>
<td class="nump">$ 18.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 13,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period for recognition</a></td>
<td class="text">2 years 6 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | Share-Based Payment Arrangement, Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Issued (in shares)</a></td>
<td class="nump">437,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 28,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period for recognition</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning of period (in shares)</a></td>
<td class="nump">5,276,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">2,195,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(3,122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(1,467,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, end of period (in shares)</a></td>
<td class="nump">6,000,626<span></span>
</td>
<td class="nump">5,276,148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">2,449,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning of period (in dollars per share)</a></td>
<td class="nump">$ 23.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">8.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">3.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">30.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, end of period (in dollars per share)</a></td>
<td class="nump">16.72<span></span>
</td>
<td class="nump">$ 23.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (in dollar per share)</a></td>
<td class="nump">$ 22.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Stock Options Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Remaining contractual life (years)</a></td>
<td class="text">7 years 9 months 29 days<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, remaining contractual life</a></td>
<td class="text">6 years 4 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value</a></td>
<td class="nump">$ 342<span></span>
</td>
<td class="nump">$ 402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, aggregate intrinsic value</a></td>
<td class="nump">$ 279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140268265632304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Potentially dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive common stock equivalent shares (in shares)</a></td>
<td class="nump">8,105,909<span></span>
</td>
<td class="nump">6,719,806<span></span>
</td>
<td class="nump">8,105,909<span></span>
</td>
<td class="nump">6,719,806<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Unvested restricted stock unit awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Potentially dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive common stock equivalent shares (in shares)</a></td>
<td class="nump">2,105,283<span></span>
</td>
<td class="nump">1,503,682<span></span>
</td>
<td class="nump">2,105,283<span></span>
</td>
<td class="nump">1,503,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Outstanding stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Potentially dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive common stock equivalent shares (in shares)</a></td>
<td class="nump">6,000,626<span></span>
</td>
<td class="nump">5,216,124<span></span>
</td>
<td class="nump">6,000,626<span></span>
</td>
<td class="nump">5,216,124<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>edit-20230930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:edit="http://www.editasmedicine.com/20230930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="edit-20230930.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <instant>2023-10-27</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">edit:FollowOn2023JuneOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">edit:AtMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">edit:AtMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">edit:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">edit:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">edit:LicenseAndServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">edit:LicensorExpenseReimbursementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">edit:LicensorExpenseReimbursementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">edit:LicensorExpenseReimbursementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">edit:LicensorExpenseReimbursementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">edit:LindaCBurklyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">edit:LindaCBurklyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="security">
        <measure>edit:security</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-25">0001650664</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-26">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-27">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-28">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-29">false</dei:AmendmentFlag>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList contextRef="c-5" id="f-96">http://fasb.org/us-gaap/2023#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList contextRef="c-6" id="f-97">http://fasb.org/us-gaap/2023#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList contextRef="c-7" id="f-98">http://fasb.org/us-gaap/2023#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList contextRef="c-1" id="f-99">http://fasb.org/us-gaap/2023#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList contextRef="c-87" id="f-471">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList contextRef="c-111" id="f-472">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList contextRef="c-88" id="f-473">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList contextRef="c-112" id="f-474">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-37687</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">EDITAS MEDICINE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">46-4097528</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">11 Hurley Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">02141</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">401-9000</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">EDIT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">81673688</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-30" unitRef="usd">82537000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-31" unitRef="usd">141522000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-3" decimals="-3" id="f-32" unitRef="usd">267080000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-4" decimals="-3" id="f-33" unitRef="usd">202752000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="c-3" decimals="-3" id="f-34" unitRef="usd">2422000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="c-4" decimals="-3" id="f-35" unitRef="usd">5145000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-36" unitRef="usd">6564000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-37" unitRef="usd">7335000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-38" unitRef="usd">358603000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-39" unitRef="usd">356754000</us-gaap:AssetsCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c-3" decimals="-3" id="f-40" unitRef="usd">96797000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c-4" decimals="-3" id="f-41" unitRef="usd">93097000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-42" unitRef="usd">11559000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-43" unitRef="usd">15569000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-44" unitRef="usd">31936000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-45" unitRef="usd">43648000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-3" id="f-46" unitRef="usd">5755000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-47" unitRef="usd">5253000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-48" unitRef="usd">504650000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-49" unitRef="usd">514321000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-50" unitRef="usd">10411000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-51" unitRef="usd">9511000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-52" unitRef="usd">30278000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">31296000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="-3" id="f-54" unitRef="usd">8221000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">8221000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-56" unitRef="usd">9693000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-57" unitRef="usd">11082000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-58" unitRef="usd">58603000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-59" unitRef="usd">60110000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-60" unitRef="usd">24918000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-61" unitRef="usd">32864000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-62" unitRef="usd">60667000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-63" unitRef="usd">60667000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-64" unitRef="usd">144188000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-65" unitRef="usd">153641000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-66"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-67"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-68" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-69" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-70" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-3" decimals="INF" id="f-71" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-72" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-73" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue contextRef="c-3" decimals="-3" id="f-74" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-3" id="f-75" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-76"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-77"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-78" unitRef="shares">195000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-79" unitRef="shares">195000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-80" unitRef="shares">81668796</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="INF" id="f-81" unitRef="shares">81668796</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-82" unitRef="shares">68847382</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-83" unitRef="shares">68847382</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-84" unitRef="usd">8000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-85" unitRef="usd">7000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-3" decimals="-3" id="f-86" unitRef="usd">1574382000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-3" id="f-87" unitRef="usd">1442405000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-3" id="f-88" unitRef="usd">-1452000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-89" unitRef="usd">-3601000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-90" unitRef="usd">-1212476000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-91" unitRef="usd">-1078131000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-92" unitRef="usd">360462000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-93" unitRef="usd">360680000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-94" unitRef="usd">504650000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-95" unitRef="usd">514321000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-3" id="f-100" unitRef="usd">5336000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-101" unitRef="usd">42000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-102" unitRef="usd">18074000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-103" unitRef="usd">13176000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-7" decimals="-3" id="f-104" unitRef="usd">40512000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-3" id="f-105" unitRef="usd">41326000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-106" unitRef="usd">108095000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-6" decimals="-3" id="f-107" unitRef="usd">122960000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-7" decimals="-3" id="f-108" unitRef="usd">14987000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-109" unitRef="usd">16236000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-110" unitRef="usd">55198000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-6" decimals="-3" id="f-111" unitRef="usd">52720000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-7" decimals="-3" id="f-112" unitRef="usd">55499000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-5" decimals="-3" id="f-113" unitRef="usd">57562000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-114" unitRef="usd">163293000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-6" decimals="-3" id="f-115" unitRef="usd">175680000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-3" id="f-116" unitRef="usd">-50163000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-3" id="f-117" unitRef="usd">-57520000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-118" unitRef="usd">-145219000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-3" id="f-119" unitRef="usd">-162504000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-3" id="f-120" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-121" unitRef="usd">1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-122" unitRef="usd">-1590000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-123" unitRef="usd">4000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InvestmentIncomeNet contextRef="c-7" decimals="-3" id="f-124" unitRef="usd">5144000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c-5" decimals="-3" id="f-125" unitRef="usd">1793000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c-1" decimals="-3" id="f-126" unitRef="usd">12464000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c-6" decimals="-3" id="f-127" unitRef="usd">2806000</us-gaap:InvestmentIncomeNet>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-7" decimals="-3" id="f-128" unitRef="usd">5144000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-129" unitRef="usd">1794000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-130" unitRef="usd">10874000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-131" unitRef="usd">2810000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-132" unitRef="usd">-45019000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-133" unitRef="usd">-55726000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-134" unitRef="usd">-134345000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-135" unitRef="usd">-159694000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-136"
      unitRef="usdPerShare">-0.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-137"
      unitRef="usdPerShare">-0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-138"
      unitRef="usdPerShare">-0.81</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-139"
      unitRef="usdPerShare">-0.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-140"
      unitRef="usdPerShare">-1.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-141"
      unitRef="usdPerShare">-1.81</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-142"
      unitRef="usdPerShare">-2.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-143"
      unitRef="usdPerShare">-2.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="0" id="f-144" unitRef="shares">81648250</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="0" id="f-145" unitRef="shares">81648250</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-146" unitRef="shares">68736125</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-147" unitRef="shares">68736125</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-148" unitRef="shares">74029645</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-149" unitRef="shares">74029645</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-150" unitRef="shares">68621574</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-151" unitRef="shares">68621574</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-152" unitRef="usd">-45019000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-153" unitRef="usd">-55726000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-154" unitRef="usd">-134345000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-155" unitRef="usd">-159694000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-7" decimals="-3" id="f-156" unitRef="usd">833000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-5" decimals="-3" id="f-157" unitRef="usd">-904000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-158" unitRef="usd">2149000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-6" decimals="-3" id="f-159" unitRef="usd">-3798000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-3" id="f-160" unitRef="usd">-44186000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-161" unitRef="usd">-56630000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-162" unitRef="usd">-132196000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-163" unitRef="usd">-163492000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding contextRef="c-8" decimals="INF" id="f-164" unitRef="shares">68847382</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-165" unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-166" unitRef="usd">1442405000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-167" unitRef="usd">-3601000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-3" id="f-168" unitRef="usd">-1078131000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-169" unitRef="usd">360680000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-12"
      decimals="INF"
      id="f-170"
      unitRef="shares">146209</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-13" decimals="-3" id="f-171" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-14" decimals="-3" id="f-172" unitRef="usd">4507000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-13" decimals="-3" id="f-173" unitRef="usd">4507000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-15" decimals="-3" id="f-174" unitRef="usd">1322000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-13" decimals="-3" id="f-175" unitRef="usd">1322000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-16" decimals="-3" id="f-176" unitRef="usd">-49036000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-3" id="f-177" unitRef="usd">-49036000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c-17"
      decimals="INF"
      id="f-178"
      unitRef="shares">68993591</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-3" id="f-179" unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-180" unitRef="usd">1446912000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-181" unitRef="usd">-2279000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-182" unitRef="usd">-1127167000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-3" id="f-183" unitRef="usd">317473000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-22"
      decimals="INF"
      id="f-184"
      unitRef="shares">12500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-22" decimals="-3" id="f-185" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-23" decimals="-3" id="f-186" unitRef="usd">117078000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-24" decimals="-3" id="f-187" unitRef="usd">117079000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-22"
      decimals="INF"
      id="f-188"
      unitRef="shares">3122</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-23" decimals="-3" id="f-189" unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-24" decimals="-3" id="f-190" unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-23" decimals="-3" id="f-191" unitRef="usd">5215000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-24" decimals="-3" id="f-192" unitRef="usd">5215000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-22"
      decimals="INF"
      id="f-193"
      unitRef="shares">64492</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-24" decimals="-3" id="f-194" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="c-22"
      decimals="INF"
      id="f-195"
      unitRef="shares">55704</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-23" decimals="-3" id="f-196" unitRef="usd">435000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-24" decimals="-3" id="f-197" unitRef="usd">435000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-25" decimals="-3" id="f-198" unitRef="usd">-6000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-24" decimals="-3" id="f-199" unitRef="usd">-6000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-26" decimals="-3" id="f-200" unitRef="usd">-40290000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-24" decimals="-3" id="f-201" unitRef="usd">-40290000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c-27"
      decimals="INF"
      id="f-202"
      unitRef="shares">81616909</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-203" unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-204" unitRef="usd">1569651000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-205" unitRef="usd">-2285000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-206" unitRef="usd">-1167457000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-207" unitRef="usd">399917000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-32" decimals="-3" id="f-208" unitRef="usd">4731000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-7" decimals="-3" id="f-209" unitRef="usd">4731000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-33"
      decimals="INF"
      id="f-210"
      unitRef="shares">51887</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-7" decimals="-3" id="f-211" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-34" decimals="-3" id="f-212" unitRef="usd">833000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-7" decimals="-3" id="f-213" unitRef="usd">833000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-35" decimals="-3" id="f-214" unitRef="usd">-45019000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-215" unitRef="usd">-45019000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c-36"
      decimals="INF"
      id="f-216"
      unitRef="shares">81668796</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-3" id="f-217" unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-3" id="f-218" unitRef="usd">1574382000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-219" unitRef="usd">-1452000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-220" unitRef="usd">-1212476000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-221" unitRef="usd">360462000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c-40"
      decimals="INF"
      id="f-222"
      unitRef="shares">68435257</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-3" id="f-223" unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-3" id="f-224" unitRef="usd">1411827000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-3" id="f-225" unitRef="usd">-493000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-43" decimals="-3" id="f-226" unitRef="usd">-857699000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-44" decimals="-3" id="f-227" unitRef="usd">553642000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-45"
      decimals="INF"
      id="f-228"
      unitRef="shares">12573</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-46" decimals="-3" id="f-229" unitRef="usd">218000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-47" decimals="-3" id="f-230" unitRef="usd">218000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-45"
      decimals="INF"
      id="f-231"
      unitRef="shares">154834</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-47" decimals="-3" id="f-232" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-46" decimals="-3" id="f-233" unitRef="usd">11431000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-47" decimals="-3" id="f-234" unitRef="usd">11431000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-48" decimals="-3" id="f-235" unitRef="usd">-2016000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-47" decimals="-3" id="f-236" unitRef="usd">-2016000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-49" decimals="-3" id="f-237" unitRef="usd">-50515000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-47" decimals="-3" id="f-238" unitRef="usd">-50515000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c-50"
      decimals="INF"
      id="f-239"
      unitRef="shares">68602664</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-50" decimals="-3" id="f-240" unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-51" decimals="-3" id="f-241" unitRef="usd">1423476000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-52" decimals="-3" id="f-242" unitRef="usd">-2509000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-53" decimals="-3" id="f-243" unitRef="usd">-908214000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-54" decimals="-3" id="f-244" unitRef="usd">512760000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-55"
      decimals="INF"
      id="f-245"
      unitRef="shares">20</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-56" decimals="-3" id="f-246" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-55"
      decimals="INF"
      id="f-247"
      unitRef="shares">77884</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-56" decimals="-3" id="f-248" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-57" decimals="-3" id="f-249" unitRef="usd">6618000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-56" decimals="-3" id="f-250" unitRef="usd">6618000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="c-55"
      decimals="INF"
      id="f-251"
      unitRef="shares">37866</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-57" decimals="-3" id="f-252" unitRef="usd">367000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-56" decimals="-3" id="f-253" unitRef="usd">367000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-58" decimals="-3" id="f-254" unitRef="usd">-878000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-56" decimals="-3" id="f-255" unitRef="usd">-878000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-59" decimals="-3" id="f-256" unitRef="usd">-53453000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-56" decimals="-3" id="f-257" unitRef="usd">-53453000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c-60"
      decimals="INF"
      id="f-258"
      unitRef="shares">68718434</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-60" decimals="-3" id="f-259" unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-61" decimals="-3" id="f-260" unitRef="usd">1430461000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-62" decimals="-3" id="f-261" unitRef="usd">-3387000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-63" decimals="-3" id="f-262" unitRef="usd">-961667000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-64" decimals="-3" id="f-263" unitRef="usd">465414000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-65"
      decimals="INF"
      id="f-264"
      unitRef="shares">4976</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-66" decimals="-3" id="f-265" unitRef="usd">80000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-5" decimals="-3" id="f-266" unitRef="usd">80000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-65"
      decimals="INF"
      id="f-267"
      unitRef="shares">38319</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-5" decimals="-3" id="f-268" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-66" decimals="-3" id="f-269" unitRef="usd">5881000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-3" id="f-270" unitRef="usd">5881000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-67" decimals="-3" id="f-271" unitRef="usd">-904000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-5" decimals="-3" id="f-272" unitRef="usd">-904000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-68" decimals="-3" id="f-273" unitRef="usd">-55726000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-274" unitRef="usd">-55726000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c-69"
      decimals="INF"
      id="f-275"
      unitRef="shares">68761729</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-69" decimals="-3" id="f-276" unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-70" decimals="-3" id="f-277" unitRef="usd">1436422000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-71" decimals="-3" id="f-278" unitRef="usd">-4291000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-72" decimals="-3" id="f-279" unitRef="usd">-1017393000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-73" decimals="-3" id="f-280" unitRef="usd">414745000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-281" unitRef="usd">-134345000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-282" unitRef="usd">-159694000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-283" unitRef="usd">14453000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-6" decimals="-3" id="f-284" unitRef="usd">23930000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation contextRef="c-1" decimals="-3" id="f-285" unitRef="usd">4598000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-6" decimals="-3" id="f-286" unitRef="usd">4760000</us-gaap:Depreciation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-1" decimals="-3" id="f-287" unitRef="usd">-1583000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-6" decimals="-3" id="f-288" unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-1" decimals="-3" id="f-289" unitRef="usd">2720000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-6" decimals="-3" id="f-290" unitRef="usd">226000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-291" unitRef="usd">-2723000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-6" decimals="-3" id="f-292" unitRef="usd">-147000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-293" unitRef="usd">-771000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-6" decimals="-3" id="f-294" unitRef="usd">-307000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <edit:IncreaseDecreaseInRightOfUseAssets contextRef="c-1" decimals="-3" id="f-295" unitRef="usd">-11712000</edit:IncreaseDecreaseInRightOfUseAssets>
    <edit:IncreaseDecreaseInRightOfUseAssets contextRef="c-6" decimals="-3" id="f-296" unitRef="usd">-3641000</edit:IncreaseDecreaseInRightOfUseAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-1" decimals="-3" id="f-297" unitRef="usd">502000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-6" decimals="-3" id="f-298" unitRef="usd">719000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-299" unitRef="usd">1102000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-6" decimals="-3" id="f-300" unitRef="usd">1674000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-1" decimals="-3" id="f-301" unitRef="usd">22000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-6" decimals="-3" id="f-302" unitRef="usd">-485000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-3" id="f-303" unitRef="usd">0</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-6" decimals="-3" id="f-304" unitRef="usd">-3333000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-305" unitRef="usd">-9335000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-6" decimals="-3" id="f-306" unitRef="usd">-5078000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-307" unitRef="usd">-109938000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-6" decimals="-3" id="f-308" unitRef="usd">-135076000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-309" unitRef="usd">3412000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-6" decimals="-3" id="f-310" unitRef="usd">3494000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfMachineryAndEquipment contextRef="c-1" decimals="-3" id="f-311" unitRef="usd">0</us-gaap:ProceedsFromSaleOfMachineryAndEquipment>
    <us-gaap:ProceedsFromSaleOfMachineryAndEquipment contextRef="c-6" decimals="-3" id="f-312" unitRef="usd">18000</us-gaap:ProceedsFromSaleOfMachineryAndEquipment>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-1" decimals="-3" id="f-313" unitRef="usd">219764000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-6" decimals="-3" id="f-314" unitRef="usd">209782000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-1" decimals="-3" id="f-315" unitRef="usd">156605000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-6" decimals="-3" id="f-316" unitRef="usd">354854000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-317" unitRef="usd">-66571000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-6" decimals="-3" id="f-318" unitRef="usd">141596000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-319" unitRef="usd">117079000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-6" decimals="-3" id="f-320" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-321" unitRef="usd">11000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-6" decimals="-3" id="f-322" unitRef="usd">298000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockPlans contextRef="c-1" decimals="-3" id="f-323" unitRef="usd">435000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans contextRef="c-6" decimals="-3" id="f-324" unitRef="usd">367000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-325" unitRef="usd">117525000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-6" decimals="-3" id="f-326" unitRef="usd">665000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-327" unitRef="usd">-58984000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-6" decimals="-3" id="f-328" unitRef="usd">7185000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-329" unitRef="usd">145399000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-44" decimals="-3" id="f-330" unitRef="usd">207396000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-331" unitRef="usd">86415000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-73" decimals="-3" id="f-332" unitRef="usd">214581000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-333" unitRef="usd">199000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-6" decimals="-3" id="f-334" unitRef="usd">413000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-335" unitRef="usd">9103000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-6" decimals="-3" id="f-336" unitRef="usd">11894000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-337" unitRef="usd">1069000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-6" decimals="-3" id="f-338" unitRef="usd">4708000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:NatureOfOperations contextRef="c-1" id="f-339">Nature of Business&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Editas Medicine, Inc. (the &#x201c;Company&#x201d;) is a clinical stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The Company was incorporated in the state of Delaware in September 2013. Its principal offices are in Cambridge, Massachusetts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since its inception, the Company has devoted substantially all of its efforts to business planning, research and development, recruiting management and technical staff, and raising capital. The Company has primarily financed its operations through various equity financings, payments received under a research collaboration with Juno Therapeutics, Inc., a wholly-owned subsidiary of the Bristol-Myers Squibb Company (&#x201c;BMS&#x201d;), and payments received under a strategic alliance and option agreement with Allergan Pharmaceuticals International Limited, which was terminated in August 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to risks common to companies in the biotechnology industry, including but not limited to, risks of failure of preclinical studies and clinical trials, the need to obtain marketing approval for any drug product candidate that it may identify and develop, the need to successfully commercialize and gain market acceptance of its product candidates, dependence on key personnel, protection of proprietary technology, compliance with government regulations, development by competitors of technological innovations and ability to transition from pilot-scale manufacturing to large-scale production of products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2023, the Company completed a public offering in which it sold 12,500,000 shares of its common stock and received net proceeds of approximately $117.1 million after deducting underwriting discounts and commissions and other offering costs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the Company entered into a common stock sales agreement with Cowen and Company, LLC (&#x201c;Cowen&#x201d;), under which the Company from time to time can issue and sell shares of its common stock through Cowen in at-the-market offerings for aggregate gross sale proceeds of up to $300.0 million (the &#x201c;ATM Facility&#x201d;). As of September&#160;30, 2023, the Company has not sold any shares of its common stock under the ATM Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has incurred annual net operating losses in every year since its inception. The Company expects that its existing cash, cash equivalents and marketable securities at September&#160;30, 2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; will enable it to fund its operating expenses and capital expenditure requirements into the third quarter of 2025. The Company had an accumulated deficit of $1.2 billion at September&#160;30, 2023, and will require substantial additional capital to fund its operations. The Company has never generated any product revenue. There can be no assurance that the Company will be able to obtain additional debt or equity financing or generate product revenue or revenues from collaborative partners, on terms acceptable to the Company, on a timely basis or at all. The failure of the Company to obtain sufficient funds on acceptable terms when needed could have a material adverse effect on the Company&#x2019;s business, results of operations, and financial condition.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-74"
      decimals="INF"
      id="f-340"
      unitRef="shares">12500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-74" decimals="-5" id="f-341" unitRef="usd">117100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <edit:SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued contextRef="c-75" decimals="-5" id="f-342" unitRef="usd">300000000</edit:SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-76"
      decimals="INF"
      id="f-343"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-8" id="f-344" unitRef="usd">-1200000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-345">Summary of Significant Accounting Policies&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Unaudited Interim Financial Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;) have been condensed or omitted from this report, as is permitted by such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 (the &#x201c;Annual Report&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Editas Securities Corporation and Editas Medicine, LLC. All intercompany transactions and balances of the subsidiaries have been eliminated in consolidation. In the opinion of management, the information furnished reflects all adjustments, all of which are of a normal and recurring nature, necessary for a fair presentation of the results for the reported interim periods. The Company considers events or transactions that occur after the balance sheet date but before &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The three months ended September&#160;30, 2023 and 2022 are referred to as the third quarter of 2023 and 2022, respectively. The results of operations for interim periods are not necessarily indicative of results to be expected for the full year or any other interim period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;The Company&#x2019;s significant accounting policies are described in Note 2, &#x201c;Summary of Significant Accounting Policies,&#x201d; to the consolidated financial statements included in the Annual Report. There have been no material changes to the significant accounting policies previously disclosed in the Annual Report.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock contextRef="c-1" id="f-346">Cash Equivalents and Marketable Securities &lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents and marketable securities consisted of the following at September&#160;30, 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Allowance&lt;br/&gt;for Credit&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents and marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;171,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;170,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;447,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,474)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;446,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents and marketable securities consisted of the following at December&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Allowance&lt;br/&gt;for Credit&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents and marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;161,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;159,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;141,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;141,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;57,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(694)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;440,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;437,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2023, the Company did not hold any marketable securities that had been in an unrealized loss position for more than twelve months. Furthermore, the Company has determined that there were no material changes in the credit risk of the securities. As of September&#160;30, 2023, the Company holds 29 securities with an aggregate fair value of $96.8 million that had remaining maturities greater than one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no realized gains or losses on available-for-sale securities during the nine months ended September&#160;30, 2023 or 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock contextRef="c-1" id="f-347">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents and marketable securities consisted of the following at September&#160;30, 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Allowance&lt;br/&gt;for Credit&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents and marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;171,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;170,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;447,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,474)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;446,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents and marketable securities consisted of the following at December&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Allowance&lt;br/&gt;for Credit&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents and marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;161,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;159,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;141,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;141,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;57,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(694)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;440,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;437,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-77" decimals="-3" id="f-348" unitRef="usd">171404000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-77" decimals="-3" id="f-349" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-77" decimals="-3" id="f-350" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-77" decimals="-3" id="f-351" unitRef="usd">1197000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-77" decimals="-3" id="f-352" unitRef="usd">170207000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-78" decimals="-3" id="f-353" unitRef="usd">143261000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-78" decimals="-3" id="f-354" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-78" decimals="-3" id="f-355" unitRef="usd">22000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-78" decimals="-3" id="f-356" unitRef="usd">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-78" decimals="-3" id="f-357" unitRef="usd">143271000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-79" decimals="-3" id="f-358" unitRef="usd">82537000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-79" decimals="-3" id="f-359" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-79" decimals="-3" id="f-360" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-79" decimals="-3" id="f-361" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-79" decimals="-3" id="f-362" unitRef="usd">82537000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-80" decimals="-3" id="f-363" unitRef="usd">38066000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-80" decimals="-3" id="f-364" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-80" decimals="-3" id="f-365" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-80" decimals="-3" id="f-366" unitRef="usd">254000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-80" decimals="-3" id="f-367" unitRef="usd">37812000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-81" decimals="-3" id="f-368" unitRef="usd">12598000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-81" decimals="-3" id="f-369" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-81" decimals="-3" id="f-370" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-81" decimals="-3" id="f-371" unitRef="usd">11000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-81" decimals="-3" id="f-372" unitRef="usd">12587000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-3" decimals="-3" id="f-373" unitRef="usd">447866000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-3" decimals="-3" id="f-374" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-3" decimals="-3" id="f-375" unitRef="usd">22000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-3" decimals="-3" id="f-376" unitRef="usd">1474000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-3" decimals="-3" id="f-377" unitRef="usd">446414000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-82" decimals="-3" id="f-378" unitRef="usd">161902000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-82" decimals="-3" id="f-379" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-82" decimals="-3" id="f-380" unitRef="usd">11000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-82" decimals="-3" id="f-381" unitRef="usd">2556000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-82" decimals="-3" id="f-382" unitRef="usd">159357000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-83" decimals="-3" id="f-383" unitRef="usd">141522000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-83" decimals="-3" id="f-384" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-83" decimals="-3" id="f-385" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-83" decimals="-3" id="f-386" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-83" decimals="-3" id="f-387" unitRef="usd">141522000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-84" decimals="-3" id="f-388" unitRef="usd">57575000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-84" decimals="-3" id="f-389" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-84" decimals="-3" id="f-390" unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-84" decimals="-3" id="f-391" unitRef="usd">694000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-84" decimals="-3" id="f-392" unitRef="usd">56883000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-85" decimals="-3" id="f-393" unitRef="usd">50019000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-85" decimals="-3" id="f-394" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-85" decimals="-3" id="f-395" unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-85" decimals="-3" id="f-396" unitRef="usd">229000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-85" decimals="-3" id="f-397" unitRef="usd">49793000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-86" decimals="-3" id="f-398" unitRef="usd">29954000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-86" decimals="-3" id="f-399" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-86" decimals="-3" id="f-400" unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-86" decimals="-3" id="f-401" unitRef="usd">141000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-86" decimals="-3" id="f-402" unitRef="usd">29816000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-4" decimals="-3" id="f-403" unitRef="usd">440972000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-4" decimals="-3" id="f-404" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-4" decimals="-3" id="f-405" unitRef="usd">19000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-4" decimals="-3" id="f-406" unitRef="usd">3620000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-4" decimals="-3" id="f-407" unitRef="usd">437371000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="c-3"
      decimals="INF"
      id="f-408"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <edit:MarketableSecuritiesNoncurrentNumberOfSecurities
      contextRef="c-3"
      decimals="INF"
      id="f-409"
      unitRef="security">29</edit:MarketableSecuritiesNoncurrentNumberOfSecurities>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c-3" decimals="-5" id="f-410" unitRef="usd">96800000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss contextRef="c-1" decimals="INF" id="f-411" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss contextRef="c-6" decimals="INF" id="f-412" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-413">Fair Value Measurements&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets measured at fair value on a recurring basis as of September&#160;30, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Quoted Prices&lt;br/&gt;in Active&lt;br/&gt;Markets for&lt;br/&gt;Identical Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;170,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;170,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash and other non-current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;450,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;229,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;220,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets measured at fair value on a recurring basis as of December&#160;31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Quoted Prices&lt;br/&gt;in Active&lt;br/&gt;Markets for&lt;br/&gt;Identical Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;141,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;141,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;159,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;159,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash and other non-current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;441,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;195,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;246,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-414">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets measured at fair value on a recurring basis as of September&#160;30, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Quoted Prices&lt;br/&gt;in Active&lt;br/&gt;Markets for&lt;br/&gt;Identical Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;170,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;170,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash and other non-current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;450,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;229,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;220,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets measured at fair value on a recurring basis as of December&#160;31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Quoted Prices&lt;br/&gt;in Active&lt;br/&gt;Markets for&lt;br/&gt;Identical Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;141,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;141,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;159,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;159,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash and other non-current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;441,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;195,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;246,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-87" decimals="-3" id="f-415" unitRef="usd">82537000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-88" decimals="-3" id="f-416" unitRef="usd">82537000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-89" decimals="-3" id="f-417" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-90" decimals="-3" id="f-418" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-91" decimals="-3" id="f-419" unitRef="usd">170207000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-92" decimals="-3" id="f-420" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-93" decimals="-3" id="f-421" unitRef="usd">170207000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-94" decimals="-3" id="f-422" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-95" decimals="-3" id="f-423" unitRef="usd">37812000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-96" decimals="-3" id="f-424" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-97" decimals="-3" id="f-425" unitRef="usd">37812000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-98" decimals="-3" id="f-426" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-99" decimals="-3" id="f-427" unitRef="usd">12587000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-100" decimals="-3" id="f-428" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-101" decimals="-3" id="f-429" unitRef="usd">12587000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-102" decimals="-3" id="f-430" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-103" decimals="-3" id="f-431" unitRef="usd">143271000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-104" decimals="-3" id="f-432" unitRef="usd">143271000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-105" decimals="-3" id="f-433" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-106" decimals="-3" id="f-434" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-87" decimals="-3" id="f-435" unitRef="usd">3877000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-88" decimals="-3" id="f-436" unitRef="usd">3877000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-89" decimals="-3" id="f-437" unitRef="usd">0</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-90" decimals="-3" id="f-438" unitRef="usd">0</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-107" decimals="-3" id="f-439" unitRef="usd">450291000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-108" decimals="-3" id="f-440" unitRef="usd">229685000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-109" decimals="-3" id="f-441" unitRef="usd">220606000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-110" decimals="-3" id="f-442" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-111" decimals="-3" id="f-443" unitRef="usd">141522000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-112" decimals="-3" id="f-444" unitRef="usd">141522000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-113" decimals="-3" id="f-445" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-114" decimals="-3" id="f-446" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-115" decimals="-3" id="f-447" unitRef="usd">159357000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-116" decimals="-3" id="f-448" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-117" decimals="-3" id="f-449" unitRef="usd">159357000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-118" decimals="-3" id="f-450" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-119" decimals="-3" id="f-451" unitRef="usd">56883000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-120" decimals="-3" id="f-452" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-121" decimals="-3" id="f-453" unitRef="usd">56883000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-122" decimals="-3" id="f-454" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-123" decimals="-3" id="f-455" unitRef="usd">49793000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-124" decimals="-3" id="f-456" unitRef="usd">49793000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-125" decimals="-3" id="f-457" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-126" decimals="-3" id="f-458" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-127" decimals="-3" id="f-459" unitRef="usd">29816000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-128" decimals="-3" id="f-460" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-129" decimals="-3" id="f-461" unitRef="usd">29816000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-130" decimals="-3" id="f-462" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-111" decimals="-3" id="f-463" unitRef="usd">3877000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-112" decimals="-3" id="f-464" unitRef="usd">3877000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-113" decimals="-3" id="f-465" unitRef="usd">0</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-114" decimals="-3" id="f-466" unitRef="usd">0</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-131" decimals="-3" id="f-467" unitRef="usd">441248000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-132" decimals="-3" id="f-468" unitRef="usd">195192000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-133" decimals="-3" id="f-469" unitRef="usd">246056000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-134" decimals="-3" id="f-470" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c-1" id="f-475">Accrued Expenses&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;External research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intellectual property and patent related fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Professional service expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-476">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;External research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intellectual property and patent related fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Professional service expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <edit:AccruedExternalResearchAndDevelopmentExpensesCurrent contextRef="c-3" decimals="-3" id="f-477" unitRef="usd">17135000</edit:AccruedExternalResearchAndDevelopmentExpensesCurrent>
    <edit:AccruedExternalResearchAndDevelopmentExpensesCurrent contextRef="c-4" decimals="-3" id="f-478" unitRef="usd">16452000</edit:AccruedExternalResearchAndDevelopmentExpensesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-479" unitRef="usd">9536000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-480" unitRef="usd">10140000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <edit:IntellectualPropertyAndPatentRelatedFees contextRef="c-3" decimals="-3" id="f-481" unitRef="usd">1385000</edit:IntellectualPropertyAndPatentRelatedFees>
    <edit:IntellectualPropertyAndPatentRelatedFees contextRef="c-4" decimals="-3" id="f-482" unitRef="usd">1809000</edit:IntellectualPropertyAndPatentRelatedFees>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-3" decimals="-3" id="f-483" unitRef="usd">943000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-484" unitRef="usd">1260000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-485" unitRef="usd">1279000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-486" unitRef="usd">1635000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-487" unitRef="usd">30278000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-488" unitRef="usd">31296000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-489">Property and Equipment, net&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(25,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(21,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-490">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(25,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(21,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-135" decimals="-3" id="f-491" unitRef="usd">24940000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-136" decimals="-3" id="f-492" unitRef="usd">24407000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-137" decimals="-3" id="f-493" unitRef="usd">9648000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-138" decimals="-3" id="f-494" unitRef="usd">9761000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-139" decimals="-3" id="f-495" unitRef="usd">875000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-140" decimals="-3" id="f-496" unitRef="usd">875000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-141" decimals="-3" id="f-497" unitRef="usd">623000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-142" decimals="-3" id="f-498" unitRef="usd">1573000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-143" decimals="-3" id="f-499" unitRef="usd">264000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-144" decimals="-3" id="f-500" unitRef="usd">264000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-145" decimals="-3" id="f-501" unitRef="usd">215000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-146" decimals="-3" id="f-502" unitRef="usd">215000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-3" decimals="-3" id="f-503" unitRef="usd">36565000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-504" unitRef="usd">37095000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-505" unitRef="usd">25006000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-506" unitRef="usd">21526000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-507" unitRef="usd">11559000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-508" unitRef="usd">15569000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-509">Commitments and Contingencies&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we entered into a license and service agreement pursuant to which we will lease manufacturing space for our continued research and development activities. As of September&#160;30, 2023, the lease has not commenced for accounting purposes and it is not expected to commence until the second quarter of 2024. The license and service agreement provides for total remaining lease payments of up to $87.8 million over a 10-year lease term. The Company may terminate the license and service agreement in its discretion upon twelve months' prior written notice.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to a number of license agreements under which the Company licenses patents, patent applications and other intellectual property from third parties. As such, the Company is obligated to pay licensors for various costs including upfront licenses fees, annual license fees, certain licensor expense reimbursements, success payments, research funding payments, and milestones triggerable upon certain development, regulatory, and commercial events as well as royalties on future products. These contracts are generally cancellable, with notice, at the Company&#x2019;s option and do not have significant cancellation penalties. The terms and conditions as well as the accounting analysis for the Company&#x2019;s significant commitments and contingencies are described in Note 8, &#x201c;Commitments and Contingencies&#x201d; to the consolidated financial statements included in the Annual Report. There have been no material changes to the terms and conditions, or the accounting conclusions, previously disclosed in the Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Licensor Expense Reimbursement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is obligated to reimburse The Broad Institute, Inc. (&#x201c;Broad&#x201d;) and the President and Fellows of Harvard College (&#x201c;Harvard&#x201d;) for expenses incurred by each of them associated with the prosecution and maintenance of the patent rights that the Company licenses from them pursuant to the license agreement by and among the Company, Broad and Harvard, including the interference and opposition proceedings involving patents licensed to the Company under the license agreement, and other license agreements between the Company and Broad. As such, the Company anticipates that it has a substantial commitment in connection with these proceedings until such time as these proceedings have been resolved, but the amount of such commitment is not determinable. The Company incurred an aggregate of $1.5 million and $6.1 million in expense during the three and nine months ended September&#160;30, 2023, respectively, for such reimbursement. The Company incurred an aggregate of $2.2 million and $6.1 million in expense during the three and nine months ended September&#160;30, 2022, respectively, for such reimbursement.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-147" decimals="-5" id="f-510" unitRef="usd">87800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-147" id="f-511">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:ProfessionalAndContractServicesExpense contextRef="c-148" decimals="-5" id="f-512" unitRef="usd">1500000</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:ProfessionalAndContractServicesExpense contextRef="c-149" decimals="-5" id="f-513" unitRef="usd">6100000</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:ProfessionalAndContractServicesExpense contextRef="c-150" decimals="-5" id="f-514" unitRef="usd">2200000</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:ProfessionalAndContractServicesExpense contextRef="c-151" decimals="-5" id="f-515" unitRef="usd">6100000</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-516">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Collaboration and Profit-Sharing Agreements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;The Company has entered into multiple collaborations, out-licenses and strategic alliances with third parties that typically involve payments to or from the Company, including up-front payments, payments for research and development services, option payments, milestone payments and royalty payments to or from the Company. The terms and conditions as well as the accounting analysis for the Company&#x2019;s significant collaborations, out-licenses and strategic alliances are described in Note 9, &#x201c;Collaboration and Profit-Sharing Agreements&#x201d; to the consolidated financial statements included in the Annual Report. There have been no material changes to the terms and conditions, or the accounting conclusions, previously disclosed in the Annual Report. &lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collaboration Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2023, the Company&#x2019;s contract liabilities were primarily related to the Company&#x2019;s collaboration with BMS. The following table presents changes in the Company&#x2019;s accounts receivable and contract liabilities for the nine months ended September&#160;30, 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Balance at September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2023, the Company did not recognize any collaboration revenue that had been allocated to deferred revenue from BMS.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <edit:ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock contextRef="c-1" id="f-517">The following table presents changes in the Company&#x2019;s accounts receivable and contract liabilities for the nine months ended September&#160;30, 2023 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Balance at September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</edit:ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock>
    <us-gaap:ReceivablesNetCurrent contextRef="c-4" decimals="-3" id="f-518" unitRef="usd">5145000</us-gaap:ReceivablesNetCurrent>
    <edit:AccountsReceivableAdditions contextRef="c-1" decimals="-3" id="f-519" unitRef="usd">2277000</edit:AccountsReceivableAdditions>
    <edit:AccountsReceivableDeductions contextRef="c-1" decimals="-3" id="f-520" unitRef="usd">5000000</edit:AccountsReceivableDeductions>
    <us-gaap:ReceivablesNetCurrent contextRef="c-3" decimals="-3" id="f-521" unitRef="usd">2422000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ContractWithCustomerLiability contextRef="c-4" decimals="-3" id="f-522" unitRef="usd">68888000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-3" decimals="-3" id="f-523" unitRef="usd">68888000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-524">Stock-based Compensation&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total compensation cost recognized for all stock-based compensation awards in the condensed consolidated statements of operations was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Unit Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of restricted stock unit awards activity for the nine months ended September&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested restricted stock unit awards as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,499,070&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,331,578&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(262,588)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(462,777)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested restricted stock unit awards as of September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,105,283&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The restricted stock units issued in the nine months ended September&#160;30, 2023 include 437,842 units granted to certain employees that contain performance-based vesting provisions. The Company recognizes the fair value of the performance-based units through the expected achievement date if the performance-based vesting provisions are deemed probable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2023, total unrecognized compensation expense related to unvested restricted stock unit awards was $13.2 million, which the Company expects to recognize over a remaining weighted-average period of 2.54 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of stock option activity for the nine months ended September&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Remaining&lt;br/&gt;Contractual Life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,276,148&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,195,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,467,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,000,626&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercisable at September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,449,032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.34&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2023, total unrecognized compensation expense related to stock options was $28.1 million, which the Company expects to recognize over a remaining weighted-average period of 2.70 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-525">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total compensation cost recognized for all stock-based compensation awards in the condensed consolidated statements of operations was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-152" decimals="-3" id="f-526" unitRef="usd">2571000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-153" decimals="-3" id="f-527" unitRef="usd">3045000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-154" decimals="-3" id="f-528" unitRef="usd">7182000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-155" decimals="-3" id="f-529" unitRef="usd">9803000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-156" decimals="-3" id="f-530" unitRef="usd">2160000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-157" decimals="-3" id="f-531" unitRef="usd">2836000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-158" decimals="-3" id="f-532" unitRef="usd">7271000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-159" decimals="-3" id="f-533" unitRef="usd">14127000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-7" decimals="-3" id="f-534" unitRef="usd">4731000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-3" id="f-535" unitRef="usd">5881000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-536" unitRef="usd">14453000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-6" decimals="-3" id="f-537" unitRef="usd">23930000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="c-1" id="f-538">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of restricted stock unit awards activity for the nine months ended September&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested restricted stock unit awards as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,499,070&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,331,578&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(262,588)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(462,777)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested restricted stock unit awards as of September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,105,283&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-160"
      decimals="INF"
      id="f-539"
      unitRef="shares">1499070</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-160"
      decimals="2"
      id="f-540"
      unitRef="usdPerShare">18.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-161"
      decimals="INF"
      id="f-541"
      unitRef="shares">1331578</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-161"
      decimals="2"
      id="f-542"
      unitRef="usdPerShare">8.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-161"
      decimals="INF"
      id="f-543"
      unitRef="shares">262588</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-161"
      decimals="2"
      id="f-544"
      unitRef="usdPerShare">19.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-161"
      decimals="INF"
      id="f-545"
      unitRef="shares">462777</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-161"
      decimals="2"
      id="f-546"
      unitRef="usdPerShare">18.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-162"
      decimals="INF"
      id="f-547"
      unitRef="shares">2105283</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-162"
      decimals="2"
      id="f-548"
      unitRef="usdPerShare">12.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-163"
      decimals="INF"
      id="f-549"
      unitRef="shares">437842</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-162" decimals="-5" id="f-550" unitRef="usd">13200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-161" id="f-551">P2Y6M14D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-552">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of stock option activity for the nine months ended September&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Remaining&lt;br/&gt;Contractual Life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,276,148&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,195,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,467,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,000,626&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercisable at September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,449,032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.34&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-164"
      decimals="INF"
      id="f-553"
      unitRef="shares">5276148</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-164"
      decimals="2"
      id="f-554"
      unitRef="usdPerShare">23.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-165" id="f-555">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-164" decimals="-3" id="f-556" unitRef="usd">402000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-166"
      decimals="INF"
      id="f-557"
      unitRef="shares">2195300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-166"
      decimals="2"
      id="f-558"
      unitRef="usdPerShare">8.74</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-166"
      decimals="INF"
      id="f-559"
      unitRef="shares">3122</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-166"
      decimals="2"
      id="f-560"
      unitRef="usdPerShare">3.38</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c-166"
      decimals="INF"
      id="f-561"
      unitRef="shares">1467700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-166"
      decimals="2"
      id="f-562"
      unitRef="usdPerShare">30.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-167"
      decimals="INF"
      id="f-563"
      unitRef="shares">6000626</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-167"
      decimals="2"
      id="f-564"
      unitRef="usdPerShare">16.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-166" id="f-565">P7Y9M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-167" decimals="-3" id="f-566" unitRef="usd">342000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-167"
      decimals="INF"
      id="f-567"
      unitRef="shares">2449032</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-167"
      decimals="2"
      id="f-568"
      unitRef="usdPerShare">22.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-166" id="f-569">P6Y4M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-167" decimals="-3" id="f-570" unitRef="usd">279000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-167" decimals="-5" id="f-571" unitRef="usd">28100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-166" id="f-572">P2Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-573">Net Loss per Share&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and potentially dilutive securities outstanding for the period determined using the treasury stock and if converted methods. Contingently issuable shares are included in the calculation of basic loss per share as of the beginning of the period in which all the necessary conditions have been satisfied. Contingently issuable shares are included in diluted loss per share based on the number of shares, if any, that would be issuable under the terms of the arrangement if the end of the reporting period was the end of the contingency period, if the results are dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For purposes of the diluted net loss per share calculation, unvested restricted stock unit awards and outstanding stock options are considered to be common stock equivalents, but they were excluded from the Company&#x2019;s calculation of diluted net loss per share allocable to common stockholders because their inclusion would have been anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders were the same for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock equivalents were excluded from the calculation of diluted net loss per share allocable to common stockholders because their inclusion would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested restricted stock unit awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,105,283&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,503,682&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,000,626&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,216,124&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,105,909&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,719,806&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-574">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock equivalents were excluded from the calculation of diluted net loss per share allocable to common stockholders because their inclusion would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested restricted stock unit awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,105,283&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,503,682&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,000,626&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,216,124&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,105,909&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,719,806&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-168" decimals="0" id="f-575" unitRef="shares">2105283</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-169" decimals="0" id="f-576" unitRef="shares">2105283</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-170" decimals="0" id="f-577" unitRef="shares">1503682</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-171" decimals="0" id="f-578" unitRef="shares">1503682</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-172" decimals="0" id="f-579" unitRef="shares">6000626</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-173" decimals="0" id="f-580" unitRef="shares">6000626</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-174" decimals="0" id="f-581" unitRef="shares">5216124</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-175" decimals="0" id="f-582" unitRef="shares">5216124</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-583" unitRef="shares">8105909</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-7" decimals="0" id="f-584" unitRef="shares">8105909</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-5" decimals="0" id="f-585" unitRef="shares">6719806</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-6" decimals="0" id="f-586" unitRef="shares">6719806</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-176" id="f-587">During the quarterly period covered by this report, Linda C. Burkly, Ph.D., our Chief Scientific Officer, entered into a Rule 10b5-1 trading arrangement that is intended to qualify as an &#x201c;eligible sell-to-cover transaction&#x201d; (as described in Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act). This sell-to-cover arrangement, which was adopted on July 3, 2023, applies to restricted stock units (&#x201c;RSUs&#x201d;), whether vesting is based on the passage of time and/or the achievement of performance goals, granted on her start date, July 24, 2023, and any RSUs that may be granted from time to time thereafter (other than those which by their terms require us to withhold shares for tax withholding obligations in connection with vesting and settlement). This arrangement provides for the automatic sale of shares of our common stock that would otherwise be issuable on each settlement date of a covered RSU in an amount necessary to satisfy the applicable withholding obligation, with the proceeds of the sale delivered to us in satisfaction of the applicable withholding obligation. The number of shares that will be sold under this arrangement is not currently determinable as the number will vary based on the extent to which vesting conditions are satisfied, the market price of our common stock at the time of settlement and the potential future grant of additional RSUs subject to this arrangement.</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrIndName contextRef="c-177" id="f-588">Linda C. Burkly, Ph.D.</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-177" id="f-589">Chief Scientific Officer</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-177" id="f-590">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrAdoptionDate contextRef="c-177" id="f-591">July 3, 2023</ecd:TrdArrAdoptionDate>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-7" id="f-592">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-7" id="f-593">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-7" id="f-594">false</ecd:NonRule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>62
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M5CZBG$'KT=_K5JPF>\5!/*0XBQ3&3C12W>".X_ TR9TS\26H)H?9Z-@B%CB
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M1@&\%H#O6\[5Z4%?%;?_&EC_!U!+ P04    " !W@&-7.8$;K0$#  !C"@
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M*U,3,2?W+$?CC'(R$8J5E?;]9J:TQ'K[T6:UXNZU<YM+>*T*&L/(PENF0*[
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M=P5[7[5MM=[_^%CDW9*K+]#]_;ZJVC\_7'?Z3U7]81_C]O]02P,$%     @
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M/27 [TH ?M]Q+E]OU N&D_;-WU!+ P04    " !W@&-7)N[1"K4'  !I$0
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M&Z>Q0W6R'5K_861GNZ*%--1CV6%)32TJ-J#UI:0#N/W@#88V>?XW4$L#!!0
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M6#)>HC1<2="8S[Q%-%GV7'P3\)WCUARLP56R5NK>&=?9S N=(!286L? Z/6
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MC=H%T'ZNE-T;+D'W0YC_ 5!+ P04    " !W@&-7:!!.$N<"  ")!@  &0
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M]+X@"C 6\W988A*0&H118F _.%66Y.1:4PI@;W541JRO;+4,UNV2@ICC+E/
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M!*U[MWK"2:D.]B?"19N@AJEH=Q&5 G%]30C?3V2 MH&._@)02P,$%     @
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MMY>%LK3VN,L$!<V;W(#>QXIFG.J&.Z@_W\W_ U!+ P04    " !W@&-7X_W
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M/?ZM@#0&N+X5F-K^PS@8_G\6?P-02P,$%     @ =X!C5S!K0$RJ P  M@D
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MC?>\%4M\6($T"W"^$,C&7C$.AJ?:ZA]02P,$%     @ =X!C5V O[9#4 @
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M.>AYH)M^U"RL*NL>L%:6.DH]S:F%HW8.M)\I9?<+%Z#]*<S^ E!+ P04
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M"!I?7/8#T,T :C96E;[IU\K2"/'+G&8V:F= ]QNE[&'C'+3_ K/_4$L#!!0
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MJ]\<KY?>Z@/)-M7*SX))R;)J=PTT!EYV4.>7C,F7@S) NP Z^Q=02P,$%
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M2N2^+*]?G\T;J=RVGZ]ZE8N]"AE1B=%'43:;&KTKUWP];#^7/3YTFSQV^X*
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MD-_?"'FWW&^T H>WA!;_ E!+ P04    " !W@&-7HELL>4$)  !E5P  &0
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MK/"M 1L2<'UMC#\&X?QWKU?Q#U!+ P04    " !W@&-7\T@Y&\<"  "?"0
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M HT_UL!4%,H^R::1]1R2KI0690-&"TK&ZS?=-G'8 R!/-\!O /YS0/@*(&@
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M[3+'"0JD$<#O"R'T;F,4M#-9_!M02P,$%     @ =X!C5XG-\USV @  >P@
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M!JND&";X=0#*;L#W*RG-?F(=5-\;X6]02P,$%     @ =X!C5R(W3YF, P
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M_H,6@A;2GI^$//L?/!=MS1GP]SQ-HJ*S\" *XOPO>2DFHM(!+8YT0$4'U.@
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M)%D61@ +*T@2#(&G$4<P!: !0Y+$G8,[YU&\/J?BS6]$H]]02P,$%     @
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M<' N>&UL4$L! A0#%     @ =X!C5RZ5!"/M    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ =X!C5YE<G",0
M!@  G"<  !,              ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " !W@&-7!#!D9+<%  "K'@  &               @($,"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ =X!C5\>. &3N
M!0  )A@  !@              ("!^0T  'AL+W=O<FMS:&5E=',O<VAE970R
M+GAM;%!+ 0(4 Q0    ( '> 8U<Y@1NM 0,  &,*   8              "
M@1T4  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !W@&-7
M<NST<V,%  "4&   &               @(%4%P  >&PO=V]R:W-H965T<R]S
M:&5E=#0N>&UL4$L! A0#%     @ =X!C5P[#L]]@ P  D0L  !@
M     ("![1P  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (
M '> 8U?=3 79+ X  *^1   8              " @8,@  !X;"]W;W)K<VAE
M971S+W-H965T-BYX;6Q02P$"% ,4    " !W@&-7UY6%J$D'  !U'P  &
M            @('E+@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#
M%     @ =X!C5R;NT0JU!P  :1$  !@              ("!9#8  'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( '> 8U>1WV8'-04  &$,
M   8              " @4\^  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q0
M2P$"% ,4    " !W@&-70IG*SW4$   R"P  &0              @(&Z0P
M>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( '> 8U??<VZW
MD@,  )X)   9              " @69(  !X;"]W;W)K<VAE971S+W-H965T
M,3$N>&UL4$L! A0#%     @ =X!C5[L7QV7$ @  ' 8  !D
M ("!+TP  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !W
M@&-7:!!.$N<"  ")!@  &0              @($J3P  >&PO=V]R:W-H965T
M<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( '> 8U>7H%B94@8  ,@/   9
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M970Q."YX;6Q02P$"% ,4    " !W@&-75/+C5+P%  #*$P  &0
M    @(%!:0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (
M '> 8U?C_<!;GP,   L)   9              " @31O  !X;"]W;W)K<VAE
M971S+W-H965T,C N>&UL4$L! A0#%     @ =X!C5S!K0$RJ P  M@D  !D
M             ("!"G,  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"
M% ,4    " !W@&-78"_MD-0"   @!@  &0              @('K=@  >&PO
M=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( '> 8U>N"T,8^0(
M ((&   9              " @?9Y  !X;"]W;W)K<VAE971S+W-H965T,C,N
M>&UL4$L! A0#%     @ =X!C5^/2-*[5 @  <P8  !D              ("!
M)GT  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !W@&-7
M1Q?R3WT$   +"P  &0              @($R@   >&PO=V]R:W-H965T<R]S
M:&5E=#(U+GAM;%!+ 0(4 Q0    ( '> 8U?][LC\ZP(  !$&   9
M      " @>:$  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%
M  @ =X!C5V++GS]:!   #!T  !D              ("!"(@  'AL+W=O<FMS
M:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " !W@&-7!-!_V4('   Q-
M&0              @(&9C   >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+
M 0(4 Q0    ( '> 8U>B6RQY00D  &57   9              " @1*4  !X
M;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ =X!C5[LO*I3S
M @  9P@  !D              ("!BIT  'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6Q02P$"% ,4    " !W@&-7'=]5?O(#   )%@  &0
M@(&TH   >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( '>
M8U?SXI[\*@(  ,D$   9              " @=VD  !X;"]W;W)K<VAE971S
M+W-H965T,S(N>&UL4$L! A0#%     @ =X!C5_-(.1O' @  GPD  !D
M         ("!/J<  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
M    " !W@&-7B<WS7/8"  !["   &0              @($\J@  >&PO=V]R
M:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( '> 8U<B-T^9C ,  +X0
M   9              " @6FM  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL
M4$L! A0#%     @ =X!C5\3KQ8;P!@  PR@  !D              ("!++$
M 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " !W@&-7]4TY
M?&8#  !T$   &0              @(%3N   >&PO=V]R:W-H965T<R]S:&5E
M=#,W+GAM;%!+ 0(4 Q0    ( '> 8U>X$@,(&P,  # 2   -
M  "  ?"[  !X;"]S='EL97,N>&UL4$L! A0#%     @ =X!C5Y>*NQS
M$P(   L              ( !-K\  %]R96QS+RYR96QS4$L! A0#%     @
M=X!C5\?R%Q6" P  -AD   \              ( !'\   'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( '> 8U>9/J*$? $  )86   :              "
M <[#  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( '>
M8U>J9Q1AF $   L7   3              "  8+%  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     M "T ,@P  $O'      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>177</ContextCount>
  <ElementCount>193</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>33</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Nature of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/NatureofBusiness</Role>
      <ShortName>Nature of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Cash Equivalents and Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecurities</Role>
      <ShortName>Cash Equivalents and Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Property and Equipment, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/PropertyandEquipmentnet</Role>
      <ShortName>Property and Equipment, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Collaboration and Profit-Sharing Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreements</Role>
      <ShortName>Collaboration and Profit-Sharing Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Stock-based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/StockbasedCompensation</Role>
      <ShortName>Stock-based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Net Loss per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/NetLossperShare</Role>
      <ShortName>Net Loss per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Cash Equivalents and Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesTables</Role>
      <ShortName>Cash Equivalents and Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecurities</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.editasmedicine.com/role/FairValueMeasurements</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.editasmedicine.com/role/AccruedExpenses</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Property and Equipment, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/PropertyandEquipmentnetTables</Role>
      <ShortName>Property and Equipment, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.editasmedicine.com/role/PropertyandEquipmentnet</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Collaboration and Profit-Sharing Agreements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsTables</Role>
      <ShortName>Collaboration and Profit-Sharing Agreements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Stock-based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/StockbasedCompensationTables</Role>
      <ShortName>Stock-based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.editasmedicine.com/role/StockbasedCompensation</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Net Loss per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/NetLossperShareTables</Role>
      <ShortName>Net Loss per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.editasmedicine.com/role/NetLossperShare</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Nature of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/NatureofBusinessDetails</Role>
      <ShortName>Nature of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.editasmedicine.com/role/NatureofBusiness</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Cash Equivalents and Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails</Role>
      <ShortName>Cash Equivalents and Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.editasmedicine.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/AccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.editasmedicine.com/role/AccruedExpensesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Property and Equipment, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails</Role>
      <ShortName>Property and Equipment, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.editasmedicine.com/role/PropertyandEquipmentnetTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Commitments and Contingencies - Lease Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CommitmentsandContingenciesLeaseAgreementDetails</Role>
      <ShortName>Commitments and Contingencies - Lease Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Commitments and Contingencies - Licensor Expense Reimbursements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CommitmentsandContingenciesLicensorExpenseReimbursementsDetails</Role>
      <ShortName>Commitments and Contingencies - Licensor Expense Reimbursements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Collaboration and Profit-Sharing Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsDetails</Role>
      <ShortName>Collaboration and Profit-Sharing Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Stock-based Compensation - Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/StockbasedCompensationExpenseDetails</Role>
      <ShortName>Stock-based Compensation - Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Stock-based Compensation - Restricted Stock and Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails</Role>
      <ShortName>Stock-based Compensation - Restricted Stock and Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="edit-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/NetLossperShareDetails</Role>
      <ShortName>Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.editasmedicine.com/role/NetLossperShareTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="edit-20230930.htm">edit-20230930.htm</File>
    <File>edit-20230930.xsd</File>
    <File>edit-20230930_cal.xml</File>
    <File>edit-20230930_def.xml</File>
    <File>edit-20230930_lab.xml</File>
    <File>edit-20230930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="546">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="8">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>68
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "edit-20230930.htm": {
   "nsprefix": "edit",
   "nsuri": "http://www.editasmedicine.com/20230930",
   "dts": {
    "inline": {
     "local": [
      "edit-20230930.htm"
     ]
    },
    "schema": {
     "local": [
      "edit-20230930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "edit-20230930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "edit-20230930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "edit-20230930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "edit-20230930_pre.xml"
     ]
    }
   },
   "keyStandard": 185,
   "keyCustom": 8,
   "axisStandard": 14,
   "axisCustom": 0,
   "memberStandard": 24,
   "memberCustom": 6,
   "hidden": {
    "total": 13,
    "http://fasb.org/us-gaap/2023": 8,
    "http://xbrl.sec.gov/dei/2023": 5
   },
   "contextCount": 177,
   "entityCount": 1,
   "segmentCount": 33,
   "elementCount": 389,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 29,
    "http://fasb.org/us-gaap/2023": 546,
    "http://xbrl.sec.gov/ecd/2023": 8
   },
   "report": {
    "R1": {
     "role": "http://www.editasmedicine.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets",
     "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations",
     "longName": "0000004 - Statement - Condensed Consolidated Statements of Operations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:ComprehensiveIncomeNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Stockholders' Equity",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-40",
      "name": "us-gaap:SharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-45",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows",
     "longName": "0000007 - Statement - Condensed Consolidated Statements of Cash Flows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.editasmedicine.com/role/NatureofBusiness",
     "longName": "0000008 - Disclosure - Nature of Business",
     "shortName": "Nature of Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.editasmedicine.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "0000009 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecurities",
     "longName": "0000010 - Disclosure - Cash Equivalents and Marketable Securities",
     "shortName": "Cash Equivalents and Marketable Securities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.editasmedicine.com/role/FairValueMeasurements",
     "longName": "0000011 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.editasmedicine.com/role/AccruedExpenses",
     "longName": "0000012 - Disclosure - Accrued Expenses",
     "shortName": "Accrued Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.editasmedicine.com/role/PropertyandEquipmentnet",
     "longName": "0000013 - Disclosure - Property and Equipment, net",
     "shortName": "Property and Equipment, net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.editasmedicine.com/role/CommitmentsandContingencies",
     "longName": "0000014 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreements",
     "longName": "0000015 - Disclosure - Collaboration and Profit-Sharing Agreements",
     "shortName": "Collaboration and Profit-Sharing Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.editasmedicine.com/role/StockbasedCompensation",
     "longName": "0000016 - Disclosure - Stock-based Compensation",
     "shortName": "Stock-based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.editasmedicine.com/role/NetLossperShare",
     "longName": "0000017 - Disclosure - Net Loss per Share",
     "shortName": "Net Loss per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R19": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesTables",
     "longName": "9954471 - Disclosure - Cash Equivalents and Marketable Securities (Tables)",
     "shortName": "Cash Equivalents and Marketable Securities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.editasmedicine.com/role/FairValueMeasurementsTables",
     "longName": "9954472 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.editasmedicine.com/role/AccruedExpensesTables",
     "longName": "9954473 - Disclosure - Accrued Expenses (Tables)",
     "shortName": "Accrued Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.editasmedicine.com/role/PropertyandEquipmentnetTables",
     "longName": "9954474 - Disclosure - Property and Equipment, net (Tables)",
     "shortName": "Property and Equipment, net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsTables",
     "longName": "9954475 - Disclosure - Collaboration and Profit-Sharing Agreements (Tables)",
     "shortName": "Collaboration and Profit-Sharing Agreements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "edit:ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "edit:ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.editasmedicine.com/role/StockbasedCompensationTables",
     "longName": "9954476 - Disclosure - Stock-based Compensation (Tables)",
     "shortName": "Stock-based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.editasmedicine.com/role/NetLossperShareTables",
     "longName": "9954477 - Disclosure - Net Loss per Share (Tables)",
     "shortName": "Net Loss per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.editasmedicine.com/role/NatureofBusinessDetails",
     "longName": "9954478 - Disclosure - Nature of Business (Details)",
     "shortName": "Nature of Business (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-74",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails",
     "longName": "9954479 - Disclosure - Cash Equivalents and Marketable Securities (Details)",
     "shortName": "Cash Equivalents and Marketable Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.editasmedicine.com/role/FairValueMeasurementsDetails",
     "longName": "9954480 - Disclosure - Fair Value Measurements (Details)",
     "shortName": "Fair Value Measurements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-107",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.editasmedicine.com/role/AccruedExpensesDetails",
     "longName": "9954481 - Disclosure - Accrued Expenses (Details)",
     "shortName": "Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "edit:AccruedExternalResearchAndDevelopmentExpensesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "edit:AccruedExternalResearchAndDevelopmentExpensesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails",
     "longName": "9954482 - Disclosure - Property and Equipment, net (Details)",
     "shortName": "Property and Equipment, net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.editasmedicine.com/role/CommitmentsandContingenciesLeaseAgreementDetails",
     "longName": "9954483 - Disclosure - Commitments and Contingencies - Lease Agreement (Details)",
     "shortName": "Commitments and Contingencies - Lease Agreement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-147",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-147",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.editasmedicine.com/role/CommitmentsandContingenciesLicensorExpenseReimbursementsDetails",
     "longName": "9954484 - Disclosure - Commitments and Contingencies - Licensor Expense Reimbursements (Details)",
     "shortName": "Commitments and Contingencies - Licensor Expense Reimbursements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-148",
      "name": "us-gaap:ProfessionalAndContractServicesExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-148",
      "name": "us-gaap:ProfessionalAndContractServicesExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsDetails",
     "longName": "9954485 - Disclosure - Collaboration and Profit-Sharing Agreements (Details)",
     "shortName": "Collaboration and Profit-Sharing Agreements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ReceivablesNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "edit:AccountsReceivableAdditions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.editasmedicine.com/role/StockbasedCompensationExpenseDetails",
     "longName": "9954486 - Disclosure - Stock-based Compensation - Expense (Details)",
     "shortName": "Stock-based Compensation - Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails",
     "longName": "9954487 - Disclosure - Stock-based Compensation - Restricted Stock and Stock Options (Details)",
     "shortName": "Stock-based Compensation - Restricted Stock and Stock Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-160",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-161",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.editasmedicine.com/role/NetLossperShareDetails",
     "longName": "9954488 - Disclosure - Net Loss per Share (Details)",
     "shortName": "Net Loss per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20230930.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Liabilities, Current [Abstract]",
        "label": "Accrued Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r367",
      "r385",
      "r557",
      "r558"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r367"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r204"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock under employee stock purchase plan (in shares)",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r35",
      "r36",
      "r61"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r510"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting of restricted common stock awards (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r35",
      "r36",
      "r61"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of stock options (in shares)",
        "negatedLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r35",
      "r36",
      "r61",
      "r232"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r240"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r510"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other income, net:",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r204"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Grant Date Fair Value Per Share",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r443",
      "r513"
     ]
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on disposal of fixed assets",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r448",
      "r459",
      "r469",
      "r494"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r443",
      "r513"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (decrease) increase in cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r52"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r443",
      "r513"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents, and restricted cash, beginning of period",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash, end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r52",
      "r99"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r302",
      "r303",
      "r304",
      "r419",
      "r420",
      "r422",
      "r423",
      "r424"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r54",
      "r66",
      "r76",
      "r89",
      "r91",
      "r95",
      "r101",
      "r107",
      "r109",
      "r110",
      "r111",
      "r112",
      "r115",
      "r116",
      "r121",
      "r130",
      "r134",
      "r138",
      "r140",
      "r174",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r275",
      "r283",
      "r345",
      "r387",
      "r403",
      "r404",
      "r417",
      "r436",
      "r543"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share, diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r120",
      "r122",
      "r123",
      "r124",
      "r128",
      "r274",
      "r275",
      "r333",
      "r348",
      "r415"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Unrealized Gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_ReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsDetails",
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "periodStartLabel": "Accounts receivable, balance at beginning of period",
        "periodEndLabel": "Accounts receivable, balance at end of period",
        "label": "Receivables, Net, Current",
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash and cash equivalents, statement of financial position [extensible enumeration]",
        "label": "Restricted Cash and Cash Equivalents, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes cash and cash equivalents restricted to withdrawal or usage."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashAndCashEquivalentsTable",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents [Table]",
        "label": "Schedule of Cash and Cash Equivalents [Table]",
        "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other comprehensive loss:",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.editasmedicine.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from offering of common stock, net of issuance costs",
        "verboseLabel": "Net proceeds from issuance of shares",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r240"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.editasmedicine.com/role/NetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potentially dilutive securities",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issued (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r239"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, beginning of period (in dollars per share)",
        "periodEndLabel": "Balance, ending of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r236"
     ]
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities",
        "label": "Marketable Securities, Current",
        "documentation": "Amount of investment in marketable security, classified as current."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share [Abstract]",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total financial assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Unobservable Inputs (Level 3)",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r278",
      "r304",
      "r419",
      "r420",
      "r422",
      "r423",
      "r424"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.editasmedicine.com/role/CommitmentsandContingenciesLeaseAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r201",
      "r205",
      "r298",
      "r411",
      "r413"
     ]
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationExpenseDetails",
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r222",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested restricted stock unit awards, beginning of period (in shares)",
        "periodEndLabel": "Unvested restricted stock unit awards, end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r236"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unrecognized stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r239"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense), net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r65",
      "r342",
      "r427",
      "r529",
      "r540",
      "r548"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancelled (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancelled (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r79",
      "r410"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/NetLossperShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Anti-Dilutive Common Stock Equivalents",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.editasmedicine.com/role/NetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndCashEquivalentsItemsLineItems",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash Equivalents and Marketable Securities",
        "label": "Restricted Cash and Cash Equivalents Items [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails",
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities",
        "verboseLabel": "Noncurrent marketable securities",
        "label": "Marketable Securities, Noncurrent",
        "documentation": "Amount of investment in marketable security, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecurities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Equivalents and Marketable Securities",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r533"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, beginning of period (in shares)",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r228"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Abstract]",
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r258"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, beginning of period (in dollars per share)",
        "periodEndLabel": "Outstanding, end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r228"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable (in dollar per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleRealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Realized gains (losses) on available-for-sale securities",
        "label": "Debt Securities, Available-for-Sale, Realized Gain (Loss)",
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r223",
      "r251",
      "r252",
      "r254",
      "r425"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails",
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "verboseLabel": "Marketable securities:",
        "label": "Debt Securities, Available-for-Sale",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r182",
      "r331",
      "r534"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r101",
      "r174",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r263",
      "r264",
      "r265",
      "r283",
      "r366",
      "r416",
      "r438",
      "r543",
      "r550",
      "r551"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249"
     ]
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, beginning of period (in shares)",
        "periodEndLabel": "Balance, end of period (in shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for Credit Losses",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r182",
      "r186",
      "r187"
     ]
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails",
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial paper",
        "verboseLabel": "Commercial paper",
        "label": "Commercial Paper [Member]",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r432",
      "r433",
      "r434",
      "r435"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails",
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Treasuries",
        "verboseLabel": "U.S. Treasuries",
        "label": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r422",
      "r424",
      "r553"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationExpenseDetails",
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r222",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r83",
      "r101",
      "r130",
      "r135",
      "r139",
      "r174",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r262",
      "r264",
      "r283",
      "r336",
      "r379",
      "r427",
      "r438",
      "r543",
      "r544",
      "r550"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r502"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee related expenses",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r504"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256",
      "r257",
      "r358",
      "r530",
      "r531",
      "r532",
      "r547",
      "r557"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r104",
      "r105",
      "r106",
      "r108",
      "r114",
      "r116",
      "r175",
      "r176",
      "r255",
      "r256",
      "r257",
      "r260",
      "r261",
      "r266",
      "r268",
      "r269",
      "r271",
      "r273",
      "r349",
      "r351",
      "r358",
      "r557"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r503"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r182",
      "r335"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r530",
      "r531",
      "r547",
      "r556",
      "r557"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction-in-progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r477"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r508"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r75",
      "r93",
      "r94",
      "r95",
      "r104",
      "r105",
      "r106",
      "r108",
      "r114",
      "r116",
      "r129",
      "r175",
      "r176",
      "r207",
      "r255",
      "r256",
      "r257",
      "r260",
      "r261",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r297",
      "r349",
      "r350",
      "r351",
      "r358",
      "r405"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r10"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive (Loss) Gain",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r6",
      "r19",
      "r267",
      "r270",
      "r297",
      "r349",
      "r350",
      "r525",
      "r526",
      "r527",
      "r530",
      "r531",
      "r532"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r506"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r42",
      "r84",
      "r340",
      "r353",
      "r354"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/PropertyandEquipmentnet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment, net",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r70",
      "r71",
      "r72"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.editasmedicine.com/role/CommitmentsandContingenciesLeaseAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expenses",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r528"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://www.editasmedicine.com/role/CommitmentsandContingenciesLeaseAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r296"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r508"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails",
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "verboseLabel": "Money market funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed asset additions included in accounts payable and accrued expenses",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r24"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r81",
      "r343"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r508"
     ]
    },
    "us-gaap_ProfessionalAndContractServicesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfessionalAndContractServicesExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.editasmedicine.com/role/CommitmentsandContingenciesLicensorExpenseReimbursementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expense for prosecution and maintenance of patent rights",
        "label": "Professional and Contract Services Expense",
        "documentation": "Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.editasmedicine.com/role/CommitmentsandContingenciesLeaseAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r508"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.editasmedicine.com/role/NatureofBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Business",
        "label": "Nature of Operations [Text Block]",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r73"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r508"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_OtherCommitmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsDomain",
     "presentation": [
      "http://www.editasmedicine.com/role/CommitmentsandContingenciesLicensorExpenseReimbursementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Domain]",
        "label": "Other Commitments [Domain]",
        "documentation": "Other future obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesNetCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesNetCurrentAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Receivables, Net, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r90",
      "r92",
      "r96",
      "r332",
      "r347"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating loss",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r134",
      "r138",
      "r140",
      "r417"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining contractual life (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_OtherCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsTable",
     "presentation": [
      "http://www.editasmedicine.com/role/CommitmentsandContingenciesLicensorExpenseReimbursementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Table]",
        "label": "Other Commitments [Table]",
        "documentation": "Disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Unvested Restricted Stock",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.editasmedicine.com/role/NetLossperShareDetails",
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restricted Stock Unit Awards",
        "terseLabel": "Unvested restricted stock unit awards",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsAxis",
     "presentation": [
      "http://www.editasmedicine.com/role/CommitmentsandContingenciesLicensorExpenseReimbursementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Axis]",
        "label": "Other Commitments [Axis]",
        "documentation": "Information by type of other commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, remaining contractual life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r444",
      "r455",
      "r465",
      "r490"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r259",
      "r552"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.editasmedicine.com/role/CommitmentsandContingenciesLeaseAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r201",
      "r205",
      "r298",
      "r412",
      "r413"
     ]
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "presentation": [
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software",
        "label": "Software and Software Development Costs [Member]",
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r281"
     ]
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://www.editasmedicine.com/role/CommitmentsandContingenciesLicensorExpenseReimbursementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies",
        "label": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Assets",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer equipment",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and office equipment",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock from public offering, net commissions, underwriting discounts and offering costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r35",
      "r36",
      "r61",
      "r358",
      "r405",
      "r408",
      "r437"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity (Deficit)",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock under employee stock purchase plan",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r35",
      "r36",
      "r61"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r281"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r232"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting of restricted common stock awards",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r61"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of stock options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r17",
      "r61"
     ]
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r442"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.editasmedicine.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock from public offering, net commissions, underwriting discounts and offering costs (in shares)",
        "terseLabel": "Number of common stock issued (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r35",
      "r36",
      "r61",
      "r356",
      "r405",
      "r408"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PerformanceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PerformanceSharesMember",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Shares",
        "label": "Performance Shares [Member]",
        "documentation": "Share-based payment arrangement awarded for meeting performance target."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r475"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r444",
      "r455",
      "r465",
      "r490"
     ]
    },
    "edit_MarketableSecuritiesNoncurrentNumberOfSecurities": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "MarketableSecuritiesNoncurrentNumberOfSecurities",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of noncurrent securities",
        "label": "Marketable Securities, Noncurrent, Number Of Securities",
        "documentation": "Number of noncurrent marketable securities held."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "edit_LicensorExpenseReimbursementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "LicensorExpenseReimbursementsMember",
     "presentation": [
      "http://www.editasmedicine.com/role/CommitmentsandContingenciesLicensorExpenseReimbursementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Licensor Expense Reimbursements",
        "label": "Licensor Expense Reimbursements [Member]",
        "documentation": "Commitment to reimburse the licensor for prosecution and maintenance of patent rights pursuant to the license agreement by and among the reporting entity, The Broad Institute Inc. and the Fellows of Harvard College."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.editasmedicine.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "edit_LaboratoryEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "LaboratoryEquipmentMember",
     "presentation": [
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Laboratory equipment",
        "label": "Laboratory Equipment [Member]",
        "documentation": "Laboratory equipment used for research and development."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, $0.0001 par value per share: 195,000,000 shares authorized; 81,668,796 and 68,847,382 shares issued and outstanding at September\u00a030, 2023 and December\u00a031, 2022, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r339",
      "r427"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r452",
      "r463",
      "r473",
      "r498"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r29"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment, Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r487"
     ]
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r487"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r477"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://www.editasmedicine.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liquidity",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r477"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.editasmedicine.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average common shares outstanding, diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r124"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r478"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r485"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.editasmedicine.com/role/CommitmentsandContingenciesLeaseAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease term",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r447",
      "r458",
      "r468",
      "r493"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r478"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average common shares outstanding, basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r124"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r479"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r446",
      "r457",
      "r467",
      "r492"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r451",
      "r462",
      "r472",
      "r489",
      "r497"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r451",
      "r462",
      "r472",
      "r497"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r451",
      "r462",
      "r472",
      "r497"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/NetLossperShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r125",
      "r126",
      "r127"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r515",
      "r528"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r451",
      "r462",
      "r472",
      "r497"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Quoted Prices in Active Markets for Identical Assets (Level 1)",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r213",
      "r218",
      "r278",
      "r302",
      "r422",
      "r423",
      "r424"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r451",
      "r462",
      "r472",
      "r497"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r17",
      "r75",
      "r93",
      "r94",
      "r95",
      "r104",
      "r105",
      "r106",
      "r108",
      "r114",
      "r116",
      "r129",
      "r175",
      "r176",
      "r207",
      "r255",
      "r256",
      "r257",
      "r260",
      "r261",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r297",
      "r349",
      "r350",
      "r351",
      "r358",
      "r405"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Other Observable Inputs (Level 2)",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r213",
      "r218",
      "r278",
      "r303",
      "r419",
      "r420",
      "r422",
      "r423",
      "r424"
     ]
    },
    "us-gaap_GranteeStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GranteeStatusAxis",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grantee Status [Axis]",
        "label": "Grantee Status [Axis]",
        "documentation": "Information by status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r222",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r190",
      "r191",
      "r409",
      "r542"
     ]
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Payment Arrangement, Employee",
        "label": "Share-Based Payment Arrangement, Employee [Member]",
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromStockPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockPlans",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock under employee stock purchase plan",
        "label": "Proceeds from Stock Plans",
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_GranteeStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GranteeStatusDomain",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grantee Status [Domain]",
        "label": "Grantee Status [Domain]",
        "documentation": "Status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r222",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain (loss) on marketable debt securities",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r87",
      "r88"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash paid in connection with operating lease liabilities",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r294"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of securities in an unrealized loss position for more than 12 months",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions",
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r100"
     ]
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails",
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government agency securities",
        "verboseLabel": "Government agency securities",
        "label": "US Government Agencies Debt Securities [Member]",
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB)."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r422",
      "r553"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents:",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r85",
      "r101",
      "r174",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r262",
      "r264",
      "r283",
      "r427",
      "r543",
      "r544",
      "r550"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash and other non-current assets:",
        "label": "Restricted Cash and Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r63",
      "r79",
      "r99",
      "r337"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from maturities of marketable securities",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r450",
      "r461",
      "r471",
      "r496"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Right-of-use assets obtained in exchange of operating lease obligations",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r426"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r106",
      "r129",
      "r330",
      "r355",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r386",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r405",
      "r431"
     ]
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails",
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate notes/bonds",
        "verboseLabel": "Corporate notes/bonds",
        "label": "Corporate Debt Securities [Member]",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r422",
      "r424",
      "r555"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other non-current assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow from financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "edit_ContractWithCustomerLiabilityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "ContractWithCustomerLiabilityRollForward",
     "presentation": [
      "http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract with Customer, Liability [Roll Forward]",
        "label": "Contract with Customer, Liability [Roll Forward]",
        "documentation": "Contract with Customer, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) provided by investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow from investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r449",
      "r460",
      "r470",
      "r495"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53",
      "r54"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue type",
        "label": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]",
        "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow from operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r367"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r106",
      "r129",
      "r330",
      "r355",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r386",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r405",
      "r431"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r36",
      "r367",
      "r385",
      "r557",
      "r558"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.editasmedicine.com/role/NetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash and other non-current assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r389"
     ]
    },
    "edit_IncreaseDecreaseInRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "IncreaseDecreaseInRightOfUseAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Right-of-use assets",
        "label": "Increase (Decrease) In Right Of Use Assets",
        "documentation": "Amount represents the increase (decrease) in right of use assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireMarketableSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of marketable securities",
        "label": "Payments to Acquire Marketable Securities",
        "documentation": "Amount of cash outflow for purchase of marketable security."
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "edit_AccountsReceivableAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "AccountsReceivableAdditions",
     "crdr": "credit",
     "presentation": [
      "http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, Additions",
        "label": "Accounts Receivable, Additions",
        "documentation": "Represents the amount of additions to accounts receivable."
       }
      }
     },
     "auth_ref": []
    },
    "edit_AccruedExternalResearchAndDevelopmentExpensesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "AccruedExternalResearchAndDevelopmentExpensesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "External research and development expenses",
        "label": "Accrued External Research And Development Expenses, Current",
        "documentation": "Represents information pertaining to accrued external research and development expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total property and equipment",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r80",
      "r344"
     ]
    },
    "edit_CollaborationAndProfitSharingAgreements": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "CollaborationAndProfitSharingAgreements",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration and Profit-Sharing Agreements",
        "label": "Collaboration And Profit-Sharing Agreements",
        "documentation": "No definition available."
       }
      }
     },
     "auth_ref": []
    },
    "edit_SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "SalesAgreementAmountOfAggregateSaleProceedsOfCommonStockAgreedToBeIssued",
     "crdr": "credit",
     "presentation": [
      "http://www.editasmedicine.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales agreement amount of aggregate sale proceeds of common stock agreed to be issued",
        "label": "Sales Agreement, Amount Of Aggregate Sale Proceeds Of Common Stock Agreed To Be Issued",
        "documentation": "Represents the amount of proceeds from common stock agreed to be issued or sold under the agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.editasmedicine.com/role/AccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/AccruedExpensesDetails",
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of cash and non-cash activities:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Balance, beginning of period",
        "periodEndLabel": "Balance, end of period",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r39",
      "r40",
      "r56",
      "r369",
      "r385",
      "r406",
      "r407",
      "r427",
      "r438",
      "r529",
      "r540",
      "r548",
      "r557"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "edit_LindaCBurklyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "LindaCBurklyMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Linda C. Burkly [Member]",
        "documentation": "Linda C. Burkly"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r334",
      "r344",
      "r427"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_InvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income, net",
        "label": "Investment Income, Net",
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r48"
     ]
    },
    "edit_ReceivablesNetCurrentRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "ReceivablesNetCurrentRollForward",
     "presentation": [
      "http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables, Net, Current [Roll Forward]",
        "label": "Receivables, Net, Current [Roll Forward]",
        "documentation": "Receivables, Net, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional service expenses",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "edit_IntellectualPropertyAndPatentRelatedFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "IntellectualPropertyAndPatentRelatedFees",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intellectual property and patent related fees",
        "label": "Intellectual Property And Patent Related Fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for fees associated with intellectual property rights."
       }
      }
     },
     "auth_ref": []
    },
    "edit_ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "ScheduleOfAccountsReceivableAndContractLiabilitiesTableTextBlockTableTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts Receivable and Contract Liabilities",
        "label": "Schedule Of Accounts Receivable And Contract Liabilities Table Text Block [Table Text Block]",
        "documentation": "Tabular disclosure of account receivable and contract liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r454",
      "r462",
      "r472",
      "r489",
      "r497",
      "r501",
      "r509"
     ]
    },
    "edit_AccountsReceivableDeductions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "AccountsReceivableDeductions",
     "crdr": "debit",
     "presentation": [
      "http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable, Deductions",
        "label": "Accounts Receivable, Deductions",
        "documentation": "Represents the amount of deductions to accounts receivable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets Measured at Fair Value on a Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r445",
      "r456",
      "r466",
      "r491"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/AccruedExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "edit_AtMarketOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "AtMarketOfferingMember",
     "presentation": [
      "http://www.editasmedicine.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At The Market Offering",
        "label": "At The Market Offering",
        "documentation": "Represents information pertaining to at market offering."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash Equivalents and Marketable Securities",
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://www.editasmedicine.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "documentation": "Different names of stock transactions and the different attributes of each transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Period for recognition",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "edit_FollowOn2023JuneOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "FollowOn2023JuneOfferingMember",
     "presentation": [
      "http://www.editasmedicine.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "June 2023 Offering",
        "label": "June 2023 Offering",
        "documentation": "June 2023 offering sale of stock after the initial public offering to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "edit_LicenseAndServiceAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.editasmedicine.com/20230930",
     "localname": "LicenseAndServiceAgreementMember",
     "presentation": [
      "http://www.editasmedicine.com/role/CommitmentsandContingenciesLeaseAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License and Service Agreement",
        "label": "License and Service Agreement [Member]",
        "documentation": "License and service agreement and related manufacturing lease space."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities:",
        "label": "Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue, current",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r209",
      "r212"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share, basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r118",
      "r120",
      "r122",
      "r123",
      "r124",
      "r128",
      "r274",
      "r275",
      "r333",
      "r348",
      "r415"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue, net of current portion",
        "label": "Contract with Customer, Liability, Noncurrent",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r209",
      "r212"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r454",
      "r462",
      "r472",
      "r489",
      "r497",
      "r501",
      "r509"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Deferred revenue, balance at beginning of period",
        "periodEndLabel": "Deferred revenue, balance at end of period",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r209",
      "r212"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.editasmedicine.com/role/NetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r26"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r278",
      "r302",
      "r303",
      "r304",
      "r419",
      "r420",
      "r422",
      "r423",
      "r424"
     ]
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails",
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r203",
      "r206",
      "r272",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r346",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r536",
      "r537",
      "r538",
      "r539"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "us-gaap_ProceedsFromSaleOfMachineryAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfMachineryAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the sale of equipment",
        "label": "Proceeds from Sale of Machinery and Equipment",
        "documentation": "The cash inflow from sale of machinery and equipment."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, $0.0001 par value per share: 5,000,000 shares authorized; no shares issued or outstanding",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r338",
      "r427"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.editasmedicine.com/role/NetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anti-dilutive common stock equivalent shares (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, net of current portion",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r282"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r452",
      "r463",
      "r473",
      "r498"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r189",
      "r390"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r390"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r453",
      "r464",
      "r474",
      "r499"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r290"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.editasmedicine.com/role/CashEquivalentsandMarketableSecuritiesDetails",
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r183",
      "r184",
      "r185",
      "r203",
      "r206",
      "r272",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r346",
      "r418",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r536",
      "r537",
      "r538",
      "r539"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.editasmedicine.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r61",
      "r341",
      "r352",
      "r354",
      "r357",
      "r368",
      "r427"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options Additional Disclosures",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/AccruedExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Expenses",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.editasmedicine.com/role/PropertyandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r221"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.editasmedicine.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r282"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r427"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r78",
      "r101",
      "r174",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r263",
      "r264",
      "r265",
      "r283",
      "r427",
      "r543",
      "r550",
      "r551"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration and other research and development revenues",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r132",
      "r133",
      "r136",
      "r137",
      "r141",
      "r142",
      "r143",
      "r210",
      "r211",
      "r330"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://www.editasmedicine.com/role/CollaborationandProfitSharingAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration and Profit-Sharing Agreements",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r74"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r479"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, aggregate intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net amortization of premiums and discounts on marketable securities",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.editasmedicine.com/role/NetLossperShareDetails",
      "http://www.editasmedicine.com/role/StockbasedCompensationRestrictedStockandStockOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options",
        "verboseLabel": "Outstanding stock options",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r451",
      "r462",
      "r472",
      "r497"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.editasmedicine.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r447",
      "r458",
      "r468",
      "r493"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.editasmedicine.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Subparagraph": "(c)",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-12A"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//808/tableOfContent"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r515": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r516": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r517": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r518": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r519": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r520": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r521": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r522": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r523": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r526": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r527": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r528": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r529": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r531": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r532": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r533": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r534": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r536": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r537": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r538": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r539": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r540": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r541": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r542": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r543": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r544": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r545": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r547": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r549": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r550": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r551": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r552": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r557": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r558": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>69
<FILENAME>0001650664-23-000017-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001650664-23-000017-xbrl.zip
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MXAT!NO)]_/ 3"Z,AR/(UCRU*S@N/>+^X^JWX- 7 YX*8U"X4NZ"8U*H3DY:
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M!P&4.0'YXV1)DJ(>8FE11)**N#&.&O)4!>0'@4A!W$C">9""4 JD0'0I;O!
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MQHYUC@GK;BB$L=]8R&)W  B[]H=!&"1I#'>]L-,^R83S1S0(9\<ZRX3U9S0
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M]*-K6%CWXJ$;N_LJ>7T&>QUB5N://N,^;=2FYF)R[]1?I+Z;2+U@ 'J8.QC
M14S80/7L'^, E3/0R;HLOP&>.=7/='0Q9UD*N98VI]Q-D(2:&U[&+ 7)'^.
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M=&2V.J:L&J9 ='1&^NOWF(W<P)?8SQ&&&K->$1%/\O86/'FDT^XH;',(WV8
M!@.0I]!?<Z#NR#)6JV/)IF4(I(F09GM8T5L#5=FMCBWK^MZ"6%#]5G7$EL1/
M4>H.JA"Z9:)3I\D[6R3R7ES2;G5TLRU;BEZ1PE(83PW2BL^8]K;([;UHST':
MLV3;W/OD/Q3MG4' NW(/\!DSSP[NX6]1Z.W$38;2ZCC 3,[>$<:R>&N0CGW&
MM+B#:WEW6E2!%G59:0XMGE06VR;72#2"U;QREPAFO8PP95Z60I:2YWEG9T@&
MT^\#-TS!:KV=@/4;*\TS6JNCJK)I.@)Y#LD#?6@W2'7TI ,]F;)IB41/9Z _
M/^#O%U'O8IPP\C7O)U[SF2/A\Q?F)HQ#]K[W>\*XU5F6'PRP-E79T2V!'(+D
M9CZL?*V4H,Q6Q]!ERV@+1%!GH,<^L"2- P]+![U))G<6X0,47%3G<#YM1MDF
M>6?AE]VM0 M#X;8I4BB<%-H#"]PJZ,A&.M+,JB(4 BFR#8KDK1>H]3K<1(-$
M\<* TML_&8%0*%A95@*T00(HAFR9564_-\6Y3?Q%_+5#0+8L?SG 7ZHAZYK:
M%/XZ*4-G?=GYE[OK7^^^W#W=W3Y*U]\^28]/]S?_^9?[+Y]N'Q[SH:[2[5]_
MOWOZGXI*TW7 A1^-,?0K<&UZT56>@:]Q4IP^"-QN,. Q.ZI0/Z7BD)'[NJXR
MA"IN3_-LWZ8[YV3Q/:.*W;*N3*7541794/<^ZL5SRQ!?G"9?;--Y*^$+S%F1
M3:'8XHP*=P"'\9C-"G<H9KK[(8& _#)3"7?D!ZW5T159LT4*;U&\]."2M1IB
MTGGP77-$"KZ?D4'QB?48X,V78O;"PC&3)X4Y%"#=M4D4W(R/^5N0]F_&"6R)
MQ1,V>=V128Q6IRUK^_O@Q%/,B:R*-E6J@:Q,\<CJC!3;:<J1-,"<HWE?'>FX
ME>0%[LL?%AI^EK-W>@'IN>(25*F\P'T)RN:9_$K[5%LK-2-AQ5L-CE#]>1W2
M>'_K$-,[J :=Z&\WX;T__3FMCJ7(JKIW=A'5H1]";^8UBSBL:2+B1U&<S>XE
M?;I*?7KGC%T+YYD;LJ.2[_B$B6HWG7IWHE);'5V3VT+U"3NI-+2BON,*I>]9
M^/SV<27OSBX:5VHLZP0G#A!I5>%.WIVT= %)Z_PJ<BKR))^Q85G<L5&60PR<
M8V'(:KLJ#5@8ET:%ZO$94UYQET99RC.Q[0>6I5,IASBD\9A&WA_]: " 3":E
M&]B"*7V5:*S@T2LWYB;<YH^XP/NOK.IG7!?N8I[;7 D2CBS]ZUNRY3N+'W%X
M[YLRYN[;YS4]E[.W<.K\[L;W,9^D[?/)3;.GYB)&F8H8ZVU9MVD]>EWKL5L=
M/A=X5>*M?""-W%AZP>?-AAY?21MWPZ\G^VV$KSJY'J?]* 82\(L)]-GNVF]
M>_WZRB%^W_5A[: ,T,?_%T! MF3)G;[O0UGP[[*]^W&:I&Z(O+VXOU[PD_D7
M_V1QM+HU6RD-^EU(XRY)QLM@?W-9ZD&6M1O(M(-0:VF0@<4:1MNILSC]!GP%
M4A1+T0Q.BX/3R6-<?K3$'*;7S ]<@^*IXFN#R<55*^V#0/YA"CH<UG#:CX1,
M$4GHT.:1<-KP330<1F&MJG#VBI)ZIUV3'KS;8@ZM!)< Z9X:IEU> RX!XGT7
M!^JOZAQ6 2Z]NXVJW-;MM:M7@5=6MTZ9V[XP4(+;JFQ9;=E>4U6T"G9L$U@W
MB>\!Y^KUYHK@C+&>MMPV;%E?D]"Z33_FS1EG4)'<5'IDHY0-NRS.CE1=D25-
MT71^ZR?FS5]2^25-EN")(P8O>&&#USV4[+,("6Z--D_)(E>/EM6@-M8A"139
MHZ#QH8/&6RD$%.53C?T*7DYT#2M&:+L#"0?F702AY+FC('4'E/VX:\7\%*3?
M :)WX4T&SSDV*!F#:X-AH,JF;:P],LD9<3*$M:UZOG+"PLHBV3 TV5!.=:ZE
MZ/+7\\;#\0 M\LE<X6@XBEF?A0FHI](@2LZLZ_B[O41Q LN'W]8TGIB F;>0
MOID'\ET(,&=? -+?6'K?>W)_EN6C-N<C<U4X_T(*[BF0V8I@/@Z9X8!+V5KC
MDCL*F9V3ECPGI7W6"[Q@MTXGC=5B:A'*#RQUX4W^K1N' (YD#LJ?,B"79! '
M>Q'*F@KZC+WJPRO.)*0C"TQ=165Q]=2E(G4I=EM6]7U$L*"*<C.2U),=,A^I
M&GH/;\9\JNDM!W19ML'&?Y8B&];>O@LJQS]% MSB]=B? /6, *WVN=7C-TBN
MSQ4?\<A="3E?L. @V^.Z=O\T]*0J^)R,3"I>R74=^OM+**.F>405X+09 XN(
MN8FY:RB6JX2YS9J&(1V1N;E^\C[%[OB3Q)FY-,^A&S\'8?9Z;9&?/ :(B*LF
M$54IIFGTF>1Z&%]QPU?,'@JC%-6-&#X.I0!6]ASS.'C,^U&D<#L0CH_]XU&8
MA1R.W ?8"T(W] )NC\('.%$]N5Q,))J#1[X(PX15CJ*$Q_"N8C9P,0'IPX_
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MHUWJJZGM31 ,YQ"&_QO_@_D7+JS*?6:PT>$0J(6[2!(I&J=)ZH:XG0+^DHJ
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M8$55/X(8<(01 V<0+* )463QDU^&L$18(BP1EO;0G XQ(4I3E%;'4&3-6>U
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M.*UYG%:*T6KO!PZLW#$L4S;6--X746T\@Q!X^6;@!=S4>TB-YG#0!@=='?W
MRWGP@(\[ANS4/\6IJ5&44R+/O:*IA%F!,5OJZ*Z^&^[JX8W):;7/\2#*.S[E
MD4PAS!)FFX794FD6!S@LK,8<%B>5?E%7:_23K \XJ&E71X-TRVYU]+:LJZNC
M0ZDT16C2HP(BPA)AB;!$6"(LB82E YD1%3=CMZIKQEXAP9U!]&CG9NPG6>M
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MPH=N_!R$V>NU11[R&  _KIHL5*4073SUF>1Z6&7IAJ_8S26,4GBZ&\/'H13
MRIYC=R"-W#C%1B\IW [$XF,9)@JPD,/1Q<8OO2!T0R^ FY,4/N")\Y=3-"[#
M(U^$8<(J1U'"T^*O8C9PT^"%??@1^&D?ML I=^Y;.7J5V5?<+JQ@G&[^BBB
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M8-18NBMG!=5$>-NL()O//SRI@J<3)ZLZJ:HJ(\C6,J6L?:KQ(-41W IZBG#
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M+XU_?1*<=W]3X?-P7@^]=+O;J@GG'<A'/PKL@@UM-GN:5=/H_ 0$JK=2>HK
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MW*;WR/0>[7W5U'F<JZ95<5FZ4E)^ [D-57+2052)QG!X+.U%!Y+6L];SZ_+
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MOEJI\*8A4/1FH61&=4;B8D"XJ2T,!=B=L]M#0=YGS8W4/<P$MIB*&VRZHLW
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MG(F4-P@?A$*,.>A+,O!6JE;%*?D1$&?B%Q>G)2HR")(EW)AL/2@>KN34KN.
M TJAS6I- .9V[>(]\H*4 4-(I:72KO*94$JLV"&?,V?J**D'I(_Q/_C!>? 5
MX!&C_9.WMD4B,X$P-+HABR@OFY%(^-]PXG.\ACJ^V.JZ;&L=.S\+#T(NO#M
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MOLTS.=Z'-8K7[^S.L1GIDTBM($JV;W8O7Q!(E"6(KZUQE"%FDUKRV;9>'IY
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ML7L#<S-9\T-JV;V=!ZR;0WKJ,&C8VF'ZECF>^X_G*O;=X*%7 3M4B3UI;'J
MS3WB0,^Z#Q1@G.5[&YCW+!"L1E9:7SYX1O7 #R--O35XIVEW=[:S!R3/<53$
M&^$X3^& R+VUZZAY(QQ&.,Y!."X&SN[S6T] *DX\67G1.M-*E6/#;T2P(P7
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M/W5OP1UT?320L#[WYB86-T 8_-TO3D->-8X*;[)$S'0*C'3#:+>)R\ICPZG
MSY?.EPGGII?PA$MI@///&M8_A>4&2<2KG&1D]O&I>39O$D<S\$,6F,Y+BA.G
M0Y/CC.3\(P\!&D=20[(3\NOOW_C<LEC+'()#XZ-[P-^Y"@(1W[BA[B(!@X!)
M(F<&=G25W63@% %%FPUK&X(#X[C)U*;_I4 :(FNA>*K2):+#Z'1ZC0X_4/+J
MP88XU$$E_.XND$@.$8G<'<X'8@JCQ$3(9T KX%-!25PZIG?1G6 O]QW> (3@
MTO[VVSOK@@*VYAOZF/[MO'EI2_;(]0HQ40K[H5L#_/\>T 8D.V.P\D0$P2:V
M5E+ B\"4234_DR];2!A0'#B8Q$;73MF<<+#;B*2<:Z4+E#"YF:OOOUNJVEKM
M:3O.NZT>D_-4IQQ&:2V39FQ8@&DV'3+S#!Z#3O^3$D%,+:02SAWW+W[Z"9F]
M7?45L1M0TA(0O?@R$ ,U'"(_0PP6A4(SF+GZ+K1V65DOR;JNMOD)2U_7Y@OD
M/P5C\AF^[XXX1:76 ZX ?)7#OTU+4\CLH!V0()@!A9\3S#SE]-V9= MB'%(S
M%W3.(,I1J/^,5YUB]$SA<7$5A?'X308Q9!0O<M]"Q! R!]HM%7YB0RQM)9D'
M!X(OR\!2Q:E+2@=>!0$P*K![U0&91CQ].7H#CQE7O,]9^ RM'X7@3"40K?H3
MH"A\@=RC%*WD/,)P O>2C_5@SQS7B&8=3F?KRYS:I*#>H3Q\#**[HQOV4#4H
M 4S0K3^F:05@IF9\VFBIXC%Q/'(";GB"&]YO1L+2N(.3G&+0=QK#]OJ/SP=K
MO[T+UK[!U=^,J_]0,ITHLK>!1#\()/HYM*=^@D",[-=%QG<!+Y7%&Y<*+O;H
M_CH8A^W=7O8HBSP'))+/<X%^+;KFN9/]D$K2$ZT7/Z**[PNG.;2'[<$Q0T 8
MCCLNCFMW[6;_>4!'SL%T7].]_68E?>J=UKV>W>T[IA>^MB?D=!R[.WQ&1(ES
M<-<^^J$;>@?0!,?;[N0X?;O;.B'<YM,\IE[O&8_H')P"C.<O5&7KRU)36?5M
ME2UK0I(T]CV\E, O[#E-PW06/P&!ZBW@%]V!/1SL/6;G"-J*#S-,RHC*V8M*
MWW8&>T*B/[^T[-1F79NK:;2.=#W]=TYV6T6B\VK5<SZB6^LLH9H!,NY8\Q $
M%NS,C\:);%JC;F'5P4"%77ASC46+091@VYX[_E=&70!XA1U&X24]RYO"GF5'
M@$=CBA-R):+9/ JI( +>>A?%/[@<ANJ+#U;[\^1W(/(*Q(HJTM]4X;C2F3W4
M>DEVN?M799/%F7A1F/AT %AEE2^@Z.:>ND6;;]&_H6H0\GI.4 ]1C&Y=2L4,
M7B8;Q6]B[A0G-@$:H&3+2J4PF\ ^LWAIPT (U3\.O\''?7A__?VRW73X>>Z,
M?4?Y)?QU7G\J-P![.B-N:'>U>ND=N*'U<&Y %IC'HG2PQ7_DR[;AL$9Y#9A6
M#X9]XWR:15]0DKJ325ZPK<,)W,(BHRQYT''7UR84>=7CM0DK3.Q7)(NKF+C7
M:_3VU&@%]VJ,.<] *5%3/S#R^B+NEC/4F_"J.NAP(7D],)<F4]-VJCUG_0N<
MKK:Q]4QZ?DUL[3(M]/\U_6@GVX]6.SVE%9ULK:N<CK.?LFJM4U8E];*M:FEW
M._?I+K:@I(NQ<</[(_-CL4D=-C5UR#@ONAXM(<!@+H]A>V@Q!0K!]C@P];/%
M7S1V*&XW3L >ZWP^J;BVJ>1SIZ]A2QS"*)?X''W'O/&P:-/#.$%O]" K6FH)
MK&73RH'[%)^S+X@=\ORP\BX^.C5LPZ)VO.5S*AIR<E@+_D"I$&L>N!0&ZH 8
MQQNF[2-1S49_+[MQCSCM=$+42;3IA$BY_\1F%ZGVHSF%6+3BY3ZL.L==U>6V
M'X$,>%)?!5G#&3LRQ\6$_V2X/2^5?6$%\E[IXBT*0^$5_;7<%703E?E4>@Y>
M%K@QHHP@#%J>N"$.S0-Z':L/^$*E9=[44R,G'G5 9_%2JLESY]QV)CNXD'ZD
MEN'OGI\N;"1BD(W5=SW",:!NKGA\B<1::$\4,5 0)6,S-9YJTY,L)FOBCF]9
M!^@Y.ID^2_)V/3UULPZ(,1'B!W$6,KT_6>1MB?";ZB=K7X"_HT'$!MZQ/T8D
MES<*"E*4WIXJSUM/(*4Q.+12[W#_W\KCD%F+E<&/Y3;>P!'Y(3;BV?)\<ZN6
M*KFI1C?$3-,D A6M\T$L_-DHB_.T)^>OHI@7EPN@IIQ3 LVI>@'ET'#9X66>
M!D.]C4V$Q8/?6%/TU35:*K+8UA_P/&1*;!2,HT"F0SV?R.![F()/4/:#-RJU
M1EH[J0+^*9*,20'WX''3=L/2NE"!'!-<=C2B]D8.(NB':.-N88'43ATN5D^I
MV'+%27&#.6LS5F#8_K_4M\BME_Z_ES#_RL:07DKMZ':Q/+LL_4RK,>+:(BJ1
M[*XEK^4G(5K24NDH5I^T\E/L^ RCE'Z/ $Z8/94=K8AKH?5J1C&A)XPC^GZQ
M74;<!1+I.XXQ*HN9[VY%F&%;:8#:&!< ;J0?: >A-ZJ63V)<(IW XUT^F8;U
MD17&+(J%#8M G=%J.KV\09W.(Q9CE:6U)AEJ/6L!@I^4CX[[5C.Q[ACWX+\K
MSXNHX9% L1 #(@BL4,CD,Q,@R49)ZG(_JR8N$VGGUQA"N5@2Z"*+;%U/5*]T
M%BK(*H+C4+=,UMU4A+0$3)*C026(*]*8@J HN-WZ+LH"\ T),,OC]8Z!6Q<V
M T "L5%Q!#XC5Y3UM"8=I(YS[0H_D>2O$ J^@#F=#OC"R2&9?% '/-KO]5@,
MR%2"CSLC+PIYA]VEU2L0Z2H0+] ?@>/P1&+-GV2@C.?T \A904,1IQ1;XE:[
MM733& @ >%? <>97?GR+3/]%0" 2TH/OJ[9E!4[H\8G0(8_0H,*WR"85]TK:
M26.<@ZAUN" $4[T,HH@NF4'%I-QH+Y\<!8AE75+;?O)#Z6B) L  >O^4NI3A
M:PD5H-AOB#HQF\D8BUA]YI(1O:5%PIKOXDB9'Y>=";Y<3T -H):Y=6-T2>&D
M.0&8IU=8?GA;ZK(/'P[>(;@(&)*ZDXERAQ13QPJF2][42;PKV@:_#XP?&13\
ME7OK^@&)SNKODR@**2< [(:X4FA(PA3>RNMB9$&&:F!$AQS-06HYI<-UV;*M
M$3B#H('=^))7",2Y1,4K)9GQ'I"P,_1&T/1'Z*3GWAP\(4O)#J/Z9?_!0#P_
M&AHJ@5%Y(%]V'E8J2&-Y]\NN 2)PQ)E,E@%_+NQU\8EMY5[50D4.=CETP&(2
MS*/#/T'<Z(M)FHT7>DPA;_8J(@H51!BF>$RFR(\]+Q-A_)9[$P[DLL<";?J[
M]W3NW]]_?[,]_+PYK8>=EIB['$M-P XHT8-#1'^+;+*<#B#1?*3Y40&Y"O,%
M IMX*J+>,&H _B/VP:4#&:8*0:DUQF(BE(M?\=M+%1QZ@>O/$B/+C\\=MK3@
M]C*RDA:C0D3KPU*4FV?4[_,+M'2V])1PD?E:SJN(,==V32:N'^^4:+'7)XC8
M'N< @/(^HRJU87CB<?VTS/.HL&Y2@36F$,;6G\'YE3%U3!E3#=;RY&5,1KGL
MJ%SNIH)N<!"@L+A<1F, !^&C'5()D(@S\6.55"]=,%&"%2W+*XS?HLUW46LP
M$XT)>;13CI8@/1/,P_K)5"9FV?\OW6GI!Y-@SJ:8_R!SZ?X$D[=N8$S_XYI^
M=?\5%7Z8*AB,8OVR4LX*04<0J_ Y<R>\:0@;N*$K8W-03^*W;[Z4EN$5Q^2R
MFI-$4(2J.HB^(@?Y46"M'3/5-65F4M03GN?FN]"3N=>[ED4 %%WF2,05,2&G
MAD-54:DG@S&7J\IWELM%Z/H&;XTNL9LIXX0$7]]!%&*7+VBXB"Z1%R^I^P,>
M2M<&?+]-M]H\#8-_>"?H B44MZ #\\M[JN,3^!Q,4L'J7=29ZI)&WE[H=]85
MU1-\NS/UX<GEH'NI"F.?"@M?#MFXQ7M\6G^4YB_3H*UE^,=7<MK?91F"M,:(
MYJ^NT\##*BH/>10 <#(0)IH![Q9&0JUOI0!BI"\ +Z3R^R148L51:([ /64!
M>AE"C'=<4<GE*&HUJ22>:5 :8A&-_L63N( 05^JZL/()BI1XKYBO&QZ;D2OC
M C'GJ>[+8/Z#MO"<5\.GHTG^3J4P5*R#\DXL@H)IRRI&'!M1%-AH92)*?@J^
M+A6R\ &+ F0[+$U7H0$8(ZS;*$_?S =+V" 6H[3@$_A#V=&UK=7Y)C*KS>:7
M-$,<8^.S1,O_OEJE="<GQ90<:GD)6S4)1BV3BE^HRQY9DY:JSPK@\2N1]V,:
M!2#>"9I.I__&BNZ DLG4G^>3YXI;];&/Z1I9)$0(^\CPTL=(2I48*#.<7A3R
M<EG2L2CR$T!'01/A:)\KM]44&;+#(A-5^GH;UOL2]5ES*/&TY0+H_EZ;1\"O
M4@O#"TCX.?R9KHC)PXISM!KE<&FA#EH."R?X40&>ZZEC1MYT$UE%1:=:G!52
M'I>C-['K)26L,,9@]>BZ!8B,!>>(SG\R$LSE5LS%-'B@$+)U0>(:V8GB-:+#
M:4NNAZ%*9RGNR 94E<%FP@^!%4'4::PNRH5D,-GDK <XMLJ8J^J\!"\C9WRK
M7<Y!T+HJ7!O.7M"<7M4+32:#Q28O I&V18N)T;9LJE);*H KZ%D(_Y)NT@O:
M<L*,1,EKD95K) NE K9\])(L)^:-EJYM[R]9P^\P*0J:RT=H%5U59%1JD(OM
M2'W<(158A:QY#JP4E,EMY935+6<G=E\\9\/#QO8&3&K&LDKH,P00-RPUQ];A
ML-W@+L8+ 07 GE<10 5RH#N*OF0_X%-_ELWXHV*P"MU) :>@[J6Q7DX!K6$3
MR@AE0WYI:ZT[RNK!0^B]X-#CLJB>*5G[)O&3;0O9*QQLI$+P?%#S:K4A"IL;
M7 JJ/@,C\U/H+6,2((%L)*DCS@<HC8#/#N#;<&)CK3V+:7-TC5?7/+H'/ D(
M"9<J&]M54\ITO EXYRV.5R_&Y<R!4)F[E/"B@^5C*_>,P(8]H35 <80Q7E^R
M6URFWCO[)S\38.F$5#YIRM"3H#@01F"%'(7 63R/5!&JGV*H6T13*OKAW\HZ
M\;4DZW#UW3U$4D-H**$4<77?3-9P++%W,2IMT->:B+&2"P[#:5YB&"=_A&:C
M>A+CLWLD_V0#6!BV]%XJ(58+< 76K<E9RSQHZ@ZMC&SM^]_8PH=WW#&.8 KQ
MV. A1R>$-+.K\)E)OZI,BA\F*?BM^36.(EIU98_RM(L,4#'PJS3F2UU),U2,
MAB/#?XBCA1O \_B_"A=03W46*#-*10I54B;3G_JW-:U:[0W!\N3T,BUZ.,A^
M<U5>,;-LJ19.>D/8W:_*YJI?G.=S"PN@K5OFV-2\L?QM,C&BWK;DT57UG.3;
M263X#:K43?0L4O$-92D+8D2%JT($6%Z3-.+H<*^.?^.X^0<X\=.(B\8I[EK_
M=%2:/T((:$L<C#7.'\E?C>4(]ZK)6W+ 7$Y"VYJS4DN$L+Z BK6N;34:\AHT
MON4TK%]E:HE"Z=8;Y)UWY9LOW,)O.?-^XPA'C9.T?#Z4JS#,:(XR5JT?G>Y0
MPV/)3+.1]J2SFJ@=ADAPC/A01O$@\Z0<'Y3\?F%W(QP&*^,)2K/(+Y3-=^E;
MF@,%W#2..,WK)@A\I=8!HD-G+R]*-G;GE.<!FD'U17%,UQ3'U& M)S=SOIK;
M6**E=Y:HRF&VD>2XY\&5\J*5%2JT$">+\1I">K[L^$I?D&Y14[J H:8D,DSL
MUJUUY[9,* SJFU @&P:Q[=\P6O)3TE9$W;]1%S+_]WOP?8,HP:2E=36*LM3Z
MG9,M7_UD>XR(.EFJF"X$(@F=)%-'V.&E-QUKT*0J)VZAY;X_Z-,FC\N.PJ7^
M-<Q%#%H%_HX.J3,5 ;7B0F@A%FIMLXS\/LKZV??,+F_WVGJ68P7_479A_;WQ
MK6'=8 07HJ6[Q. , 1JURP+-O9N[<Z':CD' Z-)EZ7*!W69^W8+IBU[=$H']
MI$Q->$"(MN^6P!DX6,=+7KH,X$(%[2#0?$LYAF@3S'2^D_(1+>%>C(3G$IHM
M]2+D?8-E,(@5"/M8J%>BNT I41DP:'^&!=CEL^+4+'VYLED5KX*Y[B9_&JZ(
M(15I+]\1Y2.3PXF7S@F<4Q%Z"]WK;5COLSPGE$S!?:2..1UKC%OI[O@(0/U-
M?'F9NT(1',8^PZM=/!LPP=C7".<QCWQL\Z:36)4(F:-%SYNR[F[>L(AI8.I!
ME!1S?4472L:+BC4<GT:9 C7I2E(YJ*706?FAW%JJA=%$0S8]:)9L_183[\."
M0%&'LS.!KT&;;-) L!8*,_&>/G0E9R'Y_QY21^2WE YMC%%*K"H?1A!AX6WY
MTF4^GV>XT$Y4DVSL= 575'9_>BCVDD=(MN-J [&=W1PZ-;>;G08Y4G$4\.%^
MP6J3,9K)&@ G;5S^![H(4S?<A7U?MY^3N9+\S(!!+E\?VNKZ4$ASX<]SHJ#8
MO9OZ8F)]^$E5=B &GR<3< 198O@S"2.(US'\F6T)IJW@) :K/_AQJ'5>C N"
M>SK!YSG!I7P_9R7)&MU2R[PNI[O)Z,GDS/TDME7^!4@]%A-X)JG)KQE:1J?M
M7CK="_&2?N1TQ_*_BC3;M\*B?U Z[\JC?)HS;'>L"_R27(S^!?G6E]AM!3LN
MKRX'0E)L((%FJ$A03R B,@%[J> ]D2[F @<]IU7D-*F&@^C!#A47)O)#I66(
M*>VD"B7P"CG@FVRP23,LX2]V7MJN3P!U.!AB;*MR._QGDLW0Z_PWO)!3L_AX
MNH,&B9/OI#A+3120Y16%K?KVX9TL3H%7T*'@@W"#Z/#<+T$R)\MOQ*"%+KA=
MKK-;]Z.'4M8](%U=S\MF&8<C"N\GPV)(#81*OBTGE*[;"M\6WP-^>8CZ#>VW
MTF>\>?7W2:[+(M9ELL"!\*82E36C"S.@)'H.X.FJ6A@%APB/D_@;X+Z PXEG
M#+[,& Z7,3&+7&M.QT)6.80H-D&\=1,"&ZGT>;A8*\_@KJ"3@OG'*;R9<M3Y
M>9)T49( F1!KQU02( H)>-&%39*KCH =L<H-<J9<9H;!=2VJ!W.8-6VUJDH4
M@RUJCT8V!-K_*QO?J,LD:1[R;O@H@= +K,/$E]C[2"6LP\)K@"A)J(QKS98;
MUJ\$.B*=:U&RZL;0/ IZZIY^ =*?]-&8&-F6=*>K#"QWL;<]+W+M<Z^"H0M%
M-?]2@%QW5_1=$=Q?<SP4*"^4KY<+4O+5"$C.R;BCX+7$@H\T+"6<%&A"S"5R
M&CD*+1TK<D@(+8^QW*PQ7XMH0$N$N*),/UB6OW&Q &@I)BDJD(^8RW":EW_C
MIU'8IZ$.J7P,ESG'&L<M^'9NP8F>I1_8N^W$S% H[E=ZZ^]7=HBA.R_,I<S)
M7\J\>7JFK5;F7ZZ^?K>NK\&-^_[7#U^MZT\?/W_]_>K[]>=/>R>!^C5/ CD-
MZS=P:0/.E@CT;(\O@_F1)M\0%E\DNRWRZAB">9$E]12<80;R9JFL/R 2S L2
M2%^6&W$8I ?,AD\%$/F<'6KSP<N"U9( BNAC[O(8D74L_)H\$M#?)X=785-6
M_@(L1M-PG67A?E[AB5AV:E-HIJ@2>Q46%QZTR M+*G]#97Z;%BN[W7%MW,U4
MD2B7C1!:PESO6[(U<XD%?W)YJ@NM:#"D:(SKTC&DQNZ2=S(1G:?:JRJ)%/A2
M$35B+4]18,2-3T77O5:/KU7+()D@LOT7]]KP3=5DF;G4O8?^1;II]24H%,0Q
MA$J(_O \HQLW+-W1RM\W5>]P#(CE9.MJ=JX:='5I?63T0%FX\Y40'K\6%X 8
MBU[KQ/HBB:55[B I2I4[NB_UWWFO+I5'\@" ]Q D:M&.(X< Z/FBT@-5P@C6
M3!L-\D0B(3#96\HC\J;,Y>>LYL_F+K,:SEU3=V03!M_**R+3-.#P5L) @3J#
M7\LHLQ2K2VA(6\ME28#&O2\!P-^HNP%8XJ;M)^341?M?:\*$LX6P;V/*":Q[
M@P6)&RTKD5F_8ET>\,Q8L?,WR@42&,BRV%'^%:\:MA33=?5R2F\A;#B),5\D
M,Z+I2E1R,,W*)2;TQE)=)//^&LA8NV)9!*Q? =M:++)R/:Q?JY8O+]*!5%D<
M;OE"RLG&KD0&\SD#1LT,&F:4-AW$NM( 6FBO5-^> \%R$:;LF(WSB\7B"V.P
M&S*+ZL]R0T@8MEA+"&^>E:CP "W2KKD6Z8+/3$RC"6,-4C=KQZ]4:Y+W?BQ0
M5HF_5.;KNV2I*ZUO[]A4Y!5-CI V3R7>P48N95MY]S(W+)/HUL7J!9/E]-Q+
MYV)RR NEEUQ:HQ>FJ+Y %\&N:57VJC=FKULWRJ$(;UPN^ "E$U[*R@U0$K#U
MW)L&8X'S$61_M30%>>6))[/\>D\.I3W+B\M=%]7TJ]4A%3XI_A9HGDP6V"]%
M[\;&8')7M3)PZGHL/Q_+2U3N2F%4R99F=-*D4S.1B*9:PS)=?U"2"A->QQ?;
M?=</2WJLVOF,%NO.WXW%\EW7S!T3,[@$T4#Q33YSP8=H@'A969 (=$9>TB4?
ME!3Q4(F)1I6/E1"SF!^A*JB)&%/EE[;\P+V3SP2S//5'?IHOX([*<A %A(:1
M%QZKM#-A%$H4%BV::$CY;(ZZE\ZZR[F\<PI]:2 7_?96Y'XSK8=G#B3KJ$M3
M383L92X38_60D#;H:DO =8A^;R-_3)?'\##T Z@L4P[?(4$IB>A>E#@V1O^S
M__,U[.13-H/?>Y1KAH5]Q4R<=^GT>R^LT)W!>H0W?OU[&@??L1W[\^1[/ ;+
M]!V^^FL 7LT+<BDFE]U!_X4E$L^=8U(XS@18MR*Q_D?N%*])L<?2+;UG47U]
M4;R2ZW#\"?Y4K&/PXNUO0%W7>H>])O$/K!3[,FV\AP,J/5Q>3NWUQN_HL!>O
M'.*]#-YC?2OF#DESOOK2I<[,7=Z/LH:BYL JKL;1' +OCX%[\\)B+@37[F?Z
M>N+_%.-+.@*UP"$$A9J<+J\I5P$:5("\@>>J.PK$8;4T:VE"<]& 7Z5Q%6!'
M?"[:# +@\DLZ6UVB5"3"ECWQ8G^DVW9:TX7W\L)Y>>'[+R_>O[QHOURC2UYB
M$ &K*K]+6[=2H#1PD$F$$=CNITSTA<6_!ZDO".F\>/M?&;!Q6UVZ+I^NNL<F
M( 5&R* Q[CQS$&^W+R3=OG[[>U)4MRA,2#5U%_8XTB^KYVZ2H&NAAH HV,?5
M]C2]7><F@LC 9D !?A;U!:08/O(U*NVFU5&EV!3HA!"[PN(*Z 4P-^H1J]DI
MRN7QQ,\+]@%HQD4ZC4"U\V%P#8T?2T@':=SD?!GEE*C0B7) &YR5BAE&M]K
MM"(!HWA%Y^IR$R\2+TLC5.!>C@RS/H*3(=D2O@+:8IPR2=<2X$:Y."ZKR (1
M(I6L2V*=![0E"Q6J<1\%6I;NK^'B"H->30V](D\-P)0>-VUG#,+)+^6P$B=$
MT?-9,-5W[WT/%XR%&0WB+&C$])#IX03/4$GM$MG]Y5AW+&0C"5_!<[\;/YZ>
M1U-<2@*P#,FHSCP/XMD#X^WYZ*NF4S7>N0C/5XY4>5<^@[-K!Z?Z*HO.2=EW
MR? <>*1%/$_R4B1H5RBP8GR.S5OXA+VY*X%;%!<>VD85N]:,?8]G8;K6BDU
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M],&VKC^]:U25R"UY!DZ7F?90@>>^7WVDTLUG"VVQC7#\VOH$T:T6A):A6[5
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M*S ,9YI:Y1'2F_,B<KW%X@Z)S0UW:I?2; .U53)SXW%P'%-)FM)?YE,$%6*
M4"@'%CKYPJ*UJOF&$UN>QW=_*9^366=G2)R9U U7-DA;C+/9EWKN73W+C&D-
M==]@X%8FZ5@0B*VW.+H3U%XE+TUX<M6'M+5+JVF(.4XFF.:+,%DO7*D+" C@
M='X.] 76U<B2,Q\%N<R0J&CCR4$0=5M5Z71,WFE7U%VNY%Y/W*L\I"D?AE-\
M&TY\=LAS[*9A<NL&S!=.$),D+@4\I7D=HJ0P&Q1+D&T41:+,[.JQO3?PXR%/
MWZO\HSU7!C=(XW.\;]0 )<^<NZ*A,%56A_"ZNMNS*I1AZV2=QM91]G9$^]3<
M.4S0:6B1UL<BD]LKV/>DF3"IKFZ-*2D,7&C*G55%4MOAO2+!'>,$QW+DNO40
MR^V(]NK\]T%8TM BCU#<K.-EN+!_PA3G.Q0Y=]RQ7;%S'^B-BIX;-S&INT%'
MAU'67?=UP 1*.$OOOR#Z1*EYCC9Q-4!GYXUX&K0B;K[W/[KEH2M&>V4I')+'
MJVOZI2(*8X:2A56".]:^RKL=T3X5/<UXLJ$9L9516H:@Q<EBF65?[/J@GR>K
MM=73?'%Y]<T; 4E3ZO[L&BQ%2U!><HC2<<!D=0R,,PS-1W(;8=^KT]X&8]]7
ML?260?#\\_HEAAY_^>'_ 5!+ P04    " !W@&-7'%)A"&8F  !_MP$ %0
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M:8"9Z+1CS]EAX 4P'<E[%<6#]WUS'2TA..XA9V:S%5SEW#J870KF@3^-##5
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M&R$17%:CM+/_N5',>RZXY&^5;_^%KW2SUPT%?^B6RAJD;[.U:L0'?TCY0:/
MU=;:.7^H8F&3I87=:)NM[M[?>-.E!4W_YDNOF:$)VB5/*O<39^_7R@%^5U=N
MJ9RM!T>D55C89U[>BH]9+GA:JBCN112ZE 6<08Y4@?> >-)TBN3_7)^X# GL
M.4;) BZ6:&X4^#<I\^9DH55T9,_"JLN.7!"I>_$HZC'GI&,S,I?6EEFM#*BU
M ;4Z5YL(D*OCT)!-".[G^DRHI9C-W/&6,+:65_Y2>2;..6\)ON-\]+8:'L;4
M'?X:-\)1HEQDB1OZZO30A\219!Q%84))B$)/$!,*_GX<9(T+9WB]^XO=8-^%
M_VLRO]=D#J^Y>+K,75PC^K8VFZUZ\XOSV[PJHL&J[->2KBJN6L04(\2B"")$
MY/^\!$&<^"[TI*$6!DF0\,3(JZ[7[=R88RMU$^?QC'/P4J4)5V88RY9+G!>J
M EQMDAE:9)ICH>OSLHWPZ#ZP!MRO-;A29ODI@UKJ339V*7=M:-ETC)D 9<U1
MIM7IQ(XS$R".'6E&;]M@J[H,L">BT/&C&(:NPR$2B$)"/ HC1,(8!3P@83*<
MFF995OF(A_Z'\V?'<=P6'VTYZ"\@N)*_4_]M]HD K\O'+$__B[-_ JNL^6E:
M[VKDC,O695'BE;KJ>PF!Z51IM@3ZU-14"7BUV0B.145]A9HOYYT)RS9KJ-C-
M*-])V>:#+)S'E:>_2"-!;O!4JPL_PBQV/00ICJG*F9G )/0]&+)$E3=,2.")
M2:ZHCZ/?W&CS*!_PR;KK&C;&=_%Q:7KGYB7UC$C_36H :WZBH]2?G.>7\-97
M_T?2[OM('##NT+Y!@>)!8@XS-K9-UH&/UZMV@-(O'*O28^QV]46EE%.N8?F
M%#-O_BF53.O2> O.HI#&7@)QB'V(?)?")& $AB@(<1@)ZD:^B9E@3;*Y+? [
MAE3',!MQJPQ2;?DW=W,-(R#M#:?>POPF@S3RDFII?(R7-NM86EJ4[,DUZ7)B
M'<[#A<!^!V^3E*QUD"=%_/#M.<VK%HJ;57T0>+ <;?+F\+L\I7P1QTD0!XF
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M5('+$A91!SM(R[?9T<?<;-1&3+"5$]2"ZF?&/H=F-^5;PFAD=C:'QRA==@\
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MHDR?JEW_+[Q\S,QK!.NT-3=#>G/@+6'E$C-P__4+V,D.:N'UK6DM-/M-:]M
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MA-YN)-\ZX^MP!;Z/W*\7#Y"U++"72S)L0:U#%;\VI56;V;,0#">A*F_J>U1
M)#P!8^*[,"1>D$2".6&"3%:],_W,;6G:Q-ENY=3A$R-<]=8."VB-3/!#@#(F
MWAX8++'CN5XFI; >50]YIN_Q@=:UVEG7517>KU76@OI>1%UMX3/_H_I5L8A8
MB#SB!-#C1)V_Q-(BID$$79\X@CA^F#C4[/Q%K^/YG<,HN?!*%142*NYW6U,%
MJ $&SVNR3*G\G>!Y9;RL>%D]EA9%;=JL5W)P_E#NI]4#8')GI2))BRI]1/.6
M?$'NJ"XH=: WIK$G=S,<$Q@Y7.YR!..0>!&&H4BBR$>!'S"MZM;CC>BT6?+V
M1O/2RCB:8Z"YK[".[-A[@0K#6F)0B[RY2+BKHB/EKI^PF$W.#"A;IK9>I].:
MQT9 ')FT9F\/3PKN>N0^+9=\$3@H=!D3,$BX Q&69F><> @*WY'$1#P:^%K^
M[U.-SXUQ*J$4X;C>#^3'YL3HU3P;^!:];A:Y%).1N<(4CD%IP _UOB@%^+:Q
MR=-_'ZIQ*O7WT3/F\<HWJR*53][G["Z3YDS*B[L\HP,*U_<V-+>YN1$8W.>X
M2NO2B-VD]Z*<K57A/..2]OV0=D]BZVB.OEDT M)JV7MMG :%0O>W/EE(M+:B
M[=!H_9<&7H*OZP(?5 ,^E>B>NH2Z'A<P8L*7F\H$0Y+X A)$DD"X3AB997'1
M[GENK//NH";Z7\P+GNLAKK?=& 7'D?FF@E!QRW$M\Y&K#QBC9;$XN5Z_DQ<B
M-X+C5-%QLP;,#9SKAX?R0UZE5:UO5+[G<IX_I2MN7F!<IZVY$8Z4.:^J=@(I
M>;;B*BO\WIF=NO0L50$[7?1-'2UP^ZT=V[B.3$ #(!VA_+@):(.L'ZT.)C.
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MYN+4HN WI5M]!F&:RN[R =8[()IVV,8VOZ<9L>GRMQZ!_-;95W<"?1^Y4X\
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M:0X0C1!(*%_K@!1\-RL%W Q-,K?-V\KI-8)Z0E+O3N1Z<UG53>N+D([;US:
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ME4Y_KP6@ZSY//0F!BZN52=;,^KV,6ZG?Z%)GDJ6X?",TS?0V[:1%B(LB3&D
MLIR)^Z0X!07!W,!)_9"2*"_"2"M \/PT<W-E9)@20))6<)]^VK9P-CXF5W'_
M3*GZ[/WU9[Y+9?[U"':6*'821IP#@>GQC>EA1=-;=B4+?OZSK'^\VV[JZHFN
MNZYR!V&K*0ZA+XI-QH6?@IB):!F<48"3/,T8#L( *H7,:,TZ-_+HY/;^*D40
M?2OYS:Y!HG)$ZQ4+,7*:X@I>QU0S!V2UNGC;1WBB-MZC2%OKYZT'T4A#;\7!
MINSHK:??44MOS9?-RUU6361V&VV7%3EG<9B# H:B#GS$ (Q""$*$$8T#%@5Y
MKEOJ\F"&^5&V$+!)/]"ORG@(GII9=Q4DSFEVCX:C2HQG5;=8A?%P_,DK,)Y5
M[USUQ?,/ZM\G[6\;Y'6RXGW2X5MSVY1[Z11K7IT!8OQ6R1P#Q[NP=X%DZ^;[
MLKY&-TA'0TUV@W1>A?X-TH4G] -MW_$O[>V:PG<5H0M(8Y(5209\BG,0YS$"
M!6((!*C(49(R"JF2=W,\\-PVGI#-$\)Y0CKU -H#L(9WWC40N/[ZJ6FO%1A[
M3E6C6-B#@28+?STG?C_B]>S?FU8QN"6$+^?FH=K4</G_E<_RMRGQ_1P%%((L
M"A(09Z)P&PH+$"=I3'.^\PA3JA Y/,W<-F*;E]^*>N,UPGI<6LV=.8#L^#ZU
M@Y?C76L*E4$-@R$DKBAA<';8B2L8#*EV6L!@\&DS7_0X_&H?QYUP @B+( 59
MG%$0!WD("A^&(,FP2&S)_4"O4L'%F>9& I]I[7VJ-LU=MA15ST.]#*F:IVH%
M*->[OY51!,HW&#GJYCX*AB4?]O(\D_JRH^H>^[3C+QC7-:F>Z*X\QR>Q4&6U
M>E\]P7*U0 5A$4D98)"$W"; *2A2'(,D3'P8^"@/&-&L8G)YMKGQ0R.LMR]=
MTHGK?6L$U@QS'X9:C3.L >C<QS;&SJ3<R#@F]HJ+#,PU=2F1<;7/% Y1>.G:
MO-G_3>&ZS9J-(&64)D#TQ ,Q9 3D4<1 %K)8)/MG>5289<WNYI@;;1QG@PI!
MK\N8W<,Y[E-8 ,DQ-1C@<T6N[ D"%C)E]V.^49[LB5*7LV1/'S6S$SYQ?X32
M>VXJ<\)8??\DJ@X]TO73/>LNTQ8)PP6*TQ@4!(4B$!>!//<+(+R+# >$Y3#1
M,1;&IYS;UI<B>GRF)SW+0 %<-?/ +F2.B: 15L23MN)Z4MX;3T@LPHX[F>V9
M"NKX6+(7%":<U&A0!^#8<M!XTS!.LF+U7]RSN5V1[L?WHHAK)8O)OZLV]:;K
M<XBH'XHV-AE-$(ASEH,\]G,0Q2DB>1B&--8J^JX\\]SXII-6,VI2&6@UTG$"
MGV/NZ02536QV_]$3VY-RNZ@,I(N6K7!+Y7FGC<#4A>,D*%-[ ,N];S[3>H%@
M&A,6Q,#/& 5QD?J@"&G$:2E/$*4L@*F6Z3,TV=Q(J)-5;B7:"7KCK>CE#[<^
MPF$64D00 <@7X?(9) #Z&0)^S.+,]R$,BTBG@;TUA"=H93\-PFID;PLWQ_S>
MB7GC24$E<G=[Y#X/(&>O?5 /$M=]@\14\V@8U%-:N5-0_QTWS7%E,%B;]G.+
MZ_*EK%^/ZAFET&>,DA20+,*<80@&>11R1S;-BB!@49$F5KOBCHLT-Z8_:*,J
M8Q@;\;U.?+N=;1763-% G70E7%NN8UE!C2(WNT5Q4M?*/K03M:Q5$&A6O6K5
M =1M4JLQLFEW6DQ+V59HPPG^7=-L=4&S((PH3$ >0NZ\HX#_%%,$HMRGF9^R
M(HJT:FZ=G65NS'F+<;45?:77.VEUN\V>PQ*R$!%N%H,\%6Y'%,< 130#-$AS
MW\<,90'4+XUQ-:+3%;(X@^N-A^!2UO.#];G:%C9P3^,TC6G&0$!" OAO;PSR
M#(HNRT4,$8H"[@KJEIRPA+K[ A%CF!_4C+"!MMI'_FK\''^W>_))_^/&:V6T
MV3)Y  )K?9+/S3%Q<^0!-4\[(@\]K)\/(NL'W/U<XZ;,B&(^R.%;<_LZ*5;J
M&,-B>)]>!X/CS2D%LUZQY++*1EDA1T--EA5R7H5^5LB%)PQ=^2XXY9Z)[N4?
MEM5?FUNT::Y!BR IA 4)XC -0,Q"_N6-<0Q"%C#JHQ3E!=-RT@<FF]LV/>BA
M):3UI+C>MTY@S7BT0: 5/6M+\+GVF<V1T_>(%2"QY>L.336M%ZN@](E_JO*.
M8<UHT29^_[L<IP6.@[0 &<LY:41A!/@?A" +:8Q9S#+F*[5N.#_\W&CB]NO7
MN\>OFA68#P%3V_SF,+C^FDO!G.SN\SK;JD9\./BT!83/*G92\_?\4X9F]./3
M]S]6SZ7H2J#=?N'B +/;CM*T?"R?Q"G$'Y\?/O:Z,&B:VF?Q4K2ZKX5J$@/\
M/$H.6L6-0F)NH)\==5I;?4BQ$[-]\&%;O7(/P\9VI586<0$C&I  0+^ HJP5
M 444(/ZA3BB.29 QM<1O[9GGQA+[&,BEC"%=MH*65#%J7!][M8^\$T0=D\F%
M'KA'<:8V2RX9H^6LY^VE>=^XV^T('.-];L<&,&.L/[\^BO&WZ]=](X(V!I*D
M>9H&60$"GW"*0@0#F(>$.P]I0A.*BA1I!9M>GFING/3G/[[^PVN%U>:A 42S
M/.*@)C%@+.;N6!!1CFCF@RR%+")QA%$8+5[H&E738MJ?\N^'JAJ=VT'*,7__
M^;4#Z/6@38WU6-QQ-"SQ\\!$DQ+RN,+'#*SPAAGEBML8N/GQL*Y>2D+);Z]_
M;BCYN/I0KN *<WYO0Q+X= N?%A"&/@4X3S-.P3 #D!8%R C+\H 0XHM#7_78
M3_6IM2AY@DA04;) EOQ];F47I=I9)[<'=X+KT8K&6JC1C!N$'=.. %<>#C_T
MP/U%2,ZMQU^]G?#>[3C,VE2DCY@E:M*8>%*JT@?DF+H,1K@F-_)38ZAN\+J4
M056?RA7]6-.GS:*@ ?9%.F2*N8,;1VD!8  3P$D-!5D(DSS3JOHY,M_<[$@I
MJ"8CC4&J1D,6@7+,/5TN9)L!V9/6^R;D]:3 %DT?16BLID%>GNT-<B!'53^?
M #G^FGFMX+(6UV&;VQ41*96<H2CG*;K9GX3N3WU1$6"811#0P(]!G'+7%)*\
M "0-8T9SGZ2QUI66WO1S8YB>]#+3XT!^_;+#&NN@QD/NT'5,2X/ NCNBOPXW
MB]6.-2:?O!2R/C#GZB0;C&(:#5Y#SI6D*V35Y7+CE#(:$)!1'(#8IPR@ &<@
M@T'*4C].D%X+YO/3S(VP[NL?=,W]"+Q]VBZAZ)KUGK(2EYKY?!<P52.EZY%R
M3#Z=@-ZN")W]$Z!A$*S%S)Z=9.*@V2%%3Z-F!Y^^-D?O[NEY6;U2^I6N7TI,
M+_3Q6B[;ZE3W[ O%U?=5^5^4/,BP<IG6O?\*!PD.@RA,@!\33B)QQGVK.,U!
M5!2,DTC(8FB8NF=9TKGQT$E&W[G.@&/MI29>;#5VF\42.B;(T53 =N5(8[O!
MY[*&2Z'7C7?[)'(X)DH-=+0"UC,&;<OY1HF$CN"^G%_H:D*#L#+R'X_5YVKU
M0*O/M!+3?UCIAY8-#3(W!N?";C?2AO?J2G0$! ]W]]YG_K\##O]05?6JJG4B
MS@:A'"9AJR@Z)E%- %T$HZD@91:0-CCR=$%I*@H>!*8IO6 8&X[QFDI">JK6
M=?E?+24)AU>F-7)/^&%-G\KMT^;CZH4VOQJ;112$<9"+&'*,0Q 7!>0F9IR
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MVL<#PTZVF<=5Z^]HA:<-FP[7/ZBH)/]4-D;![<]RLR ^RW!!*,C2(@-QP%(
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MK3[SH6R4]'Q7?:5+*G*CV_L2"Z4]+X\Y/[X;K$PI_AJN7KU.G>Y.Z9J"GP.
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M0#$ALFL77(I@GX^K=_"YK.'RG;PCE@6"%E&6QZ2("8BB) 1QGG!GA" $&#=
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MY+_!38D781:%F!($ IIR9DQB!F">9"#S,<%!GL8)UDJHT)I];NS9"0]@6RP
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M32#A#0;U<S1AG> _HOSAQ>QBNIQ?OI@E&#%AJ0L&2,P,9>-H1-D@.T%;:C!
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M1&KDR$=5P*VYH&!28L==;FY;?3=H-)^"K"#:)B#R9HI?0W&,O\%+O_17;(U
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ME42*.9Y-RVX]^S[&6(TR:J,!PGUI?2 "(Q8R)R$8YFU, @_]OL"SCJ!&L'2
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MDT 19SPK9X GUNI$HJ'@K&,VLE3=(.Y&V\!M)OL QB,SV(.6&D#?_7+EZYJ
MD4.KK0WZQ: 3<A%\)AA9:@(&E/&%$%W;N*VG9. "R1,@JX(&FN@5_^"Y[;NP
M].-I26-<!V"O9_--Q?%@.(6<,Q%)II+:B,2QXC4$[[,VBAE1.Q5U!+D#WRN>
M ).GTF5%X/;25?QM*3N!6?[E8H&_OSBH=_BC;U3L$+Z=ODI]P-_-/_OI51NF
MVT[D!6I=(Z8;!M[EJX2EG]PV*;^!(S?@\%QD)-M<9E\D1RPK;U)94I!ULH;6
M?B52A?"C$_*=BM[EJ^V"9(R"D;@O*1"@KB1RH=06ZT TYY3IH)5,M2\2'U,Q
MK,MV>DP]RKD?IY=JKELO=NOCQ?FYGU_.\L?QY^DXCV,I;U^]#R^#O%#:L=RQ
M'&#-=OQR11MW""^5+-_C96Y/5UF:RB%"7%*V3))$A]\Q0;CBTN8 S$'M1QV;
MJ3DZY;%-LI]0F+],NHJ.;(4(W!,F5"[CBS!XCRX0HP)7#!(+K';9]FZ4#=PC
MN0Y*'J4[ZBNE;:/U('?H2]7OFDKH XS6CE^N.;KE %XJ&:VKG.P#"FX@:3EG
MU$9)I$_XCZC*-#+K200I'-<9$5E[$V^GJ(=;AK/UXK[=-$[S9)/#DUZ46T M
MH33A803=!LA6)LER_53:WF0.:]8JXFB'.X6J*FO;SKWVXWDW1?4W#)S1!UWE
MN0XP:^L_5-&*[4!I):-ULU+I\CN9E<7N=& U1B.^+$G,.R*M]L0S0XEVKCR/
M\Q"JMS?;1L^Q!FO=MV]Q;B0/-F(0PWC01'*I"(8QGI@D563@P,K:KY&V$C2L
M$:J&BX<FJ)X2VC8V5SV:KCIJ'F1F'GZBHH'92EV](.Y!EZH75UWYKG&DM!+!
MNO*HD6+<+VTB+B.L)/-!@U.>R=JIJ2>)JM __VXW.#Q>'R]Y"_T[QRP#$Z7@
M!#< )WB4"V*I#H1#"KBA/ VI]GNS TD=/.BKB*HU+?![UU[;=NNZ,X._\QA^
M"LM#[->F3U6T8SM16\F>;>Q9<8.\3(..F6D2E47DT5">'T9.'&0!-"6(NH>'
M*MN)JO!48OT"Z[9!,%X)*1+A22@BE??$LNP)Q@M&*.J]T;7#NWWH&]9RU<7/
MFE<4_>BI;7-5'KZ-5U,HT :4;H3CZ6>8'IIEW_:YJ@.&=Z2Z5FKJ=KVS!^O=
MPN,&A@Z"4S(R8JV]?LR%B"0\,QF-RB:'ZH7+^Q!X=.)JE\7N)'I5EHK&1, )
MCYL%]V<HJ1 E4@@QE#$WM7N/[D?AP.FJWK#U*'O5G]Y:-W(3A/%L=5WJRT7M
M+(^790IC>:/T>0Z'I[)V_715XW< -T<:PFY2P;V%SS8N/)(Z!"F8($Z[0&0P
MG%CPDB29,@@>(2G]E%SW6?!X>W:SS#<XF\]+G="FD]^I)#)/AI0>0D263>@D
M>)*X*UVBP8.K;\QV)F\82]8;.!X;L'X4U;;UZM[TAD?C=0^I@5C_I9HU#SO0
M6LDGNU5ZU[[A9K$/,"D]N5[,%LM%-VBW(^>Z//6V!$>"\1@7$.YRB16$)#XF
M1[2C/"C.G5*U<_/'47STN-Y=5__E[NIW4LM4N:R!(E^RW-<'32Q'=\#YJ'BB
MW!A?.\%V),G#^G4GQ.>CD;\G5'7;MO,M+,OP1(SL.WX/*H-]\(F:5;#;J*MD
M)E_Y^11/X/+8N%OD]MT_8U)%:H@)2N-!S!P>Q$D3HWF6&&18)6H;P$VT'&O:
M'G[W%LG)BL"X=81Y5[H.2$X\,/0VT#,08++2U2N_-A(SK#FJ@H.'AJ:.X-LV
M(;M51'TJ_]ECC=?5]T]>Z;6.KQ/5>[ED6.E&XI1#7 JJ2IT._J?U%"2B2XK:
MG?KZK??Z&+] NB@=D]>7$7W\,ILO/\'\_,YPZ$[\M[M*&$8# T9\9J5=J)7$
M<0]$.BNL"1C5I-H7OL=3W78UV!XH>U3H>EJ%MFTFUY9<'6X5MWVN[T*Q'FW>
MUK(@Q@QGDAM"M9?H\EM%O,^44)%R$B#!B]K#TOLL%[O='C>KK.9)XM:X4PYP
M)?GT#L.3\BX9_0D,2\8/=THRRL0L%!&A[ _C0FDDHHD#&2/7E(*N+9RJ##1<
MCK8/[C;;P%,KN6US^*! ['!#N/Y#_96R]6C\GBX]LD!IM!F(D[8,+_$*8Q&'
M<,B62Q!"4%&[=4[O!6VW.^3Q4@_@[U+IYL49X2Q19!\2L5DY$H()$<.G8$3M
M$MK=J6N];&T?[&RV8E5UU+:)VE#[=;BIVO[!_JO6>C1=3]<>4:NE4H@&2DM_
M2\/1DY>&$<FYQ!,-X4=[&,8Q4.W:[7:0PGKMT&,P46( XT493" 8;CUM@P2I
M@J]=Z_(T5:W7J>V#E9WKU [32=LF:L=2AR.2;WLM</HBCAY,VEZW]4$R*S++
M)/J"U&@X\5(S1%:2F2=AT\-><<.4<G1KW#O%NS)T##9@_.VJ$OUZU/+&L_W!
M21^] :ZB)29W;Z!S**Z%)-X*9K5V0@/;B?>Z=#V#&H]]4'-MWX;68-N&<'U=
MQ>%V;^OW>J\'Z=%1._+6G6$$43I\DB!+V\_2P<Q%'HBT*1AK6 )>N[QKV*J0
MVQWW"G$SNP3X"/-OXPBW]0%WB3J;=)_L&MS@UIQ]GH[_"XGJ^IAVE-ZID4],
M<>4< 2D,>B&2$@=&$V,5.,J\-K'V8X[>F'G6E23[8'IS8#PD/!IH-_EVUMWA
MP)V6P9UMZ^2PN)IS</DH5Z -,H:.?<Z YZ"+Q./1AR>14"9X#5;7KCXXA,YA
M6U4.B.[>E=H <&]W\/HM>W<>T0:.172!9J])H"(223/^*C-*DO!EJ#1Z4:YV
MD\OCJ1ZVUV43)OLD"F_;;WY087>XP[S^0_W5 O;H(F^L!/->*<<]ZIDK020K
ME6#<!0(L2"J2T-K4KKCIJR+P3B Y78[3>')1G@S<EC6]^EZ&K$ J,[/*YKBX
M[MJXN:)-.A"0&2<,F%Z]^70A9:(DC5YZD5CN\7*F$A>-UB#N@[PM=S=#J+IQ
M^_>@S^Y+6/KQI$H[X.M/]=@5>"VU334'MJ @<D2*Y*&X@#&3P"PGU&@I5%:,
M9U[9*#31'/CC15C@7O/SRW?S<@.QO/P-EE_*,*O.H88R_1P=D.)J_'+Y^(>O
M?ZP[Y49929:-,239E(@,CA'OT=UPW'DFK'&,UQ](4H_^'Z$A\3XX?CS>9" L
MM!!=W;!SA\NS[^/%*$FKF05#N'.TG"&26(6.M,]"A1Q4B+%V*<M&8H:><C(4
M/C8"]1AEM8"Z6_+?^G/\Y:>YQ^@N%HV^G)W[\704M C  T>4Z-((+D42M$7>
M+(B8O4V:U?;EGZ:J%1P>I?Z'H*JKBP'1U=W O9Y-)K,_WDV+=O_7Q13Y01K0
M2_X-S@/,1THSWV6[ I09&38%XD7QD:T4R0C*LHI/.9([K#,P4"JK=-:/?(>&
MRMER]6#H 0LF&BJ=D21DHXC4/!)G,LK'"6TE1]\BB9T@LO[[ \]5ZA$:%>39
MPMFTSLIB, AOT.=<C$)YO,R2)EP;=#0]D\0SGTA$/U.7]S81:M>+;:=HZ#E=
M+?M&AZFM!1 6ZM\L%A>07EZ4O;2Z@ES=Z[R%/[H_*D,^61 Q.I)#$$1F:X@-
MP1(?L[8LX1_FZH'G3I0UZ"@=B(6',*NOF ;@]GX^BP!I45*,A0,,LU?W/N=7
MURTC8-&4=\_$:!^)9,J00'G"_>F=<T(D:FOGB9XDJA7+5QUD==4QZ(S"554<
M"FAQ4UYW=EX*X][EL\_X.Y_]LCLCKEF^QV;W5]*GV2^PVG$CG2D$I2QQV9>W
M"R*1@#N* "OO374*\/ *8U-%8R6*AAY(6!V"P^FK 3/X 5;3%J\O5LYBO#B_
MZ"Z\7T(>1Q0-<)&IYHIX15&FE!:9ED:&$F/P$*V!ZJ. GZ9J)Q3*9X3"GA2R
M/\3<"F+3#O>I[\NNW3I:''$%MM\")^_5T>=UV1-M%"@>IA:BQP.U#-61(A.,
M336Q.5J05ECM^YA+=*IF'8_7645<.KN,&T&6,+_TSH&$L3D&8!X8 RZ[ 6>]
MU01L(:SIEAO[8&5[RXT::FG@W+RYF'LS11%==$Y#24LSSZ.TP,J8&&1#@R8A
M*85<><&8=E)95QE=&T@9.!ZMK_2'0W4J:* !('7)2%RY:S[3U6GCJ7_GXO>6
MN\4G_.1B_1]=Y3$CS8*I\M Y.E6&;V?BG"H-O2ASUB:6JE]@UJ1_X'X;-0 U
M:T2[#2#[]X]_FV$\/>T$>=VS',+RUOFYSI:'3)7196X\="/^T !8C.R9%:8$
M^R'(VBF]76D;%I'#H6=V E4V =%/\Z[+S>4C3JA7+K+ 2>36$JFX(\%22E2,
MR1O#3,JU3>EF:H9-^S4$PRKJ:@!XO\VF<+F*!U]?3-,U%TBF-C)(0LOP45GF
M:N'?I<1JJ4U6P<GJO0+74S)LDJ\9P%504P-@>S&;?RT/P&&MR49?AC)I&5$^
M>Y1/H,0%QHFC-'A0+BE3V]!M)6C8S%XST*NGM"80>'X.\R*D]_XKS*^8 ,9S
ML=J$L<3+C:$@WFA%M,M,I<"]$;7?J*TE9"?$J3\!XHY54@-(NWT5NC[OT"7H
M;S/U,JBD@HDD=9?6-)57<]X1KE.A+BJM:Y>V[$?AP!>^O6=Q>M37H)? U_R=
M??/C29'2Z]F\W!7=M^9GY[/YLCRW+X]+N^::(UK:/FF=B8)N6%@*)(3H"*66
MZYBL"]7?G^]+X[!!<9^(>3@9MT_E-6 L'_#S@-O2&.*/4H>!__UB7JZYRF/7
M$:@H:5:& #=X(% \9T*R 3U@'P67C =5NTK]$#J'-9PG!&GO2FP J$]LQ-LK
M\K_-D;O?IW/PD[(S_X8^T2^09^5M]G=TFI.W5 64,D6GV?I$O-*4*&U 99:C
M>-@8K6_3NAOAPP;C[=C;'M3\C+%=]O$MTS8(+3B/I%27H".62RS( 'UU"SE9
MY8*OWH6Y!N'#1OO/ -N'J[EBZ4\]=-^M?+DK@)&E5D("])52*82/N'6MR(JP
M$%C*-'/-:\\*V)6V8?,# V*TBK(:,+';7:354.6+V<6#7?=^MA@7)3/^&_[$
ME\6[^:^SZ6>8O[THB9%W^?K/%Z,LDT3W"7=E!HJ[4CCB.'#",A/!*1&DK)VV
M[YFEG2"O?P#(MP2-H1\'KJM/?#N;QE73_FO>[I@!)HP*$3TM#\Z6>Q!#G..!
M6.LY5=Y3^O#B?D-M^KXK[P1/\XSAV;\^&C#+V_D;>9X=S=:6.PZ,4155Q&;0
MA$4*)AO0--<>=KF=HIU09Y\QZGI03!-)V.U&_L.=*+)+CG@5?-2:$4%C0.\F
M<1(H-67F>?*1>V.JS_3:C\*=@.A^ "#VJ+BV>X"MG7%WQ"N(K=_K>S9?GV\<
MM@Y)<]Z"\TF63G 8+<>,84J4@03TR3+#PU!6+RSL<SC?OM/:\ ?0:L\?#V\;
M28"0!(N$:>.(1,^ > ] 8E)6"^D=E;7[?%<CON&A?/O@[5$Y^R#*;< +O&'\
ME\L[1N/U'/[S J;QLBO!-DRFX%"2SI>TE_"6>)KQ5Y"BM=HH<+7?[.Q 5B-(
M/"U@-L&VDO9: N0ZAJ[J;&R(22L(!+3*&&DI(#Y009(SG ::0:7> +F9K$8
M60L*FZ!622^-0FUQLV.O:^H3+:E]3HPM,M,6PZW$$G&X98WD %'6K@C9A:Y&
MP%8+##N [2C-M(2V7RYO?OD_QS!'HKY<_@K?8-+M4<N=#X9U90$816E!,8J2
MD>1L-3 -8*#Z$\:=*!NVI*.Y\[:6#EM"YMW=]IB_JWWME #<V8YPSI Y3S5&
M^,&0&'''<:%\_8KUO0ALQ#)61,@NQK&*NEK"XIOIUXOEHI,8NS+X%K)523KB
MG<<3Q5*,[2 GQ(O0+!ACD^DM;GY,3B,XJP^"37 [4B.-@HM?L>)45L$H0_!L
M2$0R%XFU2A%P4DJ7DW$\G@!<O(4GA\."ZQ"-- HN<<6*3-Q"HD"HBJ4UK3#$
MHY4GP)Q5)GF?>6]GYF-RAJUH'!9<AVBD 7!M:!#3N1)1>,$=)3P%AG&6\<2;
M0(GB3+B898BJ]JFXF9I&H#5HD%!)5PV@[JF[QO6_>]V8VVC/59E0%*%,9(N>
M.",DD2D'E35HQVI?_QQ#;Y,-H/;&S)[ONZHIL &P;G@M;K2RX)PB6G(4G]/H
MHBJ=B!?.2YV,D5#[F>L1C_H'>[=5#PF[/>+?1RU-5+%LZD\DF71!>T>H@Y+F
M=*7$$/T*EJP)@"R*4+M.ZIB68[T5\[=Q]M;04@.VK.JK="%S$KQK#9XHD11/
M$9N<+?W!=>2ZA.ZU,\H_?ENRO0#59UNR?;3; +)W[F7EDG7>,DHLR^5MNQ;$
M^IQ(M(&+[)05L?8=[Y^P+=E>Z#FT+=D^JFSBK-_>_<4X:IA2FB1?\E)>,A+
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M.P'"3[\9#X!;,T]+^Q-/YVHOWDS?=Q2/(M<Y"&-)M-P2F64I,$8Y"0Y""N'
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M+V<E4!\)Y;,SR$I.P) ?E@D&$)[@_YGVGAI/:U_@/T73L#AN!CP[@?I 33:
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M6HBR##P&G(1CX 90K9C/5#DQ>B(IJ95\U)QFVX;Z9%%I,Y-HG8Y-Y#N^!E?
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MRSW*3/)[2J2AW/*IU!>*_J!Q<3SS5?AJMA-A[[^#MKA 1RN7K/4D%IOR$ET
M*%2!K9#-+5*YK0O  4[RDVFRQ<Z#K/^%3'TXFY?W2,BI 2FT$&7I>0PX\<?
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M[^;&X9!Z*K=^X+,"HD]QW547'@.-M=ON\H7?!#6?X>=)I_YG4?\%4$L#!!0
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M.CQY,7W?9_:&XMZ;D#DVVTH_-?F7=]GE=_%:_<B^SO\;4$L#!!0    ( '>
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M9<JN1F>8@Q#M_/@%<HSHS(BT>4]"$1O8!=N?341=="<(S]Z! 5LR0Q#$9LI
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M0PML!"J$&ZPAB)+C,1@_YF7*441&&[-X^;AEDH@Q(D:(R%[] 97WH<GJ3RV
M^ML85O>_D&%U?].PNO\5#:O[WK#Z&(*_@]Z]HJ/:6@R81%<-#CTGFN=XQGLG
M^P/M%=8DR.#)S1TTH% ^X<C-605H5:IG==4#<XU=$C$C=6X<K6;X(F$F?IZ1
M6E48=A>QG4.>Q!H4)5S!.>AO>5<W[4"O3\4SONTU4,NV6H7!F3B6XF;Q0H.6
M8EIO0;!-@<OLC%YF_"4KS+AY7CG1*\O@H?P=BE_G1"*.3YR,W-7(5!EH;@'(
M$FE<@!09?V$I?M_!;Z5 L%V #@%FR!GIDQ-VPJ0:-$T>JZ&Q LK<!P\)5E45
MK*4S7K$_TDZ80;,[V3G:Q?F6VA,E^? 02H,%!!Y'G*I@[T :*SMAE"$%&)00
M4F<)8H#Z_%F+AP7*=5^R<C(R$7V",+3>1F&=VUL#,X,H#$@!Z-N1 M_59.>S
MI\G"H\1\.&7/K@4P@#*+9TJ+PT%(R@P0J37-C<T-&P(QS$=T_[KO_%CC+BKG
M^"1>GKS/"!8".J M(,VPXD)/Q.82">%$A, TL1/B92X-FBZ,ARDMQL3(1/*Z
MN=:5_;?8_"^,QI-;V!6M@CP$52L.$_B+O!>&11_J-&E@E7\-IF,=Q7UTOK"@
M/I(?C_W+(EI>Z@:(\?Z48ZU9\$[3+HE2Y5NR21"1<CAU/N64O7BK5Y:)IJ'N
MG$YZ!E.6ZOXA2&N<*7:XHH43<SB 9 8/&T%Y'\'2;%I&'%!PQ*G"\$FP.#:\
M^#LYO7 *6NJF[P:W[6U46/K1!/3CD@("< [/2VV7P5ZZ)!];:]$C'VO43FG.
M(H51Y^^K^K8T!<@MEC6D.B!$@M\*85.1]"R2O1-@ !70_]^7)5@S*.UO4".R
M34/Z^ZQDAR 0C3<! :9H8-/R,Z0,*W$-="."0GEM!OZ\CKQPMD0-$%:/3FX+
MZF!C\2\ "^E-.;W.CQI3P!K;MFY$QP(\2OXF-D=0L8WS$7!<HF7+ :-=%.^#
M>0'?X#-8G<BNC/D R@7Z!</^%?UK:3!4#/\PXFC#Z:X1-7"?,B8I8?@9FOQ*
M%T"=MNW@J'AU$H%M,];(8#CQ,A9]SGM6>P9(0IQZL'X, P/-].*:!6-O55-<
M0.5ZI7. N6GWU1ZH*B5OLUPGRK]@4@':2X/O>@HF#(Y=NCDA6J;XE/ ?&'D#
MQM81@(#'507N@40U_JQ)(*+RG3.':7M"0';19/#)K*,394\(J$1FG;&"G9'=
MVO/0 /GW-2HN-"=[%>F?H*YK]L3Z(#CQ$,0I'+_F;_#OEM=4Z*6FM3NI3$\C
M3RK8Y%;/ -LZ0B;R*GY /HB0CWS+[J#$PE5S8YRO Y8/%A-&K( 8@.V^=Y%@
M$#)PI,'7C;]3] XX!]"AL)EKC38\01YEL<=5-3PIV,3MPA#C0#*N\/6^HG]&
M;G VX9&D2PNLD8@8U +,'1DY71 ;MB5QUI/WE2)$&!]"OE6/N]_%DH@]$T/N
M=\=ZLG@%[$"[0H;SK4R/XR]D>AQOFA['7]'T./:FQZ^7EU['!NY0JK?L%3W+
M)8Y]M@1M,->@3OV&1WAN6X_TX:5_@,CH;([^XA Z>86,O,T;ZY4F__[/>FF%
MX[\4*Q-T"L!I_P8F_<'AJK/BC[[MO)_Q+>@L8IJ\PGP%FP]&?FL6O+[H^877
M\$&/09293H^.'\3/W>/I\=0M$!CF<Y /H,*]-< G":]I-.=]#5$26!3P?%KC
M944*V3L8N"%5/9?8/:K_K'2?;B,B=PXO==L"XP:6V,%!T$HN B&]\1%W&AM?
MGB#\)^J%OFV!Y8+8GYY,GV7J[RVP\5,U5: CM.;/238R^F^(#5L'FAX_#L,<
M [[(2&HO'04CQ)S:@'MQ07O8#@?J$6)H0J(UL2^NL'2 3=0;7<Z16XU;T_07
M&GPZO1P=]@(5_5W#3FC<Q_?#+@^/DI?"Y$?3X_#6\R$$O,('.M </2S$UUKS
M 1< 4A!>)I@ I-!'MGD0+_2LYMC\957T&%38=<+)P>"IR &/O9LL_-GXPN&H
M0.V]T?E:5C@"S)>H(U>(U!&IWKFXPY/SB&32$=\MD1)>D0K&#.431CXY@H$_
MEK2\%Z&L42.^F:AWP" F;JRCXX/[QYC@ZA%<[>&[C2YJ6'QG#P:,C+-KX'EC
M.HWZ)CX,D//?"I][CB86;^O1P?3^Y/[!T6%$EMN6-7U\<'( JGJ\F()M54QK
M0W[&<]ZUKZ/)PVB, CA4B]SZQM:EJ20BBMN# 6\P)KN4X7>/_@A6-XU@%F8P
M1'?H_!5\9RMQRR(?'=P_>'#X./I^20P<-*)X&<.C5IR+RD<.QAR?@#O]N[0(
M5CU1.2[,7"_%L$47 9HP:'R@%ZVTN;.,S+*6YP6JX8"RH,?;-E;7<81YH_L"
M+*>FKJ[!V%'!6&$R0*4#E'(8T"FELA/82H2\F"0K20EBW(.N)B8WKA'CCBY<
M[S4G-V+/"5;!,N,I;G@&SKLB6T&2L4 W:$'OF('5"5(PK  '7^H/=MDOG4\A
M24U >(O/1.W=B)9(GU.R!RG00S+<I1<.U<+4\Q>IU#+)G'1.3X#[HA#2*@)"
MP"!U0QHR_2*;S@0.\+BL4?_ /WM^4*,<(Q<)HDU(:6S,'  /SX'X9R#0$*S.
M#Y&I!4"/;-K@RVJ"[2U0+6K@<C@J)C7@_E&[I\VBW4I[$ZN)((-GBKD'VCMN
M.>L.U?K<KOBQN,=LA9@BU@G[3NK<&,XZ9BV7N1-+Q4BE>+U"!:<GWDYN$;*!
MR*80*&%J2WQJ4=X?VJT@-ER27)2>$SP&_B&FOG*<V.6B 1:A-4?4[ETBMMIP
MY7I_K".F9+M9NE_A. 1;3I4!3<2F8?^Z&=":J"V96T:VQ73SE(4N"0PWH=>N
MM&;^Z<NFL<*R,>_A_H2"2Y*X\SI*W'%NF]\'P.58/CH^FJ7/_(E3<I1D8E4'
MDG_5-VDJNR^7<*Y)%X.]EIC=2(8 N?!O#?-DR;T:S3?:R"[:G?GCG$[Q$-_(
MMCOY0K;=R:9M=_(5;;L3;]O!0=\@E(=U)L1O=B;)HF\0]\FT1:$+QP>C[#7/
MSP<)X9BESB'"F7<E;F4)+F[DDT\QCBA12A9!B+EY2$)CEDL<:@.W?*')UEQ^
MI8XGE,4&ABQY2MENBXDK"DO0_T<1TS0&&X0A2D.4->P$^M2,OBQ.4^HR2C3B
M3$3F#Z"88XAOJ=\S!YOK$CVBA>R &!XLN;Y&WR!).M%I\"]BX.+PJBN0,282
MI>@8LIC:+]J18Z8L4=J:TA6)R64*F/0M5N+A5[63!L0%J8("-'BS3]+3[3IS
MG!6WWS*W(__P1SAYX"N:%M4&8#WX 5E%:T[$R.)L2G2"V:YW#-6ES\ _T1=A
M_%)A03.* +#[-7-5+1JY3@X<G#\"5MC52\[&B$-P663BQHJ)A,'D;98,FPXX
M3J"./O_,3-*ZB;;N*9$IEC.ZTJ(Q1M^64]8!@'W>D:/<.:PE0W> =)^,<UN1
M;@SG/@OE/A'G0&@U5(K5K2/  YT!J$XF'CQG$B] W$D$;$3T'QUY1U"BMY^8
M8FO*.2F]S#T%WEF$C/&ZZ:V![W\CI]4K-9X]]JN"E?FU#SNLD_1E3BBHT,76
MF=:7=@F-H O.!4P*"7RG<N"W^*@<"%"H7M=T*EPE5Y'NP=!RB7]8IS0]W.>D
M@MV9JA$,HPTY=W.,$M[7?R<^J1>V>F^*2_CGSSHWL[I^GZFK6\M:# S],PJN
M=Z *-V:?HU5SSI3T"FQCHJQ1.39BX&1*M+0N#[<4; \FP[SHORIA1,!\MH1Q
M&AK3)"-6!:?861T2!YPF2 \X^BX&!NF D9+F@_P8KL9D$4XF2/+_);U)D!9A
M1B$N45B3*!<'WQ8Z!%E=J<#X;I,Z')?7XL*\X1C@?P\GZET.)A1GE7CUURNA
ML6;]JD;4#?O=R(H%/DQ5)*T*=AM:FF ZY<%$4]=HVW#V.UE'Z-D"@Q$P=%4#
M<#%TC*X7 3PL++5)F=>Q55JBZRMA%&QP\C(C.J_'9LV"5>DC<$+FHV^/F9;#
M%P>&9IM:7IAIZ>M#V-(+:AU7&*;"<QZ92 &2E(PQ8EHS=59R3E)=JWL@_P94
MXI83?B(C9YX *>2Y4=X 5X]IE4[,4V#&X2 /VUF#!Z(JH(RTI:&T*%^0,9HW
MLF&0B3TV;HZ% ER)F;LZW)"LLY%VJL[-'*O3KQJPB##Z *H N8^?N.#M617'
M?Q-26YB2W7^60^ZH ^'6X)\8X2Q-Y%=1/X<"OG?D&NAHRI:F)!;E\JK2<]#I
MBP3DO;-]3-18XG.,,DH*%X$J)_FFW7P9SY8%RHCPDF2KQ9>,)?6+92%O!7?-
M?]''I!XH?YBG4O -L[=UB7FC;OD XE7-OIO&!X!H/(_]1%AM3ZH9G(^G:?R&
M7&/X_MZSL$E$UH@2'5VKPO6] '+E0@--E-_;Z*78O6'G3#*.OMT$KN!/EUA"
MD1SY[:*FX=MH[($#C>K^JJ!EX<_1YG?ME3P[OKR+RA:2XTY)R*O6@Y2$?NS;
MF(+%S,,RKVX($/PA&@^1B_?+ZI$#,0I!B2!N3!7 )W@!9^<]=B.[D^]\%5=,
MEKS&&@.+$Y<)_HT<&0^^D"/CP:8CX\%7=&0\\(Z,1Q@W ("N-FSU#9<"EIA;
MKGP!*ZKDDTB[./B"FBU27AC MN)NI.G9?JJ/(/;'/@QQCF=;/1Q 57JCGBS6
M>H>U]5XMI=0/> 7PHEB['*LB"]N[T66?)/0)T2!_(R0&C(VRO:BBZ"S.+F*Z
MCQ;F3=1WWK'CUX6?3_# UB[OKNB)T>6Z72"L9MCLP.3OG6$P/90J.2T57F'_
M(O!;5[XL-31LP]#8!GE![AM->$\0V[_$$LFMSAZ$L$JDW[7I/+B<;NJ.)BX<
M@!GF!CT1,.ACU./% ;_#0MRMM#,62/*M\^<;3H7;,!X =$](&/*_*1N_3%4N
M:<+"_"YQ@A>H!5#]*XF+5O*6G)8E_FYT6(CFR[Y6ATPA#7-&NA&",3$65Z8J
MO#'.WPKFRP<.U^8]Y2^Y#*5X?RAC$NN<<03%7.7J.)@V(\*(,IVB3S.?U21=
M2'0(ZKC8%K'A3.H?Y3?_XX9NFW'0@Y&!(D$  5#XB2Y.B?0Y4H>J*\T<Y>51
MKJ,KDZ\;'NR/OB#=!""#U+_>"%S$4BR:+BJSI]+5/$+#L51WUJ W#IBQCFUE
M$WQM<&*QNXT3I?4-,$PMJ?L  [/I&?:< *WPUI08(XE;M&"&!QMSI11E87,B
MK"!TS;Q2CQH9< X<AM$6)8\9G]1O3Q"]I1'<)Z2Y-5:"G\CI:DJK(P?=X*"P
MDJLAF/-9LY\[P'Y,[7)5.#IGIP[Y3LD_!VA8N<9589O!#KT2J>.4\>@PG6K@
MU8RET544,,.29%_(N.G9 9- W]2-.[5HVE-DF3@8N>"BNOFD-+)KP'BB.'4\
MMK!J,E[20!,:L(;#@_VJ]IL>N*J<$>B";Y_,+)TO?&@N8L;F"CF1\!F.H=+6
MO-6$:?G.*X,JZVQ5FTJKO3AQ.CRV;=M+QXM-=K"?L<:OAI/Y%DGM>Y;G#IXI
M:TOGW!Q>;/$M70^(\_EH_JKNQ*^2&! <"1]AM)@&=CC!]+VJ\.ESOV$4M(DJ
M9L?T'^_;<8VCZ*2)<%?LSJ:Q7"P7G4!UP8GV$HI>:F!.C5>+V:Q@]S-K"<%I
MPXD0SF=/?6%";Q+R!4J7(ABDZ-%AZ:S]32>2JR^41?I2[GB;T3[A8;+#X(.R
M%67?,J(..@S$(-C("_=9W)H:(, _\ U,]*940TX*]SGFK.PEB=VPVE<UL+=2
MLTATL?@!YT0(2BV.PQ1.Y'(UY=O/U:D?Q,%N&1]H:[KS.1(2WL81T8[TKU%H
MF?+=N3W7;.#,X=/')EMU#OH?A>@<,D6-\X@?6>^<1F>))"$E?@F<"S"&/1]:
MS319[W43K3ILO*[BI;OID0BF$_4K6+A%[(258F"O=+9>(1X#'+6; 4)KN,H?
M-Y/6RW#&2<]=_3A4B=_]T3>V+22%B',#@:^9:R9H$'RXK,PI[;Q"9QF'TE1$
M.!1T;+4T8<%M"BY-\"7/EOB-$*!4[+TQ*0V*[C042O&8&PUVI($+CN_[%HY"
M"4%]-%&O.',=W@H- C[*];T%]EC1HN/@==JCP(M-0A9+&3PB[%MWJ"Y-GRB*
M$K,HW5_%3&U$@*GI?6"?WK[D:-9.VS-1X]O$?4?^:2FBV]I,SS< 6-1U2\I)
M:O61:KZ],=XW\BX\_$+>A8>;WH6'7]&[\-![%Z*&@JX>:@LR^DK%T2.YL]=@
M-/J.;H-CE9$N=TKZ:W 0;;P;!Y6.1R6<XRT#VT$;0&D"&'H IDT L[#U[6M/
MV5'$[ANQVXTXD['M@>B :3<':EHQVN&P"5T>5J[+PVYV@MLQ2:]!JF8H7&V9
M+XQ+DDCB]JFN?\T6/U#B0$"1Y'4V<>%L))K1*9*T(MP)_5_. !_/TPQC5#JC
M%#VN(_#9KT[ROL;2,JF5:)V[0[UI0%?,0_U#@D9NQ5%OB[0*<&;6M3_L.JH!
MI/8^<3,FJ?5#SG\,0K8NX6@QC^^L;3?\=',?(L:@JC>MJ/Z*++30G%3D.A5#
M151&#FY1 *1[HY.]P_P26+3NVIJJII#NJ)NJ<%]I9X-R922G+884.V@24C1D
M43E;D).%=TG$Q H*B;=><1UPDQQ4#)X5'3+CHV;QBM*P+L?#,BI D.J:&SD4
MJK;A8T$+-C@81UOO<-TN@X,!1G*IPF)V)Z2PC(PJ'33UT9J>@+ ,=<8O].T=
M5D:4S[N=RO:C<G)RA@'<.JE]#NJA$ /'2KT<7];5+;=K@6=)X4'(&)#4$&'.
ME.XM 8W(N=@*KQ%Y'I>L@JT"UBL'E8J-K$Q*<[VN0 K1FA)U4-9)6N/'KAKU
MM[G"<NZF7C66^[RDGB[VNP2G[\X1U1X3-R\B8[^OQ+W:79F?XI\A/3[L8%SQ
M11O:I?IBT G36/+M+I8D6UQP78SPS>X.8WCUL8@E7GX7Y 7S&\=AS$=\?C!1
M%Q76=8THLI^.T?',$H%J Q:3WLK1:\-S!AIWS"8V1[AY<V*12V?MM)F9E&%Z
M-[AC8GCZI7%%6JY>9L19RTM$\ZQL76\;8O\ /HG9H8: R3YQ,DE:9LO;Q&K[
MT&LJ.DLR5SBU/0!P,Z7G4P(2W%]$9"7K\@\GZDI_B/3Y]$0OQ] K&C6T&^"8
MQ" "/THF,2"9B[DV(2($A'40&X:UB6>#CI/#I4O.=?*!(XG#)ZU90_=LSRGQ
M_%&DNV9 XVW#AJA"'F2_X;&I7 NAL33>D.]1LO[HG49H_^2&$R#C6IEA:Y?A
M>AQ8.I"%G</5*-,RK'6W!K=%,G\K<^G1%S*7'FV:2X^^HKGT*%0,HT\=!&^Y
MYCQ'8.@7YY=79^_42_CO\\M7%YFZ?/6<8:R>K9^H?_W0_H#Y>$:#:K@RK?W7
MV/]4\K_X]?274+7[*^+5&T 9RJW)U/,%5F&\,?4*"\)?<\8E?7/IC?$XL7Q4
M]PG(1#4^&%GT&MS0+%L"A^1N(.Q?<+DC=V.F;:5> OV%3"LPF&M,YQH.9*Y)
MHZ_@B.R@.\P3O\A+X",2X1DW5)6W5#<,5>()NV8(W4E'##<>S[K&<]QM'^W7
M)3JVT37,CC^R1"]9T=PQ(QP%85)T"<@61!J[)N1?[BZ+!WR5Q?B7U&)%7=7,
M1A'V+A]'SH9=VVGKE8^OFIE\*Z[S^ MQG<>;7.?QU^$Z=.U ?$F(>O?/-V]>
M7+R\>'5U]D*=_>/M!?V;VH*.F/619#<?Y+J%W?1)-L1&E,";P'2@6SP?\(LK
M/=G6-8>TAN]=<]3WKCG?N^9\[YKS?Z5KSI=I_X+^RQ$'YM!_B:^Z3C&[&\5\
M1J>8[8UB/JM3S,Y&,9_8*69'HYC/ZQ2SO5',)W:*V=4HYB]UB@E]-+YWBOG>
M*>9[IYCOG6*^=XKY(IUBOHGY.#W\,N8CCS.XV/3PZ]F/G*S[O]!7YWMCG>^-
M=;XWUOD_W5CG:#*\S<J[B,Z2_B9WMC=YEC0U&;0*2)-OR+,ZW5=KO*/X8_L(
MN!X@I =%,?4KTX"E@"0WN/.72?\#\!H<?'=_G?TLJ8Y,RB.=M2L="VXIAU?\
M+UGH8.!<-7$O@[B5!I\$_EX:XAN##@VAH)OS:8$H,"&?'#X(-,J"K]F0K]3T
MOWQKC:@GNO1MQ[I2:5M1K@^XD-5Q;5-=DRNVH63<5EQN1 /TDZ-PY5&"%4HP
M,#A5T.5TNT;O<BU'\GYZK23?&ST<RZ7X<WR.\OLIW@5V*QO_4>MVU!"PTSDZ
M;VY,6:]<11KR7<SW!9[\;^__QVO2%5J>@E2-7EGN]4%!,P6R=%E?E_7,5C7P
MM(6E*Q='EII>=SU<J235E)8%9J7>H:.S!Y0\\^'/K3Y[K'UH0K6]<@U\^!CO
MA*RTUJ!4 [Y#5:K[V)4Z\RWM<;@_ZIDJ>K(/2.K)X/ZF ,*7%I0[O,*H6Z\B
M!NJ&@0TZ+[&O/I+"(]1ZHYM@2@ZAU&KOB F\'1'#& 7[F!X:P]21*)&-9&^G
MW[OTLC(TWV^PI&\3B3WH"$119NS=H-J$4 #15@CQ96/Q=6@CS9EL&P7 Z(J;
MOF)EY^.SI_LJ3B2<R379MI.K)N1.C[J6BW,<(_89GLB'.">L5M=$(5HU%!D0
M)^J-=1#!-<-;LZ;&.W.!TFI:.=A"@$@:W>91:GN<FD2W9.!J&&=YODC?2R_7
MR-S\S6#^:$*:D=BE"T5@90_7W47P"%>^<7$V^_FW-L\:!#\&)Q37+,87.F%5
MB#LX$K]-W$B#4SNW"D"UT*U<SE?X# \\_:2:7&YX&B1?[4RVQG$EN$G+WI+R
M&@*01*51"-(U1!D *]W=+H0^HGI[#Q,?I*7Z+;[33]1[6 3'MEUP.[EJ^V>A
M+'U3V\(MK:C[65 )!F5(LB.^ 2,$9UDUV=IP;7B517193ZSB<$/"9PZ*%\Y3
M3PUTZ"KFY.Z/G=GQM**0SMD8NYQAFZ1AO9Q/6?&'YP,$MI);?EDA_*.O(HV0
MM8GH?I,1H\@'Q7T.JE\&YR:1E+CU>3Z"?-_(ZIY^(:M[.F)U3[^>U>TL@U$,
M( 3P9=C. 1Q=T,JFM)-'#6F0?.*;1SX\WA21XGRR^")QRL3B*)5<Q21F3>Y-
MM#8;H$D>HSE0?H0CD3[KL\2^6#1Y0OT*WW(6"%[A(C3RQEU)&Y-<W(@K!K:D
M,3@=TQO^E$E-EP[Q3: ?=;NM2SM)S1?QNJGW%%NEOAL9&:-X^=$> Y=U4\ZP
MQ O3_^SM:I X.>Z"0^#W!$BP]8I;C?9V6\\[_M>J(?&+TY;8<Z!H?$>I6O*N
M:[JF#C1JOJGRUJ+_ #8$]D5!1H/_2>6F+/F&RP7(+L0#E*UH[)DNGY"/4PI\
MJ)^/"RM)X-L7H/F2N%N$O+] V%MK41TM5]5UH,L-\L_I]$HS1_+HJ.BXE%?X
MRG.?08#PPC)K&&.-#I,"=M?A/V!HZ3NC*4)O-\N$%=M*&+MNZ@JT#??<-4QI
MR=>Y\WQ D+<1B8OEPL5R -X5XYX\=BHT=T8*Q#NV>9P(&WJ@+XI;C)&J2(@D
MSAFZZ [WB0Z#4^K,$;4D4[QOYXG8_#1SK0;%727]%?)]PIK1&5>+=4MQ2#2?
M(\"%BG=O;[!'1A<4P0PG0.'H3H+*@^.HY=)C=Q%8>G  &>Y"4, ""6BD]823
MCEZ/5NX<,50FT?HZ"4DT'5&F<'E1H6VD'7"/C;!K/&+,H.>9)FG9]SA#XGQB
M3'<A1[WKZ"?7S#7!363G2MCX:/(OEB/$R#G..S@RF^,M;%A$61HB;.<+E.<I
MU4>Y$>2#]?S'/><>DI]4&[BS8FRC9&RD8FR[N!CDG4>Y4#X9BBM#]@=E7)X%
M2(,Q7&-4FOTQI8I4!N+J%<-M;9C*Y[NT?%:E6RAUV[[QOU3J%M6ZC9:Z_<4J
MM_AVWZ]3Y<;P&JER^QQ,V2R&"SCCTKO_>HW;1^2(?&Z-VXCT\%KF7Z]O>_#_
ML;SMSLS@SRERVTW-=Y>X83H6.I>CR BLFE?AVH_* -3B-^1INQ5LP>TABYH,
M6I!\7O7=-A@. /:5:_#H4.^NP?-9[KZ[RPYX::_*N^8;A0/0J*\E)/3==1*V
M97NN$<MIY(I)'Y "K148PDP,O,AF^BL)N/Z+R_3>RLLH_S;.N@4]XQ)PCW\(
M!+05TR^9*));:[^-A^#H"WD(CD8\!$=?ST.PE83#);?:]V;9+'Q;&B^CO36&
M1P@VBZC<(U4&MMJF'W"EREC-@'(% =_F=+_0O>;3D7O-IU_I8G,ZW>>_7)S_
M\\4%YNQ_9= -_O/L]?GO^-]?KEZ^^.E_ %!+ 0(4 Q0    ( '> 8U<J/?.%
MJ-<  ,2A#0 1              "  0    !E9&ET+3(P,C,P.3,P+FAT;5!+
M 0(4 Q0    ( '> 8U>(/MG#_P@  #U6   1              "  =?7  !E
M9&ET+3(P,C,P.3,P+GAS9%!+ 0(4 Q0    ( '> 8U>=,0HHU!(  ,>L   5
M              "  07A  !E9&ET+3(P,C,P.3,P7V-A;"YX;6Q02P$"% ,4
M    " !W@&-7'%)A"&8F  !_MP$ %0              @ $,]   961I="TR
M,#(S,#DS,%]D968N>&UL4$L! A0#%     @ =X!C5X17IC"2J   5S@' !4
M             ( !I1H! &5D:70M,C R,S Y,S!?;&%B+GAM;%!+ 0(4 Q0
M   ( '> 8U<(ER)G^U4   \J!  5              "  6K# 0!E9&ET+3(P
M,C,P.3,P7W!R92YX;6Q02P$"% ,4    " !W@&-7&/' O8$'   X)0  %P
M            @ &8&0( 961I="TR,#(S,#DS,'AE>#,Q,2YH=&U02P$"% ,4
M    " !W@&-7H>2>F'D'   =)0  %P              @ %.(0( 961I="TR
M,#(S,#DS,'AE>#,Q,BYH=&U02P$"% ,4    " !W@&-7WE^R*-X$  #5%P
M%P              @ '\* ( 961I="TR,#(S,#DS,'AE>#,R,2YH=&U02P$"
M% ,4    " !W@&-7LR".9#$H  !?F   %P              @ $/+@( <V5P
J87)A=&EO;F%G<F5E;65N="YH=&U02P4&      H "@"> @  =58"

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
